Ligand id,Name,Species,Type,Subunit ids,Subunit names,Approved,Withdrawn,Labelled,Radioactive,PubChem SID,PubChem CID,UniProt id,INN,Single letter amino acid sequence,Three letter amino acid sequence,Post-translational modification,Chemical modification,SMILES,InChIKey
5081,4-1BB ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P41273,,MEYASDASLDPEAPWPPAPRARACRVLPWALVAGLLLLLLLAAACAVFLACPWAVSGARASPGSAASPRLREGPELSPDDPAGLLDLRQGMFAQLVAQNVLLIDGPLSWYSDPGLAGVSLTGGLSYKEDTKELVVAKAGVYYVFFQLELRRVVAGEGSGSVSLALHLQPLRSAAGAAALALTVDLPPASSEARNSAFGFQGRLLHLSAGQRLGVHLHTEARARHAWQLTQGATVLGLFRVTPEIPAGLPSPRSE,,,,,
5183,5-LOX activating protein,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20292,,MDQETVGNVVLLAIVTLISVVQNGFFAHKVEHESRTQNGRSFQRTGTLAFERVYTANQNCVDAYPTFLAVLWSAGLLCSQVPAAFAGLMYLFVRQKYFVGYLGERTQSTPGYIFGKRIILFLFLMSVAGIFNYYLIFFFGSDFENYIKTISTTISPLLLIP,,,,,
3633,ACTH,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01189,corticotropin,SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF,Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe,None.,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)CCC(=O)O)CC(C)C)Cc1ccccc1)C)CCC(=O)O)C)CO)CCC(=O)O)CC(=O)O)CCC(=O)O)C)CC(=O)N)Cc1ccc(cc1)O)C(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)Cc1ccc(cc1)O)CO)CCSC)CCC(=O)O)Cc1nc[nH]c1)Cc1ccccc1)CCCN=C(N)N)CCCCN)CCCCN)CCCCN)CCCN=C(N)N)CCCN=C(N)N,IDLFZVILOHSSID-OVLDLUHVSA-N
1331,ACTH,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01194|P01193,,SYSMEHFRWGKPVGKKRRPVKVYPNVAENESAEAFPLEF,Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe,None.,,,
4857,activin A,Human,"Endogenous peptide in human, mouse or rat",5006,inhibin βA,,,,,,,,,,,,,,
4858,activin AB,Human,"Endogenous peptide in human, mouse or rat",5006|5007,inhibin βA|inhibin βB,,,,,,,,,,,,,,
4859,activin B,Human,"Endogenous peptide in human, mouse or rat",5007,inhibin βB,,,,,,,,,,,,,,
3726,adiponectin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15848,,ETTTQGPGVLLPLPKGACTGWMAGIPGHPGHNGAPGRDGRDGTPGEKGEKGDPGLIGPKGDIGETGVPGAEGPRGFPGIQGRKGEPGEGAYVYRSAFSVGLETYVTIPNMPIRFTKIFYNQQNHYDGSTGKFHCNIPGLYYFAYHITVYMKDVKVSLFKKDKAMLFTYDQYQENNVDQASGSVLLHLEVGDQVWLQVYGEGERNGLYADNDNDSTFTGFLLYHDTN,Glu-Thr-Thr-Thr-Gln-Gly-Pro-Gly-Val-Leu-Leu-Pro-Leu-Pro-Lys-Gly-Ala-Cys-Thr-Gly-Trp-Met-Ala-Gly-Ile-Pro-Gly-His-Pro-Gly-His-Asn-Gly-Ala-Pro-Gly-Arg-Asp-Gly-Arg-Asp-Gly-Thr-Pro-Gly-Glu-Lys-Gly-Glu-Lys-Gly-Asp-Pro-Gly-Leu-Ile-Gly-Pro-Lys-Gly-Asp-Ile-Gly-Glu-Thr-Gly-Val-Pro-Gly-Ala-Glu-Gly-Pro-Arg-Gly-Phe-Pro-Gly-Ile-Gln-Gly-Arg-Lys-Gly-Glu-Pro-Gly-Glu-Gly-Ala-Tyr-Val-Tyr-Arg-Ser-Ala-Phe-Ser-Val-Gly-Leu-Glu-Thr-Tyr-Val-Thr-Ile-Pro-Asn-Met-Pro-Ile-Arg-Phe-Thr-Lys-Ile-Phe-Tyr-Asn-Gln-Gln-Asn-His-Tyr-Asp-Gly-Ser-Thr-Gly-Lys-Phe-His-Cys-Asn-Ile-Pro-Gly-Leu-Tyr-Tyr-Phe-Ala-Tyr-His-Ile-Thr-Val-Tyr-Met-Lys-Asp-Val-Lys-Val-Ser-Leu-Phe-Lys-Lys-Asp-Lys-Ala-Met-Leu-Phe-Thr-Tyr-Asp-Gln-Tyr-Gln-Glu-Asn-Asn-Val-Asp-Gln-Ala-Ser-Gly-Ser-Val-Leu-Leu-His-Leu-Glu-Val-Gly-Asp-Gln-Val-Trp-Leu-Gln-Val-Tyr-Gly-Glu-Gly-Glu-Arg-Asn-Gly-Leu-Tyr-Ala-Asp-Asn-Asp-Asn-Asp-Ser-Thr-Phe-Thr-Gly-Phe-Leu-Leu-Tyr-His-Asp-Thr-Asn,,,,
5305,ADP-ribosylation factor 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P84077,,GNIFANLFKGLFGKKEMRILMVGLDAAGKTTILYKLKLGEIVTTIPTIGFNVETVEYKNISFTVWDVGGQDKIRPLWRHYFQNTQGLIFVVDSNDRERVNEAREELMRMLAEDELRDAVLLVFANKQDLPNAMNAAEITDKLGLHSLRHRNWYIQATCATSGDGLYEGLDWLSNQLRNQK,,Serine residue at position 146 is phosphoserine; N-terminal glycine residue undergoes lipidation to N-myristoyl glycine,,,
683,adrenomedullin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35318,,YRQSMNNFQGLRSFGCRFGTCTVQKLAHQIYQFTDKDKDNVAPRSKISPQGY,Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,The cysteine residues at positions 16 and 21 form a disulphide bridge and the C-terminal tyrosine is amidated.,,,
697,adrenomedullin,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P43145,,YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY,Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,The cysteine residues at positions 14 and 19 form a disulphide bridge and the C-terminal tyrosine is amidated.,,,
3589,adrenomedullin,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P97297,,YRQSMNQGSRSNGCRFGTCTFQKLAHQIYQLTDKDKDGMAPRNKISPQGY,Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Asn-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Phe-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Leu-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,The cysteine residues at positions 14 and 19 form a disulphide bridge and the C-terminal tyrosine is amidated.,,,
3591,adrenomedullin 2/intermedin,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P61312,,PHAQLLRVGCVLGTCQVQNLSHRLWQLVRPSGRRDSAPVDPSSPHSY,Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2,The cysteine residues at positions 10 and 15 form a disulphide bridge and the C-terminal tyrosine is amidated.,,,
684,adrenomedullin 2/intermedin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q7Z4H4,,TQAQLLRVGCVLGTCQVQNLSHRLWQLMGPAGRQDSAPVDPSSPHSY,Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2,The cysteine residues at positions 10 and 15 form a disulphide bridge and the C-terminal tyrosine is amidated.,,,
3590,adrenomedullin 2/intermedin,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q7TNK8,,PHAQLLRVGCVLGTCQVQNLSHRLWQLVRPAGRRDSAPVDPSSPHSY,Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ala-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2,The cysteine residues at positions 10 and 15 form a disulphide bridge and the C-terminal tyrosine is amidated.,,,
9573,adropin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6UWT2,,CHSRSADVDSLSESSPNSSPGPCPEKAPPPQKPSHEGSYLLQP,Cys-His-Ser-Arg-Ser-Ala-Asp-Val-Asp-Ser-Leu-Ser-Glu-Ser-Ser-Pro-Asn-Ser-Ser-Pro-Gly-Pro-Cys-Pro-Glu-Lys-Ala-Pro-Pro-Pro-Gln-Lys-Pro-Ser-His-Glu-Gly-Ser-Tyr-Leu-Leu-Gln-Pro,33 amino acid signal peptide (MGAAISQGALIAIVCNGLVGFLLLLLWVILCWA) removed.,,,
3610,agouti,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99JA2,,HLVFEETLGDDRSLKSNSSINSLDFSSVSIVALNKKSKKISRKEAEKRKRSSKKKASIKKVARPPPPSPCVATRDSCKPPAPACCNPCASCQCRFFGSACTCRVLNPNC,His-Leu-Val-Phe-Glu-Glu-Thr-Leu-Gly-Asp-Asp-Arg-Ser-Leu-Lys-Ser-Asn-Ser-Ser-Ile-Asn-Ser-Leu-Asp-Phe-Ser-Ser-Val-Ser-Ile-Val-Ala-Leu-Asn-Lys-Lys-Ser-Lys-Lys-Ile-Ser-Arg-Lys-Glu-Ala-Glu-Lys-Arg-Lys-Arg-Ser-Ser-Lys-Lys-Lys-Ala-Ser-Ile-Lys-Lys-Val-Ala-Arg-Pro-Pro-Pro-Pro-Ser-Pro-Cys-Val-Ala-Thr-Arg-Asp-Ser-Cys-Lys-Pro-Pro-Ala-Pro-Ala-Cys-Cys-Asn-Pro-Cys-Ala-Ser-Cys-Gln-Cys-Arg-Phe-Phe-Gly-Ser-Ala-Cys-Thr-Cys-Arg-Val-Leu-Asn-Pro-Asn-Cys,"Disulfide bonds are formed between cysteine residues 70 and 85, 77 and 91, 84 and 102, 88 and 109, 93 and 100.",,,
3609,agouti,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P42127,,HLPPEEKLRDDRSLRSNSSVNLLDVPSVSIVALNKKSKQIGRKAAEKKRSSKKEASMKKVVRPRTPLSAPCVATRNSCKPPAPACCDPCASCQCRFFRSACSCRVLSLNC,His-Leu-Pro-Pro-Glu-Glu-Lys-Leu-Arg-Asp-Asp-Arg-Ser-Leu-Arg-Ser-Asn-Ser-Ser-Val-Asn-Leu-Leu-Asp-Val-Pro-Ser-Val-Ser-Ile-Val-Ala-Leu-Asn-Lys-Lys-Ser-Lys-Gln-Ile-Gly-Arg-Lys-Ala-Ala-Glu-Lys-Lys-Arg-Ser-Ser-Lys-Lys-Glu-Ala-Ser-Met-Lys-Lys-Val-Val-Arg-Pro-Arg-Thr-Pro-Leu-Ser-Ala-Pro-Cys-Val-Ala-Thr-Arg-Asn-Ser-Cys-Lys-Pro-Pro-Ala-Pro-Ala-Cys-Cys-Asp-Pro-CysAla-Ser-Cys-Gln-Cys-Arg-Phe-Phe-Arg-Ser-Ala-Cys-Ser-Cys-Arg-Val-Leu-Ser-Leu-Asn-Cys,"Disulfide bonds are formed between cysteine residues 71 and 86, 78 and 92, 85 and 103, 89 and 110, 94 and 101.",,,
1329,agouti,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q03288,,HLALEETLGDDRSLRSNSSMNSLDFSSVSIVALNKKSKKISRKEAEKRKRSSKKKASMKKVARPPPPSPCVATRDSCKPPAPACCDPCASCQCRFFGSACTCRVLNPNC,His-Leu-Ala-Leu-Glu-Glu-Thr-Leu-Gly-Asp-Asp-Arg-Ser-Leu-Arg-Ser-Asn-Ser-Ser-Met-Asn-Ser-Leu-Asp-Phe-Ser-Ser-Val-Ser-Ile-Val-Ala-Leu-Asn-Lys-Lys-Ser-Lys-Lys-Ile-Ser-Arg-Lys-Glu-Ala-Glu-Lys-Arg-Lys-Arg-Ser-Ser-Lys-Lys-Lys-Ala-Ser-Met-Lys-Lys-Val-Ala-Arg-Pro-Pro-Pro-Pro-Ser-Pro-Cys-Val-Ala-Thr-Arg-Asp-Ser-Cys-Lys-Pro-Pro-Ala-Pro-Ala-Cys-Cys-Asp-Pro-Cys-Ala-Ser-Cys-Gln-Cys-Arg-Phe-Phe-Gly-Ser-Ala-Cys-Thr-Cys-Arg-Val-Leu-Asn-Pro-Asn-Cys,"Disulfide bonds are formed between cysteine residues 70 and 85, 77 and 91, 84 and 102, 88 and 109, 93 and 100.",,,
3611,agouti-related protein,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P56473,,VQMGVAPLKGIRRPDQALFPEFPGLSLNGLKKTTADRAEEVLLQKAEALAEVLDPQNRESRSPRRCVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTATNLCSRT,Val-Gln-Met-Gly-Val-Ala-Pro-Leu-Lys-Gly-Ile-Arg-Arg-Pro-Asp-Gln-Ala-Leu-Phe-Pro-Glu-Phe-Pro-Gly-Leu-Ser-Leu-Asn-Gly-Leu-Lys-Lys-Thr-Thr-Ala-Asp-Arg-Ala-Glu-Glu-Val-Leu-Leu-Gln-Lys-Ala-Glu-Ala-Leu-Ala-Glu-Val-Leu-Asp-Pro-Gln-Asn-Arg-Glu-Ser-Arg-Ser-Pro-Arg-Arg-Cys-Val-Arg-Leu-His-Glu-Ser-Cys-Leu-Gly-Gln-Gln-Val-Pro-Cys-Cys-Asp-Pro-Cys-Ala-Thr-Cys-Tyr-Cys-Arg-Phe-Phe-Asn-Ala-Phe-Cys-Tyr-Cys-Arg-Lys-Leu-Gly-Thr-Ala-Thr-Asn-Leu-Cys-Ser-Arg-Thr,"Disulfide bonds are formed between cysteine residues 66 and 81, 73 and 87, 80 and 98, 84 and 108, 89 and 96.",,,
1335,agouti-related protein,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00253,,AQMGLAPMEGIRRPDQALLPELPGLGLRAPLKKTTAEQAEEDLLQEAQALAEVLDLQDREPRSSRRCVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT,Ala-Gln-Met-Gly-Leu-Ala-Pro-Met-Glu-Gly-Ile-Arg-Arg-Pro-Asp-Gln-Ala-Leu-Leu-Pro-Glu-Leu-Pro-Gly-Leu-Gly-Leu-Arg-Ala-Pro-Leu-Lys-Lys-Thr-Thr-Ala-Glu-Gln-Ala-Glu-Glu-Asp-Leu-Leu-Gln-Glu-Ala-Gln-Ala-Leu-Ala-Glu-Val-Leu-Asp-Leu-Gln-Asp-Arg-Glu-Pro-Arg-Ser-Ser-Arg-Arg-Cys-Val-Arg-Leu-His-Glu-Ser-Cys-Leu-Gly-Gln-Gln-Val-Pro-Cys-Cys-Asp-Pro-Cys-Ala-Thr-Cys-Tyr-Cys-Arg-Phe-Phe-Asn-Ala-Phe-Cys-Tyr-Cys-Arg-Lys-Leu-Gly-Thr-Ala-Met-Asn-Pro-Cys-Ser-Arg-Thr,"Disulfide bonds are formed between cysteine residues 67 and 82, 74 and 88, 81 and 99, 85 and 109, 90 and 97.",,,
5319,agrin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00468,,,,,,,
6065,alamandine,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,,,ARVYIHP,Ala-Arg-Val-Tyr-Ile-His-Pro,,,,
6123,alarin,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,APAHRSSTFPQRPTRAGRQTQLLRS,Ala-Pro-Ala-His-Arg-Ser-Ser-Thr-Phe-Pro-Gln-Arg-Pro-Thr-Arg-Ala-Gly-Arg-Gln-Thr-Gln-Leu-Leu-Arg-Ser,,,,
695,α-CGRP,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q99JA0|P01256,,SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF,Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2,The cysteine residues at positions 2 and 7 form a disulphide bridge and the C-terminal phenylalanine residue is amidated.,,,
681,α-CGRP,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06881,,ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2,Cysteine residues at positions 2 and 7 form a disulphide bridge and the C-terminal phenylalanine residue is amidated.,,,
1320,α-MSH,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01189|P01193|P01194,,SYSMEHFRWGKPV,(Ac)Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2,The N-terminal serine is acetylated and the C-terminal valine is amidated.,,,
3737,α-neodynorphin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01213,,YGGFLRKYPK,Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys,,,,
1600,α-neoendorphin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRKYPK,Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys,,,,
4864,amphiregulin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P15514,,SVRVEQVVKPPQNKTESENTSDKPKRKKKGGKNGKNRRNRKKKNPCNAEFQNFCIHGECKYIEHLEAVTCKCQQEYFGERCGEK,,"N-linked glycosylation of asparagine residue at position 19; predicted N-linked glycosylation of asparagine at position 113. Predicted disulphide bond formation between cysteine resdiues at positions 46 and 59, 54 and 70, and 72 and 81",,,
688,amylin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P12969|P12968,,KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY,Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2,The C-terminal proline is amidated into Pro-NH2 and a disulphide bridge is formed between cysteine residues at positions 2 and 7.,,,
687,amylin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10997,,KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY,Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2,The C-terminal proline is amidated into Pro-NH2 and a disulphide bridge is formed between cysteine residues at positions 2 and 7.,,,
4865,amyloid β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05067,,DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA,Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala,,,,
4867,angiopoietin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15389,,HIGCSNQRRSPENSGRRYNRIQHGQCAYTFILPEHDGNCRESTTDQYNTNALQRDAPHVEPDFSSQKLQHLEHVMENYTQWLQKLENYIVENMKSEMAQIQQNAVQNHTATMLEIGTSLLSQTAEQTRKLTDVETQVLNQTSRLEIQLLENSLSTYKLEKQLLQQTNEILKIHEKNSLLEHKILEMEGKHKEELDTLKEEKENLQGLVTRQTYIIQELEKQLNRATTNNSVLQKQQLELMDTVHNLVNLCTKEGVLLKGGKREEEKPFRDCADVYQAGFNKSGIYTIYINNMPEPKKVFCNMDVNGGGWTVIQHREDGSLDFQRGWKEYKMGFGNPSGEYWLGNEFIFAITSQRQYMLRIELMDWEGNRAYSQYDRFHIGNEKQNYRLYLKGHTGTAGKQSSLILHGADFSTKDADNDNCMCKCALMLTGGWWFDACGPSNLNGMFYTAGQNHGKLNGIKWHYFKGPSYSLRSTTMMIRPLDF,,"Predicted N-linked glycosylation of asparagine residues at positions 77, 107, 139, 228 and 280; predicted disulphide bond formation between cysteine residues at positions 271 and 300, and 424 and 437",,,
5316,angiopoietin-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15123,,YNNFRKSMDSIGKKQYQVQHGSCSYTFLLPEMDNCRSSSSPYVSNAVQRDAPLEYDDSVQRLQVLENIMENNTQWLMKLENYIQDNMKKEMVEIQQNAVQNQTAVMIEIGTNLLNQTAEQTRKLTDVEAQVLNQTTRLELQLLEHSLSTNKLEKQILDQTSEINKLQDKNSFLEKKVLAMEDKHIIQLQSIKEEKDQLQVLVSKQNSIIEELEKKIVTATVNNSVLQKQQHDLMETVNNLLTMMSTSNSAKDPTVAKEEQISFRDCAEVFKSGHTTNGIYTLTFPNSTEEIKAYCDMEAGGGGWTIIQRREDGSVDFQRTWKEYKVGFGNPSGEYWLGNEFVSQLTNQQRYVLKIHLKDWEGNEAYSLYEHFYLSSEELNYRIHLKGLTGTAGKISSISQPGNDFSTKDGDNDKCICKCSQMLTGGWWFDACGPSNLNGMYYPQRQNTNKFNGIKWYYWKGSGYSLKATTMMIRPADF,,"Disulphide bond formation between cysteine residues at positions 266 and 295, 415 and 417, and 419 and 432. Predicted N-linked glycosylation of asparagine resdiues at positions 71, 101, 115, 133, 222 and 286",,,
4868,angiopoietin-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y264,,TRQEADRGCETLVVQHGHCSYTFLLPKSEPCPPGPEVSRDSNTLQRESLANPLHLGKLPTQQVKQLEQALQNNTQWLKKLERAIKTILRSKLEQVQQQMAQNQTAPMLELGTSLLNQTTAQIRKLTDMEAQLLNQTSRMDAQMPETFLSTNKLENQLLLQRQKLQQLQGQNSALEKRLQALETKQQEELASILSKKAKLLNTLSRQSAALTNIERGLRGVRHNSSLLQDQQHSLRQLLVLLRHLVQERANASAPAFIMAGEQVFQDCAEIQRSGASASGVYTIQVSNATKPRKVFCDLQSSGGRWTLIQRRENGTVNFQRNWKDYKQGFGDPAGEHWLGNEVVHQLTRRAAYSLRVELQDWEGHEAYAQYEHFHLGSENQLYRLSVVGYSGSAGRQSSLVLQNTSFSTLDSDNDHCLCKCAQVMSGGWWFDACGLSNLNGVYYHAPDNKYKMDGIRWHYFKGPSYSLRASRMMIRPLDI,,"Predicted N-linked glycosylation of asparagine residues at positions 72, 102, 116, 134, 233, 250, 287, 313 and 403; predicted disulphide bond formation between cysteine residues at positions 267 and 296, and 420 and 433",,,
8716,angiopoietin-like 3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y5C1,,MFTIKLLLFIVPLVISSRIDQDNSSFDSLSPEPKSRFAMLDDVKILANGLLQLGHGLKDFVHKTKGQINDIFQKLNIFDQSFYDLSLQTSEIKEEEKELRRTTYKLQVKNEEVKNMSLELNSKLESLLEEKILLQQKVKYLEEQLTNLIQNQPETPEHPEVTSLKTFVEKQDNSIKDLLQTVEDQYKQLNQQHSQIKEIENQLRRTSIQEPTEISLSSKPRAPRTTPFLQLNEIRNVKHDGIPAECTTIYNRGEHTSGMYAIRPSNSQVFHVYCDVISGSPWTLIQHRIDGSQNFNETWENYKYGFGRLDGEFWLGLEKIYSIVKQSNYVLRIELEDWKDNKHYIEYSFYLGNHETNYTLHLVAITGNVPNAIPENKDLVFSTWDHKAKGHFNCPEGYSGGWWWHDECGENNLNGKYNKPRAKSKPERRRGLSWKS,,"The first 16 amino acids are the signal peptide (MFTIKLLLFIVPLVIS). N-linked glycosylation at residues 115, 296 and 357. Disulphide bonds form between Cys246-Cys274 and Cys394-Cys408.",,,
5317,angiopoietin protein-like 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95841,,GQFKIKKINQRRYPRATDGKEEAKKCAYTFLVPEQRITGPICVNTKGQDASTIKDMITRMDLENLKDVLSRQKREIDVLQLVVDVDGNIVNEVKLLRKESRNMNSRVTQLYMQLLHEIIRKRDNSLELSQLENKILNVTTEMLKMATRYRELEVKYASLTDLVNNQSVMITLLEEQCLRIFSRQDTHVSPPLVQVVPQHIPNSQQYTPGLLGGNEIQRDPGYPRDLMPPPDLATSPTKSPFKIPPVTFINEGPFKDCQQAKEAGHSVSGIYMIKPENSNGPMQLWCENSLDPGGWTVIQKRTDGSVNFFRNWENYKKGFGNIDGEYWLGLENIYMLSNQDNYKLLIELEDWSDKKVYAEYSSFRLEPESEFYRLRLGTYQGNAGDSMMWHNGKQFTTLDRDKDMYAGNCAHFHKGGWWYNACAHSNLNGVWYRGGHYRSKHQDGIFWAEYRGGSYSLRAVQMMIKPID,,Predicted N-linked glycosylation of asparagine residues at positions 137 and 165; predicted disulphide  bond formation between cysteine residues at positions 267 and 286 and 409 and 422,,,
5321,angiopoietin-related protein 7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43827,,QKLSKHKTPAQPQLKAANCCEEVKELKAQVANLSSLLSELNKKQERDWVSVVMQVMELESNSKRMESRLTDAESKYSEMNNQIDIMQLQAAQTVTQTSADAIYDCSSLYQKNYRISGVYKLPPDDFLGSPELEVFCDMETSGGGWTIIQRRKSGLVSFYRDWKQYKQGFGSIRGDFWLGNEHIHRLSRQPTRLRVEMEDWEGNLRYAEYSHFVLGNELNSYRLFLGNYTGNVGNDALQYHNNTAFSTKDKDNDNCLDKCAQLRKGGYWYNCCTDSNLNGVYYRLGEHNKHLDGITWYGWHGSTYSLKRVEMKIRPEDFKP,,"Predicted N-linked glycosylation of asparagine residues at positions 58, 227, and 241. Predicted disulphide bond formation of cysteine residues at positions 105 and 136, and 259 and 272",,,
582,angiotensin-(1-7),"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01019|P11859|P01015,,DRVYIHP,Asp-Arg-Val-Tyr-Ile-His-Pro,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C,PVHLMTREZMEJCG-GDTLVBQBSA-N
5138,angiotensin-(1-9),"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01019,,DRVYIHPFH,Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His,,,,
6894,angiotensin A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01019,,ARVYIHPF,Ala-Arg-Val-Tyr-Ile-His-Pro-Phe,,,,
583,angiotensin I,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01019|P11859|P01015,,DRVYIHPFHL,Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu,None.,,CCC(C(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)C(C(C(=O)C)CC(C)C)N)Cc1cnc[nH]1)Cc1ccccc1)Cc1cnc[nH]1)NC(=O)C(c1ccc(cc1)O)NCC(C(C)C)NC(=O)C(NC(=O)C(CC(=O)O)N)CCCN=C(N)N)C,AZSXKTYFSLKNEF-UHFFFAOYSA-N
2504,angiotensin II,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01015|P11859|P01019,angiotensin II,DRVYIHPF,Asp-Arg-Val-Tyr-Ile-His-Pro-Phe,None.,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)Cc1nc[nH]c1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C,CZGUSIXMZVURDU-JZXHSEFVSA-N
585,angiotensin III,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01019|P11859|P01015,,RVYIHPF,Arg-Val-Tyr-Ile-His-Pro-Phe,None.,,NC(=NCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1[nH]cnc1)C(C)C)Cc1ccc(cc1)O)C(C)C)NC(=O)[C@H](CC(=O)O)N)N,UCRMCWFIVZYPFA-LGXQCQDRSA-N
5368,angiotensin IV,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P11859|P01015|P01019,,VYIHPF,Val-Tyr-Ile-His-Pro-Phe,,,,
3569,annexin I,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P07150,,MAMVSEFLKQACYIEKQEQEYVQAVKSYKGGPGSAVSPYPSFNPSSDVAALHKAIMVKGVDEATIIDILTKRTNAQRQQIKAAYLQETGKPLDETLKKALTGHLEEVVLAMLKTPAQFDADELRAAMKGLGTDEDTLIEILTTRSNQQIREITRVYREELKRDLAKDITSDTSGDFRNALLALAKGDRCEDMSVNQDLADTDARALYEAGERRKGTDVNVFNTILTTRSYPHLRKVFQNYRKYSQHDMNKALDLELKGDIEKCLTTIVKCATSTPAFFAEKLYEAMKGAGTRHKTLIRIMVSRSEIDMNEIKVFYQKKYGIPLCQAILDETKGDYEKILVALCGGN,Met-(Ac)Ala-Met-Val-pSer-Glu-Phe-Leu-Lys-Gln-Ala-Cys-Tyr-Ile-Glu-Lys-Gln-Glu-Gln-Glu-pTyr-Val-Gln-Ala-Val-Lys-pSer-Tyr-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val-Ser-Pro-pTyr-Pro-Ser-Phe-Asn-Pro-Ser-Ser-Asp-Val-Ala-Ala-Leu-His-Lys-Ala-Ile-Met-Val-Lys-Gly-Val-Asp-Glu-Ala-Thr-Ile-Ile-Asp-Ile-Leu-Thr-Lys-Arg-Thr-Asn-Ala-Gln-Arg-Gln-Gln-Ile-Lys-Ala-Ala-Tyr-Leu-Gln-Glu-Thr-Gly-Lys-Pro-Leu-Asp-Glu-Thr-Leu-Lys-Lys-Ala-Leu-Thr-Gly-His-Leu-Glu-Glu-Val-Val-Leu-Ala-Met-Leu-Lys-Thr-Pro-Ala-Gln-Phe-Asp-Ala-Asp-Glu-Leu-Arg-Ala-Ala-Met-Lys-Gly-Leu-Gly-Thr-Asp-Glu-Asp-Thr-Leu-Ile-Glu-Ile-Leu-Thr-Thr-Arg-Ser-Asn-Gln-Gln-Ile-Arg-Glu-Ile-Thr-Arg-Val-Tyr-Arg-Glu-Glu-Leu-(Ac)Lys-Arg-Asp-Leu-Ala-Lys-Asp-Ile-Thr-Ser-Asp-Thr-Ser-Gly-Asp-Phe-Arg-Asn-Ala-Leu-Leu-Ala-Leu-Ala-Lys-Gly-Asp-Arg-Cys-Glu-Asp-Met-Ser-Val-Asn-GlnAsp-Leu-Ala-Asp-Thr-Asp-Ala-Arg-Ala-Leu-pTyr-Glu-Ala-Gly-Glu-Arg-Arg-Lys-Gly-Thr-Asp-Val-Asn-Val-Phe-Asn-Thr-Ile-Leu-Thr-Thr-Arg-Ser-Tyr-Pro-His-Leu-Arg-Lys-Val-Phe-Gln-Asn-Tyr-Arg-Lys-Tyr-Ser-Gln-His-Asp-Met-Asn-(Ac)Lys-Ala-Leu-Asp-Leu-Glu-Leu-Lys-Gly-Asp-Ile-Glu-Lys-Cys-Leu-Thr-Thr-Ile-Val-Lys-Cys-Ala-Thr-Ser-Thr-Pro-Ala-Phe-Phe-Ala-Glu-(Ac)Lys-Leu-Tyr-Glu-Ala-Met-Lys-Gly-Ala-Gly-Thr-Arg-His-Lys-Thr-Leu-Ile-Arg-Ile-Met-Val-Ser-Arg-Ser-Glu-Ile-Asp-Met-Asn-Glu-Ile-(Ac)Lys-Val-Phe-Tyr-Gln-Lys-Lys-Tyr-Gly-Ile-Pro-Leu-Cys-Gln-Ala-Ile-Leu-Asp-Glu-Thr-Lys-Gly-Asp-Tyr-Glu-Lys-Ile-Leu-Val-Ala-Leu-Cys-Gly-Gly-Asn,"Residues in positions 2 (Ala), 161 (Lys), 250 (Lys), 281 (Lys) and 312 (Lys) are N-linked acetylated and residues in positions 5 (Ser), 21 (Tyr), 27 (Ser), 39 (Tyr) and 207 (Tyr) are phosphorylated.",,,
1031,annexin I,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04083,,MAMVSEFLKQAWFIENEEQEYVQTVKSSKGGPGSAVSPYPTFNPSSDVAALHKAIMVKGVDEATIIDILTKRNNAQRQQIKAAYLQETGKPLDETLKKALTGHLEEVVLALLKTPAQFDADELRAAMKGLGTDEDTLIEILASRTNKEIRDINRVYREELKRDLAKDITSDTSGDFRNALLSLAKGDRSEDFGVNEDLADSDARALYEAGERRKGTDVNVFNTILTTRSYPQLRRVFQKYTKYSKHDMNKVLDLELKGDIEKCLTAIVKCATSKPAFFAEKLHQAMKGVGTRHKALIRIMVSRSEIDMNDIKAFYQKMYGISLCQAILDETKGDYEKILVALCGGN,Met-(Ac)Ala-Met-Val-pSer-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-pTyr-Val-Gln-pThr-Val-Lys-pSer-Ser-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val-Ser-Pro-pTyr-Pro-Thr-Phe-Asn-Pro-Ser-Ser-Asp-Val-Ala-Ala-Leu-His-Lys-Ala-Ile-Met-Val-Lys-Gly-Val-Asp-Glu-Ala-Thr-Ile-Ile-Asp-Ile-Leu-Thr-Lys-Arg-Asn-Asn-Ala-Gln-Arg-Gln-Gln-Ile-Lys-Ala-Ala-Tyr-Leu-Gln-Glu-Thr-Gly-Lys-Pro-Leu-Asp-Glu-Thr-Leu-Lys-Lys-Ala-Leu-Thr-Gly-His-Leu-Glu-Glu-Val-Val-Leu-Ala-Leu-Leu-Lys-Thr-Pro-Ala-Gln-Phe-Asp-Ala-Asp-Glu-Leu-Arg-Ala-Ala-Met-Lys-Gly-Leu-Gly-Thr-Asp-Glu-Asp-Thr-Leu-Ile-Glu-Ile-Leu-Ala-Ser-Arg-Thr-Asn-Lys-Glu-Ile-Arg-Asp-Ile-Asn-Arg-Val-Tyr-Arg-Glu-Glu-Leu-(Ac)Lys-Arg-Asp-Leu-Ala-Lys-Asp-Ile-Thr-Ser-Asp-Thr-Ser-Gly-Asp-Phe-Arg-Asn-Ala-Leu-Leu-Ser-Leu-Ala-Lys-Gly-Asp-Arg-Ser-Glu-Asp-Phe-Gly-Val-Asn-Glu-Asp-Leu-Ala-Asp-Ser-Asp-Ala-Arg-Ala-Leu-pTyr-Glu-Ala-Gly-Glu-Arg-Arg-Lys-Gly-Thr-Asp-Val-Asn-Val-Phe-Asn-Thr-Ile-Leu-Thr-Thr-Arg-Ser-Tyr- Pro-Gln-Leu-Arg-Arg-Val-Phe-Gln-(Ac)Lys-Tyr-Thr-Lys-Tyr-Ser-Lys-His-Asp-Met-Asn-(Ac)Lys-Val-Leu-Asp-Leu-Glu-Leu-Lys-Gly-Asp-Ile-Glu-Lys-Cys-Leu-Thr-Ala-Ile-Val-Lys-Cys- Ala-Thr-Ser-Lys-Pro-Ala-Phe-Phe-Ala-Glu-(Ac)Lys-Leu-Tyr-Glu-Ala-Met-Lys-Gly-Ala-Gly-Thr-Arg-His-Lys-Thr-Leu-Ile-Arg-Ile-Met-Val-Ser-Arg-Ser-Glu-Ile-Asp-Met-Asn-Glu-Ile-(Ac)Lys-Val-Phe-Tyr-Gln-Lys-Lys-Tyr-Gly-Ile-Pro-Leu-Cys-Gln-Ala-Ile-Leu-Asp-Glu-Thr-Lys-Gly-Asp-Tyr-Glu-Lys-Ile-Leu-Val-Ala-Leu-Cys-Gly-Gly-Asn,"Residues in positions 2 (Ala), 161 (Lys), 239 (Lys), 250 (Lys), 281 (Lys), 312 (Lys) are N-linked acetylated and residues in positions 5 (Ser), 21 (Tyr), 24 (Thr), 27 (Ser), 39 (tyr) and 207 (Tyr) are phosphorylated.",,,
3568,annexin I,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10107,,MAMVSEFLKQARFLENQEQEYVQAVKSYKGGPGSAVSPYPSFNVSSDVAALHKAIMVKGVDEATIIDILTKRTNAQRQQIKAAYLQENGKPLDEVLRKALTGHLEEVVLAMLKTPAQFDADELRGAMKGLGTDEDTLIEILTTRSNEQIREINRVYREELKRDLAKDITSDTSGDFRKALLALAKGDRCQDLSVNQDLADTDARALYEAGERRKGTDVNVFTTILTSRSFPHLRRVFQNYGKYSQHDMNKALDLELKGDIEKCLTTIVKCATSTPAFFAEKLYEAMKGAGTRHKALIRIMVSRSEIDMNEIKVFYQKKYGISLCQAILDETKGDYEKILVALCGGN,Met-(Ac)Ala-Met-Val-pSer-Glu-Phe-Leu-Lys-Gln-Ala-Arg-Phe-Leu-Glu-Asn-Gln-Glu-Gln-Glu-pTyr-Val-Gln-Ala-Val-Lys-pSer-Tyr-Lys-Gly-Gly-Pro-Gly-Ser-Ala-Val-Ser-Pro-pTyr-Pro-Ser-Phe-Asn-Val-Ser-Ser-Asp-Val-Ala-Ala-Leu-His-Lys-Ala-Ile-Met-Val-Lys-Gly-Val-Asp-Glu-Ala-Thr-Ile-Ile-Asp-Ile-Leu-Thr-Lys-Arg-Thr-Asn-Ala-Gln-Arg-Gln-Gln-Ile-Lys-Ala-Ala-Tyr-Leu-Gln-Glu-Asn-Gly-Lys-Pro-Leu-Asp-Glu-Val-Leu-Arg-Lys-Ala-Leu-Thr-Gly-His-Leu-Glu-Glu-Val-Val-Leu-Ala-Met-Leu-Lys-Thr-Pro-Ala-Gln-Phe-Asp-Ala-Asp-Glu-Leu-Arg-Gly-Ala-Met-Lys-Gly-Leu-Gly-Thr-Asp-Glu-Asp-Thr-Leu-Ile-Glu-Ile-Leu-Thr-Thr-Arg-Ser-Asn-Glu-Gln-Ile-Arg-Glu-Ile-Asn-Arg-Val-Tyr-Arg-Glu-Glu-Leu-(Ac)Lys-Arg-Asp-Leu-Ala-Lys-Asp-Ile-Thr-Ser-Asp-Thr-Ser-Gly-Asp-Phe-Arg-Lys-Ala-Leu-Leu-Ala-Leu-Ala-Lys-Gly-Asp-Arg-Cys-Gln-Asp-Leu-Ser-Val-Asn-Gln-Asp-Leu-Ala-Asp-Thr-Asp-Ala-Arg-Ala-Leu-pTyr-Glu-Ala-Gly-Glu-Arg-Arg-Lys-Gly-Thr-Asp-Val-Asn-Val-Phe-Thr-Thr-Ile-Leu-Thr-Ser-Arg-Ser-Phe-Pro-His-Leu-Arg-Arg-Val-Phe-Gln-Asn-Tyr-Gly-Lys-Tyr-Ser-Gln-His-Asp-Met-Asn-(Ac)Lys-Ala-Leu-Asp-Leu-Glu-Leu-Lys-Gly-Asp-Ile-Glu-Lys-Cys-Leu-Thr-Thr-Ile-Val-Lys-Cys-Ala-Thr-Ser-Thr-Pro-Ala-Phe-Phe-Ala-Glu-(Ac)Lys-Leu-Tyr-Glu-Ala-Met-Lys-Gly-Ala-Gly-Thr-Arg-His-Lys-Ala-Leu-Ile-Arg-Ile-Met-Val-Ser-Arg-Ser-Glu-Ile-Asp-Met-Asn-Glu-Ile-(Ac)Lys-Val-Phe-Tyr-Gln-Lys-Lys-Tyr-Gly-Ile-Ser-Leu-Cys-Gln-Ala-Ile-Leu-Asp-Glu-Thr-Lys-Gly-Asp-Tyr-Glu-Lys-Ile-Leu-Val-Ala-Leu-Cys-Gly-Gly-Asn,"Residues in positions 2 (Ala), 161 (Lys), 250 (Lys), 281 (Lys) and 312 (Lys) are N-linked acetylated and residues in positions 5 (Ser), 21 (Tyr), 27 (Ser), 39 (Tyr) and 207 (Tyr) are phosphorylated.",,,
1044,annexin I-(2-26),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04083,,AMVSEFLKQAWFIENEEQEYVQTVK,(Ac)Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-Tyr-Val-Gln-Thr-Val-Lys,The N-terminal alanine residue is N-linked acetylated.,,,
605,apelin-13,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9ULZ1|Q9R0R3|Q9R0R4,,QRPRLSHKGPMPF,Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,,,NCCCC[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CCSC)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)N)N)CCCN=C(N)N)CCCN=C(N)N)CC(C)C)CO,XXCCRHIAIBQDPX-PEWBXTNBSA-N
3556,apelin-17,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9ULZ1|Q9R0R4|Q9R0R3,,KFRRQRPRLSHKGPMPF,Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,,,,
3555,apelin-36,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9R0R3|Q9R0R4,,LVKPRTSRTGPGAWQGGRRKFRRQRPRLSHKGPMPF,Leu-Val-Lys-Pro-Arg-Thr-Ser-Arg-Thr-Gly-Pro-Gly-Ala-Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,,,,
606,apelin-36,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9ULZ1,,LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPMPF,Leu-Val-Gln-Pro-Arg-Gly-Pro-Arg-Ser-Gly-Pro-Gly-Pro-Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,,,,
7930,apelin receptor early endogenous ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0DMC3,,QRPVNLTMRRKLRKHNCLQRRCMPLHSRVPFP,Gln-Arg-Pro-Val-Asn-Leu-Thr-Met-Arg-Arg-Lys-Leu-Arg-Lys-His-Asn-Cys-Leu-Gln-Arg-Arg-Cys-Met-Pro-Leu-His-Ser-Arg-Val-Pro-Phe-Pro,N-linked glycosylation at Asn5 in the peptide sequence shown here (equivalent to Asn27 in the 54 amino acid precursor).,,,
7931,apelin receptor early endogenous ligand,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,KPVNFPRRRKLYRHNCFRRRCIPLHSRVPFP,Lys-Pro-Val-Asn-Phe-Pro-Arg-Arg-Arg-Lys-Leu-Tyr-Arg-His-Asn-Cys-Phe-Arg-Arg-Arg-Cys-Ile-Pro-Leu-His-Ser-Arg-Val-Pro-Phe-Pro,31 amino acid peptide cleaved from the 54 amino acid precursor (UniProt ID P0DMC4).,,,
5068,APRIL,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O75888,,AVLTQKQKKQHSVLHLVPINATSKDDSDVTEVMWQPALRRGRGLQAQGYGVRIQDAGVYLLYSQVLFQDVTFTMGQVVSREGQGRQETLFRCIRSMPSHPDRAYNSCYSAGVFHLHQGDILSVIIPRARAKLNLSPHGTFLGFVKL,,Predicted N-linked glycosylation of asparagine residue at position 20; predicted disulphide bond formation between cysteine residues at positions 92 and 107,,,
4871,artemin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q5T4W7,,AGGPGSRARAAGARGCRLRSQLVPVRALGLGHRSDELVRFRFCSGSCRRARSPHDLSLASLLGAGALRPPPGSRPVSQPCCRPTRYEAVSFMDVNSTWRTVDRLSATACGCLG,,"Biologically active peptide is a homodimer. Disulphide bond formation between cysteine residues at positions 16 and 81, 43 and 109, and 47 and 111. Interchain disulphide bomd between cysteine residues at position 80 of each chain; predicted N-linked glycosylation of asparagine residue at position 95",,,
9200,asprosin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35555,,STNETDASNIEDQSETEANVSLASWDVEKTAIFAFNISHVSNKVRILELLPALTTLTNHNRYLIESGNEDGFFKINQKEGISYLHFTKKKPVAGTYSLQISSTPLYKKKELNQLEDKYDKDYLSGELGDNLKMKIQVLLH,,,,,
4869,atrial natriuretic peptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01160,,SLRRSSCFGGRMDRIGAQSGLGCNSFRY,Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr,Disulphide bond formation between cysteine residues at positions 7 and 123,,,
5069,BAFF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y275,,MDDSTEREQSRLTSCLKKREEMKLKECVSILPRKESPSVRSSKDGKLLAATLLLALLSCCLTVVSFYQVAALQGDLASLRAELQGHHAEKLPAGAGAPKAGLEEAPAVTAGLKIFEPPAPGEGNSSQNSRNKRAVQGPEETVTQDCLQLIADSETPTIQKGSYTFVPWLLSFKRGSALEEKENKILVKETGYFFIYGQVLYTDKTYAMGHLIQRKKVHVFGDELSLVTLFRCIQNMPETLPNNSCYSAGIAKLEEGDELQLAIPRENAQISLDGDVTFFGALKLL,,N-linked glycosylation of asparagine residues at positions 124 and 242 (high mannose at 242); disulphide bond formation between cysteine residues at positions 232 and 245,,,
4891,B and T lymphocyte attenuator,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q7Z6A9,,KESCDVQLYIKRQSEHSILAGDPFELECPVKYCANRPHVTWCKLNGTTCVKLEDRQTSWKEEKNISFFILHFEPVLPNDNGSYRCSANFQSNLIESHSTTLYVTDVKSASERPSKDEMASRPWLLYRLLPLGGLPLLITTCFCLFCCLRRHQGKQNELSDTAGREINLVDAHLKSEQTEASTRQNSQVLLSETGIYDNDPDLCFRMQEGSEVYSNPCLEENKPGIVYASLNHSVIGPNSRLARNVKEAPTEYASICVRS,,"Predicted N-linked glcosylation of asparagine residues at positions 45, 64 and 80; disulphide bond formation between cysteine residues at positions 4 and 33, 28 and 85, and 42 and 49",,,
4872,BDNF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P23560,,HSDPARRGELSVCDSISEWVTAADKKTAVDMSGGTVTVLEKVPVSKGQLKQYFYETKCNPMGYTKEGCRGIDKRHWNSQCRTTQSYVRALTMDSKKRIGWRFIRIDTSCVCTLTIKRGR,,"Disulphide bond formation between cysteine residues at positions 13 and 80, 58 and 109, and 68 and 111",,,
5377,bestrophin-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8N1M1,,MTVTYSSKVANATFFGFHRLLLKWRGSIYKLLYREFIVFAVLYTAISLVYRLLLTGVQKRYFEKLSIYCDRYAEQIPVTFVLGFYVTLVVNRWWNQFVNLPWPDRLMFLISSSVHGSDEHGRLLRRTLMRYVNLTSLLIFRSVSTAVYKRFPTMDHVVEAGFMTTDERKLFNHLKSPHLKYWVPFIWFGNLATKARNEGRIRDSVDLQSLMTEMNRYRSWCSLLFGYDWVGIPLVYTQVVTLAVYTFFFACLIGRQFLDPTKGYAGHDLDLYIPIFTLLQFFFYAGWLKVAEQLINPFGEDDDDFETNWCIDRNLQVSLLAVDEMHMSLPKMKKDIYWDDSAARPPYTLAAADYCIPSFLGSTVQMGLSGSDFPDEEWLWDYEKHGHRHSMIRRVKRFLSAHEHPSSPRRRSYRRQTSDSSMFLPRDDLSPARDLLDVPSRNPPRASPTWKKSCFPEGSPTLHFSMGELSTIRETSQTSTLQSLTPQSSVRTSPIKMPLVPEVLITAAEAPVPTSGGYHHDSATSILSSEFTGVQPSKTEQQQGPMGSILSPSEKETPPGGPSPQTVSASAEENIFNCEEDPGDTFLKRWSLPGFLGSSHTSLGNLSPDPMSSQPALLIDTETSSEISGINIVAGSRVSSDMLYLMENLDTKETDIIELNKETEESPK,,,,,
5371,β-catenin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35222,,MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL,,"Serine residues at positions 23, 29, 33, 37, 45, 191, 246, 552 and 675 are phophoserine; threonine residues at positions 41, 551 and 556 are phosphothreonine; tyrosine residues at positions 64, 86, 142, 331, 333 and 654 are phosphotyrosine.",,,
4873,betacellulin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35070,,DGNSTRSPETNGLLCGDPEENCAATTTQSKRKGHFSRCPKQYKHYCIKGRCRFVVAEQTPSCVCDEGYIGARCERVDLFY,,"Predicted N-linked glycosylation of asparagine residue at position 3; disulphide bond formation between cysteine resdiues at positions 38 and 51, 46 and 62, and 64 and 73",,,
696,β-CGRP,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10093,,SCNTATCVTHRLAGLLRRSGGVVKDNFVPTNVGSKAF,Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Arg-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2,The cysteine residues at positions 2 and 7 form a disulphide bridge and the C-terminal phenylalanine residue is amidated.,,,
682,β-CGRP,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10092,,ACNTATCVTHRLAGLLSRSGGMVKSNFVPTNVGSKAF,Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2,The cysteine residues at positions 2 and 7 form a disulphide bridge and the C-terminal Phenylalanine residue is amidated.,,,
3588,β-CGRP,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99MP3,,SCNTATCVTHRLADLLSRSGGVLKDNFVPTDVGSEAF,Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Leu-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asp-Val-Gly-Ser-Glu-Ala-Phe-NH2,The cysteine residues at positions 2 and 7 form a disulphide bridge and the C-terminal phenylalanine residue is amidated.,,,
3648,beta-defensin 4A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15263,,GIGDPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKKP,Gly-Ile-Gly-Asp-Pro-Val-Thr-Cys-Leu-Lys-Ser-Gly-Ala-Ile-Cys-His-Pro-Val-Phe-Cys-Pro-Arg-Arg-Tyr-Lys-Gln-Ile-Gly-Thr-Cys-Gly-Leu-Pro-Gly-Thr-Lys-Cys-Cys-Lys-Lys-Pro,"Disulphide bonds between cysteine residues at positions 8 and 37; 15 and 30, and 20 and 38",,,
3722,β-endorphin,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01193,,YGGFMTSEKSQTPLVTLFKNAIIKNAHKKGQ,Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln,,,,
1643,β-endorphin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01189,,YGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE,Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu,,,,
3723,β-endorphin,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01194,,YGGFMTSEKSQTPLVTLFKNAIIKNVHKKGQ,Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Val-His-Lys-Lys-Gly-Gln,,,,
5370,β-haemoglobin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P68871,,VHLTPEEKSAVTALWGKVNVDEVGGEALGRLLVVYPWTQRFFESFGDLSTPDAVMGNPKVKAHGKKVLGAFSDGLAHLDNLKGTFATLSELHCDKLHVDPENFRLLGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH,,"N-linked glycation of lysine residues at positions 8, 17, 66, 120, 144; N-linked glycation of valine residue at position 1; tyrosine residue at position 130 is phosphotyrosine; cysteine residue at postion 93 is S-nitrocysteine",,,
3608,β-MSH,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01194,,ADGPYRVEHFRWGNPPKD,Ala-Asp-Gly-Pro-Tyr-Arg-Val-Glu-His-Phe-Arg-Trp-Gly-Asn-Pro-Pro-Lys-Asp,None.,,,
3607,β-MSH,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01193,,DDGPYRVEHFRWSNPPKD,Asp-Asp-Gly-Pro-Tyr-Arg-Val-Glu-His-Phe-Arg-Trp-Ser-Asn-Pro-Pro-Lys-Asp,None.,,,
3606,β-MSH,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01189,,DEGPYRMEHFRWGSPPKD,Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp,None.,,,
1644,β-neoendorphin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRKYP,Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro,,,,
5152,BH3 interacting-domain death agonist,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55957,,MDCEVNNGSSLRDECITNLLVFGFLQSCSDNSFRRELDALGHELPVLAPQWEGYDELQTDGNRSSHSRLGRIEADSESQEDIIRNIARHLAQVGDSMDRSIPPGLVNGLALQLRNTSRSEEDRNRDLATALEQLLQAYPRDMEKEKTMLVLALLLAKKVASHTPSLLRDVFHTTVNFINQNLRTYVRSLARNGMD,,Tyrosine residue at position 54 is phosphotyrosine; serine residue at position 78 is phosphoserine,,,
3669,big dynorphin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVT,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr,,,,
6704,BigLEN,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QXV0,,LENSSPQAPARRLLPP,Leu-Glu-Asn-Ser-Ser-Pro-Gln-Ala-Pro-Ala-Arg-Arg-Leu-Leu-Pro-Pro,,,,
4875,BMP-10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95393,,NAKGNYCKRTPLYIDFKEIGWDSWIIAPPGYEAYECRGVCNYPLAEHLTPTKHAIIQALVHLKNSQKASKACCVPTKLEPISILYLDKGVVTYKFKYEGMAVSECGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 72 of each chain. Predicted disulphide bond formation between cysteine residues at positions 7 and 73, 36 and 105, and 40 and 107",,,
4880,BMP-15,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95972,,QADGISAEVTASSSKHSGPENNQCSLHPFQISFRQLGWDHWIIAPPFYTPNYCKGTCLRVLRDGLNSPNHAIIQNLINQLVDQSVPRPSCVPYKYVPISVLMIEANGSILYKEYEGMIAESCTCR,,"The active peptide is a homodimer, which in contrast to other bone-morphogentic proteins is not disulphide linked. C-terminal glutamine residue is pyrrolidone carboxylic acid; serine residue at position 6 is phosphoserine; threonine resdiue at position 10 is O-linked glycosylated; asparagine resdiue at position 106 is predicted to be N-linked glycosylated; predicted disulphide bond formation between cysteine residues at positions 24 and 90, 53 and 122, and 57 and 124",,,
4881,BMP-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12643,,QAKHKQRKRLKSSCKRHPLYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPLADHLNSTNHAIVQTLVNSVNSKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 78. Disulphide bonds within each chain between cysteine resdiues at positions 14 and 79, 43 and 111, and 47 and 113",,,
4882,BMP-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12645,,QWIEPRNCARRYLKVDFADIGWSEWIISPKSFDAYYCSGACQFPMPKSLKPSNHATIQSIVRAVGVVPGIPEPCCVPEKMSSLSILFFDENKNVVLKVYPNMTVESCACR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 74. Disulphide bonds within each chain between cysteine resdiues at positions 8 and 77, 37 and 107, and 41 and 109;; predicted N-linked glycosylation of asparagine residue at position 101",,,
4883,BMP-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12644,,SPKHHSQRARKKNKNCRRHSLYVDFSDVGWNDWIVAPPGYQAFYCHGDCPFPLADHLNSTNHAIVQTLVNSVNSSIPKACCVPTELSAISMLYLDEYDKVVLKNYQEMVVEGCGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 80. Predicted N-linked glycosylation of asparagine residues at positions 58 and 73, and predicted disulphide bond formation between cysteine residues at positions 16 and 81, 45 and 113, and 49 and 115",,,
4884,BMP-5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P22003,,AANKRKNQNRNKSSSHQDSSRMSSVGDYNTSEQKQACKKHELYVSFRDLGWQDWIIAPEGYAAFYCDGECSFPLNAHMNATNHAIVQTLVHLMFPDHVPKPCCAPTKLNAISVLYFDDSSNVILKKYRNMVVRSCGCH,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 102 of each chain. Predicted N-linked glycososylation of asparagine residues at positions 11, 29 and 79. Predicted disulphide bond formation between cysteine residues at positions 37 and 103, 66 and 135, and 70 and 137",,,
4885,BMP-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P22004,,SASSRRRQQSRNRSTQSQDVARVSSASDYNSSELKTACRKHELYVSFQDLGWQDWIIAPKGYAANYCDGECSFPLNAHMNATNHAIVQTLVHLMNPEYVPKPCCAPTKLNAISVLYFDDNSNVILKKYRNMVVRACGCH,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 103 of each chain. Predicted N-linked glycososylation of asparagine residues at positions 12, 30 and 80. Predicted disulphide bond formation between cysteine residues at positions 38 and 104, 67 and 136, and 71 and 138",,,
4886,BMP-7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P18075,eptotermin alfa,STGSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHELYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATNHAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILKKYRNMVVRACGCH,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 103 of each chain. Predicted N-linked glycososylation of asparagine residues at positions 10, 29 and 80. Disulphide bond formation between cysteine residues at positions 38 and 104, 67 and 136, and 71 and 138",,,
4887,BMP-8A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q7Z5Y6,,AVRPLRRRQPKKSNELPQANRLPGIFDDVRGSHGRQVCRRHELYVSFQDLGWLDWVIAPQGYSAYYCEGECSFPLDSCMNATNHAILQSLVHLMKPNAVPKACCAPTKLSATSVLYYDSSNNVILRKHRNMVVKACGCH,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 103 of each chain. Predicted N-linked glycososylation of asparagine residue at position 80. Predicted disulphide bond formation between cysteine residues at positions 38 and 101, 67 and 136, and 71 and 138",,,
4888,BMP-8B,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P34820,,AVRPLRRRQPKKSNELPQANRLPGIFDDVHGSHGRQVCRRHELYVSFQDLGWLDWVIAPQGYSAYYCEGECSFPLDSCMNATNHAILQSLVHLMMPDAVPKACCAPTKLSATSVLYYDSSNNVILRKHRNMVVKACGCH,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 103 of each chain. Predicted N-linked glycososylation of asparagine residue at position 80. Predicted disulphide bond formation between cysteine residues at positions 38 and 104, 67 and 136, and 71 and 138",,,
4889,BMP-9,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UK05,,SAGAGSHCQKTSLRVNFEDIGWDSWIIAPKEYEAYECKGGCFFPLADDVTPTKHAIVQTLVHLKFPTKVGKACCVPTKLSPISVLYKDDMGVPTLKYHYEGMSVAECGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 73 of each chain. Disulphide bond formation between cysteine residues at positions 8 and 74, 37 and 107, and 41 and 109",,,
4058,bovine adrenal medulla peptide 8-22,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01210,,VGRPEWWMDYQKRYG,Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)Cc1ccc(cc1)O)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)CNC(=O)[C@H](C(C)C)N)CCCNC(=N)N)CCC(=O)O)CCSC)CC(=O)O)Cc1ccc(cc1)O)CCC(=O)N,GOEYECACIBFJGZ-NPAGUKBMSA-N
649,bradykinin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P08934|O08677|P01042,,RPPGFSPFR,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,None.,,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N,QXZGBUJJYSLZLT-FDISYFBBSA-N
4890,brain natriuretic peptide,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P16860,nesiritide,SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH,Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His,Disulphide bond formation between cysteine residues at positions 1 and 112,,,
3640,C3a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01024,,SVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLAR,Ser-Val-Gln-Leu-Thr-Glu-Lys-Arg-Met-Asp-Lys-Val-Gly-Lys-Tyr-Pro-Lys-Glu-Leu-Arg-Lys-Cys-Cys-Glu-Asp-Gly-Met-Arg-Glu-Asn-Pro-Met-Arg-Phe-Ser-Cys-Gln-Arg-Arg-Thr-Arg-Phe-Ile-Ser-Leu-Gly-Glu-Ala-Cys-Lys-Lys-Val-Phe-Leu-Asp-Cys-Cys-Asn-Tyr-Ile-Thr-Glu-Leu-Arg-Arg-Gln-His-Ala-Arg-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg,"There are 3 disulfide bonds formed between the cysteine residues at positions 22 and 49, 23 and 56, 36 and 57.",,,
3641,C3a,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01027,,SVQLMERRMDKAGQYTDKGLRKCCEDGMRDIPMRYSCQRRARLITQGENCIKAFIDCCNHITKLREQHRRDHVLGLAR,Ser-Val-Gln-Leu-Met-Glu-Arg-Arg-Met-Asp-Lys-Ala-Gly-Gln-Tyr-Thr-Asp-Lys-Gly-Leu-Arg-Lys-Cys-Cys-Glu-Asp-Gly-Met-Arg-Asp-Ile-Pro-Met-Arg-Tyr-Ser-Cys-Gln-Arg-Arg-Ala-Arg-Leu-Ile-Thr-Gln-Gly-Glu-Asn-Cys-Ile-Lys-Ala-Phe-Ile-Asp-Cys-Cys-Asn-His-Ile-Thr-Lys-Leu-Arg-Glu-Gln-His-Arg-Arg-Asp-His-Val-Leu-Gly-Leu-Ala-Arg,"There are 3 disulfide bonds formed between Cysteine residues at positions 23 and 50, 24 and 57, 37 and 58.",,,
3642,C3a,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,SVQLMERRMDKAGQYTDKGLRKCCEDGMRDIPMPYSCQRRARLITQGESCLKAFMDCCNYITKLREQHRRDHVLGLAR,Ser-Val-Gln-Leu-Met-Glu-Arg-Arg-Met-Asp-Lys-Ala-Gly-Gln-Tyr-Thr-Asp-Lys-Gly-Leu-Arg-Lys-Cys-Cys-Glu-Asp-Gly-Met-Arg-Asp-Ile-Pro-Met-Pro-Tyr-Ser-Cys-Gln-Arg-Arg-Ala-Arg-Leu-Ile-Thr-Gln-Gly-Glu-Ser-Cys-Leu-Lys-Ala-Phe-Met-Asp-Cys-Cys-Asn-Tyr-Ile-Thr-Lys-Leu-Arg-Glu-Gln-His-Arg-Arg-Asp-His-Val-Leu-Gly-Leu-Ala-Arg,"There are 3 disulfide bonds formed between cysteine residues at positions 23 and 50, 24 and 57, 37 and 58.",,,
5367,C3a des Arg,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01024,,SVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLA,Ser-Val-Gln-Leu-Thr-Glu-Lys-Arg-Met-Asp-Lys-Val-Gly-Lys-Tyr-Pro-Lys-Glu-Leu-Arg-Lys-Cys-Cys-Glu-Asp-Gly-Met-Arg-Glu-Asn-Pro-Met-Arg-Phe-Ser-Cys-Gln-Arg-Arg-Thr-Arg-Phe-Ile-Ser-Leu-Gly-Glu-Ala-Cys-Lys-Lys-Val-Phe-Leu-Asp-Cys-Cys-Asn-Tyr-Ile-Thr-Glu-Leu-Arg-Arg-Gln-His-Ala-Arg-Ala-Ser-His-Leu-Gly-Leu-Ala,,,,
6547,C4a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0C0L4,,NVNFQKAINEKLGQYASPTAKRCCQDGVTRLPMMRSCEQRAARVQQPDCREPFLSCCQFAESLRKKSRDKGQAGLQR,Asn-Val-Asn-Phe-Gln-Lys-Ala-Ile-Asn-Glu-Lys-Leu-Gly-Gln-Tyr-Ala-Ser-Pro-Thr-Ala-Lys-Arg-Cys-Cys-Gln-Asp-Gly-Val-Thr-Arg-Leu-Pro-Met-Met-Arg-Ser-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Val-Gln-Gln-Pro-Asp-Cys-Arg-Glu-Pro-Phe-Leu-Ser-Cys-Cys-Gln-Phe-Ala-Glu-Ser-Leu-Arg-Lys-Lys-Ser-Arg-Asp-Lys-Gly-Gln-Ala-Gly-Leu-Gln-Arg,"Predicted disulphide bond formation between cysteine residues at positions 22 and 48, 23 and 55, and 36 and 56.",,,
3576,C5a,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,NLHLLRQKIEEQAAKYKHSVPKKCCYDGARVNFYETCEERVARVTIGPLCIRAFNECCTIANKIRKESPHKPVQLGR,Asn-Leu-His-Leu-Leu-Arg-Gln-Lys-Ile-Glu-Glu-Gln-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Pro-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Arg-Val-Asn-Phe-Tyr-Glu-Thr-Cys-Glu-Glu-Arg-Val-Ala-Arg-Val-Thr-Ile-Gly-Pro-Leu-Cys-Ile-Arg-Ala-Phe-Asn-Glu-Cys-Cys-Thr-Ile-Ala-Asn-Lys-Ile-Arg-Lys-Glu-Ser-Pro-His-Lys-Pro-Val-Gln-Leu-Gly-Arg,,,,
3577,C5a,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08650,,DLQLLHQKVEEQAAKYKHRVPKKCCYDGARENKYETCEQRVARVTIGPHCIRAFNECCTIADKIRKESHHKGMLLGR,Asp-Leu-Gln-Leu-Leu-His-Gln-Lys-Val-Glu-Glu-Gln-Ala-Ala-Lys-Tyr-Lys-His-Arg-Val-Pro-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Arg-Glu-Asn-Lys-Tyr-Glu-Thr-Cys-Glu-Gln-Arg-Val-Ala-Arg-Val-Thr-Ile-Gly-Pro-His-Cys-Ile-Arg-Ala-Phe-Asn-Glu-Cys-Cys-Thr-Ile-Ala-Asp-Lys-Ile-Arg-Lys-Glu-Ser-His-His-Lys-Gly-Met-Leu-Leu-Gly-Arg,,,,
573,C5a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01031,,TLQKKIEEIAAKYKHSVVKKCCYDGACVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISHKDMQLGR,Thr-Leu-Gln-Lys-Lys-Ile-Glu-Glu-Ile-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Val-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Cys-Val-Asn-Asn-Asp-Glu-Thr-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-Cys-Cys-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg,,,,
574,C5a des-Arg,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,TLQKKIEEIAAKYKHSVVKKCCYDGACVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISHKDMQLG,Thr-Leu-Gln-Lys-Lys-Ile-Glu-Glu-Ile-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Val-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Cys-Val-Asn-Asn-Asp-Glu-Thr-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-Cys-Cys-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly,C5a des-ARG is one C-terminal amino acid shorter than C5a due to degradation by the serum enzyme carboxypeptidase B,,,
685,calcitonin,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01258,calcitonin,CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP,Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2,The C-terminal proline is amidated into Pro-NH2 and disulphide bridge forms between cysteine residues at positions 1 and 7.,,,
3586,calcitonin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01257|P70160,,CGNLSTCMLGTYTQDLNKFHTFPQTSIGVEAP,Cys-Gly-(GlcNAc)Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Leu-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ser-Ile-Gly-Val-Glu-Ala-Pro-NH2,"The C-terminal proline is amidated into Pro-NH2, a disulphide bridge is formed between the cysteine residues at positions 1 and 7 and the asparagine residue at position 3 is N-linked glycosylated.",,,
2351,calmodulin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P62158,,ADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK,,"Residue 1 is N-acetylalanine; residues 13, 21 and 94 are N6-acetyllysine; residues 99 and 138 are phosphotyrosine; residue 115 is N6,N6,N6-trimethyllysine; residue 44 is predicted to be phosphothreonine",,,
4906,cardiotrophin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q16619,,MSRREGSLEDPQTDSSVSLLPHLEAKIRQTHSLAHLLTKYAEQLLQEYVQLQGDPFGLPSFSPPRLPVAGLSAPAPSHAGLPVHERLRLDAAALAALPPLLDAVCRRQAELNPRAPRLLRRLEDAARQARALGAAVEALLAALGAANRGPRAEPPAATASAASATGVFPAKVLGLRVCGLYREWLSRTEGDLGQLLPGGSA,,,,,
4895,cardiotrophin-like cytokine factor 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBD9,,LNRTGDPGPGPSIQKTYDLTRYLEHQLRSLAGTYLNYLGPPFNEPDFNPPRLGAETLPRATVDLEVWRSLNDKLRLTQNYEAYSHLLCYLRGLNRQAATAELRRSLAHFCTSLQGLLGSIAGVMAALGYPLPQPLPGTEPTWTPGPAHSDFLQKMDDFWLLKELQTWLWRSAKDFNRLKKKMQPPAAAVTLHLGAHGF,,Predicted N-linked glycosylation of asparagine residue at position 2,,,
3572,cathepsin G,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P17977,,IIGGREARPNSHPYMAFLLIGSPEGLSACGGFLVREDFVLTAGHCFGSSINVTLGAHNIRRGEGTGGHITVLRAIRHPDYNPPPVIQNDIMLLQLRSRARRSRAVKPVALPQATKRVQPGALCTVAGWGLVSQRRGTNVLQEVKLRVQTDQTCANRFQFYNSQTQICVGNPRERKSAFKGDSGGPLVCNNVAQGIVSYGSSSGNPPAVFTRIQSFMPWIKRTMRRLSSRY,Ile-Ile-Gly-Gly-Arg-Glu-Ala-Arg-Pro-Asn-Ser-His-Pro-Tyr-Met-Ala-Phe-Leu-Leu-Ile-Gly-Ser-Pro-Glu-Gly-Leu-Ser-Ala-Cys-Gly-Gly-Phe-Leu-Val-Arg-Glu-Asp-Phe-Val-Leu-Thr-Ala-Gly-His-Cys-Phe-Gly-Ser-Ser-Ile-Asn-Val-Thr-Leu-Gly-Ala-His-Asn-Ile-Arg-Arg-Gly-Glu-Gly-Thr-Gly-Gly-His-Ile-Thr-Val-Leu-Arg-Ala-Ile-Arg-His-Pro-Asp-Tyr-Asn-Pro-Pro-Pro-Val-Ile-Gln-Asn-Asp-Ile-Met-Leu-Leu-Gln-Leu-Arg-Ser-Arg-Ala-Arg-Arg-Ser-Arg-Ala-Val-Lys-Pro-Val-Ala-Leu-Pro-Gln-Ala-Thr-Lys-Arg-Val-Gln-Pro-Gly-Ala-Leu-Cys-Thr-Val-Ala-Gly-Trp-Gly-Leu-Val-Ser-Gln-Arg-Arg-Gly-Thr-Asn-Val-Leu-Gln-Glu-Val-Lys-Leu-Arg-Val-Gln-Thr-Asp-Gln-Thr-Cys-Ala-Asn-Arg-Phe-Gln-Phe-Tyr-Asn-Ser-Gln-Thr-Gln-Ile-Cys-Val-Gly-Asn-Pro-Arg-Glu-Arg-Lys-Ser-Ala-Phe-Lys-Gly-Asp-Ser-Gly-Gly-Pro-Leu-Val-Cys-Asn-Asn-Val-Ala-Gln-Gly-Ile-Val-Ser-Tyr-Gly-Ser-Ser-Ser-Gly-Asn-Pro-Pro-Ala-Val-Phe-Thr-Arg-Ile-Gln-Ser-Phe-Met-Pro-Trp-Ile-Lys-Arg-Thr-Met-Arg-Arg-Leu-Ser-Ser-Arg-Tyr,not known,,,
3571,cathepsin G,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P28293,,IIGGREARPHSYPYMAFLLIQSPEGLSACGGFLVREDFVLTAAHCLGSSINVTLGAHNIQMRERTQQLITVLRAIRHPDYNPQNIRNDIMLLQLRRRARRSGSVKPVALPQASKKLQPGDLCTVAGWGRVSQSRGTNVLQEVQLRVQMDQMCANRFQFYNSQTQICVGNPRERKSAFRGDSGGPLVCSNVAQGIVSYGSNNGNPPAVFTKIQSFMPWIKRTMRRFAPRYQRPANSLSQAQ,Ile-Ile-Gly-Gly-Arg-Glu-Ala-Arg-Pro-His-Ser-Tyr-Pro-Tyr-Met-Ala-Phe-Leu-Leu-Ile-Gln-Ser-Pro-Glu-Gly-Leu-Ser-Ala-Cys-Gly-Gly-Phe-Leu-Val-Arg-Glu-Asp-Phe-Val-Leu-Thr-Ala-Ala-His-Cys-Leu-Gly-Ser-Ser-Ile-(GlcNAc)Asn-Val-Thr-Leu-Gly-Ala-His-Asn-Ile-Gln-Met-Arg-Glu-Arg-Thr-Gln-Gln-Leu-Ile-Thr-Val-Leu-Arg-Ala-Ile-Arg-His-Pro-Asp-Tyr-Asn-Pro-Gln-Asn-Ile-Arg-Asn-Asp-Ile-Met-Leu-Leu-Gln-Leu-Arg-Arg-Arg-Ala-Arg-Arg-Ser-Gly-Ser-Val-Lys-Pro-Val-Ala-Leu-Pro-Gln-Ala-Ser-Lys-Lys-Leu-Gln-Pro-Gly-Asp-Leu-Cys-Thr-Val-Ala-Gly-Trp-Gly-Arg-Val-Ser-Gln-Ser-Arg-Gly-Thr-Asn-Val-Leu-Gln-Glu-Val-Gln-Leu-Arg-Val-Gln-Met-Asp-Gln-Met-Cys-Ala-Asn-Arg-Phe-Gln-Phe-Tyr-Asn-Ser-Gln-Thr-Gln-Ile-Cys-Val-Gly-Asn-Pro-Arg-Glu-Arg-Lys-Ser-Ala-Phe-Arg-Gly-Asp-Ser-Gly-Gly-Pro-Leu-Val-Cys-Ser-Asn-Val-Ala-Gln-Gly-Ile-Val-Ser-Tyr-Gly-Ser-Asn-Asn-Gly-Asn-Pro-Pro-Ala-Val-Phe-Thr-Lys-Ile-Gln-Ser-Phe-Met-Pro-Trp-Ile-Lys-Arg-Thr-Met-Arg-Arg-Phe-Ala-Pro-Arg-Tyr-Gln-Arg-Pro-Ala-Asn-Ser-Leu-Ser-Gln-Ala-Gln-Thr,"The asparagine residue at position 51 is N-linked glycosylated; there are 3 disulfide bonds formed between cysteine residues at positions 29 and 45, 122 and 187, and 152 and 166.",,,
3570,cathepsin G,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08311,,IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNNVAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMRSFKLLDQMETPL,Ile-Ile-Gly-Gly-Arg-Glu-Ser-Arg-Pro-His-Ser-Arg-Pro-Tyr-Met-Ala-Tyr-Leu-Gln-Ile-Gln-Ser-Pro-Ala-Gly-Gln-Ser-Arg-Cys-Gly-Gly-Phe-Leu-Val-Arg-Glu-Asp-Phe-Val-Leu-Thr-Ala-Ala-His-Cys-Trp-Gly-Ser-Asn-Ile-(GlcNAc)Asn-Val-Thr-Leu-Gly-Ala-His-Asn-Ile-Gln-Arg-Arg-Glu-Asn-Thr-Gln-Gln-His-Ile-Thr-Ala-Arg-Arg-Ala-Ile-Arg-His-Pro-Gln-Tyr-Asn-Gln-Arg-Thr-Ile-Gln-Asn-Asp-Ile-Met-Leu-Leu-Gln-Leu-Ser-Arg-Arg-Val-Arg-Arg-Asn-Arg-Asn-Val-Asn-Pro-Val-Ala-Leu-Pro-Arg-Ala-Gln-Glu-Gly-Leu-Arg-Pro-Gly-Thr-Leu-Cys-Thr-Val-Ala-Gly-Trp-Gly-Arg-Val-Ser-Met-Arg-Arg-Gly-Thr-Asp-Thr-Leu-Arg-Glu-Val-Gln-Leu-Arg-Val-Gln-Arg-Asp-Arg-Gln-Cys-Leu-Arg-Ile-Phe-Gly-Ser-Tyr-Asp-Pro-Arg-Arg-Gln-Ile-Cys-Val-Gly-Asp-Arg-Arg-Glu-Arg-Lys-Ala-Ala-Phe-Lys-Gly-Asp-Ser-Gly-Gly-Pro-Leu-Leu-Cys-Asn-Asn-Val-Ala-His-Gly-Ile-Val-Ser-Tyr-Gly-Lys-Ser-Ser-Gly-Val-Pro-Pro-Glu-Val-Phe-Thr-Arg-Val-Ser-Ser-Phe-Leu-Pro-Trp-Ile-Arg-Thr-Thr-Met-Arg-Ser-Phe-Lys-Leu-Leu-Asp-Gln-Met-Glu-Thr-Pro-Leu,"The asparagine residue at position 51 is N-linked glycosylated and there are 3 disulfide bonds formed between the cysteine residues at positions 29 and 45, 122 and 187, and 152 and 166.",,,
3550,CCK-33,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09240,,KAPSGRMSVLKNLQSLDPSHRISDRDYMGWMDF,Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Val-Leu-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated and the tyrosine residue at position 27 is sulfated, as indicated by Tys which represents Tyr(SO3H).",,,
860,CCK-33,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06307,,KAPSGRMSIVKNLQNLDPSHRISDRDYMGWMDF,Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated and the tyrosine residue at position 27 is sulfated, as indicated by Tys which represents Tyr(SO3H).",,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)CCSC)c1ccc(cc1)OS(=O)(=O)O)CC(=O)O)CCCNC(=N)N)CC(=O)O)CO)C(CC)C)CCCNC(=N)N)Cc1nc[nH]c1)CO)CC(=O)O)CC(C)C)CC(=O)N)CCC(=O)N)CC(C)C)CC(=O)N)NC(=O)C(C(C)C)NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(CCCCN)N)C)CO)CCCNC(=N)N)CCSC)CO,QFLBZJPOIZFFJQ-UHFFFAOYSA-N
3551,CCK-33,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01355,,KAPSGRMSVLKNLQGLDPSHRISDRDYMGWMDF,Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Val-Leu-Lys-Asn-Leu-Gln-Gly-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated and the tyrosine residue at position 27 is sulfated, as indicated by Tys which represents Tyr(SO3H).",,,
10221,CCK-39,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,YIQQARKAPSGRMSIVKNLQNLDPSHRISDRDYMGWMDF,Tyr-Ile-Gln-Gln-Ala-Arg-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe,,,,
861,CCK-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06307,,WMDF,Trp-Met-Asp-Phe-NH2,,,CSCCC(C(=O)NC(C(=O)NC(C(=O)N)Cc1ccccc1)CC(=O)O)NC(=O)C(Cc1c[nH]c2c1cccc2)N,RGYLYUZOGHTBRF-UHFFFAOYSA-N
3554,CCK-58,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01355,,AVLRPDSEPRARLGALLARYIQQVRKAPSGRMSVLKNLQGLDPSHRISDRDYMGWMDF,Ala-Val-Leu-Arg-Pro-Asp-Ser-Glu-Pro-Arg-Ala-Arg-Leu-Gly-Ala-Leu-Leu-Ala-Arg-Tyr-Ile-Gln-Gln-Val-Arg-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Val-Leu-Lys-Asn-Leu-Gln-Gly-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated and the tyrosine residue at position 52 is sulfated, as indicated by Tys which represents Tyr(SO3H).",,,
3553,CCK-58,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09240,,AVLRTDGEPRARLGALLARYIQQVRKAPSGRMSVLKNLQSLDPSHRISDRDYMGWMDF,Ala-Val-Leu-Arg-Thr-Asp-Gly-Glu-Pro-Arg-Ala-Arg-Leu-Gly-Ala-Leu-Leu-Ala-Arg-Tyr-Ile-Gln-Gln-Val-Arg-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Val-Leu-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated and the tyrosine residue at position 52 is sulfated, as indicated by Tys which represents Tyr(SO3H).",,,
3552,CCK-58,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06307,,VSQRTDGESRAHLGALLARYIQQARKAPSGRMSIVKNLQNLDPSHRISDRDYMGWMDF,Val-Ser-Gln-Arg-Thr-Asp-Gly-Glu-Ser-Arg-Ala-His-Leu-Gly-Ala-Leu-Leu-Ala-Arg-Tyr-Ile-Gln-Gln-Ala-Arg-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Ile-Val-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated and the tyrosine residue at position 52 is sulfated, as indicated by Tys which represents Tyr(SO3H).",,,
864,CCK-8,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01355|P09240|P06307,sincalide,DYMGWMDF,Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,"The C-terminal phenylalanine is amidated; the tyrosine residue at position 2 is sulfated, as indicated by Tys, which represents Tyr(SO3H).",,CSCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)OS(=O)(=O)O,IZTQOLKUZKXIRV-YRVFCXMDSA-N
812,CCL1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P22362,,KSMQVPFSRCCFSFAEQEIPLRAILCYRNTSSICSNEGLIFKLKRGKEACALDTVGWVQRHRKMLRHCPSKRK,Lys-Ser-Met-Gln-Val-Pro-Phe-Ser-Arg-Cys-Cys-Phe-Ser-Phe-Ala-Glu-Gln-Glu-Ile-Pro-Leu-Arg-Ala-Ile-Leu-Cys-Tyr-Arg-Asn-Thr-Ser-Ser-Ile-Cys-Ser-Asn-Glu-Gly-Leu-Ile-Phe-Lys-Leu-Lys-Arg-Gly-Lys-Glu-Ala-Cys-Ala-Leu-Asp-Thr-Val-Gly-Trp-Val-Gln-Arg-His-Arg-Lys-Met-Leu-Arg-His-Cys-Pro-Ser-Lys-Arg-Lys,,,,
4404,CCL1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10146,,KSMLTVSNSCCLNTLKKELPLKFIQCYRKMGSSCPDPPAVVFRLNKGRESCASTNKTWVQNHLKKVNPC,Lys-Ser-Met-Leu-Thr-Val-Ser-Asn-Ser-Cys-Cys-Leu-Asn-Thr-Leu-Lys-Lys-Glu-Leu-Pro-Leu-Lys-Phe-Ile-Gln-Cys-Tyr-Arg-Lys-Met-Gly-Ser-Ser-Cys-Pro-Asp-Pro-Pro-Ala-Val-Val-Phe-Arg-Leu-Asn-Lys-Gly-Arg-Glu-Ser-Cys-Ala-Ser-Thr-Asn-Lys-Thr-Trp-Val-Gln-Asn-His-Leu-Lys-Lys-Val-Asn-Pro-Cys,,,,
769,CCL11,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P51671,,GPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP,Gly-Pro-Ala-Ser-Val-Pro-Thr-Thr-Cys-Cys-Phe-Asn-Leu-Ala-Asn-Arg-Lys-Ile-Pro-Leu-Gln-Arg-Leu-Glu-Ser-Tyr-Arg-Arg-Ile-Thr-Ser-Gly-Lys-Cys-Pro-Gln-Lys-Ala-Val-Ile-Phe-Lys-Thr-Lys-Leu-Ala-Lys-Asp-Ile-Cys-Ala-Asp-Pro-Lys-Lys-Lys-Trp-Val-Gln-Asp-Ser-Met-Lys-Tyr-Leu-Asp-Gln-Lys-Ser-Pro-Thr-Pro-Lys-Pro,"Biologically active, differentially O-glycosylated forms have been identified.",,,
787,CCL11,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48298,,HPGSIPTSCCFIMTSKKIPNTLLKSYKRITNNRCTLKAIVFKTRLGKEICADPKKKWVQDATKHLDQKLQTPKP,His-Pro-Gly-Ser-Ile-Pro-Thr-Ser-Cys-Cys-Phe-Ile-Met-Thr-Ser-Lys-Lys-Ile-Pro-Asn-Thr-Leu-Leu-Lys-Ser-Tyr-Lys-Arg-Ile-Thr-Asn-Asn-Arg-Cys-Thr-Leu-Lys-Ala-Ile-Val-Phe-Lys-Thr-Arg-Leu-Gly-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Lys-Lys-Lys-Trp-Val-Gln-Asp-Ala-Thr-Lys-His-Leu-Asp-Gln-Lys-Leu-Gln-Thr-Pro-Lys-Pro,"O-linked glycoslylation of residue 71 and disulphide bond formation between cysteine residues at postions 9 and 34, and 10 and 50",,,
4416,CCL11,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P97545,,HPGSIPTSCCFTMTSKKIPNTLLKSYKRITNNRCTLKAIVFKTKLGKEICADPKKKWVQDATKHLDQKLQTPKP,His-Pro-Gly-Ser-Ile-Pro-Thr-Ser-Cys-Cys-Phe-Thr-Met-Thr-Ser-Lys-Lys-Ile-Pro-Asn-Thr-Leu-Leu-Lys-Ser-Tyr-Lys-Arg-Ile-Thr-Asn-Asn-Arg-Cys-Thr-Leu-Lys-Ala-Ile-Val-Phe-Lys-Thr-Lys-Leu-Gly-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Lys-Lys-Lys-Trp-Val-Gln-Asp-Ala-Thr-Lys-His-Leu-Asp-Gln-Lys-Leu-Gln-Thr-Pro-Lys-Pro,,,,
4435,CCL12,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q62401,,GPDAVSTPVTCCYNVVKQKIHVRKLKSYRRITSSQCPREAVIFRTILDKEICADPKEKWVKNSINHLDKTSQTFILEPSCLG,Gly-Pro-Asp-Ala-Val-Ser-Thr-Pro-Val-Thr-Cys-Cys-Tyr-Asn-Val-Val-Lys-Gln-Lys-Ile-His-Val-Arg-Lys-Leu-Lys-Ser-Tyr-Arg-Arg-Ile-Thr-Ser-Ser-Gln-Cys-Pro-Arg-Glu-Ala-Val-Ile-Phe-Arg-Thr-Ile-Leu-Asp-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Lys-Glu-Lys-Trp-Val-Lys-Asn-Ser-Ile-Asn-His-Leu-Asp-Lys-Thr-Ser-Gln-Thr-Phe-Ile-Leu-Glu-Pro-Ser-Cys-Leu-Gly,,,,
770,CCL13,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99616,,FNPQGLAQPDALNVPSTCCFTFSSKKISLQRLKSYVITTSRCPQKAVIFRTKLGKEICADPKEKWVQNYMKHLGRKAHTLKT,Phe-Asn-Pro-Gln-Gly-Leu-Ala-Gln-Pro-Asp-Ala-Leu-Asn-Val-Pro-Ser-Thr-Cys-Cys-Phe-Thr-Phe-Ser-Ser-Lys-Lys-Ile-Ser-Leu-Gln-Arg-Leu-Lys-Ser-Tyr-Val-Ile-Thr-Thr-Ser-Arg-Cys-Pro-Gln-Lys-Ala-Val-Ile-Phe-Arg-Thr-Lys-Leu-Gly-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Lys-Glu-Lys-Trp-Val-Gln-Asn-Tyr-Met-Lys-His-Leu-Gly-Arg-Lys-Ala-His-Thr-Leu-Lys-Thr,2 N-terminally cleaved forms have been identified to exist in low abundance.,,,
753,CCL14,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q16627,,TKTESSSRGPYHPSECCFTYTTYKIPRQRIMDYYETNSQCSKPGIVFITKRGHSVCTNPSDKWVQDYIKDMKEN,Thr-Lys-Thr-Glu-Ser-Ser-Ser-Arg-Gly-Pro-Tyr-His-Pro-Ser-Glu-Cys-Cys-Phe-Thr-Tyr-Thr-Thr-Tyr-Lys-Ile-Pro-Arg-Gln-Arg-Ile-Met-Asp-Tyr-Tyr-Glu-Thr-Asn-Ser-Gln-Cys-Ser-Lys-Pro-Gly-Ile-Val-Phe-Ile-Thr-Lys-Arg-Gly-His-Ser-Val-Cys-Thr-Asn-Pro-Ser-Asp-Lys-Trp-Val-Gln-Asp-Tyr-Ile-Lys-Asp-Met-Lys-Glu-Asn,Glycosylated CCL14 is one of the predominant forms. N-terminally truncated forms are also identified . For further information see UniProt,,,
754,CCL15,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q16663,,QFINDAETELMMSKLPLENPVVLNSFHFAADCCTSYISQSIPCSLMKSYFETSSECSKPGVIFLTKKGRQVCAKPSGPGVQDCMKKLKPYSI,Gln-Phe-Ile-Asn-Asp-Ala-Glu-Thr-Glu-Leu-Met-Met-Ser-Lys-Leu-Pro-Leu-Glu-Asn-Pro-Val-Val-Leu-Asn-Ser-Phe-His-Phe-Ala-Ala-Asp-Cys-Cys-Thr-Ser-Tyr-Ile-Ser-Gln-Ser-Ile-Pro-Cys-Ser-Leu-Met-Lys-Ser-Tyr-Phe-Glu-Thr-Ser-Ser-Glu-Cys-Ser-Lys-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Lys-Gly-Arg-Gln-Val-Cys-Ala-Lys-Pro-Ser-Gly-Pro-Gly-Val-Gln-Asp-Cys-Met-Lys-Lys-Leu-Lys-Pro-Tyr-Ser-Ile,"3 N-terminally truncated forms are found (CCL15(22-92), CCL15(25-92), CCL15(29-92))",,,
1272,CCL16,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15467,,QPKVPEWVNTPSTCCLKYYEKVLPRRLVVGYRKALNCHLPAIIFVTKRNREVCTNPNDDWVQEYIKDPNLPLLPTRNLSTVKIITAKNGQPQLLNSQ,Gln-Pro-Lys-Val-Pro-Glu-Trp-Val-Asn-Thr-Pro-Ser-Thr-Cys-Cys-Leu-Lys-Tyr-Tyr-Glu-Lys-Val-Leu-Pro-Arg-Arg-Leu-Val-Val-Gly-Tyr-Arg-Lys-Ala-Leu-Asn-Cys-His-Leu-Pro-Ala-Ile-Ile-Phe-Val-Thr-Lys-Arg-Asn-Arg-Glu-Val-Cys-Thr-Asn-Pro-Asn-Asp-Asp-Trp-Val-Gln-Glu-Tyr-Ile-Lys-Asp-Pro-Asn-Leu-Pro-Leu-Leu-Pro-Thr-Arg-Asn-Leu-Ser-Thr-Val-Lys-Ile-Ile-Thr-Ala-Lys-Asn-Gly-Gln-Pro-Gln-Leu-Leu-Asn-Ser-Gln,,,,
797,CCL17,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q92583,,ARGTNVGRECCLEYFKGAIPLRKLKTWYQTSEDCSRDAIVFVTVQGRAICSDPNNKRVKNAVKYLQSLERS,Ala-Arg-Gly-Thr-Asn-Val-Gly-Arg-Glu-Cys-Cys-Leu-Glu-Tyr-Phe-Lys-Gly-Ala-Ile-ProLeu-Arg-Lys-Leu-Lys-Thr-Trp-Tyr-Gln-Thr-Ser-Glu-Asp-Cys-Ser-Arg-Asp-Ala-Ile-Val-Phe-Val-Thr-Val-Gln-Gly-Arg-Ala-Ile-Cys-Ser-Asp-Pro-Asn-Asn-Lys-Arg-Val-Lys-Asn-Ala-Val-Lys-Tyr-Leu-Gln-Ser-Leu-Glu-Arg-Ser,,,,
4382,CCL18,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55774,,AQVGTNKELCCLVYTSWQIPQKFIVDYSETSPQCPKPGVILLTKRGRQICADPNKKWVQKYISDLKLNA,Ala-Gln-Val-Gly-Thr-Asn-Lys-Glu-Leu-Cys-Cys-Leu-Val-Tyr-Thr-Ser-Trp-Gln-Ile-Pro-Gln-Lys-Phe-Ile-Val-Asp-Tyr-Ser-Glu-Thr-Ser-Pro-Gln-Cys-Pro-Lys-Pro-Gly-Val-Ile-Leu-Leu-Thr-Lys-Arg-Gly-Arg-Gln-Ile-Cys-Ala-Asp-Pro-Asn-Lys-Lys-Trp-Val-Gln-Lys-Tyr-Ile-Ser-Asp-Leu-Lys-Leu-Asn-Ala,Disulphide bridges between cysteine residues at positions 30 and 54 and 31 and 70.,,,
810,CCL19,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99731,,GTNDAEDCCLSVTQKPIPGYIVRNFHYLLIKDGCRVPAVVFTTLRGRQLCAPPDQPWVERIIQRLQRTSAKMKRRSS,Gly-Thr-Asn-Asp-Ala-Glu-Asp-Cys-Cys-Leu-Ser-Val-Thr-Gln-Lys-Pro-Ile-Pro-Gly-Tyr-Ile-Val-Arg-Asn-Phe-His-Tyr-Leu-Leu-Ile-Lys-Asp-Gly-Cys-Arg-Val-Pro-Ala-Val-Val-Phe-Thr-Thr-Leu-Arg-Gly-Arg-Gln-Leu-Cys-Ala-Pro-Pro-Asp-Gln-Pro-Trp-Val-Glu-Arg-Ile-Ile-Gln-Arg-Leu-Gln-Arg-Thr-Ser-Ala-Lys-Met-Lys-Arg-Arg-Ser-Ser,,,,
4417,CCL19,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O70460,,GANDAEDCCLSVTQRPIPGNIVKAFRYLLNEDGCRVPAVVFTTLRGYQLCAPPDQPWVDRIIRRLKKSSAKNKGNSTRRSPVS,Gly-Ala-Asn-Asp-Ala-Glu-Asp-Cys-Cys-Leu-Ser-Val-Thr-Gln-Arg-Pro-Ile-Pro-Gly-Asn-Ile-Val-Lys-Ala-Phe-Arg-Tyr-Leu-Leu-Asn-Glu-Asp-Gly-Cys-Arg-Val-Pro-Ala-Val-Val-Phe-Thr-Thr-Leu-Arg-Gly-Tyr-Gln-Leu-Cys-Ala-Pro-Pro-Asp-Gln-Pro-Trp-Val-Asp-Arg-Ile-Ile-Arg-Arg-Leu-Lys-Lys-Ser-Ser-Ala-Lys-Asn-Lys-Gly-Asn-Ser-Thr-Arg-Arg-Ser-Pro-Val-Ser,,,,
4407,CCL2,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P14844,,QPDAVNAPLTCCYSFTGKMIPMSRLENYKRITSSRCPKEAVVFVTKLKREICADPNKEWVQKYIRKLDQNQVRSETTVFYKIASTLRTSAPLNVNLTHKSEANASTLFSTTTSSTSVEVTSMTEN,Gln-Pro-Asp-Ala-Val-Asn-Ala-Pro-Leu-Thr-Cys-Cys-Tyr-Ser-Phe-Thr-Gly-Lys-Met-Ile-Pro-Met-Ser-Arg-Leu-Glu-Asn-Tyr-Lys-Arg-Ile-Thr-Ser-Ser-Arg-Cys-Pro-Lys-Glu-Ala-Val-Val-Phe-Val-Thr-Lys-Leu-Lys-Arg-Glu-Ile-Cys-Ala-Asp-Pro-Asn-Lys-Glu-Trp-Val-Gln-Lys-Tyr-Ile-Arg-Lys-Leu-Asp-Gln-Asn-Gln-Val-Arg-Ser-Glu-Thr-Thr-Val-Phe-Tyr-Lys-Ile-Ala-Ser-Thr-Leu-Arg-Thr-Ser-Ala-Pro-Leu-Asn-Val-Asn-Leu-Thr-His-Lys-Ser-Glu-Ala-Asn-Ala-Ser-Thr-Leu-Phe-Ser-Thr-Thr-Thr-Ser-Ser-Thr-Ser-Val-Glu-Val-Thr-Ser-Met-Thr-Glu-Asn,,,,
4406,CCL2,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10148,,QPDAVNAPLTCCYSFTSKMIPMSRLESYKRITSSRCPKEAVVFVTKLKREVCADPKKEWVQTYIKNLDRNQMRSEPTTLFKTASALRSSAPLNVKLTRKSEANASTTFSTTTSSTSVGVTSVTVN,Gln-Pro-Asp-Ala-Val-Asn-Ala-Pro-Leu-Thr-Cys-Cys-Tyr-Ser-Phe-Thr-Ser-Lys-Met-Ile-Pro-Met-Ser-Arg-Leu-Glu-Ser-Tyr-Lys-Arg-Ile-Thr-Ser-Ser-Arg-Cys-Pro-Lys-Glu-Ala-Val-Val-Phe-Val-Thr-Lys-Leu-Lys-Arg-Glu-Val-Cys-Ala-Asp-Pro-Lys-Lys-Glu-Trp-Val-Gln-Thr-Tyr-Ile-Lys-Asn-Leu-Asp-Arg-Asn-Gln-Met-Arg-Ser-Glu-Pro-Thr-Thr-Leu-Phe-Lys-Thr-Ala-Ser-Ala-Leu-Arg-Ser-Ser-Ala-Pro-Leu-Asn-Val-Lys-Leu-Thr-Arg-Lys-Ser-Glu-Ala-Asn-Ala-Ser-Thr-Thr-Phe-Ser-Thr-Thr-Thr-Ser-Ser-Thr-Ser-Val-Gly-Val-Thr-Ser-Val-Thr-Val-Asn,,,,
771,CCL2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13500,,QPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT,Gln-Pro-Asp-Ala-Ile-Asn-Ala-Pro-Val-Thr-Cys-Cys-Tyr-Asn-Phe-Thr-Asn-Arg-Lys-Ile-Ser-Val-Gln-Arg-Leu-Ala-Ser-Tyr-Arg-Arg-Ile-Thr-Ser-Ser-Lys-Cys-Pro-Lys-Glu-Ala-Val-Ile-Phe-Lys-Thr-Ile-Val-Ala-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Lys-Gln-Lys-Trp-Val-Gln-Asp-Ser-Met-Asp-His-Leu-Asp-Lys-Gln-Thr-Gln-Thr-Pro-Lys-Thr,Differentially glycosylated forms have been found  as well as N-terminally and C-terminally truncated forms ,,,
4419,CCL20,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P97884,,SNFDCCLTYTKNVYHHARNFVGFTTQMADEACDINAIIFHLKSKRSVCADPKQIWVKRILHLLSLRTKKM,Ser-Asn-Phe-Asp-Cys-Cys-Leu-Thr-Tyr-Thr-Lys-Asn-Val-Tyr-His-His-Ala-Arg-Asn-Phe-Val-Gly-Phe-Thr-Thr-Gln-Met-Ala-Asp-Glu-Ala-Cys-Asp-Ile-Asn-Ala-Ile-Ile-Phe-His-Leu-Lys-Ser-Lys-Arg-Ser-Val-Cys-Ala-Asp-Pro-Lys-Gln-Ile-Trp-Val-Lys-Arg-Ile-Leu-His-Leu-Leu-Ser-Leu-Arg-Thr-Lys-Lys-Met,,,,
4418,CCL20,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O89093,,ASNYDCCLSYIQTPLPSRAIVGFTRQMADEACDINAIIFHTKKRKSVCADPKQNWVKRAVNLLSLRVKKM,Ala-Ser-Asn-Tyr-Asp-Cys-Cys-Leu-Ser-Tyr-Ile-Gln-Thr-Pro-Leu-Pro-Ser-Arg-Ala-Ile-Val-Gly-Phe-Thr-Arg-Gln-Met-Ala-Asp-Glu-Ala-Cys-Asp-Ile-Asn-Ala-Ile-Ile-Phe-His-Thr-Lys-Lys-Arg-Lys-Ser-Val-Cys-Ala-Asp-Pro-Lys-Gln-Asn-Trp-Val-Lys-Arg-Ala-Val-Asn-Leu-Leu-Ser-Leu-Arg-Val-Lys-Lys-Met,,,,
808,CCL20,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P78556,,ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM,Ala-Ser-Asn-Phe-Asp-Cys-Cys-Leu-Gly-Tyr-Thr-Asp-Arg-Ile-Leu-His-Pro-Lys-Phe-Ile-Val-Gly-Phe-Thr-Arg-Gln-Leu-Ala-Asn-Glu-Gly-Cys-Asp-Ile-Asn-Ala-Ile-Ile-Phe-His-Thr-Lys-Lys-Lys-Leu-Ser-Val-Cys-Ala-Asn-Pro-Lys-Gln-Thr-Trp-Val-Lys-Tyr-Ile-Val-Arg-Leu-Leu-Ser-Lys-Lys-Val-Lys-Asn-Met,,,,
811,CCL21,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00585,,SDGGAQDCCLKYSQRKIPAKVVRSYRKQEPSLGCSIPAILFLPRKRSQAELCADPKELWVQQLMQHLDKTPSPQKPAQGCRKDRGASKTGKKGKGSKGCKRTERSQTPKGP,Ser-Asp-Gly-Gly-Ala-Gln-Asp-Cys-Cys-Leu-Lys-Tyr-Ser-Gln-Arg-Lys-Ile-Pro-Ala-Lys-Val-Val-Arg-Ser-Tyr-Arg-Lys-Gln-Glu-Pro-Ser-Leu-Gly-Cys-Ser-Ile-Pro-Ala-Ile-Leu-Phe-Leu-Pro-Arg-Lys-Arg-Ser-Gln-Ala-Glu-Leu-Cys-Ala-Asp-Pro-Lys-Glu-Leu-Trp-Val-Gln-Gln-Leu-Met-Gln-His-Leu-Asp-Lys-Thr-Pro-Ser-Pro-Gln-Lys-Pro-Ala-Gln-Gly-Cys-Arg-Lys-Asp-Arg-Gly-Ala-Ser-Lys-Thr-Gly-Lys-Lys-Gly-Lys-Gly-Ser-Lys-Gly-Cys-Lys-Arg-Thr-Glu-Arg-Ser-Gln-Thr-Pro-Lys-Gly-Pro,,,,
8651,Ccl21a,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P84444,,MAQMMTLSLLSLVLALCIPWTQGSDGGGQDCCLKYSQKKIPYSIVRGYRKQEPSLGCPIPAILFSPRKHSKPELCANPEEGWVQNLMRRLDQPPAPGKQSPGCRKNRGTSKSGKKGKGSKGCKRTEQTQPSRG,Met-Ala-Gln-Met-Met-Thr-Leu-Ser-Leu-Leu-Ser-Leu-Val-Leu-Ala-Leu-Cys-Ile-Pro-Trp-Thr-Gln-Gly-Ser-Asp-Gly-Gly-Gly-Gln-Asp-Cys-Cys-Leu-Lys-Tyr-Ser-Gln-Lys-Lys-Ile-Pro-Tyr-Ser-Ile-Val-Arg-Gly-Tyr-Arg-Lys-Gln-Glu-Pro-Ser-Leu-Gly-Cys-Pro-Ile-Pro-Ala-Ile-Leu-Phe-Ser-Pro-Arg-Lys-His-Ser-Lys-Pro-Glu-Leu-Cys-Ala-Asn-Pro-Glu-Glu-Gly-Trp-Val-Gln-Asn-Leu-Met-Arg-Arg-Leu-Asp-Gln-Pro-Pro-Ala-Pro-Gly-Lys-Gln-Ser-Pro-Gly-Cys-Arg-Lys-Asn-Arg-Gly-Thr-Ser-Lys-Ser-Gly-Lys-Lys-Gly-Lys-Gly-Ser-Lys-Gly-Cys-Lys-Arg-Thr-Glu-Gln-Thr-Gln-Pro-Ser-Arg-Gly,,,,
8652,Ccl21b,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P86792,,MAQMMTLSLLSLVLALCIPWTQGSDGGGQDCCLKYSQKKIPYSIVRGYRKQEPSLGCPIPAILFLPRKHSKPELCANPEEGWVQNLMRRLDQPPAPGKQSPGCRKNRGTSKSGKKGKGSKGCKRTEQTQPSRG,Met-Ala-Gln-Met-Met-Thr-Leu-Ser-Leu-Leu-Ser-Leu-Val-Leu-Ala-Leu-Cys-Ile-Pro-Trp-Thr-Gln-Gly-Ser-Asp-Gly-Gly-Gly-Gln-Asp-Cys-Cys-Leu-Lys-Tyr-Ser-Gln-Lys-Lys-Ile-Pro-Tyr-Ser-Ile-Val-Arg-Gly-Tyr-Arg-Lys-Gln-Glu-Pro-Ser-Leu-Gly-Cys-Pro-Ile-Pro-Ala-Ile-Leu-Phe-Leu-Pro-Arg-Lys-His-Ser-Lys-Pro-Glu-Leu-Cys-Ala-Asn-Pro-Glu-Glu-Gly-Trp-Val-Gln-Asn-Leu-Met-Arg-Arg-Leu-Asp-Gln-Pro-Pro-Ala-Pro-Gly-Lys-Gln-Ser-Pro-Gly-Cys-Arg-Lys-Asn-Arg-Gly-Thr-Ser-Lys-Ser-Gly-Lys-Lys-Gly-Lys-Gly-Ser-Lys-Gly-Cys-Lys-Arg-Thr-Glu-Gln-Thr-Gln-Pro-Ser-Arg-Gly,,,,
4420,CCL22,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O88430,,GPYGANVEDSICCQDYIRHPLPSRLVKEFFWTSKSCRKPGVVLITVKNRDICADPRQVWVKKLLHKLS,Gly-Pro-Tyr-Gly-Ala-Asn-Val-Glu-Asp-Ser-Ile-Cys-Cys-Gln-Asp-Tyr-Ile-Arg-His-Pro-Leu-Pro-Ser-Arg-Leu-Val-Lys-Glu-Phe-Phe-Trp-Thr-Ser-Lys-Ser-Cys-Arg-Lys-Pro-Gly-Val-Val-Leu-Ile-Thr-Val-Lys-Asn-Arg-Asp-Ile-Cys-Ala-Asp-Pro-Arg-Gln-Val-Trp-Val-Lys-Lys-Leu-Leu-His-Lys-Leu-Ser,,,,
798,CCL22,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00626,,GPYGANMEDSVCCRDYVRYRLPLRVVKHFYWTSDSCPRPGVVLLTFRDKEICADPRVPWVKMILNKLSQ,Gly-Pro-Tyr-Gly-Ala-Asn-Met-Glu-Asp-Ser-Val-Cys-Cys-Arg-Asp-Tyr-Val-Arg-Tyr-Arg-Leu-Pro-Leu-Arg-Val-Val-Lys-His-Phe-Tyr-Trp-Thr-Ser-Asp-Ser-Cys-Pro-Arg-Pro-Gly-Val-Val-Leu-Leu-Thr-Phe-Arg-Asp-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Arg-Val-Pro-Trp-Val-Lys-Met-Ile-Leu-Asn-Lys-Leu-Ser-Gln,"3 N-terminally processed forms are known (MDC(3-69), MDC(5-69), MDC(7-69)) .",,,
755,CCL23,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55773,,RVTKDAETEFMMSKLPLENPVLLDRFHATSADCCISYTPRSIPCSLLESYFETNSECSKPGVIFLTKKGRRFCANPSDKQVQVCMRMLKLDTRIKTRKN,Arg-Val-Thr-Lys-Asp-Ala-Glu-Thr-Glu-Phe-Met-Met-Ser-Lys-Leu-Pro-Leu-Glu-Asn-Pro-Val-Leu-Leu-Asp-Arg-Phe-His-Ala-Thr-Ser-Ala-Asp-Cys-Cys-Ile-Ser-Tyr-Thr-Pro-Arg-Ser-Ile-Pro-Cys-Ser-Leu-Leu-Glu-Ser-Tyr-Phe-Glu-Thr-Asn-Ser-Glu-Cys-Ser-Lys-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Lys-Gly-Arg-Arg-Phe-Cys-Ala-Asn-Pro-Ser-Asp-Lys-Gln-Val-Gln-Val-Cys-Met-Arg-Met-Leu-Lys-Leu-Asp-Thr-Arg-Ile-Lys-Thr-Arg-Lys-Asn,3 N-terminally truncated forms are detected in low levels (CCL23(19-99) CCL23(22-99) CCL23(27-99) CCL23(30-99)),,,
4421,CCL24,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9JKC0,,VTIPSSCCTSFISKKIPENRVVSYQLANGSICPKAGVIFITKKGHKICTDPKLLWVQRHIQKLDAKKNQPSKGAKAVRTKFAVQRRRGNSTEV,Val-Thr-Ile-Pro-Ser-Ser-Cys-Cys-Thr-Ser-Phe-Ile-Ser-Lys-Lys-Ile-Pro-Glu-Asn-Arg-Val-Val-Ser-Tyr-Gln-Leu-Ala-Asn-Gly-Ser-Ile-Cys-Pro-Lys-Ala-Gly-Val-Ile-Phe-Ile-Thr-Lys-Lys-Gly-His-Lys-Ile-Cys-Thr-Asp-Pro-Lys-Leu-Leu-Trp-Val-Gln-Arg-His-Ile-Gln-Lys-Leu-Asp-Ala-Lys-Lys-Asn-Gln-Pro-Ser-Lys-Gly-Ala-Lys-Ala-Val-Arg-Thr-Lys-Phe-Ala-Val-Gln-Arg-Arg-Arg-Gly-Asn-Ser-Thr-Glu-Val,,,,
775,CCL24,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00175,,VVIPSPCCMFFVSKRIPENRVVSYQLSSRSTCLKAGVIFTTKKGQQFCGDPKQEWVQRYMKNLDAKQKKASPRARAVAVKGPVQRYPGNQTTC,Val-Val-Ile-Pro-Ser-Pro-Cys-Cys-Met-Phe-Phe-Val-Ser-Lys-Arg-Ile-Pro-Glu-Asn-Arg-Val-Val-Ser-Tyr-Gln-Leu-Ser-Ser-Arg-Ser-Thr-Cys-Leu-Lys-Ala-Gly-Val-Ile-Phe-Thr-Thr-Lys-Lys-Gly-Gln-Gln-Phe-Cys-Gly-Asp-Pro-Lys-Gln-Glu-Trp-Val-Gln-Arg-Tyr-Met-Lys-Asn-Leu-Asp-Ala-Lys-Gln-Lys-Lys-Ala-Ser-Pro-Arg-Ala-Arg-Ala-Val-Ala-Val-Lys-Gly-Pro-Val-Gln-Arg-Tyr-Pro-Gly-Asn-Gln-Thr-Thr-Cys,,,,
4422,CCL25,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O35903,,QGAFEDCCLGYQHRIKWNVLRHARNYHQQEVSGSCNLRAVRFYFRQKVVCGNPEDMNVKRAIRILTARKRLVHWKSASDSQTERKKSNHMKSKVENPNSTSVRSATLGHPRMVMMPRKTNN,Gln-Gly-Ala-Phe-Glu-Asp-Cys-Cys-Leu-Gly-Tyr-Gln-His-Arg-Ile-Lys-Trp-Asn-Val-Leu-Arg-His-Ala-Arg-Asn-Tyr-His-Gln-Gln-Glu-Val-Ser-Gly-Ser-Cys-Asn-Leu-Arg-Ala-Val-Arg-Phe-Tyr-Phe-Arg-Gln-Lys-Val-Val-Cys-Gly-Asn-Pro-Glu-Asp-Met-Asn-Val-Lys-Arg-Ala-Ile-Arg-Ile-Leu-Thr-Ala-Arg-Lys-Arg-Leu-Val-His-Trp-Lys-Ser-Ala-Ser-Asp-Ser-Gln-Thr-Glu-Arg-Lys-Lys-Ser-Asn-His-Met-Lys-Ser-Lys-Val-Glu-Asn-Pro-Asn-Ser-Thr-Ser-Val-Arg-Ser-Ala-Thr-Leu-Gly-His-Pro-Arg-Met-Val-Met-Met-Pro-Arg-Lys-Thr-Asn-Asn,,,,
817,CCL25,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15444,,QGVFEDCCLAYHYPIGWAVLRRAWTYRIQEVSGSCNLPAAIFYLPKRHRKVCGNPKSREVQRAMKLLDARNKVFAKLHHNTQTFQAGPHAVKKLSSGNSKLSSSKFSNPISSSKRNVSLLISANSGL,Gln-Gly-Val-Phe-Glu-Asp-Cys-Cys-Leu-Ala-Tyr-His-Tyr-Pro-Ile-Gly-Trp-Ala-Val-Leu-Arg-Arg-Ala-Trp-Thr-Tyr-Arg-Ile-Gln-Glu-Val-Ser-Gly-Ser-Cys-Asn-Leu-Pro-Ala-Ala-Ile-Phe-Tyr-Leu-Pro-Lys-Arg-His-Arg-Lys-Val-Cys-Gly-Asn-Pro-Lys-Ser-Arg-Glu-Val-Gln-Arg-Ala-Met-Lys-Leu-Leu-Asp-Ala-Arg-Asn-Lys-Val-Phe-Ala-Lys-Leu-His-His-Asn-Thr-Gln-Thr-Phe-Gln-Ala-Gly-Pro-His-Ala-Val-Lys-Lys-Leu-Ser-Ser-Gly-Asn-Ser-Lys-Leu-Ser-Ser-Ser-Lys-Phe-Ser-Asn-Pro-Ile-Ser-Ser-Ser-Lys-Arg-Asn-Val-Ser-Leu-Leu-Ile-Ser-Ala-Asn-Ser-Gly-Leu,,,,
776,CCL26,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y258,,TRGSDISKTCCFQYSHKPLPWTWVRSYEFTSNSCSQRAVIFTTKRGKKVCTHPRKKWVQKYISLLKTPKQL,Thr-Arg-Gly-Ser-Asp-Ile-Ser-Lys-Thr-Cys-Cys-Phe-Gln-Tyr-Ser-His-Lys-Pro-Leu-Pro-Trp-Thr-Trp-Val-Arg-Ser-Tyr-Glu-Phe-Thr-Ser-Asn-Ser-Cys-Ser-Gln-Arg-Ala-Val-Ile-Phe-Thr-Thr-Lys-Arg-Gly-Lys-Lys-Val-Cys-Thr-His-Pro-Arg-Lys-Lys-Trp-Val-Gln-Lys-Tyr-Ile-Ser-Leu-Leu-Lys-Thr-Pro-Lys-Gln-Leu,,,,
3646,CCL27,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y4X3,,FLLPPSTACCTQLYRKPLSDKLLRKVIQVELQEADGDCHLQAFVLHLAQRSICIHPQNPSLSQWFEHQERKLHGTLPKLNFGMLRKMG,Phe-Leu-Leu-Pro-Pro-Ser-Thr-Ala-Cys-Cys-Thr-Gln-Leu-Tyr-Arg-Lys-Pro-Leu-Ser-Asp-Lys-Leu-Leu-Arg-Lys-Val-Ile-Gln-Val-Glu-Leu-Gln-Glu-Ala-Asp-Gly-Asp-Cys-His-Leu-Gln-Ala-Phe-Val-Leu-His-Leu-Ala-Gln-Arg-Ser-Ile-Cys-Ile-His-Pro-Gln-Asn-Pro-Ser- Leu-Ser-Gln-Trp-Phe-Glu-His-Gln-Glu-Arg-Lys-Leu-His-Gly-Thr-Leu-Pro-Lys-Leu-Asn-Phe-Gly-Met-Leu-Arg-Lys-Met-Gly,Disulphide bond formation between cysteine residues at positions 9 and 38 and 10 and 33,,,
4462,CCL27,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Z1X0,,LPLPSSTSCCTQLYRQPLPSRLLRRIVHMELQEADGDCHLQAVVLHLARRSVCVHPQNRSLARWLERQGKRLQGTVPSLNLVLQKKMYSHPQQQN,Leu-Pro-Leu-Pro-Ser-Ser-Thr-Ser-Cys-Cys-Thr-Gln-Leu-Tyr-Arg-Gln-Pro-Leu-Pro-Ser-Arg-Leu-Leu-Arg-Arg-Ile-Val-His-Met-Glu-Leu-Gln-Glu-Ala-Asp-Gly-Asp-Cys-His-Leu-Gln-Ala-Val-Val-Leu-His-Leu-Ala-Arg-Arg-Ser-Val-Cys-Val-His-Pro-Gln-Asn-Arg-Ser-Leu-Ala-Arg-Trp-Leu-Glu-Arg-Gln-Gly-Lys-Arg-Leu-Gln-Gly-Thr-Val-Pro-Ser-Leu-Asn-Leu-Val-Leu-Gln-Lys-Lys-Met-Tyr-Ser-His-Pro-Gln-Gln-Gln-Asn,,,,
4463,CCL28,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9JIL2,,FQTSEAILPMASSCCTEVSHHVSGRLLERVSSCSIQRADGDCDLAAVILHVKRRRICISPHNRTLKQWMRASEVKKNGRENVCSGKKQPSRKDRKGHTTRKHRTRGTHRHEASR,Phe-Gln-Thr-Ser-Glu-Ala-Ile-Leu-Pro-Met-Ala-Ser-Ser-Cys-Cys-Thr-Glu-Val-Ser-His-His-Val-Ser-Gly-Arg-Leu-Leu-Glu-Arg-Val-Ser-Ser-Cys-Ser-Ile-Gln-Arg-Ala-Asp-Gly-Asp-Cys-Asp-Leu-Ala-Ala-Val-Ile-Leu-His-Val-Lys-Arg-Arg-Arg-Ile-Cys-Ile-Ser-Pro-His-Asn-Arg-Thr-Leu-Lys-Gln-Trp-Met-Arg-Ala-Ser-Glu-Val-Lys-Lys-Asn-Gly-Arg-Glu-Asn-Val-Cys-Ser-Gly-Lys-Lys-Gln-Pro-Ser-Arg-Lys-Asp-Arg-Lys-Gly-His-Thr-Thr-Arg-Lys-His-Arg-Thr-Arg-Gly-Thr-His-Arg-His-Glu-Ala-Ser-Arg,,,,
3649,CCL28,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NRJ3,,SEAILPIASSCCTEVSHHISRRLLERVNMCRIQRADGDCDLAAVILHVKRRRICVSPHNHTVKQWMKVQAAKKNGKGNVCHRKKHHGKRNSNRAHQGKHETYGHKTPY,Ser-Glu-Ala-Ile-Leu-Pro-Ile-Ala-Ser-Ser-Cys-Cys-Thr-Glu-Val-Ser-His-His-Ile-Ser-Arg-Arg-Leu-Leu-Glu-Arg-Val-Asn-Met-Cys-Arg-Ile-Gln-Arg-Ala-Asp-Gly-Asp-Cys-Asp-Leu-Ala-Ala-Val-Ile-Leu-His-Val-Lys-Arg-Arg-Arg-Ile-Cys-Val-Ser-Pro-His-Asn-His- Thr-Val-Lys-Gln-Trp-Met-Lys-Val-Gln-Ala-Ala-Lys-Lys-Asn-Gly-Lys-Gly-Asn-Val-Cys-His-Arg-Lys-Lys-His-His-Gly-Lys-Arg-Asn-Ser-Asn-Arg-Ala-His-Gln-Gly-Lys-His-Glu-Thr-Tyr-Gly-His-Lys-Thr-Pro-Tyr,,,,
4408,CCL3,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10855,,APYGADTPTACCFSYSRKIPRQFIVDYFETSSLCSQPGVIFLTKRNRQICADSKETWVQEYITDLELNA,Ala-Pro-Tyr-Gly-Ala-Asp-Thr-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Ser-Arg-Lys-Ile-Pro-Arg-Gln-Phe-Ile-Val-Asp-Tyr-Phe-Glu-Thr-Ser-Ser-Leu-Cys-Ser-Gln-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Arg-Asn-Arg-Gln-Ile-Cys-Ala-Asp-Ser-Lys-Glu-Thr-Trp-Val-Gln-Glu-Tyr-Ile-Thr-Asp-Leu-Glu-Leu-Asn-Ala,,,,
756,CCL3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10147,,SLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA,Ser-Leu-Ala-Ala-Asp-Thr-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Thr-Ser-Arg-Gln-Ile-Pro-Gln-Asn-Phe-Ile-Ala-Asp-Tyr-Phe-Glu-Thr-Ser-Ser-Gln-Cys-Ser-Lys-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Arg-Ser-Arg-Gln-Val-Cys-Ala-Asp-Pro-Ser-Glu-Glu-Trp-Val-Gln-Lys-Tyr-Val-Ser-Asp-Leu-Glu-Leu-Ser-Ala,1 N-terminally truncated form is found (MIP-1-alpha(4-69)),,,
4409,CCL3,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,APYGADTPTACCFSYGRQIPRKFIADYFETSSLCSQPGVIFLTKRNRQICADPKETWVQEYITELELNA,Ala-Pro-Tyr-Gly-Ala-Asp-Thr-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Gly-Arg-Gln-Ile-Pro-Arg-Lys-Phe-Ile-Ala-Asp-Tyr-Phe-Glu-Thr-Ser-Ser-Leu-Cys-Ser-Gln-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Arg-Asn-Arg-Gln-Ile-Cys-Ala-Asp-Pro-Lys-Glu-Thr-Trp-Val-Gln-Glu-Tyr-Ile-Thr-Glu-Leu-Glu-Leu-Asn-Ala,,,,
4411,CCL4,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P50230,,APIGSDPPTSCCFSYTSRKIHRNFVMDYYETSSLCSQPAVVFLTKKGRQICADPSEPWVNEYVNDLELN,Ala-Pro-Ile-Gly-Ser-Asp-Pro-Pro-Thr-Ser-Cys-Cys-Phe-Ser-Tyr-Thr-Ser-Arg-Lys-Ile-His-Arg-Asn-Phe-Val-Met-Asp-Tyr-Tyr-Glu-Thr-Ser-Ser-Leu-Cys-Ser-Gln-Pro-Ala-Val-Val-Phe-Leu-Thr-Lys-Lys-Gly-Arg-Gln-Ile-Cys-Ala-Asp-Pro-Ser-Glu-Pro-Trp-Val-Asn-Glu-Tyr-Val-Asn-Asp-Leu-Glu-Leu-Asn,,,,
4410,CCL4,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P14097,,APMGSDPPTSCCFSYTSRQLHRSFVMDYYETSSLCSKPAVVFLTKRGRQICANPSEPWVTEYMSDLELN,Ala-Pro-Met-Gly-Ser-Asp-Pro-Pro-Thr-Ser-Cys-Cys-Phe-Ser-Tyr-Thr-Ser-Arg-Gln-Leu-His-Arg-Ser-Phe-Val-Met-Asp-Tyr-Tyr-Glu-Thr-Ser-Ser-Leu-Cys-Ser-Lys-Pro-Ala-Val-Val-Phe-Leu-Thr-Lys-Arg-Gly-Arg-Gln-Ile-Cys-Ala-Asn-Pro-Ser-Glu-Pro-Trp-Val-Thr-Glu-Tyr-Met-Ser-Asp-Leu-Glu-Leu-Asn,,,,
757,CCL4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13236,,APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN,Ala-Pro-Met-Gly-Ser-Asp-Pro-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Thr-Ala-Arg-Lys-Leu-Pro-Arg-Asn-Phe-Val-Val-Asp-Tyr-Tyr-Glu-Thr-Ser-Ser-Leu-Cys-Ser-Gln-Pro-Ala-Val-Val-Phe-Gln-Thr-Lys-Arg-Ser-Lys-Gln-Val-Cys-Ala-Asp-Pro-Ser-Glu-Ser-Trp-Val-Gln-Glu-Tyr-Val-Tyr-Asp-Leu-Glu-Leu-Asn,1 N-terminally truncated form is found (MIP-1-beta(3-69) ),,,
758,CCL5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13501,,SPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS,Ser-Pro-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser,"2 N-terminally truncated forms are found (RANTES(3-68) and RANTES(4-68) ). Also, these forms together with RANTES include post-translational glycosylation of amino acids at position 27 and 28.",,,
4412,CCL5,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P30882|P50231,,SPYGSDTTPCCFAYLSLALPRAHVKEYFYTSSKCSNLAVVFVTRRNRQVCANPEKKWVQEYINYLEMS,Ser-Pro-Tyr-Gly-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Leu-Ser-Leu-Ala-Leu-Pro-Arg-Ala-His-Val-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Ser-Lys-Cys-Ser-Asn-Leu-Ala-Val-Val-Phe-Val-Thr-Arg-Arg-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Gln-Glu-Tyr-Ile-Asn-Tyr-Leu-Glu-Met-Ser,,,,
4413,CCL7,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q03366,,QPDGPNASTCCYVKKQKIPKRNLKSYRRITSSRCPWEAVIFKTKKGMEVCAEAHQKWVEEAIAYLDMKTPTPKP,Gln-Pro-Asp-Gly-Pro-Asn-Ala-Ser-Thr-Cys-Cys-Tyr-Val-Lys-Lys-Gln-Lys-Ile-Pro-Lys-Arg-Asn-Leu-Lys-Ser-Tyr-Arg-Arg-Ile-Thr-Ser-Ser-Arg-Cys-Pro-Trp-Glu-Ala-Val-Ile-Phe-Lys-Thr-Lys-Lys-Gly-Met-Glu-Val-Cys-Ala-Glu-Ala-His-Gln-Lys-Trp-Val-Glu-Glu-Ala-Ile-Ala-Tyr-Leu-Asp-Met-Lys-Thr-Pro-Thr-Pro-Lys-Pro,,,,
759,CCL7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P80098,,QPVGINTSTTCCYRFINKKIPKQRLESYRRTTSSHCPREAVIFKTKLDKEICADPTQKWVQDFMKHLDKKTQTPKL,Gln-Pro-Val-Gly-Ile-Asn-Thr-Ser-Thr-Thr-Cys-Cys-Tyr-Arg-Phe-Ile-Asn-Lys-Lys-Ile-Pro-Lys-Gln-Arg-Leu-Glu-Ser-Tyr-Arg-Arg-Thr-Thr-Ser-Ser-His-Cys-Pro-Arg-Glu-Ala-Val-Ile-Phe-Lys-Thr-Lys-Leu-Asp-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Thr-Gln-Lys-Trp-Val-Gln-Asp-Phe-Met-Lys-His-Leu-Asp-Lys-Lys-Thr-Gln-Thr-Pro-Lys-Leu,Biologically active O-glycosylated (position 29) form is found.,,,
4414,CCL7,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QXY8,,QPDGTNSSTCCYVKKQKIPKRNLKSYRKITSSRCPWEAVIFKTKKGMEVCAEAHQKWVEEAIAYLDMKTSTPKP,Gln-Pro-Asp-Gly-Thr-Asn-Ser-Ser-Thr-Cys-Cys-Tyr-Val-Lys-Lys-Gln-Lys-Ile-Pro-Lys-Arg-Asn-Leu-Lys-Ser-Tyr-Arg-Lys-Ile-Thr-Ser-Ser-Arg-Cys-Pro-Trp-Glu-Ala-Val-Ile-Phe-Lys-Thr-Lys-Lys-Gly-Met-Glu-Val-Cys-Ala-Glu-Ala-His-Gln-Lys-Trp-Val-Glu-Glu-Ala-Ile-Ala-Tyr-Leu-Asp-Met-Lys-Thr-Ser-Thr-Pro-Lys-Pro,,,,
4415,CCL8,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Z12,,EKLTGPDKAPVTCCFHVLKLKIPLRVLKSYERINNIQCPMEAVVFQTKQGMSLCVDPTQKWVSEYMEILDQKSQILQP,Glu-Lys-Leu-Thr-Gly-Pro-Asp-Lys-Ala-Pro-Val-Thr-Cys-Cys-Phe-His-Val-Leu-Lys-Leu-Lys-Ile-Pro-Leu-Arg-Val-Leu-Lys-Ser-Tyr-Glu-Arg-Ile-Asn-Asn-Ile-Gln-Cys-Pro-Met-Glu-Ala-Val-Val-Phe-Gln-Thr-Lys-Gln-Gly-Met-Ser-Leu-Cys-Val-Asp-Pro-Thr-Gln-Lys-Trp-Val-Ser-Glu-Tyr-Met-Glu-Leu-Asp-Gln-Lys-Ser-Gln-Ile-Leu-Gln-Pro,,,,
772,CCL8,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P80075,,QPDSVSIPITCCFNVINRKIPIQRLESYTRITNIQCPKEAVIFKTKRGKEVCADPKERWVRDSMKHLDQIFQNLKP,Gln-Pro-Asp-Ser-Val-Ser-Ile-Pro-Ile-Thr-Cys-Cys-Phe-Asn-Val-Ile-Asn-Arg-Lys-Ile-Pro-Ile-Gln-Arg-Leu-Glu-Ser-Tyr-Thr-Arg-Ile-Thr-Asn-Ile-Gln-Cys-Pro-Lys-Glu-Ala-Val-Ile-Phe-Lys-Thr-Lys-Arg-Gly-Lys-Glu-Val-Cys-Ala-Asp-Pro-Lys-Glu-Arg-Trp-Val-Arg-Asp-Ser-Met-Lys-His-Leu-Asp-Gln-Ile-Phe-Gln-Asn-Leu-Lys-Pro,"N-terminally truncated form has been identified (MCP-2(6-76)). Interestingly, it is recognised as chemokine inhibitor",,,
4434,CCL9,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P51670,,QITHATETKEVQSSLKAQQGLEIEMFHMGFQDSSDCCLSYNSRIQCSRFIGYFPTSGGCTRPGIIFISKRGFQVCANPSDRRVQRCIERLEQNSQPRTYKQ,Gln-Ile-Thr-His-Ala-Thr-Glu-Thr-Lys-Glu-Val-Gln-Ser-Ser-Leu-Lys-Ala-Gln-Gln-Gly-Leu-Glu-Ile-Glu-Met-Phe-His-Met-Gly-Phe-Gln-Asp-Ser-Ser-Asp-Cys-Cys-Leu-Ser-Tyr-Asn-Ser-Arg-Ile-Gln-Cys-Ser-Arg-Phe-Ile-Gly-Tyr-Phe-Pro-Thr-Ser-Gly-Gly-Cys-Thr-Arg-Pro-Gly-Ile-Ile-Phe-Ile-Ser-Lys-Arg-Gly-Phe-Gln-Val-Cys-Ala-Asn-Pro-Ser-Asp-Arg-Arg-Val-Gln-Arg-Cys-Ile-Glu-Arg-Leu-Glu-Gln-Asn-Ser-Gln-Pro-Arg-Thr-Tyr-Lys-Gln,,,,
7693,CD274,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NZQ7,,FTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET,,"Disulphide bonds: cys40-cys114, cys155-cys209 N-linked glycosylation at residues 35, 192, 200 and 219",,,
5080,CD30 ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P32971,,MDPGLQQALNGMAPPGDTAMHVPAGSVASHLGTTSRSYFYLTTATLALCLVFTVATIMVLVVQRTDSIPNSPDNVPLKGGNCSEDLLCILKRAPFKKSWAYLQVAKHLNKTKLSWNKDGILHGVRYQDGNLVIQFPGLYFIICQLQFLVQCPNNSVDLKLELLINKHIKKQALVTVCESGMQTKHVYQNLSQFLLDYLQVNTTISVNVDTFQYIDTSTFPLENVLSIFLYSNSD,,"Predicted N-liked glycosylation of asparagine residues at positions 81, 109, 153, 189 and 201. Predicted disulphide bond formation between cysteine residues at positions 151 and 177",,,
5077,CD40 ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P29965,,MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLHEDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNPQIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSNREASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVNVTDPSQVSHGTGFTSFGLLKL,,N-linked glycosylation of asparagine at position 240; predicted phosphothreonine at position 4; predicted disulphide bond formation between cysteine residues at positions 178 and 218,,,
5079,CD70,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P32970,,MPEEGSGCSVRRRPYGCVLRAALVPLVAGLVICLVVCIQRFAQAQQQLPLESLGWDVAELQLNHTGPQQDPRLYWQGGPALGRSFLHGPELDKGQLRIHRDGIYMVHIQVTLAICSSTTASRHHPTTLAVGICSPASRSISLLRLSFHQGCTIASQRLTPLARGDTLCTNLTGTLLPSRNTDETFFGVQWVRP,,Predicted N-linked glycosylation of asparagine residues at positions 63 and 170; disulphide bond formation between cysteine residues at positions 133 and 151 ,,,
2945,chemerin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99969,,ELTEAQRRGLQVALEEFHKHPPVQWAFQETSVESAVDTPFPAGIFVRLEFKLQQTSCRKRDWKKPECKVRPNGRKRKCLACIKLGSEDKVLGRLVHCPIETQVLREAEEHQETQCLRVQRAGEDPHSFYFPGQF,Glu-Leu-Thr-Glu-Ala-Gln-Arg-Arg-Gly-Leu-Gln-Val-Ala-Leu-Glu-Glu-Phe-His-Lys-His-Pro-Pro-Val-Gln-Trp-Ala-Phe-Gln-Glu-Thr-Ser-Val-Glu-Ser-Ala-Val-Asp-Thr-Pro-Phe-Pro-Ala-Gly-Ile-Phe-Val-Arg-Leu-Glu-Phe-Lys-Leu-Gln-Gln-Thr-Ser-Cys-Arg-Lys-Arg-Asp-Trp-Lys-Lys-Pro-Glu-Cys-Lys-Val-Arg-Pro-Asn-Gly-Arg-Lys-Arg-Lys-Cys-Leu-Ala-Cys-Ile-Lys-Leu-Gly-Ser-Glu-Asp-Lys-Val-Leu-Gly-Arg-Leu-Val-His-Cys-Pro-Ile-Glu-Thr-Gln-Val-Leu-Arg-Glu-Ala-Glu-Glu-His-Gln-Glu-Thr-Gln-Cys-Leu-Arg-Val-Gln-Arg-Ala-Gly-Glu-Asp-Pro-His-Ser-Phe-Tyr-Phe-Pro-Gly-Gln-Phe,,,,
10540,Chgb (511-532),Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,O35314,,KRLGALFNPYFDPLQWKNSDFE,Lys-Arg-Leu-Gly-Ala-Leu-Phe-Asn-Pro-Tyr-Phe-Asp-Pro-Leu-Gln-Trp-Lys-Asn-Ser-Asp-Phe-Glu,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)O)Cc1ccccc1)CC(=O)O)CO)CC(=O)N)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCCN)N)CCCN=C(N)N)CC(C)C)C)CC(C)C)Cc1ccccc1)CC(=O)N)Cc1ccc(cc1)O)Cc1ccccc1)CC(=O)O)CC(C)C)CCC(=O)N,USZLWOIXWADXRT-HXRUCQLXSA-N
6616,chondroitin sulphate proteoglycan 3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14594,,EQGTQDITDASERGLHMQKLGSGSVQAALAELVALPCLFTLQPRPSAARDAPRIKWTKVRTASGQRQDLPILVAKDNVVRVAKSWQGRVSLPSYPRRRANATLLLGPLRASDSGLYRCQVVRGIEDEQDLVPLEVTGVVFHYRSARDRYALTFAEAQEACRLSSAIIAAPRHLQAAFEDGFDNCDAGWLSDRTVRYPITQSRPGCYGDRSSLPGVRSYGRRNPQELYDVYCFARELGGEVFYVGPARRLTLAGARAQCRRQGAALASVGQLHLAWHEGLDQCDPGWLADGSVRYPIQTPRRRCGGPAPGVRTVYRFANRTGFPSPAERFDAYCFRAHHPTSQHGDLETPSSGDEGEILSAEGPPVRELEPTLEEEEVVTPDFQEPLVSSGEEETLILEEKQESQQTLSPTPGDPMLASWPTGEVWLSTVAPSPSDMGAGTAASSHTEVAPTDPMPRRRGRFKGLNGRYFQQQEPEPGLQGGMEASAQPPTSEAAVNQMEPPLAMAVTEMLGSGQSRSPWADLTNEVDMPGAGSAGGKSSPEPWLWPPTMVPPSISGHSRAPVLELEKAEGPSARPATPDLFWSPLEATVSAPSPAPWEAFPVATSPDLPMMAMLRGPKEWMLPHPTPISTEANRVEAHGEATATAPPSPAAETKVYSLPLSLTPTGQGGEAMPTTPESPRADFRETGETSPAQVNKAEHSSSSPWPSVNRNVAVGFVPTETATEPTGLRGIPGSESGVFDTAESPTSGLQATVDEVQDPWPSVYSKGLDASSPSAPLGSPGVFLVPKVTPNLEPWVATDEGPTVNPMDSTVTPAPSDASGIWEPGSQVFEEAESTTLSPQVALDTSIVTPLTTLEQGDKVGVPAMSTLGSSSSQPHPEPEDQVETQGTSGASVPPHQSSPLGKPAVPPGTPTAASVGESASVSSGEPTVPWDPSSTLLPVTLGIEDFELEVLAGSPGVESFWEEVASGEEPALPGTPMNAGAEEVHSDPCENNPCLHGGTCNANGTMYGCSCDQGFAGENCEIDIDDCLCSPCENGGTCIDEVNGFVCLCLPSYGGSFCEKDTEGCDRGWHKFQGHCYRYFAHRRAWEDAEKDCRRRSGHLTSVHSPEEHSFINSFGHENTWIGLNDRIVERDFQWTDNTGLQFENWRENQPDNFFAGGEDCVVMVAHESGRWNDVPCNYNLPYVCKKGTVLCGPPPAVENASLIGARKAKYNVHATVRYQCNEGFAQHHVATIRCRSNGKWDRPQIVCTKPRRSHRMRRHHHHHQHHHQHHHHKSRKERRKHKKHPTEDWEKDEGNFC,,,,,
4893,choriomammotropin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01243,,VQTVPLSRLFDHAMLQAHRAHQLAIDTYQEFEETYIPKDQKYSFLHDSQTSFCFSDSIPTPSNMEETQQKSNLELLRISLLLIESWLEPVRFLRSMFANNLVYDTSDSDDYHLLKDLEEGIQTLMGRLEDGSRRTGQILKQTYSKFDTNSHNHDALLKNYGLLYCFRKDMDKVETFLRMVQCRSVEGSCGF,,"Disulphide bond formation between cysteine residues at positions 53 and 165. In the monomeric form of choriomammotropin, there is a disulphide bond between cysteine residues at positions 182 and 189, while in the dimeric form there are two interchain disulphide bonds between cysteine residues at positions 208 and 215 of each chain",,,
4396,chorionic gonadotropin beta subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01233,,SKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPTMTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVVSYAVALSCQCALCRRSTTDCGGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ,Ser-Lys-Glu-Pro-Leu-Arg-Pro-Arg-Cys-Arg-Pro-Ile-Asn-Ala-Thr-Leu-Ala-Val-Glu-Lys-Glu-Gly-Cys-Pro-Val-Cys-Ile-Thr-Val-Asn-Thr-Thr-Ile-Cys-Ala-Gly-Tyr-Cys-Pro-Thr-Met-Thr-Arg-Val-Leu-Gln-Gly-Val-Leu-Pro-Ala-Leu-Pro-Gln-Val-Val-Cys-Asn-Tyr-Arg-Asp-Val-Arg-Phe-Glu-Ser-Ile-Arg-Leu-Pro-Gly-Cys-Pro-Arg-Gly-Val-Asn-Pro-Val-Val-Ser-Tyr-Ala-Val-Ala-Leu-Ser-Cys-Gln-Cys-Ala-Leu-Cys-Arg-Arg-Ser-Thr-Thr-Asp-Cys-Gly-Gly-Pro-Lys-Asp-His-Pro-Leu-Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln,"N-linked glycosylation of asparagine residues at postions 13, 30, 121, 127, 132 and 138. Disulfide bons are formed between cysteine residues at positions 9 and 57; 23 and 72; 26 and 110; 34 and 88; 38 and 90 and 93 and 100. The choriogonadotropin beta subunit assembles with the common glycoprotein hormone alpha subunit to form the active hCG heterodimer",,,
4894,chorionic somatomammotropin hormone-like 1 ,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q14406,,VQTVPLSRLFKEAMLQAHRAHQLAIDTYQEFISSWGMEAYITKEQKYSFLHDSQTSFCFSDSIPTSSNMEETQQKSNLELLHISLLLIESRLEPVRFLRSTFTNNLVYDTSDSDDYHLLKDLEEGIQMLMGRLEDGSHLTGQTLKQTYSKFDTNSHNHDALLKNYGLLHCFRKDMDKVETFLRMVQCRSVEGSCGF,,Predicted disulphide bond formation between cysteine residues at positions 187 and 194,,,
5165,chromogranin A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10645,,LPVNSPMNKGDTEVMKCIVEVISDTLSKPSPMPVSQECFETLRGDERILSILRHQNLLKELQDLALQGAKERAHQQKKHSGFEDELSEVLENQSSQAELKEAVEEPSSKDVMEKREDSKEAEKSGEATDGARPQALPEPMQESKAEGNNQAPGEEEEEEEEATNTHPPASLPSQKYPGPQAEGDSEGLSQGLVDREKGLSAEPGWQAKREEEEEEEEEAEAGEEAVPEEEGPTVVLNPHPSLGYKEIRKGESRSEALAVDGAGKPGAEEAQDPEGKGEQEHSQQKEEEEEMAVVPQGLFRGGKSGELEQEEERLSKEWEDSKRWSKMDQLAKELTAEKRLEGQEEEEDNRDSSMKLSFRARAYGFRGPGPQLRRGWRPSSREDSLEAGLPLQVRGYPEEKKEEEGSANRRPEDQELESLSAIEAELEKVAHQLQALRRG,,"Serine resdiues at positions 94, 95, 118, 124, 185, 200, 252, 282, 304, 315 and 384 are phosphorylated to phosphoserine; threonine resdiues at positions 163, 165 and 233 undergo O-linked glycosylation; glycine residue at position 301 and arginine at position 438 undergo amidation",,,
4897,ciliary neurotrophic factor,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P26441,,MAFTEHSPLTPHRRDLCSRSIWLARKIRSDLTALTESYVKHQGLNKNINLDSADGMPVASTDQWSELTEAERLQENLQAYRTFHVLLARLLEDQQVHFTPTEGDFHQAIHTLLLQVAAFAYQIEELMILLEYKIPRNEADGMPINVGDGGLFEKKLWGLKVLQELSQWTVRSIHDLRFISSHQTGIPARGSHYIANNKKM,,,,,
10543,CLUL1 (52-77),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15846,,ALTGIKQMKIMMERKEKEHTNLMSTL,Ala-Leu-Thr-Gly-Ile-Lys-Gln-Met-Lys-Ile-Met-Met-Glu-Arg-Lys-Glu-Lys-Glu-His-Thr-Asn-Leu-Met-Ser-Thr-Leu,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](O)C)CO)CCSC)CC(C)C)CC(=O)N)[C@H](O)C)Cc1c[nH]cn1)CCC(=O)O)CCCCN)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC(C)C)CCCCN)CCC(=O)N)CCSC)CCCCN)CCSC)CCSC)CCC(=O)O)CCCN=C(N)N,RVUJAIDUVQKVDU-OTFOMDLSSA-N
4898,COL1A1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02452,,QLSYGYDEKSTGGISVPGPMGPSGPRGLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPRGPPGPPGKNGDDGEAGKPGRPGERGPPGPQGARGLPGTAGLPGMKGHRGFSGLDGAKGDAGPAGPKGEPGSPGENGAPGQMGPRGLPGERGRPGAPGPAGARGNDGATGAAGPPGPTGPAGPPGFPGAVGAKGEAGPQGPRGSEGPQGVRGEPGPPGPAGAAGPAGNPGADGQPGAKGANGAPGIAGAPGFPGARGPSGPQGPGGPPGPKGNSGEPGAPGSKGDTGAKGEPGPVGVQGPPGPAGEEGKRGARGEPGPTGLPGPPGERGGPGSRGFPGADGVAGPKGPAGERGSPGPAGPKGSPGEAGRPGEAGLPGAKGLTGSPGSPGPDGKTGPPGPAGQDGRPGPPGPPGARGQAGVMGFPGPKGAAGEPGKAGERGVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGERGEQGPAGSPGFQGLPGPAGPPGEAGKPGEQGVPGDLGAPGPSGARGERGFPGERGVQGPPGPAGPRGANGAPGNDGAKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADGSPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAGPAGPPGPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKGSPGADGPAGAPGTPGPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPGRDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSGLQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPPQEKAHDGGRYYRA,,,,,
4899,COL2A1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02458,,QMAGGFDEKAGGAQLGVMQGPMGPMGPRGPPGPAGAPGPQGFQGNPGEPGEPGVSGPMGPRGPPGPPGKPGDDGEAGKPGKAGERGPPGPQGARGFPGTPGLPGVKGHRGYPGLDGAKGEAGAPGVKGESGSPGENGSPGPMGPRGLPGERGRTGPAGAAGARGNDGQPGPAGPPGPVGPAGGPGFPGAPGAKGEAGPTGARGPEGAQGPRGEPGTPGSPGPAGASGNPGTDGIPGAKGSAGAPGIAGAPGFPGPRGPPGPQGATGPLGPKGQTGEPGIAGFKGEQGPKGEPGPAGPQGAPGPAGEEGKRGARGEPGGVGPIGPPGERGAPGNRGFPGQDGLAGPKGAPGERGPSGLAGPKGANGDPGRPGEPGLPGARGLTGRPGDAGPQGKVGPSGAPGEDGRPGPPGPQGARGQPGVMGFPGPKGANGEPGKAGEKGLPGAPGLRGLPGKDGETGAAGPPGPAGPAGERGEQGAPGPSGFQGLPGPPGPPGEGGKPGDQGVPGEAGAPGLVGPRGERGFPGERGSPGAQGLQGPRGLPGTPGTDGPKGASGPAGPPGAQGPPGLQGMPGERGAAGIAGPKGDRGDVGEKGPEGAPGKDGGRGLTGPIGPPGPAGANGEKGEVGPPGPAGSAGARGAPGERGETGPPGPAGFAGPPGADGQPGAKGEQGEAGQKGDAGAPGPQGPSGAPGPQGPTGVTGPKGARGAQGPPGATGFPGAAGRVGPPGSNGNPGPPGPPGPSGKDGPKGARGDSGPPGRAGEPGLQGPAGPPGEKGEPGDDGPSGAEGPPGPQGLAGQRGIVGLPGQRGERGFPGLPGPSGEPGKQGAPGASGDRGPPGPVGPPGLTGPAGEPGREGSPGADGPPGRDGAAGVKGDRGETGAVGAPGAPGPPGSPGPAGPTGKQGDRGEAGAQGPMGPSGPAGARGIQGPQGPRGDKGEAGEPGERGLKGHRGFTGLQGLPGPPGPSGDQGASGPAGPSGPRGPPGPVGPSGKDGANGIPGPIGPPGPRGRSGETGPAGPPGNPGPPGPPGPPGPGIDMSAFAGLGPREKGPDPLQYMRA,,,,,
4900,COL3A1,Human,"Endogenous peptide in human, mouse or rat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
4901,COL4A1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02462,,GERGFPGIPGTPGPPGLPGLQGPVGPPGFTGPPGPPGPPGPPGEKGQMGLSFQGPKGDKGDQGVSGPPGVPGQAQVQEKGDFATKGEKGQKGEPGFQGMPGVGEKGEPGKPGPRGKPGKDGDKGEKGSPGFPGEPGYPGLIGRQGPQGEKGEAGPPGPPGIVIGTGPLGEKGERGYPGTPGPRGEPGPKGFPGLPGQPGPPGLPVPGQAGAPGFPGERGEKGDRGFPGTSLPGPSGRDGLPGPPGSPGPPGQPGYTNGIVECQPGPPGDQGPPGIPGQPGFIGEIGEKGQKGESCLICDIDGYRGPPGPQGPPGEIGFPGQPGAKGDRGLPGRDGVAGVPGPQGTPGLIGQPGAKGEPGEFYFDLRLKGDKGDPGFPGQPGMTGRAGSPGRDGHPGLPGPKGSPGSVGLKGERGPPGGVGFPGSRGDTGPPGPPGYGPAGPIGDKGQAGFPGGPGSPGLPGPKGEPGKIVPLPGPPGAEGLPGSPGFPGPQGDRGFPGTPGRPGLPGEKGAVGQPGIGFPGPPGPKGVDGLPGDMGPPGTPGRPGFNGLPGNPGVQGQKGEPGVGLPGLKGLPGLPGIPGTPGEKGSIGVPGVPGEHGAIGPPGLQGIRGEPGPPGLPGSVGSPGVPGIGPPGARGPPGGQGPPGLSGPPGIKGEKGFPGFPGLDMPGPKGDKGAQGLPGITGQSGLPGLPGQQGAPGIPGFPGSKGEMGVMGTPGQPGSPGPVGAPGLPGEKGDHGFPGSSGPRGDPGLKGDKGDVGLPGKPGSMDKVDMGSMKGQKGDQGEKGQIGPIGEKGSRGDPGTPGVPGKDGQAGQPGQPGPKGDPGISGTPGAPGLPGPKGSVGGMGLPGTPGEKGVPGIPGPQGSPGLPGDKGAKGEKGQAGPPGIGIPGLRGEKGDQGIAGFPGSPGEKGEKGSIGIPGMPGSPGLKGSPGSVGYPGSPGLPGEKGDKGLPGLDGIPGVKGEAGLPGTPGPTGPAGQKGEPGSDGIPGSAGEKGEPGLPGRGFPGFPGAKGDKGSKGEVGFPGLAGSPGIPGSKGEQGFMGPPGPQGQPGLPGSPGHATEGPKGDRGPQGQPGLPGLPGPMGPPGLPGIDGVKGDKGNPGWPGAPGVPGPKGDPGFQGMPGIGGSPGITGSKGDMGPPGVPGFQGPKGLPGLQGIKGDQGDQGVPGAKGLPGPPGPPGPYDIIKGEPGLPGPEGPPGLKGLQGLPGPKGQQGVTGLVGIPGPPGIPGFDGAPGQKGEMGPAGPTGPRGFPGPPGPDGLPGSMGPPGTPSVDHGFLVTRHSQTIDDPQCPSGTKILYHGYSLLYVQGNERAHGQDLGTAGSCLRKFSTMPFLFCNINNVCNFASRNDYSYWLSTPEPMPMSMAPITGENIRPFISRCAVCEAPAMVMAVHSQTIQIPPCPSGWSSLWIGYSFVMHTSAGAEGSGQALASPGSCLEEFRSAPFIECHGRGTCNYYANAYSFWLATIERSEMFKKPTPSTLKAGELRTHVSRCQVCMRRT,,,,,
9414,complement C3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,SPMYSIITPNILRLESEETMVLEAHDAQGDVPVTVTVHDFPGKKLVLSSEKTVLTPATNHMGNVTFTIPANREFKSEKGRNKFVTVQATFGTQVVEKVVLVSLQSGYLFIQTDKTIYTPGSTVLYRIFTVNHKLLPVGRTVMVNIENPEGIPVKQDSLSSQNQLGVLPLSWDIPELVNMGQWKIRAYYENSPQQVFSTEFEVKEYVLPSFEVIVEPTEKFYYIYNEKGLEVTITARFLYGKKVEGTAFVIFGIQDGEQRISLPESLKRIPIEDGSGEVVLSRKVLLDGVQNPRAEDLVGKSLYVSATVILHSGSDMVQAERSGIPIVTSPYQIHFTKTPKYFKPGMPFDLMVFVTNPDGSPAYRVPVAVQGEDTVQSLTQGDGVAKLSINTHPSQKPLSITVRTKKQELSEAEQATRTMQ,,,,,
8712,complement C5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,,,,,,
8927,connective tissue growth factor,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,MTAASMGPVRVAFVVLLALCSRPAVGQNCSGPCRCPDEPAPRCPAGVSLVLDGCGCCRVCAKQLGELCTERDPCDPHKGLFCHFGSPANRKIGVCTAKDGAPCIFGGTVYRSGESFQSSCKYQCTCLDGAVGCMPLCSMDVRLPSPDCPFPRRVKLPGKCCEEWVCDEPKDQTVVGPALAAYRLEDTFGPDPTMIRANCLVQTTEWSACSKTCGMGISTRVTNDNASCRLEKQSRLCMVRPCEADLEENIKKGKKCIRTPKISKPIKFELSGCTSMKTYRAKFCGVCTDGRCCTPHRTTTLPVEFKCPDGEVMKKNMMFIKTCACHYNCPGDNDIFESLYYRKMYGDMA,,"Glycosylated at positions 28 and 225. Disulphide bonds predicted between cysteines 256-293, 273-307, 284-323, 287-325 and 292-329.",,,
6617,contactin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q12860,,EFTWYRRYGHGVSEEDKGFGPIFEEQPINTIYPEESLEGKVSLNCRARASPFPVYKWRMNNGDVDLTSDRYSMVGGNLVINNPDKQKDAGIYYCLASNNYGMVRSTEATLSFGYLDPFPPEERPEVRVKEGKGMVLLCDPPYHFPDDLSYRWLLNEFPVFITMDKRRFVSQTNGNLYIANVEASDKGNYSCFVSSPSITKSVFSKFIPLIPIPERTTKPYPADIVVQFKDVYALMGQNVTLECFALGNPVPDIRWRKVLEPMPSTAEISTSGAVLKIFNIQLEDEGIYECEAENIRGKDKHQARIYVQAFPEWVEHINDTEVDIGSDLYWPCVATGKPIPTIRWLKNGYAYHKGELRLYDVTFENAGMYQCIAENTYGAIYANAELKILALAPTFEMNPMKKKILAAKGGRVIIECKPKAAPKPKFSWSKGTEWLVNSSRILIWEDGSLEINNITRNDGGIYTCFAENNRGKANSTGTLVITDPTRIILAPINADITVGENATMQCAASFDPALDLTFVWSFNGYVIDFNKENIHYQRNFMLDSNGELLIRNAQLKHAGRYTCTAQTIVDNSSASADLVVRGPPGPPGGLRIEDIRATSVALTWSRGSDNHSPISKYTIQTKTILSDDWKDAKTDPPIIEGNMEAARAVDLIPWMEYEFRVVATNTLGRGEPSIPSNRIKTDGAAPNVAPSDVGGGGGRNRELTITWAPLSREYHYGNNFGYIVAFKPFDGEEWKKVTVTNPDTGRYVHKDETMSPSTAFQVKVKAFNNKGDGPYSLVAVINSAQDAPSEAPTEVGVKVLSSSEISVHWEHVLEKIVESYQIRYWAAHDKEEAANRVQVTSQEYSARLENLLPDTQYFIEVGACNSAGCGPPSDMIEAFTKKAPPSQPPRIISSVRSGSRYIITWDHVVALSNESTVTGYKVLYRPDGQHDGKLYSTHKHSIEVPIPRDGEYVVEVRAHSDGGDGVVSQVKIS,,,,,
6609,contactin-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9P232,,ELLLQGPVFIKEPSNSIFPVGSEDKKITLHCEARGNPSPHYRWQLNGSDIDMSMEHRYKLNGGNLVVINPNRNWDTGTYQCFATNSLGTIVSREAKLQFAYLENFKTKMRSTVSVREGQGVVLLCGPPPHSGELSYAWIFNEYPSFVEEDSRRFVSQETGHLYISKVEPSDVGNYTCVVTSMVTNARVLGSPTPLVLRSDGVMGEYEPKIEVQFPETLPAAKGSTVKLECFALGNPIPQINWRRSDGLPFSSKIKLRKFSGVLEIPNFQQEDAGSYECIAENSRGKNVARGRLTYYAKPHWVQLIKDVEIAVEDSLYWECRASGKPKPSYRWLKNGAALVLEERTQIENGALTISNLSVTDSGMFQCIAENKHGLVYSSAELKVVASAPDFSKNPMKKLVQVQVGSLVSLDCKPRASPRALSSWKKGDVSVQEHERISLLNDGGLKIANVTKADAGTYTCMAENQFGKANGTTHLVVTEPTRITLAPSNMDVSVGESVILPCQVQHDPLLDIIFTWYFNGALADFKKDGSHFEKVGGSSSGDLMIRNIQLKHSGKYVCMVQTGVDSVSSAADLIVRGSPGPPENVKVDEITDTTAQLSWKEGKDNHSPVISYSIQARTPFSVGWQTVTTVPEVIDGKTHTATVVELNPWVEYEFRVVASNKIGGGEPSLPSEKVRTEEAVPEVPPSEVNGGGGSRSELVITWDPVPEELQNGEGFGYVVAFRPLGVTTWIQTVVTSPDTPRYVFRNESIVPYSPYEVKVGVYNNKGEGPFSPVTTVFSAEEEPTVAPSQVSANSLSSSEIEVSWNTIPWKLSNGHLLGYEVRYWNGGGKEESSSKMKVAGNETSARLRGLKSNLAYYTAVRAYNSAGAGPFSATVNVTTKKTPPSQPPGNVVWNATDTKVLLNWEQVKAMENESEVTGYKVFYRTSSQNNVQVLNTNKTSAELVLPIKEDYIIEVKATTDGGDGTSSEQIRIPRITSMDARGS,,,,,
6612,contactin-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8IWV2,,DDSTLHGPIFIQEPSPVMFPLDSEEKKVKLNCEVKGNPKPHIRWKLNGTDVDTGMDFRYSVVEGSLLINNPNKTQDAGTYQCTATNSFGTIVSREAKLQFAYLDNFKTRTRSTVSVRRGQGMVLLCGPPPHSGELSYAWIFNEYPSYQDNRRFVSQETGNLYIAKVEKSDVGNYTCVVTNTVTNHKVLGPPTPLILRNDGVMGEYEPKIEVQFPETVPTAKGATVKLECFALGNPVPTIIWRRADGKPIARKARRHKSNGILEIPNFQQEDAGLYECVAENSRGKNVARGQLTFYAQPNWIQKINDIHVAMEENVFWECKANGRPKPTYKWLKNGEPLLTRDRIQIEQGTLNITIVNLSDAGMYQCLAENKHGVIFSNAELSVIAVGPDFSRTLLKRVTLVKVGGEVVIECKPKASPKPVYTWKKGRDILKENERITISEDGNLRIINVTKSDAGSYTCIATNHFGTASSTGNLVVKDPTRVMVPPSSMDVTVGESIVLPCQVTHDHSLDIVFTWSFNGHLIDFDRDGDHFERVGGQDSAGDLMIRNIQLKHAGKYVCMVQTSVDRLSAAADLIVRGPPGPPEAVTIDEITDTTAQLSWRPGPDNHSPITMYVIQARTPFSVGWQAVSTVPELIDGKTFTATVVGLNPWVEYEFRTVAANVIGIGEPSRPSEKRRTEEALPEVTPANVSGGGGSKSELVITWETVPEELQNGRGFGYVVAFRPYGKMIWMLTVLASADASRYVFRNESVHPFSPFEVKVGVFNNKGEGPFSPTTVVYSAEEEPTKPPASIFARSLSATDIEVFWASPLEKNRGRIQGYEVKYWRHEDKEENARKIRTVGNQTSTKITNLKGSVLYHLAVKAYNSAGTGPSSATVNVTTRKPPPSQPPGNIIWNSSDSKIILNWDQVKALDNESEVKGYKVLYRWNRQSSTSVIETNKTSVELSLPFDEDYIIEIKPFSDGGDGSSSEQIRIPKISNAYARGS,,,,,
6613,contactin-5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O94779,,EYSKSLPGLSTSYAALLRIKKSSSSSLFGSKTRPRYSSPSLGTLSASSPSWLGAAQNYYSPINLYHSSDAFKQDESVDYGPVFVQEPDDIIFPTDSDEKKVALNCEVRGNPVPSYRWLRNGTEIDLESDYRYSLIDGTFIISNPSEAKDSGHYQCLATNTVGSILSREATLQFAYLGNFSGRTRSAVSVREGQGVVLMCSPPPHSPEIIYSWVFNEFPSFVAEDSRRFISQETGNLYISKVQTSDVGSYICLVKNTVTNARVLSPPTPLTLRNDGVMGEYEPKIEVHFPFTVTAAKGTTVKMECFALGNPVPTITWMKVNGYIPSKARLRKSQAVLEIPNVQLDDAGIYECRAENSRGKNSFRGQLQVYTYPHWVEKLNDTQLDSGSPLRWECKATGKPRPTYRWLKNGVPLSPQSRVEMVNGVLMIHNVNQSDAGMYQCLAENKYGAIYASAELKILASAPTFALNQLKKTIIVTKDQEVVIECKPQGSPKPTISWKKGDRAVRENKRIAILPDGSLRILNASKSDEGKYVCRGENVFGSAEIIASLSVKEPTRIELTPKRTELTVGESIVLNCKAIHDASLDVTFYWTLKGQPIDFEEEGGHFESIRAQASSADLMIRNILLMHAGRYGCRVQTTADSVSDEAELLVRGPPGPPGIVIVEEITESTATLSWSPAADNHSPISSYNLQARSPFSLGWQTVKTVPEIITGDMESAMAVDLNPWVEYEFRVVATNPIGTGDPSTPSRMIRTNEAVPKTAPTNVSGRSGRRHELVIAWEPVSEEFQNGEGFGYIVAFRPNGTRGWKEKMVTSSEASKFIYRDESVPPLTPFEVKVGVYNNKGDGPFSQIVVICSAEGEPSAAPTDVKATSVSVSEILVAWKHIKESLGRPQGFEVGYWKDMEQEDTAETVKTRGNESFVILTGLEGNTLYHFTVRAYNGAGYGPPSSEVSATTKKSPPSQAPSNLRWEQQGSQVSLGWEPVIPLANESEVVGYKVFYRQEGHSNSQVIETQKLQAVVPLPDAGVYIIEVRAYSEGGDGTASSQIRVPSYSGGKITS,,,,,
6614,contactin-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UQ52,,DGLLSRPIFTQEPHDVIFPLDLSKSEVILNCAANGYPSPHYRWKQNGTDIDFTMSYHYRLDGGSLAINSPHTDQDIGMYQCLATNLLGTILSRKAKLQFAYIEDFETKTRSTVSVREGQGVVLLCGPPPHFGDLSYAWTFNDNPLYVQEDNRRFVSQETGNLYIAKVEPSDVGNYTCFITNKEAQRSVQGPPTPLVQRTDGVMGEYEPKIEVRFPETIQAAKDSSVKLECFALGNPVPDISWRRLDGSPLPGKVKYSKSQAILEIPNFQQEDEGFYECIASNLRGRNLAKGQLIFYAPPEWEQKIQNTHLSIYDNLLWECKASGKPNPWYTWLKNGERLNPEERIQIENGTLIITMLNVSDSGVYQCAAENKYQIIYANAELRVLASAPDFSKSPVKKKSFVQVGGDIVIGCKPNAFPRAAISWKRGTETLRQSKRIFLLEDGSLKIYNITRSDAGSYTCIATNQFGTAKNTGSLIVKERTVITVPPSKMDVTVGESIVLPCQVSHDPSIEVVFVWFFNGDVIDLKKGVAHFERIGGESVGDLMIRNIQLHHSGKYLCTVQTTLESLSAVADIIVRGPPGPPEDVQVEDISSTTSQLSWRAGPDNNSPIQIFTIQTRTPFSVGWQAVATVPEILNGKTYNATVVGLSPWVEYEFRVVAGNSIGIGEPSEPSELLRTKASVPVVAPVNIHGGGGSRSELVITWESIPEELQNGEGFGYIIMFRPVGSTTWSKEKVSSVESSRFVYRNESIIPLSPFEVKVGVYNNEGEGSLSTVTIVYSGEDEPQLAPRGTSLQSFSASEMEVSWNAIAWNRNTGRVLGYEVLYWTDDSKESMIGKIRVSGNVTTKNITGLKANTIYFASVRAYNTAGTGPSSPPVNVTTKKSPPSQPPANIAWKLTNSKLCLNWEHVKTMENESEVLGYKILYRQNRQSKTHILETNNTSAELLVPFEEDYLIEIRTVSDGGDGSSSEEIRIPKMSSLSS,,,,,
912,corticotrophin-releasing hormone,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01143|Q8CIT0|P06850,,SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII,Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2,The C-terminal Isoleucine is amidated.,,,
2007,cortistatin-14,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P56469|Q62949,,PCKNFFWKTFSSCK,Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys,Disulphide bond formation between cysteine residues at positions 2 and 13,,,
6266,CRAMP,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P51437,,ISRLAGLLRKGGEKIGEKLKKIGQKIKNFFQKLVPQPE,Ile-Ser-Arg-Leu-Ala-Gly-Leu-Leu-Arg-Lys-Gly-Gly-Glu-Lys-Ile-Gly-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Asn-Phe-Phe-Gln-Lys-Leu-Val-Pro-Gln-Pro-Glu,,,,
6150,CRCF1/CLCF1 heterodimer,Human,"Endogenous peptide in human, mouse or rat",4904|4895,cytokine receptor-like factor 1|cardiotrophin-like cytokine factor 1,,,,,,,,,,,,,,
2008,CST-17,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00230,,DRMPCRNFFWKTFSSCK,Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys,Disulphide bond formation between cysteine residues at positions 71 and 87,,,
4896,C-type natriuretic peptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P23582,,GLSKGCFGLKLDRIGSMSGLGC,Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys,Disulphide bond formation between cysteine residues at positions 5 and 22,,,
819,CXCL1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09341,,ASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKSN,Ala-Ser-Val-Ala-Thr-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Leu-Gln-Gly-Ile-His-Pro-Lys-Asn-Ile-Gln-Ser-Val-Asn-Val-Lys-Ser-Pro-Gly-Pro-His-Cys-Ala-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Lys-Ala-Cys-Leu-Asn-Pro-Ala-Ser-Pro-Ile-Val-Lys-Lys-Ile-Ile-Glu-Lys-Met-Leu-Asn-Ser-Asp-Lys-Ser-Asn,,,,
4423,CXCL1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12850,,APIANELRCQCLQTMAGIHLKNIQSLKVLPSGPHCTQTEVIATLKNGREACLDPEAPLVQKIVQKMLKGVPK,Ala-Pro-Ile-Ala-Asn-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Met-Ala-Gly-Ile-His-Leu-Lys-Asn-Ile-Gln-Ser-Leu-Lys-Val-Leu-Pro-Ser-Gly-Pro-His-Cys-Thr-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Glu-Ala-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Leu-Val-Gln-Lys-Ile-Val-Gln-Lys-Met-Leu-Lys-Gly-Val-Pro-Lys,,,,
826,CXCL1,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P14095,,APVANELRCQCLQTVAGIHFKNIQSLKVMPPGPHCTQTEVIATLKNGREACLDPEAPMVQKIVQKMLKGVPK,Ala-Pro-Val-Ala-Asn-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Val-Ala-Gly-Ile-His-Phe-Lys-Asn-Ile-Gln-Ser-Leu-Lys-Val-Met-Pro-Pro-Gly-Pro-His-Cys-Thr-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Glu-Ala-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Met-Val-Gln-Lys-Ile-Val-Gln-Lys-Met-Leu-Lys-Gly-Val-Pro-Lys,,,,
4430,CXCL10,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P17515,,IPLARTVRCNCIHIDDGPVRMRAIGKLEIIPASLSCPRVEIIATMKKNDEQRCLNPESKTIKNLMKAFSQKRSKRAP,Ile-Pro-Leu-Ala-Arg-Thr-Val-Arg-Cys-Asn-Cys-Ile-His-Ile-Asp-Asp-Gly-Pro-Val-Arg-Met-Arg-Ala-Ile-Gly-Lys-Leu-Glu-Ile-Ile-Pro-Ala-Ser-Leu-Ser-Cys-Pro-Arg-Val-Glu-Ile-Ile-Ala-Thr-Met-Lys-Lys-Asn-Asp-Glu-Gln-Arg-Cys-Leu-Asn-Pro-Glu-Ser-Lys-Thr-Ile-Lys-Asn-Leu-Met-Lys-Ala-Phe-Ser-Gln-Lys-Arg-Ser-Lys-Arg-Ala-Pro,,,,
4431,CXCL10,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48973,,IPLARTVRCTCIDFHEQPLRPRAIGKLEIIPASLSCPHVEIIATMKKNNEKRCLNPESEAIKSLLKAVSQRRSKRAP,Ile-Pro-Leu-Ala-Arg-Thr-Val-Arg-Cys-Thr-Cys-Ile-Asp-Phe-His-Glu-Gln-Pro-Leu-Arg-Pro-Arg-Ala-Ile-Gly-Lys-Leu-Glu-Ile-Ile-Pro-Ala-Ser-Leu-Ser-Cys-Pro-His-Val-Glu-Ile-Ile-Ala-Thr-Met-Lys-Lys-Asn-Asn-Glu-Lys-Arg-Cys-Leu-Asn-Pro-Glu-Ser-Glu-Ala-Ile-Lys-Ser-Leu-Leu-Lys-Ala-Val-Ser-Gln-Arg-Arg-Ser-Lys-Arg-Ala-Pro,,,,
835,CXCL10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02778,,VPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRVEIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP,Val-Pro-Leu-Ser-Arg-Thr-Val-Arg-Cys-Thr-Cys-Ile-Ser-Ile-Ser-Asn-Gln-Pro-Val-Asn-Pro-Arg-Ser-Leu-Glu-Lys-Leu-Glu-Ile-Ile-Pro-Ala-Ser-Gln-Phe-Cys-Pro-Arg-Val-Glu-Ile-Ile-Ala-Thr-Met-Lys-Lys-Lys-Gly-Glu-Lys-Arg-Cys-Leu-Asn-Pro-Glu-Ser-Lys-Ala-Ile-Lys-Asn-Leu-Leu-Lys-Ala-Val-Ser-Lys-Glu-Arg-Ser-Lys-Arg-Ser-Pro,,,,
836,CXCL11,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14625,,FPMFKRGRCLCIGPGVKAVKVADIEKASIMYPSNNCDKIEVIITLKENKGQRCLNPKSKQARLIIKKVERKNF,Phe-Pro-Met-Phe-Lys-Arg-Gly-Arg-Cys-Leu-Cys-Ile-Gly-Pro-Gly-Val-Lys-Ala-Val-Lys-Val-Ala-Asp-Ile-Glu-Lys-Ala-Ser-Ile-Met-Tyr-Pro-Ser-Asn-Asn-Cys-Asp-Lys-Ile-Glu-Val-Ile-Ile-Thr-Leu-Lys-Glu-Asn-Lys-Gly-Gln-Arg-Cys-Leu-Asn-Pro-Lys-Ser-Lys-Gln-Ala-Arg-Leu-Ile-Ile-Lys-Lys-Val-Glu-Arg-Lys-Asn-Phe,,,,
4432,CXCL11,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9JHH5,,FLMFKQGRCLCIGPGMKAVKMAEIEKASVIYPSNGCDKVEVIVTMKAHKRQRCLDPRSKQARLIMQAIEKKNFLRRQNM,Phe-Leu-Met-Phe-Lys-Gln-Gly-Arg-Cys-Leu-Cys-Ile-Gly-Pro-Gly-Met-Lys-Ala-Val-Lys-Met-Ala-Glu-Ile-Glu-Lys-Ala-Ser-Val-Ile-Tyr-Pro-Ser-Asn-Gly-Cys-Asp-Lys-Val-Glu-Val-Ile-Val-Thr-Met-Lys-Ala-His-Lys-Arg-Gln-Arg-Cys-Leu-Asp-Pro-Arg-Ser-Lys-Gln-Ala-Arg-Leu-Ile-Met-Gln-Ala-Ile-Glu-Lys-Lys-Asn-Phe-Leu-Arg-Arg-Gln-Asn-Met,,,,
4465,CXCL12,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P40224,,KPVSLSYRCPCRFFESHIARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNKRLKM,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Ile-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys-Arg-Leu-Lys-Met,,,,
4358,CXCL12α,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48061,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys,,,,
845,CXCL12β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48061,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNKRFKM,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys-Arg-Phe-Lys-Met,Disulphide bond formation between cysteine residues at postions 7 and 32 and 9 and 48,,,
8531,CXCL12δ,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48061,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNNLISAAPAGKRVIAGARALHPSPPRACPTARALCEIRLWPPPEWSWPSPGDV,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Asn-Leu-Ile-Ser-Ala-Ala-Pro-Ala-Gly-Lys-Arg-Val-Ile-Ala-Gly-Ala-Arg-Ala-Leu-His-Pro-Ser-Pro-Pro-Arg-Ala-Cys-Pro-Thr-Ala-Arg-Ala-Leu-Cys-Glu-Ile-Arg-Leu-Trp-Pro-Pro-Pro-Glu-Trp-Ser-Trp-Pro-Ser-Pro-Gly-Asp-Val,,,,
8532,CXCL12ε,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48061,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNNC,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Asn-Cys,,,,
8530,CXCL12γ,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48061,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNKGRREEKVGKKEKIGKKKRQKKRKAAQKRKN,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys-Gly-Arg-Arg-Glu-Glu-Lys-Val-Gly-Lys-Lys-Glu-Lys-Ile-Gly-Lys-Lys-Lys-Arg-Gln-Lys-Lys-Arg-Lys-Ala-Ala-Gln-Lys-Arg-Lys-Asn,,,,
8533,CXCL12φ,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48061,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNKIWLYGNAETSR,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys-Ile-Trp-Leu-Tyr-Gly-Asn-Ala-Glu-Thr-Ser-Arg,,,,
4466,CXCL13,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O55038,,ILEAHYTNLKCRCSGVISTVVGLNIIDRIQVTPPGNGCPKTEVVIWTKMKKVICVNPRAKWLQRLLRHVQSKSLSSTPQAPVSKRRAA,Ile-Leu-Glu-Ala-His-Tyr-Thr-Asn-Leu-Lys-Cys-Arg-Cys-Ser-Gly-Val-Ile-Ser-Thr-Val-Val-Gly-Leu-Asn-Ile-Ile-Asp-Arg-Ile-Gln-Val-Thr-Pro-Pro-Gly-Asn-Gly-Cys-Pro-Lys-Thr-Glu-Val-Val-Ile-Trp-Thr-Lys-Met-Lys-Lys-Val-Ile-Cys-Val-Asn-Pro-Arg-Ala-Lys-Trp-Leu-Gln-Arg-Leu-Leu-Arg-His-Val-Gln-Ser-Lys-Ser-Leu-Ser-Ser-Thr-Pro-Gln-Ala-Pro-Val-Ser-Lys-Arg-Arg-Ala-Ala,,,,
3645,CXCL13,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43927,,VLEVYYTSLRCRCVQESSVFIPRRFIDRIQILPRGNGCPRKEIIVWKKNKSIVCVDPQAEWIQRMMEVLRKRSSSTLPVPVFKRKIP,Val-Leu-Glu-Val-Tyr-Tyr-Thr-Ser-Leu-Arg-Cys-Arg-Cys-Val-Gln-Glu-Ser-Ser-Val-Phe-Ile-Pro-Arg-Arg-Phe-Ile-Asp-Arg-Ile-Gln-Ile-Leu-Pro-Arg-Gly-Asn-Gly-Cys-Pro-Arg-Lys-Glu-Ile-Ile-Val-Trp-Lys-Lys-Asn-Lys-Ser-Ile-Val-Cys-Val-Asp-Pro-Gln-Ala-Glu-Trp-Ile-Gln-Arg-Met-Met-Glu-Val-Leu-Arg-Lys-Arg-Ser-Ser-Ser-Thr-Leu-Pro-Val-Pro-Val-Phe-Lys-Arg-Lys-Ile-Pro,Disulphide bond formation between cysteine residues at postions 11 and 48,,,
3680,CXCL14,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95715,,SKCKCSRKGPKIRYSDVKKLEMKPKYPHCEEKMVIITTKSVSRYRGQEHCLHPKLQSTKRFIKWYNAWNEKRRVYEE,Ser-Lys-Cys-Lys-Cys-Ser-Arg-Lys-Gly-Pro-Lys-Ile-Arg-Tyr-Ser-Asp-Val-Lys-Lys-Leu-Glu-Met-Lys-Pro-Lys-Tyr-Pro-His-Cys-Glu-Glu-Lys-Met-Val-Ile-Ile-Thr-Thr-Lys-Ser-Val-Ser-Arg-Tyr-Arg-Gly-Gln-Glu-His-Cys-Leu-His-Pro-Lys-Leu-Gln-Ser-Thr-Lys-Arg-Phe-Ile-Lys-Trp-Tyr-Asn-Ala-Trp-Asn-Glu-Lys-Arg-Arg-Val-Tyr-Glu-Glu,Disulphide bond formation between amino acid residues at positions 3 and 29 and 5 and 50,,,
3862,CXCL15,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9WVL7,,QELRCLCIQEHSEFIPLKLIKNIMVIFETIYCNRKEVIAVPKNGSMICLDPDAPWVKATVGPITNRFLPEDLKQKEFPPAMKLLYSVEHEKPLYLSFGRPENKRIFPFPIRETSRHFADLAHNSDRNFLRDSSEVSLTGSDA,,,,,
855,CXCL16,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9H2A7,,NEGSVTGSCYCGKRISSDSPPSVQFMNRLRKHLRAYHRCLYYTRFQLLSWSVCGGNKDPWVQELMSCLDLKECGHAYSGIVAHQKHLLPTSPPISQASEGASSDIHTPAQMLLSTLQSTQRPTLPVGSLSSDKELTRPNETTIHTAGHSLAAGPEAGENQKQPEKNAGPTARTSATVPVLCLLAIIFILTAALSYVLCKRRRGQSPQSSPDLPVHYIPVAPDSNT,Asn-Glu-Gly-Ser-Val-Thr-Gly-Ser-Cys-Tyr-Cys-Gly-Lys-Arg-Ile-Ser-Ser-Asp-Ser-Pro-Pro-Ser-Val-Gln-Phe-Met-Asn-Arg-Leu-Arg-Lys-His-Leu-Arg-Ala-Tyr-His-Arg-Cys-Leu-Tyr-Tyr-Thr-Arg-Phe-Gln-Leu-Leu-Ser-Trp-Ser-Val-Cys-Gly-Gly-Asn-Lys-Asp-Pro-Trp-Val-Gln-Glu-Leu-Met-Ser-Cys-Leu-Asp-Leu-Lys-Glu-Cys-Gly-His-Ala-Tyr-Ser-Gly-Ile-Val-Ala-His-Gln-Lys-His-Leu-Leu-Pro-Thr-Ser-Pro-Pro-Ile-Ser-Gln-Ala-Ser-Glu-Gly-Ala-Ser-Ser-Asp-Ile-His-Thr-Pro-Ala-Gln-Met-Leu-Leu-Ser-Thr-Leu-Gln-Ser-Thr-Gln-Arg-Pro-Thr-Leu-Pro-Val-Gly-Ser-Leu-Ser-Ser-Asp-Lys-Glu-Leu-Thr-Arg-Pro-Asn-Glu-Thr-Thr-Ile-His-Thr-Ala-Gly-His-Ser-Leu-Ala-Ala-Gly-Pro-Glu-Ala-Gly-Glu-Asn-Gln-Lys-Gln-Pro-Glu-Lys-Asn-Ala-Gly-Pro-Thr-Ala-Arg-Thr-Ser-Ala-Thr-Val-Pro-Val-Leu-Cys-Leu-Leu-Ala-Ile-Ile-Phe-Ile-Leu-Thr-Ala-Ala-Leu-Ser-Tyr-Val-Leu-Cys-Lys-Arg-Arg-Arg-Gly-Gln-Ser-Pro-Gln-Ser-Ser-Pro-Asp-Leu-Pro-Val-His-Tyr-Ile-Pro-Val-Ala-Pro-Asp-Ser-Asn-Thr,,,,
4467,CXCL16,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6AXU5,,NQGSVAGSCYCDRTIPSGTQIPPATLNHMRKYLKTFHRCQFFIRFQLQSKSVCGGSQDQWVRELVNCFEHKQCGIGHGQSFHHQKHVPQASTRIPEATEGKPPDTSTAVQFQSTQQSTFPSGAPSLNKELTRHWETTILPSGYGLEARPVAEANEKQHKQQKEPGAGAGTQALVPVLSLLAIVFFLVAAMVCVLCNRRVTRQSSSGLQLCYTPVEPRPQGL,Asn-Gln-Gly-Ser-Val-Ala-Gly-Ser-Cys-Tyr-Cys-Asp-Arg-Thr-Ile-Pro-Ser-Gly-Thr-Gln-Ile-Pro-Pro-Ala-Thr-Leu-Asn-His-Met-Arg-Lys-Tyr-Leu-Lys-Thr-Phe-His-Arg-Cys-Gln-Phe-Phe-Ile-Arg-Phe-Gln-Leu-Gln-Ser-Lys-Ser-Val-Cys-Gly-Gly-Ser-Gln-Asp-Gln-Trp-Val-Arg-Glu-Leu-Val-Asn-Cys-Phe-Glu-His-Lys-Gln-Cys-Gly-Ile-Gly-His-Gly-Gln-Ser-Phe-His-His-Gln-Lys-His-Val-Pro-Gln-Ala-Ser-Thr-Arg-Ile-Pro-Glu-Ala-Thr-Glu-Gly-Lys-Pro-Pro-Asp-Thr-Ser-Thr-Ala-Val-Gln-Phe-Gln-Ser-Thr-Gln-Gln-Ser-Thr-Phe-Pro-Ser-Gly-Ala-Pro-Ser-Leu-Asn-Lys-Glu-Leu-Thr-Arg-His-Trp-Glu-Thr-Thr-Ile-Leu-Pro-Ser-Gly-Tyr-Gly-Leu-Glu-Ala-Arg-Pro-Val-Ala-Glu-Ala-Asn-Glu-Lys-Gln-His-Lys-Gln-Gln-Lys-Glu-Pro-Gly-Ala-Gly-Ala-Gly-Thr-Gln-Ala-Leu-Val-Pro-Val-Leu-Ser-Leu-Leu-Ala-Ile-Val-Phe-Phe-Leu-Val-Ala-Ala-Met-Val-Cys-Val-Leu-Cys-Asn-Arg-Arg-Val-Thr-Arg-Gln-Ser-Ser-Ser-Gly-Leu-Gln-Leu-Cys-Tyr-Thr-Pro-Val-Glu-Pro-Arg-Pro-Gln-Gly-Leu,,,,
4433,CXCL16,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,NQGSVAGSCSCDRTISSGTQIPQGTLDHIRKYLKAFHRCPFFIRFQLQSKSVCGGSQDQWVRELVDCFERKECGTGHGKSFHHQKHLPQASTQTPEAAEGTPSDTSTPAHSQSTQHSTLPSGALSLNKEHTQPWEMTTLPSGYGLEARPEAEANEKQQDDRQQEAPGAGASTPAWVPVLSLLAIVFFLTAAMAYVLCNRRATQQNSAGLQLWYTPVEPRP,Asn-Gln-Gly-Ser-Val-Ala-Gly-Ser-Cys-Ser-Cys-Asp-Arg-Thr-Ile-Ser-Ser-Gly-Thr-Gln-Ile-Pro-Gln-Gly-Thr-Leu-Asp-His-Ile-Arg-Lys-Tyr-Leu-Lys-Ala-Phe-His-Arg-Cys-Pro-Phe-Phe-Ile-Arg-Phe-Gln-Leu-Gln-Ser-Lys-Ser-Val-Cys-Gly-Gly-Ser-Gln-Asp-Gln-Trp-Val-Arg-Glu-Leu-Val-Asp-Cys-Phe-Glu-Arg-Lys-Glu-Cys-Gly-Thr-Gly-His-Gly-Lys-Ser-Phe-His-His-Gln-Lys-His-Leu-Pro-Gln-Ala-Ser-Thr-Gln-Thr-Pro-Glu-Ala-Ala-Glu-Gly-Thr-Pro-Ser-Asp-Thr-Ser-Thr-Pro-Ala-His-Ser-Gln-Ser-Thr-Gln-His-Ser-Thr-Leu-Pro-Ser-Gly-Ala-Leu-Ser-Leu-Asn-Lys-Glu-His-Thr-Gln-Pro-Trp-Glu-Met-Thr-Thr-Leu-Pro-Ser-Gly-Tyr-Gly-Leu-Glu-Ala-Arg-Pro-Glu-Ala-Glu-Ala-Asn-Glu-Lys-Gln-Gln-Asp-Asp-Arg-Gln-Gln-Glu-Ala-Pro-Gly-Ala-Gly-Ala-Ser-Thr-Pro-Ala-Trp-Val-Pro-Val-Leu-Ser-Leu-Leu-Ala-Ile-Val-Phe-Phe-Leu-Thr-Ala-Ala-Met-Ala-Tyr-Val-Leu-Cys-Asn-Arg-Arg-Ala-Thr-Gln-Gln-Asn-Ser-Ala-Gly-Leu-Gln-Leu-Trp-Tyr-Thr-Pro-Val-Glu-Pro-Arg-Pro,,,,
6479,CXCL17,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6UXB2,,SSLNPGVARGHRDRGQASRRWLQEGGQECECKDWFLRAPRRKFMTVSGLPKKQCPCDHFKGNVKKTRHQRHHRKPNKHSRACQQFLKQCQLRSFALPL,Ser-Ser-Leu-Asn-Pro-Gly-Val-Ala-Arg-Gly-His-Arg-Asp-Arg-Gly-Gln-Ala-Ser-Arg-Arg-Trp-Leu-Gln-Glu-Gly-Gly-Gln-Glu-Cys-Glu-Cys-Lys-Asp-Trp-Phe-Leu-Arg-Ala-Pro-Arg-Arg-Lys-Phe-Met-Thr-Val-Ser-Gly-Leu-Pro-Lys-Lys-Gln-Cys-Pro-Cys-Asp-His-Phe-Lys-Gly-Asn-Val-Lys-Lys-Thr-Arg-His-Gln-Arg-His-His-Arg-Lys-Pro-Asn-Lys-His-Ser-Arg-Ala-Cys-Gln-Gln-Phe-Leu-Lys-Gln-Cys-Gln-Leu-Arg-Ser-Phe-Ala-Leu-Pro-Leu,"Disulphide bond formation between cysteine residues at positions 28 and 53, and 30 and 55.",,,
4425,CXCL2,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P30348,,SELRCQCLTTLPRVDFKNIQSLTVTPPGPHCAQTEVIATLKDGHEVCLNPEAPLVQRIVQKILNKGKAN,Ser-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Thr-Thr-Leu-Pro-Arg-Val-Asp-Phe-Lys-Asn-Ile-Gln-Ser-Leu-Thr-Val-Thr-Pro-Pro-Gly-Pro-His-Cys-Ala-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asp-Gly-His-Glu-Val-Cys-Leu-Asn-Pro-Glu-Ala-Pro-Leu-Val-Gln-Arg-Ile-Val-Gln-Lys-Ile-Leu-Asn-Lys-Gly-Lys-Ala-Asn,,,,
827,CXCL2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P19875,,APLATELRCQCLQTLQGIHLKNIQSVKVKSPGPHCAQTEVIATLKNGQKACLNPASPMVKKIIEKMLKNGKSN,Ala-Pro-Leu-Ala-Thr-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Leu-Gln-Gly-Ile-His-Leu-Lys-Asn-Ile-Gln-Ser-Val-Lys-Val-Lys-Ser-Pro-Gly-Pro-His-Cys-Ala-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Gln-Lys-Ala-Cys-Leu-Asn-Pro-Ala-Ser-Pro-Met-Val-Lys-Lys-Ile-Ile-Glu-Lys-Met-Leu-Lys-Asn-Gly-Lys-Ser-Asn,,,,
4424,CXCL2,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10889,,AVVASELRCQCLKTLPRVDFKNIQSLSVTPPGPHCAQTEVIATLKGGQKVCLDPEAPLVQKIIQKILNKGKAN,Ala-Val-Val-Ala-Ser-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Lys-Thr-Leu-Pro-Arg-Val-Asp-Phe-Lys-Asn-Ile-Gln-Ser-Leu-Ser-Val-Thr-Pro-Pro-Gly-Pro-His-Cys-Ala-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Gly-Gly-Gln-Lys-Val-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Leu-Val-Gln-Lys-Ile-Ile-Gln-Lys-Ile-Leu-Asn-Lys-Gly-Lys-Ala-Asn,,,,
4426,CXCL3,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6W5C0,,SELRCQCLNTLPRVDFETIQSLTVTPPGPHCTQTEVIATLKDGQEVCLNPQGPRLQIIIKKILKSGKSS,Ser-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Asn-Thr-Leu-Pro-Arg-Val-Asp-Phe-Glu-Thr-Ile-Gln-Ser-Leu-Thr-Val-Thr-Pro-Pro-Gly-Pro-His-Cys-Thr-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asp-Gly-Gln-Glu-Val-Cys-Leu-Asn-Pro-Gln-Gly-Pro-Arg-Leu-Gln-Ile-Ile-Ile-Lys-Lys-Ile-Leu-Lys-Ser-Gly-Lys-Ser-Ser,,,,
828,CXCL3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P19876,,ASVVTELRCQCLQTLQGIHLKNIQSVNVRSPGPHCAQTEVIATLKNGKKACLNPASPMVQKIIEKILNKGSTN,Ala-Ser-Val-Val-Thr-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Leu-Gln-Gly-Ile-His-Leu-Lys-Asn-Ile-Gln-Ser-Val-Asn-Val-Arg-Ser-Pro-Gly-Pro-His-Cys-Ala-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Lys-Lys-Ala-Cys-Leu-Asn-Pro-Ala-Ser-Pro-Met-Val-Gln-Lys-Ile-Ile-Glu-Lys-Ile-Leu-Asn-Lys-Gly-Ser-Thr-Asn,,,,
4427,CXCL3,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q10746,,RELRCQCLKTLPRVDFENIQSLTVTPPGPHCTQTEVIATLKDGQEVCLNPQAPRLQKIIQKLLKSDKSS,Arg-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Lys-Thr-Leu-Pro-Arg-Val-Asp-Phe-Glu-Asn-Ile-Gln-Ser-Leu-Thr-Val-Thr-Pro-Pro-Gly-Pro-His-Cys-Thr-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asp-Gly-Gln-Glu-Val-Cys-Leu-Asn-Pro-Gln-Ala-Pro-Arg-Leu-Gln-Lys-Ile-Ile-Gln-Lys-Leu-Leu-Lys-Ser-Asp-Lys-Ser-Ser,,,,
3685,CXCL4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02776,,EAEEDGDLQCLCVKTTSQVRPRHITSLEVIKAGPHCPTAQLIATLKNGRKICLDLQAPLYKKIIKKLLES,Glu-Ala-Glu-Glu-Asp-Gly-Asp-Leu-Gln-Cys-Leu-Cys-Val-Lys-Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg-His-Ile-Thr-Ser-Leu-Glu-Val-Ile-Lys-Ala-Gly-Pro-His-Cys-Pro-Thr-Ala-Gln-Leu-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Lys-Ile-Cys-Leu-Asp-Leu-Gln-Ala-Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser,,,,
4428,CXCL5,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P50228,,APSSVIAATELRCVCLTVTPKINPKLIANLEVIPAGPQCPTVEVIAKLKNQKEVCLDPEAPVIKKIIQKILGSDKKKAKRNALAVERTASVQ,Ala-Pro-Ser-Ser-Val-Ile-Ala-Ala-Thr-Glu-Leu-Arg-Cys-Val-Cys-Leu-Thr-Val-Thr-Pro-Lys-Ile-Asn-Pro-Lys-Leu-Ile-Ala-Asn-Leu-Glu-Val-Ile-Pro-Ala-Gly-Pro-Gln-Cys-Pro-Thr-Val-Glu-Val-Ile-Ala-Lys-Leu-Lys-Asn-Gln-Lys-Glu-Val-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Val-Ile-Lys-Lys-Ile-Ile-Gln-Lys-Ile-Leu-Gly-Ser-Asp-Lys-Lys-Lys-Ala-Lys-Arg-Asn-Ala-Leu-Ala-Val-Glu-Arg-Thr-Ala-Ser-Val-Gln,,,,
829,CXCL5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P42830,,AGPAAAVLRELRCVCLQTTQGVHPKMISNLQVFAIGPQCSKVEVVASLKNGKEICLDPEAPFLKKVIQKILDGGNKEN,Ala-Gly-Pro-Ala-Ala-Ala-Val-Leu-Arg-Glu-Leu-Arg-Cys-Val-Cys-Leu-Gln-Thr-Thr-Gln-Gly-Val-His-Pro-Lys-Met-Ile-Ser-Asn-Leu-Gln-Val-Phe-Ala-Ile-Gly-Pro-Gln-Cys-Ser-Lys-Val-Glu-Val-Val-Ala-Ser-Leu-Lys-Asn-Gly-Lys-Glu-Ile-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Phe-Leu-Lys-Lys-Val-Ile-Gln-Lys-Ile-Leu-Asp-Gly-Gly-Asn-Lys-Glu-Asn,,,,
4464,CXCL5,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P97885,,APFSAMVATELRCVCLTLAPRINPKMIANLEVIPAGPHCPKVEVIAKLKNQKDNVCLDPQAPLIKKVIQKILGSENKKTKRNALALVRSASTQ,Ala-Pro-Phe-Ser-Ala-Met-Val-Ala-Thr-Glu-Leu-Arg-Cys-Val-Cys-Leu-Thr-Leu-Ala-Pro-Arg-Ile-Asn-Pro-Lys-Met-Ile-Ala-Asn-Leu-Glu-Val-Ile-Pro-Ala-Gly-Pro-His-Cys-Pro-Lys-Val-Glu-Val-Ile-Ala-Lys-Leu-Lys-Asn-Gln-Lys-Asp-Asn-Val-Cys-Leu-Asp-Pro-Gln-Ala-Pro-Leu-Ile-Lys-Lys-Val-Ile-Gln-Lys-Ile-Leu-Gly-Ser-Glu-Asn-Lys-Lys-Thr-Lys-Arg-Asn-Ala-Leu-Ala-Leu-Val-Arg-Ser-Ala-Ser-Thr-Gln,,,,
820,CXCL6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P80162,,GPVSAVLTELRCTCLRVTLRVNPKTIGKLQVFPAGPQCSKVEVVASLKNGKQVCLDPEAPFLKKVIQKILDSGNKKN,Gly-Pro-Val-Ser-Ala-Val-Leu-Thr-Glu-Leu-Arg-Cys-Thr-Cys-Leu-Arg-Val-Thr-Leu-Arg-Val-Asn-Pro-Lys-Thr-Ile-Gly-Lys-Leu-Gln-Val-Phe-Pro-Ala-Gly-Pro-Gln-Cys-Ser-Lys-Val-Glu-Val-Val-Ala-Ser-Leu-Lys-Asn-Gly-Lys-Gln-Val-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Phe-Leu-Lys-Lys-Val-Ile-Gln-Lys-Ile-Leu-Asp-Ser-Gly-Asn-Lys-Lys-Asn,,,,
830,CXCL7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02775,,SDLYAELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDESAD,Ser-Asp-Leu-Tyr-Ala-Glu-Leu-Arg-Cys-Met-Cys-Ile-Lys-Thr-Thr-Ser-Gly-Ile-His-Pro-Lys-Asn-Ile-Gln-Ser-Leu-Glu-Val-Ile-Gly-Lys-Gly-Thr-His-Cys-Asn-Gln-Val-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asp-Gly-Arg-Lys-Ile-Cys-Leu-Asp-Pro-Asp-Ala-Pro-Arg-Ile-Lys-Lys-Ile-Val-Gln-Lys-Lys-Leu-Ala-Gly-Asp-Glu-Ser-Ala-Asp,,,,
821,CXCL8,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10145,,AVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS,Ala-Val-Leu-Pro-Arg-Ser-Ala-Lys-Glu-Leu-Arg-Cys-Gln-Cys-Ile-Lys-Thr-Tyr-Ser-Lys-Pro-Phe-His-Pro-Lys-Phe-Ile-Lys-Glu-Leu-Arg-Val-Ile-Glu-Ser-Gly-Pro-His-Cys-Ala-Asn-Thr-Glu-Ile-Ile-Val-Lys-Leu-Ser-Asp-Gly-Arg-Glu-Leu-Cys-Leu-Asp-Pro-Lys-Glu-Asn-Trp-Val-Gln-Arg-Val-Val-Glu-Lys-Phe-Leu-Lys-Arg-Ala-Glu-Asn-Ser,,,,
837,CXCL9,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q07325,,TPVVRKGRCSCISTNQGTIHLQSLKDLKQFAPSPSCEKIEIIATLKNGVQTCLNPDSADVKELIKKWEKQVSQKKKQKNGKKHQKKKVLKVRKSQRSRQKKTT,Thr-Pro-Val-Val-Arg-Lys-Gly-Arg-Cys-Ser-Cys-Ile-Ser-Thr-Asn-Gln-Gly-Thr-Ile-His-Leu-Gln-Ser-Leu-Lys-Asp-Leu-Lys-Gln-Phe-Ala-Pro-Ser-Pro-Ser-Cys-Glu-Lys-Ile-Glu-Ile-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Val-Gln-Thr-Cys-Leu-Asn-Pro-Asp-Ser-Ala-Asp-Val-Lys-Glu-Leu-Ile-Lys-Lys-Trp-Glu-Lys-Gln-Val-Ser-Gln-Lys-Lys-Lys-Gln-Lys-Asn-Gly-Lys-Lys-His-Gln-Lys-Lys-Lys-Val-Leu-Lys-Val-Arg-Lys-Ser-Gln-Arg-Ser-Arg-Gln-Lys-Lys-Thr-Thr,,,,
4429,CXCL9,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P18340,,TLVIRNARCSCISTSRGTIHYKSLKDLKQFAPSPNCNKTEIIATLKNGDQTCLDPDSANVKKLMKEWEKKINQKKKQKRGKKHQKNMKNRKPKTPQSRRRSRKTT,Thr-Leu-Val-Ile-Arg-Asn-Ala-Arg-Cys-Ser-Cys-Ile-Ser-Thr-Ser-Arg-Gly-Thr-Ile-His-Tyr-Lys-Ser-Leu-Lys-Asp-Leu-Lys-Gln-Phe-Ala-Pro-Ser-Pro-Asn-Cys-Asn-Lys-Thr-Glu-Ile-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Asp-Gln-Thr-Cys-Leu-Asp-Pro-Asp-Ser-Ala-Asn-Val-Lys-Lys-Leu-Met-Lys-Glu-Trp-Glu-Lys-Lys-Ile-Asn-Gln-Lys-Lys-Lys-Gln-Lys-Arg-Gly-Lys-Lys-His-Gln-Lys-Asn-Met-Lys-Asn-Arg-Lys-Pro-Lys-Thr-Pro-Gln-Ser-Arg-Arg-Arg-Ser-Arg-Lys-Thr-Thr,,,,
856,CX3CL1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P78423,,QHHGVTKCNITCSKMTSKIPVALLIHYQQNQASCGKRAIILETRQHRLFCADPKEQWVKDAMQHLDRQAAALTRNGGTFEKQIGEVKPRTTPAAGGMDESVVLEPEATGESSSLEPTPSSQEAQRALGTSPELPTGVTGSSGTRLPPTPKAQDGGPVGTELFRVPPVSTAATWQSSAPHQPGPSLWAEAKTSEAPSTQDPSTQASTASSPAPEENAPSEGQRVWGQGQSPRPENSLEREEMGPVPAHTDAFQDWGPGSMAHVSVVPVSSEGTPSREPVASGSWTPKAEEPIHATMDPQRLGVLITPVPDAQAATRRQAVGLLAFLGLLFCLGVAMFTYQSLQGCPRKMAGEMAEGLRYIPRSCGSNSYVLVPV,,,,,
4468,CX3CL1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O35188,,QHLGMTKCEIMCDKMTSRIPVALLIRYQLNQESCGKRAIVLETTQHRRFCADPKEKWVQDAMKHLDHQAAALTKNGGKFEKRVDNVTPGITLATRGLSPSALTKPESATLEDLALELTTISQEARGTMGTSQEPPAAVTGSSLSTSEAQDAGLTAKPQSIGSFEAADISTTVWPSPAVYQSGSSSWAEEKATESPSTTAPSPQVSTTSPSTPEENVGSEGQPPWVQGQDLSPEKSLGSEEINPVHTDNFQERGPGNTVHPSVAPISSEETPSPELVASGSQAPKIEEPIHATADPQKLSVLITPVPDTQAATRRQAVGLLAFLGLLFCLGVAMFAYQSLQGCPRKMAGEMVEGLRYVPRSCGSNSYVLVPV,,,,,
4469,CX3CL1,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,O55145,,QHLGMTKCNITCHKMTSPIPVTLLIHYQLNQESCGKRAIILETRQHRHFCADPKEKWVQDAMKHLDHQTAALTRNGGKFEKRVDNVTPRITSATRGLSPTALAKPESATVEDLTLEPTAISQEARRPMGTSQEPPAAVTGSSPSTSKAQDAGLAAKPQSTGISEVAAVSTTIWPSSAVYQSGSSLWAEEKATESPPTIALSTQASTTSSPKQNVGSEGQPPWVQEQDSTPEKSPGPEETNPVHTDIFQDRGPGSTVHPSVAPTSSEKTPSPELVASGSQAPKVEEPIHATADPQKLSVFITPVPDSQAATRRQAVGLLAFLGLLFCLGVAMFAYQSLQGCPRKMAGEMVEGLRYVPRSCGSNSYVLVPV,,,,,
3729,cytokine domain of tyrosyl tRNA synthetase,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P54577,,PEEVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLVVVLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEELKPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS,,,,,
4904,cytokine receptor-like factor 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O75462,,AHTAVISPQDPTLLIGSSLLATCSVHGDPPGATAEGLYWTLNGRRLPPELSRVLNASTLALALANLNGSRQRSGDNLVCHARDGSILAGSCLYVGLPPEKPVNISCWSKNMKDLTCRWTPGAHGETFLHTNYSLKYKLRWYGQDNTCEEYHTVGPHSCHIPKDLALFTPYEIWVEATNRLGSARSDVLTLDILDVVTTDPPPDVHVSRVGGLEDQLSVRWVSPPALKDFLFQAKYQIRYRVEDSVDWKVVDDVSNQTSCRLAGLKPGTVYFVQVRCNPFGIYGSKKAGIWSEWSHPTAASTPRSERPGPGGGACEPRGGEPSSGPVRRELKQFLGWLKKHAYCSNLSFRLYDQWRAWMQKSHKTRNQDEGILPSGRRGTARGPAR,,"Predicted phosphylation of serine at position 182; predicted N-linked glycosylation of asparagine residues at positions 55, 67, 103, 131, 255, 345; disulphide bonds between cysteine residues at positions 6 and 116, and 147 and 158",,,
8452,delta like canonical Notch ligand 4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NR61,,MAAASRSASGWALLLLVALWQQRAAGSGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQAVVSPGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIEAWHAPGDDLRPEALPPDALISKIAIQGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHFGHYVCQPDGNLSCLPGWTGEYCQQPICLSGCHEQNGYCSKPAECLCRPGWQGRLCNECIPHNGCRHGTCSTPWQCTCDEGWGGLFCDQDLNYCTHHSPCKNGATCSNSGQRSYTCTCRPGYTGVDCELELSECDSNPCRNGGSCKDQEDGYHCLCPPGYYGLHCEHSTLSCADSPCFNGGSCRERNQGANYACECPPNFTGSNCEKKVDRCTSNPCANGGQCLNRGPSRMCRCRPGFTGTYCELHVSDCARNPCAHGGTCHDLENGLMCTCPAGFSGRRCEVRTSIDACASSPCFNRATCYTDLSTDTFVCNCPYGFVGSRCEFPVGLPPSFPWVAVSLGVGLAVLLVLLGMVAVAVRQLRLRRPDDGSREAMNNLSDFQKDNLIPAAQLKNTNQKKELEVDCGLDKSNCGKQQNHTLDYNLAPGPLGRGTMPGKFPHSDKSLGEKAPLRLHSEKPECRISAICSPRDSMYQSVCLISEERNECVIATEV,,,,,
644,[des-Arg10]kallidin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01042,,KRPPGFSPF,Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N,AILVBOHFGXNHCC-TZPCGENMSA-N
646,[des-Arg9]bradykinin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01042|O08677|P08934,,RPPGFSPF,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe,None.,,OCC(C(=O)N1CCCC1C(=O)NC(C(=O)O)Cc1ccccc1)NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CCCN=C(N)N)N,VCEHWDBVPZFHAG-UHFFFAOYSA-N
1499,des-Br-neuropeptide B-23,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8NG41,,WYKPAAGHSSYSVGRAAGLLSGL,Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu,None.,,,
1500,des-Br-neuropeptide B-29,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8NG41,,WYKPAAGHSSYSVGRAAGLLSGLRRSPYA,Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Ala,None.,,,
3600,[des-Gln14]ghrelin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBU3,,GSSFLSPEHQRVQRKESKKPPAKLQPR,Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,"The third residue, a serine, is octanoylated.",,,
3601,[des-Gln14]ghrelin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9EQX0|Q9QYH7,,GSSFLSPEHQKAQRKESKKPPAKLQPR,Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,"The third residue, a serine, is octanoylated.",,,
3599,[des-octanoyl]ghrelin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9EQX0|Q9QYH7,,GSSFLSPEHQKAQQRKESKKPPAKLQPR,Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,None,,,
1098,[des-octanoyl]ghrelin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBU3,,GSSFLSPEHQRVQQRKESKKPPAKLQPR,Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,"None. When cleaved from the propeptide, ghrelin undergoes ctanoylation of the serine residue at position 3 of the amino acid. This form of the ligand has not undergone this modification.",,,
3558,desulfated gastrin-14,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,WLEEEEEAYGWMDF,Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
8408,desulfated gastrin-17,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,XGPWLEEEEEAYGWMDF,pGlu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,,,,
8409,desulfated gastrin-34,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,XLGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF,pGlu-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,,,,
8410,desulfated gastrin-71,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,SWKPRSQQPDAPLGTGANRDLELPWLEQQGPASHHRRQLGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF,Ser-Trp-Lys-Pro-Arg-Ser-Gln-Gln-Pro-Asp-Ala-Pro-Leu-Gly-Thr-Gly-Ala-Asn-Arg-Asp-Leu-Glu-Leu-Pro-Trp-Leu-Glu-Gln-Gln-Gly-Pro-Ala-Ser-His-His-Arg-Arg-Gln-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,,,,
3701,Dickkopf 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O94907,,TLNSVLNSNAIKNLPPPLGGAAGHPGSAVSAAPGILYPGGNKYQTIDNYQPYPCAEDEECGTDEYCASPTRGGDAGVQICLACRKRRKRCMRHAMCCPGNYCKNGICVSSDQNHFRGEIEETITESFGNDHSTLDGYSRRTTLSSKMYHTKGQEGSVCLRSSDCASGLCCARHFWSKICKPVLKEGQVCTKHRRKGSHGLEIFQRCYCGEGLSCRIQKDHHQASNSSRLHTCQRH,,Asparagine residue at position 225 is N-linked glycosylated; O-linked glycosylation of serine residue at position 40.  Disulfide bond formation between cysteine residues at positions 158 and 170; 164 and 179; 169 and 206; 189 and 214; 208 and 232,,,
1620,dynorphin A,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRRIRPKLKWDNQ,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln,,,,
1619,dynorphin A-(1-13),"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRRIRPKLK,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys,,,,
1621,dynorphin A-(1-8),"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRRI,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile,,,,
1622,dynorphin B,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01213|O35417|P06300,,YGGFLRRQFKVVT,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N)CC(C)C)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)Cc1ccccc1,AGTSSZRZBSNTGQ-ITZCFHCWSA-N
6144,ectodysplasin A1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q92838,,MGYPEVERRELLPAAAPRERGSQGCGCGGAPARAGEGNSCLLFLGFFGLSLALHLLTLCCYLELRSELRRERGAESRLGGSGTPGTSGTLSSLGGLDPDSPITSHLGQPSPKQQPLEPGEAALHSDSQDGHQMALLNFFFPDEKPYSEEESRRVRRNKRSKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,,Predicated N-linked glycosylation of asparagine residues at positions 154 and 213 of the amino acid sequence.,,,
6143,ectodysplasin A2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q92838,,SKSNEGADGPVKNKKKGKKAGPPGPNGPPGPPGPPGPQGPPGIPGIPGIPGTTVMGPPGPPGPPGPQGPPGLQGPSGAADKAGTRENQPAVVHLQGQGSAIQVKNDLSGGVLNDWSRITMNPKVFKLHPRSGELEVLVDGTYFIYSQVEVYYINFTDFASYEVVVDEKPFLQCTRSIETGKTNYNTCYTAGVCLLKARQKIAVKMVHADISINMSKHTTFFGAIRLGEAPAS,,,,,
4916,EGF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01133,,NSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELR,,"Disulphide bond formation between cysteine residues at positions 6 and 20, 14 and 31, and 33 and 42",,,
8526,Elabela/Toddler-11,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0DMC3,,CMPLHSRVPFP,Cys-Met-Pro-Leu-His-Ser-Arg-Val-Pro-Phe-Pro,,,,
8525,Elabela/Toddler-21,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0DMC3,,LRKHNCLQRRCMPLHSRVPFP,Leu-Arg-Lys-His-Asn-Cys-Leu-Gln-Arg-Arg-Cys-Met-Pro-Leu-His-Ser-Arg-Val-Pro-Phe-Pro,,,,
8524,Elabela/Toddler-32,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0DMC3,,QRPVNLTMRRKLRKHNCLQRRCMPLHSRVPFP,Gln-Arg-Pro-Val-Asn-Leu-Thr-Met-Arg-Arg-Lys-Leu-Arg-Lys-His-Asn-Cys-Leu-Gln-Arg-Arg-Cys-Met-Pro-Leu-His-Ser-Arg-Val-Pro-Phe-Pro,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)Cc1ccccc1)C(C)C)CCCN=C(N)N)CO)Cc1nc[nH]c1)CC(C)C)CCSC)CS)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)CC(C)C)CS)CC(=O)N)Cc1nc[nH]c1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCC(=O)N)N)CCCN=C(N)N)CC(=O)N)CC(C)C)CCSC)CCCN=C(N)N)CCCN=C(N)N)CCCCN)CC(C)C)CCCN=C(N)N,AXGBCVTUKUUUPN-PXWSXZDTSA-N
1623,endomorphin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,YPWF,Tyr-Pro-Trp-Phe-NH2,The C-terminal phenylalanine is amidated,,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)N,ZEXLJFNSKAHNFH-SYKYGTKKSA-N
3668,endomorphin-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,YPFF,Tyr-Pro-Phe-Phe-NH2,The C-terminal phenylalanine is amidated.,,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)Cc1ccccc1)N,XIJHWXXXIMEHKW-LJWNLINESA-N
989,endothelin-1,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P22388|P22387|P05305,,CSCSSLMDKECVYFCHLDIIW,Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp,"There are two disulfide bonds formed, between cysteine residues at positions 1 and 15 and cysteine residues at positions 3 and 11.",,NCCCC[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC1=O)CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CO)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)[C@H](CC)C)CC(=O)O)CC(C)C)Cc1cnc[nH]1)CO,ZUBDGKVDJUIMQQ-ZTNLKOGPSA-N
3546,endothelin-2,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P22389|P23943,,CSCNSWLDKECVYFCHLDIIW,Cys-Ser-Cys-Asn-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp,"There are two disulfide bonds formed, between cysteine residues at positions 1 and 15 and cysteine residues at positions 3 and 11.",,,
990,endothelin-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20800,,CSCSSWLDKECVYFCHLDIIW,Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp,"There are two disulfide bonds formed, between cysteine residues at positions 1 and 15 and cysteine residues at positions 3 and 11.",,NCCCC[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC1=O)CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CO)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)[C@H](CC)C)CC(=O)O)CC(C)C)Cc1[nH]cnc1)CO)Cc1c[nH]c2c1cccc2,MLFJHYIHIKEBTQ-IYRKOGFYSA-N
1004,endothelin-3,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P14138|P48299|P13207,,CTCFTYKDKECVYYCHLDIIW,Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp,"There are two disulfide bonds formed, between cysteine residues at positions 1 and 15 and cysteine residues at positions 3 and 11.",,,
4908,ephrin-A1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20827,,DRHTVFWNSSNPKFRNEDYTIHVQLNDYVDIICPHYEDHSVADAAMEQYILYLVEHEEYQLCQPQSKDQVRWQCNRPSAKHGPEKLSEKFQRFTPFTLGKEFKEGHSYYYISKPIHQHEDRCLRLKVTVSGKITHSPQAHDNPQEKRLAADDPEVRVLHSIGHS,,"Disulphide bond formation between cysteine residues at positions 33 and 74, and 62 and 122. Predicted amidation of C-terminal serine residue; predicted N-linked glycosylation of asparagine at position 8",,,
4909,ephrin-A2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43921,,RAEDAARANSDRYAVYWNRSNPRFHAGAGDDGGGYTVEVSINDYLDIYCPHYGAPLPPAERMEHYVLYMVNGEGHASCDHRQRGFKRWECNRPAAPGGPLKFSEKFQLFTPFSLGFEFRPGHEYYYISATPPNAVDRPCLRLKVYVRPTNETLYEAPEPIFTSN,,"Disulphide bond formation between cysteine residues at positions 49 and 90, and 78 and 139. Predicted amidation of C-terminal asparagine residue; predicted N-linked glycosylation of asparagine residues at positions 18, 150 and 164",,,
4910,ephrin-A3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P52797,,QGPGGALGNRHAVYWNSSNQHLRREGYTVQVNVNDYLDIYCPHYNSSGVGPGAGPGPGGGAEQYVLYMVSRNGYRTCNASQGFKRWECNRPHAPHSPIKFSEKFQRYSAFSLGYEFHAGHEYYYISTPTHNLHWKCLRMKVFVCCASTSHSGEKPVPTLPQFTMGPNVKINVLEDFEGENPQVPKLEKSISG,,"Predicted disulphide bond formation between cysteine residues at positions 41 and 88, and 77 and 136. Predicted amidation of C-terminal glycine residue; predicted N-linked glycosylation of asparagine residues at positions 16, 45 and 78",,,
4911,ephrin-A4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P52798,,LRHVVYWNSSNPRLLRGDAVVELGLNDYLDIVCPHYEGPGPPEGPETFALYMVDWPGYESCQAEGPRAYKRWVCSLPFGHVQFSEKIQRFTPFSLGFEFLPGETYYYISVPTPESSGQCLRLQVSVCCKERKSESAHPVGSPGES,,"Predicted disulphide bond formation between cysteine residues at positions 33 and 74, and 61 and 119. Predicted amidation of C-terminal serine residue; predicted N-linked glycosylation of asparagine residue at position 8",,,
4912,ephrin-A5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P52803,,QDPGSKAVADRYAVYWNSSNPRFQRGDYHIDVCINDYLDVFCPHYEDSVPEDKTERYVLYMVNFDGYSACDHTSKGFKRWECNRPHSPNGPLKFSEKFQLFTPFSLGFEFRPGREYFYISSAIPDNGRRSCLKLKVFVRPTNSCMKTIGVHDRVFDVNDKVENSLEPADDTVHESAEPSRGEN,,"Predicted disulphide bond formation between cysteine residues at positions 42 and 82, and 70 and 131. Predicted amidation of C-terminal asparagine residue; predicted N-linked glycosylation of asparagine residue at position 17",,,
4913,ephrin-B1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P98172,,LAKNLEPVSWSSLNPKFLSGKGLVIYPKIGDKLDIICPRAEAGRPYEYYKLYLVRPEQAAACSTVLDPNVLVTCNRPEQEIRFTIKFQEFSPNYMGLEFKKHHDYYITSTSNGSLEGLENREGGVCRTRTMKIIMKVGQDPNAVTPEQLTTSRPSKEADNTVKMATQAPGSRGSLGDSDGKHETVNQEEKSGPGASGGSSGDPDGFFNSKVALFAAVGAGCVIFLLIIIFLTVLLLKLRKRHRKHTQQRAAALSLSTLASPKGGSGTAGTEPSDIIIPLRTTENNYCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,,"Serine residue at position 260 is phosphoserine; tyrosine residues at positions 286 and 290 are phosphotyrosine; predicted N-linked glycosylation of asparagine residue at position 112; predicted disulphide bond formation between cysteine residues at positions 17 and 74, and 62 and 126",,,
4914,ephrin-B2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P52799,,IVLEPIYWNSSNSKFLPGQGLVLYPQIGDKLDIICPKVDSKTVGQYEYYKVYMVDKDQADRCTIKKENTPLLNCAKPDQDIKFTIKFQEFSPNLWGLEFQKNKDYYIISTSNGSLEGLDNQEGGVCQTRAMKILMKVGQDASSAGSTRNKDPTRRPELEAGTNGRSSTTSPFVKPNPGSSTDGNSAGHSGNNILGSEVALFAGIASGCIIFIVIIITLVVLLLKYRRRHRKHSPQHTTTLSLSTLATPKRSGNNNGSEPSDIIIPLRTADSVFCPHYEKVSGDYGHPVYIVQEMPPQSPANIYYKV,,"Tyrosine residues at positions 277, 284, 289 and 303 are phosphotyrosine. Serine residue at position 298 is phosphoserine. Disulphide bond formation between asparagine residues at positions 35 and 74, and 62 and 126; predicted N-linked glycosylation of asparagine residues at positions 9 and 112",,,
4915,ephrin-B3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15768,,LSLEPVYWNSANKRFQAEGGYVLYPQIGDRLDLLCPRARPPGPHSSPNYEFYKLYLVGGAQGRRCEAPPAPNLLLTCDRPDLDLRFTIKFQEYSPNLWGHEFRSHHDYYIIATSDGTREGLESLQGGVCLTRGMKVLLRVGQSPRGGAVPRKPVSEMPMERDRGAAHSLEPGKENLPGDPTSNATSRGAEGPLPPPSMPAVAGAAGGLALLLLGVAGAGGAMCWRRRRAKPSESRHPGPGSFGRGGSLGLGGGGGMGPREAEPGELGIALRGGGAADPPFCPHYEKVSGDYGHPVYIVQDGPPQSPPNIYYKV,,"Predicted disulphide bond formation between cysteine residues at positions 35 and 77, and 65 and 129. Predicted N-linked glycosylation of asparagine residue at position 183",,,
4917,epigen,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6UW88,,AAVTVTPPITAQQGNWTVNKTEADNIEGPIALKFSHLCLEDHNSYCINGACAFHHELEKAICRCFTGYTGERCEHLTLTSYAVDSYEKYIAIGIGVGLLLSGFLVIFYCYIRKRCLKLKSPYNVCSGERRPL,,"Predicted N-linked glycosylation of asparagine residues at positions 15 and 19; predicted disulphide bonf formation between cysteine resdiues at positions 38 and 51, 46 and 62, and 64 and 73",,,
4918,epiregulin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14944,,VAQVSITKCSSDMNGYCLHGQCIYLVDMSQNYCRCEVGYTGVRCEHFFL,Val-Ala-Gln-Val-Ser-Ile-Thr-Lys-Cys-Ser-Ser-Asp-Met-Asn-Gly-Tyr-Cys-Leu-His-Gly-Gln-Cys-Ile-Tyr-Leu-Val-Asp-Met-Ser-Gln-Asn-Tyr-Cys-Arg-Cys-Glu-Val-Gly-Tyr-Thr-Gly-Val-Arg-Cys-Glu-His-Phe-Phe-Leu,"Disulphide bond formation between cysteine residues at positions 9 and 22, 17 and 33, and 35 and 44",,,
4921,erythropoietin,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01588,epoetin alfa,APPRLICDSRVLERYLLEAKEAENITTGCAEHCSLNENITVPDTKVNFYAWKRMEVGQQAVEVWQGLALLSEAVLRGQALLVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAISPPDAASAAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEACRTGDR,,"N-linked glycosylation of asparagine residues at positions 24, 38, and 83; O-linked glycosylation of serine at position 126; disulphide bond formation between cysteine residues at positions 7 and 161, and 29 and 33",,,
3574,F2L,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9R257|1304581,,MLGMIRNSLFGSVETWPWQVL,(Ac)Met-Leu-Gly-Met-Ile-Arg-Asn-Ser-Leu-Phe-Gly-Ser-Val-Glu-Thr-Trp-Pro-Trp-Gln-Val-Leu,The N-terminal methionine is acetylated.,,,
3935,F2L,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NRV9,,MLGMIKNSLFGSVETWPWQVL,(Ac)Met-Leu-Gly-Met-Ile-Lys-Asn-Ser-Leu-Phe-Gly-Ser-Val-Glu-Thr-Trp-Pro-Trp-Gln-Val-Leu-NH2,Amidation of C-terminal leucine residue; acetylation of N-terminal methionine,,,
5078,Fas ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48023,,MQQPFNYPYPQIYWVDSSASSPWAPPGTVLPCPTSVPRRPGQRRPPPPPPPPPLPPPPPPPPLPPLPLPPLKKRGNHSTGLCLLVMFFMVLVALVGLGLGMFQLFHLQKELAELRESTSQMHTASSLEKQIGHPSPPPEKKELRKVAHLTGKSNSRSMPLEWEDTYGIVLLSGVKYKKGGLVINETGLYFVYSKVYFRGQSCNNLPLSHKVYMRNSKYPQDLVMMEGKMMSYCTTGQMWARSSYLGAVFNLTSADHLYVNVSELSLVNFEESQTFFGLYKL,,"Predicted N-linked glycosylation of asparagine residues at positions 184, 250 and 260; predicted disulphide bond formation between cysteine residues at positions 202 and 233 ",,,
4923,FGF-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05230,,FNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD,,,,,
9641,FGF-10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15520,,QALGQDMVSPEATNSSSSSFSSPSSAGRHVRSYNHLQGDVRWRKLFSFTKYFLKIEKNGKVSGTKKENCPYSILEITSVEIGVVAVKAINSNYYLAMNKKGKLYGSKEFNNDCKLKERIEENGYNTYASFNWQHNGRQMYVALNGKGAPRRGQKTRRKNTSAHFLPMVVHS,Gln-Ala-Leu-Gly-Gln-Asp-Met-Val-Ser-Pro-Glu-Ala-Thr-Asn-Ser-Ser-Ser-Ser-Ser-Phe-Ser-Ser-Pro-Ser-Ser-Ala-Gly-Arg-His-Val-Arg-Ser-Tyr-Asn-His-Leu-Gln-Gly-Asp-Val-Arg-Trp-Arg-Lys-Leu-Phe-Ser-Phe-Thr-Lys-Tyr-Phe-Leu-Lys-Ile-Glu-Lys-Asn-Gly-Lys-Val-Ser-Gly-Thr-Lys-Lys-Glu-Asn-Cys-Pro-Tyr-Ser-Ile-Leu-Glu-Ile-Thr-Ser-Val-Glu-Ile-Gly-Val-Val-Ala-Val-Lys-Ala-Ile-Asn-Ser-Asn-Tyr-Tyr-Leu-Ala-Met-Asn-Lys-Lys-Gly-Lys-Leu-Tyr-Gly-Ser-Lys-Glu-Phe-Asn-Asn-Asp-Cys-Lys-Leu-Lys-Glu-Arg-Ile-Glu-Glu-Asn-Gly-Tyr-Asn-Thr-Tyr-Ala-Ser-Phe-Asn-Trp-Gln-His-Asn-Gly-Arg-Gln-Met-Tyr-Val-Ala-Leu-Asn-Gly-Lys-Gly-Ala-Pro-Arg-Arg-Gly-Gln-Lys-Thr-Arg-Arg-Lys-Asn-Thr-Ser-Ala-His-Phe-Leu-Pro-Met-Val-Val-His-Ser,,,,
4924,FGF-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09038,,PALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS,,Tyrosine residue at position 73 is phosphotyrosine,,,
9291,FGF-23,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9GZV9,,YPNASPLLGSSWGGLIHLYTATARNSYHLQIHKNGHVDGAPHQTIYSALMIRSEDAGFVVITGVMSRRYLCMDFRGNIFGSHYFDPENCRFQHQTLENGYDVYHSPQYHFLVSLGRAKRAFLPGMNPPPYSQFLSRRNEIPLIHFNTPIPRRHTRSAEDDSERDPLNVLKPRARMTPAPASCSQELPSAEDNSPMASDPLGVVRGGRVNTHAGGTGPEGCRPFAKFI,,,,,
9629,FGF-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P11487,,AAGPGARLRRDAGGRGGVYEHLGGAPRRRKLYCATKYHLQLHPSGRVNGSLENSAYSILEITAVEVGIVAIRGLFSGRYLAMNKRGRLYASEHYSAECEFVERIHELGYNTYASRLYRTVSSTPGARRQPSAERLWYVSVNGKGRPRRGFKTRRTQKSSLFLPRVLDHRDHEMVRQLQSGLPRPPGKGVQPRRRRQKQSPDNLEPSHVQASRLGSQLEASAH,Ala-Ala-Gly-Pro-Gly-Ala-Arg-Leu-Arg-Arg-Asp-Ala-Gly-Gly-Arg-Gly-Gly-Val-Tyr-Glu-His-Leu-Gly-Gly-Ala-Pro-Arg-Arg-Arg-Lys-Leu-Tyr-Cys-Ala-Thr-Lys-Tyr-His-Leu-Gln-Leu-His-Pro-Ser-Gly-Arg-Val-Asn-Gly-Ser-Leu-Glu-Asn-Ser-Ala-Tyr-Ser-Ile-Leu-Glu-Ile-Thr-Ala-Val-Glu-Val-Gly-Ile-Val-Ala-Ile-Arg-Gly-Leu-Phe-Ser-Gly-Arg-Tyr-Leu-Ala-Met-Asn-Lys-Arg-Gly-Arg-Leu-Tyr-Ala-Ser-Glu-His-Tyr-Ser-Ala-Glu-Cys-Glu-Phe-Val-Glu-Arg-Ile-His-Glu-Leu-Gly-Tyr-Asn-Thr-Tyr-Ala-Ser-Arg-Leu-Tyr-Arg-Thr-Val-Ser-Ser-Thr-Pro-Gly-Ala-Arg-Arg-Gln-Pro-Ser-Ala-Glu-Arg-Leu-Trp-Tyr-Val-Ser-Val-Asn-Gly-Lys-Gly-Arg-Pro-Arg-Arg-Gly-Phe-Lys-Thr-Arg-Arg-Thr-Gln-Lys-Ser-Ser-Leu-Phe-Leu-Pro-Arg-Val-Leu-Asp-His-Arg-Asp-His-Glu-Met-Val-Arg-Gln-Leu-Gln-Ser-Gly-Leu-Pro-Arg-Pro-Pro-Gly-Lys-Gly-Val-Gln-Pro-Arg-Arg-Arg-Arg-Gln-Lys-Gln-Ser-Pro-Asp-Asn-Leu-Glu-Pro-Ser-His-Val-Gln-Ala-Ser-Arg-Leu-Gly-Ser-Gln-Leu-Glu-Ala-Ser-Ala-His,,,,
4925,FGF-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08620,,APTAPNGTLEAELERRWESLVALSLARLPVAAQPKEAAVQSGAGDYLLGIKRLRRLYCNVGIGFHLQALPDGRIGGAHADTRDSLLELSPVERGVVSIFGVASRFFVAMSSKGKLYGSPFFTDECTFKEILLPNNYNAYESYKYPGMFIALSKNGKTKKGNRVSPTMKVTHFLPRL,,,,,
4926,FGF-5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12034,,AWAHGEKRLAPKGQPGPAATDRNPRGSSSRQSSSSAMSSSSASSSPAASLGSQGSGLEQSSFQWSPSGRRTGSLYCRVGIGFHLQIYPDGKVNGSHEANMLSVLEIFAVSQGIVGIRGVFSNKFLAMSKKGKLHASAKFTDDCKFRERFQENSYNTYASAIHRTEKTGREWYVALNKRGKAKRGCSPRVKPQHISTHFLPRFKQSEQPELSFTVTVPEKKKPPSPIKPKIPLSAPRKNTNSVKYRLKFRFG,,Predicted N-linked glycosylation of asparagine residue at position 93,,,
4927,FGF-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10767,,SPAGTRANNTLLDSRGWGTLLSRSRAGLAGEIAGVNWESGYLVGIKRQRRLYCNVGIGFHLQVLPDGRISGTHEENPYSLLEISTVERGVVSLFGVRSALFVAMNSKGRLYATPSFQEECKFRETLLPNNYNAYESDLYQGTYIALSKYGRVKRGSKVSPIMTVTHFLPRI,,Predicted N-linked glycosylation of asparagine residue at position 8; predicted disulphide bond formation between cysteine resdiues at positions 53 and 120,,,
4928,FGF-7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P21781,,CNDMTPEQMATNVNCSSPERHTRSYDYMEGGDIRVRRLFCRTQWYLRIDKRGKVKGTQEMKNNYNIMEIRTVAVGIVAIKGVESEFYLAMNKEGKLYAKKECNEDCNFKELILENHYNTYASAKWTHNGGEMFVALNQKGIPVRGKKTKKEQKTAHFLPMAIT,,Predicted N-linked glycosylation of asparagine residue at position 14,,,
4929,FGF-8,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55075,,QEGPGRGPALGRELASLFRAGREPQGVSQQHVREQSLVTDQLSRRLIRTYQLYSRTSGKHVQVLANKRINAMAEDGDPFAKLIVETDTFGSRVRVRGAETGLYICMNKKGKLIAKSNGKGKDCVFTEIVLENNYTALQNAKYEGWYMAFTRKGRPRKGSKTRQHQREVHFMKRLPRGHHTTEQSLRFEFLNYPPFTRSLRGSQRTWAPEPR,,Predicted N-linked glycosylation of asparagine residue at position 133,,,
4930,FGF-9,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P31371,,LGEVGNYFGVQDAVPFGNVPVLPVDSPVLLSDHLGQSEAGGLPRGPAVTDLDHLKGILRRRQLYCRTGFHLEIFPNGTIQGTRKDHSRFGILEFISIAVGLVSIRGVDSGLYLGMNEKGELYGSEKLTQECVFREQFEENWYNTYSSNLYKHVDTGRRYYVALNKDGTPREGTRTKRHQKFTHFLPRPVDPDKVPELYKDILSQS,,Predicted N-linked glycosylation of asparagine residue at position 76,,,
6749,fibrinogen,Human,"Endogenous peptide in human, mouse or rat",6750|6751|6752,fibrinogen alpha chain|fibrinogen beta chain|fibrinogen gamma chain,,,,,,,,,,,,,,
6750,fibrinogen alpha chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02671,,GPRVVERHQSACKDSDWPFCSDEDWNYKCPSGCRMKGLIDEVNQDFTNRINKLKNSLFEYQKNNKDSHSLTTNIMEILRGDFSSANNRDNTYNRVSEDLRSRIEVLKRKVIEKVQHIQLLQKNVRAQLVDMKRLEVDIDIKIRSCRGSCSRALAREVDLKDYEDQQKQLEQVIAKDLLPSRDRQHLPLIKMKPVPDLVPGNFKSQLQKVPPEWKALTDMPQMRMELERPGGNEITRGGSTSYGTGSETESPRNPSSAGSWNSGSSGPGSTGNRNPGSSGTGGTATWKPGSSGPGSTGSWNSGSSGTGSTGNQNPGSPRPGSTGTWNPGSSERGSAGHWTSESSVSGSTGQWHSESGSFRPDSPGSGNARPNNPDWGTFEEVSGNVSPGTRREYHTEKLVTSKGDKELRTGKEKVTSGSTTTTRRSCSKTVTKTVIGPDGHKEVTKEVVTSEDGSDCPEAMDLGTLSGIGTLDGFRHRHPDEAAFFDTASTGKTFPGFFSPMLGEFVSETESRGSESGIFTNTKESSSHHPGIAEFPSRGKSSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHEGTHSTKRGHAKSRPVRDCDDVLQTHPSGTQSGIFNIKLPGSSKIFSVYCDQETSLGGWLLIQQRMDGSLNFNRTWQDYKRGFGSLNDEGEGEFWLGNDYLHLLTQRGSVLRVELEDWAGNEAYAEYHFRVGSEAEGYALQVSSYEGTAGDALIEGSVEEGAEYTSHNNMQFSTFDRDADQWEENCAEVYGGGWWYNNCQAANLNGIYYPGGSYDPRNNSPYEIENGVVWVSFRGADYSLRAVRMKIRPLVTQ,,,,,
6751,fibrinogen beta chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02675,,GHRPLDKKREEAPSLRPAPPPISGGGYRARPAKAAATQKKVERKAPDAGGCLHADPDLGVLCPTGCQLQEALLQQERPIRNSVDELNNNVEAVSQTSSSSFQYMYLLKDLWQKRQKQVKDNENVVNEYSSELEKHQLYIDETVNSNIPTNLRVLRSILENLRSKIQKLESDVSAQMEYCRTPCTVSCNIPVVSGKECEEIIRKGGETSEMYLIQPDSSVKPYRVYCDMNTENGGWTVIQNRQDGSVDFGRKWDPYKQGFGNVATNTDGKNYCGLPGEYWLGNDKISQLTRMGPTELLIEMEDWKGDKVKAHYGGFTVQNEANKYQISVNKYRGTAGNALMDGASQLMGENRTMTIHNGMFFSTYDRDNDGWLTSDPRKQCSKEDGGGWWYNRCHAANPNGRYYWGGQYTWDMAKHGTDDGVVWMNWKGSWYSMRKMSMKIRPFFPQQ,,,,,
6752,fibrinogen gamma chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02679,,YVATRDNCCILDERFGSYCPTTCGIADFLSTYQTKVDKDLQSLEDILHQVENKTSEVKQLIKAIQLTYNPDESSKPNMIDAATLKSRKMLEEIMKYEASILTHDSSIRYLQEIYNSNNQKIVNLKEKVAQLEAQCQEPCKDTVQIHDITGKDCQDIANKGAKQSGLYFIKPLKANQQFLVYCEIDGSGNGWTVFQKRLDGSVDFKKNWIQYKEGFGHLSPTGTTEFWLGNEKIHLISTQSAIPYALRVELEDWNGRTSTADYAMFKVGPEADKYRLTYAYFAGGDAGDAFDGFDFGDDPSDKFFTSHNGMQFSTWDNDNDKFEGNCAEQDGSGWWMNKCHAGHLNGVYYQGGTYSKASTPNGYDNGIIWATWKTRWYSMKKTTMKIIPFNRLTIGEGQQHHLGGAKQVRPEHPAETEYDSLYPEDDL,,,,,
6754,fibronectin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P02751,,,,,,,
5186,FLICE-like inhibitory protein,Human,"Endogenous peptide in human, mouse or rat",5187|5188,FLICE-like inhibitory protein subunit p12|FLICE-like inhibitory protein subunit p43,,,,,,,,,,,,,,
5187,FLICE-like inhibitory protein subunit p12,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15519,,GPAMKNVEFKAQKRGLCTVHREADFFWSLCTADMSLLEQSHSSPSLYLQCLSQKLRQERKRPLLDLHIELNGYMYDWNSRVSAKEKYYVWLQHTLRKKLILSYT,,,,,
5188,FLICE-like inhibitory protein subunit p43,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15519,,MSAEVIHQVEEALDTDEKEMLLFLCRDVAIDVVPPNVRDLLDILRERGKLSVGDLAELLYRVRRFDLLKRILKMDRKAVETHLLRNPHLVSDYRVLMAEIGEDLDKSDVSSLIFLMKDYMGRGKISKEKSFLDLVVELEKLNLVAPDQLDLLEKCLKNIHRIDLKTKIQKYKQSVQGAGTSYRNVLQAAIQKSLKDPSNNFRLHNGRSKEQRLKEQLGAQQEPVKKSIQESEAFLPQSIPEERYKMKSKPLGICLIIDCIGNETELLRDTFTSLGYEVQKFLHLSMHGISQILGQFACMPEHRDYDSFVCVLVSRGGSQSVYGVDQTHSGLPLHHIRRMFMGDSCPYLAGKPKMFFIQNYVVSEGQLEDSSLLEVD,,,,,
5900,FLRT3,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,B1H234,,KSCPSVCRCDAGFIYCNDRSLTSIPVGIPEDATTLYLQNNQINNVGIPSDLKNLLKVQRIYLYHNSLDEFPTNLPKYVKELHLQENNIRTITYDSLSKIPYLEELHLDDNSVSAVSIEEGAFRDSNYLRLLFLSRNHLSTIPGGLPRTIEELRLDDNRISTISSPSLHGLTSLKRLVLDGNLLNNHGLGDKVFFNLVNLTELSLVRNSLTAAPVNLPGTSLRKLYLQDNHINRVPPNAFSYLRQLYRLDMSNNNLSNLPQGIFDDLDNITQLILRNNPWYCGCKMKWVRDWLQSLPVKVNVRGLMCQAPEKVRGMAIKDLSAELFDCKDSGIVSTVQITTAIPNTAYPAQGQWPAPVTKQPDIKNPKLTKDQRTTGSPSRKTILITVKSVTPDTIHISWRLALPMTALRLSWLKLGHSPAFGSITETIVTGERSEYLVTALEPESPYRVCMVPMETSNLYLFDETPVCIETQTAPLRMYNPTTTLNREQEKEPYKNPNLPLAAIIGGAVALVSIALLALVCWYVHRNGSLFSRNCAYSKGRRRKDDYAEAGTKKDNSILEIRETSFQMLPISNEPISKEEFVIHTIFPPNGMNLYKNNLSESSSNRSYRDSGIPDLDHSHS,,"Predicted N-lijnked glycosylation of asparagine residues at positions 198, 254 and 268 of the amino acid sequence.",,,
4932,Fms-related tyrosine kinase 3 ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P49771,,TQDCSFQHSPISSDFAVKIRELSDYLLQDYPVTVASNLQDEELCGGLWRLVLAQRWMERLKTVAGSKMQGLLERVNTEIHFVTKCAFQPPPSCLRFVQTNISRLLQETSEQLVALKPWITRQNFSRCLELQCQPDSSTLPPPWSPRPLEATAPTAPQPPLLLLLLLPVGLLLLAAAWCLHWQRTRRRTPRPGEQVPPVPSPQDLLLVEH,,"Predicted N-linked glycosylation of asparagine resdiues at positions 100 and 123; disulphide bond formation between cysteine resdiues at positions 4 and 85, 44 and 127, and 93 and 132",,,
4933,follistatin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P19883,,GNCWLRQAKNGRCQVLYKTELSKEECCSTGRLSTSWTEEDVNDNTLFKWMIFNGGAPNCIPCKETCENVDCGPGKKCRMNKKNKPRCVCAPDCSNITWKGPVCGLDGKTYRNECALLKARCKEQPELEVQYQGRCKKTCRDVFCPGSSTCVVDQTNNAYCVTCNRICPEPASSEQYLCGNDGVTYSSACHLRKATCLLGRSIGLAYEGKCIKAKSCEDIQCTGGKKCLWDFKVGRGRCSLCDELCPDSKSDEPVCASDNATYASECAMKEAACSSGVLLEVKHSGSCNSISEDTEEEEEDEDQDYSFPISSILEW,,"Predicted N-linked glycosylation of asparagine residues at positions 95 and 259, Disulphide bond formation between cysteine resdiues at positions 3 and 26, 13 and 59, 27 and 62, 66 and 77, 71 and 87, 89 and 121, 93 and 114, 103 and 135, 163 and 196, 167 and 189, 278 and 210, 241 and 273, 245 and 266, and 255 and 287",,,
4387,FSH,Rat,"Endogenous peptide in human, mouse or rat",4385|4378,FSH β subunit|glycoprotein hormone common alpha subunit,,,,,,,,,,,The production of biologically active FSH requires appropriately folded and glycosylated FSHβ and common α subunits that assemble to form the heterodimeric hormone.,,,
1157,FSH,Human,"Endogenous peptide in human, mouse or rat",3731|3733,glycoprotein hormone common alpha subunit|FSH β subunit,yes,,,,,,,urofollitropin,,,"The production of biologically active FSH requires appropriately folded and glycosylated FSHβ and common α subunits that assemble to form the heterodimeric hormone. FSHβ is glysolyated at asparagines 7 and 24, while the common α subunit is glycosylated at asparagines 52 and 78. They then assemble to form the biologically active FSH heterodimer .",,,
4386,FSH,Mouse,"Endogenous peptide in human, mouse or rat",4384|4377,FSH β subunit|glycoprotein hormone common alpha subunit,,,,,,,,,,,The production of biologically active FSH requires appropriately folded and glycosylated FSHβ and common α subunits that assemble to form the heterodimeric hormone.,,,
4385,FSH β subunit,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P18427,,SCELTNITISVEKEECRFCISINTTWCEGYCYTRDLVYKDPARPNTQKVCTFKELVYETIRLPGCARHSDSLYTYPVATECHCGKCDSDSTDCTVRGLGPSYCSFGEMKE,Ser-Cys-Glu-Leu-Thr-Asn-Ile-Thr-Ile-Ser-Val-Glu-Lys-Glu-Glu-Cys-Arg-Phe-Cys-Ile-Ser-Ile-Asn-Thr-Thr-Trp-Cys-Glu-Gly-Tyr-Cys-Tyr-Thr-Arg-Asp-Leu-Val-Tyr-Lys-Asp-Pro-Ala-Arg-Pro-Asn-Thr-Gln-Lys-Val-Cys-Thr-Phe-Lys-Glu-Leu-Val-Tyr-Glu-Thr-Ile-Arg-Leu-Pro-Gly-Cys-Ala-Arg-His-Ser-Asp-Ser-Leu-Tyr-Thr-Tyr-Pro-Val-Ala-Thr-Glu-Cys-His-Cys-Gly-Lys-Cys-Asp-Ser-Asp-Ser-Thr-Asp-Cys-Thr-Val-Arg-Gly-Leu-Gly-Pro-Ser-Tyr-Cys-Ser-Phe-Gly-Glu-Met-Lys-Glu,"The production of biologically active FSH requires appropriately folded and glycosylated FSHβ and common α subunits that assemble to form the heterodimeric hormone. FSHβ is glysolyated at asparagine residues at positions 6 and 23, and disulfide bond formation occurs between cysteine residues at postions 2 and 50; 16 and 65; 19 and 103; 27 and 81; 31 and 83 and 86 and 93. The FSHβ and common alpha subunits then assemble to form the biologically active FSH heterodimer.",,,
3733,FSH β subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01225,,NSCELTNITIAIEKEECRFCISINTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYETVRVPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFGEMKE,Asn-Ser-Cys-Glu-Leu-Thr-Asn-Ile-Thr-Ile-Ala-Ile-Glu-Lys-Glu-Glu-Cys-Arg-Phe-Cys-Ile-Ser-Ile-Asn-Thr-Thr-Trp-Cys-Ala-Gly-Tyr-Cys-Tyr-Thr-Arg-Asp-Leu-Val-Tyr-Lys-Asp-Pro-Ala-Arg-Pro-Lys-Ile-Gln-Lys-Thr-Cys-Thr-Phe-Lys-Glu-Leu-Val-Tyr-Glu-Thr-Val-Arg-Val-Pro-Gly-Cys-Ala-His-His-Ala-Asp-Ser-Leu-Tyr-Thr-Tyr-Pro-Val-Ala-Thr-Gln-Cys-His-Cys-Gly-Lys-Cys-Asp-Ser-Asp-Ser-Thr-Asp-Cys-Thr-Val-Arg-Gly-Leu-Gly-Pro-Ser-Tyr-Cys-Ser-Phe-Gly-Glu-Met-Lys-Glu,"The production of biologically active FSH requires appropriately folded and glycosylated FSHβ and common α subunits that assemble to form the heterodimeric hormone. FSHβ is glysolyated at asparagines 7 and 24, while the common α subunit is glycosylated at asparagines 52 and 78. They then assemble to form the biologically active FSH heterodimer .",,,
4384,FSH β subunit,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q60687,,SCELTNITISVEKEECRFCISINTTWCAGYCYTRDLVYKDPARPNTQKVCTFKELVYETVRLPGCARHSDSLYTYPVATECHCGKCDSDSTDCTVRGLGPSYCSFSEMKE,,"The production of biologically active FSH requires appropriately folded and glycosylated FSHβ and common α subunits that assemble to form the heterodimeric hormone. FSHβ is glysolyated at asparagine residues at positions 6 and 23, and disulfide bond formation occurs between cysteine residues at postions 2 and 50; 16 and 65; 19 and 103; 27 and 81; 31 and 83 and 86 and 93. The FSHβ and common alpha subunits then assemble to form the biologically active FSH heterodimer.",,,
3593,galanin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P47212|P10683,,GWTLNSAGYLLGPHAIDNHRSFSDKHGLT,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-NH2,The C-terminal threonine is amidated.,,,
3592,galanin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P22466,,GWTLNSAGYLLGPHAVGNHRSFSDKNGLTS,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser,None,,,
3596,galanin-like peptide,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QXQ6,,APAHRGRGGWTLNSAGYLLGPVLHLSSKANQGRKTDSALEILDLWKAIDGLPYSRSPRMT,Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Ser-Ser-Lys-Ala-Asn-Gln-Gly-Arg-Lys-Thr-Asp-Ser-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-Arg-Ser-Pro-Arg-Met-Thr,None,,,
3595,galanin-like peptide,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q810H5,,APAHRGRGGWTLNSAGYLLGPVLPVSSKADQGRKRDSALEILDLWKIIDGLPYSHSPRMT,Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-Pro-Val-Ser-Ser-Lys-Ala-Asp-Gln-Gly-Arg-Lys-Arg-Asp-Ser-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ile-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-His-Ser-Pro-Arg-Met-Thr,None,,,
3594,galanin-like peptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBC7,,APAHRGRGGWTLNSAGYLLGPVLHLPQMGDQDGKRETALEILDLWKAIDGLPYSHPPQPS,Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-Asp-Gly-Lys-Arg-Glu-Thr-Ala-Leu-Glu-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Ser-His-Pro-Pro-Gln-Pro-Ser,None,,,
6603,galectin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09382,,GLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD,,,,,
6619,galectin-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P17931,,ADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI,,,,,
6615,galectin-3 binding protein,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q08380,,VNDGDMRLADGGATNQGRVEIFYRGQWGTVCDNLWDLTDASVVCRALGFENATQALGRAAFGQGSGPIMLDEVQCTGTEASLADCKSLGWLKSNCRHERDAGVVCTNETRSTHTLDLSRELSEALGQIFDSQRGCDLSISVNVQGEDALGFCGHTVILTANLEAQALWKEPGSNVTMSVDAECVPMVRDLLRYFYSRRIDITLSSVKCFHKLASAYGARQLQGYCASLFAILLPQDPSFQMPLDLYAYAVATGDALLEKLCLQFLAWNFEALTQAEAWPSVPTDLLQLLLPRSDLAVPSELALLKAVDTWSWGERASHEEVEGLVEKIRFPMMLPEELFELQFNLSLYWSHEALFQKKTLQALEFHTVPFQLLARYKGLNLTEDTYKPRIYTSPTWSAFVTDSSWSARKSQLVYQSRRGPLVKYSSDYFQAPSDYRYYPYQSFQTPQHPSFLFQDKRVSWSLVYLPTIQSCWNYGFSCSSDELPVLGLTKSGGSDRTIAYENKALMLCEGLFVADVTDFEGWKAAIPSALDTNSSKSTSSFPCPAGHFNGFRTVIRPFYLTNSSGVD,,,,,
9594,galectin 9,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00182,,MAFSGSQAPYLSPAVPFSGTIQGGLQDGLQITVNGTVLSSSGTRFAVNFQTGFSGNDIAFHFNPRFEDGGYVVCNTRQNGSWGPEERKTHMPFQKGMPFDLCFLVQSSDFKVMVNGILFVQYFHRVPFHRVDTISVNGSVQLSYISFQNPRTVPVQPAFSTVPFSQPVCFPPRPRGRRQKPPGVWPANPAPITQTVIHTVQSAPGQMFSTPAIPPMMYPHPAYPMPFITTILGGLYPSKSILLSGTVLPSAQRFHINLCSGNHIAFHLNPRFDENAVVRNTQIDNSWGSEERSLPRKMPFVRGQSFSVWILCEAHCLKVAVDGQHLFEYYHRLRNLPTINRLEVGGDIQLTHVQT,,,,,
1333,γ-MSH,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01189|P01193|P01194,,YVMGHFRWDRF,Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
3543,gastric inhibitory polypeptide,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48756,,YAEGTFISDYSIAMDKIRQQDFVNWLLAQRGKKSDWKHNITQ,Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Arg-Gly-Lys-Lys-Ser-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln,,,,
1126,gastric inhibitory polypeptide,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q06145,,YAEGTFISDYSIAMDKIRQQDFVNWLLAQKGKKNDWKHNLTQ,Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Leu-Thr-Gln,,,,
3542,gastric inhibitory polypeptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09681,,YAEGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ,Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln,None,,,
8411,gastrin-14,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,WLEEEEEAYGWMDF,Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,,,,
3559,gastrin-17,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,XGPWLEEEEEAYGWMDF,pGlu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,The N-terminal glutamic acid cyclizes into pyroglutamic acid (represented by pGlu and X); the tyrosine residue at position 12 is sulfated (indicated by Tys) and the C-terminal phenylalanine is amidated.,,,
3561,gastrin-17,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04563,,XRPPMEEEEEAYGWMDF,pGlu-Arg-Pro-Pro-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,The N-terminal glutamic acid is cyclated into pyroglutamic acid (represented by X/pGlu); the tyrosine residue at position 12 is sulfated (represented by Tys) and the C-terminal phenylalanine is amidated.,,,
3560,gastrin-17,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48757,,XRPRMEEEEEAYGWMDF,pGlu-Arg-Pro-Arg-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,The N-terminal glutamic acid is cyclated into pyroglutamic acid (represented by X/pGlu); the tyrosine residue at position 12 is sulfated (represented by Tys) and the C-terminal phenylalanine is amidated.,,,
3564,gastrin-34,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04563,,XLGPQGPQHFIADLSKKQRPPMEEEEEAYGWMDF,pGlu-Leu-Gly-Pro-Gln-Gly-Pro-Gln-His-Phe-Ile-Ala-Asp-Leu-Ser-Lys-Lys-Gln-Arg-Pro-Pro-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,"The N-terminal glutamic acid is cyclated into pyroglutamic acid (represented by pGlu and X), the tyrosine residue at position 29 is sulfated (represented by Tys) and the C-terminal phenylalanine is amidated.",,,
3562,gastrin-34,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,XLGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF,pGlu-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,"The N-terminal glutamic acid cyclizes into pyroglutamic acid (represented by pGlu and X), the tyrosine residue at position 29 is sulfated (represented by Tys) and the C-terminal phenylalanine is amidated.",,,
3563,gastrin-34,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48757,,XLGLQGPQHFIADLSKKERPRMEEEEEAYGWMDF,pGlu-Leu-Gly-Leu-Gln-Gly-Pro-Gln-His-Phe-Ile-Ala-Asp-Leu-Ser-Lys-Lys-Glu-Arg-Pro-Arg-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,The N-terminal glutamic acid cyclizes into pyroglutamic acid (represented by pGlu and X); the tyrosine residue at position 29 is sulfated (Tys) and the C-terminal phenylalanine is amidated.,,,
3565,gastrin-52,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,DLELPWLEQQGPASHHRRQLGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF,Asp-Leu-Glu-Leu-Pro-Trp-Leu-Glu-Gln-Gln-Gly-Pro-Ala-Ser-His-His-Arg-Arg-Gln-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2,The C-terminal Phenylalanine is amidated.,,,
3557,gastrin-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,YGWMDF,Tys-Gly-Trp-Met-Asp-Phe-NH2,The N-terminal tyrosine is sulfated into Tyr-SO3H (Tys) and the C-terminal phenylalanine is amidated.,,,
3566,gastrin-71,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01350,,SWKPRSQQPDAPLGTGANRDLELPWLEQQGPASHHRRQLGPQGPPHLVADPSKKQGPWLEEEEEAYGWMDF,Ser-Trp-Lys-Pro-Arg-Ser-Gln-Gln-Pro-Asp-Ala-Pro-Leu-Gly-Thr-Gly-Ala-Asn-Arg-Asp-Leu-Glu-Leu-Pro-Trp-Leu-Glu-Gln-Gln-Gly-Pro-Ala-Ser-His-His-Arg-Arg-Gln-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tys-Gly-Trp-Met-Asp-Phe-NH2,"The tyrosine residue at position 66 is sulfated by tyrosyl-protein sulfotransferase, as indicated by Tys, and the C-terminal phenylalanine is amidated.",,,
612,gastrin-releasing peptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P07492,,VPLPAGGGTVLTKMYPRGNHWAVGHLM,Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2,C-terminal peptidyl-methionine amidation,,,
3579,gastrin-releasing peptide,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q8R1I2|P24393,,APVSTGAGGGTVLAKMYPRGSHWAVGHLM,Ala-Pro-Val-Ser-Thr-Gly-Ala-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Ser-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2,C-terminal peptidyl-methionine amidation,,,
4934,G-CSF,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P09919,lenograstim,ATPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLVSECATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRRAGGVLVASHLQSFLEVSYRVLRHLAQP,,"Predicted O-linked glycosylation of threonine at position 137; disulphide bond formation between cysteine residues at positions 40 and 46, and 68 and 78",,,
4940,GDNF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P39905,,SPDKQMAVLPRRERNRQAAAANPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYHILRKHSAKRCGCI,,"Biologically active peptide is a homodimer. Disulphide bonds between cysteine residues at positions 41 and 102, 68 and 131, and 72 and 133. Interchain diuslphide bond between cysteine residues at position 1 of each chain. Predicted N-linked glycosylation of asparagine residues at positions 49 and 85",,,
3597,ghrelin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9EQX0|Q9QYH7,,GSSFLSPEHQKAQQRKESKKPPAKLQPR,Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,"The third residue, a serine, is octanoylated.",,,
1099,ghrelin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBU3,,GSSFLSPEHQRVQQRKESKKPPAKLQPR,Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,"The third residue, a serine, is octanoylated.",,,
3602,GHRH,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P16043,,HVDAIFTTNYRKLLSQLYARKVIQDIMNKQGERIQEQRARLS,His-Val-Asp-Ala-Ile-Phe-Thr-Thr-Asn-Tyr-Arg-Lys-Leu-Leu-Ser-Gln-Leu-Tyr-Ala-Arg-Lys-Val-Ile-Gln-Asp-Ile-Met-Asn-Lys-Gln-Gly-Glu-Arg-Ile-Gln-Glu-Gln-Arg-Ala-Arg-Leu-Ser,None,,,
3603,GHRH,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09916,,HADAIFTSSYRRILGQLYARKLLHEIMNRQQGERNQEQRSRFN,His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Arg-Ser-Arg-Phe-Asn,None.,,,
2270,GHRH,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01286,somatorelin,YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL,Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2,C-terminal residue is leucine amide,,,
3727,globular adiponectin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15848,,AYVYRSAFSVGLETYVTIPNMPIRFTKIFYNQQNHYDGSTGKFHCNIPGLYYFAYHITVYMKDVKVSLFKKDKAMLFTYDQYQENNVDQASGSVLLHLEVGDQVWLQVYGEGERNGLYADNDNDSTFTGFLLYHDTN,Ala-Tyr-Val-Tyr-Arg-Ser-Ala-Phe-Ser-Val-Gly-Leu-Glu-Thr-Tyr-Val-Thr-Ile-Pro-Asn-Met-Pro-Ile-Arg-Phe-Thr-Lys-Ile-Phe-Tyr-Asn-Gln-Gln-Asn-His-Tyr-Asp-Gly-Ser-Thr-Gly-Lys-Phe-His-Cys-Asn-Ile-Pro-Gly-Leu-Tyr-Tyr-Phe-Ala-Tyr-His-Ile-Thr-Val-Tyr-Met-Lys-Asp-Val-Lys-Val-Ser-Leu-Phe-Lys-Lys-Asp-Lys-Ala-Met-Leu-Phe-Thr-Tyr-Asp-Gln-Tyr-Gln-Glu-Asn-Asn-Val-Asp-Gln-Ala-Ser-Gly-Ser-Val-Leu-Leu-His-Leu-Glu-Val-Gly-Asp-Gln-Val-Trp-Leu-Gln-Val-Tyr-Gly-Glu-Gly-Glu-Arg-Asn-Gly-Leu-Tyr-Ala-Asp-Asn-Asp-Asn-Asp-Ser-Thr-Phe-Thr-Gly-Phe-Leu-Leu-Tyr-His-Asp-Thr-Asn,,,,
1136,glucagon,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,yes,,,,,,P06883|P55095|P01275,glucagon,HSQGTFTSDYSKYLDSRRAQDFVQWLMNT,His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(=O)N)CCSC)CC(C)C)Cc1c[nH]c2c1cccc2)CCC(=O)N)C(C)C)Cc1ccccc1)CC(=O)O)CCC(=O)N)C)CCCN=C(N)N)CCCN=C(N)N)CO)CC(=O)O)CC(C)C)Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)N)CO)CCC(=O)N)Cc1ccccc1)CO)CC(=O)O)Cc1ccc(cc1)O)CO,MASNOZXLGMXCHN-ZLPAWPGGSA-N
5194,glucagon-like peptide 1,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P06883|P55095|P01275,,HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG,His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly,,,,
1132,glucagon-like peptide 1-(7-36) amide,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01275|P55095|P06883,,HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR,His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2,The C-terminal arginine is amidated. GLP-1 (7-36) amide is a N-terminally truncated fragment of GLP1 . GLP-1 (7-36) amide is the more predominant fragment of the precursor,,,
3544,glucagon-like peptide 1-(7-37),"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01275|P55095|P06883,,HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG,His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly,,,,
1141,glucagon-like peptide 2,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06883,,HADGSFSDEMNTILDNLATRDFINWLIQTKITD,His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
3540,glucagon-like peptide 2,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55095,,HADGSFSDEMSTILDNLATRDFINWLIQTKITD,His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Ser-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
1140,glucagon-like peptide 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01275,,HADGSFSDEMNTILDNLAARDFINWLIQTKITD,His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
1142,glucagon-like peptide 2-(2-33),Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,ADGSFSDEMNTILDNLATRDFINWLIQTKITD,Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
1143,glucagon-like peptide 2-(3-33),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01275,,DGSFSDEMNTILDNLAARDFINWLIQTKITD,Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
3541,glucagon-like peptide 2-(3-33),Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55095,,DGSFSDEMSTILDNLATRDFINWLIQTKITD,Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Ser-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
1144,glucagon-like peptide 2-(3-33),Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06883,,DGSFSDEMNTILDNLATRDFINWLIQTKITD,Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
3731,glycoprotein hormone common alpha subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01215,,APDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHTACHCSTCYYHKS,Ala-Pro-Asp-Val-Gln-Asp-Cys-Pro-Glu-Cys-Thr-Leu-Gln-Glu-Asn-Pro-Phe-Phe-Ser-Gln-Pro-Gly-Ala-Pro-Ile-Leu-Gln-Cys-Met-Gly-Cys-Cys-Phe-Ser-Arg-Ala-Tyr-Pro-Thr-Pro-Leu-Arg-Ser-Lys-Lys-Thr-Met-Leu-Val-Gln-Lys-Asn-Val-Thr-Ser-Glu-Ser-Thr-Cys-Cys-Val-Ala-Lys-Ser-Tyr-Asn-Arg-Val-Thr-Val-Met-Gly-Gly-Phe-Lys-Val-Glu-Asn-His-Thr-Ala-Cys-His-Cys-Ser-Thr-Cys-Tyr-Tyr-His-Lys-Ser,"The production of biologically active FSH, LH and TSH requires the FSHβ, LHβ and TSHβ subunits and the common α subunits to assemble to form the heterodimeric hormone. The common α subunit is glycosylated at asparagines 52 and 78, and disulfide bond formation occurs between cysteine residues at positions 7 and 31; 10 and 60; 28 and 82; 32 and 84 and 59 and 87. It then assembles with the various β subunits to form the biologically active FSH, LH and TSH heterodimers.",,,
4377,glycoprotein hormone common alpha subunit,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01216,,LPDGDFIIQGCPECKLKENKYFSKLGAPIYQCMGCCFSRAYPTPARSKKTMLVPKNITSEATCCVAKAFTKATVMGNARVENHTECHCSTCYYHKS,Leu-Pro-Asp-Gly-Asp-Phe-Ile-Ile-Gln-Gly-Cys-Pro-Glu-Cys-Lys-Leu-Lys-Glu-Asn-Lys-Tyr-Phe-Ser-Lys-Leu-Gly-Ala-Pro-Ile-Tyr-Gln-Cys-Met-Gly-Cys-Cys-Phe-Ser-Arg-Ala-Tyr-Pro-Thr-Pro-Ala-Arg-Ser-Lys-Lys-Thr-Met-Leu-Val-Pro-Lys-Asn-Ile-Thr-Ser-Glu-Ala-Thr-Cys-Cys-Val-Ala-Lys-Ala-Phe-Thr-Lys-Ala-Thr-Val-Met-Gly-Asn-Ala-Arg-Val-Glu-Asn-His-Thr-Glu-Cys-His-Cys-Ser-Thr-Cys-Tyr-Tyr-His-Lys-Ser,"The production of biologically active FSH, LH and TSH requires the FSHβ, LHβ and TSHβ subunits and the common α subunit to assemble to form the heterodimeric hormone. The common alpha subunit is glycosylated at asparagine residues 56 and 82, with disulfide bond formation between cysteine residues at positions 11 and 35; 14 and 64; 32 and 86; 36 and 88 and 63 and 91. It then assembles with the various β subunits to form the biologically active FSH, LH and TSH heterodimers.",,,
4378,glycoprotein hormone common alpha subunit,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P11962,,LPDGDLIIQGCPECKLKENKYFSKLGAPIYQCMGCCFSRAYPTPARSKKTMLVPKNITSEATCCVAKSFTKATVMGNARVENHTDCHCSTCYYHKS,Leu-Pro-Asp-Gly-Asp-Leu-Ile-Ile-Gln-Gly-Cys-Pro-Glu-Cys-Lys-Leu-Lys-Glu-Asn-Lys-Tyr-Phe-Ser-Lys-Leu-Gly-Ala-Pro-Ile-Tyr-Gln-Cys-Met-Gly-Cys-Cys-Phe-Ser-Arg-Ala-Tyr-Pro-Thr-Pro-Ala-Arg-Ser-Lys-Lys-Thr-Met-Leu-Val-Pro-Lys-Asn-Ile-Thr-Ser-Glu-Ala-Thr-Cys-Cys-Val-Ala-Lys-Ser-Phe-Thr-Lys-Ala-Thr-Val-Met-Gly-Asn-Ala-Arg-Val-Glu-Asn-His-Thr-Asp-Cys-His-Cys-Ser-Thr-Cys-Tyr-Tyr-His-Lys-Ser,"The production of biologically active FSH, LH and TSH requires the FSHβ, LHβ and TSHβ subunits and the common α subunit to assemble to form the heterodimeric hormone. The common alpha subunit is glycosylated at asparagine residues 56 and 82, with disulfide bond formation between cysteine residues at positions 11 and 35; 14 and 64; 32 and 86; 36 and 88 and 63 and 91. It then assembles with the various β subunits to form the biologically active FSH, LH and TSH heterodimers.",,,
4942,GM-CSF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04141,,APARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE,,"O-linked glycosylation of serine residues at positions 5, 7 and 9; O-linked glycosylation of threonine residue at position 10; N-linked glycosylation of asparagine residues at positions 27 and 37; disulphide bond formation between cysteine residues at positions 54 and 96, and 88 and 121",,,
1162,GnRH I,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01148|P13562|P07490,,XHWSYGLRPG,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2,The N-terminal glutamine is converted into pyroglutamate (X/ pGlu) and the C-terminal Glycine is amidated.,,OCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NCC(=O)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCC(=O)N1)Cc1[nH]cnc1,NMJREATYWWNIKX-UHFFFAOYSA-N
1164,GnRH II,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43555,,XHWSHGWYPG,pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2,The N-terminal glutamine is converted into pyroglutamate (X/ pGlu) and the C-terminal Glycine is amidated.,,,
4935,growth arrest specific protein 6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q14393,,ALLPAREATQFLRPRQRRAFQVFEEAKQGHLERECVEELCSREEAREVFENDPETDYFYPRYLDCINKYGSPYTKNSGFATCVQNLPDQCTPNPCDRKGTQACQDLMGNFFCLCKAGWGGRLCDKDVNECSQENGGCLQICHNKPGSFHCSCHSGFELSSDGRTCQDIDECADSEACGEARCKNLPGSYSCLCDEGFAYSSQEKACRDVDECLQGRCEQVCVNSPGSYTCHCDGRGGLKLSQDMDTCELEAGWPCPRHRRDGSPAARPGRGAQGSRSEGHIPDRRGPRPWQDILPCVPFSVAKSVKSLYLGRMFSGTPVIRLRFKRLQPTRLVAEFDFRTFDPEGILLFAGGHQDSTWIVLALRAGRLELQLRYNGVGRVTSSGPVINHGMWQTISVEELARNLVIKVNRDAVMKIAVAGDLFQPERGLYHLNLTVGGIPFHEKDLVQPINPRLDGCMRSWNWLNGEDTTIQETVKVNTRMQCFSVTERGSFYPGSGFAFYSLDYMRTPLDVGTESTWEVEVVAHIRPAADTGVLFALWAPDLRAVPLSVALVDYHSTKKLKKQLVVLAVEHTALALMEIKVCDGQEHVVTVSLRDGEATLEVDGTRGQSEVSAAQLQERLAVLERHLRSPVLTFAGGLPDVPVTSAPVTAFYRGCMTLEVNRRLLDLDEAAYKHSDITAHSCPPVEPAAA,,"N-linked glycosylation of asparagine residue at position 433; disulphide bond formation between cysteine residues at positions 232 and 247, 296 and 583, 457 and 483, and 656 and 683. Predicted disulphide bond formation between cysteine residues at positions 35 and 40, 90 and 103, 95 and 112, 114 and 123, 130 and 141, 137 and 150, 152 and 165, 171 and 182, 177 and 191, 193 and 206, 212 and 231, 217 and 230, 232 and 247, 296 and 583, 457 and 483, and 656 and 683",,,
4936,growth/differentiation factor-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P27539,,DAEPVLGGGPGGACRARRLYVSFREVGWHRWVIAPRGFLANYCQGQCALPVALSGSGGPPALNHAVLRALMHAAAPGAADLPCCVPARLSPISVLFFDNSDNVVLRQYEDMVVDECGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 83 of each chain. Disulphide bond formation between cysteine residues at positions 14 and 84, 43 and 116, and 47 and 118",,,
4937,growth/differentiation factor-10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55107,,QWDEPRVCSRRYLKVDFADIGWNEWIISPKSFDAYYCAGACEFPMPKIVRPSNHATIQSIVRAVGIIPGIPEPCCVPDKMNSLGVLFLDENRNVVLKVYPNMSVDTCACR,,"The active peptide is predicted to be either a homodimer or a heterodimer. Predicted interchain disulphide bond between cysteine residues at position 74 of each chain. Predicted N-linked glycosylation of asparagine residue at position 101; predicted disulphide bond formation between cysteine residues at positions 8 and 75, 37 and 107, and 41 and 109",,,
4876,growth/differentiation factor-11,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95390,,NLGLDCDEHSSESRCCRYPLTVDFEAFGWDWIIAPKRYKANYCSGQCEYMFMQKYPHTHLVQQANPRGSAGPCCTPTKMSPINMLYFNDKQQIIYGKIPGMVVDRCGCS,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 73 of each chain. Predicted disulphide bond formation between cysteine residues at positions 15 and 74, 43 and 106, and 47 and 108",,,
9735,growth differentiation factor 15,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,MPGQELRTVNGSQMLLVLLVLSWLPHGGALSLAEASRASFPGPSELHSEDSRFRELRKRYEDLLTRLRANQSWEDSNTDLVPAPAVRILTPEVRLGSGGHLHLRISRAALPEGLPEASRLHRALFRLSPTASRSWDVTRPLRRQLSLARPQAPALHLRLSPPPSQSDQLLAESSSARPQLELHLRPQAARGRRRARARNGDHCPLGPGRCCRLHTVRASLEDLGWADWVLSPREVQVTMCIGACPSQFRAANMHAQIKTSLHRLKPDTVPAPCCVPASYNPMVLIQKTDTGVSLQTYDDLLAKDCHCI,,"Signal peptide: 1-29Propeptide 30-194Mature peptide chain 195-308Three intrapeptide disulphide bonds, and one interpeptide (dimer forming) disulphide bond.",,,
4938,growth/differentiation factor-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NR23,,AAIPVPKLSCKNLCHRHQLFINFRDLGWHKWIIAPKGFMANYCHGECPFSLTISLNSSNYAFMQALMHAVDPEIPQAVCIPTKLSPISMLYQDNNDNVILRHYEDMVVDECGCG,,"The active peptide is predicted to be either a homodimer or a heterodimer, which cannot be disulphide linked. Predicted N-linked glycosylation of asparagine residue at position 56; predicted disulphide bond formation between cysteine residues at positions 14 and 79, 43 and 111, and 47 and 113",,,
4879,growth/differentiation factor-5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P43026,,APLATRQGKRPSKNLKARCSRKALHVNFKDMGWDDWIIAPLEYEAFHCEGLCEFPLRSHLEPTNHAVIQTLMNSMDPESTPPTCCVPTRLSPISILFIDSANNVVYKQYEDMVVESCGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 84 of each chain. Disulphide bond formation between cysteine residues at positions 19 and 85, 48 and 117, and 52 and 119",,,
4878,growth/differentiation factor-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6KF10,,TAFASRHGKRHGKKSRLRCSKKPLHVNFKELGWDDWIIAPLEYEAYHCEGVCDFPLRSHLEPTNHAIIQTLMNSMDPGSTPPSCCVPTKLTPISILYIDAGNNVVYKQYEDMVVESCGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 84 of each chain. Predicted disulphide bond formation between cysteine residues at positions 19 and 85, 48 and 117, and 52 and 119",,,
4877,growth/differentiation factor-7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q7Z4P5,,TALAGTRTAQGSGGGAGRGHGRRGRSRCSRKPLHVDFKELGWDDWIIAPLDYEAYHCEGLCDFPLRSHLEPTNHAIIQTLLNSMAPDAAPASCCVPARLSPISILYIDAANNVVYKQYEDMVVEACGCR,,"The active peptide is a homodimer linked by a disulphide bond between cysteine residues at position 93 of each chain. Predicted disulphide bond formation between cysteine residues at positions 28 and 94, 57 and 126, and 61 and 128",,,
4939,growth/differentiation factor-9,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O60383,,GQETVSSELKKPLGPASFNLSEYFRQFLLPQNECELHDFRLSFSQLKWDNWIVAPHRYNPRYCKGDCPRAVGHRYGSPVHTMVQNIIYEKLDSSVPRPSCVPAKYSPLSVLTIEPDGSIAYKEYEDMIATKCTCR,,"The active peptide is predicted to be either a homodimer or a heterodimer, which cannot be disulphide linked. Predicted N-linked glycosylation of asparagine residue at position 19; predicted disulphide bond formation between cysteine residues at positions 34 and 100, 63 and 132, and 67 and 134",,,
4943,growth hormone 1,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01241,somatropin,FPTIPLSRLFDNAMLRAHRLHQLAFDTYQEFEEAYIPKEQKYSFLQNPQTSLCFSESIPTPSNREETQQKSNLELLRISLLLIQSWLEPVQFLRSVFANSLVYGASDSNVYDLLKDLEEGIQTLMGRLEDGSPRTGQIFKQTYSKFDTNSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,,"Phosphorylated serine at positions 106 and 150; deamidation of glutamine at position 137 and asparagine at position 152  by deterioration; disulphide bond formation between cysteine residues at positions 53 and 165, and 182 and 189",,,
4944,growth hormone 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01242,,FPTIPLSRLFDNAMLRARRLYQLAYDTYQEFEEAYILKEQKYSFLQNPQTSLCFSESIPTPSNRVKTQQKSNLELLRISLLLIQSWLEPVQLLRSVFANSLVYGASDSNVYRHLKDLEEGIQTLMWRLEDGSPRTGQIFNQSYSKFDTKSHNDDALLKNYGLLYCFRKDMDKVETFLRIVQCRSVEGSCGF,,"Predicted disulphide bond formation between cysteine residues at positions 53 and 165, and 182 and 189; predicted N-linked glycosylation on asparagine residue at position 140",,,
3582,GRP-(18-27),"Human, Pig","Endogenous peptide in human, mouse or rat",,,,,,,,,P07492|P63153,,GNHWAVGHLM,Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2,C-terminal peptidyl-methionine amidation,,,
3583,GRP-(18-27),"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q8R1I2|P24393,,GSHWAVGHLM,Gly-Ser-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2,C-terminal peptidyl-methionine amidation,,,
4945,guanylin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q02747,,PGTCEICAYAACTGC,Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys,"Disulphide bonds between cysteine residues at positions 3 and 11, and 6 and 15",,,
9164,guanylyl cyclase-activating protein 1,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P43080|P43081,,GNVMEGKSVEELSSTECHQWYKKFMTECPSGQLTLYEFRQFFGLKNLSPSASQYVEQMFETFDFNKDGYIDFMEYVAALSLVLKGKVEQKLRWYFKLYDVDGNGCIDRDELLTIIQAIRAINPCSDTTMTAEEFTDTVFSKIDVNGDGELSLEEFIEGVQKDQMLLDTLTRSLDLTRIVRRLQNGEQDEEGADEAAEAAG,Gly-Asn-Val-Met-Glu-Gly-Lys-Ser-Val-Glu-Glu-Leu-Ser-Ser-Thr-Glu-Cys-His-Gln-Trp-Tyr-Lys-Lys-Phe-Met-Thr-Glu-Cys-Pro-Ser-Gly-Gln-Leu-Thr-Leu-Tyr-Glu-Phe-Arg-Gln-Phe-Phe-Gly-Leu-Lys-Asn-Leu-Ser-Pro-Ser-Ala-Ser-Gln-Tyr-Val-Glu-Gln-Met-Phe-Glu-Thr-Phe-Asp-Phe-Asn-Lys-Asp-Gly-Tyr-Ile-Asp-Phe-Met-Glu-Tyr-Val-Ala-Ala-Leu-Ser-Leu-Val-Leu-Lys-Gly-Lys-Val-Glu-Gln-Lys-Leu-Arg-Trp-Tyr-Phe-Lys-Leu-Tyr-Asp-Val-Asp-Gly-Asn-Gly-Cys-Ile-Asp-Arg-Asp-Glu-Leu-Leu-Thr-Ile-Ile-Gln-Ala-Ile-Arg-Ala-Ile-Asn-Pro-Cys-Ser-Asp-Thr-Thr-Met-Thr-Ala-Glu-Glu-Phe-Thr-Asp-Thr-Val-Phe-Ser-Lys-Ile-Asp-Val-Asn-Gly-Asp-Gly-Glu-Leu-Ser-Leu-Glu-Glu-Phe-Ile-Glu-Gly-Val-Gln-Lys-Asp-Gln-Met-Leu-Leu-Asp-Thr-Leu-Thr-Arg-Ser-Leu-Asp-Leu-Thr-Arg-Ile-Val-Arg-Arg-Leu-Gln-Asn-Gly-Glu-Gln-Asp-Glu-Glu-Gly-Ala-Asp-Glu-Ala-Ala-Glu-Ala-Ala-Gly,,,,
9165,Guanylyl cyclase-activating protein 2,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UMX6|Q8VBV8,,GQEFSWEEAEAAGEIDVAELQEWYKKFVMECPSGTLFMHEFKRFFKVTDDEEASQYVEGMFRAFDKNGDNTIDFLEYVAALNLVLRGTLEHKLKWTFKIYDKDGNGCIDRLELLNIVEGIYQLKKACRRELQTEQGQLLTPEEVVDRIFLLVDENGDGQLSLNEFVEGARRDKWVMKMLQMDMNPSSWLAQQRRKSAMF,Gly-Gln-Glu-Phe-Ser-Trp-Glu-Glu-Ala-Glu-Ala-Ala-Gly-Glu-Ile-Asp-Val-Ala-Glu-Leu-Gln-Glu-Trp-Tyr-Lys-Lys-Phe-Val-Met-Glu-Cys-Pro-Ser-Gly-Thr-Leu-Phe-Met-His-Glu-Phe-Lys-Arg-Phe-Phe-Lys-Val-Thr-Asp-Asp-Glu-Glu-Ala-Ser-Gln-Tyr-Val-Glu-Gly-Met-Phe-Arg-Ala-Phe-Asp-Lys-Asn-Gly-Asp-Asn-Thr-Ile-Asp-Phe-Leu-Glu-Tyr-Val-Ala-Ala-Leu-Asn-Leu-Val-Leu-Arg-Gly-Thr-Leu-Glu-His-Lys-Leu-Lys-Trp-Thr-Phe-Lys-Ile-Tyr-Asp-Lys-Asp-Gly-Asn-Gly-Cys-Ile-Asp-Arg-Leu-Glu-Leu-Leu-Asn-Ile-Val-Glu-Gly-Ile-Tyr-Gln-Leu-Lys-Lys-Ala-Cys-Arg-Arg-Glu-Leu-Gln-Thr-Glu-Gln-Gly-Gln-Leu-Leu-Thr-Pro-Glu-Glu-Val-Val-Asp-Arg-Ile-Phe-Leu-Leu-Val-Asp-Glu-Asn-Gly-Asp-Gly-Gln-Leu-Ser-Leu-Asn-Glu-Phe-Val-Glu-Gly-Ala-Arg-Arg-Asp-Lys-Trp-Val-Met-Lys-Met-Leu-Gln-Met-Asp-Met-Asn-Pro-Ser-Ser-Trp-Leu-Ala-Gln-Gln-Arg-Arg-Lys-Ser-Ala-Met-Phe,,,,
4948,HB-EGF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99075,,DLQEADLDLLRVTLSSKPQALATPNKEEHGKRKKKGKGLGKKRDPCLRKYKDFCIHGECKYVKELRAPSCICHPGYHGERCHGLSL,,"O-linked glycosylation of threonine residues at positions 13 and 23; predicted disulphide bond formation between cysteine residues at positions 46 and 59, 54 and 70, and 72 and 81",,,
1160,hCG,Human,"Endogenous peptide in human, mouse or rat",4396|3731,chorionic gonadotropin beta subunit|glycoprotein hormone common alpha subunit,,,,,,,,,,,The production of biologically active hCG requires appropriately folded and glycosylated choriogonadotropin subunit beta and the common glycoprotein hormone α subunit that assemble to form the active hCG heterodimer,,,
2087,hemokinin 1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99N14,,RSRTRQFYGLM,Arg-Ser-Arg-Thr-Arg-Gln-Phe-Tyr-Gly-Leu-Met-NH2,Amidation of C-terminal methionine residue,,,
4949,hepatocyte growth factor,Human,"Endogenous peptide in human, mouse or rat",4950|4951,hepatocyte growth factor alpha chain|hepatocyte growth factor beta chain,,,,,,,P14210,,,,,,,
4950,hepatocyte growth factor alpha chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P14210,,QRKRRNTIHEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTCNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQPRPWCYTLDPHTRWEYCAIKTCADNTMNDTDVPLETTECIQGQGEGYRGTVNTIWNGIPCQRWDSQYPHEHDMTPENFKCKDLRENYCRNPDGSESPWCFTTDPNIRVGYCSQIPNCDMSHGQDCYRGNGKNYMGNLSQTRSGLTCSMWDKNMEDLHRHIFWEPDASKLNENYCRNPDDDAHGPWCYTGNPLIPWDYCPISRCEGDTTPTIVNLDHPVISCAKTKQLR,,"N-terminal glutamine is pyrrolidone carboxylic acid; N-linked glycosylation of asparagine residues at positions 263 and 371; O-linked glycosylation of threonine at position 445. Disulphide bond formation between cysteine residues at positions 39 and 65; 43 and 53, 97 and 175, 118 and 158, and 146 and 170. Predicted disulphide bond formation between cysteine residues at positions 180 and 257, 201 and 240, 229 and 252, 274 and 352, 295 and 334, 323 and 346, 360 and 438, 381 and 431, and 409 and 433. Interchain disulphide bond between cysteine residue at position 456 of the alpha chain and 110 of the beta chain. ",,,
4951,hepatocyte growth factor beta chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P14210,,VVNGIPTRTNIGWMVSLRYRNKHICGGSLIKESWVLTARQCFPSRDLKDYEAWLGIHDVHGRGDEKCKQVLNVSQLVYGPEGSDLVLMKLARPAVLDDFVSTIDLPNYGCTIPEKTSCSVYGWGYTGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKIGSGPCEGDYGGPLVCEQHKMRMVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHKIILTYKVPQS,,"Predicted disulphide bond formation between cysteine residues at positions 25 and 41, 118 and 185, 148 and 164, and 175 and 203. Interchain disulphide bond between cysteine residue at position 456 of the alpha chain and 110 of the beta chain. ",,,
5379,hepcidin-20,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P81172,,ICIFCCGCCHRSKCGMCCKT,Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr,"Disulphide bond formation between cysteine residues at positions 2 and 18, 5 and 8, 16 and 24, and 9 and 17",,,
5378,hepcidin-25,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P81172,,DTHFPICIFCCGCCHRSKCGMCCKT,Asp-Thr-His-Phe-Pro-Ile-Cys-Ile-Phe-Cys-Cys-Gly-Cys-Cys-His-Arg-Ser-Lys-Cys-Gly-Met-Cys-Cys-Lys-Thr,"Disulphide bond formation between cysteine resdiues at positions 7 and 13, 11 and 17 and 14 and 22",,,
5315,HGF-inhibitor 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43278,,GPPPAPPGLPAGADCLNSFTAGVPGFVLDTNASVSNGATFLESPTVRRGWDCVRACCTTQNCNLALVELQPDRGEDAIAACFLINCLYEQNFVCKFAPREGFINYLTREVYRSYRQLRTQGFGGSGIPKAWAGIDLKVQPQEPLVLKDVENTDWRLLRGDTDVRVERKDPNQVELWGLKEGTYLFQLTVTSSDHPEDTANVTVTVLSTKQTEDYCLASNKVGRCRGSFPRWYYDPTEQICKSFVYGGCLGNKNNYLREEECILACRGVQGGPLRGSSGAQATFPQGPSMERRHPVCSGTCQPTQFRCSNGCCIDSFLECDDTPNCPDASDEAACEKYTSGFDELQRIHFPSDKGHCVDLPDTGLCKESIPRWYYNPFSEHCARFTYGGCYGNKNNFEEEQQCLESCRGISKKDVFGLRREIPIPSTGSVEMAVAVFLVICIVVVVAILGYCFFKNQRKDFHGHHHHPPPTPASSTVSTTEDTEHLVYNHTTRPL,,"Disulphide bond formation between cysteine residues at positions 215 and 265, 224 and 248, and 240 and 261. Predicted disulphide bond formation between cysteine residues at positions 300 and 312, 307 and 325, 319 and 334, 356 and 406, 365 and 389, and 381 and 402. predicted N-linked glycosylation of asparagine residues at positions 31, 200 and 488",,,
4953,hsp60,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10809,,AKDVKFGADARALMLQGVDLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVANNTNEEAGDGTTTATVLARSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSKPVTTPEEIAQVATISANGDKEIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQDAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQVVAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGEVIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKLSDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRCIPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQSSSEVGYDAMAGDFVNMVEKGIIDPTKVVRTALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF,,"Lysine residues at positions 5,56,99,104,107,176,192,243,326,333,370,443,447,497 are N6-acetyllysine; serine residue at position 44 is phosphoserine; tyrosine at position 201 is phosphotyrosine, and tyrosine residue at position 197 is predicted to be phosphotyrosine",,,
7752,hsp90α1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P07900,,MPPCSGGDGSTPPGPSLRDRDCPAQSAEYPRDRLDPRPGSPSEASSPPFLRSRAPVNWYQEKAQVFLWHLMVSGSTTLLCLWKQPFHVSAFPVTASLAFRQSQGAGQHLYKDLQPFILLRLLMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEDKEEEKEKEEKESEDKPEIEDVGSDEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD,,,,,
5365,hsp90β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08238,,PEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAEEEKGEKEEEDKDDEEKPKIEDVGSDEEDDSGKDKKKKTKKIKEKYIDQEELNKTKPIWTRNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEGLELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQKAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNRIYRMIKLGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD,,"Serine residues at positions 225, 254, 260, 306, 451, 531 and 717 are phosphoserine; lysine residues at positions 274,283, 353, 401, 434, 480, 567 and 623 are N6-acetyllysine; threonine residue at position 296 is phosphothreonine; tyrosine residue at position 483 is phosphotyrosine. Lysine residue at position 398 is altenately N6-acetyllysine or N6-malonyllysine. Tyrosine residue at position 304 is predicted to be phosphotyrosine and cysteine residue at position 589 is predicted to be S-nitrosocysteine.",,,
1047,humanin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8IVG9,,MAPRGFSCLLLLTSEIDLPVKRRA,Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala,None,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CCSC)N)C)CCCNC(=N)N)CO)CS)CC(C)C)CC(C)C)CC(C)C)CC(C)C)CO)CCC(=O)O)CC(=O)O)CC(C)C,DPEUWKZJZIPZKE-OFANTOPUSA-N
5199,huntingtin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P42858,,,,,,,
3578,[Hyp3]bradykinin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01042,,RPXGFSPFR,Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg,"The third residue, a proline, is hydroxylated (as indicated by X or Hyp).",,,
6757,ICAM-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05362,,QTSVSPSKVILPRGGSVLVTCSTSCDQPKLLGIETPLPKKELLLPGNNRKVYELSNVQEDSQPMCYSNCPDGQSTAKTFLTVYWTPERVELAPLPSWQPVGKNLTLRCQVEGGAPRANLTVVLLRGEKELKREPAVGEPAEVTTTVLVRRDHHGANFSCRTELDLRPQGLELFENTSAPYQLQTFVLPATPPQLVSPRVLEVDTQGTVVCSLDGLFPVSEAQVHLALGDQRLNPTVTYGNDSFSAKASVSVTAEDEGTQRLTCAVILGNQSQETLQTVTIYSFPAPNVILTKPEVSEGTEVTVKCEAHPRAKVTLNGVPAQPLGPRAQLLLKATPEDNGRSFSCSATLEVAGQLIHKNQTRELRVLYGPRLDERDCPGNWTWPENSQQTPMCQAWGNPLPELKCLKDGTFPLPIGESVTVTRDLEGTYLCRARSTQGEVTRKVTVNVLSPRYEIVIITVVAAAVIMGTAGLSTYLYNRQRKIKKYRLQQAQKGTPMKPNTQATPP,,"For a complete list of post-translational modifications for this protein, please see the UniProt entry linked to from this ligand page.",,,
6756,ICAM-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13598,,KVFEVHVRPKKLAVEPKGSLEVNCSTTCNQPEVGGLETSLDKILLDEQAQWKHYLVSNISHDTVLQCHFTCSGKQESMNSNVSVYQPPRQVILTLQPTLVAVGKSFTIECRVPTVEPLDSLTLFLFRGNETLHYETFGKAAPAPQEATATFNSTADREDGHRNFSCLAVLDLMSRGGNIFHKHSAPKMLEIYEPVSDSQMVIIVTVVSVLLSLFVTSVLLCFIFGQHLRQQRMGTYGVRAAWRRLPQAFRP,,,,,
9593,ICOS ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,MRLGSPGLLFLLFSSLRADTQEKEVRAMVGSDVELSCACPEGSRFDLNDVYVYWQTSESKTVVTYHIPQNSSLENVDSRYRNRALMSPAGMLRGDFSLRLFNVTPQDEQKFHCLVLSQSLGFQEVLSVEVTLHVAANFSVPVVSAPHSPSQDELTFTCTSINGYPRPNVYWINKTDNSLLDQALQNDTVFLNMRGLYDVVSVLRIARTPSVNIGCCIENVLLQQNLTVGSQTGNDIGERDKITENPVSTGEKNAATWSILAVLCLLVVVAVAIGWVCRDRCLQHSYAGAWAVSPETELTGHV,,Signal peptide 1-18Mature peptide 19-302Transmembrane region 257-277,,,
4956,IFN-α10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01566,,CDLPQTHSLGNRRALILLGQMGRISPFSCLKDRHDFRIPQEEFDGNQFQKAQAISVLHEMIQQTFNLFSTEDSSAAWEQSLLEKFSTELYQQLNDLEACVIQEVGVEETPLMNEDSILAVRKYFQRITLYLIERKYSPCAWEVVRAEIMRSLSFSTNLQKRLRRKD,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 99, and 29 and 139",,,
4955,IFN-α1/13,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01562,,CDLPETHSLDNRRTLMLLAQMSRISPSSCLMDRHDFGFPQEEFDGNQFQKAPAISVLHELIQQIFNLFTTKDSSAAWDEDLLDKFCTELYQQLNDLEACVMQEERVGETPLMNADSILAVKKYFRRITLYLTEKKYSPCAWEVVRAEIMRSLSLSTNLQERLRRKE,,Phosphylated threonine residue at position 128; predicted disulphide bonds between cysteine residues at positions 1 and 99 and 29 and 139,,,
4957,IFN-α14,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01570,,CNLSQTHSLNNRRTLMLMAQMRRISPFSCLKDRHDFEFPQEEFDGNQFQKAQAISVLHEMMQQTFNLFSTKNSSAAWDETLLEKFYIELFQQMNDLEACVIQEVGVEETPLMNEDSILAVKKYFQRITLYLMEKKYSPCAWEVVRAEIMRSLSFSTNLQKRLRRKD,,"N-linked glycosylation of asparagine residue at position 63; predicted disulphide bonds between cysteine residues at positions 1 and 99, and 29 and 39",,,
4958,IFN-α16,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05015,,CDLPQTHSLGNRRALILLAQMGRISHFSCLKDRYDFGFPQEVFDGNQFQKAQAISAFHEMIQQTFNLFSTKDSSAAWDETLLDKFYIELFQQLNDLEACVTQEVGVEEIALMNEDSILAVRKYFQRITLYLMGKKYSPCAWEVVRAEIMRSFSFSTNLQKGLRRKD,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 99, and 29 and 139",,,
4959,IFN-α17,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01571,,CDLPQTHSLGNRRALILLAQMGRISPFSCLKDRHDFGLPQEEFDGNQFQKTQAISVLHEMIQQTFNLFSTEDSSAAWEQSLLEKFSTELYQQLNNLEACVIQEVGMEETPLMNEDSILAVRKYFQRITLYLTEKKYSPCAWEVVRAEIMRSLSFSTNLQKILRRKD,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 99, and 29 and 139",,,
4960,IFN-α2,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01563,,CDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE,,"O-linked glycosylation of threonine residue at position 106; disulphide bond between cysteine residues at positions 1 and 98, and 29 and 138",,,
4961,IFN-α21,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01568,,CDLPQTHSLGNRRALILLAQMGRISPFSCLKDRHDFGFPQEEFDGNQFQKAQAISVLHEMIQQTFNLFSTKDSSATWEQSLLEKFSTELNQQLNDLEACVIQEVGVEETPLMNVDSILAVKKYFQRITLYLTEKKYSPCAWEVVRAEIMRSFSLSKIFQERLRRKE,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 99, and 29 and 139",,,
4962,IFN-α4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05014,,CDLPQTHSLGNRRALILLAQMGRISHFSCLKDRHDFGFPEEEFDGHQFQKAQAISVLHEMIQQTFNLFSTEDSSAAWEQSLLEKFSTELYQQLNDLEACVIQEVGVEETPLMNEDSILAVRKYFQRITLYLTEKKYSPCAWEVVRAEIMRSLSFSTNLQKRLRRKD,,"Predicted disulphide bond fromation between cysteine residues at positions 1 and 99, and 29 and 166",,,
4963,IFN-α5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01569,,LGCDLPQTHSLSNRRTLMIMAQMGRISPFSCLKDRHDFGFPQEEFDGNQFQKAQAISVLHEMIQQTFNLFSTKDSSATWDETLLDKFYTELYQQLNDLEACMMQEVGVEDTPLMNVDSILTVRKYFQRITLYLTEKKYSPCAWEVVRAEIMRSFSLSANLQERLRRKE,,"Predicted disulphide bond formation between cysteine residues at positions 3 and 101, and 31 and 141 ",,,
4964,IFN-α6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05013,,SLDCDLPQTHSLGHRRTMMLLAQMRRISLFSCLKDRHDFRFPQEEFDGNQFQKAEAISVLHEVIQQTFNLFSTKDSSVAWDERLLDKLYTELYQQLNDLEACVMQEVWVGGTPLMNEDSILAVRKYFQRITLYLTEKKYSPCAWEVVRAEIMRSFSSSRNLQERLRRKE,,"Predicted disulphide bond formation between cysteine residues at positions 4 and 102, and 32 and 142",,,
4965,IFN-α7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01567,,CDLPQTHSLRNRRALILLAQMGRISPFSCLKDRHEFRFPEEEFDGHQFQKTQAISVLHEMIQQTFNLFSTEDSSAAWEQSLLEKFSTELYQQLNDLEACVIQEVGVEETPLMNEDFILAVRKYFQRITLYLMEKKYSPCAWEVVRAEIMRSFSFSTNLKKGLRRKD,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 99, and 29 and 139",,,
4966,IFN-α8,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P32881,,CDLPQTHSLGNRRALILLAQMRRISPFSCLKDRHDFEFPQEEFDDKQFQKAQAISVLHEMIQQTFNLFSTKDSSAALDETLLDEFYIELDQQLNDLESCVMQEVGVIESPLMYEDSILAVRKYFQRITLYLTEKKYSSCAWEVVRAEIMRSFSLSINLQKRLKSKE,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 99, and 29 and 139",,,
4967,IFN-β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01574,,MSYNLLGFLQRSSNFQCQKLLWQLNGRLEYCLKDRMNFDIPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRQDSSSTGWNETIVENLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINRLTGYLRN,,Phosphorylation of serine residue at position 119; N-linked glycosylation of asparagine residue at position 80; disulphide bond between cysteine residues at positions 31 and 141,,,
4968,IFN-γ,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01579,,QDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAAKTGKRKRSQMLFRG,,Residue one is pyrrrolidine carboxylic acid; N linked glycosylation of asparagine residue at position 25; N-linked glycosylation of asparagine at position 97 in the dimeric form,,,
4969,IFN-κ,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9P0W0,,LDCNLLNVHLRRVTWQNLRHLSSMSNSFPVECLRENIAFELPQEFLQYTQPMKRDIKKAFYEMSLQAFNIFSQHTFKYWKERHLKQIQIGLDQQAEYLNQCLEEDKNENEDMKEMKENEMKPSEARVPQLSSLELRRYFHRIDNFLKEKKYSDCAWEIVRVEIRRCLYYFYKFTALFRRK,,"Predicted disulphide bond formation between cysteine residues at positions 3 and 101, and 32 and 154",,,
4993,IFN-λ1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8IU54,,GPVPTSKPTTTGKGCHIGRFKSLSPQELASFKKARDALEESLKLKNWSCSSPVFPGNWDLRLLQVRERPVALEAELALTLKVLEAAAGPALEDVLDQPLHTLHHILSQLQACIQPQPTAGPRPRGRLHHWLHRLQEAPKKESAGCLEASVTFNLFRLLTRDLKYVADGNLCLRTSTHPEST,,Predicted N-linked glycosylation of aspragine residue at position 46; disulphide bond formation between cysteine residues at positions 49 and 145,,,
4991,IFN-λ2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8IZJ0,,VPVARLHGALPDARGCHIAQFKSLSPQELQAFKRAKDALEESLLLKDCRCHSRLFPRTWDLRQLQVRERPMALEAELALTLKVLEATADTDPALVDVLDQPLHTLHHILSQFRACIQPQPTAGPRTRGRLHHWLYRLQEAPKKESPGCLEASVTFNLFRLLTRDLNCVASGDLCV,,,,,
4992,IFN-λ3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8IZI9,,VPVARLRGALPDARGCHIAQFKSLSPQELQAFKRAKDALEESLLLKDCKCRSRLFPRTWDLRQLQVRERPVALEAELALTLKVLEATADTDPALGDVLDQPLHTLHHILSQLRACIQPQPTAGPRTRGRLHHWLHRLQEAPKKESPGCLEASVTFNLFRLLTRDLNCVASGDLCV,,"Disulphide bonds between cysteine residues at positions 16 and 115, 50 and 148, and 167 and 174",,,
4970,IFN-ω,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05000,,LGCDLPQNHGLLSRNTLVLLHQMRRISPFLCLKDRRDFRFPQEMVKGSQLQKAHVMSVLHEMLQQIFSLFHTERSSAAWNMTLLDQLHTGLHQQLQHLETCLLQVVGEGESAGAISSPALTLRRYFQGIRVYLKEKKYSDCAWEVVRMEIMKSLFLSTNMQERLRSKDRDLGSS,,N-linked glycosylation of asparagine residue at position 80; predicted disulphide bond formation between cysteine residues at positions 3 and 101 and 31 and 141,,,
4975,IL-10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P22301,,SPGQGTQSENSCTHFPGNLPNMLRDLRDAFSRVKTFFQMKDQLDNLLLKESLLEDFKGYLGCQALSEMIQFYLEEVMPQAENQDPDIKAHVNSLGENLKTLRLRLRRCHRFLPCENKSKAVEQVKNAFNKLQEKGIYKAMSEFDIFINYIEAYMTMKIRN,,"Predicted N-linked glycosylation of asparagine at position 116; disulphide bonds between cysteine residues at positions 12 and 108, and 62 and 114",,,
4976,IL-11,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20809,,PGPPPGPPRVSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAMSAGALGALQLPGVLTRLRADLLSYLRHVQWLRRAGGSSLKTLEPELGTLQARLDRLLRRLQLLMSRLALPQPPPDPPAPPLAPPSSAWGGIRAAHAILGGLHLTLDWAVRGLLLLKTRL,,,,,
4977,IL-12,Human,"Endogenous peptide in human, mouse or rat",5001|5002,IL-12A|IL-12B,,,,,,,,,,,,,,
5001,IL-12A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P29459,,RNLPVATPDPGMFPCLHHSQNLLRAVSNMLQKARQTLEFYPCTSEEIDHEDITKDKTSTVEACLPLELTKNESCLNSRETSFITNGSCLASRKTSFMMALCLSSIYEDLKMYQVEFKTMNAKLLMDPKRQIFLDQNMLAVIDELMQALNFNSETVPQKSSLEEPDFYKTKIKLCILLHAFRIRAVTIDRVMSYLNAS,,"Predicted N-linked glycosylation of asparagine residues at positions 71 and 85; disulphide bond formation between cysteine residues at positions 42 and 174, and 63 and 101. In the heterodimer IL12A/IL12B an interchain disulphide bond is formed between cysteine residues at position 74 of the alpha chain and 177 of the beta chain",,,
5002,IL-12B,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P29460,,IWELKKDVYVVELDWYPDAPGEMVVLTCDTPEEDGITWTLDQSSEVLGSGKTLTIQVKEFGDAGQYTCHKGGEVLSHSLLLLHKKEDGIWSTDILKDQKEPKNKTFLRCEAKNYSGRFTCWWLTTISTDLTFSVKSSRGSSDPQGVTCGAATLSAERVRGDNKEYEYSVECQEDSACPAAEESLPIEVMVDAVHKLKYENYTSSFFIRDIIKPDPPKNLQLKPLKNSRQVEVSWEYPDTWSTPHSYFSLTFCVQVQGKSKREKKDRVFTDKTSATVICRKNASISVRAQDRYYSSSWSEWASVPCS,,"N-linked glycosylation of asparagine residue at position 100; C-linked glycosylation of tryptophan at position 297, and disulphide bond formation between cysteine residues at positions 28 and 68, 109 and 120, 148 and 171, and 278 and 305. Predicted N-linked glycosylation of aspragibe at position 113. In the IL12A/Il12B heteromer there is an interchain disulphide bond between cysteine residues at positions 177 of the beta chain and 74 in the alpha chain.",,,
4980,IL-13,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35225,,LTCLGGFASPGPVPPSTALRELIEELVNITQNQKAPLCNGSMVWSINLTAGMYCAALESLINVSGCSAIEKTQRMLSGFCPHKVSAGQFSSLHVRDTKIEVAQFVKDLLLHLKKLFREGRFN,,"Disulphide bond formation between cysteine residues at positions 38 and 66, and 54 and 80; predicted N-linked glycosylation of asparagine residues at positions 28, 39, 47 and 62",,,
4981,IL-15,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P40933,,NWVNVISDLKKIEDLIQSMHIDATLYTESDVHPSCKVTAMKCFLLELQVISLESGDASIHDTVENLIILANNSLSSNGNVTESGCKECEELEEKNIKEFLQSFVHIVQMFINTS,,"Predicted N-linked glycosylation of asparagine residue at position 79; predicted disulphide bonds between cysteine residues at positions 35 and 85, and 42 and 88",,,
4982,IL-17A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q16552,,GITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA,,"Predicted N-linked glycosylation of aspragine residue at position 45; predicted disulphide bond formation between cysteine residues at positions 71 and 121, and 76 and 123",,,
5874,IL-17A/IL-17F,Human,"Endogenous peptide in human, mouse or rat",4982|5873,IL-17A|IL-17F,,,,,,,,,,,,,,
5877,IL-17B,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UHF5,,QPRSPKSKRKGQGRPGPLAPGPHQVPLDLVSRMKPYARMEEYERNIEEMVAQLRNSSELAQRKCEVNLQLWMSNKRSLSPWGYSINHDPSRIPVDLPEARCLCLGCVNPFTMQEDRSMVSVPVFSQVPVRRRLCPPPPRTGPCRQRAVMETIAVGCTCIF,Gln-Pro-Arg-Ser-Pro-Lys-Ser-Lys-Arg-Lys-Gly-Gln-Gly-Arg-Pro-Gly-Pro-Leu-Ala-Pro-Gly-Pro-His-Gln-Val-Pro-Leu-Asp-Leu-Val-Ser-Arg-Met-Lys-Pro-Tyr-Ala-Arg-Met-Glu-Glu-Tyr-Glu-Arg-Asn-Ile-Glu-Glu-Met-Val-Ala-Gln-Leu-Arg-Asn-Ser-Ser-Glu-Leu-Ala-Gln-Arg-Lys-Cys-Glu-Val-Asn-Leu-Gln-Leu-Trp-Met-Ser-Asn-Lys-Arg-Ser-Leu-Ser-Pro-Trp-Gly-Tyr-Ser-Ile-Asn-His-Asp-Pro-Ser-Arg-Ile-Pro-Val-Asp-Leu-Pro-Glu-Ala-Arg-Cys-Leu-Cys-Leu-Gly-Cys-Val-Asn-Pro-Phe-Thr-Met-Gln-Glu-Asp-Arg-Ser-Met-Val-Ser-Val-Pro-Val-Phe-Ser-Gln-Val-Pro-Val-Arg-Arg-Arg-Leu-Cys-Pro-Pro-Pro-Pro-Arg-Thr-Gly-Pro-Cys-Arg-Gln-Arg-Ala-Val-Met-Glu-Thr-Ile-Ala-Val-Gly-Cys-Thr-Cys-Ile-Phe,"Predicted N-linked glycosylation of asparagine residue at position 55; predicted disulphide bond formation between cysteine residues at positions 101 and 156, and 106 and 158.",,,
5875,IL-17C,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9P0M4,,HHDPSLRGHPHSHGTPHCYSAEELPLGQAPPHLLARGAKWGQALPVALVSSLEAASHRGRHERPSATTQCPVLRPEEVLEADTHQRSISPWRYRVDTDEDRYPQKLAFAECLCRGCIDARTGRETAALNSVRLLQSLLVLRRRPCSRDGSGLPTPGAFAFHTEFIHVPVGCTCVLPRSV,His-His-Asp-Pro-Ser-Leu-Arg-Gly-His-Pro-His-Ser-His-Gly-Thr-Pro-His-Cys-Tyr-Ser-Ala-Glu-Glu-Leu-Pro-Leu-Gly-Gln-Ala-Pro-Pro-His-Leu-Leu-Ala-Arg-Gly-Ala-Lys-Trp-Gly-Gln-Ala-Leu-Pro-Val-Ala-Leu-Val-Ser-Ser-Leu-Glu-Ala-Ala-Ser-His-Arg-Gly-Arg-His-Glu-Arg-Pro-Ser-Ala-Thr-Thr-Gln-Cys-Pro-Val-Leu-Arg-Pro-Glu-Glu-Val-Leu-Glu-Ala-Asp-Thr-His-Gln-Arg-Ser-Ile-Ser-Pro-Trp-Arg-Tyr-Arg-Val-Asp-Thr-Asp-Glu-Asp-Arg-Tyr-Pro-Gln-Lys-Leu-Ala-Phe-Ala-Glu-Cys-Leu-Cys-Arg-Gly-Cys-Ile-Asp-Ala-Arg-Thr-Gly-Arg-Glu-Thr-Ala-Ala-Leu-Asn-Ser-Val-Arg-Leu-Leu-Gln-Ser-Leu-Leu-Val-Leu-Arg-Arg-Arg-Pro-Cys-Ser-Arg-Asp-Gly-Ser-Gly-Leu-Pro-Thr-Pro-Gly-Ala-Phe-Ala-Phe-His-Thr-Glu-Phe-Ile-His-Val-Pro-Val-Gly-Cys-Thr-Cys-Val-Leu-Pro-Arg-Ser-Val,"Predicted disulphide bond formation between cysteine residues at positions 111 and 171, and 106 and 173.",,,
5873,IL-17F,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q96PD4,,RKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ,Arg-Lys-Ile-Pro-Lys-Val-Gly-His-Thr-Phe-Phe-Gln-Lys-Pro-Glu-Ser-Cys-Pro-Pro-Val- Pro-Gly-Gly-Ser-Met-Lys-Leu-Asp-Ile-Gly-Ile-Ile-Asn-Glu-Asn-Gln-Arg-Val-Ser-Met-Ser-Arg-Asn-Ile-Glu-Ser-Arg-Ser-Thr-Ser-Pro-Trp-Asn-Tyr-Thr-Val-Thr-Trp-Asp-Pro-Asn-Arg-Tyr-Pro-Ser-Glu-Val-Val-Gln-Ala-Gln-Cys-Arg-Asn-Leu-Gly-Cys-Ile-Asn-Ala-Gln-Gly-Lys-Glu-Asp-Ile-Ser-Met-Asn-Ser-Val-Pro-Ile-Gln-Gln-Glu-Thr-Leu-Val-Val-Arg-Arg-Lys-His-Gln-Gly-Cys-Ser-Val-Ser-Phe-Gln-Leu-Glu-Lys-Val-Leu-Val-Thr-Val-Gly-Cys-Thr-Cys-Val-Thr-Pro-Val-Ile-His-His-Val-Gln,"N-linked glycosylation of asparagine residue at position 53; disulphide bonds between cysteine residues at positions 72 and 122, and 77 and 124; interchain disulphide bonds in formation of the heterodimer at positions 17 and 107.",,,
4983,IL-18,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q14116,,YFGKLESKLSVIRNLNDQVLFIDQGNRPLFEDMTDSDCRDNAPRTIFIISMYKDSQPRGMAVTISVKCEKISTLSCENKIISFKEMNPPDNIKDTKSDIIFFQRSVPGHDNKMQFESSSYEGYFLACEKERDLFKLILKKEDELGDRSIMFTVQNED,,,,,
4984,IL-19,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UHD0,,LRRCLISTDMHHIEESFQEIKRAIQAKDTFPNVTILSTLETLQIIKPLDVCCVTKNLLAFYVDRVFKDHQEPNPKILRKISSIANSFLYMQKTLRQCQEQRQCHCRQEATNATRVIHDNYDQLEVHAAAIKSLGELDVFLAWINKNHEVMFSA,,"Predicted N-linked glycosylation of asparagine residues at positions 32 and 111; disulphide bomd formation between cysteine residues at positions 4 and 97, 51 and 103, and 52 and 105",,,
4973,IL-1α,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01583,,SAPFSFLSNVKYNFMRIIKYEFILNDALNQSIIRANDQYLTAAALHNLDEAVKFDMGAYKSSKDDAKITVILRISKTQLYVTAQDEDQPVLLKEMPEIPKTITGSETNLLFFWETHGTKNYFTSVAHPNLFIATKQDYWVCLAGGPPSITDFQILENQA,,Predicted N-linked glycosylation of asparagine at position 29,,,
4974,IL-1β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01584,,APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS,,,,,
5878,IL-1 receptor antagonist,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P18510,,RPSGRKSSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMCLSCVKSGDETRLQLEAVNITDLSENRKQDKRFAFIRSDSGPTTSFESAACPGWFLCTAMEADQPVSLTNMPDEGVMVTKFYFQEDE,Arg-Pro-Ser-Gly-Arg-Lys-Ser-Ser-Lys-Met-Gln-Ala-Phe-Arg-Ile-Trp-Asp-Val-Asn-Gln-Lys-Thr-Phe-Tyr-Leu-Arg-Asn-Asn-Gln-Leu-Val-Ala-Gly-Tyr-Leu-Gln-Gly-Pro-Asn-Val-Asn-Leu-Glu-Glu-Lys-Ile-Asp-Val-Val-Pro-Ile-Glu-Pro-His-Ala-Leu-Phe-Leu-Gly-Ile-His-Gly-Gly-Lys-Met-Cys-Leu-Ser-Cys-Val-Lys-Ser-Gly-Asp-Glu-Thr-Arg-Leu-Gln-Leu-Glu-Ala-Val-Asn-Ile-Thr-Asp-Leu-Ser-Glu-Asn-Arg-Lys-Gln-Asp-Lys-Arg-Phe-Ala-Phe-Ile-Arg-Ser-Asp-Ser-Gly-Pro-Thr-Thr-Ser-Phe-Glu-Ser-Ala-Ala-Cys-Pro-Gly-Trp-Phe-Leu-Cys-Thr-Ala-Met-Glu-Ala-Asp-Gln-Pro-Val-Ser-Leu-Thr-Asn-Met-Pro-Asp-Glu-Gly-Val-Met-Val-Thr-Lys-Phe-Tyr-Phe-Gln-Glu-Asp-Glu,N-linked glycosylation of asparagine residue at position 84; disulphide bond between cysteine residues at positions 66 and 116.,,,
4985,IL-2,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P60568,,APTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT,,O-linked glycosylation of threonine residue at position 3; disulphide bond between cysteine residues at positions 58 and 105,,,
4986,IL-20,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NYY1,,LKTLNLGSCVIATNLQEIRNGFSEIRGSVQAKDGNIDIRILRRTESLQDTKPANRCCLLRHLLRLYLDRVFKNYQTPDHYTLRKISSLANSFLTIKKDLRLCHAHMTCHCGEEAMKKYSQILSHFEKLEPQAAVVKALGELDILLQWMEETE,,"Predicted disulphide bond formation between cysteine residues at positions 9 and 102, 56 and 108, and 57 and 110",,,
4987,IL-21,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9HBE4,,QGQDRHMIRMRQLIDIVDQLKNYVNDLVPEFLPAPEDVETNCEWSAFSCFQKAQLKSANTGNNERIINVSIKKLKRKPPSTNAGRRQKHRLTCPSCDSYEKKPPKEFLERFKSLLQKMIHQHLSSRTHGSEDS,,"Predicted N-linked glycosylation of asparagine residue at position 68; disulphide bond formation between cysteine residues at positions 42 and 93, and 49 and 96",,,
4988,IL-22,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9GZX6,,APISSHCRLDKSNFQQPYITNRTFMLAKEASLADNNTDVRLIGEKLFHGVSMSERCYLMKQVLNFTLEEVLFPQSDRFQPYMQEVVPFLARLSNRLSTCHIEGDDLHIQRNVQKLKDTVKKLGESGEIKAIGELDLLFMSLRNACI,,"N-linked glycosyaltion of asparagine residues at positions 21 and 64, and disulphide bond formation between cysteine residues at positions 7 and 99, and 56 and 145. Predicted N-linked glycosylation of asparagine residue at position 35",,,
4978,IL-23,Human,"Endogenous peptide in human, mouse or rat",4989|5002,IL-23A|IL-12B,,,,,,,,,,,,,,
4989,IL-23A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,RAVPGGSSPAWTQCQQLSQKLCTLAWSAHPLVGHMDLREEGDEETTNDVPHIQCGDGCDPQGLRDNSQFCLQRIHQGLIFYEKLLGSDIFTGEPSLLPDSPVGQLHASLLGLSQLLQPEGHHWETQQIPSLSPSQPWQRLLLRFKILRSLQAFVAVAARVFAHGAATLSP,,,,,
4990,IL-24,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q13007,,QEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL,,"Predicted N-linked glycosylation of asparagine residues at positions 34, 48 and 75",,,
5876,IL-25,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9H293,,YSHWPSCCPSKGQDTSEELLRWSTVPVPPLEPARPNRHPESCRASEDGPLNSRAISPWRYELDRDLNRLPQDLYHARCLCPHCVSLQTGSHMDPRGNSELLYHNQTVFYRRPCHGEKGTHKGYCLERRLYRVSLACVCVRPRVMG,Tyr-Ser-His-Trp-Pro-Ser-Cys-Cys-Pro-Ser-Lys-Gly-Gln-Asp-Thr-Ser-Glu-Glu-Leu-Leu-Arg-Trp-Ser-Thr-Val-Pro-Val-Pro-Pro-Leu-Glu-Pro-Ala-Arg-Pro-Asn-Arg-His-Pro-Glu-Ser-Cys-Arg-Ala-Ser-Glu-Asp-Gly-Pro-Leu-Asn-Ser-Arg-Ala-Ile-Ser-Pro-Trp-Arg-Tyr-Glu-Leu-Asp-Arg-Asp-Leu-Asn-Arg-Leu-Pro-Gln-Asp-Leu-Tyr-His-Ala-Arg-Cys-Leu-Cys-Pro-His-Cys-Val-Ser-Leu-Gln-Thr-Gly-Ser-His-Met-Asp-Pro-Arg-Gly-Asn-Ser-Glu-Leu-Leu-Tyr-His-Asn-Gln-Thr-Val-Phe-Tyr-Arg-Arg-Pro-Cys-His-Gly-Glu-Lys-Gly-Thr-His-Lys-Gly-Tyr-Cys-Leu-Glu-Arg-Arg-Leu-Tyr-Arg-Val-Ser-Leu-Ala-Cys-Val-Cys-Val-Arg-Pro-Arg-Val-Met-Gly,"Predicted N-linked glycosylation of asparagine residue at position 104; predicted disulphide bond formation between cysteine residues at positions 78 and 136, and 183 and 138.",,,
6151,IL-27,Human,"Endogenous peptide in human, mouse or rat",6152|6153,IL-27 subunit α|IL-27 subunit β,,,,,,,,,,,,,,
6152,IL-27 subunit α,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8NEV9,,FPRPPGRPQLSLQELRREFTVSLHLARKLLSEVRGQAHRFAESHLPGVNLYLLPLGEQLPDVSLTFQAWRRLSDPERLCFISTTLQPFHALLGGLGTQGRWTNMERMQLWAMRLDLRDLQRHLRFQVLAAGFNLPEEEEEEEEEEEEERKGLLPGALGSALQGPAQVSWPQLLSTYRLLHSLELVLSRAVRELLLLSKAGHSVWPLGFPTLSPQP,,,,,
6153,IL-27 subunit β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q14213,,RKGPPAALTLPRVQCRASRYPIAVDCSWTLPPAPNSTSPVSFIATYRLGMAARGHSWPCLQQTPTSTSCTITDVQLFSMAPYVLNVTAVHPWGSSSSFVPFITEHIIKPDPPEGVRLSPLAERQLQVQWEPPGSWPFPEIFSLKYWIRYKRQGAARFHRVGPIEATSFILRAVRPRARYYVQVAAQDLTDYGELSDWSLPATATMSLGK,,Predicted N-linked glycosylation of asparagine residues at positions 35 and 85.,,,
4994,IL-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08700,,APMTQTTPLKTSWVNCSNMIDEIITHLKQPPLPLLDFNNLNGEDQDILMENNLRRPNLEAFNRAVKSLQNASAIESILKNLLPCLPLATAAPTRHPIHIKDGDWNEFRRKLTFYLKTLENAQAQQTTLSLAIF,,Predicted N-linked glycosylation of aspragine residues at positions 15 and 70; disulphide bond fromation between cysteine residues at positions 14 and 84,,,
4995,IL-31,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6EBC2,,SHTLPVRLLRPSDDVQKIVEELQSLSKMLLKDVEEEKGVLVSQNYTLPCLSPDAQPPNNIHSPAIRAYLKTIRQLDNKSVIDEIIEHLDKLIFQDAPETNISVPTDTHECKRFILTISQQFSECMDLALKSLTSGAQQATT,,Predicted N-linked glycosylation of asparagine residues at positions 44 and 77,,,
5880,IL-33,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95760,,SITGISPITEYLASLSTYNDQSITFALEDESYEIYVEDLKKDEKKDKVLLSYYESQHPSNESGDGVDGKMLMVTLSPTKDFWLHANNKEHSVELHKCEKPLPDQAFFVLHNMHSNCVSFECKTDPGVFIGVKDNHLALIKVDSSENLCTENILFKLSET,Ser-Ile-Thr-Gly-Ile-Ser-Pro-Ile-Thr-Glu-Tyr-Leu-Ala-Ser-Leu-Ser-Thr-Tyr-Asn-Asp-Gln-Ser-Ile-Thr-Phe-Ala-Leu-Glu-Asp-Glu-Ser-Tyr-Glu-Ile-Tyr-Val-Glu-Asp-Leu-Lys-Lys-Asp-Glu-Lys-Lys-Asp-Lys-Val-Leu-Leu-Ser-Tyr-Tyr-Glu-Ser-Gln-His-Pro-Ser-Asn-Glu-Ser-Gly-Asp-Gly-Val-Asp-Gly-Lys-Met-Leu-Met-Val-Thr-Leu-Ser-Pro-Thr-Lys-Asp-Phe-Trp-Leu-His-Ala-Asn-Asn-Lys-Glu-His-Ser-Val-Glu-Leu-His-Lys-Cys-Glu-Lys-Pro-Leu-Pro-Asp-Gln-Ala-Phe-Phe-Val-Leu-His-Asn-Met-His-Ser-Asn-Cys-Val-Ser-Phe-Glu-Cys-Lys-Thr-Asp-Pro-Gly-Val-Phe-Ile-Gly-Val-Lys-Asp-Asn-His-Leu-Ala-Leu-Ile-Lys-Val-Asp-Ser-Ser-Glu-Asn-Leu-Cys-Thr-Glu-Asn-Ile-Leu-Phe-Lys-Leu-Ser-Glu-Thr,,,,
8975,IL-34,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,MPRGFTWLRYLGIFLGVALGNEPLEMWPLTQNEECTVTGFLRDKLQYRSRLQYMKHYFPINYKISVPYEGVFRIANVTRLQRAQVSERELRYLWVLVSLSATESVQDVLLEGHPSWKYLQEVETLLLNVQQGLTDVEVSPKVESVLSLLNAPGPNLKLVRPKALLDNCFRVMELLYCSCCKQSSVLNWQDCEVPSPQSCSPEPSLQYAATQLYPPPPWSPSSPPHSTGSVRPVRAQGEGLLP,,"1-20 is the signal peptide, 21-242 is the ligand sequence. N-linked glycosylation at position 76.",,,
5881,IL-36α,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UHA7,,MEKALKIDTPQQGSIQDINHRVWVLQDQTLIAVPRKDRMSPVTIALISCRHVETLEKDRGNPIYLGLNGLNLCLMCAKVGDQPTLQLKEKDIMDLYNQPEPVKSFLFYHSQSGRNSTFESVAFPGWFIAVSSEGGCPLILTQELGKANTTDFGLTMLF,Met-Glu-Lys-Ala-Leu-Lys-Ile-Asp-Thr-Pro-Gln-Gln-Gly-Ser-Ile-Gln-Asp-Ile-Asn-His-Arg-Val-Trp-Val-Leu-Gln-Asp-Gln-Thr-Leu-Ile-Ala-Val-Pro-Arg-Lys-Asp-Arg-Met-Ser-Pro-Val-Thr-Ile-Ala-Leu-Ile-Ser-Cys-Arg-His-Val-Glu-Thr-Leu-Glu-Lys-Asp-Arg-Gly-Asn-Pro-Ile-Tyr-Leu-Gly-Leu-Asn-Gly-Leu-Asn-Leu-Cys-Leu-Met-Cys-Ala-Lys-Val-Gly-Asp-Gln-Pro-Thr-Leu-Gln-Leu-Lys-Glu-Lys-Asp-Ile-Met-Asp-Leu-Tyr-Asn-Gln-Pro-Glu-Pro-Val-Lys-Ser-Phe-Leu-Phe-Tyr-His-Ser-Gln-Ser-Gly-Arg-Asn-Ser-Thr-Phe-Glu-Ser-Val-Ala-Phe-Pro-Gly-Trp-Phe-Ile-Ala-Val-Ser-Ser-Glu-Gly-Gly-Cys-Pro-Leu-Ile-Leu-Thr-Gln-Glu-Leu-Gly-Lys-Ala-Asn-Thr-Thr-Asp-Phe-Gly-Leu-Thr-Met-Leu-Phe,Tyrosine residue at position 96 is nitrated.,,,
5882,IL-36β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NZH7,,MNPQREAAPKSYAIRDSRQMVWVLSGNSLIAAPLSRSIKPVTLHLIACRDTEFSDKEKGNMVYLGIKGKDLCLFCAEIQGKPTLQLKLQGSQDNIGKDTCWKLVGIHTCINLDVRESCFMGTLDQWGIGVGRKKWKSSFQHHHLRKKDKDFSSMRTNIGMPGRM,Met-Asn-Pro-Gln-Arg-Glu-Ala-Ala-Pro-Lys-Ser-Tyr-Ala-Ile-Arg-Asp-Ser-Arg-Gln-Met-Val-Trp-Val-Leu-Ser-Gly-Asn-Ser-Leu-Ile-Ala-Ala-Pro-Leu-Ser-Arg-Ser-Ile-Lys-Pro-Val-Thr-Leu-His-Leu-Ile-Ala-Cys-Arg-Asp-Thr-Glu-Phe-Ser-Asp-Lys-Glu-Lys-Gly-Asn-Met-Val-Tyr-Leu-Gly-Ile-Lys-Gly-Lys-Asp-Leu-Cys-Leu-Phe-Cys-Ala-Glu-Ile-Gln-Gly-Lys-Pro-Thr-Leu-Gln-Leu-Lys-Leu-Gln-Gly-Ser-Gln-Asp-Asn-Ile-Gly-Lys-Asp-Thr-Cys-Trp-Lys-Leu-Val-Gly-Ile-His-Thr-Cys-Ile-Asn-Leu-Asp-Val-Arg-Glu-Ser-Cys-Phe-Met-Gly-Thr-Leu-Asp-Gln-Trp-Gly-Ile-Gly-Val-Gly-Arg-Lys-Lys-Trp-Lys-Ser-Ser-Phe-Gln-His-His-His-Leu-Arg-Lys-Lys-Asp-Lys-Asp-Phe-Ser-Ser-Met-Arg-Thr-Asn-Ile-Gly-Met-Pro-Gly-Arg-Met,,,,
5883,IL-36γ,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NZH8,,MRGTPGDADGGGRAVYQSMCKPITGTINDLNQQVWTLQGQNLVAVPRSDSVTPVTVAVITCKYPEALEQGRGDPIYLGIQNPEMCLYCEKVGEQPTLQLKEQKIMDLYGQPEPVKPFLFYRAKTGRTSTLESVAFPDWFIASSKRDQPIILTSELGKSYNTAFELNIND,Met-Arg-Gly-Thr-Pro-Gly-Asp-Ala-Asp-Gly-Gly-Gly-Arg-Ala-Val-Tyr-Gln-Ser-Met-Cys-Lys-Pro-Ile-Thr-Gly-Thr-Ile-Asn-Asp-Leu-Asn-Gln-Gln-Val-Trp-Thr-Leu-Gln-Gly-Gln-Asn-Leu-Val-Ala-Val-Pro-Arg-Ser-Asp-Ser-Val-Thr-Pro-Val-Thr-Val-Ala-Val-Ile-Thr-Cys-Lys-Tyr-Pro-Glu-Ala-Leu-Glu-Gln-Gly-Arg-Gly-Asp-Pro-Ile-Tyr-Leu-Gly-Ile-Gln-Asn-Pro-Glu-Met-Cys-Leu-Tyr-Cys-Glu-Lys-Val-Gly-Glu-Gln-Pro-Thr-Leu-Gln-Leu-Lys-Glu-Gln-Lys-Ile-Met-Asp-Leu-Tyr-Gly-Gln-Pro-Glu-Pro-Val-Lys-Pro-Phe-Leu-Phe-Tyr-Arg-Ala-Lys-Thr-Gly-Arg-Thr-Ser-Thr-Leu-Glu-Ser-Val-Ala-Phe-Pro-Asp-Trp-Phe-Ile-Ala-Ser-Ser-Lys-Arg-Asp-Gln-Pro-Ile-Ile-Leu-Thr-Ser-Glu-Leu-Gly-Lys-Ser-Tyr-Asn-Thr-Ala-Phe-Glu-Leu-Asn-Ile-Asn-Asp,,,,
5879,IL-36 receptor antagonist,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBH0,,MVLSGALCFRMKDSALKVLYLHNNQLLAGGLHAGKVIKGEEISVVPNRWLDASLSPVILGVQGGSQCLSCGVGQEPTLTLEPVNIMELYLGAKESKSFTFYRRDMGLTSSFESAAYPGWFLCTVPEADQPVRLTQLPENGGWNAPITDFYFQQCD,Met-Val-Leu-Ser-Gly-Ala-Leu-Cys-Phe-Arg-Met-Lys-Asp-Ser-Ala-Leu-Lys-Val-Leu-Tyr-Leu-His-Asn-Asn-Gln-Leu-Leu-Ala-Gly-Gly-Leu-His-Ala-Gly-Lys-Val-Ile-Lys-Gly-Glu-Glu-Ile-Ser-Val-Val-Pro-Asn-Arg-Trp-Leu-Asp-Ala-Ser-Leu-Ser-Pro-Val-Ile-Leu-Gly-Val-Gln-Gly-Gly-Ser-Gln-Cys-Leu-Ser-Cys-Gly-Val-Gly-Gln-Glu-Pro-Thr-Leu-Thr-Leu-Glu-Pro-Val-Asn-Ile-Met-Glu-Leu-Tyr-Leu-Gly-Ala-Lys-Glu-Ser-Lys-Ser-Phe-Thr-Phe-Tyr-Arg-Arg-Asp-Met-Gly-Leu-Thr-Ser-Ser-Phe-Glu-Ser-Ala-Ala-Tyr-Pro-Gly-Trp-Phe-Leu-Cys-Thr-Val-Pro-Glu-Ala-Asp-Gln-Pro-Val-Arg-Leu-Thr-Gln-Leu-Pro-Glu-Asn-Gly-Gly-Trp-Asn-Ala-Pro-Ile-Thr-Asp-Phe-Tyr-Phe-Gln-Gln-Cys-Asp,Predicted disulphide bond formation between cysteinen residues at positions 8 and 154.,,,
6149,IL-37,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NZH6,,VHTSPKVKNLNPKKFSIHDQDHKVLVLDSGNLIAVPDKNYIRPEIFFALASSLSSASAEKGSPILLGVSKGEFCLYCDKDKGQSHPSLQLKKEKLMKLAAQKESARRPFIFYRAQVGSWNMLESAAHPGWFICTSCNCNEPVGVTDKFENRKHIEFSFQPVCKAEMSPSEVSD,,,,,
4996,IL-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05112,,HKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS,,"N-linked glycosylation of asparagine residue at position 38; disulphide bond formation between cysteine residues at positions 3 and 127, 24 and 65, and 46 and 99",,,
4997,IL-5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05113,,IPTEIPTSALVKETLALLSTHRTLLIANETLRIPVPVHKNHQLCTEEIFQGIGTLESQTVQGGTVERLFKNLSLIKKYIDGQKKKCGEERRRVNQFLDYLQEFLGVMNTEWIIES,,"Il-5 is a homodimer of two amino acid chains. Predicted O linked glycosylation of threonine residue at position 3; predicted N linked glycosylation of asparagine residue at position 28, and  two interchain disulphide bonds between residues 44 and 86 of each chain",,,
4998,IL-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05231,,VPPGEDSKDVAAPHRQPLTSSERIDKQIRYILDGISALRKETCNKSNMCESSKEALAENNLNLPKMAEKDGCFQSGFNEETCLVKIITGLLEFEVYLEYLQNRFESSEEQARAVQMSTKVLIQFLQKKAKNLDAITTPDPTTNASLLTKLQAQNQWLQDMTTHLILRSFKEFLQSSLRALRQM,,"N-linked glycosylation of asparagine residue at position 44; disulphide bond formation between cysteine residues at positions 43 and 49, and 72 and 82",,,
4999,IL-7,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13232,,DCDIEGKDGKQYESVLMVSIDQLLDSMKEIGSNCLNNEFNFFKRHICDANKEGMFLFRAARKLRQFLKMNSTGDFDLHLLKVSEGTTILLNCTGQVKGRKPAALGEAQPTKSLEENKSLKEQKKLNDLCFLKRLLQEIKTCWNKILMGTKEH,,"Disulphide bond formation between cysteine residues at positions 2 and 141, 24 and 129, and 47 and 92, predicted N-linked glycosylation of asparagine residues at positions 70, 91 and 116",,,
5000,IL-9,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P15248,,QGCPTLAGILDINFLINKMQEDPASKCHCSANVTSCLCLGIPSDNCTRPCFSERLSQMTNTTMQTRYPLIFSRVKKSVEVLKNNKCPYFSCEQPCNQTTAGNALTFLKSLLEIFQKEKMRGMRGKI,,"Predicted N-linked glycosylation of asparagine resdidues at positions 32, 45, 60 and 96",,,
5010,inhibin A,Human,"Endogenous peptide in human, mouse or rat",5005|5006,inhibin α|inhibin βA,,,,,,,,,,,,,,
5005,inhibin α,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05111,,STPLMSWPWSPSALRLLQRPPEEPAAHANCHRVALNISFQELGWERWIVYPPSFIFHYCHGGCGLHIPPNLSLPVPGAPPTPAQPYSLLPGAQPCCAALPGTMRPLHVRTTSDGGYSFKYETVPNLLTQHCACI,,"Forms a dimer with either inhibin beta-A (forming Inhibin A) or inhibin beta-B (forming Inhibin B). N-linked glycosylation of asparagine residue at position 36; partial N-linked glycosylation at position 70. Predicted disulphide bond formation between cysteine resdiues at positions 30 and 96, 59 and 131, and 63 and 133. Predicted interchain disulphide bond formation between cysteine resdiues at position 95",,,
5011,inhibin B,Human,"Endogenous peptide in human, mouse or rat",5005|5007,inhibin α|inhibin βB,,,,,,,,,,,,,,
5006,inhibin βA,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08476,,GLECDGKVNICCKKQFFVSFKDIGWNDWIIAPSGYHANYCEGECPSHIAGTSGSSLSFHSTVINHYRMRGHSPFANLKSCCVPTKLRPMSMLYYDDGQNIIKKDIQNMIVEECGCS,,"Forms a heterodimer with either inhibin alpha chain (forming inhibin A) or inhibin beta-B (forming activin AB). The third form of the active peptide is a homodimer of two beta-A chains forming activin-A. Interchain disulphide bond formation between cysteine residues at position 80. Disulphide bonds between cysteine residues at positions 4 and 12; 11 and 81, 40 and 113, and 44 and 115",,,
5007,inhibin βB,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09529,,GLECDGRTNLCCRQQFFIDFRLIGWNDWIIAPTGYYGNYCEGSCPAYLAGVPGSASSFHTAVVNQYRMRGLNPGTVNSCCIPTKLSTMSMLYFDDEYNIVKRDVPNMIVEECGCA,,"Forms a heterodimer with either inhibin alpha chain (forming inhibin B) or inhibin beta-A (forming activin AB). The third form of the active peptide is a homodimer of two beta-B chains forming activin-B. Predicted interchain disulphide bond formation between cysteine residues at position 79. Predicted disulphide bond formation between cysteine residues at positions 4 and 12; 11 and 80, 40 and 112, and 44 and 114",,,
5008,inhibin βC,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55103,,GIDCQGGSRMCCRQEFFVDFREIGWHDWIIQPEGYAMNFCIGQCPLHIAGMPGIAASFHTAVLNLLKANTAAGTTGGGSCCVPTARRPLSLLYYDRDSNIVKTDIPDMVVEACGCS,,"Predicted to form an active peptide homo or heterodimer through association with alpha or beta subunits, linked by one or more disulphide bonds. Predicted interchain disulphide bond formation between cysteine residues at positions 80; predicted disulphide bond formation between cysteine resisdues at positions 4 and 12, 11 and 81, 40 and 113, and 44 and 115",,,
5009,inhibin βE,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P58166,,TPTCEPATPLCCRRDHYVDFQELGWRDWILQPEGYQLNYCSGQCPPHLAGSPGIAASFHSAVFSLLKANNPWPASTSCCVPTARRPLSLLYLDHNGNVVKTDVPDMVVEACGCS,,"Predicted to form an active peptide homo or heterodimer through association with alpha or beta subunits, linked by one or more disulphide bonds. Predicted interchain disulphide bond formation between cysteine residues at positions 80; predicted disulphide bond formation between cysteine resisdues at positions 4 and 12, 11 and 79, 40 and 111, and 44 and 113",,,
1995,INSL3,Human,"Endogenous peptide in human, mouse or rat",3749|3750,INSL3 (B chain)|INSL3 (A chain),,,,,,,P51460,,,,"Fully active INSL3 is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 34) and A chain (residue 116), and the second between B chain (residue 46) and A chain (residue 129).",,,
3750,INSL3 (A chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P51460,,AAATNPARYCCLSGCTQQDLLTLCPY,Ala-Ala-Ala-Thr-Asn-Pro-Ala-Arg-Tyr-Cys-Cys-Leu-Ser-Gly-Cys-Thr-Gln-Gln-Asp-Leu-Leu-Thr-Leu-Cys-Pro-Tyr,"Fully active INSL3 is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 34) and A chain (residue 116), and the second between B chain (residue 46) and A chain (residue 129).",,,
3749,INSL3 (B chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P51460,,PTPEMREKLCGHHFVRALVRVCGGPRWSTEA,Pro-Thr-Pro-Glu-Met-Arg-Glu-Lys-Leu-Cys-Gly-His-His-Phe-Val-Arg-Ala-Leu-Val-Arg-Val-Cys-Gly-Gly-Pro-Arg-Trp-Ser-Thr-Glu-Ala,"Fully active INSL3 is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 34) and A chain (residue 116), and the second between B chain (residue 46) and A chain (residue 129).",,,
2000,INSL5,Human,"Endogenous peptide in human, mouse or rat",3752|3751,INSL5 (A chain)|INSL5 (B chain),,,,,,,Q9Y5Q6,,,,"Fully active INSL5 is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 29) and A chain (residue 122), and the second between B chain (residue 41) and A chain (residue 135).",,,
6519,INSL5,Mouse,"Endogenous peptide in human, mouse or rat",6520|6521,INSL5 (A chain)|INSL5 (B chain),,,,,,,Q9WUG6,,,,,,,
6520,INSL5 (A chain),Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,RDLQALCCREGCSMKELSTLC,Arg-Asp-Leu-Gln-Ala-Leu-Cys-Cys-Arg-Glu-Gly-Cys-Ser-Met-Lys-Glu-Leu-Ser-Thr-Leu-Cys,"Predicted disulphide bond formation between cysteine residues at positions 6 and 11. Interchain disulphide bond formation between cysteine residues at positions 7 of A chain and 6 of B chain, and 20 of A chain and 19 of B chain.",,,
3752,INSL5 (A chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y5Q6,,XDLQTLCCTDGCSMTDLSALC,pGlu-Asp-Leu-Gln-Thr-Leu-Cys-Cys-Thr-Asp-Gly-Cys-Ser-Met-Thr-Asp-Leu-Ser-Ala-Leu-Cys,"The N-terminal glutamine is cyclised into pyroglutamate (represented by pGlu and X). Fully active INSL5 is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 29) and A chain (residue 122), and the second between B chain (residue 41) and A chain (residue 135).",,,
3751,INSL5 (B chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y5Q6,,KESVRLCGLEYIRTVIYICASSRW,Lys-Glu-Ser-Val-Arg-Leu-Cys-Gly-Leu-Glu-Tyr-Ile-Arg-Thr-Val-Ile-Tyr-Ile-Cys-Ala-Ser-Ser-Arg-Trp,"Fully active INSL5 is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 29) and A chain (residue 122), and the second between B chain (residue 41) and A chain (residue 135).",,,
6521,INSL5 (B chain),Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,RQTVKLCGLDYVRTVIYICASSRW,Arg-Gln-Thr-Val-Lys-Leu-Cys-Gly-Leu-Asp-Tyr-Val-Arg-Thr-Val-Ile-Tyr-Ile-Cys-Ala-Ser-Ser-Arg-Trp,"Interchain disulphide bond formation between cysteine residues at positions 7 of A chain and 6 of B chain, and 20 of A chain and 19 of B chain.",,,
5012,insulin,Human,"Endogenous peptide in human, mouse or rat",5013|5014,insulin A chain|insulin B chain,yes,,,,,,P01308,insulin human,,,,,,
5013,insulin A chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01308,,GIVEQCCTSICSLYQLENYCN,Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Asn,"An internal disulphide bond forms between cysteine residues at positions 6 and 11. Two inter-chain disulphide bonds form with the insulin B chain to form the active peptide, between cysteine residues 7 of the B chain and 7 of the A chain, and 20 of the B chain and 19 of the A chain (numbering relative to the amino acid sequences of the individual peptide chains).",,,
5014,insulin B chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01308,,FVNQHLCGSHLVEALYLVCGERGFFYTPKT,Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr,"Two inter-chain disulphide bonds form with the insulin A chain to form the active peptide, between cysteine residues 7 of the B chain and 7 of the A chain, and 20 of the B chain and 19 of the A chain (numbering relative to the amino acid sequences of the individual peptide chains).",,,
2495,insulin-like growth factor 1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P05017,,GPETLCGAELVDALQFVCGPRGFYFNKPTGYGSSIRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPTKAA,Gly-Pro-Glu-Thr-Leu-Cys-Gly-Ala-Glu-Leu-Val-Asp-Ala-Leu-Gln-Phe-Val-Cys-Gly-Pro-Arg-Gly-Phe-Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ile-Arg-Arg-Ala-Pro-Gln-Thr-Gly-Ile-Val-Asp-Glu-Cys-Cys-Phe-Arg-Ser-Cys-Asp-Leu-Arg-Arg-Leu-Glu-Met-Tyr-Cys-Ala-Pro-Leu-Lys-Pro-Thr-Lys-Ala-Ala,"Disulphide bonds are formed between cysteine residues at positions 6 and 48, 18 and 61 and 47 and 52",,,
4971,insulin-like growth factor 1,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P05019,mecasermin,GPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA,,"Disulphide bond formation between cysteine residues at positions 6 and 48, 18 and 61, and 47 and 52",,,
4972,insulin-like growth factor 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01344,,AYRPSETLCGGELVDTLQFVCGDRGFYFSRPASRVSRRSRGIVEECCFRSCDLALLETYCATPAKSE,,"Disulphide bond formation between cysteine residues at positions 9 and 47, 21 and 60, and 46 and 51",,,
650,kallidin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01042,,KRPPGFSPFR,Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,None.,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)N,FYSKZKQBTVLYEQ-FSLKYBNLSA-N
3711,kisspeptin-10,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q6Y4S4|Q7TSB7,,YNWNSFGLRY,Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2,The C-terminal phenylalanine is amidated.,,,
1283,kisspeptin-10,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,YNWNSFGLRF,Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,OC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCN=C(N)N)CC(C)C)Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)CC(=O)N)CC(=O)N,RITKWYDZSSQNJI-INXYWQKQSA-N
1284,kisspeptin-13,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15726,,LPNYNWNSFGLRF,Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
1285,kisspeptin-14,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15726,,DLPNYNWNSFGLRF,Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
3709,kisspeptin-52,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6Y4S4,,SSPCPPVEGPAGRQRPLCASRSRLIPAPRGAVLVQREKDLSTYNWNSFGLRY,Ser-Ser-Pro-Cys-Pro-Pro-Val-Glu-Gly-Pro-Ala-Gly-Arg-Gln-Arg-Pro-Leu-Cys-Ala-Ser-Arg-Ser-Arg-Leu-Ile-Pro-Ala-Pro-Arg-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Ser-Thr-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
3710,kisspeptin-52,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q7TSB7,,TSPCPPVENPTGHQRPPCATRSRLIPAPRGSVLVQREKDMSAYNWNSFGLRY,Thr-Ser-Pro-Cys-Pro-Pro-Val-Glu-Asn-Pro-Thr-Gly-His-Gln-Arg-Pro-Pro-Cys-Ala-Thr-Arg-Ser-Arg-Leu-Ile-Pro-Ala-Pro-Arg-Gly-Ser-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Met-Ser-Ala-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
1288,kisspeptin-54,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q15726,,GTSLSPPPESSGSPQQPGLSAPHSRQIPAPQGAVLVQREKDLPNYNWNSFGLRF,Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Pro-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-Gln-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
3702,kremen 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q96MU8,,ARPAPSPGLGPECFTANGADYRGTQNWTALQGGKPCLFWNETFQHPYNTLKYPNGEGGLGEHNYCRNPDGDVSPWCYVAEHEDGVYWKYCEIPACQMPGNLGCYKDHGNPPPLTGTSKTSNKLTIQTCISFCRSQRFKFAGMESGYACFCGNNPDYWKYGEAASTECNSVCFGDHTQPCGGDGRIILFDTLVGACGGNYSAMSSVVYSPDFPDTYATGRVCYWTIRVPGASHIHFSFPLFDIRDSADMVELLDGYTHRVLARFHGRSRPPLSFNVSLDFVILYFFSDRINQAQGFAVLYQAVKEELPQERPAVNQTVAEVITEQANLSVSAARSSKVLYVITTSPSHPPQTVPGSNSWAPPMGAGSHRVEGWTVYGLATLLILTVTAIVAKILLHVTFKSHRVPASGDLRDCHQPGTSGEIWSIFYKPSTSISIFKKKLKGQSQQDDRNPLVSD,,"N-linked glycosylation of residues at positions 26, 40, 198, 274, 314 and 326; disulfide bonds between cysteine residues at positions 13 and 95; 36 and 76; 65 and 90; 195 and 221",,,
3703,kremen 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8NCW0,,GSLHSPGLSECFQVNGADYRGHQNRTGPRGAGRPCLFWDQTQQHSYSSASDPHGRWGLGAHNFCRNPDGDVQPWCYVAETEEGIYWRYCDIPSCHMPGYLGCFVDSGAPPALSGPSGTSTKLTVQVCLRFCRMKGYQLAGVEAGYACFCGSESDLARGRLAPATDCDQICFGHPGQLCGGDGRLGVYEVSVGSCQGNWTAPQGVIYSPDFPDEYGPDRNCSWALGPPGAALELTFRLFELADPRDRLELRDAASGSLLRAFDGARPPPSGPLRLGTAALLLTFRSDARGHAQGFALTYRGLQDAAEDPEAPEGSAQTPAAPLDGANVSCSPRPGAPPAAIGARVFSTVTAVSVLLLLLLGLLRPLRRRSCLLAPGKGPPALGASRGPRRSWAVWYQQPRGVALPCSPGDPQAEGSAAGYRPLSASSQSSLRSLISAL,,See Uniprot entry for a list of predicted post-translational modifications,,,
5303,large neuromedin N,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9D3P9,,SDSEEDVRALEADLLTNMHTSKISKASPPSWKMTLLNVCSLINNVNSPAEEAGDMHDDDLVGKRKLPLVLDGFSLEAMLTIFQLQKICRSRAFQHWEIIQEDILDNVNDKNEKEEVIKRKIPYIL,,,,,
1576,large neuromedin N,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P30990,,SDSEEEMKALEADFLTNMHTSKISKAHVPSWKMTLLNVCSLVNNLNSPAEETGEVHEEELVARRKLPTALDGFSLEAMLTIYQLHKICHSRAFQHWELIQEDILDTGNDKNGKEEVIKRKIPYIL,,,,,
5304,large neuromedin N,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20068,,SDSEEDVRALEADLLTNMHASKVSKGSPPSWKMTLLNVCSLINNLNSAAEEAGEMRDDDLVAKRKLPLVLDDFSLEALLTVFQLQKICRSRAFQHWEIIQEDILDHGNEKTEKEEVIKRKIPYIL,,,,,
1577,large neurotensin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,DSEEEMKALEADFLTNMHTSKISKAHVPSWKMTLLNVCSLVNNLNSPAEETGEVHEEELVARRKLPTALDGFSLEAMLTIYQLHKICHSRAFQHWELIQEDILDTGNDKNGKEEVIKRKIPYILKRQLYENKPRRPYILKR,,,,,
5015,leptin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P41159,,VPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLPWASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC,,Disulphide bond formation between cysteine residues at positions 96 and 146,,,
1613,[Leu]enkephalin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01210|P22005|P04094,,YGGFL,Tyr-Gly-Gly-Phe-Leu,,,O=C(CNC(=O)C(Cc1ccc(cc1)O)N)NCC(=O)NC(C(=O)NC(C(=O)O)CC(C)C)Cc1ccccc1,URLZCHNOLZSCCA-UHFFFAOYSA-N
4391,LH,Rat,"Endogenous peptide in human, mouse or rat",4378|4390,glycoprotein hormone common alpha subunit|LH β subunit,,,,,,,,,,,The production of biologically active LH requires appropriately folded and glycosylated LHβ and common α subunits that assemble to form the active LH heterodimer.,,,
1159,LH,Human,"Endogenous peptide in human, mouse or rat",3732|3731,LH β subunit|glycoprotein hormone common alpha subunit,yes,,,,,,,lutropin alfa,,,The production of biologically active LH requires appropriately folded and glycosylated LHβ and common α subunits that assemble to form the active LH heterodimer .,,,
4389,LH,Mouse,"Endogenous peptide in human, mouse or rat",4388|4377,LH β subunit|glycoprotein hormone common alpha subunit,,,,,,,,,,,The production of biologically active LH requires appropriately folded and glycosylated LHβ and common α subunits that assemble to form the active LH heterodimer.,,,
3732,LH β subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01229,,SREPLRPWCHPINAILAVEKEGCPVCITVNTTICAGYCPTMMRVLQAVLPPLPQVVCTYRDVRFESIRLPGCPRGVDPVVSFPVALSCRCGPCRRSTSDCGGPKDHPLTCDHPQLSGLLFL,Ser-Arg-Glu-Pro-Leu-Arg-Pro-Trp-Cys-His-Pro-Ile-Asn-Ala-Ile-Leu-Ala-Val-Glu-Lys-Glu-Gly-Cys-Pro-Val-Cys-Ile-Thr-Val-Asn-Thr-Thr-Ile-Cys-Ala-Gly-Tyr-Cys-Pro-Thr-Met-Met-Arg-Val-Leu-Gln-Ala-Val-Leu-Pro-Pro-Leu-Pro-Gln-Val-Val-Cys-Thr-Tyr-Arg-Asp-Val-Arg-Phe-Glu-Ser-Ile-Arg-Leu-Pro-Gly-Cys-Pro-Arg-Gly-Val-Asp-Pro-Val-Val-Ser-Phe-Pro-Val-Ala-Leu-Ser-Cys-Arg-Cys-Gly-Pro-Cys-Arg-Arg-Ser-Thr-Ser-Asp-Cys-Gly-Gly-Pro-Lys-Asp-His-Pro-Leu-Thr-Cys-Asp-His-Pro-Gln-Leu-Ser-Gly-Leu-Leu-Phe-Leu,"N-linked glycosylation at residue 50; disulphide bonds between residues 29 and 77, 43 and 92, 46 and 130, 54 and 108, 58 and 110 and 113 and 120. The production of biologically active LH requires appropriately folded and glycosylated LHβ and common α subunits that assemble to form the active LH heterodimer .",,,
4390,LH β subunit,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01230,,SRGPLRPLCRPVNATLAAENEFCPVCITFTTSICAGYCPSMVRVLPAALPPVPQPVCTYRELRFASVRLPGCPPGVDPIVSFPVALSCRCGPCRLSSSDCGGPRTQPMTCDLPHLPGLLLF,Ser-Arg-Gly-Pro-Leu-Arg-Pro-Leu-Cys-Arg-Pro-Val-Asn-Ala-Thr-Leu-Ala-Ala-Glu-Asn-Glu-Phe-Cys-Pro-Val-Cys-Ile-Thr-Phe-Thr-Thr-Ser-Ile-Cys-Ala-Gly-Tyr-Cys-Pro-Ser-Met-Val-Arg-Val-Leu-Pro-Ala-Ala-Leu-Pro-Pro-Val-Pro-Gln-Pro-Val-Cys-Thr-Tyr-Arg-Glu-Leu-Arg-Phe-Ala-Ser-Val-Arg-Leu-Pro-Gly-Cys-Pro-Pro-Gly-Val-Asp-Pro-Ile-Val-Ser-Phe-Pro-Val-Ala-Leu-Ser-Cys-Arg-Cys-Gly-Pro-Cys-Arg-Leu-Ser-Ser-Ser-Asp-Cys-Gly-Gly-Pro-Arg-Thr-Gln-Pro-Met-Thr-Cys-Asp-Leu-Pro-His-Leu-Pro-Gly-Leu-Leu-Leu-Phe,N-linked glycosylation of the asparagine residue at position 13; disulfide bond formation between cysteine residues at positions 9 and 57; 23 and 72; 34 and 88; 38 and 90 and 93 and 100. The production of biologically active LH requires appropriately folded and glycosylated LHβ and common α subunits that assemble to form the active LH heterodimer,,,
4388,LH β subunit,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,O09108,,SRGPLRPLCRPVNATLAAENEFCPVCITFTTSICAGYCPSMVRVLPAALPPVPQPVCTYRELAFASVRLPGCPPGVDPIVSFPVALSCRCGPCRLSSSDCGGPRTQPMACDLPHLPGLLLL,Glu-Phe-Cys-Pro-Val-Cys-Ile-Thr-Phe-Thr-Thr-Ser-Ile-Cys-Ala-Gly-Tyr-Cys-Pro-Ser-Met-Val-Arg-Val-Leu-Pro-Ala-Ala-Leu-Pro-Pro-Val-Pro-Gln-Pro-Val-Cys-Thr-Tyr-Arg-Glu-Leu-Ala-Phe-Ala-Ser-Val-Arg-Leu-Pro-Gly-Cys-Pro-Pro-Gly-Val-Asp-Pro-Ile-Val-Ser-Phe-Pro-Val-Ala-Leu-Ser-Cys-Arg-Cys-Gly-Pro-Cys-Arg-Leu-Ser-Ser-Ser-Asp-Cys-Gly-Gly-Pro-Arg-Thr-Gln-Pro-Met-Ala-Cys-Asp-Leu-Pro-His-Leu-Pro-Gly-Leu-Leu-Leu-Leu,N-linked glycosylation of the asparagine residue at position 13; disulfide bond formation between cysteine residues at positions 9 and 57; 23 and 72; 34 and 88; 38 and 90 and 93 and 100. The production of biologically active LH requires appropriately folded and glycosylated LHβ and common α subunits that assemble to form the active LH heterodimer,,,
5016,LIF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P15018,,SPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF,,"N-linked glycosylation of asparagine residues at positions 9, 34, 63, 73, 96 and 116; disulphide bond formation between cysteine residues at positions 12 and 134, 18 and 131, and 60 and 163",,,
5070,LIGHT,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43557,,MEESVVRPSVFVVDGQTDIPFTRLGRSHRRQSCSVARVGLGLLLLLMGAGLAVQGWFLLQLHWRLGEMVTRLPDGPAGSWEQLIQERRSHEVNPAAHLTGANSSLTGSGGPLLWETQLGLAFLRGLSYHDGALVVTKAGYYYIYSKVQLGGVGCPLGLASTITHGLYKRTPRYPEELELLVSQQSPCGRATSSSRVWWDSSFLGGVVHLEAGEKVVVRVLDERLVRLRDGTRSYFGAFMV,,N-linked glycosylation of asparagine residue at position 102; predicted disulphide bond between cysteine resisues at positons 154 and 187,,,
9734,liver enriched antimicrobial peptide 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q969E1,,MWHLKLCAVLMIFLLLLGQIDGSPIPEVSSAKRRPRRMTPFWRGVSLRPIGASCRDDSECITRLCRKRRCSLSVAQE,,"Residues 1-22 are a signal peptide, and residues 23-37 is cleaved leaving amino acids 38-77 to form the mature peptide. Two disulphide bonds between Cys54and Cys65 and Cys60 and Cys70.",,,
5527,LL-37,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P49913,,LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES,Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CCC(=O)O)[C@H](O)C)CCCN=C(N)N)C(C)C)CC(C)C)CC(=O)N)CCCN=C(N)N)CC(C)C)Cc1ccccc1)CC(=O)O)CCCCN)[C@H](CC)C)CCCN=C(N)N)CCC(=O)N)C(C)C)[C@H](CC)C)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)N)CC(C)C)CC(=O)O)Cc1ccccc1)Cc1ccccc1)CCCN=C(N)N)CCCCN)CO)CCCCN)CCC(=O)O)CCCCN)CCCCN)CCC(=O)O)Cc1ccccc1,POIUWJQBRNEFGX-XAMSXPGMSA-N
5320,low-density lipoprotein receptor-related protein 4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O75096,,,,,,,
5353,LVV-hemorphin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P68871,,LVVYPWTQRF,Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg-Phe,,,,
5064,lymphotoxin-α,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01374,,LPGVGLTPSAAQTARQHPKMHLAHSTLKPAAHLIGDPSKQNSLLWRANTDRAFLQDGFSLSNNSLLVPTSGIYFVYSQVVFSGKAYSPKATSSPLYLAHEVQLFSSQYPFHVPLLSSQKMVYPGLQEPWLHSMYHGAAFQLTQGDQLSTHTDGIPHLVLSPSTVFFGAFAL,,Partial O-linked glycosylation of threonine residue at position 7; N-linked glycosylation of asparagine at position 62,,,
5075,lymphotoxin-β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q06643,,MGALGLEGRGGRLQGRGSLLLAVAGATSLVTLLLAVPITVLAVLALVPQDQGGLVTETADPGAQAQQGLGFQKLPEEEPETDLSPGLPAAHLIGAPLKGQGLGWETTKEQAFLTSGTQFSDAEGLALPQDGLYYLYCLVGYRGRAPPGGGDPQGRSVTLRSSLYRAGGAYGPGTPELLLEGAETVTPVLDPARRQGYGPLWYTSVGFGGLVQLRRGERVYVNISHPDMVDFARGKTFFGAVMVG,,Predicted N-linked glycosylation of asparagine residue at position 222,,,
6142,lymphotoxin β2α1 heterotrimer,Human,"Endogenous peptide in human, mouse or rat",5075|5064,lymphotoxin-β|lymphotoxin-α,,,,,,,,,,,,,,
3580,Lys-[Hyp3]-bradykinin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01042|O08677|P08934,,KRPXGFSPFR,Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg,Contains a hydroxylated proline residue (indicated by X or Hyp).,,,
9981,macrophage migration inhibitory factor,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P14174,,PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA,,Note that the initiator methionine is removed.,,,
5023,macrophage stimulating protein 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09603,,EEVSEYCSHMIGSGHLQSLQRLIDSQMETSCQITFEFVDQEQLKDPVCYLKKAFLLVQDIMEDTMRFRDNTPNAIAIVQLQELSLRLKSCFTKDYEEHDKACVRTFYETPLQLLEKVKNVFNETKNLLDKDWNIFSKNCNNSFAECSSQDVVTKPDCNCLYPKAIPSSDPASVSPHQPLAPSMAPVAGLTWEDSEGTEGSSLLPGEQPLHTVDPGSAKQRPPRSTCQSFEPPETPVVKDSTIGGSPQPRPSVGAFNPGMEDILDSAMGTNWVPEEASGEASEIPVPQGTELSPSRPGGGSMQTEPARPSNFLSASSPLPASAKGQQPADVTGTALPRVGPVRPTGQDWNHTPQKTDHPSALLRDPPEPGSPRISSLRPQGLSNPSTLSAQPQLSRSHSSGSVLPLGELEGRRSTRDRRSPAEPEGGPASEGAARPLPRFNSVPLTDTGHERQSEGSFSPQLQESVFHLLVPSVILVLLAVGGLLFYRWRRRSHQEPQRADSPLEQPEGSPLTQDDRQVELPV,,"The active peptide is a homodimer linked by three interchain disulphide bonds between cysteine residues at positions 31, 158 and 160 of each chain. Further disulphide bond formation within each chain between cysteine residues at positions 7 and 90, 48 and 139, and 132 and 146. Predicted N-linked glycosylation of asparagine residues at positions 122 and 140",,,
10539,MANSC (415-431),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9H8J5,,KRYSRLDYLINGIYVDI,Lys-Arg-Tyr-Ser-Arg-Leu-Asp-Tyr-Leu-Ile-Asn-Gly-Ile-Tyr-Val-Asp-Ile,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)CC(=O)O)C(C)C)Cc1ccc(cc1)O)[C@H](CC)C)CC(=O)N)[C@H](CC)C)CC(C)C)Cc1ccc(cc1)O)CC(=O)O)CC(C)C)CCCN=C(N)N)CO)Cc1ccc(cc1)O)CCCN=C(N)N)N,CCMVMLBWJFAFRO-IAMXVIFYSA-N
6655,matrix metalloproteinase 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P45452,,,,,,,
6656,matrix metalloproteinase 13,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P45452,,,,,,,
4470,matrix metalloproteinase 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08253,,,,,,,
4471,matrix metalloproteinase 2,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P33434,,,,,,,
4472,matrix metalloproteinase 2,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P33436,,,,,,,
4905,M-CSF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09603,,EEVSEYCSHMIGSGHLQSLQRLIDSQMETSCQITFEFVDQEQLKDPVCYLKKAFLLVQDIMEDTMRFRDNTPNAIAIVQLQELSLRLKSCFTKDYEEHDKACVRTFYETPLQLLEKVKNVFNETKNLLDKDWNIFSKNCNNSFAECSSQDVVTKPDCNCLYPKAIPSSDPASVSPHQPLAPSMAPVAGLTWEDSEGTEGSSLLPGEQPLHTVDPGSAKQRPPRSTCQSFEPPETPVVKDSTIGGSPQPRPSVGAFNPGMEDILDSAMGTNWVPEEASGEASEIPVPQGTELSPSRPGGGSMQTEPARPSNFLSASSPLPASAKGQQPADVTGTALPRVGPVRPTGQDWNHTPQKTDHPSALLRDPPEPGSPRISSLRPQGLSNPSTLSAQPQLSRSHSSGSVLPLGELEGRRSTRDRRSPAEPEGGPASEGAARPLPRFNSVPLTDTGHERQSEGSFSPQLQESVFHLLVPSVILVLLAVGGLLFYRWRRRSHQEPQRADSPLEQPEGSPLTQDDRQVELPV,,,,,
1298,melanin-concentrating hormone,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P20382|P56942|P14200,,DFDMLRCMLGRVYRPCWQV,Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val,Cysteine residues at positions 7 and 16 form a disulphide bond.,,CSCCC1NC(=O)C(CSSCC(NC(=O)C2CCCN2C(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)C(C)C)CCCNC(=N)N)C(C)C)Cc1ccc(cc1)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)C(C)C)CCC(=O)O)Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(CC(=O)O)N)CCSC)CCCNC(=N)N,ORRDHOMWDPJSNL-UHFFFAOYSA-N
1614,[Met]enkephalin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01210|P22005|P04094,metenkefalin,YGGFM,Tyr-Gly-Gly-Phe-Met,,,CSCC[C@@H](C(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)N,YFGBQHOOROIVKG-FKBYEOEOSA-N
9275,microtubule associated protein tau,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,,,,,,
1458,motilin,"Human, Pig","Endogenous peptide in human, mouse or rat",,,,,,,,,P12872|P01307,,FVPIFTYGELQRMQEKERNKGQ,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,None.,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CCC(=O)N)CCCCN)CC(=O)N)CCCNC(=N)N)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1ccccc1)Cc1ccc(cc1)O)CCC(=O)O)CC(C)C)CCC(=O)N)CCCNC(=N)N)CCSC)CCC(=O)N)CCC(=O)O,LVRVABPNVHYXRT-BQWXUCBYSA-N
5376,motilin-associated peptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12872,,SLSVWQRSGEEGPVDPAEPIREEENEMIKLTAPLEIGMRMNSRQLEKYPATLEGLLSEMLPQHAAK,,,,,
10541,MSMB (91-114),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P08118,,EDCKYIVVEKKDPKKTCSVSEWII,Glu-Asp-Cys(1)-Lys-Tyr-Ile-Val-Val-Glu-Lys-Lys-Asp-Pro-Lys-Lys-Thr-Cys(1)-Ser-Val-Ser-Glu-Trp-Ile-Ile,,,NCCCC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)[C@H](CC)C)Cc1c[nH]c2c1cccc2)CCC(=O)O)CO)C(C)C)CO)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N)CC(=O)O)CCCCN)Cc1ccc(cc1)O)[C@H](CC)C)C(C)C)C(C)C,JXASPFJVDIPKEB-XNSPQFCGSA-N
9339,mucosal addressin cell adhesion molecule 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q13477,,MDFGLALLLAGLLGLLLGQSLQVKPLQVEPPEPVVAVALGASRQLTCRLACADRGASVQWRGLDTSLGAVQSDTGRSVLTVRNASLSAAGTRVCVGSCGGRTFQHTVQLLVYAFPDQLTVSPAALVPGDPEVACTAHKVTPVDPNALSFSLLVGGQELEGAQALGPEVQEEEEEPQGDEDVLFRVTERWRLPPLGTPVPPALYCQATMRLPGLELSHRQAIPVLHSPTSPEPPDTTSPESPDTTSPESPDTTSQEPPDTTSPEPPDKTSPEPAPQQGSTHTPRSPGSTRTRRPEISQAGPTQGEVIPTGSSKPAGDQLPAALWTSSAVLGLLLLALPTYHLWKRCRHLAEDDTHPPASLRLLPQVSAWAGLRGTGQVGISPS,,"Disulfide bonds: Cys47-Cys 95, Cys 51-Cys98, Cys134-Cys204Glycosylation: Asn83",,,
6686,Müllerian inhibiting substance,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P03971,,,,,,,
5025,myostatin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14793,,DFGLDCDEHSTESRCCRYPLTVDFEAFGWDWIIAPKRYKANYCSGECEFVFLQKYPHTHLVHQANPRGSAGPCCTPTKMSPINMLYFNGKEQIIYGKIPAMVVDRCGCS,,"Predicted to form a disulphide-linked homodimer, with bonds between cysteine residues at positions 73. Predicted disulphide bond formation between cysteine residues at positions 15 and 74, 43 and 106, and 47 and 108",,,
6607,netrin-G3 ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NT99,,AGGGGVAVTSAAGGGSPPATSCPVACSCSNQASRVICTRRDLAEVPASIPVNTRYLNLQENGIQVIRTDTFKHLRHLEILQLSKNLVRKIEVGAFNGLPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRLDLGELKRLEYISEAAFEGLVNLRYLNLGMCNLKDIPNLTALVRLEELELSGNRLDLIRPGSFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVHLNHNPWHCNCDVLWLSWWLKETVPSNTTCCARCHAPAGLKGRYIGELDQSHFTCYAPVIVEPPTDLNVTEGMAAELKCRTGTSMTSVNWLTPNGTLMTHGSYRVRISVLHDGTLNFTNVTVQDTGQYTCMVTNSAGNTTASATLNVSAVDPVAAGGTGSGGGGPGGSGGVGGGSGGYTYFTTVTVETLETQPGEEALQPRGTEKEPPGPTTDGVWGGGRPGDAAGPASSSTTAPAPRSSRPTEKAFTVPITDVTENALKDLDDVMKTTKIIIGCFVAITFMAAVMLVAFYKLRKQHQLHKHHGPTRTVEIINVEDELPAASAVSVAAAAAVASGGGVGGDSHLALPALERDHLNHHHYVAAAFKAHYSSNPSGGGCGGKGPPGLNSIHEPLLFKSGSKENVQETQI,,,,,
5027,neuregulin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q02297,,SGKKPESAAGSQSPALPPRLKEMKSQESAAGSKLVLRCETSSEYSSLRFKWFKNGNELNRKNKPQNIKIQKKPGKSELRINKASLADSGEYMCKVISKLGNDSASANITIVESNEIITGMPASTEGAYVSSESPIRISVSTEGANTSSSTSTSTTGTSHLVKCAEKEKTFCVNGGECFMVKDLSNPSRYLCKCQPGFTGARCTENVPMKVQNQEKAEELYQK,,"Predicted N-linked glycosylation of asparagine residues at positions 101, 107 and 145; predicted disulphide bond formation between cysteine resdiues at positions 38 and 93. Disulphide bond formation between cysteine residues at positions 163 and 177, 171 and 191, and 193 and 202",,,
5029,neuregulin-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14511,,CYSPSLKSVQDQAYKAPVVVEGKVQGLVPAGGSSSNSTREPPASGRVALVKVLDKWPLRSGGLQREQVISVGSCVPLERNQRYIFFLEPTEQPLVFKTAFAPLDTNGKNLKKEVGKILCTDCATRPKLKKMKSQTGQVGEKQSLKCEAAAGNPQPSYRWFKDGKELNRSRDIRIKYGNGRKNSRLQFNKVKVEDAGEYVCEAENILGKDTVRGRLYVNSVSTTLSSWSGHARKCNETAKSYCVNGGVCYYIEGINQLSCKCPNGFFGQRCLEKLPLRLYMPDPKQKAEELYQK,,"Predicted N-linked glycosylation of asparagine residuest at positions 36, 167 and 235. Predicted disulphide bond formation between cysteine resdiues at positions 146 and 200, 234 and 248, 242 and 259, and 261 and 270",,,
5030,neuregulin-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P56975,,MSEGAAAASPPGAASAAAASAEEGTAAAAAAAAAGGGPDGGGEGAAEPPRELRCSDCIVWNRQQTWLCVVPLFIGFIGLGLSLMLLKWIVVGSVKEYVPTDLVDSKGMGQDPFFLSKPSSFPKAMETTTTTTSTTSPATPSAGGAASSRTPNRISTRLTTITRAPTRFPGHRVPIRASPRSTTARNTAAPATVPSTTAPFFSSSTLGSRPPVPGTPSTQAMPSWPTAAYATSSYLHDSTPSWTLSPFQDAASSSSSSSSSATTTTPETSTSPKFHTTTYSTERSEHFKPCRDKDLAYCLNDGECFVIETLTGSHKHCRCKEGYQGVRCDQFLPKTDSILSDPTDHLGIEFMESEEVYQR,,"Serine residues at positions 116 and 119 are phosphoserine; predicted disulphide bond formation between cysteine resdiues at positions 290 and 304, 298 and 317, and 319 and 328",,,
5031,neuregulin-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8WWG1,,MPTDHEEPCGPSHKSFCLNGGLCYVIPTIPSPFCRCVENYTGARCEEVFLPGSSIQTKSNL,,"Predicted N-linked glycosylation of asparagine residue at position 39; predicted disulphide bond formation between cysteine residues at positions 9 and 23, 17 and 34, and 36 and 45",,,
2089,neurokinin A,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P20366|P41539|P06767,,HKTDSFVGLM,His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2,The C-terminal methionine is amidated.,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CO)CC(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1[nH]cnc1)N,HEAUFJZALFKPBA-JPQUDPSNSA-N
2090,neurokinin B,"Human, Mouse, Rat, Pig","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UHF0|P55099|P08435|P67934,,DMHDFFVGLM,Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2,The C-terminal methionine is amidated.,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N,NHXYSAFTNPANFK-HDMCBQFHSA-N
613,neuromedin B,"Human, Mouse, Rat, Pig","Endogenous peptide in human, mouse or rat",,,,,,,,,P01297|Q9CR53|P08949,,GNLWATGHFM,Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2,C-terminal peptidyl-methionine amidation,,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(O)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(NC(=O)CN)CC(=O)N)CC(C)C)C)Cc1ccccc1,YPFNACALNKVZNK-UHFFFAOYSA-N
3625,neuromedin N,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P30990,,IPYIL,Ile-Pro-Tyr-Ile-Leu,None.,,,
1578,neuromedin N,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9D3P9|P20068,,KIPYIL,Lys-Ile-Pro-Tyr-Ile-Leu,None.,,,
1468,neuromedin S-33,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q5H8A3,,ILQRGSGTAAVDFTKKDHTATWGRPFFLFRPRN,Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
3615,neuromedin S-36,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q5H8A2,,LPRLLHTDSRMATIDFPKKDPTTSLGRPFFLFRPRN,Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
3614,neuromedin S-36,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q5H8A1,,LPRLLRLDSRMATVDFPKKDPTTSLGRPFFLFRPRN,Leu-Pro-Arg-Leu-Leu-Arg-Leu-Asp-Ser-Arg-Met-Ala-Thr-Val-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
1469,neuromedin U-23,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12760,,YKVNEYQGPVAPSGGFFLFRPRN,Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
3613,neuromedin U-23,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QXK8,,FKAEYQSPSVGQSKGYFLFRPRN,Phe-Lys-Ala-Glu-Tyr-Gln-Ser-Pro-Ser-Val-Gly-Gln-Ser-Lys-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
1470,neuromedin U-25,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48645,,FRVDEEFQSPFASQSRGYFLFRPRN,Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
5654,neuronostatin,"Human, Pig","Endogenous peptide in human, mouse or rat",,,,,,,,,,,LRQFLQKSLAAAA,Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Ala,,,,
4442,neuropeptide AF,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9WVA9,,EFWSLAAPQRF,Glu-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe,Amidation of C-terminal phenylalanine residue,,,
4443,neuropeptide AF,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9WVA8,,QFWSLAAPQRF,Gln-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe,Amidation of C-terminal phenylalanine residue,,,
3735,neuropeptide AF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15130,,AGEGLNSQFWSLAAPQRF,Ala-Gly-Glu-Gly-Leu-Asn-Ser-Gln-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe,,,,
3628,neuropeptide B-23,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8K4P1,,WYKPAAGPHHYSVGRASGLLSSF,(Br)Trp-Tyr-Lys-Pro-Ala-Ala-Gly-Pro-His-His-Tyr-Ser-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Ser-Ser-Phe,The N-terminal tryptophan is brominated.,,,
3629,neuropeptide B-23,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8K4P2,,WYKPAAGSHHYSVGRAAGLLSSF,(Br)Trp-Tyr-Lys-Pro-Ala-Ala-Gly-Ser-His-His-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Ser-Phe,The N-terminal tryptophan is brominated.,,,
1501,neuropeptide B-23,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8NG41,,WYKPAAGHSSYSVGRAAGLLSGL,(Br)Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu,The N-terminal tryptophan is brominated.,,,
3631,neuropeptide B-29,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8K4P2,,WYKPAAGSHHYSVGRAAGLLSSFHRFPST,(Br)Trp-Tyr-Lys-Pro-Ala-Ala-Gly-Ser-His-His-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Ser-Phe-His-Arg-Phe-Pro-Ser-Thr,The N-terminal tryptophan is brominated.,,,
1502,neuropeptide B-29,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8NG41,,WYKPAAGHSSYSVGRAAGLLSGLRRSPYA,(Br)Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Ala,The N-terminal tryptophan is brominated.,,,
3630,neuropeptide B-29,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8K4P1,,WYKPAAGPHHYSVGRASGLLSSFHRFPST,(Br)Trp-Tyr-Lys-Pro-Ala-Ala-Gly-Pro-His-His-Tyr-Ser-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Ser-Ser-Phe-His-Arg-Phe-Pro-Ser-Thr,The N-terminal tryptophan is brominated.,,,
5374,neuropeptide EI,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20382,,EIGDEENSAKFPI,Glu-Ile-Gly-Asp-Glu-Glu-Asn-Ser-Ala-Lys-Phe-Pro-Ile,The C-terminal isoleucine residue is undergoes amidation,,,
1479,neuropeptide FF,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9WVA9|O15130|Q9WVA8,,FLFQPQRF,Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,Amidation of C-terminal phenylalanine,,,
3667,neuropeptide γ,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P20366|P41539|P06767,,DAGHGQISHKRHKTDSFVGLM,Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2,The C-terminal methionine is amidated.,,,
5375,neuropeptide GE,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20382,,GSVAFPAENGVQNTESTQE,Gly-Ser-Val-Ala-Phe-Pro-Ala-Glu-Asn-Gly-Val-Gln-Asn-Thr-Glu-Ser-Thr-Gln-Glu,,,,
2091,neuropeptide K,"Human, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P20366|P06767,,DADSSIEKQVALLKALYGHGQISHKRHKTDSFVGLM,Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2,The C-terminal methionine is amidated.,,,
1491,neuropeptide S,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0C0P8,,SFRNGVGSGAKKTSFRRAKQ,Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Ala-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln,None.,,,
1492,neuropeptide S,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0C0P7,,SFRNGVGSGVKKTSFRRAKQ,Ser-Phe-Arg-Asn-Gly-Val-Gly-Ser-Gly-Val-Lys-Lys-Thr-Ser-Phe-Arg-Arg-Ala-Lys-Gln,None.,,,
1490,neuropeptide S,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0C0P6,,SFRNGVGTGMKKTSFQRAKS,Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,None.,,,
4444,neuropeptide SF,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9WVA8,,SPAFLFQPQRF,Ser-Pro-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,C-terminal phenylalanine amidation,,,
4445,neuropeptide SF,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9WVA9,,NPAFLFQPQRF,Asn-Pro-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,Amidation of C-terminal phenylalanine residue,,,
3736,neuropeptide SF,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O15130,,SQAFLFQPQRF,Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,Amidation of C-terminal phenylalanine,,,
1495,neuropeptide W-23,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8N729,,WYKHVASPRYHTVGRAAGLLMGL,Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu,None.,,,
3616,neuropeptide W-23,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q3V2F0|Q8K1M5,,WYKHVASPRYHTVGRASGLLMGL,Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu,None.,,,
3620,neuropeptide W-30,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8K1M5,,WYKHVASPRYHTVGRASGLLMGLRRSPYLW,Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp,None.,,,
3618,neuropeptide W-30,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q3V2F0,,WYKHVASPRYHTVGRASGLLMGLRRSPYQW,Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Gln-Trp,None.,,,
1496,neuropeptide W-30,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8N729,,WYKHVASPRYHTVGRAAGLLMGLRRSPYLW,Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp,None.,,,
1504,neuropeptide Y,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P57774|P07808|P01303,,YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1c[nH]cn1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)CCSC)CC(=O)O)CCC(=O)O)C)C)CC(=O)O)CCC(=O)O)CC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)N)CO,XKWCTHKJQNUFOQ-HRPSIEBRSA-N
3627,neuropeptide Y-(3-36),"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01303|P57774|P07808,,SKPDNPGEDAPAEDMARYYSALRHYINLITRQRY,Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
1579,neurotensin,"Human, Mouse, Rat, Bovine","Endogenous peptide in human, mouse or rat",,,,,,,,,P30990|Q9D3P9|P20068|P01156,,XLYENKPRRPYIL,pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu,The N-terminal glutamine is cyclised into a pyroglutamate (X / pGlu),,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CC(=O)N,PCJGZPGTCUMMOT-ISULXFBGSA-N
5033,neurotrophin-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P20783,,YAEHKSHRGEYSVCDSESLWVTDKSSAIDIRGHQVTVLGEIKTGNSPVKQYFYETRCKEARPVKNGCRGIDDKHWNSQCKTSQTYVRALTSENNKLVGWRWIRIDTSCVCALSRKIGRT,,"Disulphide bond formation between cysteine residues at positions 14 and 79, 57 and 108, and 67 and 110",,,
5034,neurotrophin-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P34130,,GVSETAPASRRGELAVCDAVSGWVTDRRTAVDLRGREVEVLGEVPAAGGSPLRQYFFETRCKADNAEEGGPGAGGGGCRGVDRRHWVSECKAKQSYVRALTADAQGRVGWRWIRIDTACVCTLLSRTGRA,,"Disulphide bond formation between cysteine residues at positions 17 and 90, 161 and 119, and 78 and 121",,,
5032,neurturin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99748,,ARLGARPCGLRELEVRVSELGLGYASDETVLFRYCAGACEAAARVYDLGLRRLRQRRRLRRERVRAQPCCRPTAYEDEVSFLDAHSRYHTVHELSARECACV,,"Biologically active peptide is a homodimer. Predicted disulphide bond formation between cysteine residues at positions 8 and 70, 35 and 99, and 39 and 101. Interchain disulphide bond between cysteine residues at position 69 of each of the two chains",,,
5026,NGF,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01138,cenegermin,SSSHPIFHRGEFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVDSGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSRKAVRRA,,"Disulphide bond formation between cysteine residues at positions 15 and 80, 58 and 108, and 68 and 110",,,
1681,nociceptin/orphanin FQ,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q13519|Q64387|Q62923,,FGGFTGARKSARKLANQ,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCC(=O)N)CC(=O)N)C)CC(C)C)CCCCN)CCCNC(=N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)C)CCCNC(=N)N,PULGYDLMFSFVBL-SMFNREODSA-N
2947,norrin,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P48744,,KTDSSFLMDSQRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECSS,Lys-Thr-Asp-Ser-Ser-Phe-Leu-Met-Asp-Ser-Gln-Arg-Cys-Met-Arg-His-His-Tyr-Val-Asp-Ser-Ile-Ser-His-Pro-Leu-Tyr-Lys-Cys-Ser-Ser-Lys-Met-Val-Leu-Leu-Ala-Arg-Cys-Glu-Gly-His-Cys-Ser-Gln-Ala-Ser-Arg-Ser-Glu-Pro-Leu-Val-Ser-Phe-Ser-Thr-Val-Leu-Lys-Gln-Pro-Phe-Arg-Ser-Ser-Cys-His-Cys-Cys-Arg-Pro-Gln-Thr-Ser-Lys-Leu-Lys-Ala-Leu-Arg-Leu-Arg-Cys-Ser-Gly-Gly-Met-Arg-Leu-Thr-Ala-Thr-Tyr-Arg-Tyr-Ile-Leu-Ser-Cys-His-Cys-Glu-Glu-Cys-Ser-Ser,Disulfide bonds formed between cysteine residues at positions 13 and 70; 29 and 84; 39 and 100; 43 and 102,,,
1063,norrin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q00604,,KTDSSFIMDSDPRRCMRHHYVDSISHPLYKCSSKMVLLARCEGHCSQASRSEPLVSFSTVLKQPFRSSCHCCRPQTSKLKALRLRCSGGMRLTATYRYILSCHCEECNS,Lys-Thr-Asp-Ser-Ser-Phe-Ile-Met-Asp-Ser-Asp-Pro-Arg-Arg-Cys-Met-Arg-His-His-Tyr-Val-Asp-Ser-Ile-Ser-His-Pro-Leu-Tyr-Lys-Cys-Ser-Ser-Lys-Met-Val-Leu-Leu-Ala-Arg-Cys-Glu-Gly-His-Cys-Ser-Gln-Ala-Ser-Arg-Ser-Glu-Pro-Leu-Val-Ser-Phe-Ser-Thr-Val-Leu-Lys-Gln-Pro-Phe-Arg-Ser-Ser-Cys-His-Cys-Cys-Arg-Pro-Gln-Thr-Ser-Lys-Leu-Lys-Ala-Leu-Arg-Leu-Arg-Cys-Ser-Gly-Gly-Met-Arg-Leu-Thr-Ala-Thr-Tyr-Arg-Tyr-Ile-Leu-Ser-Cys-His-Cys-Glu-Glu-Cys-Asn-Ser,Disulfide bonds formed between cysteine residues at positions 15 and 72; 31 and 86; 41 and 102; 45 and 104,,,
5337,obestatin,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QYH7|Q9EQX0,,FNAPFDVGIKLSGAQYQQHGRAL,Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2,Amidation of Leu-98 is essential for obestatin activity,,,
5336,obestatin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBU3,,FNAPFDVGIKLSGVQYQQHSQAL,Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2,Amidation of Leu-98 is essential for obestatin activity,,,
5035,oncostatin M,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13725,,AAIGSCSKEYRVLLGQLQKQTDLMQDTSRLLDPYIRIQGLDVPKLREHCRERPGAFPSEETLRGLGRRGFLQTLNATLGCVLHRLADLEQRLPKAQDLERSGLNIEDLEKLQMARPNILGLRNNIYCMAQLLDNSDTAEPTKAGRGASQPPTPTPASDAFQRKLEGCRFLHGYHRFMHSVGRVFSKWGESPNRSR,,"Predicted N-linked glycosylation of asparagine residues at positions 75 and 192; disulphide bond formation between cysteine residues at positions 6 and 127, and 49 and 167",,,
1697,orexin-A,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,O43612|O55241|O55232,,XPLPDCCRQKTCSCRLYELLHGAGNHAAGILTL,pGlu-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2,"The N-terminal glutamine residue is cyclised into pyroglutamate (pGlu), the C-terminal leucine residue is amidated. There are two disulfide bonds formed between cysteine residues at positions 6 and 12, 7 and 14.",,,
1699,orexin-B,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43612,,RSGPPGLQGRLQRLLQASGNHAAGILTM,Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2,The C-terminal methionine is amidated.,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCN=C(N)N)CO)CC(C)C)CCC(=O)N)CCCN=C(N)N)CC(C)C)CCC(=O)N)CCCN=C(N)N)CC(C)C)CC(C)C)CCC(=O)N)C)CO)CC(=O)N)Cc1nc[nH]c1)C)C)[C@H](CC)C)CC(C)C)[C@H](O)C)N,OHOWSYIKESXDMN-WMQZXSDYSA-N
3720,orexin-B,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,O55241|O55232,,RPGPPGLQGRLQRLLQANGNHAAGILTM,Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2,The C-terminal methionine is amidated.,,,
5036,osteocrin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P61366,,SFSGFGSPLDRLSAGSVDHKGKQRKVVDHPKRRFGIPMDRIGRNRLSNSR,Ser-Phe-Ser-Gly-Phe-Gly-Ser-Pro-Leu-Asp-Arg-Leu-Ser-Ala-Gly-Ser-Val-Asp-His-Lys-Gly-Lys-Gln-Arg-Lys-Val-Val-Asp-His-Pro-Lys-Arg-Arg-Phe-Gly-Ile-Pro-Met-Asp-Arg-Ile-Gly-Arg-Asn-Arg-Leu-Ser-Asn-Ser-Arg-NH2,Amidation of C-terminal arginine,,,
6753,osteopontin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10451,,IPVKQADSGSSEEKQLYNKYPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSKSNESHDHMDDMDDEDDDDHVDSQDSIDSNDSDDVDDTDDSHQSDESHHSDESDELVTDFPTDLPATEVFTPVVPTVDTYDGRGDSVVYGLRSKSKKFRRPDIQYPDATDEDITSHMESEELNGAYKAIPVAQDLNAPSDWDSRGKDSYETSQLDDQSAETHSHKQSRLYKRKANDESNEHSDVIDSQELSKVSREFHSHEFHSHEDMLVVDPKSKEEDKHLKFRISHELDSASSEVN,,,,,
5076,OX-40 ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P23510,,MERVQPLEENVGNAARPRFERNKLLLVASVIQGLGLLLCFTYICLHFSALQVSHRYPRIQSIKVQFTEYKKEKGFILTSQKEDEIMKVQNNSVIINCDGFYLISLKGYFSQEVNISLHYQKDEEPLFQLKKVRSVNSLMVASLTYKDKVYLNVTTDNTSLDDFHVNGGELILIHQNPGEFCVL,,"N-linked glycosylation of asparagine residue at position 152; predicted N-linked glycosylation of asparagines at positions 90, 114 and 157; disulphide bond formation between cysteine residues at positions 97 and 181",,,
2174,oxytocin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01178|P01179|P35454,oxytocin,CYIQNCPLG,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,A disulfide bond is formed between cysteine residues at positions 1 and 6 and the C-terminal glycine is amidated.,,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C,XNOPRXBHLZRZKH-DSZYJQQASA-N
5237,p122-RhoGAP,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q63744,,MCRDEPDTMILTQIEAKEACDWLRVTGFPQYAQLYEDLLFPIDIALVKREHDFLDRDAIEALCRRLNTLNKCAVMKLEISPHRKRSEDSDEEEPCAISGKWTFQRDSKRWSRLEEFDVFSPKQDPIPGSPDNSRLQSATSRESMLTDLSEHQEVSSIRSLSSTSSSAPTHVPHSGEATTPRTNSVISVCSSSHFVGNEDSFSSLPSPKELSSFSFSMKGHEKNTKSKTRSLLKRMESLKLKGSHHSKHKAPSKLGLIISAPILQEGMDEEKLKQLNCVEISALNGNHINVPMVRKRSVSNSTQTSSSSSQSETSSAVSTPSPVTRTRSLSTCNKRVGMYLEGFDPFSQSAFNNVTEQNYKNRESYPEDTVFYIPEDHKPGTFPKALSNGSFCPSGNSSVNWRTGSFHGPGHLSLRRENSSDSPKELKRRNSSSSVSSRMSIYDNVPGSILYSSSGELADLENEDIFPELDDILYHVKGMQRIVNQWSEKFSDEGDSDSALDSVSPCPSSPKQIHLDVDHDRRTPSDLDSTGNSLNEPEEPTDIPERRDSGVGASLTRCNRHRLRWHSFQSSHRPSLNSVSLQINCQSVAQMNLLQKYSLLKLTALLEKYTPSNKHGFSWAVPKFMKRIKVPDYKDRSVFGVPLTVNVQRSGQPLPQSIQQAMRYLRNHCLDQVGLFRKSGVKSRIQALRQMNESAEDYVNYEGQSAYDVADMLKQYFRDLPEPLMTNKLSETFLQIYQYVPKDQRLQAIKAAIMLLPDENREVLQTLLYFLSHVTAAVKENQMTPTNLAVCLAPSLFHLNTLKRENSSPRVMQRKQSLGKPDQKDLNENLAATQGLAHMIAECKKLFQVPEEMSRCRNSYTEQELKPLTLEALGHLSNDQPADYRHFLQDCVDGLFKEVKEKFKGWVSYPTSEQAELSYKKVSEGPPLRLWRATIEVPAAPEEILKRLLKEQHLWDVDLLDSKVIEILDSQTEIYQYVQNSMAPHPARDYVVLRTWRTNLPRGACALLFTSVDHDRAPVAGVRVNVLLSRYLIEPCGSGKSKLTYMCRADLRGHMPEWYTKSFGHLCAAEVVKIRDSFSNQSTESKDTRSR,,"Serine residues at positions 305,306,311, 314 and 318 are phosphoserine; predicted phophorylation of serine at positions 86, 89 and 413. Threonine residues at positions 313 and 319 are phosphothreonine",,,
2257,PACAP-27,"Human, Mouse, Rat, Sheep","Endogenous peptide in human, mouse or rat",,,,,,,,,P18509|P13589|O70176|P16613,,HSDGIFTDSYSRYRKQMAVKKYLAAVL,His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2,C-terminal residue is leucine amide,,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N)CC(C)C)C(C)C)C)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(CC)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]cnc1)N)CO)CC(=O)O)Cc1ccccc1)CC(=O)O)CO)Cc1ccc(cc1)O)CO)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N,RZGBUJXSKLDAFE-UHFFFAOYSA-N
2258,PACAP-38,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,O70176|P18509|P13589,,HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK,His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2,C-terminal residue is lysine amide,,,
4057,PAMP-20,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35318,,ARLDVASEFRKKWNKWALSR,Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg,C-terminal residue is arginine amide,,,
1512,pancreatic polypeptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01298,,APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY,Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
1513,pancreatic polypeptide,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06303,,APLEPMYPGDYATHEQRAQYETQLRRYINTLTRPRY,Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
3626,pancreatic polypeptide,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10601,,APLEPMYPGDYATPEQMAQYETQLRRYINTLTRPRY,Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
5042,PDGFA,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04085,,SIEEAVPAVCKTRTVIYEIPRSQVDPTSANFLIWPPCVEVKRCTGCCNTSSVKCQPSRVHHRSVKVAKVEYVRKKPKLKEVQVRLEEHLECACATTSLNPDYREEDTGRPRESGKKRKRKRLKPT,,"Predicted N-linked glycosylation of asparagine residue at position 128; disulphide bond formation between cysteine resdues at positions 10 and 54, 43 and 91, and 47 and 93. Interchain disulphide bonds when the alpha chain froms a homodimer with another alpha chain or a heterodimer with a beta chain- from cysteine residues at positions 37 and 46",,,
5038,PDGF AA,Human,"Endogenous peptide in human, mouse or rat",5042,PDGFA,,,,,,,,,,,The biologically active peptide is a homodimer of two PDGF A subunits linked by two disulphide bonds ,,,
5041,PDGF AB,Human,"Endogenous peptide in human, mouse or rat",5042|5043,PDGFA|PDGFB,,,,,,,,,,,The biologically active peptide is a heterodimer conistsing of a PDGF A subunit and a PDGF B subunit linked by two disulphide bonds ,,,
5043,PDGFB,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01127,,SLGSLTIAEPAMIAECKTRTEVFEISRRLIDRTNANFLVWPPCVEVQRCSGCCNNRNVQCRPTQVQLRPVQVRKIEIVRKKPIFKKATVTLEDHLACKCETVAAARPVT,,"Disulphide bond formation between cysteine residues at positions 16 and 60, 49 and 97, and 53 and 99. Interchain disulphide bonds when the beta chain froms a homodimer with another beta chain or a heterodimer with an alpha chain- from cysteine residues at positions 43 and 52",,,
5039,PDGF BB,Human,"Endogenous peptide in human, mouse or rat",5043,PDGFB,yes,,,,,,,becaplermin,,,The biologically active peptide is a homodimer of two PDGF B subunits linked by two disulphide bonds ,,,
5323,PDGFD,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9GZP0,,SYHDRKSKVDLDRLNDDAKRYSCTPRNYSVNIREELKLANVVFFPRCLLVQRCGGNCGCGTVNWRSCTCNSGKTVKKYHEVLQFEPGHIKRRGRAKTMALVDIQLDHHERCDCICSSRPPR,,,,,
9139,PEN,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,SVDQDLGPEVPPENVLGALLRV,Ser-Val-Asp-Gln-Asp-Leu-Gly-Pro-Glu-Val-Pro-Pro-Glu-Asn-Val-Leu-Gly-Ala-Leu-Leu-Arg-Val,,,,
9140,PEN,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,,,,,,
1515,peptide YY,"Mouse, Rat, Pig","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9EPS2|P10631|P68005,,YPAKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY,Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,"The C-terminal tyrosine is amidated. In the porcine peptide the serine residue at position 13 has been shown to be phosphorylated , and this modification is predicted to  occur in the rodent orthologues of the peptide",,,
1514,peptide YY,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10082,,YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY,Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
5045,persephin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O60542,,WGPDARGVPVADGEFSSEQVAKAGGTWLGTHRPLARLRRALSGPCQLWSLTLSVAELGLGYASEEKVIFRYCAGSCPRGARTQHGLALARLQGQGRAHGGPCCRPTRYTDVAFLDDRHRWQRLPQLSAAACGCGG,,"Biologically active peptide is a homodimer. Predicted disulphide bond formation between cysteine residues at positions 45 and 103, 72 and 131, and 76 and 135. Predicted interchain disulphide bond between cysteine residues  at position 102 of each chain",,,
4397,PHI,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P32648,,HADGVFTSDYSRLLGQISAKKYLESLIGKRISSSISEDPVPI,His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Tyr-Ser-Arg-Leu-Leu-Gly-Gln-Ile-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-Gly-Lys-Arg-Ile-Ser-Ser-Ser-Ile-Ser-Glu-Asp-Pro-Val-Pro-Ile,,,,
2274,PHM,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01282,,HADGVFTSDFSKLLGQLSAKKYLESLM,His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2,C-terminal residue is methionine amide,,,
3706,PHV,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01282,,HADGVFTSDFSKLLGQLSAKKYLESLMGKRVSSNISEDPVPV,His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-Gly-Lys-Arg-Val-Ser-Ser-Asn-Ile-Ser-Glu-Asp-Pro-Val-Pro-Val,None,,,
2275,PHV,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01283,,HADGVFTSDYSRLLGQISAKKYLESLIGKRISSSISEDPVPV,His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Tyr-Ser-Arg-Leu-Leu-Gly-Gln-Ile-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-Gly-Lys-Arg-Ile-Ser-Ser-Ser-Ile-Ser-Glu-Asp-Pro-Val-Pro-Val-NH2,C-terminal residue is valine amide,,,
5314,placental growth factor,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P49763,,LPAVPPQQWALSAGNGSSEVEVVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVETANVTMQLLKIRSGDRPSYVELTFSQHVRCECRHSPGRQSPDMPGDFRADAPSFLPPRRSLPMLFRMEWGCALTGSQSAVWPSSPVPEEIPRMHPGRNGKKQQRKPLREKMKPERCGDAVPRR,,"Interchain disulphide bonds between cysteine residues at positions 77 ad 86; intrachain disulphide bonds between cysteine residues at positions 34 and 76, 65 and 110, and 69 and 112. Predicted N-linked glycosylation on asparagine residues at positions 15 and 83",,,
6618,pleiotrophin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,C9JR52,,GKKEKPEKKVKKSDCGEWQWSVCVPTSGDCGLGTREGTRTGAECKQTMKTQRCKIPCNWKKQFGAECKYQFQAWGECDLNTALKTRTGSLKRALHNAECQKTVTISKPCGKLTKPKPQAESKKKKKEGKKQEKMLD,,,,,
9606,programmed cell death 1 ligand 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NZQ7,,MRIFAVFIFMTYWHLLNAFTVTVPKDLYVVEYGSNMTIECKFPVEKQLDLAALIVYWEMEDKNIIQFVHGEEDLKVQHSSYRQRARLLKDQLSLGNAALQITDVKLQDAGVYRCMISYGGADYKRITVKVNAPYNKINQRILVVDPVTSEHELTCQAEGYPKAEVIWTSSDHQVLSGKTTTTNSKREEKLFNVTSTLRINTTTNEIFYCTFRRLDPEENHTAELVIPELPLAHPPNERTHLVILGAILLCLGVALTFIFRLRKGRMMDVKKCGIQDTNSKKQSDTHLEET,,"Disulphide bonds: cys40-cys114, cys155-cys209 N-linked glycosylation at residues 35, 192, 200 and 219",,,
6145,proinsulin C-peptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01308,,EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ,Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln,,,,
1866,prokineticin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9HC23,,AVITGACERDVQCGAGTCCAISLWLRGLRMCTPLGREGEECHPGSHKVPFFRKRKHHTCPCLPNLLCSRFPDGRYRCSMDLKNINF,Ala-Val-Ile-Thr-Gly-Ala-Cys-Glu-Arg-Asp-Val-Gln-Cys-Gly-Ala-Gly-Thr-Cys-Cys-Ala-Ile-Ser-Leu-Trp-Leu-Arg-Gly-Leu-Arg-Met-Cys-Thr-Pro-Leu-Gly-Arg-Glu-Gly-Glu-Glu-Cys-His-Pro-Gly-Ser-His-Lys-Val-Pro-Phe-Phe-Arg-Lys-Arg-Lys-His-His-Thr-Cys-Pro-Cys-Leu-Pro-Asn-Leu-Leu-Cys-Ser-Arg-Phe-Pro-Asp-Gly-Arg-Tyr-Arg-Cys-Ser-Met-Asp-Leu-Lys-Asn-Ile-Asn-Phe,"There are 5 disulfide bonds formed between cysteine residues at positions 7 and 19, 13 and 31, 18 and 59, 41 and 67, 61 and 77.",,,
3715,prokineticin-1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q14A28,,AVITGACERDIQCGAGTCCAISLWLRGLRLCTPLGREGEECHPGSHKIPFLRKRQHHTCPCSPSLLCSRFPDGRYRCFRDLKNANF,Ala-Val-Ile-Thr-Gly-Ala-Cys-Glu-Arg-Asp-Ile-Gln-Cys-Gly-Ala-Gly-Thr-Cys-Cys-Ala-Ile-Ser-Leu-Trp-Leu-Arg-Gly-Leu-Arg-Leu-Cys-Thr-Pro-Leu-Gly-Arg-Glu-Gly-Glu-Glu-Cys-His-Pro-Gly-Ser-His-Lys-Ile-Pro-Phe-Leu-Arg-Lys-Arg-Gln-His-His-Thr-Cys-Pro-Cys-Ser-Pro-Ser-Leu-Leu-Cys-Ser-Arg-Phe-Pro-Asp-Gly-Arg-Tyr-Arg-Cys-Phe-Arg-Asp-Leu-Lys-Asn-Ala-Asn-Phe,"There are 5 disulfide bonds formed between cysteine residues at positions 7 and 19, 13 and 31, 18 and 59, 41 and 67, 61 and 77.",,,
3716,prokineticin-1,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8R414,,AVITGACERDVQCGAGTCCAISLWLRGLRLCTPLGREGEECHPGSHKIPFFRKRQHHTCPCSPSLLCSRFPDGRYRCSQDLKNVNF,Ala-Val-Ile-Thr-Gly-Ala-Cys-Glu-Arg-Asp-Val-Gln-Cys-Gly-Ala-Gly-Thr-Cys-Cys-Ala-Ile-Ser-Leu-Trp-Leu-Arg-Gly-Leu-Arg-Leu-Cys-Thr-Pro-Leu-Gly-Arg-Glu-Gly-Glu-Glu-Cys-His-Pro-Gly-Ser-His-Lys-Ile-Pro-Phe-Phe-Arg-Lys-Arg-Gln-His-His-Thr-Cys-Pro-Cys-Ser-Pro-Ser-Leu-Leu-Cys-Ser-Arg-Phe-Pro-Asp-Gly-Arg-Tyr-Arg-Cys-Ser-Gln-Asp-Leu-Lys-Asn-Val-Asn-Phe,"There are 5 disulfide bonds formed between cysteine residues at positions 7 and 19, 13 and 31, 18 and 59, 41 and 67, 61 and 77.",,,
3717,prokineticin-2,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QXU7|Q8R413,,AVITGACDKDSQCGGGMCCAVSIWVKSIRICTPMGQVGDSCHPLTRKSHVANGRQERRRAKRRKRKKEVPFWGRRMHHTCPCLPGLACLRTSFNRFICLARK,Ala-Val-Ile-Thr-Gly-Ala-Cys-Asp-Lys-Asp-Ser-Gln-Cys-Gly-Gly-Gly-Met-Cys-Cys-Ala-Val-Ser-Ile-Trp-Val-Lys-Ser-Ile-Arg-Ile-Cys-Thr-Pro-Met-Gly-Gln-Val-Gly-Asp-Ser-Cys-His-Pro-Leu-Thr-Arg-Lys-Ser-His-Val-Ala-Asn-Gly-Arg-Gln-Glu-Arg-Arg-Arg-Ala-Lys-Arg-Arg-Lys-Arg-Lys-Lys-Glu-Val-Pro-Phe-Trp-Gly-Arg-Arg-Met-His-His-Thr-Cys-Pro-Cys-Leu-Pro-Gly-Leu-Ala-Cys-Leu-Arg-Thr-Ser-Phe-Asn-Arg-Phe-Ile-Cys-Leu-Ala-Arg-Lys,"There are 5 disulfide bonds formed between cysteine residues at positions 7 and 19, 13 and 31, 18 and 80, 41 and 88, 82 and 98.",,,
1867,prokineticin-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9HC23,,AVITGACDKDSQCGGGMCCAVSIWVKSIRICTPMGKLGDSCHPLTRKNNFGNGRQERRKRKRSKRKKEVPFFGRRMHHTCPCLPGLACLRTSFNRFICLAQK,Ala-Val-Ile-Thr-Gly-Ala-Cys-Asp-Lys-Asp-Ser-Gln-Cys-Gly-Gly-Gly-Met-Cys-Cys-Ala-Val-Ser-Ile-Trp-Val-Lys-Ser-Ile-Arg-Ile-Cys-Thr-Pro-Met-Gly-Lys-Leu-Gly-Asp-Ser-Cys-His-Pro-Leu-Thr-Arg-Lys-Asn-Asn-Phe-Gly-Asn-Gly-Arg-Gln-Glu-Arg-Arg-Lys-Arg-Lys-Arg-Ser-Lys-Arg-Lys-Lys-Glu-Val-Pro-Phe-Phe-Gly-Arg-Arg-Met-His-His-Thr-Cys-Pro-Cys-Leu-Pro-Gly-Leu-Ala-Cys-Leu-Arg-Thr-Ser-Phe-Asn-Arg-Phe-Ile-Cys-Leu-Ala-Gln-Lys,"There are 5 disulfide bonds formed between cysteine residues at positions 7 and 19, 13 and 31, 18 and 80, 41 and 88, 82 and 98.",,,
1868,prokineticin-2β,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,AVITGACDKDSQCGGGMCCAVSIWVKSIRICTPMGKLGDSCHPLTRKVPFFGRRMHHTCPCLPGLACLRTSFNRFICLAQK,Ala-Val-Ile-Thr-Gly-Ala-Cys-Asp-Lys-Asp-Ser-Gln-Cys-Gly-Gly-Gly-Met-Cys-Cys-Ala-Val-Ser-Ile-Trp-Val-Lys-Ser-Ile-Arg-Ile-Cys-Thr-Pro-Met-Gly-Lys-Leu-Gly-Asp-Ser-Cys-His-Pro-Leu-Thr-Arg-Lys-Val-Pro-Phe-Phe-Gly-Arg-Arg-Met-His-His-Thr-Cys-Pro-Cys-Leu-Pro-Gly-Leu-Ala-Cys-Leu-Arg-Thr-Ser-Phe-Asn-Arg-Phe-Ile-Cys-Leu-Ala-Gln-Lys,,,,
5049,prolactin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01236,,LPICPGGAARCQVTLRDLFDRAVVLSHYIHNLSSEMFSEFDKRYTHGRGFITKAINSCHTSSLATPEDKEQAQQMNQKDFLSLIVSILRSWNEPLYHLVTEVRGMQEAPEAILSKAVEIEEQTKRLLEGMELIVSQVHPETKENEIYPVWSGLPSLQMADEESRLSAYYNLLHCLRRDSHKIDNYLKLLKCRIIHNNNC,,"Partial N-linked glycosylation of asparagine residue at positon 31; disulphide bonmds between cysteine residues at positions 4 and 11, 58 and 174, and 191 and 199",,,
6067,prosaptide,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P07602,,CEFLVKEVTKLIDNNKTEKEIL,Cys-Glu-Phe-Leu-Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu,,,,
4479,protein C,Rat,"Endogenous peptide in human, mouse or rat",4480|4481,protein C light chain|protein C heavy chain,,,,,,,P31394,,,,,,,
4476,protein C,Mouse,"Endogenous peptide in human, mouse or rat",4477|4478,protein C light chain|protein C heavy chain,,,,,,,P33587,,,,,,,
4473,protein C,Human,"Endogenous peptide in human, mouse or rat",4474|4475,protein C light chain|protein C heavy chain,,,,,,,P04070,,,,,,,
4481,protein C heavy chain,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,DIDPEDEELELGPRIVNGTLTKQGDSPWQAILLDSKKKLACGGVLIHTSWVLTAAHCLESSKKLTVRLGEYDLRRRDPWELDLDIKEVLVHPNYTRSNSDNDIALLRLSQPATLSKTIVPICLPNSGLAQELSQAGQETVVTGWGYQSDKVKDGRRNRTFILTFIRIPLAARNDCMQVMNNVVSENMLCAGIIGDTRDACDGDSGGPMVVFFRGTWFLVGLVSWGEGCGHLNNYGVYTKVGSYLKWIHSYIGERDVSLKSPKL,,Rat protein C consists of a light chain and a heavy chain held together by a disulfide bond between cysteine residues at positions 141 of the light chain and 122 of the heavy chain,,,
4475,protein C heavy chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04070,,DTEDQEDQVDPRLIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRDKEAPQKSWAP,,"N-linked glycosylation of asparagine residues at positions 90, 155 and 171. Disulphide bonds between cysteine residues at positions 38 and 54, 173 and 187 and 198 and 226. Protein C consists of a light chain and a heavy chain held together by a disulfide bond between cysteine residues at positions 141 of the light chain and 120 of the heavy chain",,,
4478,protein C heavy chain,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,DTDLEDELEPDPRIVNGTLTKQGDSPWQAILLDSKKKLACGGVLIHTSWVLTAAHCVEGTKKLTVRLGEYDLRRRDHWELDLDIKEILVHPNYTRSSSDNDIALLRLAQPATLSKTIVPICLPNNGLAQELTQAGQETVVTGWGYQSDRIKDGRRNRTFILTFIRIPLVARNECVEVMKNVVSENMLCAGIIGDTRDACDGDSGGPMVVFFRGTWFLVGLVSWGEGCGHTNNYGIYTKVGSYLKWIHSYIGEKGVSLKSQKL,,Mouse protein C consists of a light chain and a heavy chain held together by a disulfide bond between cysteine residues at positions 141 of the light chain and 121 of the heavy chain,,,
4480,protein C light chain,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,ANSFLEEVRAGSLERECMEEICDFEEAQEIFQNVEDTLAFWIKYFDGDQCSTPPLDHQCDSPCCGHGTCIDGLGGFSCSCDKGWEGRFCQQEMGFQDCRVKNGGCYHYCLEETRGRRCRCAPGYELADDHMHCRPTVNFPCGKLWKRTDKKRKNF,,Rat protein C consists of a light chain and a heavy chain held together by a disulfide bond between cysteine residues at positions 141 of the light chain and 122 of the heavy chain,,,
4474,protein C light chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04070,,ANSFLEELRHSSLERECIEEICDFEEAKEIFQNVDDTLAFWSKHVDGDQCLVLPLEHPCASLCCGHGTCIDGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCTHYCLEEVGWRRCSCAPGYKLGDDLLQCHPAVKFPCGRPWKRMEKKRSHL,,"Carboxylation of glutamate residues at positions 6, 7, 14, 16, 19, 20, 25, 26, 29, 71 and 97. Disulphide bonds between cysteine residues at positions 17 and 22,  50 and 69, 59 and 64, 63 and 78, 80 and 89, 98 and 109, 105 and 118, and 140 and 133. N-linked glycosylation of asparagine residue at position 97.Protein C consists of a light chain and a heavy chain held together by a disulfide bond between cysteine residues at positions 141 of the light chain and 120 of the heavy chain",,,
4477,protein C light chain,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,ANSFLEEMRPGSLERECMEEICDFEEAQEIFQNVEDTLAFWIKYFDGDQCSAPPLDHQCDSPCCGHGTCIDGIGSFSCSCDKGWEGKFCQQELRFQDCRVNNGGCLHYCLEESNGRRCACAPGYELADDHMRCKSTVNFPCGKLGRWIEKKRKIL,,Mouse protein C consists of a light chain and a heavy chain held together by a disulfide bond between cysteine residues at positions 141 of the light chain and 121 of the heavy chain,,,
5050,protein S,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P07225,,ANSLLEETKQGNLERECIEELCNKEEAREVFENDPETDYFYPKYLVCLRSFQTGLFTAARQSTNAYPDLRSCVNAIPDQCSPLPCNEDGYMSCKDGKASFTCTCKPGWQGEKCEFDINECKDPSNINGGCSQICDNTPGSYHCSCKNGFVMLSNKKDCKDVDECSLKPSICGTAVCKNIPGDFECECPEGYRYNLKSKSCEDIDECSENMCAQLCVNYPGGYTCYCDGKKGFKLAQDQKSCEVVSVCLPLNLDTKYELLYLAEQFAGVVLYLKFRLPEISRFSAEFDFRTYDSEGVILYAESIDHSAWLLIALRGGKIEVQLKNEHTSKITTGGDVINNGLWNMVSVEELEHSISIKIAKEAVMDINKPGPLFKPENGLLETKVYFAGFPRKVESELIKPINPRLDGCIRSWNLMKQGASGIKEIIQEKQNKHCLVTVEKGSYYPGSGIAQFHIDYNNVSSAEGWHVNVTLNIRPSTGTGVMLALVSGNNTVPFAVSLVDSTSEKSQDILLSVENTVIYRIQALSLCSDQQSHLEFRVNRNNLELSTPLKIETISHEDLQRQLAVLDKAMKAKVATYLGGLPDVPFSATPVNAFYNGCMEVNINGVQLDLDEAISKHNDIRAHSCPSVWKKTKNS,,"Glutamic acid residues at positions 6,7,14,16,19,20,25,26,29,32 and 36 are 4-carboxyglutamate; asparagine residues at positions 458 and 489 are N-linked glycosylated, and disulphide bonds are formed between cysteine residues at positions 164 and 176, 171 and 185, 187 and 200, 206 and 215, 211 and 224 and 226 and 241. Predicted (3R)-3-hydroxyaspartate formationfrom aspartate residue at positiomn 195; predicted N-linked glycosylation of asparagine residue at position 465. Predicted disulphide bond formation between cysteine resdiues at positions 17 and 22, 80 and 93, 85 and 102, 104 and 113, 120 and 144, 130 and 143,  145 and 158, 408 and 434, and 598 and 625",,,
1872,PrRP-20,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P81278,,TPDINPAWYTGRGIRPVGRF,Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2,C-terminal phenylalanine amidation,,,
1871,PrRP-20,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P81277,,TPDINPAWYASRGIRPVGRF,Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2,C -terminal phenylalamine amidation,,,
1873,PrRP-31,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P81277,,SRTHRHSMEIRTPDINPAWYASRGIRPVGRF,Ser-Arg-Thr-His-Arg-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2,C-terminal phenylalanine amidation,,,
1874,PrRP-31,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P81278,,SRAHQHSMETRTPDINPAWYTGRGIRPVGRF,Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Thr-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2,C-terminal phenylalanine amidation,,,
3632,PTH,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Z0L6,,AVSEIQLMHNLGKHLASMERMQWLRRKLQDMHNFVSLGVQMAARDGSHQKPTKKEENVLVDGNPKSLGEGDKADVDVLVKSKSQ,Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Met-Glu-Arg-Met-Gln-Trp-Leu-Arg-Arg-Lys-Leu-Gln-Asp-Met-His-Asn-Phe-Val-Ser-Leu-Gly-Val-Gln-Met-Ala-Ala-Arg-Asp-Gly-Ser-His-Gln-Lys-Pro-Thr-Lys-Lys-Glu-Glu-Asn-Val-Leu-Val-Asp-Gly-Asn-Pro-Lys-Ser-Leu-Gly-Glu-Gly-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Val-Lys-Ser-Lys-Ser-Gln,None.,,,
1786,PTH,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04089,,AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNFVSLGVQMAAREGSYQRPTKKEENVLVDGNSKSLGEGDKADVDVLVKAKSQ,Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ser-Leu-Gly-Val-Gln-Met-Ala-Ala-Arg-Glu-Gly-Ser-Tyr-Gln-Arg-Pro-Thr-Lys-Lys-Glu-Glu-Asn-Val-Leu-Val-Asp-Gly-Asn-Ser-Lys-Ser-Leu-Gly-Glu-Gly-Asp-Lys-Ala-Asp-Val-Asp-Val-Leu-Val-Lys-Ala-Lys-Ser-Gln,None.,,,
1785,PTH,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01270,parathyroid hormone,SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ,Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln,None.,,,
3738,PTHrP,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12272,,AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEIRATSEVSPNSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKPGKRKEQEKKKRRTRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSRRH,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser-Glu-Val-Ser-Pro-Asn-Ser-Lys-Pro-Ser-Pro-Asn-Thr-Lys-Asn-His-Pro-Val-Arg-Phe-Gly-Ser-Asp-Asp-Glu-Gly-Arg-Tyr-Leu-Thr-Gln-Glu-Thr-Asn-Lys-Val-Glu-Thr-Tyr-Lys-Glu-Gln-Pro-Leu-Lys-Thr-Pro-Gly-Lys-Lys-Lys-Lys-Gly-Lys-Pro-Gly-Lys-Arg-Lys-Glu-Gln-Glu-Lys-Lys-Lys-Arg-Arg-Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg-Arg-His,,,,
3670,PTHrP-(107-139),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12272,,TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSR,Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg,,,,
3719,PTHrP-(107-139),Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P13085,,TRSAWPGTTGSGLLEDPQPHTSPTSTSLEPSSR,Thr-Arg-Ser-Ala-Trp-Pro-Gly-Thr-Thr-Gly-Ser-Gly-Leu-Leu-Glu-Asp-Pro-Gln-Pro-His-Thr-Ser-Pro-Thr-Ser-Thr-Ser-Leu-Glu-Pro-Ser-Ser-Arg,,,,
3718,PTHrP-(107-139),Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P22858,,TRSAWPSTAASGLLEDPLPHTSRTSLEPSLR,Thr-Arg-Ser-Ala-Trp-Pro-Ser-Thr-Ala-Ala-Ser-Gly-Leu-Leu-Glu-Asp-Pro-Leu-Pro-His-Thr-Ser-Arg-Thr-Ser-Leu-Glu-Pro-Ser-Leu-Arg,,,,
1790,PTHrP-(1-36),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12272,,AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEI,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
3671,PTHrP-(38-94),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12272,,ATSEVSPNSKPSPNTKNHPVRFGSDDEGRYLTQETNKVETYKEQPLKTPGKKKKGKP,Ala-Thr-Ser-Glu-Val-Ser-Pro-Asn-Ser-Lys-Pro-Ser-Pro-Asn-Thr-Lys-Asn-His-Pro-Val-Arg-Phe-Gly-Ser-Asp-Asp-Glu-Gly-Arg-Tyr-Leu-Thr-Gln-Glu-Thr-Asn-Lys-Val-Glu-Thr-Tyr-Lys-Glu-Gln-Pro-Leu-Lys-Thr-Pro-Gly-Lys-Lys-Lys-Lys-Gly-Lys-Pro,,,,
599,[Pyr1]apelin-13,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9ULZ1|Q9R0R4|Q9R0R3,,XRPRLSHKGPMPF,pGlu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,"N-terminal glutamate cyclisation, represented by X and pGlu",,,
1517,PYY-(3-36),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10082,,IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY,Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
1554,PYY-(3-36),"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q9EPS2|P10631,,AKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY,Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
5895,QRFP26,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,TSGPLGNLAEELNGYSRKKGGFSFRF,Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
5896,QRFP26,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,ASGPLGTLAEELSSYSRRKGGFSFRF,Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
10251,QRFP26,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,ASGPLGTLAEELSSYSRRKGGFSFRF,Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,The C-terminal phenylalanine is amidated.,,,
3712,QRFP43,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8CE23,,XDGSSEAAGFLPADSEKASGPLGTLAEELSSYSRRKGGFSFRF,pGlu-Asp-Gly-Ser-Ser-Glu-Ala-Ala-Gly-Phe-Leu-Pro-Ala-Asp-Ser-Glu-Lys-Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,The N-terminal glutamine is cyclised into pyroglutamate and the C-terminal phenylalanine is amidated.,,,
3665,QRFP43,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P83859,,XDEGSEATGFLPAAGEKTSGPLGNLAEELNGYSRKKGGFSFRF,pGlu-Asp-Glu-Gly-Ser-Glu-Ala-Thr-Gly-Phe-Leu-Pro-Ala-Ala-Gly-Glu-Lys-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,The N-terminal glutamine is cyclised into pyroglutamate and the C-terminal phenylalanine is amidated.,,,
3713,QRFP43,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P83860,,XDSGSEATGFLPTDSEKASGPLGTLAEELSSYSRRKGGFSFRF,pGlu-Asp-Ser-Gly-Ser-Glu-Ala-Thr-Gly-Phe-Leu-Pro-Thr-Asp-Ser-Glu-Lys-Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,The N-terminal glutamine is cyclised into pyroglutamate and the C-terminal phenylalanine is amidated.,,,
5250,Rac1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P63000,,MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLCPPPVKKRKRKC,,Serine residue at position 21 is phosphoserine; C-terminal cysteine residue undergoes lipidation to form S-geranylgeranyl cysteine,,,
5251,Rac2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P15153,,MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDSKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASYENVRAKWFPEVRHHCPSTPIILVGTKLDLRDDKDTIEKLKEKKLAPITYPQGLALAKEIDSVKYLECSALTQRGLKTVFDEAIRAVLCPQPTRQQKRAC,,Lysine residue at position 147 is N6-acetyllysine; C-terminal cysteine residue undergoes lipidation to become S-geranylgeranyl cysteine,,,
5252,Rac3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P60763,,MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTDVFLICFSLVSPASFENVRAKWYPEVRHHCPHTPILLVGTKLDLRDDKDTIERLRDKKLAPITYPQGLAMAREIGSVKYLECSALTQRGLKTVFDEAIRAVLCPPPVKKPGKKC,,Threonine residue at position 167 is phosphothreonine; C-terminal cysteine residue is predicted to undergo lipidation to become S-geranylgeranyl cysteine,,,
5066,RANK ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14788,,MRRASRDYTKYLRGSEEMGGGPGAPHEGPLHAPPPPAPHQPPAASRSMFVALLGLGLGQVVCSVALFFYFRAQMDPNRISEDGTHCIYRILRLHENADFQDTTLESQDTKLIPDSCRRIKQAFQGAVQKELQHIVGSQHIRAEKAMVDGSWLDLAKRSKLEAQPFAHLTINATDIPSGSHKVSLSSWYHDRGWAKISNMTFSNGKLIVNQDGFYYLYANICFRHHETSGDLATEYLQLMVYVTKTSIKIPSSHTLMKGGSTKYWSGNSEFHFYSINVGGFFKLRSGEEISIEVSNPSLLDPDQDATYFGAFKVRDID,,Predicted N-linked glycosyaltion of asparagine residues at positions 171 and 198,,,
1993,relaxin,Rat,"Endogenous peptide in human, mouse or rat",4437|4436,relaxin B chain|relaxin A chain,,,,,,,,,,,"Fully active rat relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 14) and A chain (residue 151), and the second between B chain (residue 26) and A chain (residue 164).",,,
1989,relaxin,Human,"Endogenous peptide in human, mouse or rat",3746|3745,relaxin (A chain)|relaxin (B chain),,,,,,,,,,,"Fully active H2 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 172), and the second between B chain (residue 47) and A chain (residue 185).",,,
1988,relaxin-1,Human,"Endogenous peptide in human, mouse or rat",3744|3743,relaxin-1 (A chain)|relaxin-1 (B chain),,,,,,,,,,,"Fully active H1 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 172), and the second between B chain (residue 47) and A chain (residue 185).",,,
3744,relaxin-1 (A chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04808,,PYVALFEKCCLIGCTKRSLAKYC,Pro-Tyr-Val-Ala-Leu-Phe-Glu-Lys-Cys-Cys-Leu-Ile-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Lys-Tyr-Cys,"Fully active H1 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 172), and the second between B chain (residue 47) and A chain (residue 185).",,,
3743,relaxin-1 (B chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04808,,VAAKWKDDVIKLCGRELVRAQIAICGMSTWS,Val-Ala-Ala-Lys-Trp-Lys-Asp-Asp-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser,"Fully active H1 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 172), and the second between B chain (residue 47) and A chain (residue 185).",,,
1990,relaxin-3,Human,"Endogenous peptide in human, mouse or rat",3748|1997,relaxin-3 (A chain)|relaxin-3 (B chain),,,,,,,,,,,"Fully active H3 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 129), and the second between B chain (residue 47) and A chain (residue 142).",,,
3748,relaxin-3 (A chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8WXF3,,DVLAGLSSSCCKWGCSKSEISSLC,Asp-Val-Leu-Ala-Gly-Leu-Ser-Ser-Ser-Cys-Cys-Lys-Trp-Gly-Cys-Ser-Lys-Ser-Glu-Ile-Ser-Ser-Leu-Cys,"Fully active H3 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 129), and the second between B chain (residue 47) and A chain (residue 142).",,,
1997,relaxin-3 (B chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8WXF3,,RAAPYGVRLCGREFIRAVIFTCGGSRW,Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Cys-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Cys-Gly-Gly-Ser-Arg-Trp,"Fully active H3 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 129), and the second between B chain (residue 47) and A chain (residue 142).",,,
3746,relaxin (A chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04090,,XLYSALANKCCHVGCTKRSLARFC,pGlu-Leu-Tyr-Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Arg-Phe-Cys,"The N-terminal glutamine is cyclised into pyroglutamate (pGlu/X). Fully active H2 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 172), and the second between B chain (residue 47) and A chain (residue 185).",,,
4436,relaxin A chain,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01347,,QSGALLSEQCCHIGCTRRSIAKLC,Gln-Ser-Gly-Ala-Leu-Leu-Ser-Glu-Gln-Cys-Cys-His-Ile-Gly-Cys-Thr-Arg-Arg-Ser-Ile-Ala-Lys-Leu-Cys,"Fully active rat relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 14) and A chain (residue 151), and the second between B chain (residue 26) and A chain (residue 164).",,,
3745,relaxin (B chain),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04090,,DSWMEEVIKLCGRELVRAQIAICGMSTWS,Asp-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser,"Fully active H2 relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 35) and A chain (residue 172), and the second between B chain (residue 47) and A chain (residue 185).",,,
4437,relaxin B chain,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,RVSEEWMDQVIQVCGRGYARAWIEVCGASVGRLAL,Arg-Val-Ser-Glu-Glu-Trp-Met-Asp-Gln-Val-Ile-Gln-Val-Cys-Gly-Arg-Gly-Tyr-Ala-Arg-Ala-Trp-Ile-Glu-Val-Cys-Gly-Ala-Ser-Val-Gly-Arg-Leu-Ala-Leu,"Fully active rat relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 14) and A chain (residue 151), and the second between B chain (residue 26) and A chain (residue 164).",,,
5253,retinoblastoma-associated protein,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P06400,,PPKTPRKTAATAAAAAAEPPAPPPPPPPEEDPEQDSGPEDLPLVRLEFEETEEPDFTALCQKLKIPDHVRERAWLTWEKVSSVDGVLGGYIQKKKELWGICIFIAAVDLDEMSFTFTELQKNIEISVHKFFNLLKEIDTSTKVDNAMSRLLKKYDVLFALFSKLERTCELIYLTQPSSSISTEINSALVLKVSWITFLLAKGEVLQMEDDLVISFQLMLCVLDYFIKLSPPMLLKEPYKTAVIPINGSPRTPRRGQNRSARIAKQLENDTRIIEVLCKEHECNIDEVKNVYFKNFIPFMNSLGLVTSNGLPEVENLSKRYEEIYLKNKDLDARLFLDHDKTLQTDSIDSFETQRTPRKSNLDEEVNVIPPHTPVRTVMNTIQQLMMILNSASDQPSENLISYFNNCTVNPKESILKRVKDIGYIFKEKFAKAVGQGCVEIGSQRYKLGVRLYYRVMESMLKSEEERLSIQNFSKLLNDNIFHMSLLACALEVVMATYSRSTSQNLDSGTDLSFPWILNVLNLKAFDFYKVIESFIKAEGNLTREMIKHLERCEHRIMESLAWLSDSPLFDLIKQSKDREGPTDHLESACPLNLPLQNNHTAADMYLSPVRSPKKKGSTTRVNSTANAETQATSAFQTQKPLKSTSLSLFYKKVYRLAYLRLNTLCERLLSEHPELEHIIWTLFQHTLQNEYELMRDRHLDQIMMCSMYGICKVKNIDLKFKIIVTAYKDLPHAVQETFKRVLIKEEEYDSIIVFYNSVFMQRLKTNILQYASTRPPTLSPIPHIPRSPYKFPSSPLRIPGGNIYISPLKSPYKISEGLPTPTKMTPRSRILVSIGESFGTSEKFQKINQMVCNSDRVLKRSAEGSNPPKPLKKLRFDIEGSDEADGSKHLPGESKFQQKLAEMTSTRTRMQKQKMNDSMDTSNKEEK,,"Serine residues at positions 36, 248, 566, 611, 794, 806, 810, 854 and 881 are phosphoserine; threonine residues at positions 251, 355, 372, 820, 822, 825 and 840 are phosphothreonine; N-terminal proline is predicted to be N,N-dimethylproline; lysine residues at positions 547 and 895 are N6-acetyllysine; lysine residue at position 859 is N6-methyllysine",,,
5340,RFRP-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9HCQ7,,MPHSFANLPLRF,Met-Pro-His-Ser-Phe-Ala-Asn-Leu-Pro-Leu-Arg-Phe-NH2,Amidation of C-terminal phenylalanine residue,,,
5373,RFRP-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9HCQ7,,SAGATANLPLRS,Ser-Ala-Gly-Ala-Thr-Ala-Asn-Leu-Pro-Leu-Arg-Ser,,,,
4016,RFRP-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9HCQ7,,VPNLPGRF,Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2,Amidation of C-terminal phenylalanine,,,
5174,Rho GDP dissociation inhibitor beta,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P52566,,TEKAPEPHVEEDDDDELDSKLNYKPPPQKSLKELQEMDKDDESLIKYKKTLLGDGPVVTDPKAPNVVVTRLTLVCESAPGPITMDLTGDLEALKKETIVLKEGSEYRVKIHFKVNRDIVSGLKYVQHTYRTGVKVDKATFMVGSYGPRPEEYEFLTPVEEAPKGMLARGTYHNKSFFTDDDKQDHLSWEWNLSIKKEWTE,,"Lysine residues at positions 20, 24, 40, 46, 101, 123, 144, 174 are N6-acetyllysine; N-terminal residue is N-acetylthreonine; serine residue at position 145 is phosphoserine",,,
3728,ribosomal protein S19,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P39019,,PGVTVKDVNQQEFVRALAAFLKKSGKLKVPEWVDTVKLAKHKELAPYDENWFYTRAASTARHLYLRGGAGVGSMTKIYGGRQRNGVMPSHFSRGSKSVARRVLQALEGLKMVEKDQDGGRKLTPQGQRDLDRIAGQVAAANKKH,Pro-Gly-Val-Thr-Val-Lys-Asp-Val-Asn-Gln-Gln-Glu-Phe-Val-Arg-Ala-Leu-Ala-Ala-Phe-Leu-Lys-Lys-Ser-Gly-Lys-Leu-Lys-Val-Pro-Glu-Trp-Val-Asp-Thr-Val-Lys-Leu-Ala-Lys-His-Lys-Glu-Leu-Ala-Pro-Tyr-Asp-Glu-Asn-Trp-Phe-Tyr-Thr-Arg-Ala-Ala-Ser-Thr-Ala-Arg-His-Leu-Tyr-Leu-Arg-Gly-Gly-Ala-Gly-Val-Gly-Ser-Met-Thr-Lys-Ile-Tyr-Gly-Gly-Arg-Gln-Arg-Asn-Gly-Val-Met-Pro-Ser-His-Phe-Ser-Arg-Gly-Ser-Lys-Ser-Val-Ala-Arg-Arg-Val-Leu-Gln-Ala-Leu-Glu-Gly-Leu-Lys-Met-Val-Glu-Lys-Asp-Gln-Asp-Gly-Gly-Arg-Lys-Leu-Thr-Pro-Gln-Gly-Gln-Arg-Asp-Leu-Asp-Arg-Ile-Ala-Gly-Gln-Val-Ala-Ala-Ala-Asn-Lys-Lys-His,,,,
5256,ribosomal protein S6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P62753,,MKLNISFPATGCQKLIEVDDERKLRTFYEKRMATEVAADALGEEWKGYVVRISGGNDKQGFPMKQGVLTHGRVRLLLSKGHSCYRPRRTGERKRKSVRGCIVDANLSVLNLVIVKKGEKDIPGLTDTTVPRRLGPKRASRIRKLFNLSKEDDVRQYVVRKPLNKEGKKPRTKAPKIQRLVTPRVLQHKRRRIALKKQRTKKNKEEAAEYAKLLAKRMKEAKEKRQEQIAKRRRLSSLRASTSKSESSQK,,"Lysine residues at positions 30 and 211 are N6-acetyllysine; serine residues at positions 78, 148, 235, 236, 240, 244, 246 and 247 are phosphorylated to phosphoserine",,,
3697,R-spondin-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q2MKA7,,SRGIKGKRQRRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCKEGLYLHKGRCYPACPEGSSAANGTMECSSPAQCEMSEWSPWGPCSKKQQLCGFRRGSEERTRRVLHAPVGDHAACSDTKETRRCTVRRVPCPEGQKRRKGGQGRRENANRNLARKESKEAGAGSRRRKGQQQQQQQGTVGPLTSAGPA,,Asparagine residue at position 117 is N-linked glycosylated; disulfide bonds between cysteine residues at positions 128 and 170; 139 and 146; 179 and 186,,,
5539,R-spondin-1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Z132,,SRGIKGKRQRRISAEGSQACAKGCELCSEVNGCLKCSPKLFILLERNDIRQVGVCLPSCPPGYFDARNPDMNKCIKCKIEHCEACFSHNFCTKCQEALYLHKGRCYPACPEGSTAANSTMECGSPAQCEMSEWSPWGPCSKKRKLCGFRKGSEERTRRVLHAPGGDHTTCSDTKETRKCTVRRTPCPEGQKRRKGGQGRRENANRHPARKNSKEPRSNSRRHKGQQQPQPGTTGPLTSVGPTWAQ,,"Predicted N-linked glycosylation of asparagine residue at position 117; predicted disulphide bond formation between cysteine residues at positions 128 and 170, 139 and 146, and 179 and 186",,,
5540,R-spondin-2,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8BFU0,,NRWRRNKRASYVSNPICKGCLSCSKDNGCSRCQQKLFFFLRREGMRQYGECLHSCPSGYYGHRAPDMNRCARCRIENCDSCFSKDFCTKCKVGFYLHRGRCFDECPDGFAPLDETMECVEGCEVGHWSEWGTCSRNNRTCGFKWGLETRTRQIVKKPAKDTIPCPTIAESRRCKMAMRHCPGGKRTPKAKEKRNKKKRRKLIERAQEQHSVFLATDRVNQ,,"Predicted N-linked glycosylation of aspragine residue at position 137; predicted disulphide bond formation between cysteine residues at positions 122 and 164; 133 and 140, and 173 and 180",,,
3698,R-spondin-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6UXX9,,QGNRWRRSKRASYVSNPICKGCLSCSKDNGCSRCQQKLFFFLRREGMRQYGECLHSCPSGYYGHRAPDMNRCARCRIENCDSCFSKDFCTKCKVGFYLHRGRCFDECPDGFAPLEETMECVEGCEVGHWSEWGTCSRNNRTCGFKWGLETRTRQIVKKPVKDTILCPTIAESRRCKMTMRHCPGGKRTPKAKEKRNKKKKRKLIERAQEQHSVFLATDRANQ,,Asparagine residue at position 139 is N-linked glycosylated; disulfide bonds between cysteine residues at positions 124 and 166; 135 and 142; 175 and 182,,,
5541,R-spondin-3,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q2TJ95,,QNASRGRRQRRMHPNVSQGCQGGCATCSDYNGCLSCKPRLFFVLERIGMKQIGVCLSSCPSGYYGTRYPDINKCTKCKVDCDTCFNKNFCTKCKSGFYLHLGKCLDSCPEGLEANNHTMECVSIVHCEASEWSPWSPCMKKGKTCGFKRGTETRVRDILQHPSAKGNLCPPTSETRTCIVQRKKCSKGERGKKGRERKRKKLNKEERKETSSSSDSKGLESSIETPDQQENKERQQQQKRRARDKQQKSVSVSTVH,,"Predicted N-linked glycosylation of asparagine residue at position 15; predicted disulphide bond foramtion between cysteine residues at positions 127 and 169, 138 and 145, and 178 and 185",,,
3699,R-spondin-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9BXY4,,QNASRGRRQRRMHPNVSQGCQGGCATCSDYNGCLSCKPRLFFALERIGMKQIGVCLSSCPSGYYGTRYPDINKCTKCKADCDTCFNKNFCTKCKSGFYLHLGKCLDNCPEGLEANNHTMECVSIVHCEVSEWNPWSPCTKKGKTCGFKRGTETRVREIIQHPSAKGNLCPPTNETRKCTVQRKKCQKGERGKKGRERKRKKPNKGESKEAIPDSKSLESSKEIPEQRENKQQQKKRKVQDKQKSVSVSTVH,,Asparagine residue at position 15 is N-linked glycosylated; disulfide bonds between cysteine residues at positions 127 and 169; 138 and 145; 178 and 185,,,
3700,R-spondin-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q2I0M5,,LNRRKKQVGTGLGGNCTGCIICSEENGCSTCQQRLFLFIRREGIRQYGKCLHDCPPGYFGIRGQEVNRCKKCGATCESCFSQDFCIRCKRQFYLYKGKCLPTCPPGTLAHQNTRECQGECELGPWGGWSPCTHNGKTCGSAWGLESRVREAGRAGHEEAATCQVLSESRKCPIQRPCPGERSPGQKKGRKDRRPRKDRKLDRRLDVRPRQPGLQP,,Phosphorylation of tyrosine residue at position 93; asparagine residue at position 15 is N-linked glycosylated; disulfide bonds between cysteine residues at positions 120 and 162; 131 and 138; 171 and 177,,,
4383,R-spondin-4,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8BJ73,,LYRRKKQAGTGLGGNCTGCVICSEENGCSTCQQRLFLFIRREGIRQYGKCVHDCPLGFFGIRGQEANRCKKCGATCESCFSQDFCIRCKRRFHLYKGKCLPSCPPGTLTHQSTRECQEECEPSPWGSWSPCIHNGKTCGSGWGLETRVREAGPAKQEETASCRVLSESRKCPIKRLCPGERNPRQKNRKDRRQRKDRKLERRPHQRGSQ,,Asparagine residue at position 15 is N-linked glycosylated; disulfide bonds between Cysteine residues at positions 120 and 162; 131 and 138; 171 and 177,,,
3704,sclerostin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9BQB4,,QGWQAFKNDATEIIPELGEYPEPPPELENNKTMNRAENGGRPPHHPFETKDVSEYSCRELHFTRYVTDGPCRSAKPVTELVCSGQCGPARLLPNAIGRGKWWRPSGPDFRCIPDRYRAQRVQLLCPGGEAPRARKVRLVASCKCKRLTRFHNQSELKDFGTEAARPQKGRKPRPRARSAKANQAELENAY,Gln-Gly-Trp-Gln-Ala-Phe-Lys-Asn-Asp-Ala-Thr-Glu-Ile-Ile-Pro-Glu-Leu-Gly-Glu-Tyr-Pro-Glu-Pro-Pro-Pro-Glu-Leu-Glu-Asn-Asn-Lys-Thr-Met-Asn-Arg-Ala-Glu-Asn-Gly-Gly-Arg-Pro-Pro-His-His-Pro-Phe-Glu-Thr-Lys-Asp-Val-Ser-Glu-Tyr-Ser-Cys-Arg-Glu-Leu-His-Phe-Thr-Arg-Tyr-Val-Thr-Asp-Gly-Pro-Cys-Arg-Ser-Ala-Lys-Pro-Val-Thr-Glu-Leu-Val-Cys-Ser-Gly-Gln-Cys-Gly-Pro-Ala-Arg-Leu-Leu-Pro-Asn-Ala-Ile-Gly-Arg-Gly-Lys-Trp-Trp-Arg-Pro-Ser-Gly-Pro-Asp-Phe-Arg-Cys-Ile-Pro-Asp-Arg-Tyr-Arg-Ala-Gln-Arg-Val-Gln-Leu-Leu-Cys-Pro-Gly-Gly-Glu-Ala-Pro-Arg-Ala-Arg-Lys-Val-Arg-Leu-Val-Ala-Ser-Cys-Lys-Cys-Lys-Arg-Leu-Thr-Arg-Phe-His-Asn-Gln-Ser-Glu-Leu-Lys-Asp-Phe-Gly-Thr-Glu-Ala-Ala-Arg-Pro-Gln-Lys-Gly-Arg-Lys-Pro-Arg-Pro-Arg-Ala-Arg-Ser-Ala-Lys-Ala-Asn-Gln-Ala-Glu-Leu-Glu-Asn-Ala-Tyr,"N-linked glycosylation of  residues 30 and 152; disulfide bonds formed between Cysteine residues at positions 57 and 111, 71 and 125, 82 and 142, and 86 and 144.",,,
2943,secretin,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,HSDGTFTSELSRLQDSARLQRLLQGLV,His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Gln-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,C-terminal residue is valine amide,,,
3643,secretin,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P09683,secretin human,HSDGTFTSELSRLREGARLQRLLQGLV,His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,The C-terminal valine is amidated.,,,
3644,secretin,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q08535,,HSDGMFTSELSRLQDSARLQRLLQGLV,His-Ser-Asp-Gly-Met-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Gln-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,The C-terminal valine is amidated.,,,
10014,selectin P ligand,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q14242,,QATEYEYLDYDFLPETEPPEMLRNSTDTTPLTGPGTPESTTVEPAARRSTGLDAGGAVTELTTELANMGNLSTDSAAMEIQTTQPAATEAQTTQPVPTEAQTTPLAATEAQTTRLTATEAQTTPLAATEAQTTPPAATEAQTTQPTGLEAQTTAPAAMEAQTTAPAAMEAQTTPPAAMEAQTTQTTAMEAQTTAPEATEAQTTQPTATEAQTTPLAAMEALSTEPSATEALSMEPTTKRGLFIPFSVSSVTHKGIPMAASNLSVNYPVGAPDHISVKQCLLAILILALVATIFFVCTVVLAVRLSRKGHMYPVRNYSPTEMVCISSLLPDGGEGPSATANGGLSKAKSPGLTPEPREDREGDDLTLHSFLP,,,,,
9902,semaphorin 3A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,,,MGWLTRIVCLFWGVLLTARANYQNGKNNVPRLKLSYKEMLESNNVITFNGLANSSSYHTFLLDEERSRLYVGAKDHIFSFDLVNIKDFQKIVWPVSYTRRDECKWAGKDILKECANFIKVLKAYNQTHLYACGTGAFHPICTYIEIGHHPEDNIFKLENSHFENGRGKSPYDPKLLTASLLIDGELYSGTAADFMGRDFAIFRTLGHHHPIRTEQHDSRWLNDPKFISAHLISESDNPEDDKVYFFFRENAIDGEHSGKATHARIGQICKNDFGGHRSLVNKWTTFLKARLICSVPGPNGIDTHFDELQDVFLMNFKDPKNPVVYGVFTTSSNIFKGSAVCMYSMSDVRRVFLGPYAHRDGPNYQWVPYQGRVPYPRPGTCPSKTFGGFDSTKDLPDDVITFARSHPAMYNPVFPMNNRPIVIKTDVNYQFTQIVVDRVD,,MGWLTRIVCLFWGVLLTARA is a signal peptide.,,,
6242,serum amyloid A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P0DJI8,,MRSFFSFLGEAFDGARDMWRAYSDMREANYIGSDKYFHARGNYDAAKRGPGGVWAAEAISNARENIQRFFGRGAEDSLADQAANEWGRSGKDPNHFRPAGLPEKY,Met-Arg-Ser-Phe-Phe-Ser-Phe-Leu-Gly-Glu-Ala-Phe-Asp-Gly-Ala-Arg-Asp-Met-Trp-Arg-Ala-Tyr-Ser-Asp-Met-Arg-Glu-Ala-Asn-Tyr-Ile-Gly-Ser-Asp-Lys-Tyr-Phe-His-Ala-Arg-Gly-Asn-Tyr-Asp-Ala-Ala-Lys-Arg-Gly-Pro-Gly-Gly-Val-Trp-Ala-Ala-Glu-Ala-Ile-Ser-Asn-Ala-Arg-Glu-Asn-Ile-Gln-Arg-Phe-Phe-Gly-Arg-Gly-Ala-Glu-Asp-Ser-Leu-Ala-Asp-Gln-Ala-Ala-Asn-Glu-Trp-Gly-Arg-Ser-Gly-Lys-Asp-Pro-Asn-His-Phe-Arg-Pro-Ala-Gly-Leu-Pro-Glu-Lys-Tyr,,,,
3691,sFRP-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q8N474,,SEYDYVSFQSDIGPYQSGRFYTKPPQCVDIPADLRLCHNVGYKKMVLPNLLEHETMAEVKQQASSWVPLLNKNCHAGTQVFLCSLFAPVCLDRPIYPCRWLCEAVRDSCEPVMQFFGFYWPEMLKCDKFPEGDVCIAMTPPNATEASKPQGTTVCPPCDNELKSEAIIEHLCASEFALRMKIKEVKKENGDKKIVPKKKKPLKLGPIKKKDLKKLVLYLKNGADCPCHQLDNLSHHFLIMGRKVKSQYLLTAIHKWDKKNKEFKNFMKKMKNHECPTFQSVFK,,N-linked glycosylation od aspargine residue at position 142; disulfide bonds between Cysteine residues at positions 27 and 90; 37 and 83; 74 and 109; 98 and 135; 102 and 126; 155 and 225; 158 and 227; 172 and 275,,,
3692,sFRP-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q96HF1,,LFLFGQPDFSYKRSNCKPIPANLQLCHGIEYQNMRLPNLLGHETMKEVLEQAGAWIPLVMKQCHPDTKKFLCSLFAPVCLDDLDETIQPCHSLCVQVKDRCAPVMSAFGFPWPDMLECDRFPQDNDLCIPLASSDHLLPATEEAPKVCEACKNKNDDDNDIMETLCKNDFALKIKVKEITYINRDTKIILETKSKTIYKLNGVSERDLKKSVLWLKDSLQCTCEEMNDINAPYLVMGQKQGGELVITSVKRWQKGQREFKRISRSIRKLQC,,Phosphorylation of the serine residue at position 265; disulfide bonds between cysteine residues at positions 16 and 79; 26 and 72; 63 and 101; 90and 128; 94 and 118; 148 and 221; 151 and 223; 166 and 271,,,
3693,sFRP-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q92765,,AACEPVRIPLCKSLPWNMTKMPNHLHHSTQANAILAIEQFEGLLGTHCSPDLLFFLCAMYAPICTIDFQHEPIKPCKSVCERARQGCEPILIKYRHSWPENLACEELPVYDRGVCISPEAIVTADGADFPMDSSNGNCRGASSERCKCKPIRATQKTYFRNNYNYVIRAKVKEIKTKCHDVTAVVEVKEILKSSLVNIPRDTVNLYTSSGCLCPPLNVNEEYIIMGYEDEERSRLLLVEGSIAEKWKDRLGKKVKRWDMKLRHLGLSKSDSSNSDSTQSQKSGRNSNPRQARN,,Asparagine residue at position 17 is N-linked glycosylated; disulfide bonds formed between cysteine residues at positions 3 and 64; 11 and 57; 48 and 87; 76 and 115; 80 and 104,,,
3694,sFRP-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6FHJ7,,VRGAPCEAVRIPMCRHMPWNITRMPNHLHHSTQENAILAIEQYEELVDVNCSAVLRFFLCAMYAPICTLEFLHDPIKPCKSVCQRARDDCEPLMKMYNHSWPESLACDELPVYDRGVCISPEAIVTDLPEDVKWIDITPDMMVQERPLDVDCKRLSPDRCKCKKVKPTLATYLSKNYSYVIHAKIKAVQRSGCNEVTTVVDVKEIFKSSSPIPRTQVPLITNSSCQCPHILPHQDVLIMCYEWRSRMMLLENCLVEKWRDQLSKRSIQWEERLQEQRRTVQDKKKTAGRTSRSNPPKPKGKPPAPKPASPKKNIKTRSAQKRTNPKRV,,"Residues at positions 20, 50, 98, 176 and 222 are N-linked glycosylated; disulfide bonds between Cysteine residues at positions 6 and 67; 14 and 60; 51 and 90; 79 and 118; 83 and 107",,,
3695,sFRP-5,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q6FHJ7,,EEYDYYGWQAEPLHGRSYSKPPQCLDIPADLPLCHTVGYKRMRLPNLLEHESLAEVKQQASSWLPLLAKRCHSDTQVFLCSLFAPVCLDRPIYPCRSLCEAVRAGCAPLMEAYGFPWPEMLHCHKFPLDNDLCIAVQFGHLPATAPPVTKICAQCEMEHSADGLMEQMCSSDFVVKMRIKEIKIENGDRKLIGAQKKKKLLKPGPLKRKDTKRLVLHMKNGAGCPCPQLDSLAGSFLVMGRKVDGQLLLMAVYRWDKKNKEMKFAVKFMFSYPCSLYYPFFYGAAEPH,Glu-Glu-Tyr-Asp-Tyr-Tyr-Gly-Trp-Gln-Ala-Glu-Pro-Leu-His-Gly-Arg-Ser-Tyr-Ser-Lys-Pro-Pro-Gln-Cys-Leu-Asp-Ile-Pro-Ala-Asp-Leu-Pro-Leu-Cys-His-Thr-Val-Gly-Tyr-Lys-Arg-Met-Arg-Leu-Pro-Asn-Leu-Leu-Glu-His-Glu-Ser-Leu-Ala-Glu-Val-Lys-Gln-Gln-Ala-Ser-Ser-Trp-Leu-Pro-Leu-Leu-Ala-Lys-Arg-Cys-His-Ser-Asp-Thr-Gln-Val-Phe-Leu-Cys-Ser-Leu-Phe-Ala-Pro-Val-Cys-Leu-Asp-Arg-Pro-Ile-Tyr-Pro-Cys-Arg-Ser-Leu-Cys-Glu-Ala-Val-Arg-Ala-Gly-Cys-Ala-Pro-Leu-Met-Glu-Ala-Tyr-Gly-Phe-Pro-Trp-Pro-Glu-Met-Leu-His-Cys-His-Lys-Phe-Pro-Leu-Asp-Asn-Asp-Leu-Cys-Ile-Ala-Val-Gln-Phe-Gly-His-Leu-Pro-Ala-Thr-Ala-Pro-Pro-Val-Thr-Lys-Ile-Cys-Ala-Gln-Cys-Glu-Met-Glu-His-Ser-Ala-Asp-Gly-Leu-Met-Glu-Gln-Met-Cys-Ser-Ser-Asp-Phe-Val-Val-Lys-Met-Arg-Ile-Lys-Glu-Ile-Lys-Ile-Glu-Asn-Gly-Asp-Arg-Lys-Leu-Ile-Gly-Ala-Gln-Lys-Lys-Lys-Lys-Leu-Leu-Lys-Pro-Gly-Pro-Leu-Lys-Arg-Lys-Asp-Thr-Lys-Arg-Leu-Val-Leu-His-Met-Lys-Asn-Gly-Ala-Gly-Cys-Pro-Cys-Pro-Gln-Leu-Asp-Ser-Leu-Ala-Gly-Ser-Phe-Leu-Val-Met-Gly-Arg-Lys-Val-Asp-Gly-Gln-Leu-Leu-Leu-Met-Ala-Val-Tyr-Arg-Trp-Asp-Lys-Lys-Asn-Lys-Glu-Met-Lys-Phe-Ala-Val-Lys-Phe-Met-Phe-Ser-Tyr-Pro-Cys-Ser-Leu-Tyr-Tyr-Pro-Phe-Phe-Tyr-Gly-Ala-Ala-Glu-Pro-His,Disulfide bonds between cysteine residues at positions 24 and 87; 34 and 80; 71 and 106; 95 and 133; 99 and 123; 152 and 224; 155 and 226; 169 and 274,,,
10542,SPAG11B (61-103),Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q08648,,DLLPPRTPPYQVHISHREARGPSFRICVDFLGPRWARGCSTGN,Asp-Leu-Leu-Pro-Pro-Arg-Thr-Pro-Pro-Tyr-Gln-Val-His-Ile-Ser-His-Arg-Glu-Ala-Arg-Gly-Pro-Ser-Phe-Arg-Ile-Cys(1)-Val-Asp-Phe-Leu-Gly-Pro-Arg-Trp-Ala-Arg-Gly-Cys(1)-Ser-Thr-Gly-Asn,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)CC(=O)O)Cc1ccccc1)CC(C)C)CCC2)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CC(=O)N)[C@H](O)C)CO)[C@H](CC)C)CCCN=C(N)N)Cc1ccccc1)CO)CCCN=C(N)N)C)CCC(=O)O)CCCN=C(N)N)Cc1nc[nH]c1)CO)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CC(C)C)CC(C)C)CCCN=C(N)N)Cc1ccc(cc1)O)CCC(=O)N)Cc1nc[nH]c1)C,NZRXPCZWIFPFBB-SZWZVGMQSA-N
2019,SRIF-14,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P61278|P60041|P60042,,AGCKNFFWKTFTSC,Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys,Disulphide bond formed between cysteine residues at positions 3 and 14,,NCCCC[C@H]1NC(=O)[C@@H](CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)C(=O)O)NC(=O)CNC(=O)[C@@H](N)C,VVEJUSYNERNRME-XGFVQVCISA-N
2020,SRIF-28,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P60042|P60041|P61278,,SANSNPAMAPRERKAGCKNFFWKTFTSC,Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys,Disulphide bond formed between cysteine residues at positions 17 and 28,,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCCCN)CC(=O)N)Cc1ccccc1)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCCCN)[C@H](O)C)[C@H](O)C)C(=O)O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(=O)N)CO)CC(=O)N)C)CCSC)C)CCCNC(=N)N)CCC(=O)O)CCCNC(=N)N,GGYTXJNZMFRSLX-DFTNLTQTSA-N
5055,stem cell factor,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P21583,,EGICRNRVTNNVKDVTKLVANLPKDYMITLKYVPGMDVLPSHCWISEMVVQLSDSLTDLLDKFSNISEGLSNYSIIDKLVNIVDDLVECVKENSSKDLKKSFKSPEPRLFTPEEFFRIFNRSIDAFKDFVVASETSDCVVSSTLSPEKDSRVSVTKPFMLPPVAASSLRNDSSSSNRKAKNPPGDSSLHWAAMALPALFSLIIGFAFGALYWKKRQPSLTRAVENIQINEEDNEISMLQEKEREFQEV,,"Partial N linked glycosylation of asparagine residues at positions 65 and 93, N-linked glycosylation of asparagine at position 120; O-linked glycosylation of serine at position 142, and of threonine at positions 143 and 155. Disulphide bond formation between cysteine residues at positions 4 and 89, and 43 and 138. Predicted N-linked glycosylation of asparagine at position 170",,,
2098,substance P,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P41539|P06767|P20366,,RPKPQQFFGLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,The C-terminal methionine is amidated.,,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)Cc1ccccc1)Cc1ccccc1)CCC(=O)N)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N,ADNPLDHMAVUMIW-CUZNLEPHSA-N
5059,TGFα,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01135,,VVSHFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCEHADLLA,Val-Val-Ser-His-Phe-Asn-Asp-Cys-Pro-Asp-Ser-His-Thr-Gln-Phe-Cys-Phe-His-Gly-Thr-Cys-Arg-Phe-Leu-Val-Gln-Glu-Asp-Lys-Pro-Ala-Cys-Val-Cys-His-Ser-Gly-Tyr-Val-Gly-Ala-Arg-Cys-Glu-His-Ala-Asp-Leu-Leu-Ala,"Disulphide bond formation between cysteine residues at positions 8 and 21, 16 and 32, and 34 and 43",,,
5060,TGFβ1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01137,,ALDTNYCFSSTEKNCCVRQLYIDFRKDLGWKWIHEPKGYHANFCLGPCPYIWSLDTQYSKVLALYNQHNPGASAAPCCVPQALEPLPIVYYVGRKPKVEQLSNMIVRSCKCS,,"The active form of the peptide is a disulphide linked homodimer, with the bond between cysteine residues at position 77. Disulphide bonds between cysteine residues at positions 7 and 16, 15 and 78, 44 and 109, and 48 and 111. The sequence provided here is for TGFβ, and represents amino acids 279-390 of the TGFβ1 proprotein.",,,
5061,TGFβ2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P61812,,ALDAAYCFRNVQDNCCLRPLYIDFKRDLGWKWIHEPKGYNANFCAGACPYLWSSDTQHSRVLSLYNTINPEASASPCCVSQDLEPLTILYYIGKTPKIEQLSNMIVKSCKCS,,"The active form of the peptide is a disulphide linked homodimer, with the bond between cysteine residues at position 77. Disulphide bonds between cysteine residues at positions 7 and 16, 15 and 78, 44 and 109, and 48 and 111",,,
5062,TGFβ3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P10600,,ALDTNYCFRNLEENCCVRPLYIDFRQDLGWKWVHEPKGYYANFCSGPCPYLRSADTTHSTVLGLYNTLNPEASASPCCVPQDLEPLTILYYVGRTPKVEQLSNMVVKSCKCS,,"The active form of the peptide is a disulphide linked homodimer, with the bond between cysteine residues at position 77. Disulphide bonds between cysteine residues at positions 7 and 16, 15 and 78, 44 and 109, and 48 and 111",,,
4456,thrombin,Mouse,"Endogenous peptide in human, mouse or rat",4454|4455,thrombin light chain|thrombin heavy chain,,,,,,,P19221,,,,,,,
4453,thrombin,Human,"Endogenous peptide in human, mouse or rat",4451|4452,thrombin light chain|thrombin heavy chain,,,,,,,P00734,,,,,,,
4459,thrombin,Rat,"Endogenous peptide in human, mouse or rat",4457|4458,thrombin light chain|thrombin heavy chain,,,,,,,P18292,,,,,,,
4458,thrombin heavy chain,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P18292,,IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEKIYIHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLQAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPYNHRWYQMGIVSWGEGCDRNGKYGFYTHVFRLKRWMQKVIDQHR,,"Active rat thrombin is a complex between thrombin light chain and thrombin heavy chain. The chains are linked by a disulphide bond between cysteine residues at position 8 of the light chain and 199 of the heavy chain.Disulphide bodn formation in the heavy chain between cysteine residues at positions 28 and 44, 173 and 187, and 200 and 230",,,
4455,thrombin heavy chain,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P19221,,IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLLVRIGKHSRTRYERNVEKISMLEKIYVHPRYNWRENLDRDIALLKLKKPVPFSDYIHPVCLPDKQTVTSLLRAGYKGRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKASTRIRITDNMFCAGFKVNDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQKVIDQFG,,"Active mouse thrombin is a complex between thrombin light chain and thrombin heavy chain. The chains are linked by a disulphide bond between cysteine residues at position 9 of the light chain and 155 of the heavy chain. The heavy chain exhibits disulphide bond formation between cysteine residues at positions 28 and 44, 173 and 187, and 201 and 231; N-linked glycosylation of asparagine residues at positions 53 and 193",,,
4452,thrombin heavy chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P00734,,IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE,,"Active thrombin is a complex between thrombin light chain and thrombin heavy chain. The chains are linked by a disulphide bond between cysteine residues at position 9 of the light chain and 118 of the heavy chain. Disulphide bond formation in the heavy chain between cysteine residues at positions 28 and 44, 173  and 187, and  201 and 231; N-linked glycosylation of asparagine residue at postion 53",,,
4454,thrombin light chain,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P19221,,TFGLGEADCGLRPLFEKKSLKDTTEKELLDSYIDGR,Thr-Phe-Gly-Leu-Gly-Glu-Ala-Asp-Cys-Gly-Leu-Arg-Pro-Leu-Phe-Glu-Lys-Lys-Ser-Leu-Lys-Asp-Thr-Thr-Glu-Lys-Glu-Leu-Leu-Asp-Ser-Tyr-Ile-Asp-Gly-Arg,Active mouse thrombin is a complex between thrombin light chain and thrombin heavy chain. The chains are linked by a disulphide bond between cysteine residues at position 9 of the light chain and 155 of the heavy chain.,,,
4457,thrombin light chain,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P18292,,TFGLGEADCGLRPLFEKKSLTDKTEKELLDSYIDGR,Thr-Phe-Gly-Leu-Gly-Glu-Ala-Asp-Cys-Gly-Leu-Arg-Pro-Leu-Phe-Glu-Lys-Lys-Ser-Leu-Thr-Asp-Lys-Thr-Glu-Lys-Glu-Leu-Leu-Asp-Ser-Tyr-Ile-Asp-Gly-Arg,Active rat thrombin is a complex between thrombin light chain and thrombin heavy chain. The chains are linked by a disulphide bond between cysteine residues at position 8 of the light chain and 199 of the heavy chain.,,,
4451,thrombin light chain,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P00734,,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,Thr-Phe-Gly-Ser-Gly-Glu-Ala-Asp-Cys-Gly-Leu-Arg-Pro-Leu-Phe-Glu-Lys-Lys-Ser-Leu-Glu-Asp-Lys-Thr-Glu-Arg-Glu-Leu-Leu-Glu-Ser-Tyr-Ile-Asp-Gly-Arg,Active thrombin is a complex between thrombin light chain and thrombin heavy chain. The chains are linked by a disulphide bond between cysteine residues at position 9 of the light chain and 118 of the heavy chain,,,
5063,thrombopoietin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P40225,,SPAPPACDLRVLSKLLRDSHVLHSRLSQCPEVHPLPTPVLLPAVDFSLGEWKTQMEETKAQDILGAVTLLLEGVMAARGQLGPTCLSSLLGQLSGQVRLLLGALQSLLGTQLPPQGRTTAHKDPNAIFLSFQHLLRGKVRFLMLVGGSTLCVRRAPPTTAVPSRTSLVLTLNELPNRTSGLLETNFTASARTTGSGLLKWQQGFRAKIPGLLNQTSRSLDQIPGYLNRIHELLNGTRGLFPGPSRRTLGAPDISSGTSDTGSLPPNLQPGYSPSPTHPPTGQYTLFPLPPTLPTPVVQLHPLLPDPSAPTPTPTSPLLNTSYTHSQNLSQEG,,"O-linked glycosylation of predicted N-linked glycosylation of asparagine residues at positions 319 and 327; disulphide bond formation between cysteine residues at positions 7 and 151, and 29 and 85",,,
5083,thymic stromal lymphopoietin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q969D9,,YDFTNCDFEKIKAAYLSTISKDLITYMSGTKSTEFNNTVSCSNRPHCLTEIQSLTFNPTAGCASLAKEMFAMKTKAALAIWCPGYSETQINATQAMKKRRKRKVTTNKCLEQVSQLQGLWRRFNRPLLKQQ,,Predicted N-linked glycosylation of asparagine residues at positions 36 and 91,,,
5309,TIMP1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01033,,CTCVPPHPQTAFCNSDLVIRAKFVGTPEVNQTTLYQRYEIKMTKMYKGFQALGDAADIRFVYTPAMESVCGYFHRSHNRSEEFLIAGKLQDGLLHITTCSFVAPWNSLSLAQRRGFTKTYTVGCEECTVFPCLSIPCKLQSGTHCLWTDQLLQGSEKGFQSRHLACLPREPGLCTWQSLRSQIA,,"N-linked glycosylation of asparagine residues at positions 30 and 78; disulphide bond formation between cysteine residues at positions 1 and 70, 3 and 99, 13 and 124, 127 and 174, 132 and 137 and 145 and 166.",,,
5310,TIMP2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P16035,,CSCSPVHPQQAFCNADVVIRAKAVSEKEVDSGNDIYGNPIKRIQYEIKQIKMFKGPEKDIEFIYTAPSSAVCGVSLDVGGKKEYLIAGKAEGDGKMHITLCDFIVPWDTLSTTQKKSLNHRYQMGCECKITRCPMIPCYISSPDECLWMDWVTEKNINGHQAKFFACIKRSDGSCAWYRGAAPPKQEFLDIEDP,,"Disulphide bond formation between cysteine residues at positions 1 and 72, 3 and 101, 13 and 126, 128 and 175, 133 and 138 and 146 and 167",,,
5311,TIMP3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P35625,,CTCSPSHPQDAFCNSDIVIRAKVVGKKLVKEGPFGTLVYTIKQMKMYRGFTKMPHVQYIHTEASESLCGLKLEVNKYQYLLTGRVYDGKMYTGLCNFVERWDQLTLSQRKGLNYRYHLGCNCKIKSCYYLPCFVTSKNECLWTDMLSNFGYPGYQSKHYACIRQKGGYCSWYRGWAPPDKSIINATDP,,"Disulphide bond formation between cysteine residues at positions 1 and 68, 3 and 95,  and 13 and 120. Predicted disulphide bond formation between cysteine residues at positions 122 and 169, 127 and 132, and 140 and 161.",,,
5312,TIMP4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99727,,CSCAPAHPQQHICHSALVIRAKISSEKVVPASADPADTEKMLRYEIKQIKMFKGFEKVKDVQYIYTPFDSSLCGVKLEANSQKQYLLTGQVLSDGKVFIHLCNYIEPWEDLSLVQRESLNHHYHLNCGCQITTCYTVPCTISAPNECLWTDWLLERKLYGYQAQHYVCMKHVDGTCSWYRGHLPLRKEFVDIVQP,,"Predicted disulphide bond formation between cysteine residues at positions 1 and 93, 3 and 102, 13 and 127, 129 and 176, 134 and 139, and 147 and 168.",,,
1815,TIP39,"Human, Bovine","Endogenous peptide in human, mouse or rat",,,,,,,,,Q96A98|P0C171,,SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP,Ser-Leu-Ala-Leu-Ala-Asp-Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro,None.,,,
3624,TIP39,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q91W27|P0C172,,SLALADDAAFRERARLLAALERRRWLDSYMQKLLLLDAP,Ser-Leu-Ala-Leu-Ala-Asp-Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-Arg-Trp-Leu-Asp-Ser-Tyr-Met-Gln-Lys-Leu-Leu-Leu-Leu-Asp-Ala-Pro,None.,,,
639,T-kinin,"Human, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01042|P01048|P08932,,ISRPPGFSPFR,Ile-Ser Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,None,,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)N)CO)CCCN=C(N)N,GKCWYHPGFSRBQV-WRBAKOPXSA-N
5071,TL1A,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95150,,MAEDLGLSFGETASVEMLPEHGSCRPKARSSSARWALTCCLVLLPFLAGLTTYLLVSQLRAQGEACVQFQALKGQEFAPSHQQVYAPLRADGDKPRAHLTVVRQTPTQHFKNQFPALHWEHELGLAFTKNRMNYTNKFLLIPESGDYFIYSQVTFRGMTSECSEIRQAGRPNKPDSITVVITKVTDSYPEPTQLLMGTKSVCEVGSNWFQPIYLGAMFSLQEGDKLMVNVSDISLVDYTKEDKTFFGAFLL,,Predicted N-linked glycosylation of asparagine residues at positions 133 and 229; disulphide bond formation between cysteine residues at positions 162 and 202,,,
5072,TL6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UNG2,,MTLHPSPITCEFLFSTALISPKMCLSHLENMPLSHSRTQGAQRSSWKLWLFCSIVMLLFLCSFSWLIFIFLQLETAKEPCMAKFGPLPSKWQMASSEPPCVNKVSDWKLEILQNGLYLIYGQVAPNANYNDVAPFEVRLYKNKDMIQTLTNKSKIQNVGGTYELHVGDTIDLIFNSEHQVLKNNTYWGIILLANPQFIS,,Predicted N-linked glycosylation of asparagine residues at positions 151 and 183; disulphide bond formation between cysteine residues at positions 80 and 100,,,
5065,TRAIL,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P50591,,MAMMEVQGGPSLGQTCVLIVIFTVLLQSLCVAVTYVYFTNELKQMQDKYSKSGIACFLKEDDSYWDPNDEESMNSPCWQVKWQLRQLVRKMILRTSEETISTVQEKQQNISPLVRERGPQRVAAHITGTRGRSNTLSSPNSKNEKALGRKINSWESSRSGHSFLSNLHLRNGELVIHEKGFYYIYSQTYFRFQEEIKENTKNDKQMVQYIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFELKENDRIFVSVTNEHLIDMDHEASFFGAFLVG,,,,,
2139,TRH,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01150|Q62361|P20396,protirelin,XHP,pGlu-His-Pro-NH2,N-terminal pyroglutamate (X or pGlu) and C terminal amidation.,,O=C1CC[C@H](N1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N)Cc1nc[nH]c1,XNSAINXGIQZQOO-SRVKXCTJSA-N
3920,TSH,Human,"Endogenous peptide in human, mouse or rat",3734|3731,TSH β subunit|glycoprotein hormone common alpha subunit,yes,,,,,,,thyrotropin alfa,,,The production of biologically active TSH requires appropriately folded TSHβ and common α subunits that assemble to form the TSH heterodimer.,,,
4395,TSH,Rat,"Endogenous peptide in human, mouse or rat",4378|4394,glycoprotein hormone common alpha subunit|TSH β subunit,,,,,,,,,,,The production of biologically active TSH requires appropriately folded TSHβ and common α subunits that assemble to form the TSH heterodimer.,,,
4393,TSH,Mouse,"Endogenous peptide in human, mouse or rat",4377|4392,glycoprotein hormone common alpha subunit|TSH β subunit,,,,,,,,,,,The production of biologically active TSH requires appropriately folded TSHβ and common α subunits that assemble to form the TSH heterodimer.,,,
3734,TSH β subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01222,thyrotropin alfa,FCIPTEYTMHIERRECAYCLTINTTICAGYCMTRDINGKLFLPKYALSQDVCTYRDFIYRTVEIPGCPLHVAPYFSYPVALSCKCGKCNTDYSDCIHEAIKTNYCTKPQKSY,Phe-Cys-Ile-Pro-Thr-Glu-Tyr-Thr-Met-His-Ile-Glu-Arg-Arg-Glu-Cys-Ala-Tyr-Cys-Leu-Thr-Ile-Asn-Thr-Thr-Ile-Cys-Ala-Gly-Tyr-Cys-Met-Thr-Arg-Asp-Ile-Asn-Gly-Lys-Leu-Phe-Leu-Pro-Lys-Tyr-Ala-Leu-Ser-Gln-Asp-Val-Cys-Thr-Tyr-Arg-Asp-Phe-Ile-Tyr-Arg-Thr-Val-Glu-Ile-Pro-Gly-Cys-Pro-Leu-His-Val-Ala-Pro-Tyr-Phe-Ser-Tyr-Pro-Val-Ala-Leu-Ser-Cys-Lys-Cys-Gly-Lys-Cys-Asn-Thr-Asp-Tyr-Ser-Asp-Cys-Ile-His-Glu-Ala-Ile-Lys-Thr-Asn-Tyr-Cys-Thr-Lys-Pro-Gln-Lys-Ser-Tyr,"Asparagine residue at position 23 is N-linked glycosylated; disulfide bonds between cysteine residues at position 2 and 52, 16 and 67, 19 and 105, 27 and 83,  31 and 85 and 88 and 95. The production of biologically active TSH requires appropriately folded TSHβ and common α subunits that assemble to form the TSH heterodimer.",,,
4392,TSH β subunit,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P12656,,FCIPTEYTMYVDRRECAYCLTINTTICAGYCMTRDINGKLFLPKYALSQDVCTYRDFIYRTVEIPGCPHHVTPYFSFPVAVSCKCGKCNTDNSDCIHEAVRTNYCTKPQSFY,Phe-Cys-Ile-Pro-Thr-Glu-Tyr-Thr-Met-Tyr-Val-Asp-Arg-Arg-Glu-Cys-Ala-Tyr-Cys-Leu-Thr-Ile-Asn-Thr-Thr-Ile-Cys-Ala-Gly-Tyr-Cys-Met-Thr-Arg-Asp-Ile-Asn-Gly-Lys-Leu-Phe-Leu-Pro-Lys-Tyr-Ala-Leu-Ser-Gln-Asp-Val-Cys-Thr-Tyr-Arg-Asp-Phe-Ile-Tyr-Arg-Thr-Val-Glu-Ile-Pro-Gly-Cys-Pro-His-His-Val-Thr-Pro-Tyr-Phe-Ser-Phe-Pro-Val-Ala-Val-Ser-Cys-Lys-Cys-Gly-Lys-Cys-Asn-Thr-Asp-Asn-Ser-Asp-Cys-Ile-His-Glu-Ala-Val-Arg-Thr-Asn-Tyr-Cys-Thr-Lys-Pro-Gln-Ser-Phe-Tyr,"Asparagine residue at position 23 is N-linked glycosylated; disulfide bonds between cysteine residues at position 2 and 52, 16 and 67, 19 and 105, 27 and 83, 31 and 85 and 88 and 95. The production of biologically active TSH requires appropriately folded TSHβ and common α subunits that assemble to form the TSH heterodimer.",,,
4394,TSH β subunit,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04652,,FCIPTEYMMYVDRRECAYCLTINTTICAGYCMTRDINGKLFLPKYALSQDVCTYRDFTYRTVEIPGCPHHVAPYFSYPVALSCKCGKCNTDYSDCTHEAVKTNYCTKPQTFY,Phe-Cys-Ile-Pro-Thr-Glu-Tyr-Met-Met-Tyr-Val-Asp-Arg-Arg-Glu-Cys-Ala-Tyr-Cys-Leu-Thr-Ile-Asn-Thr-Thr-Ile-Cys-Ala-Gly-Tyr-Cys-Met-Thr-Arg-Asp-Ile-Asn-Gly-Lys-Leu-Phe-Leu-Pro-Lys-Tyr-Ala-Leu-Ser-Gln-Asp-Val-Cys-Thr-Tyr-Arg-Asp-Phe-Thr-Tyr-Arg-Thr-Val-Glu-Ile-Pro-Gly-Cys-Pro-His-His-Val-Ala-Pro-Tyr-Phe-Ser-Tyr-Pro-Val-Ala-Leu-Ser-Cys-Lys-Cys-Gly-Lys-Cys-Asn-Thr-Asp-Tyr-Ser-Asp-Cys-Thr-His-Glu-Ala-Val-Lys-Thr-Asn-Tyr-Cys-Thr-Lys-Pro-Gln-Thr-Phe-Tyr,"Asparagine residue at position 23 is N-linked glycosylated; disulfide bonds between cysteine residues at position 2 and 52, 16 and 67, 19 and 105, 27 and 83, 31 and 85 and 88 and 95. The production of biologically active TSH requires appropriately folded TSHβ and common α subunits that assemble to form the TSH heterodimer.",,,
5073,tumour necrosis factor membrane form,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01375,,MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL,,Predicted phosphorylation of serine residue at position 2; residues 19 and 20 are N6-myristoyl lysine,,,
5074,tumour necrosis factor shed form,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P01375,,VRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL,,O-linked glycosylation of serine residue at position 4; disulphide bond formation between cysteine residues at positions 69 and 101,,,
5067,TWEAK,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43508,,MAARRSQRRRGRRGEPGTALLVPLALGLGLALACLGLLLAVVSLGSRASLSAQEPAQEELVAEEDQDPSELNPQTEESQDPAPFLNRLVRPRRSAPKGRKTRARRAIAAHYEVHPRPGQDGAQAGVDGTVSGWEEARINSSSPLRYNRQIGEFIVTRAGLYYLYCQVHFDEGKAVYLKLDLLVDGVLALRCLEEFSATAASSLGPQLRLCQVSGLLALRPGSSLRIRTLPWAHLKAAPFLTYFGLFQVH,,,,,
10359,ulinastatin,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,,ulinastatin,AVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETFQYGGCMGNGNNFVTEKECLQTCRTVAACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGNGNKFYSEKECREYCGVPGDGDEELL,,"N-glycan at Asn45, glycosaminoglycan chain of low-sulfated chondroitin 4-sulfate at Ser10",,,
919,urocortin 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P55089,,DNPSLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV,Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2,The C-terminal valine is amidated,,,
920,urocortin 1,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P81615|P55090,,DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV,Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2,The C-terminal valine is amidated,,,
921,urocortin 2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q96RP3,,IVLSLDVPIGLLQILLEQARARAAREQATTNARILARV,Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2,The C-terminal valine is amidated.,,,
3545,urocortin 2,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q91WW1,,VILSLDVPIGLLRILLEQARNKAARNQAATNAQILARV,Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Asn-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-Arg-Val-NH2,The C-terminal Valine is amidated.,,,
927,urocortin 2,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q99ML8,,VILSLDVPIGLLRILLEQARYKAARNQAATNAQILAHV,Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2,The C-terminal Valine is amidated.,,,
929,urocortin 3,"Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q924A4|A1YKY5,,FTLSLDVPTNIMNILFNIDKAKNLRAKAAANAQLMAQI,Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH2,The C-terminal isoleucine is amidated.,,,
928,urocortin 3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q969E3,,FTLSLDVPTNIMNLLFNIAKAKNLRAQAAANAHLMAQI,Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2,The C-terminal isoleucine is amidated.,,,
5084,uroguanylin,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q16661,,NDDCELCVNVACTGCL,Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu,"Disulphide bonds between cysteine residues at positions 3 and 11, and 6 and 14",,,
2153,urotensin-II,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O95399,,ETPDCFWKYCV,Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val,A disulfide bond is formed between cysteine residues at positions 5 and 10.,,,
2155,urotensin-II,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QZQ4,,QHGTAPECFWKYCI,Gln-His-Gly-Thr-Ala-Pro-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Ile,A disulfide bond is formed between cysteine residues at positions 8 and 13.,,,
2154,urotensin-II,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9QZQ3,,QHGAAPECFWKYCI,Gln-His-Gly-Ala-Ala-Pro-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Ile,A disulfide bond is formed between cysteine residues at positions 8 and 13.,,,
2156,urotensin II-related peptide,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q765I2|Q765I1|Q765I0,,ACFWKYCV,Ala-Cys-Phe-Trp-Lys-Tyr-Cys-Val,One disulfide bond is formed between cysteine residues at positions 2 and 7.,,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC2CCCCC2)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)O)C(C)C)NC(=O)[C@@H](N)C)Cc1c[nH]c2c1cccc2,BKBNRUZZGBUWOM-KOOAXUMWSA-N
6758,vascular cell adhesion protein 1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P19320,,FKIETTPESRYLAQIGDSVSLTCSTTGCESPFFSWRTQIDSPLNGKVTNEGTTSTLTMNPVSFGNEHSYLCTATCESRKLEKGIQVEIYSFPKDPEIHLSGPLEAGKPITVKCSVADVYPFDRLEIDLLKGDHLMKSQEFLEDADRKSLETKSLEVTFTPVIEDIGKVLVCRAKLHIDEMDSVPTVRQAVKELQVYISPKNTVISVNPSTKLQEGGSVTMTCSSEGLPAPEIFWSKKLDNGNLQHLSGNATLTLIAMRMEDSGIYVCEGVNLIGKNRKEVELIVQEKPFTVEISPGPRIAAQIGDSVMLTCSVMGCESPSFSWRTQIDSPLSGKVRSEGTNSTLTLSPVSFENEHSYLCTVTCGHKKLEKGIQVELYSFPRDPEIEMSGGLVNGSSVTVSCKVPSVYPLDRLEIELLKGETILENIEFLEDTDMKSLENKSLEMTFIPTIEDTGKALVCQAKLHIDDMEFEPKQRQSTQTLYVNVAPRDTTVLVSPSSILEEGSSVNMTCLSQGFPAPKILWSRQLPNGELQPLSENATLTLISTKMEDSGVYLCEGINQAGRSRKEVELIIQVTPKDIKLTAFPSESVKEGDTVIISCTCGNVPETWIILKKKAETGDTVLKSIDGAYTIRKAQLKDAGVYECESKNKVGSQLRSLTLDVQGRENNKDYFSPELLVLYFASSLIIPAIGMIIYFARKANMKGSYSLVEAQKSKV,,,,,
2168,vasopressin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,yes,,,,,,P01186|P35455|P01185,vasopressin injection,CYFQNCPRG,Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,One disulfide bond is formed between cysteine residues at positions 1 and 6 and the C-terminal glycine is amidated.,,NC(=O)C[C@@H]1NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)N,KBZOIRJILGZLEJ-LGYYRGKSSA-N
5085,VEGFA,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P15692,,APMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR,,"Homodimer formed by interchain disulphide bonds between cysteine residues at positions 51 and 60; further disulphide bonds formed between cysteine residues at positions 26 and 68, 57 and 102, and 61 and 104. Lysine residues at positions 121, 123 and 126 are N6-acetyllysine. N-linked glycosylation of asparagine residue at position 75",,,
5086,VEGFB,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P49765,,PVSQPDAPGHQRKVVSWIDVYTRATCQPREVVVPLTVELMGTVAKQLVPSCVTVQRCGGCCPDDGLECVPTGQHQVRMQILMIRYPSSQLGEMSLEEHSQCECRPKKKDSAVKPDRAATPHHRPQPRSVPGWDSAPGAPSPADITHPTPAPGPSAHAAPSTTSALTPGPAAAAADAAASSVAKGGA,,"Homodimer formed by interchain disulphide bonds between cysteine residues at positions 51 and 60; further disulphide bonds formed between cysteine residues at positions 26 and 68, 57 and 102, and 61 and 103.",,,
5087,VEGFC,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P49767,,AHYNTEILKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKLDVYRQVHSIIRR,,"Homodimer formed by interchain disulphide bonds between cysteine residues at positions 45 and 54; further disulphide bonds formed between cysteine residues at positions 20 and 62, 51 and 108, and 55 and 100. N-linked glycosylation of asparagine residues at positions 66 and 94; predicted N-linked glycosylation of asparagine at 129",,,
5088,VEGFD,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O43915,,FAATFYDIETLKVIDEEWQRTQCSPRETCVEVASELGKSTNTFFKPPCVNVFRCGGCCNEESLICMNTSTSYISKQLFEISVPLTSVPELVPVKVANHTGCKCLPTAPRHPYSIIRR,,"Homodimer formed by interchain disulphide bonds between cysteine residues at positions 48 and 57; further disulphide bonds formed between cysteine residues at positions 23 and 65, 54 and 101, and 58 and 103. N-linked glycosylation of asparagine residues at positions 67 and 97; predicted N-linked glycosylation of asparagine at 199",,,
5089,VEGFE,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9NRA1,,,,,,,
1152,VIP,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,P01283|P32648|P01282,,HSDAVFTDNYTRLRKQMAVKKYLNSILN,His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2,C-terminal residue is asparagine amide,,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N,VBUWHHLIZKOSMS-UHFFFAOYSA-N
6746,vitronectin,Human,"Endogenous peptide in human, mouse or rat",6747|6748,vitronectin V65 subunit|vitronectin V10 subunit,,,,,,,P04004,,DQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAECKPQVTRGDVFTMPEDEYTVYDDGEEKNNATVHEQVGGPSLTSDLQAQSKGNPEQTPVLKPEEEAPAPEVGASKPEGIDSRPETLHPGRPQPPAEEELCSGKPFDAFTDLKNGSLFAFRGQYCYELDEKAVRPGYPKLIRDVWGIEGPIDAAFTRINCQGKTYLFKGSQYWRFEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGRERVYFFKGKQYWEYQFQHQPSQEECEGSSLSAVFEHFAMMQRDSWEDIFELLFWGRTSAGTRQPQFISRDWHGVPGQVDAAMAGRIYISGMAPRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQNSRRPSRATWLSLFSSEESNLGANNYDDYRMDWLVPATCEPIQSVFFF,Asp-Gln-Glu-Ser-Cys-Lys-Gly-Arg-Cys-Thr-Glu-Gly-Phe-Asn-Val-Asp-Lys-Lys-Cys-Gln-Cys-Asp-Glu-Leu-Cys-Ser-Tyr-Tyr-Gln-Ser-Cys-Cys-Thr-Asp-Tyr-Thr-Ala-Glu-Cys-Lys-Pro-Gln-Val-Thr-Arg-Gly-Asp-Val-Phe-Thr-Met-Pro-Glu-Asp-Glu-Tyr-Thr-Val-Tyr-Asp-Asp-Gly-Glu-Glu-Lys-Asn-Asn-Ala-Thr-Val-His-Glu-Gln-Val-Gly-Gly-Pro-Ser-Leu-Thr-Ser-Asp-Leu-Gln-Ala-Gln-Ser-Lys-Gly-Asn-Pro-Glu-Gln-Thr-Pro-Val-Leu-Lys-Pro-Glu-Glu-Glu-Ala-Pro-Ala-Pro-Glu-Val-Gly-Ala-Ser-Lys-Pro-Glu-Gly-Ile-Asp-Ser-Arg-Pro-Glu-Thr-Leu-His-Pro-Gly-Arg-Pro-Gln-Pro-Pro-Ala-Glu-Glu-Glu-Leu-Cys-Ser-Gly-Lys-Pro-Phe-Asp-Ala-Phe-Thr-Asp-Leu-Lys-Asn-Gly-Ser-Leu-Phe-Ala-Phe-Arg-Gly-Gln-Tyr-Cys-Tyr-Glu-Leu-Asp-Glu-Lys-Ala-Val-Arg-Pro-Gly-Tyr-Pro-Lys-Leu-Ile-Arg-Asp-Val-Trp-Gly-Ile-Glu-Gly-Pro-Ile-Asp-Ala-Ala-Phe-Thr-Arg-Ile-Asn-Cys-Gln-Gly-Lys-Thr-Tyr-Leu-Phe-Lys-Gly-Ser-Gln-Tyr-Trp-Arg-Phe-Glu-Asp-Gly-Val-Leu-Asp-Pro-Asp-Tyr-Pro-Arg-Asn-Ile-Ser-Asp-Gly-Phe-Asp-Gly-Ile-Pro-Asp-Asn-Val-Asp-Ala-Ala-Leu-Ala-Leu-Pro-Ala-His-Ser-Tyr-Ser-Gly-Arg-Glu-Arg-Val-Tyr-Phe-Phe-Lys-Gly-Lys-Gln-Tyr-Trp-Glu-Tyr-Gln-Phe-Gln-His-Gln-Pro-Ser-Gln-Glu-Glu-Cys-Glu-Gly-Ser-Ser-Leu-Ser-Ala-Val-Phe-Glu-His-Phe-Ala-Met-Met-Gln-Arg-Asp-Ser-Trp-Glu-Asp-Ile-Phe-Glu-Leu-Leu-Phe-Trp-Gly-Arg-Thr-Ser-Ala-Gly-Thr-Arg-Gln-Pro-Gln-Phe-Ile-Ser-Arg-Asp-Trp-His-Gly-Val-Pro-Gly-Gln-Val-Asp-Ala-Ala-Met-Ala-Gly-Arg-Ile-Tyr-Ile-Ser-Gly-Met-Ala-Pro-Arg-Pro-Ser-Leu-Ala-Lys-Lys-Gln-Arg-Phe-Arg-His-Arg-Asn-Arg-Lys-Gly-Tyr-Arg-Ser-Gln-Arg-Gly-His-Ser-Arg-Gly-Arg-Asn-Gln-Asn-Ser-Arg-Arg-Pro-Ser-Arg-Ala-Thr-Trp-Leu-Ser-Leu-Phe-Ser-Ser-Glu-Glu-Ser-Asn-Leu-Gly-Ala-Asn-Asn-Tyr-Asp-Asp-Tyr-Arg-Met-Asp-Trp-Leu-Val-Pro-Ala-Thr-Cys-Glu-Pro-Ile-Gln-Ser-Val-Phe-Phe-Phe,"The vitronectin precursor protein can be cleaved into three subunits: vitronectin V65 subunit, vitronectin V10 subunit and somatomedin-B. Vitronectin can exist in two forms, one being a single chain uncleaved form (V75), and the other a cleaved form composed of the V65 and V10 subunits which are held together by a disulfide bond.",,,
6748,vitronectin V10 subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04004,,ATWLSLFSSEESNLGANNYDDYRMDWLVPATCEPIQSVFFFSGDKYYRVNLRTRRVDTVDPPYPRSIAQYWLGCPAPGHL,Ala-Thr-Trp-Leu-Ser-Leu-Phe-Ser-Ser-Glu-Glu-Ser-Asn-Leu-Gly-Ala-Asn-Asn-Tyr-Asp-Asp-Tyr-Arg-Met-Asp-Trp-Leu-Val-Pro-Ala-Thr-Cys-Glu-Pro-Ile-Gln-Ser-Val-Phe-Phe-Phe-Ser-Gly-Asp-Lys-Tyr-Tyr-Arg-Val-Asn-Leu-Arg-Thr-Arg-Arg-Val-Asp-Thr-Val-Asp-Pro-Pro-Tyr-Pro-Arg-Ser-Ile-Ala-Gln-Tyr-Trp-Leu-Gly-Cys-Pro-Ala-Pro-Gly-His-Leu,,,,
6747,vitronectin V65 subunit,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04004,,DQESCKGRCTEGFNVDKKCQCDELCSYYQSCCTDYTAECKPQVTRGDVFTMPEDEYTVYDDGEEKNNATVHEQVGGPSLTSDLQAQSKGNPEQTPVLKPEEEAPAPEVGASKPEGIDSRPETLHPGRPQPPAEEELCSGKPFDAFTDLKNGSLFAFRGQYCYELDEKAVRPGYPKLIRDVWGIEGPIDAAFTRINCQGKTYLFKGSQYWRFEDGVLDPDYPRNISDGFDGIPDNVDAALALPAHSYSGRERVYFFKGKQYWEYQFQHQPSQEECEGSSLSAVFEHFAMMQRDSWEDIFELLFWGRTSAGTRQPQFISRDWHGVPGQVDAAMAGRIYISGMAPRPSLAKKQRFRHRNRKGYRSQRGHSRGRNQNSRRPSR,,,,,
6755,von Willebrand factor,Human,"Endogenous peptide in human, mouse or rat",,,yes,,,,,,P04275,,,,,,,
3672,Wnt-1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P04628,,ANSSGRWWGIVNVASSTNLLTDSKSLQLVLEPSLQLLSRKQRRLIRQNPGILHSVSGGLQSAVRECKWQFRNRRWNCPTAPGPHLFGKIVNRGCRETAFIFAITSAGVTHSVARSCSEGSIESCTCDYRRRGPGGPDWHWGGCSDNIDFGRLFGREFVDSGEKGRDLRFLMNLHNNEAGRTTVFSEMRQECKCHGMSGSCTVRTCWMRLPTLRAVGDVLRDRFDGASRVLYGNRGSNRASRAELLRLEPEDPAHKPPSPHDLVYFEKSPNFCTYSGRLGTAGTAGRACNSSSPALDGCELLCCGRGHRTRTQRVTERCNCTFHWCCHVSCRNCTHTRVLHECL,Ala-Asn-Ser-Ser-Gly-Arg-Trp-Trp-Gly-Ile-Val-Asn-Val-Ala-Ser-Ser-Thr-Asn-Leu-Leu-Thr-Asp-Ser-Lys-Ser-Leu-Gln-Leu-Val-Leu-Glu-Pro-Ser-Leu-Gln-Leu-Leu-Ser-Arg-Lys-Gln-Arg-Arg-Leu-Ile-Arg-Gln-Asn-Pro-Gly-Ile-Leu-His-Ser-Val-Ser-Gly-Gly-Leu-Gln-Ser-Ala-Val-Arg-Glu-Cys-Lys-Trp-Gln-Phe-Arg-Asn-Arg-Arg-Trp-Asn-Cys-Pro-Thr-Ala-Pro-Gly-Pro-His-Leu-Phe-Gly-Lys-Ile-Val-Asn-Arg-Gly-Cys-Arg-Glu-Thr-Ala-Phe-Ile-Phe-Ala-Ile-Thr-Ser-Ala-Gly-Val-Thr-His-Ser-Val-Ala-Arg-Ser-Cys-Ser-Glu-Gly-Ser-Ile-Glu-Ser-Cys-Thr-Cys-Asp-Tyr-Arg-Arg-Arg-Gly-Pro-Gly-Gly-Pro-Asp-Trp-His-Trp-Gly-Gly-Cys-Ser-Asp-Asn-Ile-Asp-Phe-Gly-Arg-Leu-Phe-Gly-Arg-Glu-Phe-Val-Asp-Ser-Gly-Glu-Lys-Gly-Arg-Asp-Leu-Arg-Phe-Leu-Met-Asn-Leu-His-Asn-Asn-Glu-Ala-Gly-Arg-Thr-Thr-Val-Phe-Ser-Glu-Met-Arg-Gln-Glu-Cys-Lys-Cys-His-Gly-Met-Ser-Gly-Ser-Cys-Thr-Val-Arg-Thr-Cys-Trp-Met-Arg-Leu-Pro-Thr-Leu-Arg-Ala-Val-Gly-Asp-Val-Leu-Arg-Asp-Arg-Phe-Asp-Gly-Ala-Ser-Arg-Val-Leu-Tyr-Gly-Asn-Arg-Gly-Ser-Asn-Arg-Ala-Ser-Arg-Ala-Glu-Leu-Leu-Arg-Leu-Glu-Pro-Glu-Asp-Pro-Ala-His-Lys-Pro-Pro-Ser-Pro-His-Asp-Leu-Val-Tyr-Phe-Glu-Lys-Ser-Pro-Asn-Phe-Cys-Thr-Tyr-Ser-Gly-Arg-Leu-Gly-Thr-Ala-Gly-Thr-Ala-Gly-Arg-Ala-Cys-Asn-Ser-Ser-Ser-Pro-Ala-Leu-Asp-Gly-Cys-Glu-Leu-Leu-Cys-Cys-Gly-Arg-Gly-His-Arg-Thr-Arg-Thr-Gln-Arg-Val-Thr-Glu-Arg-Cys-Asn-Cys-Thr-Phe-His-Trp-Cys-Cys-His-Val-Ser-Cys-Arg-Asn-Cys-Thr-His-Thr-Arg-Val-Leu-His-Glu-Cys-Leu,"Residues at positions 2, 289, 319 and 332 are N-linked glycosylated",,,
3687,Wnt-10a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9GZT5,,MPRSAPNDILDLRLPPEPVLNANTVCLTLPGLSRRQMEVCVRHPDVAASAIQGIQIAIHECQHQFRDQRWNCSSLETRNKIPYESPIFSRGFRESAFAYAIAAAGVVHAVSNACALGKLKACGCDASRRGDEEAFRRKLHRLQLDALQRGKGLSHGVPEHPALPTASPGLQDSWEWGGCSPDMGFGERFSKDFLDSREPHRDIHARMRLHNNRVGRQAVMENMRRKCKCHGTSGSCQLKTCWQVTPEFRTVGALLRSRFHRATLIRPHNRNGGQLEPGPAGAPSPAPGAPGPRRRASPADLVYFEKSPDFCEREPRLDSAGTVGRLCNKSSAGSDGCGSMCCGRGHNILRQTRSERCHCRFHWCCFVVCEECRITEWVSVCK,,Residues at positions 71 and 328 are N-linked glycosylated,,,
3688,Wnt-10b,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00744,,NEILGLKLPGEPPLTANTVCLTLSGLSKRQLGLCLRNPDVTASALQGLHIAVHECQHQLRDQRWNCSALEGGGRLPHHSAILKRGFRESAFSFSMLAAGVMHAVATACSLGKLVSCGCGWKGSGEQDRLRAKLLQLQALSRGKSFPHSLPSPGPGSSPSPGPQDTWEWGGCNHDMDFGEKFSRDFLDSREAPRDIQARMRIHNNRVGRQVVTENLKRKCKCHGTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHNRNSGAFQPRLRPRRLSGELVYFEKSPDFCERDPTMGSPGTRGRACNKTSRLLDGCGSLCCGRGHNVLRQTRVERCHCRFHWCCYVLCDECKVTEWVNVCK,,Threonine residues at positions 18 and 22 and serine residue at position 24 are phosphorylated; and residues at positions 65 and 307 are N-linked glycosylated,,,
3689,Wnt-11,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O96014,,IKWLALSKTPSALALNQTQHCKQLEGLVSAQVQLCRSNLELMHTVVHAAREVMKACRRAFADMRWNCSSIELAPNYLLDLERGTRESAFVYALSAAAISHAIARACTSGDLPGCSCGPVPGEPPGPGNRWGGCADNLSYGLLMGAKFSDAPMKVKKTGSQANKLMRLHNSEVGRQALRASLEMKCKCHGVSGSCSIRTCWKGLQELQDVAADLKTRYLSATKVVHRPMGTRKHLVPKDLDIRPVKDSELVYLQSSPDFCMKNEKVGSHGTQDRQCNKTSNGSDSCDLMCCGRGYNPYTDRVVERCHCKYHWCCYVTCRRCERTVERYVCK,,"Residues at positions 16, 66, 136, 276 and 280 are N-linked glycosylated",,,
3690,Wnt-16,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBV4,,NWMWLGIASFGVPEKLGCANLPLNSRQKELCKRKPYLLPSIREGARLGIQECGSQFRHERWNCMITAAATTAPMGASPLFGYELSSGTKETAFIYAVMAAGLVHSVTRSCSAGNMTECSCDTTLQNGGSASEGWHWGGCSDDVQYGMWFSRKFLDFPIGNTTGKENKVLLAMNLHNNEAGRQAVAKLMSVDCRCHGVSGSCAVKTCWKTMSSFEKIGHLLKDKYENSIQISDKTKRKMRRREKDQRKIPIHKDDLLYVNKSPNYCVEDKKLGIPGTQGRECNRTSEGADGCNLLCCGRGYNTHVVRHVERCECKFIWCCYVRCRRCESMTDVHTCK,,"Residues at positions 114, 160 and 282 are N-linked glycosylated",,,
3673,Wnt-2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P09544,,SWWYMRATGGSSRVMCDNVPGLVSSQRQLCHRHPDVMRAISQGVAEWTAECQHQFRQHRWNCNTLDRDHSLFGRVLLRSSRESAFVYAISSAGVVFAITRACSQGEVKSCSCDPKKMGSAKDSKGIFDWGGCSDNIDYGIKFARAFVDAKERKGKDARALMNLHNNRAGRKAVKRFLKQECKCHGVSGSCTLRTCWLAMADFRKTGDYLWRKYNGAIQVVMNQDGTGFTVANERFKKPTKNDLVYFENSPDYCIRDREAGSLGTAGRVCNLTSRGMDSCEVMCCGRGYDTSHVTRMTKCGCKFHWCCAVRCQDCLEALDVHTCKAPKNADWTTAT,Ser-Trp-Trp-Tyr-Met-Arg-Ala-Thr-Gly-Gly-Ser-Ser-Arg-Val-Met-Cys-Asp-Asn-Val-Pro-Gly-Leu-Val-Ser-Ser-Gln-Arg-Gln-Leu-Cys-His-Arg-His-Pro-Asp-Val-Met-Arg-Ala-Ile-Ser-Gln-Gly-Val-Ala-Glu-Trp-Thr-Ala-Glu-Cys-Gln-His-Gln-Phe-Arg-Gln-His-Arg-Trp- Asn-Cys-Asn-Thr-Leu-Asp-Arg-Asp-His-Ser-Leu-Phe-Gly-Arg-Val-Leu-Leu-Arg-Ser-Ser-Arg-Glu-Ser-Ala-Phe-Val-Tyr-Ala-Ile-Ser-Ser-Ala-Gly-Val-Val-Phe-Ala-Ile-Thr-Arg-Ala-Cys-Ser-Gln-Gly-Glu-Val-Lys-Ser-Cys-Ser-Cys-Asp-Pro-Lys-Lys-Met-Gly-Ser-Ala-Lys-Asp-Ser-Lys-Gly-Ile-Phe-Asp-Trp-Gly-Gly-Cys-Ser-Asp-Asn-Ile-Asp-Tyr-Gly-Ile-Lys-Phe-Ala-Arg-Ala-Phe-Val-Asp-Ala-Lys-Glu-Arg-Lys-Gly-Lys-Asp-Ala-Arg-Ala-Leu-Met-Asn-Leu-His-Asn-Asn-Arg-Ala-Gly-Arg-Lys-Ala-Val-Lys-Arg-Phe-Leu-Lys-Gln-Glu-Cys-Lys-Cys-His-Gly-Val-Ser-Gly-Ser-Cys-Thr-Leu-Arg-Thr-Cys-Trp-Leu-Ala-Met-Ala-Asp-Phe-Arg-Lys-Thr-Gly-Asp-Tyr-Leu-Trp-Arg-Lys-Tyr-Asn-Gly-Ala-Ile-Gln-Val-Val-Met-Asn-Gln-Asp-Gly-Thr-Gly-Phe-Thr-Val-Ala-Asn-Glu-Arg-Phe-Lys-Lys-Pro-Thr-Lys-Asn-Asp-Leu-Val-Tyr-Phe-Glu-Asn-Ser-Pro-Asp-Tyr-Cys-Ile-Arg-Asp-Arg-Glu-Ala-Gly- Ser-Leu-Gly-Thr-Ala-Gly-Arg-Val-Cys-Asn-Leu-Thr-Ser-Arg-Gly-Met-Asp-Ser-Cys-Glu-Val-Met-Cys-Cys-Gly-Arg-Gly-Tyr-Asp-Thr-Ser-His-Val-Thr-Arg-Met-Thr-Lys-Cys-Gly-Cys-Lys-Phe-His-Trp-Cys-Cys-Ala-Val-Arg-Cys-Gln-Asp-Cys-Leu-Glu-Ala-Leu-Asp-Val-His-Thr-Cys-Lys-Ala-Pro-Lys-Asn-Ala-Asp-Trp-Thr-Thr-Ala-Thr,Residue at position 270 is N-linked glycosylated,,,
3674,Wnt-2b,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q93097,,MLRPGGAEEAAQLPLRRASAPVPVPSPAAPDGSRASARLGLACLLLLLLLTLPARVDTSWWYIGALGARVICDNIPGLVSRQRQLCQRYPDIMRSVGEGAREWIRECQHQFRHHRWNCTTLDRDHTVFGRVMLRSSREAAFVYAISSAGVVHAITRACSQGELSVCSCDPYTRGRHHDQRGDFDWGGCSDNIHYGVRFAKAFVDAKEKRLKDARALMNLHNNRCGRTAVRRFLKLECKCHGVSGSCTLRTCWRALSDFRRTGDYLRRRYDGAVQVMATQDGANFTAARQGYRRATRTDLVYFDNSPDYCVLDKAAGSLGTAGRVCSKTSKGTDGCEIMCCGRGYDTTRVTRVTQCECKFHWCCAVRCKECRNTVDVHTCKAPKKAEWLDQT,,N-linked glycosylation of residues 117 and 283,,,
3675,Wnt-3,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P56703,,GYPIWWSLALGQQYTSLGSQPLLCGSIPGLVPKQLRFCRNYIEIMPSVAEGVKLGIQECQHQFRGRRWNCTTIDDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTSTICGCDSHHKGPPGEGWKWGGCSEDADFGVLVSREFADARENRPDARSAMNKHNNEAGRTTILDHMHLKCKCHGLSGSCEVKTCWWAQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRAKYSLFKPPTERDLVYYENSPNFCEPNPETGSFGTRDRTCNVTSHGIDGCDLLCCGRGHNTRTEKRKEKCHCIFHWCCYVSCQECIRIYDVHTCK,,Residues at positions 69 and 280 are N-linked glycosylated,,,
3549,Wnt-3a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P56704,,SYPIWWSLAVGPQYSSLGSQPILCASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRRWNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRSCAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSREFADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGLSGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRESRGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFGTRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFHWCCYVSCQECTRVYDVHTCK,,Lipidation of serine residue at position 209 is (O-palmitoyl serine); predicted lipidation of cysteine residue at position 59 to S-palmitoyl cysteine; predicted N-linked glycosylation of asparagine residues at positions 69 amd 280.,,,
3547,Wnt-4,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P56705,,SNWLYLAKLSSVGSISEEETCEKLKGLIQRQVQMCKRNLEVMDSVRRGAQLAIEECQYQFRNRRWNCSTLDSLPVFGKVVTQGTREAAFVYAISSAGVAFAVTRACSSGELEKCGCDRTVHGVSPQGFQWSGCSDNIAYGVAFSQSFVDVRERSKGASSSRALMNLHNNEAGRKAILTHMRVECKCHGVSGSCEVKTCWRAVPPFRQVGHALKEKFDGATEVEPRRVGSSRALVPRNAQFKPHTDEDLVYLEPSPDFCEQDMRSGVLGTRGRTCNKTSKAIDGCELLCCGRGFHTAQVELAERCSCKFHWCCFVKCRQCQRLVELHTCR,,Predicted N-linked glycosylation os asparagine residues at positions 66 and 275,,,
3548,Wnt-5a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P41221,,IIGAQPLCSQLAGLSQGQKKLCHLYQDHMQYIGEGAKTGIKECQYQFRHRRWNCSTVDNTSVFGRVMQIGSRETAFTYAVSAAGVVNAMSRACREGELSTCGCSRAARPKDLPRDWLWGGCGDNIDYGYRFAKEFVDARERERIHAKGSYESARILMNLHNNEAGRRTVYNLADVACKCHGVSGSCSLKTCWLQLADFRKVGDALKEKYDSAAAMRLNSRGKLVQVNSRFNSPTTQDLVYIDPSPDYCVRNESTGSLGTQGRLCNKTSEGMDGCELMCCGRGYDQFKTVQTERCHCKFHWCCYVKCKKCTEIVDQFVCK,,"Predicted N-linked glycosylation of asparagine residues at positions 53, 59, 251 and 265. Cysteine residue at position 43 is predicted to be S-palmitoyl cysteine",,,
3676,Wnt-5b,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9H1J7,,QLLTDANSWWSLALNPVQRPEMFIIGAQPVCSQLPGLSPGQRKLCQLYQEHMAYIGEGAKTGIKECQHQFRQRRWNCSTADNASVFGRVMQIGSRETAFTHAVSAAGVVNAISRACREGELSTCGCSRTARPKDLPRDWLWGGCGDNVEYGYRFAKEFVDAREREKNFAKGSEEQGRVLMNLQNNEAGRRAVYKMADVACKCHGVSGSCSLKTCWLQLAEFRKVGDRLKEKYDSAAAMRVTRKGRLELVNSRFTQPTPEDLVYVDPSPDYCLRNESTGSLGTQGRLCNKTSEGMDGCELMCCGRGYNQFKSVQVERCHCKFHWCCFVRCKKCTEIVDQYICK,,"Residues at positions 76, 82, 274 and 288 are N-linked glycosylated",,,
3678,Wnt-6,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y6F9,,LWWAVGSPLVMDPTSICRKARRLAGRQAELCQAEPEVVAELARGARLGVRECQFQFRFRRWNCSSHSKAFGRILQQDIRETAFVFAITAAGASHAVTQACSMGELLQCGCQAPRGRAPPRPSGLPGTPGPPGPAGSPEGSAAWEWGGCGDDVDFGDEKSRLFMDARHKRGRGDIRALVQLHNNEAGRLAVRSHTRTECKCHGLSGSCALRTCWQKLPPFREVGARLLERFHGASRVMGTNDGKALLPAVRTLKPPGRADLLYAADSPDFCAPNRRTGSPGTRGRACNSSAPDLSGCDLLCCGRGHRQESVQLEENCLCRFHWCCVVQCHRCRVRKELSLCL,,Residues at positions 62 and 287 are N-linked glycosylated,,,
3679,Wnt-7a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O00755,,LGASIICNKIPGLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNCSALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQGNLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVFVDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVSGSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNKRPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGTQGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKFHWCCYVKCNTCSERTEMYTCK,,"Residues at positions 52, 96 and 264 are N-linked glycosylated",,,
3681,Wnt-7b,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P56706,,ALSSVVALGANIICNKIPGLAPRQRAICQSRPDAIIVIGEGAQMGINECQYQFRFGRWNCSALGEKTVFGQELRVGSREAAFTYAITAAGVAHAVTAACSQGNLSNCGCDREKQGYYNQAEGWKWGGCSADVRYGIDFSRRFVDAREIKKNARRLMNLHNNEAGRKVLEDRMQLECKCHGVSGSCTTKTCWTTLPKFREVGHLLKEKYNAAVQVEVVRASRLRQPTFLRIKQLRSYQKPMETDLVYIEKSPNYCEEDAATGSVGTQGRLCNRTSPGADGCDTMCCGRGYNTHQYTKVWQCNCKFHWCCFVKCNTCSERTEVFTCK,,"Residues at positions 59, 103 and 271 are N-linked glycosylated",,,
3682,Wnt-8a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9H1J5,,VNNFLITGPKAYLTYTTSVALGAQSGIEECKFQFAWERWNCPENALQLSTHNRLRSATRETSFIHAISSAGVMYIITKNCSMGDFENCGCDGSNNGKTGGHGWIWGGCSDNVEFGERISKLFVDSLEKGKDARALMNLHNNRAGRLAVRATMKRTCKCHGISGSCSIQTCWLQLAEFREMGDYLKAKYDQALKIEMDKRQLRAGNSAEGHWVPAEAFLPSAEAELIFLEESPDYCTCNSSLGIYGTEGRECLQNSHNTSRWERRSCGRLCTECGLQVEERKTEVISSCNCKFQWCCTVKCDQCRHVVSKYYCARSPGSAQSLGKGSA,,"Residues at positions 79, 238 and 257 are N-linked glycosylated",,,
3683,Wnt-8b,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q93098,,WSVNNFLMTGPKAYLIYSSSVAAGAQSGIEECKYQFAWDRWNCPERALQLSSHGGLRSANRETAFVHAISSAGVMYTLTRNCSLGDFDNCGCDDSRNGQLGGQGWLWGGCSDNVGFGEAISKQFVDALETGQDARAAMNLHNNEAGRKAVKGTMKRTCKCHGVSGSCTTQTCWLQLPEFREVGAHLKEKYHAALKVDLLQGAGNSAAGRGAIADTFRSISTRELVHLEDSPDYCLENKTLGLLGTEGRECLRRGRALGRWERRSCRRLCGDCGLAVEERRAETVSSCNCKFHWCCAVRCEQCRRRVTKYFCSRAERPRGGAAHKPGRKP,,Residues at positions 81 and 237 are N-linked glycosylated,,,
3684,Wnt-9a,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14904,,YFGLTGSEPLTILPLTLEPEAAAQAHYKACDRLKLERKQRRMCRRDPGVAETLVEAVSMSALECQFQFRFERWNCTLEGRYRASLLKRGFKETAFLYAISSAGLTHALAKACSAGRMERCTCDEAPDLENREAWQWGGCGDNLKYSSKFVKEFLGRRSSKDLRARVDFHNNLVGVKVIKAGVETTCKCHGVSGSCTVRTCWRQLAPFHEVGKHLKHKYETALKVGSTTNEAAGEAGAISPPRGRASGAGGSDPLPRTPELVHLDDSPSFCLAGRFSPGTAGRRCHREKNCESICCGRGHNTQSRVVTRPCQCQVRWCCYVECRQCTQREEVYTCKG,,Residue at position 74 is N-linked glycosylated,,,
3686,Wnt-9b,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,O14905,,SYFGLTGREVLTPFPGLGTAAAPAQGGAHLKQCDLLKLSRRQKQLCRREPGLAETLRDAAHLGLLECQFQFRHERWNCSLEGRMGLLKRGFKETAFLYAVSSAALTHTLARACSAGRMERCTCDDSPGLESRQAWQWGVCGDNLKYSTKFLSNFLGSKRGNKDLRARADAHNTHVGIKAVKSGLRTTCKCHGVSGSCAVRTCWKQLSPFRETGQVLKLRYDSAVKVSSATNEALGRLELWAPARQGSLTKGLAPRSGDLVYMEDSPSFCRPSKYSPGTAGRVCSREASCSSLCCGRGYDTQSRLVAFSCHCQVQWCCYVECQQCVQEELVYTCKH,,Residue at position 77 is N-linked glycosylated,,,
5372,Wnt-inhibitory factor,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9Y5W5,,GPPQEESLYLWIDAHQARVLIGFEEDILIVSEGKMAPFTHDFRKAQQRMPAIPVNIHSMNFTWQAAGQAEYFYEFLSLRSLDKGIMADPTVNVPLLGTVPHKASVVQVGFPCLGKQDGVAAFEVDVIVMNSEGNTILQTPQNAIFFKTCQQAECPGGCRNGGFCNERRICECPDGFHGPHCEKALCTPRCMNGGLCVTPGFCICPPGFYGVNCDKANCSTTCFNGGTCFYPGKCICPPGLEGEQCEISKCPQPCRNGGKCIGKSKCKCSKGYQGDLCSKPVCEPGCGAHGTCHEPNKCQCQEGWHGRHCNKRYEASLIHALRPAGAQLRQHTPSLKKAEERRDPPESNYIW,,"Disulphide bond formation between cysteine residues at positions 112 and 149. For a complete list of predicted post-translation modifications, see the Uniprot entry for this protein",,,
3647,XCL1,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,P47992,,VGSEVSDKRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG,Val-Gly-Ser-Glu-Val-Ser-Asp-Lys-Arg-Thr-Cys-Val-Ser-Leu-Thr-Thr-Gln-Arg-Leu-Pro-Val-Ser-Arg-Ile-Lys-Thr-Tyr-Thr-Ile-Thr-Glu-Gly-Ser-Leu-Arg-Ala-Val-Ile-Phe-Ile-Thr-Lys-Arg-Gly-Leu-Lys-Val-Cys-Ala-Asp-Pro-Gln-Ala-Thr-Trp-Val-Arg-Asp-Val-Val-Arg-Ser-Met-Asp-Arg-Lys-Ser-Asn-Thr-Arg-Asn-Asn-Met-Ile-Gln-Thr-Lys-Pro-Thr-Gly-Thr-Gln-Gln-Ser-Thr-Asn-Thr-Ala-Val-Thr-Leu-Thr-Gly,Disulphide bond formation between cysteine residues at positions 11 and 48,,,
4447,XCL1,Mouse,"Endogenous peptide in human, mouse or rat",,,,,,,,,P47993,,VGTEVLEESSCVNLQTQRLPVQKIKTYIIWEGAMRAVIFVTKRGLKICADPEAKWVKAAIKTVDGRASTRKNMAETVPTGAQRSTSTAITLTG,Val-Gly-Thr-Glu-Val-Leu-Glu-Glu-Ser-Ser-Cys-Val-Asn-Leu-Gln-Thr-Gln-Arg-Leu-Pro-Val-Gln-Lys-Ile-Lys-Thr-Tyr-Ile-Ile-Trp-Glu-Gly-Ala-Met-Arg-Ala-Val-Ile-Phe-Val-Thr-Lys-Arg-Gly-Leu-Lys-Ile-Cys-Ala-Asp-Pro-Glu-Ala-Lys-Trp-Val-Lys-Ala-Ala-Ile-Lys-Thr-Val-Asp-Gly-Arg-Ala-Ser-Thr-Arg-Lys-Asn-Met-Ala-Glu-Thr-Val-Pro-Thr-Gly-Ala-Gln-Arg-Ser-Thr-Ser-Thr-Ala-Ile-Thr-Leu-Thr-Gly,,,,
4446,XCL1,Rat,"Endogenous peptide in human, mouse or rat",,,,,,,,,P51672,,VGTEVLQESICVSLRTQRLPVQKIKTYTIKEGAMRAVIFVTKRGLRICADPQAKWVKTAIKTVDGRASASKSKAETIPTQAQRSASTAVTLTG,Val-Gly-Thr-Glu-Val-Leu-Gln-Glu-Ser-Ile-Cys-Val-Ser-Leu-Arg-Thr-Gln-Arg-Leu-Pro-Val-Gln-Lys-Ile-Lys-Thr-Tyr-Thr-Ile-Lys-Glu-Gly-Ala-Met-Arg-Ala-Val-Ile-Phe-Val-Thr-Lys-Arg-Gly-Leu-Arg-Ile-Cys-Ala-Asp-Pro-Gln-Ala-Lys-Trp-Val-Lys-Thr-Ala-Ile-Lys-Thr-Val-Asp-Gly-Arg-Ala-Ser-Ala-Ser-Lys-Ser-Lys-Ala-Glu-Thr-Ile-Pro-Thr-Gln-Ala-Gln-Arg-Ser-Ala-Ser-Thr-Ala-Val-Thr-Leu-Thr-Gly,Disulphide bond formation between cysteiene residues at positions 10 and 48,,,
4370,XCL2,Human,"Endogenous peptide in human, mouse or rat",,,,,,,,,Q9UBD3,,MRLLILALLGICSLTAYIVEGVGSEVSHRRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG,,,,,
1587,xenin,"Human, Mouse, Rat","Endogenous peptide in human, mouse or rat",,,,,,,,,Q8CIE6|Q5BJV4|P53621,,MLTKFETKSARVKGLSFHPKRPWIL,Met-Leu-Thr-Lys-Phe-Glu-Thr-Lys-Ser-Ala-Arg-Val-Lys-Gly-Leu-Ser-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu,None.,,NCCCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)CCCCN)Cc1[nH]cnc1)Cc1ccccc1)CO)CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](CCSC)N)CC(C)C)CCCCN)Cc1ccccc1)CCC(=O)O)CCCCN)CO)C)CCCNC(=N)N,IDHVLSACPFUBDY-QCDLPZBNSA-N
1477,1DMe,,Other peptide,,,,,,,,,,,YLFQPQRF,D-Tyr-Leu-(N-Me)-Phe-Gln-Pro-Gln-Arg-Phe-NH2,,,CC(C[C@H](N(C(=O)[C@H](Cc1ccc(cc1)O)N)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CCCN=C(N)N)CCC(=O)N)CCC(=O)N)Cc1ccccc1)C,UQGBICZACVFETI-YTAGXALCSA-N
4050,2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 ,,Other peptide,,,,,yes,,,,,,,,,,,
4049,2-furoyl-LIGRL[N[3H]propionyl]-O-NH2,,Other peptide,,,,,yes,yes,,,,,LIGRLX,2-furoyl-Leu-Ile-Gly-Arg-Leu-[N[3H]propionyl]-Orn-NH2,,,,
3851,2-furoyl-LIGRLO-amide,,Other peptide,,,,,,,,,,,LIGRLX,(2-Furoyl)Leu-Ile-Gly-Arg-Leu-Orn-NH2,,,,
9436,[3-iodo-Tyr6]U-II-(4-11) (human),,Other peptide,,,,,,,,,,,DCFWKYCV,Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val,,,,
2193,3-N3-Phpa-LVA,,Other peptide,,,,,,,,,,,YFQNRPRY,3-(N3)phenylpropionyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2,,,,
627,"[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14)",,Other peptide,,,,,,,,,,,XHWAVAHPF,(3-Ph-Pr)-His-Trp-Ala-Val-D-Ala-His-D-Pro-(ψ)Phe,,,,
2161,4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide,,Other peptide,,,,,,,,,,,CAWXVCH,4-Cl-cinnamoyl-D-Cys-Pal-D-Trp-Orn-Val-Cys-His-NH2,,,,
4014,4-fluorobenzoyl-FGLRW-NH2,,Other peptide,,,,,,,,,,,FGLRW,Phe-Gly-Leu-Arg-Trp-NH2,,,,
137,5-HT-moduline,,Other peptide,,,,,,,,,,,LSAL,Leu-Ser-Ala-Leu,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)C)NC(=O)[C@H](CC(C)C)N,IMIVWAUMTAIVPJ-XUXIUFHCSA-N
8723,5nd,,Other peptide,,,,,,,,,,,YWCKGLCK,Tyr-Trp-c [Cys-Lys-Gly-Leu-Cys]-Lys-NH2,,,,
8330,A(10-24)INSL3,,Other peptide,,,,,,,,,,,CCLSGCTQQDLLTLC,Cys-Cys-Leu-Ser-Gly-Cys-Thr-Gln-Gln-Asp-Leu-Leu-Thr-Leu-Cys,,,,
8346,A(4-24)(B7-24)H2,,Other peptide,8347|8348,A(4-24)(B7-24)H2 chain A|A(4-24)(B7-24)H2 chain B,,,,,,,,,,,,,,
8347,A(4-24)(B7-24)H2 chain A,,Other peptide,,,,,,,,,,,SALANKCCHVGCTKRSLARFC,Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Arg-Phe-Cys,,,,
8348,A(4-24)(B7-24)H2 chain B,,Other peptide,,,,,,,,,,,VIKLCGRELVRAQIAICG,Val-Ile-Lys-Leu-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly,,,,
8349,A(4-24)(F23A)H2,,Other peptide,,,,,,,,,,,SALANKCCHVGCTKRSLARAC,Ser-Ala-Leu-Ala-Asn-Lys-Cys-Cys-His-Val-Gly-Cys-Thr-Lys-Arg-Ser-Leu-Ala-Arg-Ala-Cys,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CS)C)CCCN=C(N)N)C)CC(C)C)CO)CCCN=C(N)N)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)C)CC(C)C)C)CC(=O)N)CCCCN)CS)CS)Cc1nc[nH]c1)CS,JPICFXXNKSFHNE-FHWINVSDSA-N
894,A-71378,,Other peptide,,,,,,,,,,,XGWXDF,deamino-Tyr(SO3H)-Nle-Gly-Trp-Nle-(NMe)Asp-Phe-NH2,,,CCCC[C@@H](C(=O)NC(=O)c1ccccc1C[C@H](NC(=O)[C@H](CC(=O)O)NC)C)NC(=O)N(C(=O)CNC(=O)[C@@H](NC(=O)CCc1ccc(cc1)OS(=O)(=O)O)CCCC)Cc1c[nH]c2c1cccc2,DLOJBPLQFCFYKX-QQYYTUMTSA-N
858,A-71623,,Other peptide,,,,,,,,,,,XWKDF,Boc-Trp-Lys(O-toluylaminocarbonyl)-Asp-(NMe)Phe-NH2,,,OC(=O)C[C@@H](C(=O)N([C@H](C(=O)N)Cc1ccccc1)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)OC(C)(C)C)CCCCNC(=O)Nc1ccccc1C,KNHCBYMGWWTGSO-ZYADHFCISA-N
4856,A-71915,,Other peptide,,,,,,,,,,,RCAGGRIDRIXRC,Arg-Cys-β-Cha-Gly-Gly-Arg-Ile-Asp-Arg-Ile-D-Tic-Arg-Cys-NH2,,,,
5780,A8Δ71-73,,Other peptide,,,,,,,,,,,TLQKKIEEIAAKYKHSVVKKCCYDGAAVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISFKRS,Thr-Leu-Gln-Lys-Lys-Ile-Glu-Glu-Ile-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Val-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Ala-Val-Asn-Asn-Asp-Glu-Thr-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-Cys-Cys-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-Phe-Lys-Arg-Ser,,,,
8329,A(9-26)INSL3,,Other peptide,,,,,,,,,,,YCCLSGCTQQDLLTLCPY,Tyr-Cys-Cys-Leu-Ser-Gly-Cys-Thr-Gln-Gln-Asp-Leu-Leu-Thr-Leu-Cys-Pro-Tyr,,,SC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)CS)CC(C)C)[C@H](O)C)CC(C)C)CC(C)C)CC(=O)O)CCC(=O)N)CCC(=O)N)[C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)CS)CS)CC(C)C)CO,HHIHBEIJOBMKLZ-XYUOUADWSA-N
8299,abaloparatide,,Other peptide,,,yes,,,,,,,abaloparatide,AVSEHQLLHDKGKSIQDLRRRELLEKLLAKLHTA,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Ala-Lys-Leu-His-Thr-Ala,,,,
1188,abarelix,,Other peptide,,,yes,,,,,,,abarelix,AFASYNLKPA,Ac-Nal-Cpa-Pal-Ser-(Me)Tyr-Asn-Leu-(i-Pr)Lys-Pro-Ala-NH2,,,OC[C@@H](C(=O)N([C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)CC(=O)N)Cc1ccc(cc1)O)C)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1,AIWRTTMUVOZGPW-HSPKUQOVSA-N
8371,abicipar pegol,,Other peptide,,,,,,,,,,abicipar pegol,GSDLDKKLLEAARAGQDDEVRILMANGADVNARDSTGWTPLHLAAPWGHPEIVEVLLKNGADVNAADFQGWTPLHLAAAVGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDNGNEDLAEILQKAAGGGSGGGSC,,,,,
5308,ABS-201,,Other peptide,,,,,,,,,,,,,,,NCCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@H](C(=O)O)CC(C)C)Cc1ccc(cc1)O)CCCNC(=N)N)C,BLKOJISPADSFAG-JPDBKSEFSA-N
5307,ABS-212,,Other peptide,,,,,,,,,,,XRPYLL,Me-Orn-Arg-Pro-Tyr-tLeu-Leu,,,,
5132,Abz-Ser-Pro-Tyr(NO2)-OH,,Other peptide,,,,,,,,,,,SPT,Abz-Ser-Pro-Tyr-NO2,,,,
8331,A(C10/15S)INSL3,,Other peptide,,,,,,,,,,,AAATNPARTSCLSGSTQQDLLTLCPY,Ala-Ala-Ala-Thr-Asn-Pro-Ala-Arg-Thr-Ser-Cys-Leu-Ser-Gly-Ser-Thr-Gln-Gln-Asp-Leu-Leu-Thr-Leu-Cys-Pro-Tyr,,,,
2065,"AC-178,335",,Other peptide,,,,,,,,,,,HFIRWF,Ac-D-His-D-Phe-D-Ile-D-Arg-D-Trp-D-Phe-NH2,,,,
689,AC187,,Other peptide,,,,,,,,,,,VLGKLSQELHKLQTYPRTNTGSNTY,Ac-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Asn-Thr-Tyr-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)[C@H](O)C)CC(=O)N)CO)[C@H](O)C)CC(=O)N)[C@H](O)C)CCCNC(=N)N)Cc1ccc(cc1)O)[C@H](O)C)CCC(=O)N)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)C)CC(C)C)CCCCN)CC(C)C)CO)CCC(=O)N)CCC(=O)O)CC(C)C)Cc1nc[nH]c1,ZLFXHYNEZYAYPG-AABHONRUSA-N
1342,Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2,,Other peptide,,,,,,,,,,,CEHFRWCPPKD,Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2,,,,
5583,"[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II",,Other peptide,,,,,,,,,,,AFASHAWLPA,Ac-D-Nal-CPA-Pal-Ser-His-Pal-Trp-Leu-Pro-Ala-NH2,,,,
625,Ac-GRP-(20-26)-methylester,,Other peptide,,,,,,,,,,,HWAVGHL,Ac-His-Trp-Ala-Val-Gly-His-Leu-O-CH2CH3,,,,
2263,[Ac-His1]PACAP-27,,Other peptide,,,,,,,,,,,HSDGIFTDSYSRYRKQMAVKKYLAAVL,Ac-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2,,,,
1290,Ac-hMCH-(6-16)-NH2,,Other peptide,,,,,,,,,,,RCMLGRVYRPC,Ac-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-NH2,,,,
8300,aclerastide,,Other peptide,,,,,,,,,,aclerastide,DRXYIHP,H-Asp-Arg-Nle-Tyr-Ile-His-Pro-OH,,,,
651,"Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin",,Other peptide,,,,,,,,,,,KRPPGFAPL,Ac-Lys-Arg-Pro-Pro-Gly-Phe-(Me)Ala-Pro-Leu,,,,
3853,AcPhe-Orn-Pro-D-Cha-Trp-Arg,,Other peptide,,,,,,,,,,,FXPXWR,Ac-Phe-Orn-Pro-D-Cha-Trp-Arg,,,,
6191,Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2,,Other peptide,,,,,,,,,,,FWAHXGR,Phe-Trp-Ala-His-Nip-Gly-Arg,,,,
8380,Ac-RHYPLWR,,Other peptide,,,,,,,,,,,RHYPLWR,Ac-Arg-His-Tyr-Pro-Leu-Trp-Arg,,,,
1679,Ac-RYYRIK-NH2,,Other peptide,,,,,,,,,,,RYYRIK,Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2,,,,
1680,Ac-RYYRWK-NH2,,Other peptide,,,,,,,,,,,RYYRWK,Ac-Arg-Tyr-Tyr-Arg-Trp-Lys-NH2,,,,
10060,Ac-SDKP,,Other peptide,,,,,,,,,,,SDKP,Ac-Ser-Asp-Lys-Pro,,,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CO)CC(=O)O,HJDRXEQUFWLOGJ-AJNGGQMLSA-N
1332,ACTH-(11-24),,Other peptide,,,,,,,,,,,KPVGKKRRPVKVYP,Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro,,,,
1330,ACTH-(1-24),,Other peptide,,,,,,,,,,,SYSMEHFRWGKPVGKKRRPVKVYP,Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro,,,,
1125,"[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human)",,Other peptide,,,,,,,,,,,YRDAIFTNSYRKVLGQLSARKLLQDIMSR,Ac-Tyr-D-Arg-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2,,,,
8332,A(Δ10/15C)INSL3,,Other peptide,,,,,,,,,,,AAATNPARTCLSGTQQDLLTLCPY,Ala-Ala-Ala-Thr-Asn-Pro-Ala-Arg-Thr-Cys-Leu-Ser-Gly-Thr-Gln-Gln-Asp-Leu-Leu-Thr-Leu-Cys-Pro-Tyr,,,,
4861,AF12198,,Other peptide,,,,,,,,,,,FEWTPGWYQXYALPL,Ac-Phe-Glu-Trp-Thr-Pro-Gly-Trp-Tyr-Gln-Aze-Tyr-Ala-Leu-Pro-Leu-NH2,,,,
1324,afamelanotide,,Other peptide,,,yes,,,,,,,afamelanotide,SYSXEHFRWGKPV,Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2,,,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)C(C)C)CCCCN)Cc1c[nH]c2c1cccc2)CCCNC(=N)N)Cc1ccccc1)Cc1[nH]cnc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CO)Cc1ccc(cc1)O)CO,UAHFGYDRQSXQEB-LEBBXHLNSA-N
2613,AFT-II,,Other peptide,,,,,,,,,P10454,,GGVPCLCDSDGPSVRGNTLSGIIWLAGCPSGWHNCKAHGPTIGWCCKQ,Gly-Gly-Val-Pro-Cys-Leu-Cys-Asp-Ser-Asp-Gly-Pro-Ser-Val-Arg-Gly-Asn-Thr-Leu-Ser-Gly-Ile-Ile-Trp-Leu-Ala-Gly-Cys-Pro-Ser-Gly-Trp-His-Asn-Cys-Lys-Ala-His-Gly-Pro-Thr-Ile-Gly-Trp-Cys-Cys-Lys-Gln,"Disulphide bond formation between cysteine residues in positions 5 and 45, 7 and 35, and 28 and 46",,,
9219,AL-78898A,,Other peptide,,,,,,,,,,,,Ac-Ile-[Cys-Val-Trp(Me)-Gln-Asp-Trp-Gly-His-His-Arg-Cys]-Thr-NH2,,,,
9503,alafosfalin,,Other peptide,,,,,,,,,,alafosfalin,,,,,C[C@@H](P(=O)(O)O)NC(=O)[C@@H](N)C,BHAYDBSYOBONRV-IUYQGCFVSA-N
9342,alarelin,,Other peptide,,,,,,,,,,,XHWSYGLRP,pGlu-Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-NHEt,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)C)CC(C)C)CCCN=C(N)N,QLGKMLRGKPKGKI-QWQCQAQZSA-N
2278,"[Ala11,22,28]VIP",,Other peptide,,,,,,,,,,,HSDAVFTDNYARLRKQMAVKKALNSILA,His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH2,,,,
5575,"[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human)",,Other peptide,,,,,,,,,,,AVXEIQLMHQXAKWLNSMRRV,Ala-Val-Aib-Glu-Ile-Gln-Leu-Met-His-Gln-Har-Ala-Lys-Trp-Leu-Asn-Ser-Met-Arg-Arg-Val-NH2,,,,
5574,"[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human)",,Other peptide,,,,,,,,,,,AVXEIQLMHQXAKWLNSMRRVEWLRKKL,Ala-Val-Aib-Glu-Ile-Gln-Leu-Met-His-Gln-Har-Ala-Lys-Trp-Leu-Asn-Ser-Met-Arg-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-NH2,,,,
5573,"[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2",,Other peptide,,,,,,,,,,,AVXEIQLMHQXAKWLNSMRRVEWLRKKLQDVHNF,Ala-Val-Aib-Glu-Ile-Gln-Leu-Met-His-Gln-Har-Ala-Lys-Trp-Leu-Asn-Ser-Met-Arg-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-NH2,,,,
5576,"[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2",,Other peptide,,,,,,,,,,,AVXEIQLMHQXAKW,Ala-Val-Aib-Glu-Ile-Gln-Leu-Met-His-Gln-Har-Ala-Lys-Trp-NH2,,,,
1700,"[Ala11, D-Leu15]orexin-B",,Other peptide,,,,,,,,,,,RSGPPGLQGRLQRLLQASGNHAAGILTM,Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2,,,,
3837,"[Ala1,3,11,15]ET-1",,Other peptide,,,,,,,,,,,ASASSLMDKEAVYFAHLDIIW,Ala-Ser-Ala-Ser-Ser-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,,,,
1560,"[Ala31,Aib32]NPY",,Other peptide,,,,,,,,,,,YPSKPDNPGEDAPAEDMARYYSALRHYINLLXRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2,,,,
1522,"[Ala31,Aib32]NPY (pig)",,Other peptide,,,,,,,,,,,YPSKPDNPGEDAPAEDLARYYSALRHYINLAXRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2,,,,
6146,"[Ala6, D-Trp8]galanin-(1-15)-ol",,Other peptide,,,,,,,,,,,GWTLNTAWYLLGPHA,Gly-Trp-Thr-Leu-Asn-Thr-Ala-Trp-Tyr-Leu-Leu-Gly-Pro-His-Ala,,,,
7386,albiglutide,,Other peptide,,,yes,,,,,,,albiglutide,,,,,,
10226,albutensin A,,Other peptide,,,,,,,,,,,ALKAWSVAR,H-Ala-Leu-Lys-Ala-Trp-Ser-Val-Ala-Arg-OH,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)C)C(C)C)CO)Cc1c[nH]c2c1cccc2)C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC(C)C,CWUCHJAUTZCVMY-YUIUFFEESA-N
7561,alglucosidase alfa,,Other peptide,,,yes,,,,,,,alglucosidase alfa,,,,,,
7487,alpha1-proteinase inhibitor,,Other peptide,,,yes,,,,,,,,EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFAFSLYRQLAHQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGDTEEAKKQINDYVEKGTQGKIVDLVKELDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNATAIFFLPDEGKLQHLENELTHDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNGADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQK,Glu-Asp-Pro-Gln-Gly-Asp-Ala-Ala-Gln-Lys-Thr-Asp-Thr-Ser-His-His-Asp-Gln-Asp-His-Pro-Thr-Phe-Asn-Lys-Ile-Thr-Pro-Asn-Leu-Ala-Glu-Phe-Ala-Phe-Ser-Leu-Tyr-Arg-Gln-Leu-Ala-His-Gln-Ser-Asn-Ser-Thr-Asn-Ile-Phe-Phe-Ser-Pro-Val-Ser-Ile-Ala-Thr-Ala-Phe-Ala-Met-Leu-Ser-Leu-Gly-Thr-Lys-Ala-Asp-Thr-His-Asp-Glu-Ile-Leu-Glu-Gly-Leu-Asn-Phe-Asn-Leu-Thr-Glu-Ile-Pro-Glu-Ala-Gln-Ile-His-Glu-Gly-Phe-Gln-Glu-Leu-Leu-Arg-Thr-Leu-Asn-Gln-Pro-Asp-Ser-Gln-Leu-Gln-Leu-Thr-Thr-Gly-Asn-Gly-Leu-Phe-Leu-Ser-Glu-Gly-Leu-Lys-Leu-Val-Asp-Lys-Phe-Leu-Glu-Asp-Val-Lys-Lys-Leu-Tyr-His-Ser-Glu-Ala-Phe-Thr-Val-Asn-Phe-Gly-Asp-Thr-Glu-Glu-Ala-Lys-Lys-Gln-Ile-Asn-Asp-Tyr-Val-Glu-Lys-Gly-Thr-Gln-Gly-Lys-Ile-Val-Asp-Leu-Val-Lys-Glu-Leu-Asp-Arg-Asp-Thr-Val-Phe-Ala-Leu-Val-Asn-Tyr-Ile-Phe-Phe-Lys-Gly-Lys-Trp-Glu-Arg-Pro-Phe-Glu-Val-Lys-Asp-Thr-Glu-Glu-Glu-Asp-Phe-His-Val-Asp-Gln-Val-Thr-Thr-Val-Lys-Val-Pro-Met-Met-Lys-Arg-Leu-Gly-Met-Phe-Asn-Ile-Gln-His-Cys-Lys-Lys-Leu-Ser-Ser-Trp-Val-Leu-Leu-Met-Lys-Tyr-Leu-Gly-Asn-Ala-Thr-Ala-Ile-Phe-Phe-Leu-Pro-Asp-Glu-Gly-Lys-Leu-Gln-His-Leu-Glu-Asn-Glu-Leu-Thr-His-Asp-Ile-Ile-Thr-Lys-Phe-Leu-Glu-Asn-Glu-Asp-Arg-Arg-Ser-Ala-Ser-Leu-His-Leu-Pro-Lys-Leu-Ser-Ile-Thr-Gly-Thr-Tyr-Asp-Leu-Lys-Ser-Val-Leu-Gly-Gln-Leu-Gly-Ile-Thr-Lys-Val-Phe-Ser-Asn-Gly-Ala-Asp-Leu-Ser-Gly-Val-Thr-Glu-Glu-Ala-Pro-Leu-Lys-Leu-Ser-Lys-Ala-Val-His-Lys-Ala-Val-Leu-Thr-Ile-Asp-Glu-Lys-Gly-Thr-Glu-Ala-Ala-Gly-Ala-Met-Phe-Leu-Glu-Ala-Ile-Pro-Met-Ser-Ile-Pro-Pro-Glu-Val-Lys-Phe-Asn-Lys-Pro-Phe-Val-Phe-Leu-Met-Ile-Glu-Gln-Asn-Thr-Lys-Ser-Pro-Leu-Phe-Met-Gly-Lys-Val-Val-Asn-Pro-Thr-Gln-Lys,,,,
3964,α-bungarotoxin,,Other peptide,,,,,,,,,,,IVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,Ile-Val-Cys-His-Thr-Thr-Ala-Thr-Ser-Pro-Ile-Ser-Ala-Val-Thr-Cys-Pro-Pro-Gly-Gly-Asn-Leu-Cys-Tyr-Arg-Lys-Met-Trp-Cys-Asp-Ala-Phe-Cys-Ser-Ser-Arg-Gly-Lys-Val-Val-Glu-Leu-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ser-Lys-Lys-Pro-Tyr-Glu-Glu-Val-Thr-Cys-Cys-Ser-Thr-Asp-Lys-Cys-Asn-Pro-His-Pro-Lys-Gln-Arg-Pro-Gly,"Disulfide bridges between amino acids 3 - 23, 16 - 44, 29 - 33, 48 - 59, 60 - 65",,,
700,α-CGRP-(8-37) (human),,Other peptide,,,,,,,,,,,VTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C)CCCCN)CO)C(C)C)CC(=O)N)[C@H](O)C)C(C)C)Cc1ccccc1)CC(=O)N)CC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](C(C)C)N)Cc1nc[nH]c1)CCCN=C(N)N)CC(C)C)C)CC(C)C)CC(C)C)CO)CCCN=C(N)N)CO,LBOFHYKFMRHUFW-YVQXRMNASA-N
701,α-CGRP-(8-37) (rat),,Other peptide,,,,,,,,,,,VTHRLAGLLSRSGGVVKDNFVPTNVGSEAF,Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C)CCC(=O)O)CO)C(C)C)CC(=O)N)[C@H](O)C)C(C)C)Cc1ccccc1)CC(=O)N)CC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](C(C)C)N)Cc1nc[nH]c1)CCCN=C(N)N)CC(C)C)C)CC(C)C)CC(C)C)CO)CCCN=C(N)N)CO,FENOOIMBDDRVMP-QZMRZBIOSA-N
4007,α-conotoxin ArIB,,Other peptide,,,,,,,,,P0C8R2,,DECCSNPACRVNNPHVC,Asp-Glu-Cys-Cys-Ser-Asn-Pro-Ala-Cys-Arg-Val-Asn-Asn-Pro-His-Val-Cys,,,,
3973,α-conotoxin AuIB,,Other peptide,,,,,,,,,P56640,,GCCSYPPCFATNPDC,Gly-Cys-Cys-Ser-Tyr-Pro-Pro-Cys-Phe-Ala-Thr-Asn-Pro-Asp-Cys-NH2,C-terminal cysteine residue undergoes amidation; diuslphide bond formation between cysteine residues at positions 2 and 8 and 3 and 15,,NCC(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CCCN3C(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)Cc1ccccc1)C)[C@H](O)C)CC(=O)N)C(=O)N)CO)Cc1ccc(cc1)O)CCC3,SVNSCQIKKAACJG-SBLJLSJOSA-N
3983,α-conotoxin GI,,Other peptide,,,,,,,,,P01519,,ECCNPACGRHYSC,Glu-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Arg-His-Tyr-Ser-Cys-NH2,C-terminal cysteine residue undergoes amidation; diuslphide bond formation between cysteine residues at positions 2 and 7 and 3 and 13,,OC[C@@H]1NC(=O)[C@H](Cc2cccc(c2)O)NC(=O)[C@H](Cc2[nH]cnc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@H](NC1=O)C(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N2)C)NC(=O)[C@H](CCC(=O)O)N,CSUQNJQRLCOOSR-NAKBKFBQSA-N
4009,α-conotoxin-GIC,,Other peptide,,,,,,,,,Q86RB2,,GCCSHPACAGNNQHIC,Gly-Cys-Cys-Ser-His-Pro-Ala-Cys-Ala-Gly-Asn-Asn-Gln-His-Ile-Cys-NH2,Amidation of the C-terminal cysteine residue; disulphide bond formation bwtween cysteine residues at postions 2 and 8 and 3 and 16,,,
3965,α-conotoxin ImI,,Other peptide,,,,,,,,,P50983,,GCCSDPRCAWRC,Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys-NH2,"C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 2 and 8, and 3 and 12.",,,
3999,α-conotoxin MI,,Other peptide,,,,,,,,,P01521,,GRCCHPACGKNYSC,Gly-Arg-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Tyr-Ser-Cys-NH2,"Amidation of C-terminal cysteine residue; disulphide bond formation between cysteine residues at positions 3 and 8, and 4 and 14",,,
3970,α-conotoxin MII,,Other peptide,,,,,,,,,P56636,,GCCSNPVCHLEHSNLC,Gly-Cys-Cys-Ser-Asn-Pro-Val-Cys-His-Leu-Glu-His-Ser-Asn-Leu-Cys-NH2,Amidation of C-terminal cysteine residue; disulphide bond formation between cysteine residues at postions 2 and 8 and 3 and 16,,,
4010,"α-conotoxin MII [H9A, L15A]",,Other peptide,,,,,,,,,P56636,,GCCSNPVCALEHSNAC,Gly-Cys-Cys-Ser-Asn-Pro-Val-Cys-Ala-Leu-Glu-His-Ser-Asn-Ala-Cys-NH2,Amidation of C-terminal cysteine residue; disulphide bond formation between cysteine residues at postions 2 and 8 and 3 and 16,Amidation of C-terminal cysteine residue; disulphide bond formation between cysteine residues at postions 2 and 8 and 3 and 16,,
3985,α-conotoxin PIA,,Other peptide,,,,,,,,,P69658,,RDPCCSNPVCTVHNPQIC,Arg-Asp-Pro-Cys-Cys-Ser-Asn-Pro-Val-Cys-Thr-Val-His-Asn-Pro-Gln-Ile-Cys-NH2,"Amidation of C-terminal cysteine residue; disulphide bonds between cysteine residues at positions 4 and 10, and 5 and 18",,,
3982,α-conotoxin PnIA,,Other peptide,,,,,,,,,P50984,,GCCSLPPCAANNPDYC,Gly-Cys-Cys-Ser-Leu-Pro-Pro-Cys-Ala-Ala-Asn-Asn-Pro-Asp-Tyr(SO3H)-Cys-NH2,Residue 15 is sulfated tyrosine (Tyr(SO3H)); amidation of C-terminal cysteine residue; disulphide bond formation between cysteine residues at positions 2 and 8 and 3 and 16,,NCC(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H]3CCCN3C(=O)[C@H]3N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CSSC[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)C)C)CC(=O)N)CC(=O)N)C(=O)N)CO)CC(C)C)CCC3,VUVGEYBNLLGGBG-MVPSLEAZSA-N
4008,α-conotoxin RgIA,,Other peptide,,,,,,,,,P0C1D0,,GCCSDPRCRYRC,Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Arg-Tyr-Arg-Cys,Disulphide bond formation between cysteine residues at positions 2 and 8 and 3 and 11,,,
4011,α-conotoxin TxIA,,Other peptide,,,,,,,,,,,GCCSRPPCIANNPDLC,Gly-Cys-Cys-Ser-Arg-Pro-Pro-Cys-Ile-Ala-Asn-Asn-Pro-Asp-Leu-Cys,,,,
2563,α-dendrotoxin,,Other peptide,,,,,,,,,P00980,,QPRRKLCILHRNPGRCYDKIPAFYYNQKKKQCERFDWSGCGGNSNRFKTIEECRRTCIG,Gln-Pro-Arg-Arg-Lys-Leu-Cys-Ile-Leu-His-Arg-Asn-Pro-Gly-Arg-Cys-Tyr-Asp-Lys-Ile-Pro-Ala-Phe-Tyr-Tyr-Asn-Gln-Lys-Lys-Lys-Gln-Cys-Glu-Arg-Phe-Asp-Trp-Ser-Gly-Cys-Gly-Gly-Asn-Ser-Asn-Arg-Phe-Lys-Thr-Ile-Glu-Glu-Cys-Arg-Arg-Thr-Cys-Ile-Gly,"Residue 1 is pyrrolidone carboxylic acid; disulphide bond formation between cysteine residues at positions 7 and 57, 16 and 40 and 32 and 53",,,
923,α-helical CRF,,Other peptide,,,,,,,,,,,DLTFHLLREMLEMAKAEQEAEQAALNRLLLEEA,Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala,,,,
2550,α-KTx 13.2,,Other peptide,,,,,,,,,,,ACGPGCSGSCRQKGDRIKCINGSCHCYP,Ala-Cys-Gly-Pro-Gly-Cys-Ser-Gly-Ser-Cys-Arg-Gln-Lys-Gly-Asp-Arg-Ile-Lys-Cys-Ile-Asn-Gly-Ser-Cys-His-Cys-Tyr-Pro,"Predicted disulphide bonds between cysteine residues at positions 2 and 19, 6 and 24, and 10 and 26",,,
5897,α-latrotoxin,,Other peptide,,,,,,,,,P23631,,EGEDLTLEEKAEICSELELQQKYVDIASNIIGDLSSLPIAGKIAGTIAAAAMTATHVASGRLDIEQTLLGCSDLPFDQIKEVLENRFNEIDRKLDSHSAALEEITKLVEKSISVVEKTRKQMNKRFDEVMKSIQDAKVSPIISKINNFARYFDTEKERIRGLKLNDYILKLEEPNGILLHFKESRTPTDDSLQAPLFSIIEEGYAVPKSIDDELAFKVLYALLYGTQTYVSVMFFLLEQYSFLANHYYEKGYLEKYDEYFNSLNNVFLDFKSSLVGTGTSNNEGLLDRVLQVLMTVKNSEFLGLEKNGVDEMLNEKINLFNKIKEEIEGKQKMTLSETPENFAQISFDKDITTPIGDWRDGREVRYAVQYASETLFSKISHWSDPVSVREKACPTLRMPVDQTRRNVLVFRKFDSSKPQLVGEITPYLSNFIDIDRDLYNAASNPDSAVGFKEFTKLNYDGANIRATFDHGRTVFHAAAKSGNDKIMFGLTFLAKSTELNQPDKKGYTPIHVAADSGNAGIVNLLIQRGVSINSKTYHFLQTPLHLAAQRGFVTTFQRLMESPEININERDKDGFTPLHYAIRGGERILEAFLNQISIDVNAKSNTGLTPFHLAIIKNDWPVASTLLGSKKVDINAVDENNITALHYAAILGYLETTKQLINLKEINANVVSSPGLLSALHYAILYKHDDVASFLMRSSNVNVNLKALGGITPLHLAVIQGRKQILSLMFDIGVNIEQKTDEKYTPLHLAAMSKYPELIQILLDQGSNFEAKTNSGATPLHLATFKGKSQAALILLNNEVNWRDTDENGQMPIHGAAMTGLLDVAQAIISIDATVVDIEDKNSDTPLNLAAQNSHIDVIKYFIDQGADINTRNKKGLAPLLAFSKKGNLDMVKYLFDKNANVYIADNDGMNFFYYAVQNGHLNIVKYAMSEKDKFEWSNTDNNRRDECPNEECAISHFAVCDAVQFDRIEIVKYFVGTLGNFAICGPLHQAARYGHLDIVKYLVEEEFLSVDGSKTDTPLCYASENGHFTVVQYLVSNGAKVNHDCGNGMTAIDKAITKNHLQVVQFLAANGVDFRRKNSRGTTPFLTAVAENALHIAEYLIREKRQDININEQNVDKDTALHLAVYYKNLQMIKLLIKYGIDVTIRNAYDKTALDIAIDAKFSNIVEYLKTKSGKFRR,,Predicted disulphide bond formation between cysteine residues at positions 393 and 1046.,,,
2618,α-scorpion toxin 2,,Other peptide,,,,,,,,,P59355,,IKDGYIVDDVNCTYFCGRNAYCNEECTKLKGESGYCQWASPYGNACYCYKLPDHVRTKGPGRCR,Ile-Lys-Asp-Gly-Tyr-Ile-Val-Asp-Asp-Val-Asn-Cys-Thr-Tyr-Phe-Cys-Gly-Arg-Asn-Ala-Tyr-Cys-Asn-Glu-Glu-Cys-Thr-Lys-Leu-Lys-Gly-Glu-Ser-Gly-Tyr-Cys-Gln-Trp-Ala-Ser-Pro-Tyr-Gly-Asn-Ala-Cys-Tyr-Cys-Tyr-Lys-Leu-Pro-Asp-His-Val-Arg-Thr-Lys-Gly-Pro-Gly-Arg-Cys-Arg,"Residue one is arginine amide; predicated disulphide bond formation between cysteine residues at positions 12 and 63, 16 and 36, 22 and 46, and 26 and 48.",,,
7373,AlprolixTM,,Other peptide,,,yes,,,,,,,,,,,,,
9615,ALT-803,,Other peptide,,,,,,,,,,,,,,,,
607,ALX40-4C,,Other peptide,,,,,,,,,,,RRRRRRRRR,NAc-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-NH2,,,NC(=N)NCCC[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)C)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N)CCCNC(=N)N,LGLVVVCSQBZONM-HCCLCSBVSA-N
704,AM-(11-50) (rat),,Other peptide,,,,,,,,,,,STGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY,Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,,,,
705,AM-(20-50) (rat),,Other peptide,,,,,,,,,,,TMQKLAHQIYQFTDKDKDGMAPRNKISPQGY,Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,,,,
706,AM-(22-52) (human),,Other peptide,,,,,,,,,,,TVQKLAHQIYQFTDKDKDNVAPRSKISPQGY,Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,,,,
5635,AM3,,Other peptide,,,,,,,,,,,CFWKTC,Cys-Phe-D-Trp-Lys-Thr-Cys,,,,
10119,AM-6120,,Other peptide,,,,,,,,,,,EXCQKWXWTCDSARACCECLRCKLXCRKEI,Glu-Pra-Cys-Gln-Lys-Trp-Nle-Trp-Thr-Cys-Asp-Ser-Ala-Arg-Ala-Cys-Cys-Glu-Cys-Leu-Arg-Cys-Lys-Leu-Trp-Cys-Arg-Lys-Glu-Ile-NH2,,,,
4632,amanitin,,Other peptide,,,,,,,,,P85421,,IWGIGCNP,"((3R,4R)-4,5-dihydroxyisoleucine)-Trp-Gly-Ile-Gly-Cys-Asn-Hyp","N-terminal isoleucine is (3R,4R)-4,5-dihydroxyisoleucine; C-terminal proline is hydroxyproline; cross-linking between residues 1 and 8 (Ile-Pro), and 2 and 6 (Trp-Cys, 2'-cysteinyl-6'-hydroxytryptophan sulfoxide) to form a cyclic peptide",,OC[C@@H](C([C@@H]1NC(=O)[C@@H]2CC(CN2C(=O)[C@H](CC(=O)N)NC(=O)[C@@H]2CS(=O)c3c(C[C@H](NC1=O)C(=O)NCC(=O)N[C@@H](C(CC)C)C(=O)NCC(=O)N2)c1ccc(cc1[nH]3)O)O)C)O,CIORWBWIBBPXCG-JZTFPUPKSA-N
9587,AMG3054,,Other peptide,,,,,,,,,,,KFRRQRPXXQHKKXXPX,Lys-Phe-Arg-Arg-Gln-Arg-Pro-hArg-Cha-Glu-His-Lys-Lys-Oic-Nle-Pro-4-Cl-Phe,,,,
6972,anakinra,,Other peptide,,,yes,,,,,,,anakinra,MRPSGRKSSKMQAFRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKIDVVPIEPHALFLGIHGGKMCLSCVKSGDETRLQLEAVNITDLSENRKQDKRFAFIRSDSGPTTSFESAACPGWFLCTAMEADQPVSLTNMPDEGVMVTKFYFQEDE,Met-Arg-Pro-Ser-Gly-Arg-Lys-Ser-Ser-Lys-Met-Gln-Ala-Phe-Arg-Ile-Trp-Asp-Val-Asn-Gln-Lys-Thr-Phe-Tyr-Leu-Arg-Asn-Asn-Gln-Leu-Val-Ala-Gly-Tyr-Leu-Gln-Gly-Pro-Asn-Val-Asn-Leu-Glu-Glu-Lys-Ile-Asp-Val-Val-Pro-Ile-Glu-Pro-His-Ala-Leu-Phe-Leu-Gly-Ile-His-Gly-Gly-Lys-Met-Cys-Leu-Ser-Cys-Val-Lys-Ser-Gly-Asp-Glu-Thr-Arg-Leu-Gln-Leu-Glu-Ala-Val-Asn-Ile-Thr-Asp-Leu-Ser-Glu-Asn-Arg-Lys-Gln-Asp-Lys-Arg-Phe-Ala-Phe-Ile-Arg-Ser-Asp-Ser-Gly-Pro-Thr-Thr-Ser-Phe-Glu-Ser-Ala-Ala-Cys-Pro-Gly-Trp-Phe-Leu-Cys-Thr-Ala-Met-Glu-Ala-Asp-Gln-Pro-Val-Ser-Leu-Thr-Asn-Met-Pro-Asp-Glu-Gly-Val-Met-Val-Thr-Lys-Phe-Tyr-Phe-Gln-Glu-Asp-Glu,,,,
5647,analog 30 [PMID:18543899],,Other peptide,,,,,,,,,,,XCKNFXXKTFTSCX,DOTA-Phe(4-Cl)-D-Cys(1)-Lys-Asn-Phe-Phe(NH2)(L-hyrdoorotyl)-D-Phe(NH2)-CONH2-Lys-Thr-Phe-Thr-Ser-Cys(1)-2Nal-NH2,,,,
5648,analog 31 [PMID:18543899],,Other peptide,,,,,,,,,,,XXKNFXXKTFTSCX,DOTA-Phe(4-Cl)-D-Cys(1)-Lys-Asn-Phe-Phe(NH2)(L-hyrdoorotyl)-D-Phe(NH2)-CONH2-Lys-Thr-Phe-Thr-Ser-Cys(1)-D-Tyr-NH2,,,,
7763,analog 32 [PMID:18543899],,Other peptide,,,,,,,,,,,XXKNFXXKTFTSCX,DOTA-Phe(NO2)-D-Cys(1)-Lys-Asn-Phe-Tyr(I)-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys(1)-D-Tyr-NH2,,,,
5646,analog 3 [PMID:18543899],,Other peptide,,,,,,,,,,,XXKNFYXKTFTSCX,DOTA-Phe(NO2)-D-Cys(1)-Lys-Asn-Phe-Tyr-D-Phe(NH2)-CONH2-Lys-Thr-Phe-Thr-Ser-Cys(1)-D-Tyr-NH2,,,,
4866,anantin,,Other peptide,,,,,,,,,,,GFIGWGNDIFGHYSGDF,c[Gly-Phe-Ile-Gly-Trp-Gly-Asn-β-Asp]-Ile-Phe-Gly-His-Tyr-Ser-Gly-Asp-Phe,,,,
7576,andexanet alfa,,Other peptide,,,yes,,,,,,,andexanet alfa,ANSFLFWNKYKDGDQCETSPCQNQGKCKDGLGEYTCTCLEGFEGKNCELFTRKLCSLDNGDCDQFCHEEQNSVVCSCARGYTLADNGKACIPTGPYPCGKQTLERRKRRKRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVGDRNTEQEEGGEAVHEVEVVIKHNRFTKETYDFDIAVLRLKTPITFRMNVAPACLPERDWAESTLMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSFIITQNMFCAGYDTKQEDACQGDAGGPHVTRFKDTYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMKTRGLPKAKSHAPEVITSSPLK,,,,,
1189,antarelix,,Other peptide,,,,,,,,,,teverelix,AFASYXLKPA,Ac-D-Nal-D-Cpa-D-Pal-Ser-Tyr-D-Hci-Leu-Lys(iPr)-Pro-D-Ala-NH2,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@@H]1C(=O)NC(C(=O)N)C)CCCCNC(C)C)CC(C)C)CCCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1,NOENHWMKHNSHGX-FAZSUBJTSA-N
931,antisauvagine,,Other peptide,,,,,,,,,,,FHLLRKMIEIEKQEKEKQQAANNRLLLDTI,D-Phe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2,,,,
4870,AP811,,Other peptide,,,,,,,,,,,RIDR,Arg-Ile-Asp-Arg,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NC[C@H](CC)C)CCCNC(=N)N)CC(=O)O)NC(=O)[C@@H](NC(=O)Cc1ccc(cc1)NC(=O)c1ccc2c(c1)cccc2)CCCNC(=N)C)C,SSSOLDGLOKWDSV-VLDRZRDYSA-N
2311,apamin,,Other peptide,,,,,,,,,,,CNCKAPETALCARRCQQH,Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2,"Amidation of histidine C-terminal residue; disulphide bond formation between cysteine residues at positions 1 and 11, and 3 and 15.",,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC1=O)C)CCC2)CCC(=O)O)[C@H](O)C)C)CC(C)C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1cnc[nH]1)CCC(=O)N)CCC(=O)N,YVIIHEKJCKCXOB-STYWVVQQSA-N
5354,apelin-13(F13A),,Other peptide,,,,,,,,,,,QRPRLSHKGPMPA,Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala,,,,
2609,APETx-1,,Other peptide,,,,,,,,,P61541,,GTTCYCGKTIGIYWFGTKTCPSNRGYTGSCGYFLGICCYPVD,Gly-Thr-Thr-Cys-Tyr-Cys-Gly-Lys-Thr-Ile-Gly-Ile-Tyr-Trp-Phe-Gly-Thr-Lys-Thr-Cys-Pro-Ser-Asn-Arg-Gly-Tyr-Thr-Gly-Ser-Cys-Gly-Tyr-Phe-Leu-Gly-Ile-Cys-Cys-Tyr-Pro-Val-Asp,"Disulphide bond formation between cysteine residues at positions 4 and 37, 6 and 30, and 20 and 38.",,,
4135,APETx2,,Other peptide,,,,,,,,,P61542,,GTACSCGNSKGIYWFYRPSCPTDRGYTGSCRYFLGTCCTPAD,Gly-Thr-Ala-Cys-Ser-Cys-Gly-Asn-Ser-Lys-Gly-Ile-Tyr-Trp-Phe-Tyr-Arg-Pro-Ser-Cys-Pro-Thr-Asp-Arg-Gly-Tyr-Thr-Gly-Ser-Cys-Arg-Tyr-Phe-Leu-Gly-Thr-Cys-Cys-Thr-Pro-Ala-Asp,"Disulphide bond formation between cysteine residues at positions 4 and 37, 6 and 30 and 20 and 38",,,
6570,aprotinin,Bovine,Other peptide,,,yes,,,,,,P00974,aprotinin,RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA,Arg-Pro-Asp-Phe-Cys-Leu-Glu-Pro-Pro-Tyr-Thr-Gly-Pro-Cys-Lys-Ala-Arg-Ile-Ile-Arg-Tyr-Phe-Tyr-Asn-Ala-Lys-Ala-Gly-Leu-Cys-Gln-Thr-Phe-Val-Tyr-Gly-Gly-Cys-Arg-Ala-Lys-Arg-Asn-Asn-Phe-Lys-Ser-Ala-Glu-Asp-Cys-Met-Arg-Thr-Cys-Gly-Gly-Ala,,,,
7043,AR305352,,Other peptide,,,,,,,,,,,,,,,,
2169,arginine vasotocin,,Other peptide,,,,,,,,,,argiprestocin,CYIQNCPRG,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,CC[C@@H](C1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)C,OXDZADMCOWPSOC-ICBIOJHSSA-N
1689,[Arg14Lys15]N/OFQ,,Other peptide,,,,,,,,,,,FGGFTGARKSARKRKNQ,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Arg-Lys-Asn-Gln,,,,
3293,[Arg16]chicken secretin,,Other peptide,,,,,,,,,,,HSDGLFTSEYSKMRGRAQVQKFIQNLM,His-Ser-Asp-Gly-Leu-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Met-Arg-Gly-Arg-Ala-Gln-Val-Gln-Lys-Phe-Ile-Gln-Asn-Leu-Met-NH2,,,,
1792,[Arg19]PTH-(1-34) (human),,Other peptide,,,,,,,,,,,SVSEIQLMHNLGKHLNSMRRVEWLRKKLQDVHNF,Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Arg-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
859,ARL-15849,,Other peptide,,,,,,,,,,,XGWXDF,Hpa(SO3H)-Nle-Gly-Trp-Nle-N(Me)-Asp-Phe-NH2,,,,
1327,ASIP [90-132 (L89Y)],,Other peptide,,,,,,,,,,,YSAPCVATRNSCKPPAPACCDPCASCQCRFFRSACSCRVLSLNC,Tyr-Ser-Ala-Pro-Cys-Val-Ala-Thr-Arg-Asn-Ser-Cys-Lys-Pro-Pro-Ala-Pro-Ala-Cys-Cys-Asp-Pro-Cys-Ala-Ser-Cys-Gln-Cys-Arg-Phe-Phe-Arg-Ser-Ala-Cys-Ser-Cys-Arg-Val-Leu-Ser-Leu-Asn-Cys,,,,
925,astressin,,Other peptide,,,,,,,,,,,FHLLREVLEXARAEQLAQEAHKNRKLXEII,D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(-Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2,,,CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C)Cc1nc[nH]c1)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)[C@H](CC)C)CCC(=O)O)CCCC)CC(C)C)CCCCN)CCCNC(=N)N)CC(=O)N)CCC(=O)N)C)CC(C)C)CCC(=O)N)CCC(=O)O)C)CCCNC(=N)N)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)O)CC(C)C)CCC(=O)O,HPYIIXJJVYSMCV-MGDXKYBTSA-N
10335,astressin 2B,,Other peptide,,,,,,,,,,,DLSFHLLRKXIEIEKQEKEKQQAENNKLLLDLI,Ac-Asp-Leu-Ser-D-Phe-His-D-aMeLeu-Leu-Arg-Lys-Nle-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Glu(1)-Asn-Asn-Lys(1)-Leu-Leu-Leu-Asp-D-aMeLeu-Ile-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H]1CCC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)N)CC(=O)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)(CC(C)C)C)CC(=O)O)CC(C)C)CC(C)C)CC(C)C)C)CCC(=O)N)CCC(=O)N)CCCCN)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(=O)O)CC(C)C)CO)Cc1ccccc1)Cc1c[nH]cn1)(CC(C)C)C)CC(C)C)CCCNC(=N)N)CCCCN)CCCC)CCC(=O)O)CCC(=O)O)CCCCN)CCC(=O)N)CCC(=O)O,IVIBPRHVUKMKSX-YJHXGIRISA-N
4852,"[Asu7,23']β-ANP-(7-28)",,Other peptide,,,,,,,,,,,CFGGRMDRIGAQSGLGXNSFRY,Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Asu-Asn-Ser-Phe-Arg-Tyr,,,,
9517,atacicept,,Other peptide,,,,,,,,,,atacicept,AMRSCPEEQYWDPLLGTCMSCKTICNHQSQRTCAAFCRSLSCRKEQGKFYDHLLRDCISCASICGQHPKQCAYFCENKLRSEPKSSDKTHTCPPCPAPEAEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPSSIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK,,,,,
2213,atosiban,,Other peptide,,,yes,,,,,,,atosiban,XYITNCPXG,Mpa-D-(2Et)-Tyr-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2,,,NCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSCCC(=O)N[C@H](Cc2ccc(cc2)OCC)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)[C@H](O)C)[C@H](CC)C,VWXRQYYUEIYXCZ-OBIMUBPZSA-N
2614,ATX-II,,Other peptide,,,,,,,,,P01528,,GVPCLCDSDGPSVRGNTLSGIIWLAGCPSGWHNCKKHGPTIGWCCKQ,Gly-Val-Pro-Cys-Leu-Cys-Asp-Ser-Asp-Gly-Pro-Ser-Val-Arg-Gly-Asn-Thr-Leu-Ser-Gly-Ile-Ile-Trp-Leu-Ala-Gly-Cys-Pro-Ser-Gly-Trp-His-Asn-Cys-Lys-Lys-His-Gly-Pro-Thr-Ile-Gly-Trp-Cys-Cys-Lys-Gln,"Disulphide bond formation between cysteine residues at positions 4 and 44, 6 and 34, and 27 and 45",,,
8738,aTyr 1940,,Other peptide,,,,,,,,,,,,,,,,
10117,AUNP-12,,Other peptide,,,,,,,,,,,SNTSESFK(SNTSESF)FRVTQLAPKAQIKE-NH2,,,,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](O)C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC(=O)N)CO)CCC(=O)O)CO)Cc1ccccc1)CCCCNN[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C=O)CO)CC(=O)N)[C@@H](O)C)CO)CCC(=O)O)CO)Cc1ccccc1)Cc1ccccc1)CCCNC(=N)N)CCC(=O)N)CC(C)C)C)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NN)CCCCN)CCC(=O)N)C,YQYGGOPUTPQHAY-KIQLFZLRSA-N
3855,Ava3,,Other peptide,,,,,,,,,,,WYKXXXGRAAGLLSGL,Trp-Tyr-Lys-Ava-Ava-Ava-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu,,,,
3856,Ava5,,Other peptide,,,,,,,,,,,WYKXXXXXGRAAGLLSGL,Trp-Tyr-Lys-Ava-Ava-Ava-Ava-Ava-Ava-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu,,,,
1307,"[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2",,Other peptide,,,,,,,,,,,RCMXXRVYXYC,Ac-Arg-Cys-Met-Ava-Ava-Arg-Val-Tyr-Ava-Ava-Cys-NH2,,,,
9455,AY77,,Other peptide,,,,,,,,,,,,Isox-Cha-Chg-NH2,,,,
4061,AYPGKF-NH2,,Other peptide,,,,,,,,,,,AWPGKF,Ala-Tyr-Pro-Gly-Lys-Phe-NH2,,,,
9221,azapro-3,,Other peptide,,,,,,,,,,,ABZ-VAD(aza)norVADYQ-Y(NO2),,,,,
652,B-10356,,Other peptide,,,,,,,,,,,RKRPXGGSXG,D-Arg-Lys-Arg-Pro-Hyp-Gly-CpG-Ser-D-Tic-CpG,,,,
9321,(B7-33)H2,,Other peptide,,,,,,,,,,,,,,,,
653,B-9430,,Other peptide,,,,,,,,,,,RRPXGXSXXR,D-Arg-Arg-Pro-Hyp-Gly-Igl-Ser-D-Igl-Oic-Arg,,,,
654,B-9858,,Other peptide,,,,,,,,,,,KKRPXGXSXX,Lys-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-Igl-Oic,,,,
655,B-9958,,Other peptide,,,,,,,,,,,,,,,,
5644,BASS antagonist,,Other peptide,,,,,,,,,,,FCYWKTCY,Phe-Cys-Tyr-Trp-Lys-Thr-Cys-Tyr,,,,
2269,BAY 55-9837,,Other peptide,,,,,,,,,,,HSDAVFTDNYTRLRKQVAAKKYLQSIKNKRY,His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Val-Ala-Ala-Lys-Lys-Tyr-Leu-Gln-Ser-Ile-Lys-Asn-Lys-Arg-Tyr,,,,
895,BBL-454,,Other peptide,,,,,,,,,,,WXDF,H-(CH2)5NHCO-CH2CO-Trp-(NMe)Nle-Asp-Phe-NH2,,,,
896,BC-254,,Other peptide,,,,,,,,,,,XYXKWXDF,D-Ggu-Tyr-Nle-D-Lys-Trp-Nle-Asp-Phe,,,,
897,BC-264,,Other peptide,,,,,,,,,,,YXGWXDF,Boc-Tyr(SO3H)-gNle-mGly-Trp-(NMe)Nle-Asp-Phe-NH2,,,CCCC[C@H](NC(=O)[C@H](Cc1ccc(cc1)OS(=O)(=O)O)NC(=O)OC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N(C(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CC(=O)N)C)CCCC)CC(=O)O)Cc1ccccc1,LEXXPLMUWFLNAN-OZUMUDGSSA-N
2615,Bc-III,,Other peptide,,,,,,,,,Q7M425,,GVACRCDSDGPTSRGNTLTGTLWLTGGCPSGWHNCRGSGPFIGYCCKK,Gly-Val-Ala-Cys-Arg-Cys-Asp-Ser-Asp-Gly-Pro-Thr-Ser-Arg-Gly-Asn-Thr-Leu-Thr-Gly-Thr-Leu-Trp-Leu-Thr-Gly-Gly-Cys-Pro-Ser-Gly-Trp-His-Asn-Cys-Arg-Gly-Ser-Gly-Pro-Phe-Ile-Gly-Tyr-Cys-Cys-Lys-Lys,"Predicted disulphide bond formation between cysteine residues at positions 4 and 45, 6 and 35, and 28 and 46",,,
2610,BeKm-1,,Other peptide,,,,,,,,,Q9BKB7,,RPTDIKCSESYQCFPVCKSRFGKTNGRCVNGFCDCF,Arg-Pro-Thr-Asp-Ile-Lys-Cys-Ser-Glu-Ser-Tyr-Gln-Cys-Phe-Pro-Val-Cys-Lys-Ser-Arg-Phe-Gly-Lys-Thr-Asn-Gly-Arg-Cys-Val-Asn-Gly-Phe-Cys-Asp-Cys-Phe,"Disulphide bond formation between cysteine residues at positions 7 and 28, 13 and 33, and 19 and 35",,,
9501,β-Ala-Lys-AMCA,,Other peptide,,,,,yes,,,,,,AK,β-Ala-Lys,,,NCCC(=O)N[C@H](C(=O)O)CCCCNC(=O)Cc1c(=O)oc2c(c1C)ccc(c2)N,BXZFTTVQAOLWHY-INIZCTEOSA-N
2112,[βAla8]neurokinin A-(4-10),,Other peptide,,,,,,,,,,,DSFVALM,Asp-Ser-Phe-Val-βAla-Leu-Met-NH2,,,,
2632,β-scorpion toxin Cn2,,Other peptide,,,,,,,,,P01495,,KEGYLVDKNTGCKYECLKLGDNDYCLRECKQQYGKGAGGYCYAFACWCTHLYEQAIVWPLPNKRCS,Lys-Glu-Gly-Tyr-Leu-Val-Asp-Lys-Asn-Thr-Gly-Cys-Lys-Tyr-Glu-Cys-Leu-Lys-Leu-Gly-Asp-Asn-Asp-Tyr-Cys-Leu-Arg-Glu-Cys-Lys-Gln-Gln-Tyr-Gly-Lys-Gly-Ala-Gly-Gly-Tyr-Cys-Tyr-Ala-Phe-Ala-Cys-Trp-Cys-Thr-His-Leu-Tyr-Glu-Gln-Ala-Ile-Val-Trp-Pro-Leu-Pro-Asn-Lys-Arg-Cys-Ser-NH2,"C-terminal serine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 12 and 65, 16 and 41, 25 and 46, and 29 and 48.",,,
2620,β-scorpion toxin Css IV,,Other peptide,,,,,,,,,P60266,,KEGYLVNSYTGCKFECFKLGDNDYCLRECRQQYGKGSGGYCYAFGCWCTHLYEQAVVWPLPNKTCN,Lys-Glu-Gly-Tyr-Leu-Val-Asn-Ser-Tyr-Thr-Gly-Cys-Lys-Phe-Glu-Cys-Phe-Lys-Leu-Gly-Asp-Asn-Asp-Tyr-Cys-Leu-Arg-Glu-Cys-Arg-Gln-Gln-Tyr-Gly-Lys-Gly-Ser-Gly-Gly-Tyr-Cys-Tyr-Ala-Phe-Gly-Cys-Trp-Cys-Thr-His-Leu-Tyr-Glu-Gln-Ala-Val-Val-Trp-Pro-Leu-Pro-Asn-Lys-Thr-Cys-Asn-NH2,"C-terminal asparagine residue is predicted to undergo amidation; predicted disulphide bond formation between cysteine residues at positions 12 and 65, 16 and 41, 25 and 46, and 29 and 48",,,
2627,β-scorpion toxin TiTXγ,,Other peptide,,,,,,,,,P15226,,KEGYLMDHEGCKLSCFIRPSGYCGRECGIKKGSSGYCAWPACYCYGLPNWVKVWDRATNKC,Lys-Glu-Gly-Tyr-Leu-Met-Asp-His-Glu-Gly-Cys-Lys-Leu-Ser-Cys-Phe-Ile-Arg-Pro-Ser-Gly-Tyr-Cys-Gly-Arg-Glu-Cys-Gly-Ile-Lys-Lys-Gly-Ser-Ser-Gly-Tyr-Cys-Ala-Trp-Pro-Ala-Cys-Tyr-Cys-Tyr-Gly-Leu-Pro-Asn-Trp-Val-Lys-Val-Trp-Asp-Arg-Ala-Thr-Asn-Lys-Cys-Nh2,"C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 11 and 61, 15 and 37, 23 and 42, 27 and 44.",,,
2078,β3-tetrapeptide,,Other peptide,,,,,,,,,,,YWK,Ac-(S)-β3-HTyr-(R)-Trp-(S)-β3-HLys-(R)-4-amino-5-methyl-dihydro-furan-2-one,,,NCCCC[C@H](NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C[C@H](Cc1cccc(c1)O)NC(=O)C)CC(=O)N[C@@H]1CC(=O)O[C@@H]1C,GQYXVIIYXPRQJK-JZYDGZRSSA-N
2551,BgK,,Other peptide,,,,,,,,,P29186,,VCRDWFKETACRHAKSLGNCRTSQKYRANCAKTCELC,Val-Cys-Arg-Asp-Trp-Phe-Lys-Glu-Thr-Ala-Cys-Arg-His-Ala-Lys-Ser-Leu-Gly-Asn-Cys-Arg-Thr-Ser-Gln-Lys-Tyr-Arg-Ala-Asn-Cys-Ala-Lys-Thr-Cys-Glu-Leu-Cys,"Disulphide bond formation between cysteine residues at positions 2 and 37, 11 and 30, and 20 and 34.",,,
9183,bihelical apoA-I mimetic peptide 5A,,Other peptide,,,,,,,,,,,DWLKAFYDKVAEKLKEAFPDWAKAAYDKAAEKAKEAA,Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Glu-Ala-Phe-Pro-Asp-Trp-Ala-Lys-Ala-Ala-Tyr-Asp-Lys-Ala-Ala-Glu-Lys-Ala-Lys-Glu-Ala-Ala,,,[NH3]CCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C)C)CCC(=O)O)CCCC[NH3])C)CCCC[NH3])CCC(=O)O)C)C)CCCC[NH3])CC(=O)O)Cc1ccc(cc1)O)C)C)CCCC[NH3])C)Cc1c[nH]c2c1cccc2)CC(=O)O)Cc1ccccc1)C)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](CC(=O)O)N)CC(C)C)CCCC[NH3])C)Cc1ccccc1)Cc1ccc(cc1)O)CC(=O)O)CCCC[NH3])C)CCC(=O)O)CCCC[NH3])CC(C)C,FOIYDQXBMQZAML-GNGNDROBSA-N
2032,BIM 23023,,Other peptide,,,,,,,,,,,FCYWKXCT,D-Phe-c[Cys-Tyr-D-Trp-Lys-Abu-Cys]-Thr-NH2,,,,
2033,BIM 23027,,Other peptide,,,,,,,,,,,XFAYWK,c[N-Me-Ala-Tyr-D-Trp-Lys-Abu-Phe],,,,
2034,BIM 23030,,Other peptide,,,,,,,,,,,XYWKVCF,c[MPA-Tyr-D-Trp-Lys-Val-Cys]-Phe-NH2,,,,
2035,BIM 23034,,Other peptide,,,,,,,,,,,FCYWKVCA,D-Phe-Cys-Tyr-Trp-Lys-Val-Cys-Nal-NH2,,,,
2003,BIM 23050,,Other peptide,,,,,,,,,,,AYWKVF,N-Me-D-Ala-Tyr-D-Trp-Lys-Val-Phe-NH2,,,,
2004,BIM 23052,,Other peptide,,,,,,,,,,,FFFWKTFT,D-Phe-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-NH2,,,,
2036,BIM 23056,,Other peptide,,,,,,,,,,,FFYWKVFA,D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-D-Nal-NH2,,,,
2068,BIM 23058,,Other peptide,,,,,,,,,,,FFYWKVFT,D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-Thr-NH2,,,,
2037,BIM 23059,,Other peptide,,,,,,,,,,,ACYWKTCT,D-Nal-c[Cys-Tyr-D-Trp-Lys-Thr-Cys]-Thr-NH2,,,,
2038,BIM 23060,,Other peptide,,,,,,,,,,,FCYWKTCA,D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Nal-NH2,,,,
2039,BIM 23066,,Other peptide,,,,,,,,,,,FFYWKVFT,D-Phe-p-NO2-Phe-Tyr-D-Trp-Lys-Val-Phe-Thr-NH2,,,,
2040,BIM 23068,,Other peptide,,,,,,,,,,,FFYWKTFT,D-Phe-Cpa-Tyr-D-Trp-Lys-Thr-Phe-Thr-NH2,,,,
2162,BIM 23127,,Other peptide,,,,,,,,,,,ACYWXVCA,D-Nal-Cys-Tyr-D-Trp-Orn-Val-Cys-Nal-NH2,,,,
2041,BIM 23197,,Other peptide,,,,,,,,,,,FCYWKXCT,Hepes-D-Phe-c[Cys-Tyr-D-Trp-Lys-Abu-Cys]-Thr-NH2,,,,
2083,BIM 23268,,Other peptide,,,,,,,,,,,CFFWKTFC,c[Cys-Phe-Phe-D-Trp-Lys-Thr-Phe-Cys]-NH2,,,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)Cc1ccccc1)C(=O)N)Cc1c[nH]c2c1cccc2,JNMPZUZCPFIJGJ-OCZUONHDSA-N
2069,BIM 23295,,Other peptide,,,,,,,,,,,CFYWKTFC,c[Cys-Phe-Tyr-D-Trp-Lys-Thr-Phe-Cys]-NH2,,,,
2084,BIM 23313,,Other peptide,,,,,,,,,,,CFYWKTFC,c[Cys-Phe-I-Tyr-D-Trp-Lys-Thr-Phe-Cys]-NH2,,,,
2026,BIM 23454,,Other peptide,,,,,,,,,,,FCAWKVCA,Cpa-Cys-(pyridinyl)Ala-Trp-Lys-Val-Cys-Nap-Ala-NH2,,,,
2027,BIM 23627,,Other peptide,,,,,,,,,,,FCAWKVCA,pCpa-D-Cys-βPal-Trp-Lys-Val-Cys-Nal-NH2,,,,
3857,BIM28011,,Other peptide,,,,,,,,,,,YADAIFTAAYRKVLAQLSARKLLQDIASR,Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Ala-Ala-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Ala-Ser-D-Arg-NH2,,,,
1101,BIM 28163,,Other peptide,,,,,,,,,,,,,,,,
6589,BIO1211,,Other peptide,,,,,,,,,,,MPUPA-LDVP,,,,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)C(C)C)CC(=O)O)NC(=O)Cc1ccc(cc1)NC(=O)Nc1ccccc1C)C,NVVGCQABIHSJSQ-KFZSMJGVSA-N
6470,bivalirudin,,Other peptide,,,yes,,,,,,,bivalirudin,FPRPGGGGNGDFEEIPEEYL,D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu,,,CC[C@@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)Cc1ccc(cc1)O)CCC(=O)O)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1ccccc1)N)CCCNC(=N)N)CC(=O)N)Cc1ccccc1)CCC(=O)O)CCC(=O)O)C,OIRCOABEOLEUMC-GEJPAHFPSA-N
9518,blisibimod,,Other peptide,,,,,,,,,,blisibimod,GCKWDLLIKQWVCDPLGSGSATGGSGSTASSGSGSATHMLPGCKWDLLIKQWVCDPLGGGGGVDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK,,,,,
2042,BOC-ATE,,Other peptide,,,,,,,,,,,FCXWKTCT,D-Phe-Cys-(Bz)Thi-D-Trp-Lys-Thr-Cys-Thr,,,,
3858,BODIPY® TMR-NMU,,Other peptide,,,,,,,,,,,FRVDEEFQSPFASQSRGYFLFRPRN,Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn,,,,
616,bombesin,,Other peptide,,,,,,,,,,,XQRLGNQWAVGHLM,pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2,C-terminal amidation of methionine; pyroglutamate formation at N-terminus,,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)N)CCCNC(=N)N)CC(C)C)CC(=O)N)CCC(=O)N)C)CC(C)C,QXZBMSIDSOZZHK-DOPDSADYSA-N
1452,"[Bpa1,Ile13]motilin (human)",,Other peptide,,,,,,,,,,,XVPIFTYGELQRIQEKERNKGQ,Bpa-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Ile-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
1154,"[Bpa6,Tyr10]secretin-27 (rat)",,Other peptide,,,,,yes,yes,,,,,HSDGTXTSEYSRLQDSARLQRLLQGLV,His-Ser-Asp-Gly-Thr-Bpa-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Gln-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,,,,
752,BP-CCL3,,Other peptide,,,,,,,,,,,SLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA,p-benzoylphenylthiocarbamyl-Ser-Leu-Ala-Ala-Asp-Thr-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Thr-Ser-Arg-Gln-Ile-Pro-Gln-Asn-Phe-Ile-Ala-Asp-Tyr-Phe-Glu-Thr-Ser-Ser-Gln-Cys-Ser-Lys-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Arg-Ser-Arg-Gln-Val-Cys-Ala-Asp-Pro-Ser-Glu-Glu-Trp-Val-Gln-Lys-Tyr-Val-Ser-Asp-Leu-Glu-Leu-Ser-Ala,,,,
7897,BPTI-K15R/R17G,,Other peptide,,,,,,,,,,,RPDFCLEPPYTGPCRAGIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA,,,,,
997,BQ123,,Other peptide,,,,,,,,,,,DPVLW,D-Asp-Pro-D-Val-Leu-D-Trp,,,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)CC(=O)O)C(C)C)C,VYCMAAOURFJIHD-PJNXIOHISA-N
3859,BQ 3020,,Other peptide,,,,,,,,,,,LMDKEAVYFAHLDIIW,N-acetyl-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)C(C)C)[C@H](CC)C)CC(=O)O)CC(C)C)Cc1nc[nH]c1)C)Cc1ccccc1)Cc1ccc(cc1)O)C(C)C)C)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C)CC(C)C)CCSC)CC(=O)O,KBQLINQFUQUHIY-SGOWJZKMSA-N
4371,B-R13/17K H2 relaxin,,Other peptide,,,,,,,,,,,DSWMEEVIKLCGKELVKAQIAICGMSTWS,Asp-Ser-Trp-Met-Glu-Glu-Val-Ile-Lys-Leu-Cys-Gly-Lys-Glu-Leu-Val-Lys-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Met-Ser-Thr-Trp-Ser,,,,
10408,bremelanotide,,Other peptide,,,yes,,,,,,,bremelanotide,,Ac-Nle-Asp(1)-His-D-Phe-Arg-Trp-Lys(1)-OH,,,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)O)NC(=O)C,FFHBJDQSGDNCIV-MFVUMRCOSA-N
9101,brimapitide,,Other peptide,,,,,,,,,,brimapitide,DQSRPVQPFLNLTTPRKPRPPRRRQRRKKRG,Asp-Gln-Ser-Arg-Pro-Val-Gln-Pro-Phe-Leu-Asn-Leu-Thr-Thr-Pro-Arg-Lys-Pro-Arg-Pro-Pro-Arg-Arg-Arg-Gln-Arg-Arg-Lys-Lys-Arg-Gly,,,,
3860,buserelin,,Other peptide,,,yes,,,,,,,buserelin,XHWSYSLRP,pGlu-His-Trp-(t-Bu)Ser-Tyr-Ser-Leu-Arg-Pro,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)COC(C)(C)C)CC(C)C)CCCN=C(N)N,CUWODFFVMXJOKD-UVLQAERKSA-N
5362,Bv8,,Other peptide,,,,,,,,,,,AVITGACDKDVQCGSGTCCAASAWSRNIRFCIPLGNSGEDCHPASHKVPYDGKRLSSLCPCKSGLTCSKSGEKFKCS,,,,,
2159,[Bz-Phe6]U-II (human),,Other peptide,,,,,,,,,,,ETPDCFWKYCV,Glu-Thr-Pro-Asp-Cys-(p-benzoyl)Phe-Trp-Lys-Tyr-Cys-Val,,,,
5779,C089,,Other peptide,,,,,,,,,,,FKPXWR,NMe-Phe-Lys-Pro-D-Cha-Trp-D-Arg-COOH,,,,
9508,C12-iE-DAP,,Other peptide,,,,,,,,,,,,,,,,
7037,C21,,Other peptide,,,,,,,,,,,GKGGKGLGKGGAKRHRKV,Gly-Lys-Gly-Gly-Lys-Gly-Leu-Gly-Lys-Gly-Gly-Ala-Lys-Arg-His-Arg-Lys-Val,,,,
1534,C2-NPY (pig),,Other peptide,,,,,,,,,,,YCSKRHCINLITRQRY,Tyr-Cys-Ser-Lys-8-aminooctanoyl-Arg-His-D-Cys-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
1291,C3,,Other peptide,,,,,,,,,,,RCMLGRAYRPCW,Arg-Cys-Met-Leu-Gly-Arg-Ala-Tyr-Arg-Pro-Cys-Trp,,,NCCCCC(C(=O)NC(C(=O)NC(C(=O)O)C)C)NC(=O)C(NC(=O)C(NC(=O)C(OC1C(O)C(CO)OC(C1NC(=O)C)OP(=O)(OP(=O)(OCC1OC(C(C1O)O)n1ccc(=O)[nH]c1=O)O)O)C)C)CCC(=O)O,QAXSYKNMKWGHOF-UHFFFAOYSA-N
5768,C5a hexapeptide analogue,,Other peptide,,,,,,,,,,,FKAXXR,Phe-Lys-Ala-D-Cha-Cha-D-Arg,,,,
3861,C7,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPRPKPQQWFWLL,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Arg-Pro-Lys-Pro-Gln-Gln-Trp-Phe-Trp-Leu-Leu,,,,
4149,calciseptine,,Other peptide,,,,,,,,,P22947,,RICYIHKASLPRATKTCVENTCYKMFIRTQREYISERGCGCPTAMWPYQTECCKGDRCNK,Arg-Ile-Cys-Tyr-Ile-His-Lys-Ala-Ser-Leu-Pro-Arg-Ala-Thr-Lys-Thr-Cys-Val-Glu-Asn-Thr-Cys-Tyr-Lys-Met-Phe-Ile-Arg-Thr-Gln-Arg-Glu-Tyr-Ile-Ser-Glu-Arg-Gly-Cys-Gly-Cys-Pro-Thr-Ala-Met-Trp-Pro-Tyr-Gln-Thr-Glu-Cys-Cys-Lys-Gly-Asp-Arg-Cys-Asn-Lys,"Disulphide bond formation between cysteine residues at postions 3 and 22, 17 and 39, 41 and 52 and 53 and 58",,,
6973,calcitonin (salmon),,Other peptide,,,yes,,,,,,,,CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP,Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2,,,,
4892,cANF4-23,,Other peptide,,,,,,,,,,,RSSCFGGRMDRIGAC,Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Cys-NH2,,,,
7568,cangitoxin II,,Other peptide,,,,,,,,,P0C7P9,,GVACRCDSDGPTVRGDSLSGTLWLTGGCPSGWHNCRGSGPFIGYCCKK,Gly-Val-Ala-Cys-Arg-Cys-Asp-Ser-Asp-Gly-Pro-Thr-Val-Arg-Gly-Asp-Ser-Leu-Ser-Gly-Thr-Leu-Trp-Leu-Thr-Gly-Gly-Cys-Pro-Ser-Gly-Trp-His-Asn-Cys-Arg-Gly-Ser-Gly-Pro-Phe-Ile-Gly-Tyr-Cys-Cys-Lys-Lys,"Predicted disulphide bond formation between cysteine residues at positions 4 and 45, 6 and 35, and 28 and 46.",,,
10224,casoxin C,,Other peptide,,,,,,,,,,,YIPIQYVLSR,H-Tyr-Ile-Pro-Ile-Gln-Tyr-Val-Leu-Ser-Arg-OH,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)CO)CC(C)C)C(C)C)Cc1ccc(cc1)O)CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](CC)C)NC(=O)[C@H](Cc1ccc(cc1)O)N)C,FLMZYYASMMUDFC-FJKDSYQFSA-N
862,CCK-58,Dog,Other peptide,,,,,,,,,Q9TS44,,AVQKVDGEPRAHLGALLARYIQQARKAPSGRMSVIKNLQNLDPSHRISDRDYMGWMDF,Ala-Val-Gln-Lys-Val-Asp-Gly-Glu-Pro-Arg-Ala-His-Leu-Gly-Ala-Leu-Leu-Ala-Arg-Tyr-Ile-Gln-Gln-Ala-Arg-Lys-Ala-Pro-Ser-Gly-Arg-Met-Ser-Val-Ile-Lys-Asn-Leu-Gln-Asn-Leu-Asp-Pro-Ser-His-Arg-Ile-Ser-Asp-Arg-Asp-Tys-Met-Gly-Trp-Met-Asp-Phe-NH2,Tyrosine residue at position 52 is sulphated (Tys); C-terminal phenylalanine residue is amidated,,,
809,CCL20-SEAP(His)6,,Other peptide,,,,,,,,,,,,,,,,
9066,cenderitide,,Other peptide,,,,,,,,,,cenderitide,GLSKGCFGLKLDRIGSMSGLGCPSLRDPRPDAPSTSA,Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Arg-Pro-Asp-Ala-Pro-Ser-Thr-Ser-Ala,,,,
1190,cetrorelix,,Other peptide,,,yes,,,,,,,cetrorelix,AFASYXLRPA,Ac-D-Nal-D-Cpa-D-Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCN=C(N)N)CC(C)C)CCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(cc1)Cl)NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C,SBNPWPIBESPSIF-MHWMIDJBSA-N
6241,CGEN-855A,,Other peptide,,,,,,,,,,,TIPMFVPESTSKLQKFTSWFM,Thr-Ile-Pro-Met-Phe-Val-Pro-Glu-Ser-Thr-Ser-Lys-Leu-Gln-Lys-Phe-Thr-Ser-Trp-Phe-Met-NH2,,,,
7041,CGEN-856,,Other peptide,,,,,,,,,,,FLGYCIYLNRKRRGDPAFKRRLRD,Phe-Leu-Gly-Tyr-Cys-Ile-Tyr-Leu-Asn-Arg-Lys-Arg-Arg-Gly-Asp-Pro-Ala-Phe-Lys-Arg-Arg-Leu-Arg-Asp,,,,
7040,CGEN-857,,Other peptide,,,,,,,,,,,SMCHRWSRAVLFPAAHRP,Ser-Met-Cys-His-Arg-Trp-Ser-Arg-Ala-Val-Leu-Phe-Pro-Ala-Ala-His-Arg-Pro,,,,
2005,CGP 23996,,Other peptide,,,,,,,,,,,KNFFWKTYTS,c[Aha Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser],,,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)C(CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)CCCCC[C@H](NC(=O)[C@@H](NC(=O)C(NC(=O)[C@@H](NC(=O)C(NC1=O)[C@H](O)C)Cc1ccc(cc1)O)[C@H](O)C)CO)C(=O)O)Cc1c[nH]c2c1cccc2,HTEPNQQGQXAYEW-YQENAMKYSA-N
3944,CGP42112,,Other peptide,,,,,,,,,,,YKHPI,Nic-Tyr-Lys-(N-α-Z-Arg)-His-Pro-Ile,,,CC[C@@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cccnc1)Cc1ccc(cc1)O)CCCCNC(=O)[C@@H](NC(=O)OCc1ccccc1)CCCN=C(N)N)Cc1[nH]cnc1)C,UXGNARZDONUMMK-LRMQDCNJSA-N
2006,CH 275,,Other peptide,,,,,,,,,,,CKFFWFTFTSC,Cys-Lys-Phe-Phe-D-Trp-Phe-Thr-IAmp-Thr-Ser-Cys,,,,
2328,charybdotoxin,,Other peptide,,,,,,,,,P13487,,QFTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS,pGlu-Phe-Thr-Asn-Val-Ser-Cys-Thr-Thr-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Gln-Arg-Leu-His-Asn-Thr-Ser-Arg-Gly-Lys-Cys-Met-Asn-Lys-Lys-Cys-Arg-Cys-Tyr-Ser,"C-terminal glutamine is pyrrolidone carboxylic acid; disulphide bond formation between cysteine residues at positions 7 and 28, 13 and 33, and 17 and 35.",,,
2329,charybdotoxin-GLU32 analog,,Other peptide,,,,,,,,,,,QFTNVSCTTSKECWSVCQRLHNTSRGKCMNKECRCYS,pGlu-Phe-Thr-Asn-Val-Ser-Cys-Thr-Thr-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Gln-Arg-Leu-His-Asn-Thr-Ser-Arg-Gly-Lys-Cys-Met-Asn-Lys-Glu-Cys-Arg-Cys-Tyr-Ser,,,,
9439,[Cha6]U-II-(4-11),,Other peptide,,,,,,,,,,,DCXWKYCV,Asp-Cys-Cha-Trp-Lys-Tyr-Cys-Val,,,,
3422,chemerin C-terminal peptide,,Other peptide,,,,,,,,,,,YFPGQFAFS,Tyr-Phe-Pro-Gly-Gln-Phe-Ala-Phe-Ser,,,,
3724,CHIPS,,Other peptide,,,,,,,,,,,FTFEPFPTNEEIESNKKMLEKEKAYKESFKNSGLPTTLGKLDERLRNYLKKGTKNSAQFEKMVILTENKGYYTVYLNTPLAEDRKNVELLGKMYKTYFFKKGESKSSYVINGPGKTNEYAY,,,,,
5770,CHIPS-(28-149),,Other peptide,,,,,,,,,,,AFTFEPFPTNEEIESNKKMLEKEKAYKESFKNSGLPTTLGKLDERLRNYLKKGTKNSAQFEKMVILTENKGYYTVYLNTPLAEDRKNVELLGKMYKTYFFKKGESKSSYVINGPGKTNEYAY,,,,,
3755,"[(CH2NH)4,5]secretin",,Other peptide,,,,,,,,,,,,,,,,
9677,cibinetide,,Other peptide,,,,,,,,,,cibinetide,XEQLERALNSS,H-Pyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH,,,OC[C@@H](C(=O)N[C@H](C(=O)O)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)CCC(=O)O)CCC(=O)N)CC(C)C)CCC(=O)O)CCCN=C(N)N)C)CC(C)C)CC(=O)N,WZTIQQBMSJTRBR-WYKNNRPVSA-N
6597,cilengitide,,Other peptide,,,,,,,,,,cilengitide,,,,,OC(=O)C[C@@H]1NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N(C(=O)[C@H](NC1=O)Cc1ccccc1)C)C(C)C,AMLYAMJWYAIXIA-VWNVYAMZSA-N
7801,compound 1 [PMID: 25241924],,Other peptide,,,,,,,,,,,VTLPLWATYTYR,Palmitate-Val-Thr-Leu-Pro-Leu-Trp-Ala-Thr-Tyr-Thr-Tyr-Arg-NH2,"The N-terminal valine residue is linked to a palmitate chemical group, and the C-terminal arginine residue has an amide group attached.",,,
1292,compound 2 [PMID: 11375253],,Other peptide,,,,,,,,,,,YGGRCMLGRVYRPCW,(I)Tyr-Gly-Gly-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp,N-terminal tyrosine is iodinised,,,
9008,compound 5d [PMID: 25815150],,Other peptide,,,,,,,,,,,,,,,NC(=N)NCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)Cc1cccs1)Cc1ccc(cc1)F,TZCCKCLHNUSAMQ-DUGSHLAESA-N
7927,compound 6b [PMID: 24999562],,Other peptide,,,,,,,,,,,,,,,NC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC1CCCCC1)CC(C)C)CCC(C)C,KAFZOLYKKCWUBI-HPMAGDRPSA-N
7926,compound 8d [PMID: 24999562],,Other peptide,,,,,,,,,,,,,,,NC(=N)NCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc2c(c1)cccc2)NC(=O)CCc1cccnc1)Cc1ccccc1,HPJGEESDHAUUQR-SKGSPYGFSA-N
9218,compstatin,,Other peptide,,,,,,,,,,,ICVVQDWGHHRCT,Ile-Cys-Val-Val-Gln-Asp-Trp-Gly-His-His-Arg-Cys-Thr-NH2,,,CC[C@@H]([C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2[nH]cnc2)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)C(C)C)CCC(=O)N)CC(=O)O)Cc1c[nH]c2c1cccc2)Cc1[nH]cnc1)C(=O)N[C@H](C(=O)N)[C@H](O)C)N)C,RDTRHBCZFDCUPW-KWICJJCGSA-N
4161,conantokin-G,,Other peptide,,,,,,,,,P07231,,GEEELQENQELIREKSN,Gly-Glu-(4-carboxy)Glu-(4-carboxy)Glu-Leu-Gln-(4-carboxy)Glu-Asn-Gln-(4-carboxy)Glu-Leu-Ile-Arg-(4-carboxy)Glu-Lys-Ser-Asn-NH2,"Amidation of C-terminal asparagine residue; carboxylation of glutamate residues at positions 3, 4, 7, 10, and 14 (represented by (4-carboxy)).",,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)CCC(=O)O)CC(C(=O)O)C(=O)O)CC(C(=O)O)C(=O)O)CC(C)C)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(=O)N)CCC(=O)N)CC(C(=O)O)C(=O)O)CC(C)C)CCCNC(=N)N)CC(C(=O)O)C(=O)O,HTBKFGWATIYCSF-QGXIKSNHSA-N
4162,concanavalin A,,Other peptide,,,,,,,,,,,ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVGKRLSAVVSYPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKLKSNSTHETNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGNSVGRALFYAPVHIWESSAVVASFDATFTFLIKSPDSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN,Ala-Asp-Thr-Ile-Val-Ala-Val-Glu-Leu-Asp-Thr-Tyr-Pro-Asn-Thr-Asp-Ile-Gly-Asp-Pro-Ser-Tyr-Pro-His-Ile-Gly-Ile-Asp-Ile-Lys-Ser-Val-Arg-Ser-Lys-Lys-Thr-Ala-Lys-Trp-Asn-Met-Gln-Asn-Gly-Lys-Val-Gly-Thr-Ala-His-Ile-Ile-Tyr-Asn-Ser-Val-Gly-Lys-Arg-Leu-Ser-Ala-Val-Val-Ser-Tyr-Pro-Asn-Gly-Asp-Ser-Ala-Thr-Val-Ser-Tyr-Asp-Val-Asp-Leu-Asp-Asn-Val-Leu-Pro-Glu-Trp-Val-Arg-Val-Gly-Leu-Ser-Ala-Ser-Thr-Gly-Leu-Tyr-Lys-Glu-Thr-Asn-Thr-Ile-Leu-Ser-Trp-Ser-Phe-Thr-Ser-Lys-Leu-Lys-Ser-Asn-Ser-Thr-His-Glu-Thr-Asn-Ala-Leu-His-Phe-Met-Phe-Asn-Gln-Phe-Ser-Lys-Asp-Gln-Lys-Asp-Leu-Ile-Leu-Gln-Gly-Asp-Ala-Thr-Thr-Gly-Thr-Asp-Gly-Asn-Leu-Glu-Leu-Thr-Arg-Val-Ser-Ser-Asn-Gly-Ser-Pro-Gln-Gly-Asn-Ser-Val-Gly-Arg-Ala-Leu-Phe-Tyr-Ala-Pro-Val-His-Ile-Trp-Glu-Ser-Ser-Ala-Val-Val-Ala-Ser-Phe-Asp-Ala-Thr-Phe-Thr-Phe-Leu-Ile-Lys-Ser-Pro-Asp-Ser-His-Pro-Ala-Asp-Gly-Ile-Ala-Phe-Phe-Ile-Ser-Asn-Ile-Asp-Ser-Ser-Ile-Pro-Ser-Gly-Ser-Thr-Gly-Arg-Leu-Leu-Gly-Leu-Phe-Pro-Asp-Ala-Asn,,,,
7627,conestat alfa,,Other peptide,,,yes,,,,,,,conestat alfa,NPNATSSSSQDPESLQDRGEGKVATTVISKMLFVEPILEVSSLPTTNSTTNSATKITANTTDEPTTQPTTEPTTQPTIQPTQPTTQLPTDSPTQPTTGSFCPGPVTLCSDLESHSTEAVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFTTKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNNSDANLELINTWVAKNTNNKISRLLDSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVARTLLVFEVQQPFLFVLWDQQHKFPVFMGRVYDPRA,,"Heavily glycosylated, and forms two intramolecular di-sulphide bonds (see P05155 for sequence and modification positions).",,,
7758,conkunitzin-S1 toxin,,Other peptide,,,,,,,,,P0C1X2,,KDRPSLCDLPADSGSGTKAEKRIYYNSARKQCLRFDYTGQGGNENNFRRTYDCQRTCLYT,,"Disulphide bond formation between cysteine residues at positions 7 and 57, and 22 and 53. C-terminal threonine residue is threonine amide.",,,
7742,conopeptide Y-PI1,,Other peptide,,,,,,,,,B3SVF0,,ARFLHPFQYYTLYRYLTRFLHRYPIYYIRY,Ala-Arg-Phe-Leu-His-Pro-Phe-Gln-Tyr-Tyr-Thr-Leu-Tyr-Arg-Tyr-Leu-Thr-Arg-Phe-Leu-His-Arg-Tyr-Pro-Ile-Tyr-Tyr-Ile-Arg-Tyr,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)CCCN=C(N)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1ccc(cc1)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N)Cc1ccccc1)CC(C)C)Cc1c[nH]cn1)Cc1ccccc1)CCC(=O)N)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CC(C)C)Cc1ccc(cc1)O)CCCN=C(N)N)Cc1ccc(cc1)O)CC(C)C)CCCN=C(N)N)Cc1ccccc1)CC(C)C)Cc1c[nH]cn1)CCCN=C(N)N)Cc1ccc(cc1)O)C,MNFKIRAJURGUGP-CWBJURCASA-N
1575,contulakin-G,,Other peptide,,,,,,,,,Q9XYR5,,QSEEGGSNATKKPYIL,pGlu-Ser-Glu-Glu-Gly-Gly-Ser-Asn-Ala-(GlcOAc)Thr-Lys-Lys-Pro-Tyr-Ile-Leu,N-terminal glutamic acid is pyrrolidone carboxylic acid; threonine residue at position 10 is O-linked glycosylated,,,
913,corticotropin-releasing factor,Sheep,Other peptide,,,,,,,,,P01142,,SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA,Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2,Amidation of C-terminal alanine residue,,,
6967,corticotropin zinc hydroxide,,Other peptide,,,yes,,,,,,,corticotropin zinc hydroxide,SEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII,Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)[C@H](CC)C)CCC(=O)O)CCSC)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)N)CCC(=O)O)CCC(=O)O)CO)CC(C)C)CC(=O)O)CC(C)C)Cc1ccccc1)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCN=C(N)N)CCC(=O)O)CC(C)C)CCC(=O)O)CCSC)C)CCCN=C(N)N)C)CCC(=O)O)CCC(=O)N)CC(C)C)C)CCC(=O)N)CCC(=O)N)C)Cc1nc[nH]c1)CO)CC(=O)N)CCCN=C(N)N,PNMZQWKBJIQQJL-FAUHKOHMSA-N
6965,cosyntropin,,Other peptide,,,yes,,,,,,,tetracosactide,SYSMEHFRWGKPVGKKRRPVKVYP,Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro,,,,
10380,CPN-267,,Other peptide,,,,,,,,,,,XWXRPRN,,,,NC(=N)NCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CC(=O)N)CCCNC(=N)N)NC(=O)[C@](Cc1c[nH]c2c1cccc2)(NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)Cc1cccs1)C,HIFICJJBGBSZMZ-YWIJTBFMSA-N
7347,crisantaspase,,Other peptide,,,yes,,,,,,,crisantaspase,ADKLPNIVILATGGTIAGSAATGTQTTGYKAGALGVDTLINAVPEVKKLANVKGEQFSNMASENMTGDVVLKLSQRVNELLARDDVDGVVITHGTDTVEESAYFLHLTVKSDKPVVFVAAMRPATAISADGPMNLLEAVRVAGDKQSRGRGVMVVLNDRIGSARYITKTNASTLDTFKANEEGYLGVIIGNRIYYQNRIDKLHTTRSVFDVRGLTSLPKVDILYGYQDDPEYLYDAAIQHGVKGIVYAGMGAGSVSVRGIAGMRKAMEKGVVVIRSTRTGNGIVPPDEELPGLVSDSLNPAHARILLMLALTRTSDPKVIQEYFHTY,,,,,
690,CT-(8-32) (salmon),,Other peptide,,,,,,,,,,calcitonin,CVLGKLSQELHKLQTYPRTNTGSG,Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly,,,,
1635,CTAP,,Other peptide,,,,,,,,,,,FCYWRTXT,Phe-Cys-Tyr-Trp-Arg-Thr-Pen-Thr-NH2,,,NC(=NCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC([C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1c[nH]c2c1cccc2)N,OFMQLVRLOGHAJI-RWMSPKCPSA-N
1674,CTOP,,Other peptide,,,,,,,,,,,FCYWXTXT,Phe-Cys-Tyr-Trp-Orn-Thr-Pen-Thr-NH2,,,NCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC([C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)C(=O)N[C@H](C(=O)N)[C@H](O)C)(C)C)NC(=O)[C@@H](Cc1ccccc1)N)Cc1ccc(cc1)O)Cc1c[nH]c2c1cccc2,PZWWYAHWHHNCHO-FGHAYEPSSA-N
5369,CTR-stimulating peptide,Pig,Other peptide,,,,,,,,,Q862B1,,SCNTATCMTHRLVGLLSRSGSMVRSNLLPTKMGFKVFG,Ser-Cys-Asn-Thr-Ala-Thr-Cys-Met-Thr-His-Arg-Leu-Val-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Ser-Met-Val-Arg-Ser-Asn-Leu-Leu-Pro-Thr-Lys-Met-Gly-Phe-Lys-Val-Phe-Gly,C-terminal glycine residue undergoes amidation;; disulphide bond formation between cysteine residues at positions 2 and 7,,,
846,CXCL12-(1-17),,Other peptide,,,,,,,,,,,KPVSLSYRCPCRFFESH,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His,,,,
847,CXCL12-(1-9),,Other peptide,,,,,,,,,,,KPVSLSYRC,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys,,,,
848,CXCL12-(1-9) dimer,,Other peptide,847,CXCL12-(1-9),,,,,,,,,,,,,,
8535,CXCL122 (dimer),,Other peptide,,,,,,,,,,,KPVSLSYRCPCRFFESHVARANVKHCKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKCLNK,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Cys-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Cys-Leu-Asn-Lys,,,,
8534,CXCL12H25R (monomer),,Other peptide,,,,,,,,,,,KPVSLSYRCPCRFFESHVARANVKRLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-Arg-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys,,,,
3863,Cy3B-NMU-8,,Other peptide,,,,,yes,,,,,,YFLFRPRN,Cy3B-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn,,,,
9166,[Cy5-Lys19]NPS,,Other peptide,,,,,yes,,,,,,SFRNGVGTGMKKTSFQRAKS,Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,,,,
8333,cyclic INSL3 B-chain analogue 6,,Other peptide,,,,,,,,,,,CPEMREKLSGHHFVRALVRCSGGPRW,Ac-Cys-Pro-Glu-Met-Arg-Glu-Lys-Leu-Ser-Gly-His-His-Phe-Val-Arg-Ala-Leu-Val-Arg-Cys-Ser-Gly-Gly-Pro-Arg-Trp-NH2,,,,
2025,"cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,IAmp9,m-I-Tyr11,hhLys12]SRIF",,Other peptide,,,,,,,,,,,CKFEWXTYKSC,Cys-Lys-Phe-Glu-D-Trp-IAmp-Thr-m-I-Tyr-hhLys-Ser-Cys,,,,
6313,cyclo apelin-12 (1-12),,Other peptide,,,,,,,,,,,RPRLSHKGPMPF,[Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe],,,,
6311,cyclo apelin-12 (7-12),,Other peptide,,,,,,,,,,,RPRLSHKGPMPF,Arg-Pro-Arg-Leu-Ser-His-[Lys-Gly-Pro-Met-Pro-Phe],,,,
1191,cyclorelix,,Other peptide,,,,,,,,,,,AFASYXLRPA,Ac-D-Nal-D-Cpa-D-Pal-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2,,,,
1024,cyclosporin A,,Other peptide,,,yes,,,,,,,ciclosporin,XXXLVLAALLV,Aaa-Abu-Sar-Leu-Val-Leu-Ala-D-Ala-Leu-Leu-Val,"Residue 1 is 2-aminooctanoy-amino acid, residue 2 is 2-aminobutanoic acid, residue 3 is sarcosine; alanine residue 8 is D-alanine",,C/C=C/C[C@H]([C@H]([C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N([C@H](C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C,PMATZTZNYRCHOR-CGLBZJNRSA-N
1025,cyclosporin H,,Other peptide,,,,,,,,,,,XXXLVLAALLV,Aaa-Abu-Sar-Leu-Val-Leu-Ala-D-Ala-Leu-Leu-D-Val,,,,
6312,cyclourea apelin-12 (1-7),,Other peptide,,,,,,,,,,,RPRLSHKGPMPF,[Arg-Pro-Arg-Leu-Ser-His-Lys]-Gly-Pro-Met-Pro-Phe,,,,
698,"[Cys(ACM)2,7]CGRP",,Other peptide,,,,,,,,,,,ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,Ala-Cys(Acm)-Asp-Thr-Ala-Thr-Cys(Acm)-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2,,,,
693,"[Cys(Et)2,7]α-CGRP (human)",,Other peptide,,,,,,,,,,,ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe,,,,
1180,D-23487,,Other peptide,,,,,,,,,,,AFASYKLRPA,Ac-D-Nal-D-Cpa-D-Pal-Ser-Tyr-D-Lys-Leu-Arg-Pro-D-Ala-NH2,,,,
1181,D-24710,,Other peptide,,,,,,,,,,,ASYKLKP,N-[3-(4-fluorophenyl)-propionyl]-D-Nal-Ser-N-methyl-Tyr-D-Lys(Nic)-Leu-Lys(iPr)-Pro-ethylamide,,,,
1607,DADLE,,Other peptide,,,,,,,,,,,YAGFL,Tyr-Ala-Gly-Phe-Leu,,,Oc1ccc(cc1)C[C@@H](C(=O)N[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)O)CC(C)C)Cc1ccccc1)C)N,ZHUJMSMQIPIPTF-IBURTVSXSA-N
5421,D-Ala-Lys-AMCA,,Other peptide,,,,,yes,,,,,,AK,D-Ala-Lys,,,,
6179,(D-Ala11]bombesin,,Other peptide,,,,,,,,,,,EQRLGNQWAVAHLMA,Glu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Ala-His-Leu-Met,,,,
3838,[D-Ala2]deltorphin I,,Other peptide,,,,,,,,,P21850,,YAFDVVG,Tyr-Ala-Phe-Asp-Val-Val-Gly-NH2,Amidation of C-terminal glycine residue,,,
4060,[D-Ala2]deltorphin II,,Other peptide,,,,,,,,,P21850,,YAFEVVG,Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2,Amidation of C-terminal glycine residue; alanine residue 2 is the D-isomer,,,
1657,"[D-Ala2,F5,Phe4]dynorphin-(1-13)-NH2",,Other peptide,,,,,,,,,,,YAGFLRRIRPKLK,Tyr-D-Ala-Gly-(5F)Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-NH2,,,,
1658,"[D-Ala2,F5,Phe4]dynorphin-(1-17)-NH2",,Other peptide,,,,,,,,,,,YAGFLRRIRPKLKWDNQ,Tyr-D-Ala-Gly-(F5)Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2,,,,
6081,[D-Ala7]-angiotensin(1-7),,Other peptide,,,,,,,,,,,DRVYIHA,Asp-Arg-Val-Tyr-Ile-His-Ala,,,,
1647,DAMGO,,Other peptide,,,,,,,,,,,YAGFG,Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol,,,OCCNC(=O)[C@@H](N(C(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)C)Cc1ccccc1,HPZJMUBDEAMBFI-WTNAPCKOSA-N
1102,"[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P",,Other peptide,,,,,,,,,,,RPKPFQWFWLL,D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2,,,,
6184,"[D-Arg1,D-Trp7,9,Leu11]substance P",,Other peptide,,,,,,,,,,,RPKPQQWFWLL,Arg-Pro-Lys-Pro-Gln-Gln-Trp-Phe-Trp-Leu-Leu,,,,
2181,dAVP,,Other peptide,,,,,,,,,,,XYFQNCPRG,Mpa-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O,NFLWUMRGJYTJIN-UHFFFAOYSA-N
2170,DAVP,,Other peptide,,,,,,,,,,,CYFQNCPRG,Cys-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2,,,,
2043,DC 23-60,,Other peptide,,,,,,,,,,,ACYWKVCT,D-Nal-Cys-Tyr-Trp-Lys-Val-Cys-Thr,,,,
2187,d[Cha4]AVP,,Other peptide,,,,,,,,,,,CYFXNCPRG,deamino-Cys-Tyr-Phe-Cha-Asn-Cys-Pro-Arg-Gly-NH2,,,,
2186,"d[Cha4,Dab8]VP",,Other peptide,,,,,,,,,,,CYFXNCPXG,deamino-Cys-Tyr-Phe-Cha-Asn-Cys-Pro-Dab-Gly-NH2,,,,
2188,d[Cha4]LVP,,Other peptide,,,,,,,,,,,CYFXNCPKG,deamino-Cys-Tyr-Phe-Cha-Asn-Cys-Pro-Lys-Gly-NH2,,,,
2215,"d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP",,Other peptide,,,,,,,,,,,CIFINCPRGA,Pmp-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg-Gly-Ala-NH2,,,,
2214,"d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP",,Other peptide,,,,,,,,,,,CYFQNCPRG,Pmp-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg-Ala-NH2,,,,
2236,"d(CH2)5[D-Ile2,Ile4]AVP",,Other peptide,,,,,,,,,,,XIFINCPRG,Pmp-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg-Gly-NH2,,,CC[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N)CS)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)CC1CCCCC1=S)Cc1ccccc1)C,CNWFVLCMGVAHSD-HAEBMLOOSA-N
2235,"d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP",,Other peptide,,,,,,,,,,,CIFINCPRY,Pmp-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
2237,"d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP",,Other peptide,,,,,,,,,,,CIFVNCPRY,Pmp-D-Ile-Phe-Val-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
2216,"d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP",,Other peptide,,,,,,,,,,,CYFVNCPRY,Pmp-D-(Et)Tyr-Phe-Val-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
2217,"d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP",,Other peptide,,,,,,,,,,,CYFVNCPR,Pmp-(Et)Tyr-Phe-Val-Asn-Cys-Pro-Arg,,,CCOc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)C(C)C)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N)CCCN=C(N)N,DRLYXDZRLDZVIS-XXNQTUAPSA-N
3867,"d(CH2)5[Tyr(Me)2,Arg8]VP",,Other peptide,,,,,,,,,,,YFQNCPRG,Pmp-Tyr(Me)-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,,
2223,d(CH2)5[Tyr(Me)2]AVP,,Other peptide,,,,,,,,,,,CYFQNCPRG,Pmp-(Me)Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,COc1ccc(cc1)C[C@H]1NC(=O)CC2(CCCCC2)SSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CCCN=C(N)N,QVQOGNOOAMQKCE-OVSZNHMYSA-N
2222,"d(CH2)5[Tyr(Me)2,Thr4]OVT",,Other peptide,,,,,,,,,,,CYITNCPXG,Pmp-(OMe)Tyr-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2,,,,
2219,"d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT",,Other peptide,,,,,,,,,,,CYITNCPXF,"Pmp-Tyr(Me)-Ile-Thr-Asn-Cys-Pro-Orn-Phe(3I,4N3)-NH2",,,,
2218,"d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT",,Other peptide,,,,,yes,yes,,,,,CYITNCPXF,"Pmp-Tyr(Me)-Ile-Thr-Asn-Cys-Pro-Orn-Phe(3I,4N3)-NH2",,,,
2220,"d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT",,Other peptide,,,,,yes,yes,,,,,YITNCPXY,Pmp-(Me)Tyr-Ile-Thr-Asn-Cys-Pro-Orn-Tyr(3125I)-NH2,,,,
2221,"d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT",,Other peptide,,,,,,,,,,,CYITNCPXY,Pmp-(Me)Tyr-Ile-Thr-Asn-Cys-Pro-Orn-Tyr-NH2,,,,
5810,[D-Cys(tBu)5]NPS,,Other peptide,,,,,,,,,,,SFRNCVGTGMKKTSFQRAKS,Ser-Phe-Arg-Asn-Cys-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,,,,
5585,degarelix,,Other peptide,,,yes,,,,,,,degarelix,AFASXXLKPA,Ac-D-2Nal-D-4Cpa-D-3Pal-Ser-4Aph-(L-hydrorootyl)-D-4Aph-(carbamoyl)-Leu-Ilys-Pro-D-Ala-NH2,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)Cc1ccc(cc1)NC(=O)N)Cc1ccc(cc1)NC(=O)[C@@H]1CC(=O)NC(=O)N1)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1,MEUCPCLKGZSHTA-XYAYPHGZSA-N
7840,delcasertib,,Other peptide,,,,,,,,,,delcasertib,,Cys(1)-Ser-Phe-Asn-Ser-Tyr-Glu-Leu-Gly-Ser-Leu  Cys(1)-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg,,,,
7569,δ-hexatoxin-Mg1a,,Other peptide,,,,,,,,,P83560,,CGSKRAWCKEKKDCCCGYNCVYAWYNQQSSCERKWKYLFTGEC,Cys-Gly-Ser-Lys-Arg-Ala-Trp-Cys-Lys-Glu-Lys-Lys-Asp-Cys-Cys-Cys-Gly-Tyr-Asn-Cys-Val-Tyr-Ala-Trp-Tyr-Asn-Gln-Gln-Ser-Ser-Cys-Glu-Arg-Lys-Trp-Lys-Tyr-Leu-Phe-Thr-Gly-Glu-Cys,"Disulphide bond formation between cysteine residues at positions 1 and 14, 8 and 20, 14 and 31, and 16 and 43.",,,
1615,deltorphin II,,Other peptide,,,,,,,,,,,YAFEVVG,Tyr-Ala-Phe-Glu-Val-Val-Gly-NH2,,,OC(=O)CC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)C(C)C)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)C)Cc1ccccc1,NUNBRHVOPFWRRG-LJXGPVSSSA-N
5636,demotate 2,,Other peptide,,,,,,,,,,,DFYWKTCT,Asp-Phe-Tyr-Trp-Lys-Thr-Cys-Thr-OH,,,,
2544,dendrotoxin-I,,Other peptide,,,,,,,,,P00979,,QPLRKLCILHRNPGRCYQKIPAFYYNQKKKQCEGFTWSGCGGNSNRFKTIEECRRTCIRK,,"Disulphide bond formation between cysteine residues at positions 7 and 57, 16 and 40, and 32 and 53",,,
7738,dendrotoxin-k,,Other peptide,,,,,,,,,P00981,,AAKYCKLPLRIGPCKRKIPSFYYKWKAKQCLPFDYSGCGGNANRFKTIEECRRTCVG,Ala-Ala-Lys-Tyr-Cys-Lys-Leu-Pro-Leu-Arg-Ile-Gly-Pro-Cys-Lys-Arg-Lys-Ile-Pro-Ser-Phe-Tyr-Tyr-Lys-Trp-Lys-Ala-Lys-Gln-Cys-Leu-Pro-Phe-Asp-Tyr-Ser-Gly-Cys-Gly-Gly-Asn-Ala-Asn-Arg-Phe-Lys-Thr-Ile-Glu-Glu-Cys-Arg-Arg-Thr-Cys-Val-Gly,"Disulphide bond formation between cysteine residues at positions 5 and 55, 14 and 38, and 30 and 51.",,,
7044,denileukin diftitox,,Other peptide,,,yes,,,,,,,denileukin diftitox,MGADDVVDSSKSFVMENFSSYHGTKPGYVDSIQKGIQKPKSGTQGNYDDDWKGFYSTDNKYDAAGYSVDNENPLSGKAGGVVKVTYPGLTKVLALKVDNAETIKKELGLSLTEPLMEQVGTEEFIKRFGDGASRVVLSLPFAEGSSSVEYINNWEQAKALSVELEINFETRGKRGQDAMYEYMAQACAGNRVRRSVGSSLSCINLDWDVIRDKTKTKIESLKEHGPIKNKMSESPNKTVSEEKAKQYLEEFHQTALEHPELSELKTVTGTNPVFAGANYAAWAVNVAQVIDSETADNLEKTTAALSILPGIGSVMGIADGAVHHNTEEIVAQSIALSSLMVAQAIPLVGELVDIGFAAYNFVESIINLFQVVHNSYNRPAYSPGHKTHAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT,,,,,
3754,(des 1-8) A-chain INSL3 analogue,,Other peptide,,,,,,,,,,,YCCLSGCTQQDLLTLCPY,Tyr-Cys-Cys-Leu-Ser-Gly-Cys-Thr-Gln-Gln-Asp-Leu-Leu-Thr-Leu-Cys-Pro-Tyr,,,,
2009,"Des-AA1,2,5,12,13-[D-Trp8]SRIF",,Other peptide,,,,,,,,,,,CKFFWKTFC,Cys-Lys-Phe-Phe-D-Trp-Lys-Thr-Phe-Cys,,,,
2011,"Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF",,Other peptide,,,,,,,,,,,YCKFFWXTFTSC,Tyr-Cys-Lys-Phe-Phe-D-Trp-IAmp-Thr-Phe-Thr-Ser-Cys,,,,
2012,Des-AA5-[D-Trp8]SRIF,,Other peptide,,,,,,,,,,,AGCKFFWKTFTSC,Ala-Gly-Cys-Lys-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys,,,,
2010,"Des-Ala1,2,5-[D-Trp8,IAmp9]SRIF",,Other peptide,,,,,,,,,,,CKFFWXTFTSC,Cys-Lys-Phe-Phe-D-Trp-IAmp-Thr-Phe-Thr-Ser-Cys,,,,
663,[des-Arg10]icatibant,,Other peptide,,,,,,,,,,,RRPXGXSXX,D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic,,,,
645,[des-Arg11]T-kinin,,Other peptide,,,,,,,,,,,ISRPPGFSPF,Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe,,,,
3870,"desGlyNH2-d(CH2)5[Tyr(Me)2,Thr4,Orn8]OT",,Other peptide,,,,,,,,,,,CYITNCPX,d(CH2)5(Me)Tyr-Ile-Thr-Asn-Cys-Pro-Orn,,,,
1174,"[des-Gly10,D-Ala6]GnRH N-ethylamide",,Other peptide,,,,,,,,,,,XHWSYGLRP,pGlu-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-(Et)Pro-NH2,,,,
1150,des-His1-[Glu9]glucagon-NH2,,Other peptide,,,,,,,,,,,SQGTFTSEYSKYLDSRRAQDFVQWLMNT,Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr,,,,
1151,des-His1-[Leu4-Glu9]glucagon-NH2,,Other peptide,,,,,,,,,,,SQLTFTSEYSKYLDSRRAQDFVQWLMNT,Ser-Gln-Leu-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr,,,,
6458,desirudin,,Other peptide,,,yes,,,,,,,desirudin,VVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIPEEYLQ,Val-Val-Tyr-Thr-Asp-Cys-Thr-Glu-Ser-Gly-Gln-Asn-Leu-Cys-Leu-Cys-Glu-Gly-Ser-Asn-Val-Cys-Gly-Gln-Gly-Asn-Lys-Cys-Ile-Leu-Gly-Ser-Asp-Gly-Glu-Lys-Asn-Gln-Cys-Val- Thr-Gly-Glu-Gly-Thr-Pro-Lys-Pro-Gln-Ser-His-Asn-Asp-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln,Disulfide bridges: 6-14; 16-28; 22-39,,,
9343,deslorelin,,Other peptide,,,,,,,,,,,XHWSYWLRP,pGlu-Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N,GJKXGJCSJWBJEZ-XRSSZCMZSA-N
2182,desmopressin,,Other peptide,,,yes,,,,,,,desmopressin,CYFQNCPRG,deamino-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2,,,NC(=O)CC1NC(=O)C(CCC(=O)N)NC(=O)C(Cc2ccccc2)NC(=O)C(NC(=O)CCSSCC(NC1=O)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N)Cc1ccc(cc1)O,NFLWUMRGJYTJIN-UHFFFAOYSA-N
647,"[des-Phe9,des-Arg10]kallidin",,Other peptide,,,,,,,,,,,KRPPGFSP,Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro,,,,
648,"[des-Pro8,des-Phe9,des-Arg10]kallidin",,Other peptide,,,,,,,,,,,KRPPGFS,Lys-Arg-Pro-Pro-Gly-Phe-Ser,,,,
3725,desulfated cholecystokinin-8,,Other peptide,,,,,,,,,,,DYMGWMDF,Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2,,,CSCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)C(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)O)CCSC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NN)CC(=O)O,ZBTPHEHKAHBSMT-YRVFCXMDSA-N
3023,DFGYVAE,,Other peptide,,,,,,,,,,,DFGYVAE,Asp-Phe-Gly-Tyr-Val-Ala-Glu,,,OC(=O)CC[C@@H](C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccccc1)C,RRCWAJVJCDGGKS-UQPWSHDPSA-N
9044,difelikefalin,,Other peptide,,,,,,,,,,difelikefalin,,,,,NCCCC[C@H](C(=O)N1CCC(CC1)(N)C(=O)O)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccccc1)N)Cc1ccccc1)CC(C)C,FWMNVWWHGCHHJJ-SKKKGAJSSA-N
4178,DkTx,,Other peptide,,,,,,,,,P0CH43,,DCAKEGEVCSWGKKCCDLDNFYCPMEFIPHCKKYKPYVPVTTNCAKEGEVCGWGSKCCHGLDCPLAFIPYCEKYRGRND,Asp-Cys-Ala-Lys-Glu-Gly-Glu-Val-Cys-Ser-Trp-Gly-Lys-Lys-Cys-Cys-Asp-Leu-Asp-Asn-Phe-Tyr-Cys-Pro-Met-Glu-Phe-Ile-Pro-His-Cys-Lys-Lys-Tyr-Lys-Pro-Tyr-Val-Pro-Val-Thr-Thr-Asn-Cys-Ala-Lys-Glu-Gly-Glu-Val-Cys-Gly-Trp-Gly-Ser-Lys-Cys-Cys-His-Gly-Leu-Asp-Cys-Pro-Leu-Ala-Phe-Ile-Pro-Tyr-Cys-Glu-Lys-Tyr-Arg-Gly-Arg-Asn-Asp,,,,
2190,d[Leu4]AVP,,Other peptide,,,,,,,,,,,CYFLNCPRG,deamino-Cys-Tyr-Phe-Leu-Asn-Cys-Pro-Arg-Gly-NH2,,,,
2189,"d[Leu4,Dap8]VP",,Other peptide,,,,,,,,,,,CYFLNCPXG,deamino-Cys-Tyr-Phe-Leu-Asn-Cys-Pro-Dap-Gly-NH2,,,,
2191,d[Leu4]LVP,,Other peptide,,,,,,,,,,,CYFLNCPKG,deamino-Cys-Tyr-Phe-Leu-Asn-Cys-Pro-Lys-Gly-NH2,,,,
5581,[D-Lys6]GnRH-II,,Other peptide,,,,,,,,,,,XHWSHKWYPG,pGlu-His-Trp-Ser-His-D-Lys-Trp-Tyr-Pro-Gly-NH2,,,,
635,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2,,Other peptide,,,,,,,,,,,ACYWKVCA,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2,,,,
6172,"D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH2  ",,Other peptide,,,,,,,,,,,ACYWRVCA,Ala-Cys-Tyr-Trp-Arg-Val-Cys-Ala,,,,
3871,dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2,,Other peptide,,,,,,,,,,,ACYWXVA,dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2,,,,
1489,dNPA,,Other peptide,,,,,,,,,,,NPAFLFQPQRF,D-Asn-Pro-(N-Me)Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,,,,
10011,dolcanatide,,Other peptide,,,,,,,,,,,NDECELCVNVACTGCL,H-D-Asn-Asp-Glu-Cys(1)-Glu-Leu-Cys(2)-Val-Asn-Val-Ala-Cys(1)-Thr-Gly-Cys(2)-D-Leu-OH,,,OC(=O)CC[C@@H]1NC(=O)[C@H](CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(C)C)CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@H](O)C)C(=O)N[C@@H](C(=O)O)CC(C)C)C(C)C)CC(=O)N)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](CC(=O)N)N)CC(=O)O)CCC(=O)O,NSPHQWLKCGGCQR-HLHYUOOASA-N
5645,DOTA-BASS,,Other peptide,,,,,,,,,,,FCYTKTCY,Phe-Cys-Tyr-Trp-Lys-Thr-Cys-Tyr,,,,
10113,DOTA-JR11,,Other peptide,,,,,,,,,,,,DOTA-[Cpa-c(DCys-Aph(Hor)-DAph(Cbm)-Lys-Thr-Cys)-DTyr-NH2],,,,
1608,DPDPE,,Other peptide,,,,,,,,,,,YXGFX,Tyr-D-Pen-Gly-Phe-D-Pen,,,O=C1CNC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)N)C(C)(C)SSC([C@@H](NC(=O)[C@@H](N1)Cc1ccccc1)C(=O)O)(C)C,MCMMCRYPQBNCPH-WMIMKTLMSA-N
2225,"d[Pen1,Tyr(Me)2]AVP",,Other peptide,,,,,,,,,,,XYFQNCPRG,Pen-(OMe)Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,COc1ccc(cc1)CC1NC(=O)CC(C)(C)SSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)Cc1ccccc1)CCC(=O)N)CC(=O)N)C(=O)N1CCCC1C(=O)NC(C(=O)NCC(=O)N)CCCN=C(N)N,HNOGCDKPALYUIG-UHFFFAOYSA-N
3865,D-Phe-CRF-(12-41),,Other peptide,,,,,,,,,,,FHLLREVLEMARAEQLAQQAHSNRKLMEII,Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)[C@H](CC)C)CCC(=O)O)CCSC)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCN=C(N)N)CCC(=O)O)CC(C)C)CCC(=O)O)CCSC)C)CCCN=C(N)N)C)CCC(=O)O)CCC(=O)N)CC(C)C)C)CCC(=O)N)CCC(=O)N)C)Cc1nc[nH]c1)CO)CC(=O)N)CCCN=C(N)N,ROYJPMVPEBZLCY-FEYNDHCKSA-N
6181,[D-Phe12]bombesin,,Other peptide,,,,,,,,,,,EQRLGNQWAVGFLM,Glu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-Phe-Leu-Met,,,,
632,"[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14)",,Other peptide,,,,,,,,,,,FQWAVAHFX,D-Phe-Gln-Trp-Ala-Val-βAla-His-Phe-Nle,,,,
6180,[D-Phe6]bombesin(6-13)methyl ester,,Other peptide,,,,,,,,,,,FQWAVGHL,Phe-Gln-Trp-Ala-Val-Gly-His-Leu,,,,
6182,[D-Phe6]bombesin(6-13)propylamide,,Other peptide,,,,,,,,,,,FQWAVGHL,Phe-Gln-Trp-Ala-Val-Gly-His-Leu,,,,
3840,"[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14)",,Other peptide,,,,,,,,,,,FQWAVGHLF,D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-(ψ13-14)Cpa,,,,
6185,"[D-Pro4,D-Trp7,9,10]substance P (4-11)",,Other peptide,,,,,,,,,,,PQQWFWWM,Pro-Gln-Gln-Trp-Phe-Trp-Trp-Met,,,,
6788,drotrecogin alfa,,Other peptide,,,yes,yes,,,,,,drotrecogin alfa (activated),LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKKLLVRLGEYDLRRWEKWELDLDIKEVFVHPNYSKSTTDNDIALLHLAQPATLSQTIVPICLPDSGLAERELNQAGQETLVTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEVMSNMVSENMLCAGILGDRQDACEGDSGGPMVASFHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRDKEAPQKSWAP.SKHVDGDQCLVLPLEHPCASLCCGHGTCIXGIGSFSCDCRSGWEGRFCQREVSFLNCSLDNGGCTHYCLEEVGWRRCSCAPGYKLGDDLLQCHPAVKFPCGRPWKRMEKKRSHL,,,,,
1609,DSLET,,Other peptide,,,,,,,,,,,YSGFLT,Tyr-D-Ser-Gly-Phe-Leu-Thr,Serine at position 2 is D-Ser,,OC[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CC(C)C)Cc1ccccc1)NC(=O)[C@H](Cc1ccc(cc1)O)N,PKSODCLCMBUCPW-LVNBQDLPSA-N
2184,d[D-Pal2]AVP,,Other peptide,,,,,,,,,,,CAFQNCPRG,deamino-Cys-D-Pal-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,,
2185,d[D-Phe2]AVP,,Other peptide,,,,,,,,,,,CFFQNCPRG,deamino-Cys-D-Phe-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,,
3873,DSTBULET,,Other peptide,,,,,,,,,,,YSGFLT,Tyr-D-Ser(OtBu)-Gly-Phe-Leu-Thr,Serine residue at position 2 is D-Ser(OtBu),,CC(C[C@@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)COC(C)(C)C)C,DOMQMNWQZKXZCU-GUVNKXFDSA-N
6133,"(D-Thr6, D-Trp8,9)galanin(1-15)ol",,Other peptide,,,,,,,,,,,GWTLNTAWWLLGPHA,Gly-Trp-Thr-Leu-Asn-Thr-Ala-Trp-Trp-Leu-Leu-Gly-Pro-His-Ala,,,,
6183,"[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14)",,Other peptide,,,,,,,,,,,XQWAVGHLL,D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-ψ(CH2NH)-Leu,,,CC(C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1NCc2c(C1)c1ccccc1[nH]2)CCC(=O)N)C)CN[C@H](C(=O)N)CC(C)C)C,IUYCRRDHLJIJBB-QAGBKCHLSA-N
1584,[D-Trp11]neurotensin,,Other peptide,,,,,,,,,,,XLYENKPRRPWIL,pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Trp-Ile-Leu,,,,
1820,[D-Trp12]PTH-(7-34) (bovine),,Other peptide,,,,,,,,,,,FMHNLWKHLSSMERVEWLRKKLQDVHNF,Phe-Met-His-Asn-Leu-D-Trp-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
1819,"[D-Trp12,Tyr34]PTH-(7-34) (bovine)",,Other peptide,,,,,,,,,,,FMHNLYKHLSSMERVEWLRKKLQDVHNY,Phe-Met-His-Asn-Leu-D-Trp-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr,,,,
3866,[D-Trp2]galanin-(1-29),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAVGNHRSFSDKNGLT,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr,,,,
1544,[D-Trp32]NPY,,Other peptide,,,,,,,,,,,YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-D-Tyr-NH2,,,,
1334,[D-Trp8]γ-MSH,,Other peptide,,,,,,,,,,,YVMGHFRWDRFG,Tyr-Val-Met-Gly-His-Phe-Arg-D-Trp-Asp-Arg-Phe-Gly,,,,
3946,"[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14)",,Other peptide,,,,,,,,,,,WQWAVXHFX,D-Trp-Gln-Trp-Ala-Val-Apa(4Cl)-His-Phe-Nle,,,,
633,"[D-Tyr6,(R)-APA11,Phe13,Nle14]bombesin-(6-14)",,Other peptide,,,,,,,,,,,YQWAVXHFX,D-Tyr-Gln-Trp-Ala-Val-APA-His-Phe-Nle,,,,
2028,[D-Tyr8]CYN 154806,,Other peptide,,,,,,,,,,,FCYWKTCY,Ac-(4-NO2-Phe)-cyc(D-Cys-Tyr-D-Trp-Lys-Thr-Cys)-D-Tyr-NH2,,,,
7638,dulaglutide,,Other peptide,,,yes,,,,,,,dulaglutide,HGEGTFTSDVSSYLEEQAAKEFIAWLVKGGGGGGGSGGGGSGGGGSAESKYGPPCPPCPAPEAAGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLG,,,,,
841,duramycin,,Other peptide,,,,,,,,,,,AKQAAAFGPFXFVADGNXL,Ala-Lys-Gln-Ala-Ala-Ala-Phe-Gly-Pro-Phe-Abu-Phe-Val-Ala-Asp-Gly-Asn-Abu-Lys,,,,
3869,"d[Val4,DArg8]VP",,Other peptide,,,,,,,,,,,CYFVNCPRG,deamino-Cys-Tyr-Phe-Val-Asn-Cys-Pro-D-Arg-Gly-NH2,,,,
5811,[D-Val5]NPS,,Other peptide,,,,,,,,,,,SFRNVVGTGMKKTSFQRAKS,Ser-Phe-Arg-Asn-Val-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,,,,
2183,dVDAVP,,Other peptide,,,,,,,,,,,XYFQNCPRG,3-mercaptopropionyl-Tyr-Phe-Val-Asn-Cys-Pro-D-Arg-Gly-NH2,,,,
2527,DW13.3,,Other peptide,,,,,,,,,P60979,,AECLMIGDTSCVPRLGRRCCYGAWCYCDQQLSCRRVGRKRECGWVEVNCKCGWSWSQRIDDWRADYSCKCPEDQ,,,,,
1618,dynorphin-(1-11),,Other peptide,,,,,,,,,,,YGGFLRRIRPK,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys,,,,
1661,dynorphin-(1-17)-NH2,,Other peptide,,,,,,,,,,,YGGFLRRIRPKLKWDNQ,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2,,,,
4015,[dY]1KP-10,,Other peptide,,,,,,,,,,,NWNSFGLRF,Asn-Trp-Asn-Ser-Phe-Leu-Arg-Phe-NH2,,,,
1648,E2078,,Other peptide,,,,,,,,,,,YGGFLRRL,Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Leu,,,CCNC(=O)[C@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)NC)CC(C)C)CCCN=C(N)N)C)CCCN=C(N)N)CC(C)C,JENWDDCMEATQSR-ONSKYXJOSA-N
3915,E7,,Other peptide,,,,,,,,,,,WWGKKYRASKLGLAR,Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg,,,,
2044,EC 5-21,,Other peptide,,,,,,,,,,,FCFWKTCA,D-Phe-Cys-Phe-Trp-Lys-Thr-Cys-Nal-NH2,,,,
6955,ecallantide,,Other peptide,,,yes,,,,,,,ecallantide,EAMHSFCAFKADDGPCRAAHPRWFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRD,Glu-Ala-Met-His-Ser-Phe-Cys-Ala-Phe-Lys-Ala-Asp-Asp-Gly-Pro-Cys-Arg-Ala-Ala-His-Pro-Arg-Trp-Phe-Phe-Asn-Ile-Phe-Thr-Arg-Gln-Cys-Glu-Glu-Phe-Ile-Tyr-Gly-Gly-Cys-Glu-Gly-Asn-Gln-Asn-Arg-Phe-Glu-Ser-Leu-Glu-Glu-Cys-Lys-Lys-Met-Cys-Thr-Arg-Asp,,,,
6594,echistatin,,Other peptide,,,,,,,,,,,ECESGPCCRNCKFLKEGTICKRARGDDMDDYCNGKTCDCPRNPHKGPAT,Glu-Cys-Glu-Ser-Gly-Pro-Cys-Cys-Arg-Asn-Cys-Lys-Phe-Leu-Lys-Glu-Gly-Thr-Ile-Cys-Lys-Arg-Ala-Arg-Gly-Asp-Asp-Met-Asp-Asp-Tyr-Cys-Asn-Gly-Lys-Thr-Cys-Asp-Cys-Pro-Arg-Asn-Pro-His-Lys-Gly-Pro-Ala-Thr,"Disulphide bond formation between cysteine residues at positions 2 and 11, 7 and 32, 8 and 37, and 20 and 39.",,,
5638,edotreotide,,Other peptide,,,yes,,,,,,,edotreotide,FCFWKTCT,Phe-Cys-Phe-Trp-Lys-Thr-Cys-Thr-ol,Disulphide bond: 2-7,Disulphide bond: 2-7,,
1478,EFWSLAAPQRF-NH2,,Other peptide,,,,,,,,,,,EFWSLAAPQRF,Glu-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2,,,,
1566,EISAI-1,,Other peptide,,,,,,,,,,,RKPWLL,Me-Arg-Lys-Pro-Trp-tLeu-Leu-OEt,,,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](C(C)(C)C)C(=O)N[C@H](C(=O)OCC)CC(C)C)Cc1c[nH]c2c1cccc2)NC(=O)[C@H](CCCN=C(N)N)NC,BLWANJSERJECRU-ULWXFTFZSA-N
1567,EISAI-2,,Other peptide,,,,,,,,,,,RKPWLL,Me-Arg-Lys-Pro-Trp-tLeu-Leu,,,,
2086,eledoisin,,Other peptide,,,,,,,,,,eledoisin,XPSKDAFIGLM,pGlu-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2,N-terminal glutamine is cyclated to pyrrolidone carboxylic acid (represented by pGlu/X); C-terminal methionine is amidated.,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCSC)CC(C)C)[C@H](CC)C)Cc1ccccc1)C)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)CO,AYLPVIWBPZMVSH-FCKMLYJASA-N
7392,elosulfase alfa,,Other peptide,,,yes,,,,,,,elosulfase alfa,MAAVVAATRWWQLLLVLSAAGMGASGAPQPPNILLLLMDDMGWGDLGVYGEPSRETPNLDRMAAEGLLFPNFYSANPLCSPSRAALLTGRLPIRNGFYTTNAHARNAYTPQEIVGGIPDSEQLLPELLKKAGYVSKIVGKWHLGHRPQFH150PLKHGFDEWFGSPNCHFGPYDNKARPNIPVYRDWEMVGRYYEEFPINLKT200GEANLTQIYLQEALDFIKRQARHHPFFLYWAVDATHAPVYASKPFLGTSQRGRYGDAVREIDDSIGKILELLQDLHVADNTFVFFTSDNGAALISAPEQGGSNGPFLCGKQTTFEGGMREPALAWWPGHVTAGQVSHQLGSIMDLFTTSLALAGLTPPSDRAIDGLNLLPTLLQGRLMDRPIFYYRGDTLMAATLGQHKAHFWTWTNSWENFRQGIDFCPGQNVSGVTTHNLEDHTKLPLIFHLGRDPGERFPLSFASAEYQEALSRITSVVQQHQEALVPAQPQLNVCNWAVMNWAPPGCEKLGKCLTPPESIPKKCLWSH,,,,,
2612,ErgTx-1,,Other peptide,,,,,,,,,Q86QT3,,DRDSCVDKSRCAKYGYYQECQDCCKNAGHNGGTCMFFKCKCA,Asp-Arg-Asp-Ser-Cys-Val-Asp-Lys-Ser-Arg-Cys-Ala-Lys-Tyr-Gly-Tyr-Tyr-Gln-Glu-Cys-Gln-Asp-Cys-Cys-Lys-Asn-Ala-Gly-His-Asn-Gly-Gly-Thr-Cys-Met-Phe-Phe-Lys-Cys-Lys-Cys-Ala,"Disulphide bonds between cysteine residues at positions 5 and 23, 11 and 34, 20 and 39, and 24 and 41.",,,
8375,etelcalcetide,,Other peptide,,,yes,,,,,,,etelcalcetide,CARRRAR,Ac-D-Cys(L-Cys)-D-Ala-D-Arg-D-Arg-D-Arg-D-Ala-D-Arg-NH2,,,,
3875,europium-labelled INSL3,,Other peptide,,,,,yes,,,,,,,,,,,
4375,europium-labelled INSL5,,Other peptide,,,,,yes,,,,,,,,,,,
6522,europium-labelled mouse INSL5,,Other peptide,,,,,yes,,,,,,,,,,,
8342,europium-labelled R3(B1-22R),,Other peptide,,,,,yes,,,,,,RAAPYGVRLSGREFIRAVIFTSR,Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Ser-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Ser-Arg-NH2,,,,
3874,europium-labelled relaxin,,Other peptide,,,,,yes,,,,,,,,,,,
4374,europium-labelled relaxin-3-B/INSL5 A chimera,,Other peptide,,,,,yes,,,,,,,,,,,
1100,examorelin,,Other peptide,,,,,,,,,,examorelin,HWAWFK,His-D-2Me-Trp-Ala-Trp-D-Phe-Lys-NH2,,,,
3730,exendin-3,,Other peptide,,,,,,,,,P20394,,HSDGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS,His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser,,,,
1135,exendin-4,,Other peptide,,,yes,,,,,,P26349,exenatide,HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS,His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser,Amidation of C-terminal serine residue,,,
1138,exendin-(9-39),,Other peptide,,,,,,,,,,,DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS,Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser,,,,
2171,F180,,Other peptide,,,,,,,,,,,FIKNCPXG,(CHCO)Phe-Ile-Lys-Asn-Cys-Pro-(Abu)Dab-Gly-NH2,,,,
1045,F2L-[125I]Tyr,,Other peptide,,,,,yes,yes,,,,,MLGMIKNSLFGSVETWPWQVLY,Met-Leu-Gly-Met-Ile-Lys-Asn-Ser-Leu-Phe-Gly-Ser-Val-Glu-Thr-Trp-Pro-Trp-Gln-Val-Leu-[125I]Y,,,,
9341,fertirelin,,Other peptide,,,,,,,,,,,XHWSYGLRP,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-NHEt,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N,DGCPIBPDYFLAAX-YTAGXALCSA-N
1690,[F/G]N/OFQ-(1-13)-NH2,,Other peptide,,,,,,,,,,,FGGFTGARKSARKLA,Phe-ψ(CH2-NH)Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-NH2,,,,
6968,filgrastim,,Other peptide,,,yes,,,,,,,filgrastim,MAGPATQSPMKLMALQLLLWHSALWTVQEATPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLVSECATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRR AGGVLVASHLQSFLEVSYRVLRHLAQP,,,,,
2103,FK 224,,Other peptide,,,,,,,,,,,TYLFTNS,Thr-(Me)Tyr-Leu-Phe-Thr-Asn-Ser,Lactone bridge between threonine residue at position 1 and serine residue at position 7; tyrosine at position 2 is methylated; N-terminal threonine undergoes an undetermined modification,,CCCCCc1ccccc1CCC(=O)NC1C(C)OC(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)/C(=C/c2ccc(cc2)O)/N(C1=O)C)CC(C)C)Cc1ccccc1)C(O)C,BEWCDVTWUFJSSM-MBMPTNJISA-N
5761,FLPLAR,,Other peptide,,,,,,,,,,,FLPLAR,Phe-Leu-Pro-Leu-Ala-Arg,,,,
5777,FLTChaAR,,Other peptide,,,,,,,,,,,FLTXAR,Phe-Leu-Thr-Cha-Ala-Arg,,,,
760,Flu-CCL3,,Other peptide,,,,,yes,,,,,,SLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA,fluoresceinthiocarbamyl-Ser-Leu-Ala-Ala-Asp-Thr-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Thr-Ser-Arg-Gln-Ile-Pro-Gln-Asn-Phe-Ile-Ala-Asp-Tyr-Phe-Glu-Thr-Ser-Ser-Gln-Cys-Ser-Lys-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Arg-Ser-Arg-Gln-Val-Cys-Ala-Asp-Pro-Ser-Glu-Glu-Trp-Val-Gln-Lys-Tyr-Val-Ser-Asp-Leu-Glu-Leu-Ser-Ala,,,,
1021,fMet-Ile-Phe-Leu,,Other peptide,,,,,,,,,,,MIFL,fMet-Ile-Phe-Leu,,,,
5842,fMet-Ile-Val-Ile-Leu,,Other peptide,,,,,,,,,,,MIVIL,fMet-Ile-Val-Ile-Leu,N-terminal methionine is formyl-methionine.,,,
5841,fMet-Ile-Val-Thr-Leu-Phe,,Other peptide,,,,,,,,,,,MIVTLF,fMet-Ile-Val-Thr-Leu-Phe,N-terminal methionine residue is formyl-methionine.,,,
1022,fMet-Leu-Phe,,Other peptide,,,,,,,,,,,MLP,fMet-Leu-Phe,,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)CC(C)C)NC=O,PRQROPMIIGLWRP-BZSNNMDCSA-N
5840,fMet-Leu-Phe-Glu,,Other peptide,,,,,,,,,,,MLPE,fMet-Leu-Phe-Glu,N-terminal methionine is formyl-methionine.,,,
5843,fMet-Leu-Phe-Ile-Ile-Lys-FITC,,Other peptide,,,,,yes,,,,,,MLFIIK,fMet-Leu-Phe-Ile-Ile-Lys-FITC,N-terminal methionine is formyl-methionine.,N-terminal methionine is formyl-methionine.,,
5837,fMet-Met-Trp-Leu-Leu,,Other peptide,,,,,,,,,,,MMWLL,fMet-Met-Trp-Leu-Leu,,,,
1023,fMet-Met-Tyr-Ala-Leu-Phe,,Other peptide,,,,,,,,,,,MMYALF,fMet-Met-Tyr-Ala-Leu-Phe,,,,
4195,FMRFamide,,Other peptide,,,,,,,,,,,FMRF,Phe-Met-Arg-Phe-NH2,Amidation of C-terminal phenylalanine residue,,,
6247,F peptide,,Other peptide,,,,,,,,,,,EGSDTITLPCRIKQFINMWQE,Glu-Gly-Ser-Asp-Thr-Ile-Thr-Leu-Pro-Cys-Arg-Ile-Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu,,,,
6264,FPRL1-inhibitor protein,,Other peptide,,,,,,,,,A6QG57,,FFSYEWKGLEIAKNLADQAKKDDERIDKLMKESDKNLTPYKAETVNDLYLIVKKLSQGDVKKAVVRIKDDGPRDYYTFDLTRPLEENRKNIKVVKNGEIDSITWY,,,,,
3024,FPYVAE peptide [PMID: 20494585],,Other peptide,,,,,,,,,,,,,,,OC(=O)CC[C@@H](C(=O)O)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)N)Cc1ccc(cc1)O)C,QKSOHTFYHNYHRK-YFVDCHTDSA-N
5536,FSH α subunit-deglycosylated form,,Other peptide,,,,,,,,,,,APDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKQVTSESTCCVAKSYNRVTVMGGFKVEQHTACHCSTCYYHKS,,,,,
5537,FSH β subunit-deglycosylated form,,Other peptide,,,,,,,,,,,NSCELTQITIAIEKEECRFCISIQTTWCAGYCYTRDLVYKDPARPKIQKTCTFKELVYETVRVPGCAHHADSLYTYPVATQCHCGKCDSDSTDCTVRGLGPSYCSFGEMKE,,,,,
1158,FSH deglycosylated α/β,,Other peptide,5536|5537,FSH α subunit-deglycosylated form|FSH β subunit-deglycosylated form,,,,,,,,,,,,,,
8668,furin inhibitor peptide,,Other peptide,,,,,,,,,,,TPRARRRKKRT-NH2,Thr-Pro-Arg-Ala-Arg-Arg-Arg-Lys-Lys-Arg-Thr,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCN=C(N)N)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](O)C)N)CCCN=C(N)N)C)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N,XIHRZTWKTVFWSV-HQSWAJDZSA-N
10324,Fz7-21,,Other peptide,,,,,,,,,,,LPSDDLEFWCHVMY,(Ac)-Leu-Pro-Ser-Asp-Asp-Leu-Glu-Phe-Trp-Cys-His-Val-Met-Tyr-NH2,,,,
6588,G4120,,Other peptide,,,,,,,,,,,YRGDC,Tyr-Arg-Gly-Asp-Cys,,,SC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)CCCN=C(N)N,BIEZITROCMXFHL-QAETUUGQSA-N
5639,Ga-DOTA-NOC,,Other peptide,,,,,,,,,,,FCXWKTCT,Phe-Cys-Nal-Trp-Lys-Thr-Cys-Thr,Disulphide bond:2-7,Disulphide bond:2-7,,
5632,"[Ga-DOTA,Tyr3,Thr8]octreotide",,Other peptide,,,,,,,,,,,FCFWKTCT,Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-ol,,,,
5640,Ga-KE88,,Other peptide,,,,,,,,,,,XRFFWKTF,Dab-Arg-Phe-Phe-Trp-Lys-Thr-Phe,,,,
6129,galanin,Pig,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAIDNHRSFHDKYGLA,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
6094,galanin(10-29) (pig),,Other peptide,,,,,,,,,,,LLGPHAIDNHRSFHDKYGLA,Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
6093,galanin(10-29) (rat/mouse),,Other peptide,,,,,,,,,,,LLGPHAIDNHRSFSDKHGLT,Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr,,,,
6140,galanin(1-10),,Other peptide,,,,,,,,,,,GWTLNSAGYL,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu,,,,
5356,galanin-(1-11),,Other peptide,,,,,,,,,,,GWTLNSAGYLL,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu,,,,
6084,galanin(1-11),,Other peptide,,,,,,,,,,,GWTLNSAGYLL,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu,,,,
6141,galanin(1-12),,Other peptide,,,,,,,,,,,GWTLNSAGYLLG,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly,,,,
6085,galanin(1-13)amide,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGP,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro,,,,
6086,galanin(1-15),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHA,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala,,,,
6087,galanin(1-16) (rat/mouse/pig),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAI,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile,,,,
6088,galanin(1-19) (human),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAVGNH,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His,,,,
6139,galanin(1-19) (rat/mouse),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAIDNH,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His,,,,
6137,galanin(1-20)  (human),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAVGNHR,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg,,,,
5357,galanin(2-11),,Other peptide,,,,,,,,,,,WTLNSAGYLLG,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly,,,,
6130,galanin(2-29) (pig),,Other peptide,,,,,,,,,,,WTLNSAGYLLGPHAIDNHRSFHDKYGLA,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
3876,galanin(2-29) (rat/mouse),,Other peptide,,,,,,,,,,,WTLNSAGYLLGPHAVGNHRSFSDKNGLT,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr,,,,
6090,galanin(2-30) (human),,Other peptide,,,,,,,,,,,WTLNSAGYLLGPHAVGNHRSFSDKNGLTS,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser,,,,
6091,galanin(3-29) (pig),,Other peptide,,,,,,,,,,,TLNSAGYLLGPHAIDNHRSFHDKYGLA,Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
6092,galanin(3-29) (rat/mouse),,Other peptide,,,,,,,,,,,TLNSAGYLLGPHAIDNHRSFSDKHGLT,Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr,,,,
6138,galanin(3-30) (human),,Other peptide,,,,,,,,,,,TLNSAGYLLGPHAVGNHRSFSDKNGLTS,Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser,,,,
5359,galanin(5-29) (pig),,Other peptide,,,,,,,,,,,NSAGYLLGPHAIDNHRSFHDKYGLA,Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
6134,galanin(5-29) (rat/mouse),,Other peptide,,,,,,,,,,,NSAGYLLGPHAIDNHRSFSDKHGLT,Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr,,,,
6083,galanin(7-29) (pig),,Other peptide,,,,,,,,,,,AGYLLGPHAIDNHRSFHDKYGLA,Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
6136,galanin(9-25) (rat/mouse),,Other peptide,,,,,,,,,,,YLLGPHAIDNHRSFSDK,Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys,,,,
6135,galanin(9-29) (rat/mouse),,Other peptide,,,,,,,,,,,YLLGPHAIDNHRSFSDKHGLT,Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr,,,,
6095,galanin(D-Trp2) (pig),,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPHAIDNHRSFHDKYGLA,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
6120,galanin-like peptide,Pig,Other peptide,,,,,,,,,Q9TT95,,APVHRGRGGWTLNSAGYLLGPVLHPPSRAEGGGKGKTALGILDLWKAIDGLPYPQSQLAS,Ala-Pro-Val-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Pro-Pro-Ser-Arg-Ala-Glu-Gly-Gly-Gly-Lys-Gly-Lys-Thr-Ala-Leu-Gly-Ile-Leu-Asp-Leu-Trp-Lys-Ala-Ile-Asp-Gly-Leu-Pro-Tyr-Pro-Gln-Ser-Gln-Leu-Ala-Ser,,,,
6105,Gal-B2,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6112,Gal-B2-C10,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6113,Gal-B2-C12,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6114,Gal-B2-C14,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6115,Gal-B2-C18,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,GlyTrp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6111,Gal-B2-C8,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6106,Gal-B2-dPEG24,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6116,Gal-B2-MPEG4,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6107,Gal-B5,,Other peptide,,,,,,,,,,,WTLNSAGYLLGPKKKK,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6110,Gal-(K)4,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6121,GALP(1-32) (human),,Other peptide,,,,,,,,,,,APAHRGRGGWTLNSAGYLLGPVLHLPQMGDQD,Ala-Pro-Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-Asp,,,,
6122,GALP(3-32) (human),,Other peptide,,,,,,,,,,,AHRGRGGWTLNSAGYLLGPVLHLPQMGDQD,Ala-His-Arg-Gly-Arg-Gly-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-His-Leu-Pro-Gln-Met-Gly-Asp-Gln-Asp,,,CSCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(=O)O)CCC(=O)N)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C)Cc1nc[nH]c1)CCCN=C(N)N)CCCN=C(N)N)CC(C)C)CC(=O)N)CO)C)CC(C)C)CC(C)C)CC(C)C)Cc1nc[nH]c1)CC(C)C)CCC(=O)N,XKXOALDYCBSJGJ-VGPQRCSDSA-N
6096,galparan,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPINLKALAALAKKIL,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu,,,,
6108,Gal-R2-dPEG24,,Other peptide,,,,,,,,,,,WTLNSAGYLLGPKKKKK,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys-Lys,,,,
9504,γ-iE-DAP,,Other peptide,,,,,,,,,,,,,,,O=C(N[C@@H](C(=O)O)CCC[C@@H](C(=O)O)N)CC[C@H](C(=O)O)N,QIFGMZZTJRULMA-XLPZGREQSA-N
7689,γ-KTx1.7,,Other peptide,,,,,,,,,P0C892,,DRDSCVDKSRCSKYGYYQECQDCCKKAGHNGGTCMFFKCKCA,Asp-Arg-Asp-Ser-Cys-Val-Asp-Lys-Ser-Arg-Cys-Ser-Lys-Tyr-Gly-Tyr-Tyr-Gln-Glu-Cys-Gln-Asp-Cys-Cys-Lys-Lys-Ala-Gly-His-Asn-Gly-Gly-Thr-Cys-Met-Phe-Phe-Lys-Cys-Lys-Cys-Ala,"Predicted disulphide bond formation between cysteine residues at positions 5-23, 11-34, 20-39 and 24-41.",,,
3877,ganirelix,,Other peptide,,,yes,,,,,,,ganirelix,AFASYXLXPA,Ac-Nal-Cpa-Pal-Ser-Tyr-(Et)Har-Leu-(Et)Har-Pro-Ala-NH2,,,CCNC(=NCCCC[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCCC1C(=O)N[C@@H](C(=O)N)C)CCCCN=C(NCC)NCC)CC(C)C)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)C(Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1)CO)Cc1ccc(cc1)O)NCC,GJNXBNATEDXMAK-RXXWGPEVSA-N
5643,Ga-NODAGA-LM3,,Other peptide,,,,,,,,,,,FCYFKTCY,Phe-Cys-Tyr-Phe-Lys-Thr-Cys-Tyr,Disulphide bond: 2-7,Disulphide bond: 2-7,,
3581,gastrin-releasing peptide,Pig,Other peptide,,,,,,,,,P63153,,APVSVGGGTVLAKMYPRGNHWAVGHLM,Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2,C-terminal peptidyl-methionine amidation,,,
6175,gastrin releasing peptide(14-27) (human),,Other peptide,,,,,,,,,,,MYPRGNHWAVGHLM,Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met,,,,
4198,GaTx1,,Other peptide,,,,,,,,,P85066,,CGPCFTTDHQMEQKCAECCGGIGKCYGPQCLCNR,Cys-Gly-Pro-Cys-Phe-Thr-Thr-Asp-His-Gln-Met-Glu-Gln-Lys-Cys-Ala-Glu-Cys-Cys-Gly-Gly-Ile-Gly-Lys-Cys-Tyr-Gly-Pro-Gln-Cys-Leu-Cys-Asn-Arg-NH2,"C-terminal arginine residue is arginine amide; predicted disulphide bond formation between cysteine residues at positions 1 and 18, 4 and 25, 15 and 30, and 19 and 32",,,
4199,GaTx2,,Other peptide,,,,,,,,,P80670,,VSCEDCPDHCSTQKARAKCDNDKCVCEPI,Val-Ser-Cys-Glu-Asp-Cys-Pro-Asp-His-Cys-Ser-Thr-Gln-Lys-Ala-Arg-Ala-Lys-Cys-Asp-Asn-Asp-Lys-Cys-Val-Cys-Glu-Pro-Ile,"Disulphide bond formation between cysteine residues at positions 3 and 19, 6 and 24 and 10 and 26",,,
8585,GE-137,,Other peptide,,,,,yes,,,,,,AGSCYCSGPPRFECWCYETEGTGGGK,Ala-Gly-Ser-Cys-Tyr-Cys-Ser-Gly-Pro-Pro-Arg-Phe-Glu-Cys-Trp-Cys-Tyr-Glu-Thr-Glu-Gly-Thr-Gly-Gly-Gly-Lys,,,OC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CCC(=O)O)Cc1ccccc1)CCCNC(=N)N)Cc1c[nH]c2c1cccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N)CCCCNC(=O)CCCCCN1c2ccc(cc2C(/C/1=C/C=C/C=C/C1=[N+](CCCCS(=O)(=O)O)c2c(C1(C)CCCCS(=O)(=O)O)cc(cc2)S(=O)(=O)[O-])(C)C)S(=O)(=O)O)[C@H](O)C)CCC(=O)O)[C@H](O)C)CCC(=O)O)Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)C)C,UQYUYHHXESUXGH-ABPLELQPSA-N
5839,gG-2p20,,Other peptide,,,,,,,,,,,GLLWVEVGGEGPGPT,Gly-Leu-Leu-Trp-Val-Glu-Val-Gly-Gly-Glu-Gly-Pro-Gly-Pro-Thr,,,,
1103,GHRH-(1-29)-NH2 (human),,Other peptide,,,,,,,,,,,YADAIFTNSYRKVLGQLSARKLLQDIMSR,Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2,,,,
1104,GHRH-(1-29)-NH2 (rat),,Other peptide,,,,,,,,,,,HADAIFTSSYRRILGQLYARKLLHEIMNR,His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-NH2,,,,
1105,GHRH-(1-29)-OH (human),,Other peptide,,,,,,,,,,,YADAIFTNSYRKVLGQLSARKLLQDIMSR,Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-OH,,,,
1093,GHRP-6,,Other peptide,,,,,,,,,,,HWAWFK,Me-His-Trp-Ala-Trp-Phe-Lys-NH2,,,NCCCCC(C(=O)N)NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(Cc1cnc[nH]1)N)C,WZHKXNSOCOQYQX-UHFFFAOYSA-N
1128,GIP-(10-30),,Other peptide,,,,,,,,,,,YSIAMDKIRQQDFVNWLLAQK,Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys,,,,
1129,GIP-(6-30)-amide,,Other peptide,,,,,,,,,,,FISDYSIAMDKIHQQDFVNWLLAQK,Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys,,,,
1130,GIP-(7-30),,Other peptide,,,,,,,,,,,ISDYSIAMDKIRQQDFVNWLLAQK,Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys,,,,
1169,[Gln8]GnRH,,Other peptide,,,,,,,,,,,XHWSYGLQPG,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2,,,,
6524,GLP-1-(9-36),,Other peptide,,,,,,,,,,,EGTFTSDVSSYLEGQAAKEFIAWLVKGR,Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2,,,,
1139,GLP-2-(1-29) (rat),,Other peptide,,,,,,,,,,,HADGSFSDEMNTILDNLATRDFINWLIQT,His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr,,,,
9896,GLP-2 analogue 10,,Other peptide,,,,,,,,,,,HGDGSFSDEMCTILDNLCARDFINWLIQTKITDPSSGAPPPS-NH2,,,,,
2980,GLPDGG peptide [PMID: 20494585],,Other peptide,,,,,,,,,,,,,,,NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)O)CC(=O)O)CC(C)C,SKODABHETMRRBC-IHRRRGAJSA-N
1146,glucagon-(1-21),,Other peptide,,,,,,,,,,,HSQGTFTSDYSKYLDSRRAQD,His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp,,,,
1147,glucagon-(1-6),,Other peptide,,,,,,,,,,,HSQGTF,His-Ser-Gln-Gly-Thr-Phe,,,OC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)[C@H](O)C)CCC(=O)N)NC(=O)[C@H](Cc1[nH]cnc1)N,VDWWLJRQDNTHJB-MXAMYCJDSA-N
7450,glucarpidase,,Other peptide,,,yes,,,,,,,glucarpidase,,,,,,
6737,glutathione,,Other peptide,,,,,,,,,,,CEG,Cys-Glu-Gly,,,SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,RWSXRVCMGQZWBV-WDSKDSINSA-N
9505,glycyl-sarcosine,,Other peptide,,,,,,,,,,,,H-Gly-Sar-OH,,,CN(C(=O)CN)CC(=O)O,VYAMLSCELQQRAE-UHFFFAOYSA-N
1466,GM-109,,Other peptide,,,,,,,,,,,FKYA,Phe-Nε-Lys-Tyr(3-tBu)-βAla,,,O=C1NCCCC[C@H](NC(=O)[C@H](Cc2ccccc2)N)C(=O)N[C@H](C(=O)NCC1)Cc1ccc(c(c1)C(C)(C)C)O,RRXAKVUZGASTMY-SDHOMARFSA-N
6131,GMAP(1-41),Pig,Other peptide,,,,,,,,,P07480,,ELEPEDEARPGGFDRLQSEDKAIRTIMEFLAFLHLKEAGAL,Glu-Leu-Glu-Pro-Glu-Asp-Glu-Ala-Arg-Pro-Gly-Gly-Phe-Asp-Arg-Leu-Gln-Ser-Glu-Asp-Lys-Ala-Ile-Arg-Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu,,,,
6132,GMAP(44-59),Pig,Other peptide,,,,,,,,,P07480,,LPGLPSAASSEDAGQS,Leu-Pro-Gly-Leu-Pro-Ser-Ala-Ala-Ser-Ser-Glu-Asp-Ala-Gly-Gln-Ser,,,,
3878,GnRH III,,Other peptide,,,,,,,,,P30948,,QHWSHDWKPG,Glu-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly,Amidation of C-terminal glycine residue; N-terminal residue is pyrrolidine carboxylic acid,,,
3879,goserelin,,Other peptide,,,yes,,,,,,,goserelin,XHWSYSLRP,pGlu-His-Trp-(t-Bu)Ser-Tyr-Ser-Leu-Arg-Pro,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)CCCN=C(N)N)CC(C)C)COC(C)(C)C)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1[nH]cnc1,BLCLNMBMMGCOAS-URPVMXJPSA-N
3880,GR100679,,Other peptide,,,,,,,,,,,GAWF,cyclohexylcarbonyl-Gly-Ala-D-Trp-Phe-NMe2,,,O=C(N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N(C)C)Cc1ccccc1)Cc1c[nH]c2c1cccc2)C)CNC(=O)C1CCCCC1,IBHXDZADSPABSD-GJDOKZOISA-N
2128,GR138676,,Other peptide,,,,,,,,,,,DMHDFFF,Asp-Met-His-Asp-Phe-Phe-Phe,,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CC[C@H]2[C@@H]1C(=O)N(C2)[C@@H](C(=O)NC(COCc1ccccc1)COCc1ccccc1)CC(C)C)Cc1ccccc1)Cc1ccccc1)Cc1ccccc1)CC(=O)O)Cc1[nH]cnc1)NC(=O)[C@H](CC(=O)O)N,SHZVIDXXKGEHEF-QEPUNBJPSA-N
1529,GR231118,,Other peptide,,,,,,,,,,,IEPXYRLRY,Ile-Glu-Pro-Dpr-Tyr-Arg-Leu-Arg-Tyr-CONH2,,,,
3881,GR64349,,Other peptide,,,,,,,,,,,KDSFVXLM,Lys-Asp-Ser-Phe-Val-Aaa-Leu-Met-NH2,,,,
3882,GR94800,,Other peptide,,,,,,,,,,,AAWFPPX,Bz-Ala-Ala-D-Trp-Phe-D-Pro-Pro-Nle-NH2,,,CC[C@@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1ccccc1)C)C)Cc1ccccc1)C,KIPTYYXCLIQOHM-KKMBCTKYSA-N
4206,GsMTx-4,,Other peptide,,,,,,,,,Q7YT39,,GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSF,Gly-Cys-Leu-Glu-Phe-Trp-Trp-Lys-Cys-Asn-Pro-Asn-Asp-Asp-Lys-Cys-Cys-Arg-Pro-Lys-Leu-Lys-Cys-Ser-Lys-Leu-Phe-Lys-Leu-Cys-Asn-Phe-Ser-Phe-NH2,"Disulphide bonds between cysteine residues: Cys2-Cys17, Cys9-Cys23, and Cys16-Cys30.",,,
7760,GxTx-1E,,Other peptide,,,,,,,,,P84835,,EGECGGFWWKCGSGKPACCPKYVCSPKWGLCNFPMP,Glu-Gly-Glu-Cys-Gly-Gly-Phe-Trp-Trp-Lys-Cys-Gly-Ser-Gly-Lys-Pro-Ala-Cys-Cys-Pro-Lys-Tyr-Val-Cys-Ser-Pro-Lys-Trp-Gly-Leu-Cys-Asn-Phe-Pro-Met-Pro,"Disulphide bonds between cysteine residues at positions 4 and 19, 11 and 24, and 18 and 31.",,,
3883,GYPGKF-NH2,,Other peptide,,,,,,,,,,,GYPGKF,Gly-Tyr-Pro-Gly-Lys-Phe-NH2,,,,
3739,GYPGQV-NH2,,Other peptide,,,,,,,,,,,GYPGQV,Gly-Tyr-Pro-Gly-Gln-Val-NH2,,,,
7035,H3-CoA-20,,Other peptide,,,,,,,,,,,,,,,,
7925,HAS-NMU,,Other peptide,,,,,,,,,,,,,,,,
7762,HaTx1,,Other peptide,,,,,,,,,P56852,,ECRYLFGGCKTTSDCCKHLGCKFRDKYCAWDFTFS,Glu-Cys-Arg-Tyr-Leu-Phe-Gly-Gly-Cys-Lys-Thr-Thr-Ser-Asp-Cys-Cys-Lys-His-Leu-Gly-Cys-Lys-Phe-Arg-Asp-Lys-Tyr-Cys-Ala-Trp-Asp-Phe-Thr-Phe-Ser,"Disulphide bonds between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 28.",,,
2079,"H-c[Cys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH",,Other peptide,,,,,,,,,,,CFXWKTFC,"Cys-Phe-LAgl(NβMe, benzoyl)-D-Trp-Lys-Thr-Phe-Cys",,,,
2080,"H-c[Cys-Phe-LAgl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH",,Other peptide,,,,,,,,,,,CFXWKTFC,"Cys-Phe-LAbl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys",,,,
2081,"H-c[DCys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH",,Other peptide,,,,,,,,,,,CFXWKTFC,"D-Cys-Phe-LAbl(NβMe,benzoyl)-D-Trp-Lys-Thr-Phe-Cys",,,,
7737,HelaTx1,,Other peptide,,,,,,,,,P0DJ41,,SCKKECSGSRRTKKCMQKCNREHGH,Ser-Cys-Lys-Lys-Glu-Cys-Ser-Gly-Ser-Arg-Arg-Thr-Lys-Lys-Cys-Met-Gln-Lys-Cys-Asn-Arg-Glu-His-Gly-His,"Disulphide bond formation between cysteine residues at positions 2 and 19, and 7 and 15. C terminal histidine residue is histidine amide.",,,
2280,helodermin,,Other peptide,,,,,,,,,P04204,,HSDAIFTEEYSKLLAKLALQKYLASILGSRTSPPP,His-Ser-Asp-Ala-Ile-Phe-Thr-Glu-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Ala-Ser-Ile-Leu-Gly-Ser-Arg-Thr-Ser-Pro-Pro-Pro-NH2,C-terminal residue is proline amide,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N)CO)[C@H](O)C)CCCNC(=N)N)CO)CC(C)C)[C@H](CC)C)CO)C)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCC(=O)N)CC(C)C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)CO)CC(=O)O)C)Cc1ccccc1)CCC(=O)N)CCC(=O)N)Cc1ccc(cc1)O)CO)CCCCN)CC(C)C)CC(C)C)C,SSAAJZQUEUTACT-MDBKHZGBSA-N
2581,heteropodatoxin-2,,Other peptide,,,,,,,,,P58426,,DDCGKLFSGCDTNADCCEGYVCRLWCKLDW,Asp-Asp-Cys-Gly-Lys-Leu-Phe-Ser-Gly-Cys-Asp-Thr-Asn-Ala-Asp-Cys-Cys-Glu-Gly-Tyr-Val-Cys-Arg-Leu-Trp-Cys-Lys-Leu-Asp-Trp-NH2,"C-terminal tryptophan residue undergoes amidation; disulphide bond formation between cysteine residues at positions 3 and 17, 10 and 22, and 16 and 26.",,,
9324,hINSL5: A8-21 (T9R),,Other peptide,,,,,,,,,,,,,,,,
5197,Hip-His Leu,,Other peptide,,,,,,,,,,,HL,Hip-His-Leu,,,,
5572,"[His4, Tyr5, Trp6, His7]TIP39 (human)",,Other peptide,,,,,,,,,,,SLAHYWHAAFRERARLLAALERRHWLNSYMHKLLVLDAP,Ser-Leu-Ala-His-Tyr-Trp-His-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro,,,,
1793,"[His5,Arg19]PTH-(1-34) (human)",,Other peptide,,,,,,,,,,,SVSEHQLMHNLGKHLNSMRRVEWLRKKLQDVHNF,Ser-Val-Ser-Glu-His-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Arg-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
1794,[His5]PTH-(1-34) (human),,Other peptide,,,,,,,,,,,SVSEHQLMHNLGKHLNSMERVEWLRKKLQDVHNF,Ser-Val-Ser-Glu-His-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
1170,"[His5,D-Tyr6]GnRH",,Other peptide,,,,,,,,,,,XHWSHYLRPG,pGlu-His-Trp-Ser-His-D-Tyr-Leu-Arg-Pro-Gly-NH2,,,,
9344,histerelin,,Other peptide,,,,,,,,,,,XHWSYXLRP,pGlu-Pyr-His-Trp-Ser-Tyr-D-His(Bzl)-Leu-Arg-Pro-NHEt,,,,
9485,histidyl-leucine,,Other peptide,,,,,,,,,,,HL,H-His-Leu-OH,,,N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)Cc1[nH]cnc1,MMFKFJORZBJVNF-UWVGGRQHSA-N
3884,histrelin,,Other peptide,,,yes,,,,,,,histrelin,XHWSYHLRP,pGlu-His-Trp-Ser-Tyr-(Bzl)His-Leu-Arg-Pro,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](Cc1ncn(c1)Cc1ccccc1)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CCCN=C(N)N,HHXHVIJIIXKSOE-QILQGKCVSA-N
8495,HIV-1 matrix protein p17,,Other peptide,,,,,,,,,,,MGARASVLSGGELDRWEKIRLRPGGKKKYKLKHIVWASRELERFAVNPGLLETSEGCRQILGQLQPSLQTGSEELRSLYNTVATLYCVHQRIEIKDTKEALDKIEEEQNKSKKKAQQAAADTGHSSQVSQNY,,,,,
773,HIV-Tat,,Other peptide,,,,,,,,,,,MEPVDPRLEPWKHPGSQPKTACTNCYCKKCCFHCQVCFITKALGISYGRKKRRQRRRAHQNSQTHQASLSKQPTSQPRGDPTGPKE,,,,,
8672,hK2p01 derivative KLK2 inhibitor,,Other peptide,,,,,,,,,,,ARFKVWWAAG,Ala-Arg-Phe-Lys-Val-Trp-Trp-Ala-Ala-Gly,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)O)C)C)Cc1c[nH]c2c1cccc2)Cc1c[nH]c2c1cccc2)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N)Cc1ccccc1,BVRWWHKWGPOKPN-NXOPMQQOSA-N
9553,Hm1a,,Other peptide,,,,,,,,,,,ECRYLFGGCSSTSDCCKHLSCRSDWKYCAWDGTF,Glu-Cys-Arg-Tyr-Leu-Phe-Gly-Gly-Cys-Ser-Ser-Thr-Ser-Asp-Cys-Cys-Lys-His-Leu-Ser-Cys-Arg-Ser-Asp-Trp-Lys-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Phe,,,,
2580,HmTx1,,Other peptide,,,,,,,,,P60992,,ECRYLFGGCSSTSDCCKHLSCRSDWKYCAWDGTFS,Glu-Cys-Arg-Tyr-Leu-Phe-Gly-Gly-Cys-Ser-Ser-Thr-Ser-Asp-Cys-Cys-Lys-His-Leu-Ser-Cys-Arg-Ser-Asp-Trp-Lys-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Phe-Ser,"Predicted disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 28.",,,
2545,hongotoxin-1,,Other peptide,,,,,,,,,P59847,,TVIDVKCTSPKQCLPPCKAQFGIRAGAKCMNGKCKCYPH,Thr-Val-Ile-Asp-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Ile-Arg-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His,"Disulphide bond formation between cysteine residues at positions 7 and 29, 13 and 34, and 17 and 36.",,,
1046,Hp(2-20),,Other peptide,,,,,,,,,,,AKKVFKRLEKLFSKIQNDK,Ala-Lys-Lys-Val-Phe-Lys-Arg-Leu-Glu-Lys-Leu-Phe-Ser-Lys-Ile-Gln-Asn-Asp-Lys,,,,
9685,HpARI,,Other peptide,,,,,,,,,,,MYRLFLALGFLTFINAAGQRCRFTDVERDKGYTGMLLKGRLRKTAGNGRTVELICGRGNHNYTCESGVLKESSPRQARCGCKGILEMLFDMPKEERPSPMYDSVTYDPTPNTPTTVGKDGIWNGVDYRNGSTVKPYCDTGPVINGSSKAVCVSGKWVPTLGVCPKMCSIGSLKENGKFVDVTATTKGDELNPPPREQTLIPIVRKVDKDKVQHGVKVVALCKAEDSTTAAEGVQEFECDNGKWKPEPVPCP,,,,,
1321,HS014,,Other peptide,,,,,,,,,,,CEHARWGCPPKD,Ac-Cys-Glu-His-D-Nal-Arg-Trp-Gly-Cys-Pro-Pro-Lys-Asp-NH2,,,,
1328,HS024,,Other peptide,,,,,,,,,,,CXRHARWGC,Ac-Cys-Nle-Arg-His-D-Nal-Arg-Trp-Gly-Cys-NH2,,,,
9582,HsTX1[R14A],,Other peptide,,,,,,,,,,,ASCRTPKDCADPCAKETGCPYGKCMNRKCKCNRC,,,,,
8973,human GIP(1-30)NH2,,Other peptide,,,,,,,,,,,YAEGTFISDYSIAMDKIHQQDFVNWLLAQKNH2,Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys,,,,
8971,human GIP(3-30)NH2,,Other peptide,,,,,,,,,,,EGTFISDYSIAMDKIHQQDFVNWLLAQK-NH2,Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys,,,,
8970,human GIP(3-42)NH2,,Other peptide,,,,,,,,,,,EGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ-NH2,Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln,,,,
8972,human GIP(5-30)NH2,,Other peptide,,,,,,,,,,,TFISDYSIAMDKIHQQDFVNWLLAQK-NH2,Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCCN)Cc1c[nH]c2c1cccc2)CC(=O)O)CC(=O)N)CCCCN)CCCCN)CCCCN)CCC(=O)N)C)CC(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)CC(=O)N)C(C)C)Cc1ccccc1)CC(=O)O)CCC(=O)N)CCC(=O)N)Cc1nc[nH]c1)[C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)N)Cc1ccccc1)CO)CC(=O)O)Cc1ccc(cc1)O)CO)C)CCSC)CC(=O)O,NEJABMGLOVSGDX-RKHUIQFASA-N
7570,huwentoxin IV,,Other peptide,,,,,,,,,P83303,,ECLEIFKACNPSNDQCCKSSKLVCSRKTRWCKYQI,Glu-Cys-Leu-Glu-Ile-Phe-Lys-Ala-Cys-Asn-Pro-Ser-Asn-Asp-Gln-Cys-Cys-Lys-Ser-Ser-Lys-Leu-Val-Cys-Ser-Arg-Lys-Thr-Arg-Trp-Cys-Lys-Tyr-Gln-Ile,"C terminal residue is isoleucine amide. Disulphide bond formation between cysteine residues at positions 2 and 17, 9 and 24, and 16 and 31.",,,
3841,"[Hyp3,Tyr(Me)8]BK",,Other peptide,,,,,,,,,,,RPXGFSPYR,Arg-Pro-Hyp-Gly-Phe-Ser-Pro-(Me)Tyr-Arg,,,,
4218,iberiotoxin,,Other peptide,,,,,,,,,P24663,,XFTDVDCSVSKECWSVCKDLFGVDRGKCMGKKCRCYQ,pGlu-Phe-Thr-Asp-Val-Asp-Cys-Ser-Val-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Lys-Asp-Leu-Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Arg-Cys-Tyr-Gln,"N-terminal pyrrolidone carboxylic acid formation from glutamine residue (represented by pGlu); disulphide bond formation between cysteine residues at positions 7 and 28, 13 and 33 and 17 and 35",,NCCCCC1NC(=O)C(CSSCC(NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC(=O)O)CC(C)C)Cc1ccccc1)C(C)C)CC(=O)O)C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC1CSSCC(NC(=O)C(NC1=O)CCCNC(=N)N)C(=O)NC(C(=O)NC(C(=O)O)CCC(=O)N)Cc1ccc(cc1)O)CCCCN)CCCCN)CCSC)NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C1CSSCC(NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C2CCC(=O)N2)Cc2ccccc2)CC(=O)O)CC(=O)O)C(=O)NC(CO)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCC(=O)O)CCCCN)CO)C(C)C)CO,VDNVVLOBNHIMQA-UHFFFAOYSA-N
1028,i-Boc-Met-Leu-Phe,,Other peptide,,,,,,,,,,,MLF,i-Boc-Met-Leu-Phe,,,,
667,icatibant,,Other peptide,,,yes,,,,,,,icatibant,RRPXGXSXXR,D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic-Arg,,,,
1636,"ICI 174,864",,Other peptide,,,,,,,,,,,YXXFL,Tyr-Aib-Aib-Phe-Leu,,,C=CCN([C@H](C(=O)NC(C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)Cc1ccccc1)(C)C)Cc1ccc(cc1)O)CC=C,BGJPRBZZLWCLJW-AWCRTANDSA-N
9070,Dendroaspis natriuretic peptide,,Other peptide,,,,,,,,,,,EVKYDPCFGHKIDRINHVSNLGCPSLRDPRPNAPSTSA,Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Arg-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala,Disulphide bond C7:C23,,,
4854,E. coli heat-stable enterotoxin (STa),,Other peptide,,,,,,,,,,,,,,,,
8338,IFN-α2b (recombinant human),,Other peptide,,,yes,,,,,,,,CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE,,,,,
8339,IFN-β1a (recombinant human),,Other peptide,,,yes,,,,,,,interferon beta,MSYNLLGFLQRSSNFCCQKLLWQLNGRLEYCLKDRMNFDIPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRQDSSSTGWNETIVENLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINRLTGYLRN,,,,,
8340,IFN-β1b (recombinant human),,Other peptide,,,yes,,,,,,,interferon beta,MSYNLLGFLQRSSNFNCQKLLWQLNGRLEYCLKDRMNFDIPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRDSSSTGWNETIVENLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINRLTGYLRN,,,,,
8341,IFN-γ1b (human recombinant),,Other peptide,,,yes,,,,,,,interferon gamma,MQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAAKTGKRKRSQMLFR,,,,,
9557,IgE heavy chain,,Other peptide,,,,,,,,,P01854,,ASTQSPSVFPLTRCCKNIPSNATSVTLGCLATGYFPEPVMVTWDTGSLNGTTMTLPATTLTLSGHYATISLLTVSGAWAKQMFTCRVAHTPSSTDWVDNKTFSVCSRDFTPPTVKILQSSCDGGGHFPPTIQLLCLVSGYTPGTINITWLEDGQVMDVDLSTASTTQEGELASTQSELTLSQKHWLSDRTYTCQVTYQGHTFEDSTKKCADSNPRGVSAYLSRPSPFDLFIRKSPTITCLVVDLAPSKGTVNLTWSRASGKPVNHSTRKEEKQRNGTLTVTSTLPVGTRDWIEGETYQCRVTHPHLPRALMRSTTKTSGPRAAPEVYAFATPEWPGSRDKRTLACLIQNFMPEDISVQWLHNEVQLPDARHSTTQPRKTKGSGFFVFSRLEVTRAEWEQKDEFICRAVHEAASPSQTVQRAVSVNPGK,,,,,
9713,H. polygyrus TGF-β mimic,,Other peptide,,,,,,,,,,,MLLTVVIGLLEVAATDDSGCMPFSDEAATYKYVAKGPKNIEIPAQIDNSGMYPDYTHVKRFCKGLHGEDTTGWFVGICLASQWYYYEGVQECDDRRCSPLPTNDTVSFEYLKATVNPGIIFNITVHPDASGKYPELTYIKRICKNFPTDSNVQGHIIGMCYNAEWQFSSTPTCPASGCPPLPDDGIVFYEYYGYAGDRHTVGPVVTKDSSGNYPSPTHARRRCRALSQEADPGEFVAICYKSGTTGESHWEYYKNIGKCPDPRCKPLEANESVHYEYFTMTNETDKKKGPPAKVGKSGKYPEHTCVKKVCSKWPYTCSTGGPIFGECIGATWNFTALMECINARGCSSDDLFDKLGFEKVIVRKGEGSDSYKDDFARFYATGSKVIAECGGKTVRLECSNGEWHEPGTKTVHRCTKDGIRTL,,,,,
1555,"[Ile31,Gln34]PP (human)",,Other peptide,,,,,,,,,,,APLEPVYPGDNATPEQMAQYAADLRRYINMITRQRY,Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
1796,"[Ile5,Glu19]PTHrP-(1-34) (human)",,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLERRFFLHHLIAEIHTA,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Glu-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala,,,,
1795,"[Ile5,Glu19,Val21]PTHrP-(1-34) (human)",,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLERVFFLHHLIAEIHTA,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Glu-Arg-Val-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala,,,,
1803,[Ile5]PTHrP-(1-34) (human),,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLRRRFFLHHLIAEIHTA,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala,,,,
1825,[Ile5]PTHrP-(1-36),,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLRRRFFLHHLIAEIHTAE,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu,,,,
1804,[Ile5]PTHrP-(1-36) (human),,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEI,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1798,"[Ile5,Trp23]PTHrP-(1-36) (human)",,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1799,"[Ile5,Trp23]PTHrP-(2-36) (human)",,Other peptide,,,,,,,,,,,VSEIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1800,"[Ile5,Trp23]PTHrP-(3-36) (human)",,Other peptide,,,,,,,,,,,SEIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1801,"[Ile5,Trp23]PTHrP-(4-36) (human)",,Other peptide,,,,,,,,,,,EIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1821,"[Ile5,Trp23]PTHrP-(5-36)",,Other peptide,,,,,,,,,,,IQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1824,"[Ile5,Trp23]PTHrP-(5-36) (human)",,Other peptide,,,,,,,,,,,IQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1797,"[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human)",,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEY,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-NH2,,,,
1802,"[Ile5,Val21]PTHrP-(1-34) (human)",,Other peptide,,,,,,,,,,,AVSEIQLLHDKGKSIQDLRRVFFLHHLIAEIHTA,Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Val-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala,,,,
1532,N-α-Ac-PYY-(22-36) (rat),,Other peptide,,,,,,,,,,,ASLRHYLNLVTRQRY,NAc-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
1533,N-α-Ac-PYY-(25-36) (rat),,Other peptide,,,,,,,,,,,RHYLNLVTRQRY,NAc-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
572,N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H,,Other peptide,,,,,,,,,,,FKPXXR,NMe-Phe-Lys-Pro-D-Cha-Cha-D-Arg-COOH,,,,
576,N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H,,Other peptide,,,,,,,,,,,FKPXWA,NMe-Phe-Lys-Pro-D-Cha-Trp-D-Arg,,,,
5642,In-NODAGATOC,,Other peptide,,,,,,,,,,,FCYWKTCT,Phe-Cys-Tyr-Trp-Lys-Thr-Cys-Thr,Disulphide bridge: 2-7. Terminal Thr is amino alcohol (ol).,Disulphide bridge: 2-7. Terminal Thr is amino alcohol (ol).,,
3885,INSL3 B-chain analogue,,Other peptide,,,,,,,,,,,HHFVRALVRVSGGPRWSTEA,His-His-Phe-Val-Arg-Ala-Leu-Val-Arg-Val-Ser-Gly-Gly-Pro-Arg-Trp-Ser-Thr-Glu-Ala,,,,
4372,INSL3 B chain dimer analogue 8,,Other peptide,,,,,,,,,,,CGHHFVRALVRVC,Cys-Gly-His-His-Phe-Val-Arg-Ala-Leu-Val-Arg-Val-Cys,,,,
8350,INSL5 amide (human),,Other peptide,,,,,,,,,,,,,,,,
8351,INSL5 amide (mouse),,Other peptide,,,,,,,,,,,,,,,,
7572,insulin glargine,,Other peptide,,,yes,,,,,,,insulin glargine,,,,,,
3886,IRL 1620,,Other peptide,,,,,,,,,,,DEEAVYFAHLDIIW,Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)CCC(=O)O)CCC(=O)O)C)Cc1ccc(cc1)O)Cc1ccccc1)C)Cc1nc[nH]c1)CC(C)C)CC(=O)O)C,DXPHNGAMYPPTBJ-TZMIJSMNSA-N
3887,IRL 2500,,Other peptide,,,,,,,,,,,AW,"N-(3,5-dimethylbenzoyl)-N-methyl-(D)-(4-phenylphenyl)-Ala-Trp",,,Cc1cc(C)cc(c1)C(=O)N([C@@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)c1ccccc1)C,UZDORQWMYRRLQV-JHOUSYSJSA-N
1041,isopropylureido-FLFLF,,Other peptide,,,,,,,,,,,FLFLF,Phe-Leu-Phe-Leu-Phe,,,,
9704,isunakinra,,Other peptide,,,,,,,,,,isunakinra,APVRSLNCRIWDVNQKTFYLRNNQLVAGYLQGPNVNLEEKFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWFLCTAMEADQPVSLTNMPDEGVMVTKFYMQFVSS,,,,,
5812,[tBu-D-Gly5]NPS,,Other peptide,,,,,,,,,,,SFRNGVGTGMKKTSFQRAKS,Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,,,,
3854,iturelix,,Other peptide,,,,,,,,,,iturelix,AFASKKLKPA,Ala-Phe-Ala-Ser-Lys-Lys-Leu-Lys-Pro-Ala,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCCNC(C)C)CC(C)C)CCCCNC(=O)c1cccnc1)CCCCNC(=O)c1cccnc1)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C)Cc1ccc(cc1)Cl)Cc1cccnc1,QRYFGTULTGLGHU-NBERXCRTSA-N
6075,J18 (galanin analogue),,Other peptide,,,,,,,,,,,RGRGNWTLNSAGYLLGPKKKK,Arg-Gly-Arg-Gly-Asn-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
6076,J20 (galanin analogue),,Other peptide,,,,,,,,,,,RGRGNWTLNSAGYLLGPAAKK,Arg-Gly-Arg-Gly-Asn-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Ala-Ala-Lys-Lys,,,,
6523,JI-38,,Other peptide,,,,,,,,,,,YADAIFTQSYRKVLGQLSARKLLQDIMDR,Dat-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Orn-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Orn-Leu-Leu-Gln-Asp-Ile-Nle-Asp-Agm,,,,
2574,jingzhaotoxin-III,,Other peptide,,,,,,,,,P62520,,DGECGGFWWKCGRGKPPCCKGYACSKTWGWCAVEAP,Asp-Gly-Glu-Cys-Gly-Gly-Phe-Trp-Trp-Lys-Cys-Gly-Arg-Gly-Lys-Pro-Pro-Cys-Cys-Lys-Gly-Tyr-Ala-Cys-Ser-Lys-Thr-Trp-Gly-Trp-Cys-Ala-Val-Glu-Ala-Pro,"Disulphide bond formation between cysteine residues at positions 4 and 19, 11 and 24, and 18 and 31.",,,
2575,jingzhaotoxin-XI,,Other peptide,,,,,,,,,P0C247,,ECRKMFGGCSVDSDCCAHLGCKPTLKYCAWDGTF,Glu-Cys-Arg-Lys-Met-Phe-Gly-Gly-Cys-Ser-Val-Asp-Ser-Asp-Cys-Cys-Ala-His-Leu-Gly-Cys-Lys-Pro-Thr-Leu-Lys-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Phe-NH2,"C-terminal phenylalanine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 28.",,,
9114,JMR-132,,Other peptide,,,,,,,,,,,,,,,,
670,JMV1116,,Other peptide,,,,,,,,,,,RRPXGXSXGR,D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT-Gly-Arg,,,,
656,JMV1431,,Other peptide,,,,,,,,,,,RRPXGXS,D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-BT,,,OC[C@@H](C(=O)N[C@@H]1CSc2c(N(C1=O)CC(=O)O)cccc2)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)[C@@H]1CC(CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O,YMROZBYZFLPAPA-RONNJKQASA-N
3888,JMV180,,Other peptide,,,,,,,,,,,YXGWXD,Boc-Tyr(SO3H)-Nle-Gly-Trp-Nle-Asp-2-phenylethylester,,,CCCC[C@@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)OCCc1ccccc1)CC(=O)O)CCCC)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)OC(C)(C)C)Cc1ccc(cc1)OS(=O)(=O)O,IOXMTWKALARBDR-FDXDWZSASA-N
1568,JMV2004,,Other peptide,,,,,,,,,,,KKPWIL,Lys-Lys-Pro-ω(CH2-NH)-D-Trp-Ile-Leu,,,,
898,JMV310,,Other peptide,,,,,,,,,,,YKGWKDF,Tyr-Lys-Gly-Trp-Lys-Asp-Phe,,,,
1569,JMV431,,Other peptide,,,,,,,,,,,RRPYIL,Boc-Arg-Arg-Pro-Tyr-ω(CH2-NH)-Ile-Leu,,,,
1570,JMV449,,Other peptide,,,,,,,,,,,KPYIL,(ψ(CH2NH)-Lys-Pro-Tyr-Ile-Leu,,,NCCCC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)[C@H](CC)C)Cc1ccc(cc1)O)NC[C@H](CCCCN)N,TZCYVPLNMOJUIL-GULBXNHPSA-N
1571,JMV457,,Other peptide,,,,,,,,,,,RRPWIL,Boc-Arg-Arg-Pro-D-Trp-Ile-Leu,,,,
1572,JMV458,,Other peptide,,,,,,,,,,,RRPWIL,Boc-Arg-Arg-Pro-Trp-Ile-Leu,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)OC(C)(C)C)CCCN=C(N)N)CCCN=C(N)N)C,KOHSYJYVCLITLX-OLPQHFNPSA-N
624,JMV594,,Other peptide,,,,,,,,,,,FQWAVGHXL,Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2,,,,
3889,JMV641,,Other peptide,,,,,,,,,,,FQWAVGH,D-Phe-Gln-Trp-Ala-Val-Gly-His-NH-CH[CH2-CH(CH3)2]-CHOH-(CH2)3-CH3,,,,
5763,JPE1375,,Other peptide,,,,,,,,,,,XFXPXFF,Hoo-Phe-Orn-Pro-hle-Phe(4-F)-Phe-NH2,,,,
1106,JV-1-10,,Other peptide,,,,,,,,,,,YADAIFTNSYRKVLXQLSARKLLQDIMSR,PhAc-Tyr-Ala-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg-NH2,,,,
1107,JV-1-36,,Other peptide,,,,,,,,,,,YRDAIFTNRYRKVLXQLSARKLLQDIXRR,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1108,JV-1-37,,Other peptide,,,,,,,,,,,YRDAIFTNRYRKVLXQLSARKLLQDIXRR,(indol-3-acetic acid)-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1109,JV-1-38,,Other peptide,,,,,,,,,,,YRDAIFTNXYRKVLXQLSARKLLQDIXRX,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Har-(Me)Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1110,JV-1-39,,Other peptide,,,,,,,,,,,YRDAIFTNXYRKVLXQLSARKLLQDIXRX,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Har-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1111,JV-1-40,,Other peptide,,,,,,,,,,,YRDAIFTNRYRKVLXQLSARKLLQDIXRX,NAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1112,JV-1-41,,Other peptide,,,,,,,,,,,YRDAIFTNRYRKVLXQLSARKLLQDIXRX,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-(Me)Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1113,JV-1-42,,Other peptide,,,,,,,,,,,HRDAIFTNRYRKVLXQLSARKLLQDIXRR,PhAc-His-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Tyr-Arg-Lys-Val-Leu-Abu-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-D-Arg-Har-NH2,,,,
1114,JV-1-43,,Other peptide,,,,,,,,,,,HRDAIFTNRYRKVLXQLSARKLLQDIXRR,NAc-His-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Tyr-Arg-Lys-Val-Leu-Abu-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-D-Arg-Har-NH2,,,,
1115,JV-1-62,,Other peptide,,,,,,,,,,,YRDAIFTNRXRKVLXQLSARKLLQDIXRX,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Arg-Amp-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
1116,JV-1-63,,Other peptide,,,,,,,,,,,YRDAIFTNXXRKVLXQLSARKLLQDIXRX,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Har-Amp-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har-NH2,,,,
3890,K31440,,Other peptide,,,,,,,,,,,YHLLRKBIEIEKQEKEKQQAANNRLLLDTI,Tyr-His-Leu-Leu-Arg-Lys-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)[C@H](O)C)CC(=O)O)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N)CC(=O)N)CC(=O)N)C)C)CCC(=O)N)CCC(=O)N)CCCCN)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)N)Cc1c[nH]cn1)CC(C)C)CC(C)C)CCCN=C(N)N)CCCCN)CCC(=O)O)CCC(=O)O)CCCCN)CCC(=O)N)CCC(=O)O,MTYZMMGEGHDKQA-WQJRYCLWSA-N
3891,K41498,,Other peptide,,,,,,,,,,,FHLLRKXIEIEKQEKEKQQAANNRLLLDTI,Phe-His-Leu-Leu-Arg-Lys-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)[C@H](O)C)CC(=O)O)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N)CC(=O)N)CC(=O)N)C)C)CCC(=O)N)CCC(=O)N)CCCCN)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)N)Cc1nc[nH]c1)CC(C)C)CC(C)C)CCCN=C(N)N)CCCCN)CCC(=O)O)CCC(=O)O)CCCCN)CCC(=O)N)CCC(=O)O,NXDTZPDUWWAHAM-JXLAGIIJSA-N
2546,kaliotoxin,,Other peptide,,,,,,,,,Q9NII7,,VGINVKCKHSGQCLKPCKDAGMRFGKCINGKCDCTPK,Val-Gly-Ile-Asn-Val-Lys-Cys-Lys-His-Ser-Gly-Gln-Cys-Leu-Lys-Pro-Cys-Lys-Asp-Ala-Gly-Met-Arg-Phe-Gly-Lys-Cys-Ile-Asn-Gly-Lys-Cys-Asp-Cys-Thr-Pro-Lys-NH2,"C-terminal lysine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 7 and 47, 13 and 32, and 17 and 34.",,,
2088,kassinin,,Other peptide,,,,,,,,,P08611,,DVPKSDQFVGLM,Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2,Amidation of C-terminal methionine residue,,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CCSC)CC(C)C)C(C)C)Cc1ccccc1)CCC(=O)N)CC(=O)O)CO)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C(CC(=O)O)N,NXTPETCPVNEEOP-UHFFFAOYSA-N
2013,KE 108,,Other peptide,,,,,,,,,,,YXRFFWKTF,Tyr-D-Dab-Arg-Phe-Phe-D-Trp-Lys-Thr-Phe,,,,
5306,KH28,,Other peptide,,,,,,,,,,,KRPYLL,Me-Lys-Arg-Pro-Tyr-tLeu-Leu,,,,
1286,kisspeptin-15,,Other peptide,,,,,,,,,,,KDLPNYNWNSFGLRF,Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe,,,,
1287,kisspeptin-28,,Other peptide,,,,,,,,,,,GTSLSPPPESSGSPQQPGLSAPHSRQIP,Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Pro-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-Gln-Ile-Pro,,,,
1289,kisspeptin-9,,Other peptide,,,,,,,,,,,GTSLSPPPE,Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu,,,,
2521,kurtoxin,,Other peptide,,,,,,,,,P58910,,KIDGYPVDYWNCKRICWYNNKYCNDLCKGLKADSGYCWGWTLSCYCQGLPDNARIKRSGRCRA,Lys-Ile-Asp-Gly-Tyr-Pro-Val-Asp-Tyr-Trp-Asn-Cys-Lys-Arg-Ile-Cys-Trp-Tyr-Asn-Asn-Lys-Tyr-Cys-Asn-Asp-Leu-Cys-Lys-Gly-Leu-Lys-Ala-Asp-Ser-Gly-Tyr-Cys-Trp-Gly-Trp-Thr-Leu-Ser-Cys-Tyr-Cys-Gln-Gly-Leu-Pro-Asp-Asn-Ala-Arg-Ile-Lys-Arg-Ser-Gly-Arg-Cys-Arg-Ala,"Disulphide bond formation between cysteine residues at positions 12 and 61, 16 and 37, 23 and 44, and 27 and 46.",,,
577,"L-156,602",,Other peptide,,,,,,,,,,,LXAGXA,Leu-Orn-Ala-Gly-Orn-Ala,,,,
2072,"L-362,823",,Other peptide,,,,,,,,,,,CXCFWKT,Cys-Aha-Cys-Phe-Trp-Lys-Thr,,,,
2014,"L-362,855",,Other peptide,,,,,,,,,,,KTFXFWW,Lys-Thr-Phe-Aha-Phe-Trp-D-Trp,,,,
2047,"L-363,301",,Other peptide,,,,,,,,,,,PFWKTF,Pro-Phe-D-Trp-Lys-Thr-Phe,,,,
2048,"L-363,377",,Other peptide,,,,,,,,,,,PYWKTF,c[Pro-Tyr-D-Trp-Lys-Thr-Phe],,,,
2049,"L-363,409",,Other peptide,,,,,,,,,,,AFWKTF,Me-Ala-Phe-Trp-Lys-Thr-Phe,,,,
2241,"L-365,209",,Other peptide,,,,,,,,,,,XXFPFI,Aaa-Aaa-D-Phe-Pro-Phe-Ile,,,CC[C@@H]([C@@H]1NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](N(C(=O)[C@H]2N(C(=O)[C@@H]3N(C1=O)N=CCC3)N=CCC2)C)Cc1ccccc1)C,IFHSSGUGRIXWQU-NSTWBPGMSA-N
2243,"L-366,682",,Other peptide,,,,,,,,,,,HPWIXX,His-Pro-Trp-Ile-Pip-Pip,,,C=C[C@@H]([C@@H](C(=O)N1CCCC[C@]1(C=O)C(=O)N1CCCCC1)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](Cc1cnc[nH]1)N)C,QHUGACUEEILSLD-NNWJBWDNSA-N
2244,"L-366,875",,Other peptide,,,,,,,,,,,PWIXXH,"c[Pro-D-Trp-Ile-1,6-didehydro-D-Pyz-Pip-D-His]",,,,
2245,"L-366,948",,Other peptide,,,,,,,,,,,PAIXXH,c[Pro-Nal-Ile-Pip-Pip-His],,,CC[C@@H]([C@@H](C(=O)[C@@]1(C=O)CCCN1C(=O)[C@@H](CC1=NC(N=C1)(C(=O)N1CCCCC1)C(=O)N1CCCCC1)N)NC(=O)[C@H](Cc1ccc2c(c1)cccc2)N)C,OCVKQRQVXSMCCJ-HWFQYKCLSA-N
672,labradimil,,Other peptide,,,,,,,,,,labradimil,RPXGXSPYR,Arg-Pro-Hyp-Gly-Thi-Ser-Pro-(Me)Tyrψ(CH2NH)-Arg,,,COc1ccc(cc1)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N)O)CO)CN[C@H](C(=O)O)CCCN=C(N)N,IDXCXSCCZNCXCL-XMADEQCMSA-N
10228,lactomedin 1,,Other peptide,,,,,,,,,,,FKDCHLAR,Phe-Lys-Asp-Cys-His-Leu-Ala-Arg,,,,
2031,lanreotide,,Other peptide,,,yes,,,,,,,lanreotide,ACYWKVCT,D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2,,,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccc(cc2)O)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(C)C)C(=O)NC(C(=O)N)C(O)C)NC(=O)C(Cc1ccc2c(c1)cccc2)N)Cc1c[nH]c2c1cccc2,PUDHBTGHUJUUFI-UHFFFAOYSA-N
5899,lasso D,,Other peptide,,,,,,,,,,,,,,,,
6759,LDV-FITC,,Other peptide,,,,,yes,,,,,,LDVPAAK,Leu-Asp-Val-Pro-Ala-Ala-Lys,,,,
2315,Lei-Dab7,,Other peptide,,,,,,,,,,,AFCNLRXCQLSCRSLGLLGKCIGDKCECVKH,Ala-Phe-Cys-Asn-Leu-Arg-Dab-Cys-Gln-Leu-Ser-Cys-Arg-Ser-Leu-Gly-Leu-Leu-Gly-Lys-Cys-Ile-Gly-Asp-Lys-Cys-Glu-Cys-Val-Lys-His-NH2,,,,
2316,leiurotoxin I,,Other peptide,,,,,,,,,P16341,,AFCNLRMCQLSCRSLGLLGKCIGDKCECVKH,Ala-Phe-Cys-Asn-Leu-Arg-Met-Cys-Gln-Leu-Ser-Cys-Arg-Ser-Leu-Gly-Leu-Leu-Gly-Lys-Cys-Ile-Gly-Asp-Lys-Cys-Glu-Cys-Val-Lys-His-NH2,"C-terminal histidine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 3 and 21, 8 and 26, and 12 and 28.",,,
6469,lepirudin,,Other peptide,,,yes,,,,,,,lepirudin,LVYTDCTESGQNLCLCEGSNVCGQGNKCILGSDGEKNQCVTGEGTPKPQSHNDGDFEEIPEEYLQ,Leu-Val-Tyr-Thr-Asp-Cys-Thr-Glu-Ser-Gly-Gln-Asn-Leu-Cys-Leu-Cys-Glu-Gly-Ser-Asn-Val-Cys-Gly-Gln-Gly-Asn-Lys-Cys-Ile-Leu-Gly-Ser-Asp-Gly-Glu-Lys-Asn-Gln-Cys-Val-Thr-Gly-Glu-Gly-Thr-Pro-Lys-Pro-Gln-Ser-His-Asn-Asp-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln,I1L at the N-terminal and absence of a sulfate group at  Y63.,,,
1175,leuprolide,,Other peptide,,,yes,,,,,,,leuprorelin,XHWSYLLRP,pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)CC(C)C)CC(C)C)CCCN=C(N)N,GFIJNRVAKGFPGQ-LIJARHBVSA-N
1453,[Leu13]motilin (human),,Other peptide,,,,,,,,,,,FVPIFTYGELQRLQEKERNKGQ,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)O)CCC(=O)N)CCCCN)CC(=O)N)CCCNC(=N)N)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccccc1)N)Cc1ccccc1)Cc1ccc(cc1)O)CCC(=O)O)CC(C)C)CCC(=O)N)CCCNC(=N)N)CC(C)C)CCC(=O)N)CCC(=O)O,GFOZQXMKARUPQI-HYOAWBISSA-N
629,"[Leu14, ψ 13-14)]bombesin",,Other peptide,,,,,,,,,,,XQRLGNQWAVGHLM,pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2,,,,
1545,"[Leu31,Pro34]NPY",,Other peptide,,,,,,,,,,,YPLKPPNPGEDAPAEDMARYYSALRHYINLLTRPRY,Tyr-Pro-Leu-Lys-Pro-Pro-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr,,,,
1524,"[Leu31,Pro34]NPY (pig)",,Other peptide,,,,,,,,,,,YPSKPDNPGEDAPAEDLARYYSALRHYINLLTRPRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,,,,
1527,"[Leu31,Pro34]PYY (human)",,Other peptide,,,,,,,,,,,YPIKPEAPGEDASPEELNRYYASLRHYLNLLTRPRY,Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,,,,
1526,"[Leu31,Pro34]PYY (pig)",,Other peptide,,,,,,,,,,,YPAKPEAPGEDASPEELSRYYASLRHYLNLLTRPRY,Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,,,,
641,"[Leu8,des-Arg9]bradykinin",,Other peptide,,,,,,,,,,,RPPGFSPL,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu,,,OC[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N,BGAPYBBQGHUQNM-YYGRSCHNSA-N
6168,[Leu8]-phyllolitorin,,Other peptide,,,,,,,,,P08948,,QLWAVGSLM,Gln-Leu-Trp-Ala-Val-Gly-Ser-Leu-Met,,,,
642,"[Leu9,des-Arg10]kallidin",,Other peptide,,,,,,,,,,,KRPPGFSPL,Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu,,,,
3893,LGR7-truncate,,Other peptide,,,,,,,,,,,,,,,,
5017,linaclotide,,Other peptide,,,yes,,,,,,,linaclotide,CCQYCCNPACTGCY,Cys-Cys-Gln-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr,,,,
1133,liraglutide,,Other peptide,,,yes,,,,,,,liraglutide,HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG,His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly,,,CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)O)CCC(=O)NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1[nH]cnc1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C,YSDQQAXHVYUZIW-QCIJIYAXSA-N
617,litorin,,Other peptide,,,,,,,,,P08945,,XQWAVGHFM,pGlu-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2,C-terminal methionine residue is amidated; N-terminal glutamine is pyrrolidine carboxylic acid,,,
7387,lixisenatide,,Other peptide,,,yes,,,,,,,lixisenatide,HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK,His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCCN)CCCCN)CCCCN)CCCCN)CCCCN)CO)C)CO)CO)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1[nH]cnc1)N)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CC(C)C)CO)CCCCN)CCC(=O)N)CCSC)CCC(=O)O)CCC(=O)O)CCC(=O)O)C)CCCNC(=N)N)CC(C)C)Cc1ccccc1)CCC(=O)O)CC(C)C,XVVOERDUTLJJHN-IAEQDCLQSA-N
5898,LTX(N4C),,Other peptide,,,,,,,,,,,,,,,,
2029,[L-Tyr8]CYN 154806,,Other peptide,,,,,,,,,,,FCYWKTCY,Ac-4NO2-Phe-D-Cys-Tyr-D-Trp-Lys-Thr-Cys-Tyr-NH2,,,,
9442,LV-2172,,Other peptide,,,,,,,,,,,,,,,,
10252,LV-2186,,Other peptide,,,,,,,,,,,,,,,,
2172,LVP,Pig,Other peptide,,,,,,,,,P01183,,CYFQNCPKG,Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2,Disulfide bonds formed between cysteine residues at positions 1 and 6; C-terminal glycine amidation,,NCCCC[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1,BJFIDCADFRDPIO-DZCXQCEKSA-N
637,Lys-kallidin,,Other peptide,,,,,,,,,,,KKRPPGFSPFR,Lys-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,,,,
3842,"[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2",,Other peptide,,,,,,,,,,,HSDAVFTNSYRKVLKRLSARKLLQDIL,His-Ser-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH2,,,,
3843,"[Lys5,Me-Leu9,Nle10]NKA-(4-10)",,Other peptide,,,,,,,,,,,DKFVGLX,Asp-Lys-Phe-Val-Gly-(Me)Leu-Nle,,,,
9486,Lys[Z(NO2)]-Val,,Other peptide,,,,,,,,,,,,,,,,
6101,M1145,,Other peptide,,,,,,,,,,,RGRGNWTLNSAGYLLGPVLPPPALALA,Arg-Gly-Arg-Gly-Asn-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala,,,,
6102,M1151,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys,,,,
6103,M1152,,Other peptide,,,,,,,,,,,WTLNSAGYLLGPK,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys,,,,
6104,M1153,,Other peptide,,,,,,,,,,,RGRGNWTLNSAGYLLGPK,Arg-Gly-Arg-Gly-Asn-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys,,,,
6074,M1160,,Other peptide,,,,,,,,,,,RGRGNWLNSAGYLLGPVLPPPALALA,Arg-Gly-Arg-Gly-Asn-Trp-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Val-Leu-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala,,,,
3896,M15,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPQQFFGLM,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,,,,
6099,M242,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPRHYINLIWRQRY,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Arg-His-Tyr-Ile-Asn-Leu-Ile-Trp-Arg-Gln-Arg-Tyr,,,,
3897,M32,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPRHYINLITRQRY,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
3898,M35,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPPPGFSPFR,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2,,,,
5020,M372049,,Other peptide,,,,,,,,,,,,,,,CC[C@@H]([C@H](N1CC[C@H](C1=O)NC(=O)Cc1ccc(cc1)NC(=O)c1cnc2c(n1)cccc2)C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)CCCNC(=N)N)CC(=O)O)C,VINFYKMOVBYUSF-ZCWPROOASA-N
3899,M40,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPPPALALA,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala-NH2,,,,
6100,M617,,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPQPPGFSPFR,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Gln-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,,,,
3305,M65,,Other peptide,,,,,,,,,,,CDATCQFRKAIDDCQKQAHHSNVLLPGNSVFKECMKQKKKEFKAGK,Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Leu-Leu-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-Gly-Lys,,,,
3900,M871,,Other peptide,,,,,,,,,,,WTLNSAGYLLGPEHPPPALALA,Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Glu-His-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala-NH2,,,,
5631,"maltotriose-[125I][Tyr3,Thr8]octreotide",,Other peptide,,,,,yes,yes,,,,,FCYWKTCT,Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr,,,,
10308,mambalgin-1,,Other peptide,,,,,,,,,P0DKR6,,LKCYQHGKVVTCHRDMKFCYHNTGMPFRNLKLILQGCSSSCSETENNKCCSTDRCNK,Leu-Lys-Cys-Tyr-Gln-His-Gly-Lys-Val-Val-Thr-Cys-His-Arg-Asp-Met-Lys-Phe-Cys-Tyr-His-Asn-Thr-Gly-Met-Pro-Phe-Arg-Asn-Leu-Lys-Leu-Ile-Leu-Gln-Gly-Cys-Ser-Ser-Ser-Cys-Ser-Glu-Thr-Glu-Asn-Asn-Lys-Cys-Cys-Ser-Thr-Asp-Arg-Cys-Asn-Lys,,,,
2547,margatoxin,,Other peptide,,,,,,,,,P40755,,TIINVKCTSPKQCLPPCKAQFGQSAGAKCMNGKCKCYPH,Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Leu-Pro-Pro-Cys-Lys-Ala-Gln-Phe-Gly-Gln-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Pro-His,"Disulphide bonds between cysteine residues at positions 7 and 29, 13 and 34, and 17 and 36.",,,
2548,mast cell degranulating peptide,,Other peptide,,,,,,,,,P01499,,IKCNCKRHVIKPHICRKICGKN,Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH2,C-terminal residue is asparagine amide; disulphide bond formation between cysteine residues at positions 3 and 15 and 5 and 19,,NCCCCC1NC(=O)C(CCCNC(=N)N)NC(=O)C2CSSCC(NC(=O)C(NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(CC)C)C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CC(=O)N)CCCCN)NC(=O)C(NC(=O)C(C(CC)C)N)CCCCN)CC(=O)N)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1N=CN=C1)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1C(C(=O)NC(C(=O)NC(C(=O)N2)C(CC)C)CC2N=CN=C2)CCC1)CCCCN)C(CC)C)C(C)C,QMBRLNFAEHGOLY-UHFFFAOYSA-N
2332,maurotoxin,,Other peptide,,,,,,,,,P80719,,VSCTGSKDCYAPCRKQTGCPNAKCINKSCKCYGC,Val-Ser-Cys-Thr-Gly-Ser-Lys-Asp-Cys-Tyr-Ala-Pro-Cys-Arg-Lys-Gln-Thr-Gly-Cys-Pro-Asn-Ala-Lys-Cys-Ile-Asn-Lys-Ser-Cys-Lys-Cys-Tyr-Gly-Cys-NH2,"C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 3 and 24, 9 and 29, 13 and 19, and 31 and 34.",,,
2264,maxadilan,,Other peptide,,,,,,,,,P30659,,CDATCQFRKAIDDCQKQAHHSNVLQTSVQTTATFTSMDTSQLPGNSVFKECMKQKKKEFKA,Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Leu-Gln-Thr-Ser-Val-Gln-Thr-Thr-Ala-Thr-Phe-Thr-Ser-Met-Asp-Thr-Ser-Gln-Leu-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-NH2,C-terminal residue is alanine amide,,,
2265,Max.d.4,,Other peptide,,,,,,,,,,,CDATCQFRKAIDDCQKQAHHSNVPGNSVFKECMKQKKKEFKAGK,Cys-Asp-Ala-Thr-Cys-Gln-Phe-Arg-Lys-Ala-Ile-Asp-Asp-Cys-Gln-Lys-Gln-Ala-His-His-Ser-Asn-Val-Pro-Gly-Asn-Ser-Val-Phe-Lys-Glu-Cys-Met-Lys-Gln-Lys-Lys-Lys-Glu-Phe-Lys-Ala-Gly-Lys,"There are predicted to be disulphide bonds between Cys1 and Cys5, and Cys14 and Cys32.",,,
1339,MBP10,,Other peptide,,,,,,,,,,,ARWK,cyclo(6β-10ε)(succinyl6-D-(2')Nal7-Arg8-Trp9-Lys10)-NH2,,,,
7038,MBP7,,Other peptide,,,,,,,,,,,KAQLRRLS,Lys-Ala-Gln-Leu-Arg-Arg-Leu-Ser,,,,
778,MC148R,,Other peptide,,,,,,,,,,,MRARAVFASVVLTLLLALPRPGVSLSRRKCCLNPTNRPIPNPLLQDLDKVDYQPMGHDCGREAFRVTLQDGRQCVSVGNQSLLDWLKGHKDLCPRMWPGCESL,,,,,
1301,MCH (salmon),,Other peptide,,,,,,,,,,,DTMRCMVGRVYRPCWEV,Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val,,,,
1293,MCH6-17,,Other peptide,,,,,,,,,,,RCMLGRVYRPCW,Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp,,,,
2116,MEN 10376,,Other peptide,,,,,,,,,,,DYWVWWK,Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2,,,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)Cc1ccc(cc1)O,QQHOFZNACVKNHK-SXVLBCBNSA-N
3901,MEN10627,,Other peptide,,,,,,,,,,,XLMDWF,c[Dpr-Leu-Met-Asp-Trp-Phe],,,CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H]2CNC(=O)C[C@@H](NC1=O)C(=O)N[C@H](Cc1c[nH]c3c1cccc3)C(=O)N[C@H](C(=O)N2)Cc1ccccc1,CFDNUNSOUUFTQO-JYMVZIKVSA-N
788,Met-Ckβ7,,Other peptide,,,,,,,,,,,MQVGTNKELCCLVYTSWQIPQKFIVDYSETSPQCPKPGVILLTKRGRQICADPNKKWVQKYISDLKLNA,Met-Gln-Val-Gly-Thr-Asn-Lys-Glu-Leu-Cys-Cys-Leu-Val-Tyr-Thr-Ser-Trp-Gln-Ile-Pro-Gln-Lys-Phe-Ile-Val-Asp-Tyr-Ser-Glu-Thr-Ser-Pro-Gln-Cys-Pro-Lys-Pro-Gly-Val-Ile-Leu-Leu-Thr-Lys-Arg-Gly-Arg-Gln-Ile-Cys-Ala-Asp-Pro-Asn-Lys-Lys-Trp-Val-Gln-Lys-Tyr-Ile-Ser-Asp-Leu-Lys-Leu-Asn-Ala,,,,
638,Met-Lys-bradykinin,,Other peptide,,,,,,,,,,,MKRPPGFSPFR,Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N)NC(=O)[C@H](CCSC)N,SSXPFNXUSFJJEI-BHEJXMHWSA-N
5836,Met-Met-Trp-Leu-Leu,,Other peptide,,,,,,,,,,,MMWLL,Met-Met-Trp-Leu-Leu,,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)NC(=O)[C@H](CCSC)N,HOPVQBLVLLHWOU-BLVAWXTGSA-N
7333,metreleptin,,Other peptide,,,yes,,,,,,,metreleptin,MVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLPWASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC,Met-Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp-Ile-Ser-His-Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys-Val-Thr-Gly-Leu-Asp-Phe-Ile-Pro-Gly-Leu-His-Pro-Ile-Leu-Thr-Leu-Ser-Lys-Met-Asp-Gln-Thr-Leu-Ala-Val-Tyr-Gln-Gln-Ile-Leu-Thr-Ser-Met-Pro-Ser-Arg-Asn-Val-Ile-Gln-Ile-Ser-Asn-Asp-Leu-Glu-Asn-Leu-Arg-Asp-Leu-Leu-His-Val-Leu-Ala-Phe-Ser-Lys-Ser-Cys(1)-His-Leu-Pro-Trp-Ala-Ser-Gly-Leu-Glu-Thr-Leu-Asp-Ser-Leu-Gly-Gly-Val-Leu-Glu-Ala-Ser-Gly-Tyr-Ser-Thr-Glu-Val-Val-Ala-Leu-Ser-Arg-Leu-Gln-Gly-Ser-Leu-Gln-Asp-Met-Leu-Trp-Gln-Leu-Asp-Leu-Ser-Pro-Gly-Cys(1),,,,
1659,[Met5]dynorphin-(1-17),,Other peptide,,,,,,,,,,,YGGFMRRIRPKLKWDNQ,Tyr-Gly-Gly-Phe-Met-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln,,,,
6250,MHC binding peptide,,Other peptide,,,,,,,,,,,MYFINILTL,Met-Tyr-Phe-Ile-Asn-Ile-Leu-Thr-Leu,,,,
8334,minimised INSL5 analogue 7,,Other peptide,8335,minimised INSL5 analogue 7 A chain,,,,,,,,,,,,,,
8335,minimised INSL5 analogue 7 A chain,,Other peptide,,,,,,,,,,,CTDGASMTDLSALC,Cys-Thr-Asp-Gly-Ala-Ser-Met-Thr-Asp-Leu-Ser-Ala-Leu-Cys,,,,
8336,minimised relaxin-3 analogue 2,,Other peptide,8327,minimised relaxin-3 analogue A chain,,,,,,,,,,,,,,
8326,minimised relaxin-3 analogue 3,,Other peptide,8327|8328,minimised relaxin-3 analogue A chain|minimised relaxin-3 analogue 3 B chain,,,,,,,,,,,,,,
8328,minimised relaxin-3 analogue 3 B chain,,Other peptide,,,,,,,,,,,CKWGASKSEISSLC,Cys-Lys-Trp-Gly-Ala-Ser-Lys-Ser-Glu-Ile-Ser-Ser-Leu-Cys,,,,
8327,minimised relaxin-3 analogue A chain,,Other peptide,,,,,,,,,,,RAAPYGVRLCGREFIRAVIFTCR,Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Cys-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Cys-Arg,,,,
823,mini-TyrRS,,Other peptide,,,,,,,,,,,GDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVI,,,,,
1865,MIT1,,Other peptide,,,,,,,,,P25687,,AVITGACERDLQCGKGTCCAVSLWIKSVRVCTPVGTSGEDCHPASHKIPFSGQRMHHTCPCAPNLACVQTSPKKFKCLSKS,Ala-Val-Ile-Thr-Gly-Ala-Cys-Glu-Arg-Asp-Leu-Gln-Cys-Gly-Lys-Gly-Thr-Cys-Cys-Ala-Val-Ser-Leu-Trp-Ile-Lys-Ser-Val-Arg-Val-Cys-Thr-Pro-Val-Gly-Thr-Ser-Gly-Glu-Asp-Cys-His-Pro-Ala-Ser-His-Lys-Ile-Pro-Phe-Ser-Gly-Gln-Arg-Met-His-His-Thr-Cys-Pro-Cys-Ala-Pro-Asn-Leu-Ala-Cys-Val-Gln-Thr-Ser-Pro-Lys-Lys-Phe-Lys-Cys-Leu-Ser-Lys-Ser,Disulfide bond formation between cysteine residues at positions 7 and 19; 13 and 31; 18 and 59; 41 and 67 and 61 and 77,,,
9351,MLCK inhibitor peptide 18,,Other peptide,,,,,,,,,,,RKKYKYRRK,H-Arg-Lys-Lys-Tyr-Lys-Tyr-Arg-Arg-Lys-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCN=C(N)N)CCCN=C(N)N)Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)N)CCCCN)CCCCN)Cc1ccc(cc1)O,JPOKAKNGULMYHZ-UILVTTEASA-N
8523,MM07,,Other peptide,,,,,,,,,,,CRPRLCHKGPMPF,Cys-Arg-Pro-Arg-Leu-Cys-His-Lys-Gly-Pro-Met-Pro-Phe,Disulphide bond between cysteine residues at positions 1 and 6,,NCCCC[C@@H](C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)CCSC)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N2[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(C)C)CCCNC(=N)N)CCC2,RKFGCZWTURNFPN-SVENNQHVSA-N
6186,MM54,,Other peptide,,,,,,,,,,,CRPRLCKHCRPRLC,Cys-Arg-Pro-Arg-Leu-Cys-Lys-His-Cys-Arg-Pro-Arg-Leu-Cys,,,,
6240,MMK-1,,Other peptide,,,,,,,,,,,LESIFRSLLFRVM,Leu-Glu-Ser-Ile-Phe-Arg-Ser-Leu-Leu-Phe-Arg-Val-Met,,,CSCC[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)N)CCC(=O)O)CO)Cc1ccccc1)CCCN=C(N)N)CO)CC(C)C)CC(C)C)Cc1ccccc1)CCCN=C(N)N,PWBQRCXCXXGUGY-AJOXZCOLSA-N
1457,motilin,Dog,Other peptide,,,,,,,,,P19863,,FVPIFTHSELQKIREKERNKGQ,Phe-Val-Pro-Ile-Phe-Thr-His-Ser-Glu-Leu-Gln-Lys-Ile-Arg-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
1459,motilin,Rabbit,Other peptide,,,,,,,,,P27114,,FVPIFTYSELQRMQERERNRGH,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Ser-Glu-Leu-Gln-Arg-Met-Gln-Glu-Arg-Glu-Arg-Asn-Arg-Gly-His,,,,
1460,motilin-(1-11) (human),,Other peptide,,,,,,,,,,,FVPIFTYGELQ,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln,,,,
1461,motilin-(1-12) (human),,Other peptide,,,,,,,,,,,FVPIFTYGELQR,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg,,,,
1462,motilin-(1-13) (human),,Other peptide,,,,,,,,,,,FVPIFTYGELQRM,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met,,,,
1463,motilin-(1-19) (human),,Other peptide,,,,,,,,,,,FVPIFTYGELQRMQEKERN,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn,,,,
1464,motilin-(2-22) (human),,Other peptide,,,,,,,,,,,VPIFTYGELQRMQEKERNKGQ,Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
2255,"[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT",,Other peptide,,,,,,,,,,,XYIQNCXLX,Mpa-Tyr-Ile-Gln-Asn-Cys-D-Tic-Leu-Aib-NH2,,,,
2256,"[Mpa1,D-Tyr(Et)2,D-Tic7]OT",,Other peptide,,,,,,,,,,,XYIQNCPLG,Mpa-D-(Et)Tyr-Ile-Gln-Asn-Cys-D-Tic-Leu-Gly-NH2,,,,
2254,"[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT",,Other peptide,,,,,,,,,,,xYIQNCXLX,Mpa-D-(Et)Tyr-Ile-Gln-Asn-Cys-Tic-Leu-Tic-NH2,,,,
1322,MS05,,Other peptide,,,,,,,,,,,SSIISHFRWGKPV,Ser-Ser-Ile-Ile-Ser-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2,,,,
1323,MT-II,,Other peptide,,,,,,,,,,,XDHFRWK,Ac-Nle4-cyclo(5β->10ε)(Asp5-His6-D-Phe7-Arg8-Trp9-Lys10)-NH2,,,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C,JDKLPDJLXHXHNV-MFVUMRCOSA-N
2630,μ-conotoxin GIIIA,,Other peptide,,,,,,,,,P01523,,RDCCTPPKKCKDRQCKPQRCCA,Arg-Asp-Cys-Cys-Thr-Pro-Pro-Lys-Lys-Cys-Lys-Asp-Arg-Gln-Cys-Lys-Pro-Gln-Arg-Cys-Cys-Ala-NH2,"Proline residues at positions 6 and 7 are partially hydroxylated; proline residue at position 17 undergoes full hydroxylation; C-terminal alanine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 3 and 15, 4 and 20, and 10 and 21.",,,
2631,μ-conotoxin PIIIA,,Other peptide,,,,,,,,,P58925,,QRLCCGFPKSCRSRQCKPHRCC,pGlu-Arg-Leu-Cys-Cys-Gly-Phe-Pro-Lys-Ser-Cys-Arg-Ser-Arg-Gln-Cys-Lys-Pro-His-Arg-Cys-Cys-NH2,"N-terminal glutamine is pyrrolidone carboxylic acid; proline residues at positions 8 and 18 are hydroxyproline; C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 4 and 16, 5 and 21, and 11 and 22.",,,
7567,μ-conotoxin SmIIIA,,Other peptide,,,,,,,,,P60207,,QRCCNGRRGCSSRWCRDHSRCC,Gln-Arg-Cys-Cys-Asn-Gly-Arg-Arg-Gly-Cys-Ser-Ser-Arg-Trp-Cys-Arg-Asp-His-Ser-Arg-Cys-Cys,"Disulphide bond formation between cysteine residues at positions 3 and 15, 4 and 21, and 10 and 22. Predicted pyrrolidone carboxylic acid at position 1.",,,
8648,multi-Leu (ML)-peptide,,Other peptide,,,,,,,,,,,Ac-LLLRVKR-NH2,Leu-Leu-Leu-Arg-Val-Lys-Arg,,,,
311,muscarinic toxin 1,,Other peptide,,,,,,,,,P81030,,LTCVTSKSIFGITTENCPDGQNLCFKKWYYIVPRYSDITWGCAATCPKPTNVRETIRCCETDKCNE,Leu-Thr-Cys-Val-Thr-Ser-Lys-Ser-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Asp-Gly-Gln-Asn-Leu-Cys-Phe-Lys-Lys-Trp-Tyr-Tyr-Ile-Val-Pro-Arg-Tyr-Ser-Asp-Ile-Thr-Trp-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Lys-Pro-Thr-Asn-Val-Arg-Glu-Thr-Ile-Arg-Cys-Cys-Glu-Thr-Asp-Lys-Cys-Asn-Glu,"Disulphide bond formation between cysteine residues at positions 3 and 24, 17 and 42, 46 and 58 and 59 and 64",,,
312,muscarinic toxin 2,,Other peptide,,,,,,,,,P18328,,LTCVTTKSIGGVTTEDCPAGQNVCFKRWHYVTPKNYDIIKGCAATCPKVDNNDPIRCCGTDKCND,Leu-Thr-Cys-Val-Thr-Thr-Lys-Ser-Ile-Gly-Gly-Val-Thr-Thr-Glu-Asp-Cys-Pro-Ala-Gly-Gln-Asn-Val-Cys-Phe-Lys-Arg-Trp-His-Tyr-Val-Thr-Pro-Lys-Asn-Tyr-Asp-Ile-Ile-Lys-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Lys-Val-Asp-Asn-Asn-Asp-Pro-Ile-Arg-Cys-Cys-Gly-Thr-Asp-Lys-Cys-Asn-Asp,"Disulphide bond formation between cysteine residues at positions 2 and 24, 17 and 42, 46 and 57 and 58 and 63",,,
313,muscarinic toxin 3,,Other peptide,,,,,,,,,P81031,,LTCVTKNTIFGITTENCPAGQNLCFKRWHYVIPRYTEITRGCAATCPIPENYDSIHCCKTDKCNE,Leu-Thr-Cys-Val-Thr-Lys-Asn-Thr-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asn-Cys-Pro-Ala-Gly-Gln-Asn-Leu-Cys-Phe-Lys-Arg-Trp-His-Tyr-Val-Ile-Pro-Arg-Tyr-Thr-Glu-Ile-Thr-Arg-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ile-Pro-Glu-Asn-Tyr-Asp-Ser-Ile-His-Cys-Cys-Lys-Thr-Asp-Lys-Cys-Asn-Glu,"Disulphide bond formation between cysteine residues at positions 3 and 24, 17 and 42, 46 and 57 and 58 and 63",,,
314,muscarinic toxin 7,,Other peptide,,,,,,,,,Q8QGR0,,LTCVKSNSIWFPTSEDCPDGQNLCFKRWQYISPRMYDFTRGCAATCPKAEYRDVINCCGTDKCNK,Leu-Thr-Cys-Val-Lys-Ser-Asn-Ser-Ile-Trp-Phe-Pro-Thr-Ser-Glu-Asp-Cys-Pro-Asp-Gly-Gln-Asn-Leu-Cys-Phe-Lys-Arg-Trp-Gln-Tyr-Ile-Ser-Pro-Arg-Met-Tyr-Asp-Phe-Thr-Arg-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Lys-Ala-Glu-Tyr-Arg-Asp-Val-Ile-Asn-Cys-Cys-Gly-Thr-Asp-Lys-Cys-Asn-Lys,"Disulphide bond formation between cysteine residues at positions 3-24, 17 and 42, 46 and 57 and 58 and 63",,,
10211,mutant ANP,,Other peptide,,,,,,,,,,,SLRRSSCFGGRMDRIGAQSGLGCNSFRYRITAREDKQGWA,Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-Arg-Ile-Thr-Ala-Arg-Glu-Asp-Lys-Gln-Gly-Trp-Ala,,,,
1117,MZ-4-169,,Other peptide,,,,,,,,,,,YRDAIFTNSYRKVLXQLSARKLLQDIXSR,NAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg-NH2,,,,
1118,MZ-4-181,,Other peptide,,,,,,,,,,,HRDAIFTNSYRKVLXQLSARKLLQDIXSR,NAc-His-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Ser-Nle-NH2,,,,
1119,MZ-4-243,,Other peptide,,,,,,,,,,,YRDAIFTNSYRKVLXQLSARKLLQDIXS,NAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Agm,,,,
1120,MZ-4-71,,Other peptide,,,,,,,,,,,YRDAIFTNSYRKVLXQLSARKLLQDIMS,(Ibu)Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Agm,,,,
1121,MZ-5-156,,Other peptide,,,,,,,,,,,YRDAIFTNSYRKVLXQLSARKLLQDIXS,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Agm,,,,
1122,MZ-5-192,,Other peptide,,,,,,,,,,,YRDAIFTXSYRKVLAQLSARKLLQDIXS,PheAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Abu-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-NH2,,,,
1123,MZ-5-78,,Other peptide,,,,,,,,,,,YRDAIFTXSYRKVLXQLSARKLLQDIXD,PhAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Abu-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Asp-Agm,,,,
1124,MZ-6-55,,Other peptide,,,,,,,,,,,YRDAIFTNSYRKVLXQLSARKLLQDIXRR,PheAc-Tyr-D-Arg-Asp-Ala-Ile-pCpa-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Abu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-D-Arg-Har,,,,
6246,N36,,Other peptide,,,,,,,,,,,SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARIL,Ser-Gly-Ile-Val-Gln-Gln-Gln-Asn-Asn-Leu-Leu-Arg-Ala-Ile-Glu-Ala-Gln-Gln-His-Leu-Leu-Gln-Leu-Thr-Val-Trp-Gly-Ile-Lys-Gln-Leu-Gln-Ala-Arg-Ile-Leu,,,,
3902,nafarelin,,Other peptide,,,yes,,,,,,,nafarelin,XEHWSYXLRPG,pGlu-His-Trp-Ser-Tyr-D-Nal-Leu-Arg-Pro-Gly-NH2,,,,
2017,NC 4-28B,,Other peptide,,,,,,,,,,,FCYWKSCA,D-Phe-Cys-Tyr-Trp-Lys-Ser-Cys-Nal-NH2,,,,
2052,NC 8-12,,Other peptide,,,,,,,,,,,FCYWKXCA,D-Phe-Cys-Tyr-D-Trp-Lys-Abu-Cys-Nal-NH2,,,,
2123,nepadutant,,Other peptide,,,,,,,,,,nepadutant,NDWFXL,Asn-Asp-Trp-Phe-Dpr-Leu,,,OC[C@H]1O[C@@H](NC(=O)C[C@@H](C(=O)N[C@H]2CC(=O)NC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)Cc2c[nH]c3c2cccc3)Cc2ccccc2)C(=O)N[C@H](C(=O)O)CC(C)C)N)[C@@H]([C@H]([C@@H]1O)O)NC(=O)C,NPSVXOVMLVOMDD-SXRVEDALSA-N
6163,neuromedin B (1-30) (human),,Other peptide,,,,,,,,,,,LSWDLPEPRSRASKIRVHSRGNLWATGHFM,Leu-Ser-Trp-Asp-Leu-Pro-Glu-Pro-Arg-Ser-Arg-Ala-Ser-Lys-Ile-Arg-Val-His-Ser-Arg-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met,,,,
6178,neuromedin C,,Other peptide,,,,,,,,,,,GNHWAVGHLM,Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met,,,,
1471,neuromedin U-25,Pig,Other peptide,,,,,,,,,P34964,,FKVDEEFQGPIVSQNRRYFLFRPRN,Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,The C-terminal asparagine is amidated.,,,
1473,neuromedin U-8,Pig,Other peptide,,,,,,,,,P34964,,YFLFRPRN,Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn,,,,
1472,neuromedin U-8,Dog,Other peptide,,,,,,,,,P34962,,QFLFRPRN,Gln-Phe-Leu-Phe-Arg-Pro-Arg-Asn,,,,
2092,neuropeptide-γ,,Other peptide,,,,,,,,,,,DAGHGQISHKRHKTDSFVGLM,Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met,,,,
2496,neuropeptide head activator,,Other peptide,,,,,,,,,,,XPPGGSKVILF,pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe,The N-terminal glutamine is converted into pyroglutamate (X/pGlu),,,
7363,neurotensin-(8-13),,Other peptide,,,,,,,,,,,RRPYIL,Arg-Arg-Pro-Tyr-Ile-Leu,,,,
10254,NG29,,Other peptide,,,,,,,,,,,,NH2-Sar-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-(D-Phe)-COOH,,,,
10255,NG291,,Other peptide,,,,,,,,,,,,H-Arg-Pro-Hyp-Gly-Thi-Ser-NChg-Thi-Arg-OH,,,,
1805,"[Nle8,18,Tyr34]PTH-(1-34)-NH2 (bovine)",,Other peptide,,,,,,,,,,,AVSEIQFXHNLGKHLSSXERVEWLRKKLQDVHNY,Ala-Val-Ser-Glu-Ile-Gln-Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr,,,,
1806,"[Nle8,18,Tyr34]PTH-(3-34)-NH2 (bovine)",,Other peptide,,,,,,,,,,,SEIQFXHNLGKHLSSXERVEWLRKKLQDVHNY,Ser-Glu-Ile-Gln-Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr,,,,
1455,"[nLeu13,Glu14]motilin (human)",,Other peptide,,,,,,,,,,,FVPIFTYGELQRXEEKERNKGQ,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-nLeu-Glu-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
9009,NM4-C16,,Other peptide,,,,,,,,,,,,,,,CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCC)CCCCCC(=O)NC(C(=O)NC(C(=O)N[C@H](C(=O)NC(C(=O)N[C@H](C(=O)N1CCCC1C(=O)N[C@H](C(=O)NC(C(=O)N)CC(=O)N)CCCNC(=N)N)CCCNC(=N)N)Cc1ccccc1)CC(C)C)Cc1ccccc1)(C)C,GDPUTCQTCXMCTL-YPQIROLXSA-N
6109,"[N-Me,des-Sar]Gal-B2",,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPKKKK,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Lys-Lys-Lys-Lys,,,,
9760,NNC1702,,Other peptide,,,,,,,,,,,,,,,,
2053,NOC-ATE,,Other peptide,,,,,,,,,,,FCXWKTCT,D-Phe-Cys-Nal-D-Trp-Lys-Thr-Cys-Thr,,,,
5627,NODAGA-[Tyr3]-octreotide,,Other peptide,,,,,,,,,,,FCYWKTCT,[NODAGA]-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr,,,,
1682,N/OFQ-(1-13)-NH2,,Other peptide,,,,,,,,,,,FGGFTGARKSARK,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCN=C(N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)C)CCCN=C(N)N,RHMALYOXPBRJBG-CGUXNFSNSA-N
1683,N/OFQ-NH2,,Other peptide,,,,,,,,,,,FGGFTGARKSARKLANQ,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-NH2,,,,
6893,novokinin,,Other peptide,,,,,,,,,,,RPLKPW,Arg-Pro-Leu-Lys-Pro-Trp,,,,
2552,noxiustoxin,,Other peptide,,,,,,,,,P08815,,TIINVKCTSPKQCSKPCKELYGSSAGAKCMNGKCKCYNN,Thr-Ile-Ile-Asn-Val-Lys-Cys-Thr-Ser-Pro-Lys-Gln-Cys-Ser-Lys-Pro-Cys-Lys-Glu-Leu-Tyr-Gly-Ser-Ser-Ala-Gly-Ala-Lys-Cys-Met-Asn-Gly-Lys-Cys-Lys-Cys-Tyr-Asn-Asn-NH2,"C-terminal asparagine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 7 and 29, 13 and 34, and 17 and 36.",,,
657,NPC 17731,,Other peptide,,,,,,,,,,,RRPXGFSXXR,D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-X-Oic-Arg,,,CCCO[C@@H]1CN[C@H](C1)C(=O)N([C@@](C(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)CCN=C(N)N)(C(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H]1NCC(C1)O)CO)C(=O)O)C(=O)C1N[C@@H]2[C@H](C1)CCCC2,WYWZCALINPVKJW-KOCZGPIPSA-N
658,NPC 18565,,Other peptide,,,,,,,,,,,RRPXGFSPX,D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Hype(trans-propyl)-Oic,,,,
675,NPC-349,,Other peptide,,,,,,,,,,,RRXXGXSFXR,D-Arg-Arg-Hyp-Hyp-Gly-Thi-Ser-D-Phe-Thi-Arg,,,OC[C@@H](C(=O)N[C@@H](C(=O)N([C@](C(C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)CCN=C(N)N)(C(=O)CNC(=O)[C@H]1NC[C@@H](C1)O)C(=O)O)C(=O)[C@H](Cc1cccs1)N)Cc1ccccc1)NC(=O)[C@H](Cc1cccs1)N,MHBUKMPYIGAURU-WIDHDRDXSA-N
676,NPC-567,,Other peptide,,,,,,,,,,,RRPXGFSFFR,Arg-Arg-Pro-Hyp-Gly-Phe-Ser-Phe-Phe-Arg,,,OC[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)Cc1ccccc1)Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCN=C(N)N)N)CCCN=C(N)N)O,RBIXVHPHNGXTCI-QJTYZATASA-N
1695,[Nphe1]N/OFQ-(1-13)-NH2,,Other peptide,,,,,,,,,,,FGGFTGARKSARK,NPhe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2,,,,
1505,NPY,Pig,Other peptide,,,,,,,,,P01304,,YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,The C-terminal tyrosine is amidated.,,,
3903,NPY-(13-36),,Other peptide,,,,,,,,,,,PAEDMARYYSALRHYINLITRQRY,Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(cc1)O)CCCN=C(N)N)CCC(=O)N)CCCN=C(N)N)[C@H](O)C)[C@H](CC)C)CC(C)C)CC(=O)N)[C@H](CC)C)Cc1ccc(cc1)O)Cc1nc[nH]c1)CCCN=C(N)N)CC(C)C)C)CO)Cc1ccc(cc1)O)Cc1ccc(cc1)O)CCCN=C(N)N)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1)C)CCC(=O)O)CC(=O)O,WNYKZOWMSHGMPJ-YGPTWXQHSA-N
1535,NPY-(13-36) (human),,Other peptide,,,,,,,,,,,PAEDMARYYSALRHYINLITRQRY,Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1507,NPY-(13-36) (pig),,Other peptide,,,,,,,,,,,PAEDLARYYSALRHYINLITRQRY,Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1536,NPY-(16-36) (pig),,Other peptide,,,,,,,,,,,DLARYYSALRHYINLITRQRY,Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1557,"NPY-(18-36) (human, pig)",,Other peptide,,,,,,,,,,,ARYYSALRHYINLITRQRY,Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1538,NPY-(20-36) (pig),,Other peptide,,,,,,,,,,,YYSALRHYINLITRQRY,Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1539,NPY-(22-36) (pig),,Other peptide,,,,,,,,,,,SALRHYINLITRQRY,Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1549,NPY-(2-36),,Other peptide,,,,,,,,,,,PSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY,Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1508,NPY-(2-36) (pig),,Other peptide,,,,,,,,,,,PSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY,Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1540,NPY-(26-36) (pig),,Other peptide,,,,,,,,,,,HYINLITRQRY,His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1510,NPY-(3-36) (pig),,Other peptide,,,,,,,,,,,SKPDNPGEDAPAEDLARYYSALRHYINLITRQRY,Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
8772,Nrf2 peptide [PMID: 23647822],,Other peptide,,,,,,,,,,,AFFAQLQLDEETGEFL,Ala-Phe-Phe-Ala-Gln-Leu-Gln-Leu-Asp-Glu-Glu-Thr-Gly-Glu-Phe-Leu,,,,
2266,N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28),,Other peptide,,,,,,,,,,,KPRRPYTDNYTRLRKQXAVKKYLNSILN,stearyl-Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Nle-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2,,,,
2271,N-stearyl-[Nle17]VIP,,Other peptide,,,,,,,,,,,HSDAVFTDNYTRLRKQXAVKKYLNSILN,stearyl-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Nle-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2,,,,
6581,obtustatin,,Other peptide,,,,,,,,,P83469,,CTTGPCCRQCKLKPAGTTCWKTSLTSHYCTGKSCDCPLYPG,Cys-Thr-Thr-Gly-Pro-Cys-Cys-Arg-Gln-Cys-Lys-Leu-Lys-Pro-Ala-Gly-Thr-Thr-Cys-Trp-Lys-Thr-Ser-Leu-Thr-Ser-His-Tyr-Cys-Thr-Gly-Lys-Ser-Cys-Asp-Cys-Pro-Leu-Tyr-Pro-Gly,"Disulfide bridge between residues 1 and 10, 6 and 29, 7 and 34, 19 and 36",,,
7446,ocriplasmin,,Other peptide,,,yes,,,,,,,,,,,,,
2055,octreotide,,Other peptide,,,yes,,,,,,,octreotide,FCFWKTCT,D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr,,,NCCCCC1NC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)C(CSSCC(NC(=O)C(NC1=O)C(O)C)C(=O)NC(C(O)C)CO)NC(=O)C(Cc1ccccc1)N)Cc1c[nH]c2c1cccc2,DEQANNDTNATYII-UHFFFAOYSA-N
2195,OH-LVA,,Other peptide,,,,,,,,,,,YFQNRPR,4-OH-phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2,,,,
1467,OHM-11526,,Other peptide,,,,,,,,,,,FVFIFTYGELQRLQEKERNKGQ,Phe-Val-Phe-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
9729,olamkicept,,Other peptide,,,,,,,,,,olamkicept,ELLDPCGYISPESPVVQLHSNFTAVCVLKEKCMDYFHVNANYIVWKTNHFTIPKEQYTIINRTASSVTFTDIASLNIQLTCNILTFGQLEQNVYGITIISGLPPEKPKNLSCIVNEGKKMRCEWDGGRETHLETNFTLKSEWATHKFADCKAKRDTPTSCTVDYSTVYFVNIEVWVEAENALGKVTSDHINFDPVYKVKPNPPHNLSVINSEELSSILKLTWTNPSIKSVIILKYNIQYRTKDASTWSQIPPEDTASTRSSFTVQDLKPFTEYVFRIRCMKEDGKGYWSDWSEEASGITYEDRPSKAPSFWYKIDPSHTQGYRTVQLVWKTLPPFEANGKILDYEVTLTRWKSHLQNYTVNATKLTVNLTNDRYLATLTVRNLVGKSDAAVLTIPACDFQATHPVMDLKAFPKDNMLWVEWTTPRESVKKYILEWCVLSDKAPCITDWQQEDGTVHRTYLRGNLAESKCYLITVTPVYADGPGSPESIKAYLKQAPPSKGPTVRTKKVGKNEAVLEWDQLPVDVQNGFIRNYTIFYRTIIGNETAVNVDSSHTEYTLSSLTSDTLYMVRMAAYTDEGGKDGPEFTFTTPKFAQGEDKTHTCPPCPAPEAEGAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK,,,,,
2528,ω-agatoxin IIIA,,Other peptide,,,,,,,,,P33034,,SCIDIGGDCDGEKDDCQCCRRNGYCSCYSLFGYLKSGCKCVVGTSAEFQGICRRKARQCYNSDPDKCESHNKPKRR,Ser-Cys-Ile-Asp-Ile-Gly-Gly-Asp-Cys-Asp-Gly-Glu-Lys-Asp-Asp-Cys-Gln-Cys-Cys-Arg-Arg-Asn-Gly-Tyr-Cys-Ser-Cys-Tyr-Ser-Leu-Phe-Gly-Tyr-Leu-Lys-Ser-Gly-Cys-Lys-Cys-Val-Val-Gly-Thr-Ser-Ala-Glu-Phe-Gln-Gly-Ile-Cys-Arg-Arg-Lys-Ala-Arg-Gln-Cys-Tyr-Asn-Ser-Asp-Pro-Asp-Lys-Cys-Glu-Ser-His-Asn-Lys-Pro-Lys-Arg-Arg,,,,
2529,ω-agatoxin IVA,,Other peptide,,,,,,,,,P30288,,KKKCIAKDYGRCKWGGTPCCRGRGCICSIMGTNCECKPRLIMEGLGLA,Lys-Lys-Lys-Cys-Ile-Ala-Lys-Asp-Tyr-Gly-Arg-Cys-Lys-Trp-Gly-Gly-Thr-Pro-Cys-Cys-Arg-Gly-Arg-Gly-Cys-Ile-Cys-Ser-Ile-Met-Gly-Thr-Asn-Cys-Glu-Cys-Lys-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Gly-Leu-Ala,,,,
2530,ω-agatoxin IVB,,Other peptide,,,,,,,,,P37045,,EDNCIAEDYGKCTWGGTKCCRGRPCRCSMIGTNCECTPRLIMEGLSFA,Glu-Asp-Asn-Cys-Ile-Ala-Glu-Asp-Tyr-Gly-Lys-Cys-Thr-Trp-Gly-Gly-Thr-Lys-Cys-Cys-Arg-Gly-Arg-Pro-Cys-Arg-Cys-Ser-Met-Ile-Gly-Thr-Asn-Cys-Glu-Cys-Thr-Pro-Arg-Leu-Ile-Met-Glu-Gly-Leu-Ser-Phe-Ala,Serine residue at position 48 is D-Ser,,,
2531,ω-conotoxin CVIA,,Other peptide,,,,,,,,,P58917,,CKSTGASCRRTSYDCCTGSCRSGRC,Cys-Lys-Ser-Thr-Gly-Ala-Ser-Cys-Arg-Arg-Thr-Ser-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Arg-Cys-NH2,"C-terminal cysteine residue undergoes amidation; predicted disulphide bond formatiohn between cysteine residues at positions 1 and 16, 8 and 20 and 15 and 25.",,,
2532,ω-conotoxin CVIB,,Other peptide,,,,,,,,,P58918,,CKGKGASCRKTMYDCCRGSCRSGRC,Cys-Lys-Gly-Lys-Gly-Ala-Ser-Cys-Arg-Lys-Thr-Met-Tyr-Asp-Cys-Cys-Arg-Gly-Ser-Cys-Arg-Ser-Gly-Arg-Cys-NH2,"C-terminal cysteine residue undergoes amidation; predicted disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 20, and 15 and 25.",,,
2533,ω-conotoxin CVIC,,Other peptide,,,,,,,,,P58919,,CKGKGQSCSKLMYDCCTGSCSRRGKC,Cys-Lys-Gly-Lys-Gly-Gln-Ser-Cys-Ser-Lys-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Ser-Arg-Arg-Gly-Lys-Cys-NH2,"C-terminal cysteine residue undergoes amidation; predicted disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 20, and 15 and 25.",,,
2534,ω-conotoxin CVID,,Other peptide,,,,,,,,,P58920,,CKSKGAKCSKLMYDCCSGSCSGTVGRC,Cys-Lys-Ser-Lys-Gly-Ala-Lys-Cys-Ser-Lys-Leu-Met-Tyr-Asp-Cys-Cys-Ser-Gly-Ser-Cys-Ser-Gly-Thr-Val-Gly-Arg-Cys-NH2,"C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 20, and 15 and 25.",,,
2535,ω-conotoxin GVIA,,Other peptide,,,,,,,,,P01522,,CKSPGSSCSPTSYNCCRSCNPYTKRCY,Cys-Lys-Ser-Pro-Gly-Ser-Ser-Cys-Ser-Pro-Thr-Ser-Tyr-Asn-Cys-Cys-Arg-Ser-Cys-Asn-Pro-Tyr-Thr-Lys-Arg-Cys-Tyr,"C-terminal tyrosine residue undergoes amidation; proline residues at positions 4, 10 and 21 are 4-hydroxyproline; disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 19, and 15 and 26.",,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccc(cc1)O)CS)CCCNC(=N)N)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)N)CCCCN)CO)O)CO)CO)CS)CO)O)CO)Cc1ccc(cc1)O)CC(=O)N)CS)CS)CCCNC(=N)N)CO)CS)CC(=O)N)O)Cc1ccc(cc1)O,XJKFZICVAPPHCK-NZPQQUJLSA-N
2536,ω-conotoxin MVIIA,,Other peptide,,,,,,,,,P05484,ziconotide,CKGKGAKCSRLMYDCCTGSCRSGKC,Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH2,"C-terminal cysteine residue is amidated; disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 20, and 15 and 25",,NCCCC[C@@H]1NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H]2C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]3CSSC[C@H](NC1=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N2)CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC3=O)CCCNC(=N)N)CO)CCCCN)C(=O)N)CO)[C@H](O)C,BPKIMPVREBSLAJ-QTBYCLKRSA-N
2537,ω-conotoxin MVIIC,,Other peptide,,,,,,,,,P37300,,CKGKGAPCRKTMYDCCSGSCGRRGKC,Cys-Lys-Gly-Lys-Gly-Ala-Pro-Cys-Arg-Lys-Thr-Met-Tyr-Asp-Cys-Cys-Ser-Gly-Ser-Cys-Gly-Arg-Arg-Gly-Lys-Cys-NH2,"C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 20 and 15 and 26.",,,
2538,ω-conotoxin MVIID,,Other peptide,,,,,,,,,Q26350,,CQGRGASCRKTMYNCCSGSCNRGRC,Cys-Gln-Gly-Arg-Gly-Ala-Ser-Cys-Arg-Lys-Thr-Met-Tyr-Asn-Cys-Cys-Ser-Gly-Ser-Cys-Asn-Arg-Gly-Arg-Cys-NH2,"C-terminal cysteine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 1 and 16, 8 and 20, and 15 and 25.",,,
2539,ω-grammotoxin SIA,,Other peptide,,,,,,,,,P60590,,DCVRFWGKCSQTSDCCPHLACKSKWPRNICVWDGSV,Asp-Cys-Val-Arg-Phe-Trp-Gly-Lys-Cys-Ser-Gln-Thr-Ser-Asp-Cys-Cys-Pro-His-Leu-Ala-Cys-Lys-Ser-Lys-Trp-Pro-Arg-Asn-Ile-Cys-Val-Trp-Asp-Gly-Ser-Val,"C-terminal valine residue is predicted to be valine-amide;  disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 30.",,,
2540,ω-phonetoxin-IIA,,Other peptide,,,,,,,,,P81790,,SCINVGDFCDGKKDDCQCCRDNAFCSCSVIFGYKTNCRCEVGTTATSYGICMAKHKCGRQTTCTKPCLSKRCKKNH,,"C-terminal histidine residue undergoes amidation; predicted disulphide bond formation between cysteine residues at positions 3 and 20, 10 and 26, 17 and 52, 19 and 40, 28 and 38, 58 and 64 and 68 and 73.",,,
2541,ω-PnTx3-3,,Other peptide,,,,,,,,,P81789,,GCANAYKSCNGPHTCCWGYNGYKKACICSGXNWK,Gly-Cys-Ala-Asn-Ala-Tyr-Lys-Ser-Cys-Asn-Gly-Pro-His-Thr-Cys-Cys-Trp-Gly-Tyr-Asn-Gly-Tyr-Lys-Lys-Ala-Cys-Ile-Cys-Ser-Gly-Asn-Trp-Lys,Predicted disulphide bond formation between cysteine residues at positions 2 and 16 and 9 and 26.,,,
6971,oprelvekin,,Other peptide,,,yes,,,,,,,oprelvekin,MNCVCRLVLVVLSLWPDTAVAPGPPPGPPRVSPDPRAELDSTVLLTRSLLADTRQLAAQLRDKFPADGDHNLDSLPTLAMSAGALGALQLPGVLTRLRADLLSYLRHVQWLRRAGGSSLKTLEPELGTLQARLDRLLRRLQLLMSRLALPQPPPDPPAPPLAPPSSAWGGIRAAHAILGG LHLTLDWAVRGLLLLKTRL,,,,,
9438,[Orn5]URP,,Other peptide,,,,,,,,,,,ACFWOYCV,Ala-Cys-Phe-Trp-Orn-Tyr-Cys-Val,,,NCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)CS)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C)CS)Cc1ccccc1,AJUZRHILBXDUEG-LSKWFVNGSA-N
10227,oryzatensin,,Other peptide,,,,,,,,,,,GYPMYPLPR,H-Gly-Tyr-Pro-Met-Tyr-Pro-Leu-Pro-Arg-OH,,,CSCC[C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)CCCN=C(N)N)CC(C)C)Cc1ccc(cc1)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(cc1)O)NC(=O)CN,CUWIGJUCRMYFBS-BXXNOCLASA-N
2556,OSK1-K16-D20,,Other peptide,,,,,,,,,,,GVIINVKCKISRQCLKPCKDAGMRFGKCMNGKCHCTPK,Gly-Val-Ile-Ile-Asn-Val-Lys-Cys-Lys-Ile-Ser-Arg-Gln-Cys-Leu-Lys-Pro-Cys-Lys-Asp-Ala-Gly-Met-Arg-Phe-Gly-Lys-Cys-Met-Asn-Gly-Lys-Cys-His-Cys-Thr-Pro-Lys,,,,
2325,P05,,Other peptide,,,,,,,,,P31719,,TVCNLRRCQLSCRSLGLLGKCIGVKCECVKH,Thr-Val-Cys-Asn-Leu-Arg-Arg-Cys-Gln-Leu-Ser-Cys-Arg-Ser-Leu-Gly-Leu-Leu-Gly-Lys-Cys-Ile-Gly-Val-Lys-Cys-Glu-Cys-Val-Lys-His,"Disulphide bond formation between cysteine residues at positions 3 and 21, 8 and 26, and 12 and 28",,,
6595,P11,,Other peptide,,,,,,,,,,,HSDVHK,His-Ser-Asp-Val-His-Lys,,,,
6659,P2pal18s,,Other peptide,,,,,,,,,,,RSSAMDENSEKKRKSAIK,Arg-Ser-Ser-Ala-Met-Asp-Glu-Asn-Ser-Glu-Lys-Lys-Arg-Lys-Ser-Ala-Ile-Lys,,,,
9384,P32 [PMID: 27108698],,Other peptide,,,,,,,,,,,RHYPYWR,Arg-His-Tyr-Pro-Tyr-Trp-Arg,,,,
10270,P4pal-10,,Other peptide,,,,,,,,,,,SGRRYGHALR,Ser-Gly-Arg-Arg-Tyr-Gly-His-Ala-Leu-Arg,,,,
8344,P4 [PMID: 25923432],,Other peptide,,,,,,,,,,,SLGHPEPLSNGRP,Ser-Leu-Gly-His-Pro-Glu-Pro-Leu-Ser-Asn-Gly-Arg-Pro,,,OC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)O)CCCN=C(N)N)CC(=O)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1nc[nH]c1)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CO)N)CC(C)C)CCC(=O)O)CC(C)C,UGSPCJRSHHDBMB-OEAGQSEASA-N
9385,P59 [PMID: 27108698],,Other peptide,,,,,,,,,,,LIRLWR,Leu-Ile-Arg-Leu-Trp-Arg,,,,
8345,P8 [PMID: 25923432],,Other peptide,,,,,,,,,,,EEEDEEL,Glu-Glu-Glu-Asp-Glu-Glu-Leu,,,,
2267,PACAP-(6-38),,Other peptide,,,,,,,,,,,FTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK,Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2,C-terminal residue is lysine amide,,,
6954,palifermin,,Other peptide,,,yes,,,,,,,palifermin,MSYDYMEGGDIRVRRLFCRTQWYLRIDKRGKVKGTQEMKNNYNIMEIRTVAVGIVAIKGVESEFYLAMNKEGKLYAKKECNEDCNFKELILENHYNTYASAKWTHNGGEMFVALNQKGIPVRGKKTKKEQKTAHFLPMAIT,,,,,
8560,Pam2CSK4,,Other peptide,,,,,,,,,,,CSKKKK,"S-[2,3-Bis(palmitoyloxy)-(2-R)-propyl]-Cys-Ser-Lys-Lys-Lys-Lys",,,CCCCCCCCCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)CSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCCN)CCCCN)CCCCN)CCCCN)CO)N,LJUIOEFZFQRWJG-KKIBDXJDSA-N
8558,Pam3CSK4,,Other peptide,,,,,,,,,,,CSKKKK,"S-[2,3-Bis(palmitoyloxy)-(2-RS)-propyl]-N-palmitoyl]-Cys-Ser-Lys-Lys-Lys-Lys",,,,
595,[p-aminoPhe6]ang II,,Other peptide,,,,,,,,,,,DRVYIFPF,Asp-Arg-Val-Tyr-Ile-(p-amino-Phe)-Pro-Phe,,,,
4056,PAMP-12 (human),,Other peptide,,,,,,,,,,,FRKKWNKWALSR,Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2,Amidation of C-terminal arginine residue,,,
1480,pancreatic polypeptide,European common frog,Other peptide,,,,,,,,,P31229,,APSEPHHPGDQATQDQLAQYYSDLYQYITFVTRPRF,Ala-Pro-Ser-Glu-Pro-His-His-Pro-Gly-Asp-Gln-Ala-Thr-Gln-Asp-Gln-Leu-Ala-Gln-Tyr-Tyr-Ser-Asp-Leu-Tyr-Gln-Tyr-Ile-Thr-Phe-Val-Thr-Arg-Pro-Arg-Phe,Amidation of C-terminal phenylalanine,,,
1511,pancreatic polypeptide,Bovine,Other peptide,,,,,,,,,P01302,,APLEPEYPGDNATPEQMAQYAAELRRYINMLTRPRY,Ala-Pro-Leu-Glu-Pro-Glu-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Glu-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr,Amidation of C-terminal tyrosine residue.,,,
2553,pandinotoxin-K α,,Other peptide,,,,,,,,,,,TISCTNPKQCYPHCKKETGYPNAKCMNRKCKCFGR,Thr-Ile-Ser-Cys-Thr-Asn-Pro-Lys-Gln-Cys-Tyr-Pro-His-Cys-Lys-Lys-Glu-Thr-Gly-Tyr-Pro-Asn-Ala-Lys-Cys-Met-Asn-Arg-Lys-Cys-Lys-Cys-Phe-Gly-Arg,"Disulphide bond formation between cysteine residues at positions 4 and 25, 10 and 30, and 14 and 32",,,
2018,pasireotide,,Other peptide,,,yes,,,,,,,pasireotide,XXWKYF,Hyp-Phg-Trp-Lys-(Bzl)Tyr-Phe,,,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)Cc1ccc(cc1)OCc1ccccc1)Cc1ccccc1)C[C@@H](C2)OC(=O)NCCN)c1ccccc1)Cc1c[nH]c2c1cccc2,VMZMNAABQBOLAK-DBILLSOUSA-N
3948,PBC-264,,Other peptide,,,,,,,,,,,YXGWXDF,propionyl-Tyr-(SO3H)-gNle-mGly-Trp-(NMe)Nle-Asp-Phe-NH2,,,CCCC[C@H](NC(=O)[C@H](Cc1ccc(cc1)OS(=O)(=O)O)NC(=O)CC)NCC(=O)C(=O)N[C@H](C(=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCC)NC)CC(=O)O)Cc1ccccc1)Cc1c[nH]c2c1cccc2,VNNMDTHCFFZSSJ-HWQWZYBXSA-N
1043,PBP10,,Other peptide,,,,,,,,,,,QRLFQVKGRR,Rho-B-Gln-Arg-Leu-Phe-Gln-Val-Lys-Gly-Arg-Arg,,,,
9938,pCXCL8-1aa,,Other peptide,,,,,,,,,,,EKFLKRAENS,Ac-Glu-Lys-Phe-Leu-Lys-Arg-Ala-Glu-Asn-Ser-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)CC(=O)N)CCC(=O)O)C)CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N)CCCCN)Cc1ccccc1)CC(C)C,WAKZDRBORDWUSJ-NXCVNOGKSA-N
7928,PEG40-NMU,,Other peptide,,,,,,,,,,,FRVDEEFQSPFASQSRGYFLFRPRN,PEG40-Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn,,,,
10472,pegdinetanib,,Other peptide,,,,,,,,,,pegdinetanib,GEVVAATPTSLLISWRHPHFPTRYYRITYGETGGNSPVQEFTVPLQPPTATISGLKPGVDYTITVYAVTDGRNGRLLSIPISINYRTEIDKPCQ,,,,,
6969,pegfilgrastim,,Other peptide,,,yes,,,,,,,pegfilgrastim,MAGPATQSPMKLMALQLLLWHSALWTVQEATPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLVSECATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRR AGGVLVASHLQSFLEVSYRVLRHLAQP,,,,,
7447,peginesatide,,Other peptide,,,yes,,,,,,,peginesatide,,,,,,
7462,peginterferon alfa-2b,,Other peptide,,,yes,,,,,,,peginterferon alfa-2b,CDLPQTHSLGSRRTLMLLAQMRRISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETLLDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQESLRSKE,Cys-Asp-Leu-Pro-Gln-Thr-His-Ser-Leu-Gly-Ser-Arg-Arg-Thr-Leu-Met-Leu-Leu-Ala-Gln-Met-Arg-Arg-Ile-Ser-Leu-Phe-Ser-Cys-Leu-Lys-Asp-Arg-His-Asp-Phe-Gly-Phe-Pro-Gln-Glu-Glu-Phe-Gly-Asn-Gln-Phe-Gln-Lys-Ala-Glu-Thr-Ile-Pro-Val-Leu-His-Glu-Met-Ile-Gln-Gln-Ile-Phe-Asn-Leu-Phe-Ser-Thr-Lys-Asp-Ser-Ser-Ala-Ala-Trp-Asp-Glu-Thr-Leu-Leu-Asp-Lys-Phe-Tyr-Thr-Glu-Leu-Tyr-Gln-Gln-Leu-Asn-Asp-Leu-Glu-Ala-Cys-Val-Ile-Gln-Gly-Val-Gly-Val-Thr-Glu-Thr-Pro-Leu-Met-Lys-Glu-Asp-Ser-Ile-Leu-Ala-Val-Arg-Lys-Tyr-Phe-Gln-Arg-Ile-Thr-Leu-Tyr-Leu-Lys-Glu-Lys-Lys-Tyr-Ser-Pro-Cys-Ala-Trp-Glu-Val-Val-Arg-Ala-Glu-Ile-Met-Arg-Ser-Phe-Ser-Leu-Ser-Thr-Asn-Leu-Gln-Glu-Ser-Leu-Arg-Ser-Lys-Glu,,,,
7637,peginterferon beta-1a,,Other peptide,,,yes,,,,,,,peginterferon beta-1a,MSYNLLGFLQRSSNFQCQKLLWQLNGRLEYCLKDRMNFDIPEEIKQLQQFQKEDAALTIYEMLQNIFAIFRQDSSSTGWNETIVENLLANVYHQINHLKTVLEEKLEKEDFTRGKLMSSLHLKRYYGRILHYLKAKEYSHCAWTIVRVEILRNFYFINRLTGYLRN,,,,,
7463,pegloticase,,Other peptide,,,yes,,,,,,,pegloticase,,,,,,
7485,pegvisomant,,Other peptide,,,yes,,,,,,,pegvisomant,,,,,,
2160,[Pen5]U-(4-11) (human),,Other peptide,,,,,,,,,,,DXFWKYCV,Asp-Pen-Phe-Trp-Lys-Tyr-Cys-Val,,,,
870,pentagastrin,,Other peptide,,,yes,,,,,,,pentagastrin,XWMDF,Boc-βAla-Trp-Met-Asp-Phe-NH2,,,CSCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CCNC(=O)OCC(C)C,ALXRNCVIQSDJAO-KRCBVYEFSA-N
9188,pepcan-12,,Other peptide,,,,,,,,,,,RVDPVNFKLLSH,Arg-Val-Asp-Pro-Val-Asn-Phe-Lys-Leu-Leu-Ser-His,,,,
4012,peptide 234,,Other peptide,,,,,,,,,,,ANWNGFGWRF,Ac-D-Ala-Asn-Trp-Asn-Gly-Phe-Gly-D- Trp-Arg-Phe-NH2,,,,
9253,peptide 30 [PMID: 27019010],,Other peptide,,,,,,,,,,,GGFL,"H
H2N-Gly-Gly-Phe-Leu-OMe",,,NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)OC)CC(C)C)Cc1ccccc1,CSHFHJNMIMPJST-HOTGVXAUSA-N
9588,Peptide 5 [PMID: 28562585],,Other peptide,,,,,,,,,,,,Cap1-c-Tet-Ala-Gly-Thr-X1-Thr-Ser-Asp-X2-X3,,,,
9220,peptide Cp40 [PMID: 25982307],,Other peptide,,,,,,,,,,,,D-Tyr-Ile-[Cys-Val-(1Me)Trp-Gln-Asp-Trp-Sar-Ala-His-Arg-Cys]-(Me)Ile,,,,
1696,peptide III-BTD,,Other peptide,,,,,,,,,,,RXR,Arg-D-Cha-ATA-D-Arg-D-Fcl-BTD,,,CC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]1CCC2N(C1=O)[C@H](CS2)C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N)Cc1ccc(cc1)Cl)CCCN=C(N)N)CC1CCCCC1)CCCN=C(N)N,TVMPRXGFXMXJRH-DLYPAOLNSA-N
8484,peptide KLK2b(c1),,Other peptide,,,,,,,,,,,GCAARFKVWWAACG,Gly-Cys-Ala-Ala-Arg-Phe-Lys-Val-Trp-Trp-Ala-Ala-Cys-Gly,,,,
9163,peptide P19 [PMID: 15652659],,Other peptide,,,,,,,,,,,GLSKGCFGRSLDRIGSLSGLGCNS,Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Arg-Ser-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Ser,,,,
1686,[(pF)Phe4]N/OFQ-(1-13)-NH2,,Other peptide,,,,,,,,,,,FGGFTGARKSARK,Phe-Gly-Gly-(F)Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2,,,,
6546,PG-106,,Other peptide,,,,,,,,,,,XDXXRWK,Ac-Nle-[Asp-βAla-DNal(2′)-Arg-Trp-Lys]-NH2,,,,
1341,PG-901,,Other peptide,,,,,,,,,,,XDPARWK,Ac-Nle-Asp-Pro-D-Nal-Arg-Trp-Lys-NH2,,,,
2268,PG 97-269,,Other peptide,,,,,,,,,,,HFDAVFTNSYRKVLKRLSARKLLQDIL,Ac-His-D-Phe-Asp-Ala-Val-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Lys-Arg-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-NH2,,,,
2272,PG 99-465,,Other peptide,,,,,,,,,,,HSDAVFTDNYTKLRKQMAVKKYLNSIKKGGT,Myr-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Lys-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Lys-Lys-Gly-Gly-Thr,,,,
1300,p-guanidinobenzoyl-MCH-(7-17),,Other peptide,,,,,,,,,,,XCMLGRVYRPCW,Gua-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp,,,,
2208,"[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP",,Other peptide,,,,,,,,,,,YFQNKPR,PhAc-D-Tyr(Et)-Phe-Gln-Asn-Lys-Pro-Arg-NH2,,,,
2209,"[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP",,Other peptide,,,,,,,,,,,YFVNKPY,PhAc-D-Tyr(Et)-Phe-Val-Asn-Lys-Pro-Tyr-NH2,,,,
2210,"[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP",,Other peptide,,,,,,,,,,,YFQNRPRY,PhAc-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2,,,,
2211,"[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP",,Other peptide,,,,,,,,,,,YFVNRPRR,PhAc-D-Tyr-Phe-Val-Asn-Arg-Pro-Arg-Arg-NH2,,,,
2113,[Phe(Me)7]neurokinin B,,Other peptide,,,,,,,,,,,DMHDFFFGLM,Asp-Met-His-Asp-Phe-Phe-(Me)Phe-Gly-Leu-Met-NH2,,,,
615,[Phe13]bombesin,,Other peptide,,,,,,,,,,,XQRLGNQWAVGHFM,pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2,,,,
1297,"[Phe13,Tyr19]MCH",,Other peptide,,,,,,,,,,,DFDMLRCMLGRVFRPCWQY,Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr,,,,
1807,[Phe23]PTH-(1-34) (human),,Other peptide,,,,,,,,,,,SVSEIQLMHNLGKHLNSMERVEFLRKKLQDVHNF,Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Phe-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
1454,"[Phe3,Leu13]motilin (human)",,Other peptide,,,,,,,,,,,FVFIFTYGELQRMQEKERNKGQ,Phe-Val-Phe-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
2178,[Phe3]OT,,Other peptide,,,,,,,,,,,CYFQNCPLG,Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Leu-Gly-NH2,,,CC(C[C@@H](C(=O)NCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(cc2)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC(=O)N)CCC(=O)N)Cc1ccccc1)C,WTHKESHUHBGMGM-DZCXQCEKSA-N
3846,"[Phe8,ψ(CH2-NH)Arg9]BK",,Other peptide,,,,,,,,,,,RPPGFSPFR,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe[ψ(CH2-NH)]Arg,,,,
2273,PHI,Pig,Other peptide,,,,,,,,,,,HADGVFTSDYSRLLGQLSAKKYLESLI,His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Arg-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH2,C-terminal residue is isoleucine amide,,,
2582,phrixotoxin 1,,Other peptide,,,,,,,,,P61230,,YCQKWMWTCDSARKCCEGLVCRLWCKKII,Tyr-Cys-Gln-Lys-Trp-Met-Trp-Thr-Cys-Asp-Ser-Ala-Arg-Lys-Cys-Cys-Glu-Gly-Leu-Val-Cys-Arg-Leu-Trp-Cys-Lys-Lys-Ile-Ile-NH2,"C-terminal isoleucine residue undergoes amidation; disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 25",,,
2583,phrixotoxin 2,,Other peptide,,,,,,,,,P61231,,YCQKWMWTCDEERKCCEGLVCRLWCKRIINM,Tyr-Cys-Gln-Lys-Trp-Met-Trp-Thr-Cys-Asp-Glu-Glu-Arg-Lys-Cys-Cys-Glu-Gly-Leu-Val-Cys-Arg-Leu-Trp-Cys-Lys-Arg-Ile-Ile-Asn-Met-NH2,"C-terminal methionine residue is predicted to undergo amidation; predicted disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 25.",,,
6166,phyllolitorin,,Other peptide,,,,,,,,,P08947,,QLWAVGSFM,Gln-Leu-Trp-Ala-Val-Gly-Ser-Phe-Met,,,,
2093,phyllomedusin,,Other peptide,,,,,,,,,P08610,,QNPNRFIGLM,pGlu-Asn-Pro-Asn-Arg-Phe-Ile-Gly-Leu-Met-NH2,Amidation of methionine residue at C-terminus; pyrrolidone carboxylic acid.,,,
2094,physalaemin,,Other peptide,,,,,,,,,P08615,,XADPNKFYGLM,pGlu-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2,Amidation of C-terminal methionine residue; N-terminal glutamine is cyclised into a pyrrolidone carboxylic acid (represented by pGlu/X),,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N)CCSC)CC(C)C)Cc1ccc(cc1)O)Cc1ccccc1)NC(=O)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(NC(=O)C1CCC(=O)N1)C)CC(=O)O)CC(=O)N,SHSUJLMLURFKID-UHFFFAOYSA-N
10306,Pi-hexatoxin-Hi1a,,Other peptide,,,,,,,,,A0A1L1QJU3,,NECIRKWLSCVDRKNDCCEGLECYKRRHSFEVCVPIPGFCLVKWKQCDGRERDCCAGLECWKRSGNKSSVCAPIT,Asn-Glu-Cys-Ile-Arg-Lys-Trp-Leu-Ser-Cys-Val-Asp-Arg-Lys-Asn-Asp-Cys-Cys-Glu-Gly-Leu-Glu-Cys-Tyr-Lys-Arg-Arg-His-Ser-Phe-Glu-Val-Cys-Val-Pro-Ile-Pro-Gly-Phe-Cys-Leu-Val-Lys-Trp-Lys-Gln-Cys-Asp-Gly-Arg-Glu-Arg-Asp-Cys-Cys-Ala-Gly-Leu-Glu-Cys-Trp-Lys-Arg-Ser-Gly-Asn-Lys-Ser-Ser-Val-Cys-Ala-Pro-Ile-Thr,,,,
10305,Pi-theraphotoxin-Hm3a,,Other peptide,,,,,,,,,C0HKD0,,EPCIPKWKSCVNRHGDCCAGLECWKRRKSFEVCVPKV,Glu-Pro-Cys-Ile-Pro-Lys-Trp-Lys-Ser-Cys-Val-Asn-Arg-His-Gly-Asp-Cys-Cys-Ala-Gly-Leu-Glu-Cys-Trp-Lys-Arg-Arg-Lys-Ser-Phe-Glu-Val-Cys-Val-Pro-Lys-Val,,,,
1671,PL017,,Other peptide,,,,,,,,,,,YPFP,Tyr-Pro-(NMe)Phe-D-Pro-NH2,,,Oc1ccc(cc1)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N([C@H](C(=O)N1CCC[C@@H]1C(=O)N)Cc1ccccc1)C)N,JAKBYSTWCHUQOK-NDBXHCKUSA-N
9067,PL-3994,,Other peptide,,,,,,,,,,,,,,,,
9069,plecanatide,,Other peptide,,,yes,,,,,,,plecanatide,NDECELCVNVACTGCL,Asn-Asp-Glu-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu,,,OC(=O)CC[C@@H]1NC(=O)[C@H](CSSC[C@@H]2NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(C)C)CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@H](O)C)C(=O)N[C@H](C(=O)O)CC(C)C)C(C)C)CC(=O)N)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)N)CC(=O)O)CCC(=O)O,NSPHQWLKCGGCQR-DLJDZFDSSA-N
5762,PMX205,,Other peptide,,,,,,,,,,,XPAWR,Orn-Pro-Ala-Trp-Arg,,,,
579,PMX53,,Other peptide,,,,,,,,,,,FXPXWR,Ac-Phe-[Orn-Pro-dCha-Trp-Arg],,,NC(=NCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC2CCCCC2)NC(=O)[C@H]2N(C(=O)[C@H](CCCNC1=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)C)CCC2)Cc1c[nH]c2c1cccc2)N,YOKBGCTZYPOSQM-HPSWDUTRSA-N
2542,PnTx-3-6,,Other peptide,,,,,,,,,P81792,,ACIPRGEICTDDCECCGCDNQCYCPPGSSLGIFKCSCAHANKYFCNRKKEKCKKA,Ala-Cys-Ile-Pro-Arg-Gly-Glu-Ile-Cys-Thr-Asp-Asp-Cys-Glu-Cys-Cys-Gly-Cys-Asp-Asn-Gln-Cys-Tyr-Cys-Pro-Pro-Gly-Ser-Ser-Leu-Gly-Ile-Phe-Lys-Cys-Ser-Cys-Ala-His-Ala-Asn-Lys-Tyr-Phe-Cys-Asn-Arg-Lys-Lys-Glu-Lys-Cys-Lys-Lys-Ala,"Predicted disulphide bond formation  between cysteine residues at positions 2 and 16, 9 and 22, 15 and 37, 24 and 35, and 45 and 52",,,
8861,polybia-MP1,,Other peptide,,,,,,,,,,,IDWKKLLDAAKQIL,Ile-Asp-Trp-Lys-Lys-Leu-Leu-Asp-Ala-Ala-Lys-Gln-Ile-Leu-NH2,,,,
10338,polymyxin B,,Other peptide,,,yes,,,,,,,polymyxin B,,Unk-DL-Dab-DL-xiThr-DL-Dab-DL-Dab(1)-DL-Dab-DL-Phe-DL-Leu-DL-Dab-DL-Dab-DL-xiThr-(1),,,NCCC(C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)Cc1ccccc1)CC(C)C)CCN)C(O)C)NC(=O)C(C(O)C)NC(=O)C(NC(=O)CCCCC(CC)C)CCN,WQVJHHACXVLGBL-UHFFFAOYSA-N
1550,PP-(13-36) (human),,Other peptide,,,,,,,,,,,TPEQMAQYAADLRRYINMLTRPRY,Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr,,,,
1552,PP-(20-36) (human),,Other peptide,,,,,,,,,,,AADLRRYINMLTRPRY,Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr,,,,
1551,PP-(2-36) (human),,Other peptide,,,,,,,,,,,PLEPVYPGDNATPEQMAQYAADLRRY,Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr,,,,
1561,"[PP1-17,Ala31,Aib32]NPY (human)",,Other peptide,,,,,,,,,,,APLEPVYPGDNATPEQMARYYSALRHYINLAXRQRY,Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2,,,,
8263,pr1 nanopeptide,,Other peptide,,,,,,,,,,,VLQELNVTV,Val-Leu-Gln-Glu-Leu-Asn-Val-Thr-Val,,,,
1092,pralmorelin,,Other peptide,,,yes,,,,,,,pralmorelin,AAAWFK,Ala-Nal-Ala-Trp-Phe-Lys-NH2,,,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)[C@H](N)C)C,HRNLPPBUBKMZMT-RDRUQFPZSA-N
7482,pramlintide,,Other peptide,,,yes,,,,,,,pramlintide,KCNTATCATQRLANFLVHSSNNFGPILPPTNVGSNTY,Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr,,,,
2066,PRL-2915,,Other peptide,,,,,,,,,,,FCAWKVCA,Cpa-D-Cys-Pal-Trp-Lys-Tle-Cys-Nal-NH2,,,,
2067,PRL-2970,,Other peptide,,,,,,,,,,,FCYWKTCA,Cpa-D-Cys-Tyr-D-Trp-Lys-Thr-Cys-Nal-NH2,,,,
3848,[Pro34]NPY,,Other peptide,,,,,,,,,,,YPSKPPNPGEDAPAEDMARYYSALRHYINLITRQRY,Tyr-Pro-Ser-Lys-Pro-Pro-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr,,,,
1546,[Pro34]PYY (human),,Other peptide,,,,,,,,,,,YPIKPEAPGEDASPEELNRYYASLRHYLNLVTRPRY,Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Pro-Arg-Tyr-NH2,,,,
3847,[Pro3]GIP,,Other peptide,,,,,,,,,,,YAPGTFISDYSIAMDKIHQQDFVNWLLAQKGKKNDWKHNITQ,Tyr-Ala-Pro-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln,,,,
2126,[Pro7]neurokinin B,,Other peptide,,,,,,,,,,,DMHDFFVGLM,Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2,,,,
3849,[Pro9]SP,,Other peptide,,,,,,,,,,,RPKPQQFFPLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met-NH2,,,,
7571,protoxin II,,Other peptide,,,,,,,,,P83476,,YCQKWMWTCDSERKCCEGMVCRLWCKKKLW,Tyr-Cys-Gln-Lys-Trp-Met-Trp-Thr-Cys-Asp-Ser-Glu-Arg-Lys-Cys-Cys-Glu-Gly-Met-Val-Cys-Arg-Leu-Trp-Cys-Lys-Lys-Lys-Leu-Trp,"Disulphide bonds between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 25.",,,
6244,PrP106-126,,Other peptide,,,,,,,,,P04156,,KTNMKHMAGAAAAGAVVGGLG,Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly,,,,
1870,PrRP-(24-31) (human),,Other peptide,,,,,,,,,,,GIRPVGRF,Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe,,,,
4292,psalmotoxin 1,,Other peptide,,,,,,,,,P60514,,EDCIPKWKGCVNRHGDCCEGLECWKRRRSFEVCVPKTPKT,Glu-Asp-Cys-Ile-Pro-Lys-Trp-Lys-Gly-Cys-Val-Asn-Arg-His-Gly-Asp-Cys-Cys-Glu-Gly-Leu-Glu-Cys-Trp-Lys-Arg-Arg-Arg-Ser-Phe-Glu-Val-Cys-Val-Pro-Lys-Thr-Pro-Lys-Thr-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N)[C@H](O)C)CCCCN)[C@H](O)C)CCCCN)C(C)C)CS)C(C)C)CCC(=O)O)Cc1ccccc1)CO)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N)CC(=O)O)CS)CCCCN)CCCCN)CS)CC(=O)N)CCCN=C(N)N)Cc1nc[nH]c1)CC(=O)O)CS)CS)CCC(=O)O)CC(C)C)CCC(=O)O)CS,OWCAPCHWSIBSKD-ACYSAVFESA-N
2354,pseudechetoxin,,Other peptide,,,,,,,,,Q8AVA4,,SNKKNYQKEIVDKHNALRRSVKPTARNMLQMKWNSRAAQNAKRWANRCTFAHSPPNKRTVGKLRCGENIFMSSQPFPWSGVVQAWYDEIKNFVYGIGAKPPGSVIGHYTQVVWYKSYLIGCASAKCSSSKYLYVCQYCPAGNIRGSIATPYKSGPPCADCPSACVNKLCTNPCKRNNDFSNCKSLAKKSKCQTEWIKKKCPASCFCHNKII,,"Disulphide bond formation between cysteine residues at positions 48 and 126, 65 and 138, 121 and 135, 157 and 164, 160 and 169, 173 and 206, 182 and 200, and 191 and 204",,,
6267,PSMα3,,Other peptide,,,,,,,,,,,MEFVAKLFKFFKDLLGKFLGNN,f-Met-Glu-Phe-Val-Ala-Lys-Leu-Phe-Lys-Phe-Phe-Lys-Asp-Leu-Leu-Gly-Lys-Phe-Leu-Gly-Asn-Asn,,,,
4449,PTH-(1-34) (rat),,Other peptide,,,,,,,,,,,AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF,Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
1787,PTHrP-(1-20)/TIP-(23-39) (human),,Other peptide,,,,,,,,,,,AVSEHQLLHDKGKSIQDLRRRHWLNSYMHKLLVLDAP,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro,,,,
1788,PTHrP-(1-21)/PTH-(22-34) (human),,Other peptide,,,,,,,,,,,AVSEHQLLHDKGKSIQDLRRREWLRKKLQDVHNF,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
1822,PTHrP-(1-34) (human),,Other peptide,,,,,,,,,,,AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala,,,,
1814,"PTHrP-(7-34) (human, rat, mouse)",,Other peptide,,,,,,,,,,,LLHDKGKSIQDLRRRFFLHHLIAEIHTA,Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala,,,,
9167,PWT1-NPS,,Other peptide,,,,,,,,,,,SFRNGVGTGMKKTSFQRAKS,Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Met-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,,,,
8865,PWT2-N/OFQ,,Other peptide,,,,,,,,,,,,,,,,
1516,"PYY-(13-36) (mouse, rat, pig)",,Other peptide,,,,,,,,,,,SPEELSRYYASLRHYLNLVTRQRY,Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr,,,,
1543,PYY-(3-36) (pig),,Other peptide,,,,,,,,,,,AKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY,Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr,,,,
9568,QWF,,Other peptide,,,,,,,,,,,Gln-Trp-Phe,QWF,,,,
2118,R396,,Other peptide,,,,,,,,,,,LDQWFG,Ac-Leu-Asp-Gln-Trp-Phe-Gly-NH2,,,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)CCC(=O)N)CC(=O)O)NC(=O)C)C,VTQMNICJVWMKEV-QKUYTOGTSA-N
4373,R3-B1-22R,,Other peptide,,,,,,,,,,,RAAPYGVRLSGREFIRAVIFTSR,Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Ser-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Ser-Arg-NH2,,,,
3907,R3(BΔ23-27)R/I5 chimeric peptide,,Other peptide,3909,R3(BΔ23-27)R/I5 chimeric peptide (B chain),,,,,,,,,,,,,,
3909,R3(BΔ23-27)R/I5 chimeric peptide (B chain),,Other peptide,,,,,,,,,,,RAAPYGVRLCGREFIRAVIFTCR,Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Cys-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Cys-Arg,,,,
1998,R3/I5,,Other peptide,,,,,,,,,,,,,,,,
2105,R-486,,Other peptide,,,,,,,,,,,DSFWXLM,Asp-Ser-Phe-Trp-βAla-Leu-Met-NH2,,,,
3910,R5-HIV-1 gp120,,Other peptide,,,,,,,,,,,,,,,,
661,R-715,,Other peptide,,,,,,,,,,,KRPPGFSAI,Ac-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Nal-Ile,,,,
3906,R-954,,Other peptide,,,,,,,,,,,,Ac-Orn-Arg-Oic-Pro-Gly-αMePhe-Ser-D-2Nal-Ile-OH,,,NCCC[C@@H](C(=O)N[C@H](C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)O)Cc1ccc2c(c1)cccc2)CO)(Cc1ccccc1)C)CCCN=C(N)N)NC(=O)C,JDPPVMXSBUBLMX-IRXBPQMASA-N
10271,RAG8,,Other peptide,,,,,,,,,,,RAGLFQRS,Arg-Ala-Gly-Leu-Phe-Gln-Arg-Ser,,,,
618,ranatensin,,Other peptide,,,,,,,,,,,XVPQWAVGHFM,pGlu-Val-Pro-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2,Amidation of C-terminal methionine; pyroglutamate at N-terminal,,CSCCC(C(=O)N)NC(=O)C(NC(=O)C(Cc1[nH]cnc1)NC(=O)CNC(=O)C(C(C)C)NC(=O)C(NC(=O)C(Cc1c[nH]c2c1cccc2)NC(=O)C(NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)C1CCC(=O)N1)CCC(=O)N)C)Cc1ccccc1,AUOCWSNQHWTPIJ-UHFFFAOYSA-N
7467,rasburicase,,Other peptide,,,yes,,,,,,,rasburicase,,,,,,
900,RB-400,,Other peptide,,,,,,,,,,,WXDF,carboxyacetyl-Trp-(Me)Nle-Asp-Phe-NH2,,,CCCC[C@H](N(C(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CC(=O)O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)CC(=O)O,QUSCQANKQSFCGJ-FWEHEUNISA-N
1992,relaxin,Pig,Other peptide,4438|4439,relaxin A chain|relaxin B chain,,,,,,,,,,,"Fully active porcine relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 10) and A chain (residue 145), and the second between B chain (residue 22) and A chain (residue 158).",,,
1994,relaxin,Rhesus macaque,Other peptide,4441|4440,relaxin B chain|relaxin A chain,,,,,,,,,,,"Fully active rhesus macaque relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 11) and A chain (residue 48), and the second between B chain (residue 23) and A chain (residue 161).",,,
8337,relaxin-3 B chain dimer,,Other peptide,,,,,,,,,,,,,,,,
4440,relaxin A chain,Rhesus macaque,Other peptide,,,,,,,,,P19884,,QLYMTLSNKCCHIGCTKKSLAKFC,Gln-Leu-Tyr-Met-Thr-Leu-Ser-Asn-Lys-Cys-Cys-His-Ile-Gly-Cys-Thr-Lys-Lys-Ser-Leu-Ala-Lys-Phe-Cys,"Fully active rhesus macaque relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 11) and A chain (residue 48), and the second between B chain (residue 23) and A chain (residue 161).",,,
4438,relaxin A chain,Pig,Other peptide,,,,,,,,,P01348,,RMTLSEKCCQVGCIRKDIARLC,Arg-Met-Thr-Leu-Ser-Glu-Lys-Cys-Cys-Gln-Val-Gly-Cys-Ile-Arg-Lys-Asp-Ile-Ala-Arg-Leu-Cys,"Fully active porcine relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 10) and A chain (residue 145), and the second between B chain (residue 22) and A chain (residue 158).",,,
4439,relaxin B chain,Pig,Other peptide,,,,,,,,,,,QSTNDFIKACGRELVRLWVEICGSVSWGRTAL,Gln-Ser-Thr-Asn-Asp-Phe-Ile-Lys-Ala-Cys-Gly-Arg-Glu-Leu-Val-Arg-Leu-Trp-Val-Glu-Ile-Cys-Gly-Ser-Val-Ser-Trp-Gly-Arg-Thr-Ala-Leu,"Fully active porcine relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 10) and A chain (residue 145), and the second between B chain (residue 22) and A chain (residue 158).",,,
4441,relaxin B chain,Rhesus macaque,Other peptide,,,,,,,,,P19884,,AKWMDDVIKACGRELVRAQIAICGKSTLG,Ala-Lys-Trp-Met-Asp-Asp-Val-Ile-Lys-Ala-Cys-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Cys-Gly-Lys-Ser-Thr-Leu-Gly,"Fully active rhesus macaque relaxin is a heterodimer of the B chain and the A chain linked by two disulfide bonds, the first between B chain (residue 11) and A chain (residue 48), and the second between B chain (residue 23) and A chain (residue 161).",,,
3911,RES7011,,Other peptide,,,,,,,,,,,GNWHGTAPDWFFNYYW,cyc(Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp)-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp,,,,
8736,resokine,,Other peptide,,,,,,,,,,,MAERAALEELVKLQGERVRGLKQQKASAELIEEEVAKLLKLKAQLGPDESKQKFVLKTPK,,,,,
1486,RF9,,Other peptide,,,,,,,,,,,,,,,NC(=N)NCCC[C@@H](C(=O)N[C@H](C(=O)N)Cc1ccccc1)NC(=O)C12CC3CC(C2)CC(C1)C3,UMKHUSRDQFQHAK-RNJMTYCLSA-N
9472,RgIA4,,Other peptide,,,,,,,,,,,,GlyCysCysThrAspProArgCysCitTyrGlnCysTyr,,,,
6663,ρ-Da1a,,Other peptide,,,,,,,,,P85092,,LTCVTSKSIFGITTEDCPDGQNLCFKRRHYVVPKIYDSTRGCAATCPIPENYDSIHCCKTDKCNE,Leu-Thr-Cys-Val-Thr-Ser-Lys-Ser-Ile-Phe-Gly-Ile-Thr-Thr-Glu-Asp-Cys-Pro-Asp-Gly-Gln-Asn-Leu-Cys-Phe-Lys-Arg-Arg-His-Tyr-Val-Val-Pro-Lys-Ile-Tyr-Asp-Ser-Thr-Arg-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ile-Pro-Glu-Asn-Tyr-Asp-Ser-Ile-His-Cys-Cys-Lys-Thr-Asp-Lys-Cys-Asn-Glu,"Disulphide bridges between cys 3-24, 17-42, 46-57, 58-63 create a three-finger-fold peptide.",,,
6165,Rhodei-litorin,,Other peptide,,,,,,,,,P08946,,QLWATGHFM,Gln-Leu-Trp-Ala-Thr-Gly-His-Phe-Met,,,,
507,rho-TIA,,Other peptide,,,,,,,,,P58811,,FNWRCCLIPACRRNHKKFC,Phe-Asn-Trp-Arg-Cys-Cys-Leu-Ile-Pro-Ala-Cys-Arg-Arg-Asn-His-Lys-Lys-Phe-Cys-NH2,"C-terminal cysteine residue is amidated;  disulphide bonds between cysteine residues at positions 5 and 11, and 6 and 19",,,
2276,Ro 25-1392,,Other peptide,,,,,,,,,,,HSDAVFTENYTKLRKQXAAKKYLNDLKK,His-Ser-Asp-Ala-Val-Phe-Thr-Glu-Asn-Tyr-Thr-Lys-Leu-Arg-Lys-Gln-Nle-Ala-Ala-Lys-Lys-Tyr-Leu-Asn-Asp-Leu-Lys-Lys-NH2,,,,
2259,Ro 25-1553,,Other peptide,,,,,,,,,,,HSDAVFTENYTKLRKQXAAKKYLNDLKKGGT,Ac-His-Ser-Asp-Ala-Val-Phe-Thr-Glu-Asn-Tyr-Thr-Lys-Leu-Arg-Lys-Gln-Nle-Ala-Ala-Lys-Lys-Tyr-Leu-Asn-Asp-Leu-Lys-Lys-Gly-Gly-Thr-NH2,,,,
6974,romiplostim,,Other peptide,,,yes,,,,,,,romiplostim,MDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKGGGGGIEGPTLRQWLAARAGGGGGGGGIEGPTLRQWLAARA,,,,,
9214,rotigaptide,,Other peptide,,,,,,,,,,rotigaptide,,Ac-D-Tyr-D-Pro-D-aHyp-Gly-D-Ala-Gly-NH2,,,O[C@H]1C[C@@H](N(C1)C(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1ccc(cc1)O)NC(=O)C)C(=O)NCC(=O)N[C@@H](C(=O)NCC(=O)N)C,GFJRASPBQLDRRY-TWTQBQJDSA-N
10412,RSLV-132,,Other peptide,,,,,,,,,,,,,,,,
1294,S36057,,Other peptide,,,,,,,,,,,YXRCMLGRVFRPCW,(I)Tyr-ADO-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp,,,,
1295,S36077,,Other peptide,,,,,,,,,,,RSMLGRVYRPSW,Arg-Ser-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Ser-Trp,,,,
1308,S36539,,Other peptide,,,,,,,,,,,XXXLGAXYRXDX,Gua-Dab-Nle-Leu-Gly-Arg-Nva-Tyr-Arg-Acp-Asp-Bta,,,,
1309,S36540,,Other peptide,,,,,,,,,,,XXXLGAXYRXDX,Gua-Dap-Nle-Leu-Gly-Arg-Nva-Tyr-Arg-Acp-Asp-Bta,,,,
1310,S36541,,Other peptide,,,,,,,,,,,XCXLGRXYRXDX,Gua-Cys-Nle-Leu-Gly-Arg-Nva-Tyr-Arg-Acp-Asp-Bta,,,,
1311,S38151,,Other peptide,,,,,,,,,,,XCMLRVYRPCW,Gua-Cys-Met-Leu-Arg-Val-Tyr-Arg-Pro-Cys-Trp,,,,
5053,sANP,,Other peptide,,,,,,,,,,,SLRRSSCFTGSIDRIRAQSGLGCNSFRY,Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Thr-Gly-Ser-Ile-Asp-Arg-Ile-Arg-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr,,,,
995,sarafotoxin S6b,,Other peptide,,,,,,,,,P13208,,CSCKDMTDKECLYFCHQDVIW,Cys-Ser-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-Leu-Tyr-Phe-Cys-His-Gln-Asp-Val-Ile-Trp,Disulphide bond formation between cysteine residues at positions 1 and 14,,NCCCC[C@@H]1NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CC(=O)O)CCSC)[C@H](O)C)CC(=O)O)CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N2)CO)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)C(C)C)CC(=O)O)CCC(=O)N)Cc1c[nH]cn1)Cc1ccccc1,ZHRYDGYRZIWZPS-RAALVGGVSA-N
1008,sarafotoxin S6c,,Other peptide,,,,,,,,,P13208,,CTCNDMTDEECLNFCHQDVIW,Cys-Thr-Cys-Asn-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp,"Disulphide bond formation between cysteine residues at positions 1 and 15, and 3 and 11",,,
598,saralasin,,Other peptide,,,,,,,,,,saralasin,XRVYVHPA,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,,,CNCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1CCCC1C(=O)NC(C(=O)O)C)Cc1[nH]cnc1)C(C)C)Cc1ccc(cc1)O)C(C)C)CCCN=C(N)N,PFGWGEPQIUAZME-UHFFFAOYSA-N
7905,sargramostim,,Other peptide,,,yes,,,,,,,sargramostim,APARSPSPSTQPWEHVNAIQEALRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE,,,,,
643,"[Sar,D-Phe8,des-Arg9]bradykinin",,Other peptide,,,,,,,,,,,XRPPGFSPF,Sar-Arg-Pro-Pro-Gly-Phe-Ser-Pro-D-Phe,,,CNCC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)O)Cc1ccccc1)CO)Cc1ccccc1)CCCN=C(N)N,YIUBSFCQATYQJB-VCMDLEIESA-N
6915,"[Sar1,Ala8]Ang-II",,Other peptide,,,,,,,,,,,XRVYVHPA,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,,,,
6903,"[Sar1,Cha4]Ang-II",,Other peptide,,,,,,,,,,,XRVXVHPF,Sar-Arg-Val-Cha-Val-His-Pro-Phe-COOH,,,,
6904,"[Sar1,Cha8]Ang-II",,Other peptide,,,,,,,,,,,XRVYVHPX,Sar-Arg-Val-Tyr-Val-His-Pro-Cha-COOH,,,,
6082,"[Sar1, D-Ala12]galanin(1-16)",,Other peptide,,,,,,,,,,,GWTLNSAGYLLAPHAV,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Ala-Pro-His-Ala-Val,,,,
6916,"[Sar1,Gly4,Gly8]Ang-II",,Other peptide,,,,,,,,,,,XRVGVHPG,Sar-Arg-Val-Gly-Val-His-Pro-Gly,,,,
6914,"[Sar1,Ile4,Ile8]Ang-II",,Other peptide,,,,,,,,,,,XRVIIHPI,Sar-Arg-Val-Ile-Ile-His-Pro-Ile-OH,,,,
6905,"[Sar1,Ile8]Ang-II",,Other peptide,,,,,,,,,,,XRVYIHPI,Sar-Arg-Val-Tyr-Ile-His-Pro-Ile-OH,,,,
3850,"[Sar9,Met(O2)11]SP",,Other peptide,,,,,,,,,,,RPKPQQFFXLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-O2,,,,
918,sauvagine,,Other peptide,,,,,,,,,P01144,,XGPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI,pGlu-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2,Pyrrolidone carboxylic acid at N-terminal (pGlu) and amidation of C-terminal leucine residue,,,
2584,sBmTX 3,,Other peptide,,,,,,,,,,,QVETNVKCQGGSCASVCRKAIGVAAGKCINGRCVC,Gln-Val-Glu-Thr-Asn-Val-Lys-Cys-Gln-Gly-Gly-Ser-Cys-Ala-Ser-Val-Cys-Arg-Lys-Ala-Ile-Gly-Val-Ala-Ala-Gly-Lys-Cys-Ile-Asn-Gly-Arg-Cys-Val-Cys,,,,
8889,SC-67655,,Other peptide,,,,,,,,,,,,(S)-CBA-Val-Pec-Asp-Pro-Thr-NH-n-Pr,,,,
6251,sCKβ8-1,,Other peptide,,,,,,,,,,,MLWRRKIGPQMTLSHAAGFHATSADCCISYTPRSIPCSLLESYFETNSECSKPGVIFLTKKGRRFCANPSDKQVQVCVRMLKLDTRIKTRKN,,,,,
2576,ScTx1,,Other peptide,,,,,,,,,P60991,,DCTRMFGACRRDSDCCPHLGCKPTSKYCAWDGTI,Asp-Cys-Thr-Arg-Met-Phe-Gly-Ala-Cys-Arg-Arg-Asp-Ser-Asp-Cys-Cys-Pro-His-Leu-Gly-Cys-Lys-Pro-Thr-Ser-Lys-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Ile-NH2,"C-terminal isoleucine undergoes amidation; predicted disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 28.",,,
851,"SDF-1, 1-9[P2G] dimer",,Other peptide,,,,,,,,,,,KGVSLSYRC,Lys-Gly-Val-Ser-Leu-Ser-Tyr-Arg-Cys,,,,
8536,SDF1 P2G,,Other peptide,,,,,,,,,,,KGVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK,Lys-Gly-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys,,,,
2578,sea anemone toxin BDS-I,,Other peptide,,,,,,,,,P11494,,AAPCFCSGKPGRGDLWILRGTCPGGYGYTSNCYKWPNICCYPH,Ala-Ala-Pro-Cys-Phe-Cys-Ser-Gly-Lys-Pro-Gly-Arg-Gly-Asp-Leu-Trp-Ile-Leu-Arg-Gly-Thr-Cys-Pro-Gly-Gly-Tyr-Gly-Tyr-Thr-Ser-Asn-Cys-Tyr-Lys-Trp-Pro-Asn-Ile-Cys-Cys-Tyr-Pro-His,"Disulphide bond formation between cysteine residues at positions 4 and 39, 6 and 32, and 22 and 40",,,
1155,secretin,Pig,Other peptide,,,,,,,,,,secretin,HSDGTFTSELSRLRDSARLQRLLQGLV,His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,C-terminal residue is valine amide,,OCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)O)C(C)C)CC(C)C)CCC(=O)N)CC(C)C)CC(C)C)CCCNC(=N)N)CCC(=O)N)CC(C)C)CCCNC(=N)N)C)CO)CC(=O)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(O)C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(Cc1[nH]ccn1)N)CO)CC(=O)O)Cc1ccccc1)CO)CCC(=O)O)CC(C)C,KKNIUBFRGPFELP-UHFFFAOYSA-N
1156,secretin-(5-27) (pig),,Other peptide,,,,,,,,,,,TFTSELSRLRDSARLQRLLQGLV,Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,C-terminal valine is amidated,,,
2051,seglitide,,Other peptide,,,,,,,,,,seglitide,AYWKVF,c[N(Me)Ala-Tyr-D-Trp-Lys-Val-Phe],,,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)C(C)C)Cc1ccccc1)C)C)Cc1c[nH]c2c1cccc2,NPJIOCBFOAHEDO-AVWFULIKSA-N
9724,semaglutide,,Other peptide,,,yes,,,,,,,semaglutide,HAEGTFTSDVSSYLEGQAAKEFIAWLVRGRG,H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)O)CCCNC(=N)N)CCCNC(=N)N)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)C(NC(=O)[C@H](Cc1[nH]cnc1)N)(C)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C)CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@H](C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)CCC(=O)O)Cc1ccccc1)C,DLSWIYLPEUIQAV-CCUURXOWSA-N
2127,senktide,,Other peptide,,,,,,,,,,,DFFGLM,Suc-Asp-Phe-(Me)Phe-Gly-Leu-Met-NH2,,,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)Cc1ccccc1)C)Cc1ccccc1)CC(C)C,HMHYXLVEFVGOPM-QKUYTOGTSA-N
2095,septide,,Other peptide,,,,,,,,,,,XFFPLM,pGlu-Phe-Phe-Pro-Leu-Met-NH2,,,CSCC[C@@H](C(=O)N)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCC(=O)N1)CC(C)C,UUZURPUIMYJOIL-JNRWAQIZSA-N
6966,seractide acetate,,Other peptide,,,yes,,,,,,,,SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEF,Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe,,,,
6998,sermorelin,,Other peptide,,,yes,yes,,,,,,sermorelin,YADAIFTNSYRKVLGQLSARKLLQDIMSRQ,Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln,,,,
4853,"[Ser11](N-CNP,C-ANP)pBNP2-15",,Other peptide,,,,,,,,,,,GLSKGCFGRSLDRIGSLSGLGCNSF,Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Arg-Ser-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe,,,,
1171,[Ser8]GnRH,,Other peptide,,,,,,,,,,,XHWSYGLSPG,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Ser-Pro-Gly-NH2,,,,
9272,setmelanotide,,Other peptide,,,,,,,,,,setmelanotide,RCAHFRWC,Ac-Arg-Cys(1)-D-Ala-His-D-Phe-Arg-Trp-Cys(1)-NH2,,,NC(=NCCC[C@@H](C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC1=O)C)Cc1[nH]cnc1)Cc1ccccc1)CCCN=C(N)N)Cc1c[nH]c2c1cccc2)C(=O)N)NC(=O)C)N,HDHDTKMUACZDAA-PHNIDTBTSA-N
5361,SFLLRN-NH2,,Other peptide,,,,,,,,,,,SFLLRN,Ser-Phe-Leu-Leu-Arg-Asn-NH2,,,,
7761,SGTx1,,Other peptide,,,,,,,,,P56855,,TCRYLFGGCKTTADCCKHLACRSDGKYCAWDGTF,Thr-Cys-Arg-Tyr-Leu-Phe-Gly-Gly-Cys-Lys-Thr-Thr-Ala-Asp-Cys-Cys-Lys-His-Leu-Ala-Cys-Arg-Ser-Asp-Gly-Lys-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Phe,"Disulphide bonds between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 28.",,,
6275,SHAAGtide,,Other peptide,,,,,,,,,,,MLWRRKIGPQMTLSHAAG,Met-Leu-Trp-Arg-Arg-Lys-Ile-Gly-Pro-Gln-Met-Thr-Leu-Ser-His-Ala-Ala-Gly,,,,
2557,ShK(L5),,Other peptide,,,,,,,,,,,RSCIDTIPKSRCTAFQCKHSMKYRLSFCRKTCGTC,pTyr-Arg-Ser-Cys-Ile-Asp-Thr-Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-Phe-Gln-Cys-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys-Arg-Lys-Thr-Cys-Gly-Thr-Cys,"Disulphide bond formation between cysteine residues at positions 3 and 35, 12 and 28, and 17 and 32.","Disulphide bond formation between cysteine residues at positions 3 and 35, 12 and 28, and 17 and 32.",,
2549,ShK Toxin,,Other peptide,,,,,,,,,P29187,,RSCIDTIPKSRCTAFQCKHSMKYRLSFCRKTCGTC,Arg-Ser-Cys-Ile-Asp-Thr-Ile-Pro-Lys-Ser-Arg-Cys-Thr-Ala-Phe-Gln-Cys-Lys-His-Ser-Met-Lys-Tyr-Arg-Leu-Ser-Phe-Cys-Arg-Lys-Thr-Cys-Gly-Thr-Cys,"Disulphide bond formation between cysteine residues at positions 3 and 35, 12 and 28, and 17 and 32",,,
1325,SHU9119,,Other peptide,,,,,,,,,,,CDHARWCK,Ac-Cys-Asp-His-D-Nal-Arg-Trp-Cys-Lys-NH2,,,CCCC[C@@H](C(=O)N[C@H]1CC(=O)NCCC/C=C(\C(=O)NC(=O)[C@@H](NC1=O)CC1N=CN=C1)/NC(=O)[C@H](CC1CNc2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)N)CCCN=C(N)N)NC(=O)C,ORTUTLYEGOSCRP-ATNXLWBUSA-N
5634,SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate,,Other peptide,,,,,,,,,,,FCFWKTCT,Phe-Cys-Tyr-Trp-Lys-Thr-Cys-Thr-OH,"Disulphide bond: 2-7, Tyr3 is D form.","Disulphide bond: 2-7, Tyr3 is D form.",,
5633,SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate,,Other peptide,,,,,,,,,,,FCYWKTCT,Phe-Cys-Tyr-Trp-Lys-Thr-Cys-Thr-OH,"Disulphide bridge: 2-7, Tyr3 is D form.","Disulphide bridge: 2-7, Tyr3 is D form.",,
2229,SKF-105494,,Other peptide,,,,,,,,,,,YFVNXRR,o-ethyl-D-Tyr-Phe-Val-Asn-Aaa-Arg-D-Arg-NH2,,,,
3740,SLIGKV-NH2,,Other peptide,,,,,,,,,,,SLIGKV,Ser-Leu-Ile-Gly-Lys-Val-NH2,,,,
3741,SLIGRL-NH2,,Other peptide,,,,,,,,,,,SLIGRL,Ser-Leu-Ile-Gly-Arg-Leu-NH2,,,,
2310,slotoxin,,Other peptide,,,,,,,,,P0C182,,TFIDVDCTVSKECWAPCKAAFGVDRGKCMGKKCKCYV,Thr-Phe-Ile-Asp-Val-Asp-Cys-Thr-Val-Ser-Lys-Glu-Cys-Trp-Ala-Pro-Cys-Lys-Ala-Ala-Phe-Gly-Val-Asp-Arg-Gly-Lys-Cys-Met-Gly-Lys-Lys-Cys-Lys-Cys-Tyr-Val,"Predicted disulphide bond formation between cysteine residues at positions 7 and 28, 13 and 33, and 17 and 35.",,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)Cc1ccc(cc1)O)CS)CCCCN)CS)CCCCN)CCCCN)CCSC)CS)CCCCN)CCCNC(=N)N)CC(=O)O)C(C)C)Cc1ccccc1)C)C)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)N)Cc1ccccc1)CC(=O)O)CC(=O)O)CS)CO)CCCCN)CCC(=O)O)CS)C)CS,IYKSHBADGOZWIF-UTPLJIOFSA-N
1450,"[D-Bpa5,Ile13]motilin (human)",,Other peptide,,,,,,,,,,,FVPIXTYGELQRIQEKERNKGQ,Phe-Val-Pro-Ile-D-Bpa-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Ile-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
636,D-Lys0-[des-Arg10]kallidin,,Other peptide,,,,,,,,,,,KKRPPGFSPF,D-Lys-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe,,,,
640,"[D-Lys1,des-Arg10]kallidin",,Other peptide,,,,,,,,,,,KRPPGFSPF,D-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe,,,,
1451,"[L-Bpa5,Ile13]motilin (human)",,Other peptide,,,,,,,,,,,FVPIXTYGELQRIQEKERNKGQ,Phe-Val-Pro-Ile-L-Bpa-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Ile-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
4315,SNX482,,Other peptide,,,,,,,,,P56854,,GVDKAGCRYMFGGCSVNDDCCPRLGCHSLFSYCAWDLTFSD,Gly-Val-Asp-Lys-Ala-Gly-Cys-Arg-Tyr-Met-Phe-Gly-Gly-Cys-Ser-Val-Asn-Asp-Asp-Cys-Cys-Pro-Arg-Leu-Gly-Cys-His-Ser-Leu-Phe-Ser-Tyr-Cys-Ala-Trp-Asp-Leu-Thr-Phe-Ser-Asp,"Disulphide bond formation between cysteine residues at positions 7 and 21, 14 and 26 and 20 and 33",,,
2096,spantide I,,Other peptide,,,,,,,,,,,RPKPQQWFWLL,D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2,Amidation of C terminal leucine residue,Amidation of C terminal leucine residue,,
2097,spantide II,,Other peptide,,,,,,,,,,,KPAPFNWFWLX,"D-Lys(nicotinoyl)-Pro-Pal-Pro-Phe-Asn-Trp-D-3,4Cpa-D-Trp-Leu-Nle-NH2",,,CCCC[C@@H](C(=O)N(C(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1cccnc1)N)C(=O)[C@@H]1CCCN1C(=O)[C@@H](CCCCNC(=O)c1cccnc1)N)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc(c(c1)Cl)Cl)N)CC(=O)N)Cc1ccccc1)CC(C)C,AZZJAARMZMEIHY-BBKUSFMUSA-N
1026,spinorphin,,Other peptide,,,,,,,,,,,LVVYPWT,Leu-Val-Val-Tyr-Pro-Trp-Thr,None,,CC(C[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)C(C)C)C(C)C)N)C,BXIFNVGZIMFBQB-DYDSHOKNSA-N
8379,SQ007-5,,Other peptide,,,,,,,,,,,WWDRRWRASKLGLAR,Trp-Trp-Asp-Arg-Arg-Trp-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CCCN=C(N)N)C)CC(C)C)CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)N)CC(=O)O)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N)C)CO,CZCSLPSTPNFNFR-WILIORGOSA-N
7764,SsmTx-1,,Other peptide,,,,,,,,,,,EESMLLSCPDLSCPTGYTCDVLTKKCKRLSDELWDH,Glu-Glu-Ser-Met-Leu-Leu-Ser-Cys-Pro-Asp-Leu-Ser-Cys-Pro-Thr-Gly-Tyr-Thr-Cys-Asp-Val-Leu-Thr-Lys-Lys-Cys-Lys-Arg-Leu-Ser-Asp-Glu-Leu-Trp-Asp-His,,,,
2077,sst3-ODN-8,,Other peptide,,,,,,,,,,,CFYXKTFC,"carbamoyl-D-Cys-Phe-Tyr-D-Agl(Me,2-naphthoyl)-Lys-Thr-Phe-Cys",,,,
2099,substance P-(4-11),,Other peptide,,,,,,,,,,,PQQFFGLM,Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,,,,
2100,substance P-(6-11),,Other peptide,,,,,,,,,,,QFFGLM,Gln-Phe-Phe-Gly-Leu-Met-NH2,Amidation of C-terminal methionine,,,
2101,substance P-OMe,,Other peptide,,,,,,,,,,,RPKPQQFFGLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-OMe,,,,
2063,[111In]DOTA-BOC-ATE,,Other peptide,,,,,yes,yes,,,,,FCXWKTCT,[InIII-DOTA]-D-Phe-Cys-BzThi-D-Trp-Lys-Thr-Cys-Thr,,,,
3756,[111In]DOTA-dLVT,,Other peptide,,,,,yes,yes,,,,,CYIQNCPKG,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-[111I-DOTA]Lys-Gly-NH2,,,,
2045,[111In]DOTA-NOC,,Other peptide,,,,,yes,yes,,,,,FCXWKTCT,D-Phe-Cys-Nal-D-Trp-Lys-Thr-Cys-Threoninol,,,,
2064,[111In]DOTA-NOC-ATE,,Other peptide,,,,,yes,yes,,,,,FCXWKTCT,D-Phe-Cys-(Bz)Thi-D-Trp-Lys-Thr-Cys-Thr,,,,
2056,"[111In,90Y]DOTA-LAN",,Other peptide,,,,,yes,yes,,,,,,,,,,
2057,"[111In,90Y]DOTA-NOC",,Other peptide,,,,,yes,yes,,,,,,,,,,
2058,"[111In,90Y]DOTA-OC",,Other peptide,5538,DOTA,,,yes,yes,,,,,,,,,,
2059,"[111In,90Y]DOTA-TOC",,Other peptide,,,,,yes,yes,,,,,,,,,,
1483,[125I]1DMe,,Other peptide,,,,,yes,yes,,,,,YLFQPQRF,D-Tyr-Leu-(N-Me)-Phe-Gln-Pro-Gln-Arg-Phe-NH2,,,,
10253,[125I]26RFa (human),,Other peptide,,,,,yes,yes,,,,,TSGPLGNLAEELNGYSRKKGGFSFRF,Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,,,,
1316,[125I](3-iodo-Tyr13)-MCH,,Other peptide,,,,,yes,yes,,,,,DFDMLRCMLGRVYRPCWQV,Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val,,,,
2206,[125I]3-N3-Phpa-LVA,,Other peptide,,,,,yes,yes,,,,,YFQNRPRY,3-(N3)phenylpropionyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-Tyr-NH2,,,,
2260,[125I][Ac-His1]PACAP-27,,Other peptide,,,,,yes,yes,,,,,HSDGIFTDSYSRYRKQMAVKKYLAAVL,Ac-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2,,,,
3767,[125I]ACTH-(1-24),,Other peptide,,,,,yes,yes,,,,,SYSMEHFRWGKPVGKKRRPVKVYP,Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro,,,,
3760,"[125I][Ala1,3,11,15]ET-1",,Other peptide,,,,,yes,yes,,,,,ASASSLMDKEAVYFAHLDIIW,Ala-Ser-Ala-Ser-Ser-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,,,,
3972,[125I]α-bungarotoxin,,Other peptide,,,,,yes,yes,,,,,IVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,Ile-Val-Cys-His-Thr-Thr-Ala-Thr-Ser-Pro-Ile-Ser-Ala-Val-Thr-Cys-Pro-Pro-Gly-Glu-Asn-Leu-Cys-Tyr-Arg-Lys-Met-Trp-Cys-Asp-Ala-Phe-Cys-Ser-Ser-Arg-Gly-Lys-Val-Val-Glu-Leu-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ser-Lys-Lys-Pro-Tyr-Glu-Glu-Val-Thr-Cys-Cys-Ser-Thr-Asp-Lys-Cys-Asn-Pro-His-Pro-Lys-Gln-Arg-Pro-Gly,"Disulfide bridges between amino acids 3 - 23, 16 - 44, 29 - 33, 48 - 59, 60 - 65",,,
6567,"[125I]αCGRP (mouse, rat)",,Other peptide,,,,,yes,yes,,,,,SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF,Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-[125I]His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2,,,,
3975,[125I]α-conotoxin MII,,Other peptide,,,,,yes,yes,,,,,GCCSNPVCHLEHSNLC,Gly-Cys-Cys-Ser-Asn-Pro-Val-Cys-His-Leu-Glu-His-Ser-Asn-Leu-Cys-NH2,Amidation of C-terminal cysteine residue; disulphide bond formation between cysteine residues at postions 2 and 8 and 3 and 16,,,
2564,[125I]α-DTX,,Other peptide,,,,,yes,yes,,,,,QPRRKLCILHRNPGRCYDKIPAFYYNQKKKQCERFDWSGCGGNSNRFKTIEECRRTCIG,Gln-Pro-Arg-Arg-Lys-Leu-Cys-Ile-Leu-His-Arg-Asn-Pro-Gly-Arg-Cys-Tyr-Asp-Lys-Ile-Pro-Ala-Phe-Tyr-Tyr-Asn-Gln-Lys-Lys-Lys-Gln-Cys-Glu-Arg-Phe-Asp-Trp-Ser-Gly-Cys-Gly-Gly-Asn-Ser-Asn-Arg-Phe-Lys-Thr-Ile-Glu-Glu-Cys-Arg-Arg-Thr-Cys-Ile-Gly,,,,
3768,[125I]AM (rat),,Other peptide,,,,,yes,yes,,,,,YRQSMNQGSRSTGCRFGTCTMQKLAHQIYQFTDKDKDGMAPRNKISPQGY,Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2,,,,
5578,"[125I]angiotensin-(1-7) (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,DRVYIHP,Asp-Arg-Val-Tyr-Ile-His-Pro,,,,
4845,[125I]ANP (human),,Other peptide,,,,,yes,yes,,,,,SLRRSSCFGGRMDRIGAQSGLGCNSFRY,Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr,Disulphide bond formation between cysteine residues at positions 7 and 123,,,
930,[125I]antisauvagine,,Other peptide,,,,,yes,yes,,,,,FHLLRKMIEIEKQEKEKQQAANNRLLLDTI,D-Phe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2,,,,
602,[125I]apelin-13,,Other peptide,,,,,yes,yes,,,,,QRPRLSHKGPMPF,Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,,,,
924,[125I]astressin,,Other peptide,,,,,yes,yes,,,,,FHLLREVLEXARAEQLAQEAHKNRKLXEII,D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(-Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2,,,,
2281,[125I]BAY 55-9837,,Other peptide,,,,,yes,yes,,,,,HSDAVFTDNYTRLRKQVAAKKYLQSIKNKRY,His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Val-Ala-Ala-Lys-Lys-Tyr-Leu-Gln-Ser-Ile-Lys-Asn-Lys-Arg-Tyr,,,,
4846,[125I]BDNF (human),,Other peptide,,,,,yes,yes,,,,,HSDPARRGELSVCDSISEWVTAADKKTAVDMSGGTVTVLEKVPVSKGQLKQYFYETKCNPMGYTKEGCRGIDKRHWNSQCRTTQSYVRALTMDSKKRIGWRFIRIDTSCVCTLTIKRGR,,,,,
2565,[125I]BgK (W5Y / Y26F),,Other peptide,,,,,yes,yes,,,,,VCRDYFKETACRHAKSLGNCRTSQKFRANCAKTCELC,Val-Cys-Arg-Asp-Tyr-Phe-Lys-Glu-Thr-Ala-Cys-Arg-His-Ala-Lys-Ser-Leu-Gly-Asn-Cys-Arg-Thr-Ser-Gln-Lys-Phe-Arg-Ala-Asn-Cys-Ala-Lys-Thr-Cys-Glu-Leu-Cys,,,,
3770,"[125I]BH-AMY (rat, mouse)",,Other peptide,,,,,yes,yes,,,,,KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY,Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2,The C-terminal proline is amidated into Pro-NH2 and disulphide bridge forms between Cysteine residues at positions 2 and 7,,,
8522,[125I]BH-MIT1,,Other peptide,,,,,yes,yes,,,,,AVITGACERDLQCGKGTCCAVSLWIKSVRVCTPVGTSGEDCHPASHKIPFSGQRMHHTCPCAPNLACVQTSPKKFKCLSKS,Ala-Val-Ile-Thr-Gly-Ala-Cys-Glu-Arg-Asp-Leu-Gln-Cys-Gly-Lys-Gly-Thr-Cys-Cys-Ala-Val-Ser-Leu-Trp-Ile-Lys-Ser-Val-Arg-Val-Cys-Thr-Pro-Val-Gly-Thr-Ser-Gly-Glu-Asp-Cys-His-Pro-Ala-Ser-His-Lys-Ile-Pro-Phe-Ser-Gly-Gln-Arg-Met-His-His-Thr-Cys-Pro-Cys-Ala-Pro-Asn-Leu-Ala-Cys-Val-Gln-Thr-Ser-Pro-Lys-Lys-Phe-Lys-Cys-Leu-Ser-Lys-Ser,,,,
3771,"[125I]BH-NMB (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,GNLWATGHFM,Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2,,,,
3769,"[125I]BH-[Sar9,Met(O2)11]SP",,Other peptide,,,,,yes,yes,,,,,RPKPQQFFXLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(O2)-NH2,,,,
3772,[125I]BIM23027,,Other peptide,,,,,yes,yes,,,,,XFAYWK,c[N-Me-Ala-Tyr-D-Trp-Lys-Abu-Phe],,,,
1005,[125I]BQ3020,,Other peptide,,,,,yes,yes,,,,,LMDKEAVYFAHLDIIW,NAc-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,,,,
1167,[125I]buserelin,,Other peptide,,,,,yes,yes,,,,,XHWSYSLRP,pGlu-His-Trp-(t-Bu)Ser-Tyr-Ser-Leu-Arg-Pro,,,,
3773,[125I]C3a (human),,Other peptide,,,,,yes,yes,,,,,SVQLTEKRMDKVGKYPKELRKCCEDGMRENPMRFSCQRRTRFISLGEACKKVFLDCCNYITELRRQHARASHLGLAR,Ser-Val-Gln-Leu-Thr-Glu-Lys-Arg-Met-Asp-Lys-Val-Gly-Lys-Tyr-Pro-Lys-Glu-Leu-Arg-Lys-Cys-Cys-Glu-Asp-Gly-Met-Arg-Glu-Asn-Pro-Met-Arg-Phe-Ser-Cys-Gln-Arg-Arg-Thr-Arg-Phe-Ile-Ser-Leu-Gly-Glu-Ala-Cys-Lys-Lys-Val-Phe-Leu-Asp-Cys-Cys-Asn-Tyr-Ile-Thr-Glu-Leu-Arg-Arg-Gln-His-Ala-Arg-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg,,,,
3774,[125I]C5a (human),,Other peptide,,,,,yes,yes,,,,,TLQKKIEEIAAKYKHSVVKKCCYDGACVNNDETCEQRAARISLGPRCIKAFTECCVVASQLRANISHKDMQLGR,Thr-Leu-Gln-Lys-Lys-Ile-Glu-Glu-Ile-Ala-Ala-Lys-Tyr-Lys-His-Ser-Val-Val-Lys-Lys-Cys-Cys-Tyr-Asp-Gly-Ala-Cys-Val-Asn-Asn-Asp-Glu-Thr-Cys-Glu-Gln-Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu-Cys-Cys-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg,,,,
1017,[125I]cathepsin G (human),,Other peptide,,,,,yes,yes,,,,,IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGSNINVTLGAHNIQRRENTQQHITARRAIRHPQYNQRTIQNDIMLLQLSRRVRRNRNVNPVALPRAQEGLRPGTLCTVAGWGRVSMRRGTDTLREVQLRVQRDRQCLRIFGSYDPRRQICVGDRRERKAAFKGDSGGPLLCNNVAHGIVSYGKSSGVPPEVFTRVSSFLPWIRTTMRSFKLLDQMETPL,,,,,
794,[125I]CCL11 (human),,Other peptide,,,,,yes,yes,,,,,GPASVPTTCCFNLANRKIPLQRLESYRRITSGKCPQKAVIFKTKLAKDICADPKKKWVQDSMKYLDQKSPTPKP,Gly-Pro-Ala-Ser-Val-Pro-Thr-Thr-Cys-Cys-Phe-Asn-Leu-Ala-Asn-Arg-Lys-Ile-Pro-Leu-Gln-Arg-Leu-Glu-Ser-Tyr-Arg-Arg-Ile-Thr-Ser-Gly-Lys-Cys-Pro-Gln-Lys-Ala-Val-Ile-Phe-Lys-Thr-Lys-Leu-Ala-Lys-Asp-Ile-Cys-Ala-Asp-Pro-Lys-Lys-Lys-Trp-Val-Gln-Asp-Ser-Met-Lys-Tyr-Leu-Asp-Gln-Lys-Ser-Pro-Thr-Pro-Lys-Pro,,,,
1275,[125I]CCL16 (human),,Other peptide,,,,,yes,yes,,,,,QPKVPEWVNTPSTCCLKYYEKVLPRRLVVGYRKALNCHLPAIIFVTKRNREVCTNPNDDWVQEYIKDPNLPLLPTRNLSTVKIITAKNGQPQLLNSQ,Gln-Pro-Lys-Val-Pro-Glu-Trp-Val-Asn-Thr-Pro-Ser-Thr-Cys-Cys-Leu-Lys-Tyr-Tyr-Glu-Lys-Val-Leu-Pro-Arg-Arg-Leu-Val-Val-Gly-Tyr-Arg-Lys-Ala-Leu-Asn-Cys-His-Leu-Pro-Ala-Ile-Ile-Phe-Val-Thr-Lys-Arg-Asn-Arg-Glu-Val-Cys-Thr-Asn-Pro-Asn-Asp-Asp-Trp-Val-Gln-Glu-Tyr-Ile-Lys-Asp-Pro-Asn-Leu-Pro-Leu-Leu-Pro-Thr-Arg-Asn-Leu-Ser-Thr-Val-Lys-Ile-Ile-Thr-Ala-Lys-Asn-Gly-Gln-Pro-Gln-Leu-Leu-Asn-Ser-Gln,,,,
3652,[125I]CCL17 (human),,Other peptide,,,,,yes,yes,,,,,ARGTNVGRECCLEYFKGAIPLRKLKTWYQTSEDCSRDAIVFVTVQGRAICSDPNNKRVKNAVKYLQSLERS,Ala-Arg-Gly-Thr-Asn-Val-Gly-Arg-Glu-Cys-Cys-Leu-Glu-Tyr-Phe-Lys-Gly-Ala-Ile-ProLeu-Arg-Lys-Leu-Lys-Thr-Trp-Tyr-Gln-Thr-Ser-Glu-Asp-Cys-Ser-Arg-Asp-Ala-Ile-Val-Phe-Val-Thr-Val-Gln-Gly-Arg-Ala-Ile-Cys-Ser-Asp-Pro-Asn-Asn-Lys-Arg-Val-Lys-Asn-Ala-Val-Lys-Tyr-Leu-Gln-Ser-Leu-Glu-Arg-Ser,,,,
3655,[125I]CCL19 (human),,Other peptide,,,,,yes,yes,,,,,GTNDAEDCCLSVTQKPIPGYIVRNFHYLLIKDGCRVPAVVFTTLRGRQLCAPPDQPWVERIIQRLQRTSAKMKRRSS,Gly-Thr-Asn-Asp-Ala-Glu-Asp-Cys-Cys-Leu-Ser-Val-Thr-Gln-Lys-Pro-Ile-Pro-Gly-Tyr-Ile-Val-Arg-Asn-Phe-His-Tyr-Leu-Leu-Ile-Lys-Asp-Gly-Cys-Arg-Val-Pro-Ala-Val-Val-Phe-Thr-Thr-Leu-Arg-Gly-Arg-Gln-Leu-Cys-Ala-Pro-Pro-Asp-Gln-Pro-Trp-Val-Glu-Arg-Ile-Ile-Gln-Arg-Leu-Gln-Arg-Thr-Ser-Ala-Lys-Met-Lys-Arg-Arg-Ser-Ser,,,,
814,[125I]CCL1 (human),,Other peptide,,,,,yes,yes,,,,,KSMQVPFSRCCFSFAEQEIPLRAILCYRNTSSICSNEGLIFKLKRGKEACALDTVGWVQRHRKMLRHCPSKRK,Lys-Ser-Met-Gln-Val-Pro-Phe-Ser-Arg-Cys-Cys-Phe-Ser-Phe-Ala-Glu-Gln-Glu-Ile-Pro-Leu-Arg-Ala-Ile-Leu-Cys-Tyr-Arg-Asn-Thr-Ser-Ser-Ile-Cys-Ser-Asn-Glu-Gly-Leu-Ile-Phe-Lys-Leu-Lys-Arg-Gly-Lys-Glu-Ala-Cys-Ala-Leu-Asp-Thr-Val-Gly-Trp-Val-Gln-Arg-His-Arg-Lys-Met-Leu-Arg-His-Cys-Pro-Ser-Lys-Arg-Lys,,,,
5546,[125I]CCL1 (mouse),,Other peptide,,,,,yes,yes,,,,,KSMLTVSNSCCLNTLKKELPLKFIQCYRKMGSSCPDPPAVVFRLNKGRESCASTNKTWVQNHLKKVNPC,Lys-Ser-Met-Leu-Thr-Val-Ser-Asn-Ser-Cys-Cys-Leu-Asn-Thr-Leu-Lys-Lys-Glu-Leu-Pro-Leu-Lys-Phe-Ile-Gln-Cys-Tyr-Arg-Lys-Met-Gly-Ser-Ser-Cys-Pro-Asp-Pro-Pro-Ala-Val-Val-Phe-Arg-Leu-Asn-Lys-Gly-Arg-Glu-Ser-Cys-Ala-Ser-Thr-Asn-Lys-Thr-Trp-Val-Gln-Asn-His-Leu-Lys-Lys-Val-Asn-Pro-Cys,,,,
3654,[125I]CCL20 (human),,Other peptide,,,,,yes,yes,,,,,ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLSKKVKNM,Ala-Ser-Asn-Phe-Asp-Cys-Cys-Leu-Gly-Tyr-Thr-Asp-Arg-Ile-Leu-His-Pro-Lys-Phe-IleVal-Gly-Phe-Thr-Arg-Gln-Leu-Ala-Asn-Glu-Gly-Cys-Asp-Ile-Asn-Ala-Ile-Ile-Phe-His-Thr-Lys-Lys-Lys-Leu-Ser-Val-Cys-Ala-Asn-Pro-Lys-Gln-Thr-Trp-Val-Lys-Tyr-Ile-Val-Arg-Leu-Leu-Ser-Lys-Lys-Val-Lys-Asn-Met,,,,
3656,[125I]CCL21 (human),,Other peptide,,,,,yes,yes,,,,,SDGGAQDCCLKYSQRKIPAKVVRSYRKQEPSLGCSIPAILFLPRKRSQAELCADPKELWVQQLMQHLDKTPSPQKPAQGCRKDRGASKTGKKGKGSKGCKRTERSQTPKGP,Ser-Asp-Gly-Gly-Ala-Gln-Asp-Cys-Cys-Leu-Lys-Tyr-Ser-Gln-Arg-Lys-Ile-Pro-Ala-Lys-Val-Val-Arg-Ser-Tyr-Arg-Lys-Gln-Glu-Pro-Ser-Leu-Gly-Cys-Ser-Ile-Pro-Ala-Ile-Leu-Phe-Leu-Pro-Arg-Lys-Arg-Ser-Gln-Ala-Glu-Leu-Cys-Ala-Asp-Pro-Lys-Glu-Leu-Trp-Val-Gln-Gln-Leu-Met-Gln-His-Leu-Asp-Lys-Thr-Pro-Ser-Pro-Gln-Lys-Pro-Ala-Gln-Gly-Cys-Arg-Lys-Asp-Arg-Gly-Ala-Ser-Lys-Thr-Gly-Lys-Lys-Gly-Lys-Gly-Ser-Lys-Gly-Cys-Lys-Arg-Thr-Glu-Arg-Ser-Gln-Thr-Pro-Lys-Gly-Pro,,,,
3657,[125I]CCL25 (human),,Other peptide,,,,,yes,yes,,,,,QGVFEDCCLAYHYPIGWAVLRRAWTYRIQEVSGSCNLPAAIFYLPKRHRKVCGNPKSREVQRAMKLLDARNKVFAKLHHNTQTFQAGPHAVKKLSSGNSKLSSSKFSNPISSSKRNVSLLISANSGL,Gln-Gly-Val-Phe-Glu-Asp-Cys-Cys-Leu-Ala-Tyr-His-Tyr-Pro-Ile-Gly-Trp-Ala-Val-Leu-Arg-Arg-Ala-Trp-Thr-Tyr-Arg-Ile-Gln-Glu-Val-Ser-Gly-Ser-Cys-Asn-Leu-Pro-Ala-Ala-Ile-Phe-Tyr-Leu-Pro-Lys-Arg-His-Arg-Lys-Val-Cys-Gly-Asn-Pro-Lys-Ser-Arg-Glu-Val-Gln-Arg-Ala-Met-Lys-Leu-Leu-Asp-Ala-Arg-Asn-Lys-Val-Phe-Ala-Lys-Leu-His-His-Asn-Thr-Gln-Thr-Phe-Gln-Ala-Gly-Pro-His-Ala-Val-Lys-Lys-Leu-Ser-Ser-Gly-Asn-Ser-Lys-Leu-Ser-Ser-Ser-Lys-Phe-Ser-Asn-Pro-Ile-Ser-Ser-Ser-Lys-Arg-Asn-Val-Ser-Leu-Leu-Ile-Ser-Ala-Asn-Ser-Gly-Leu,,,,
3653,[125I]CCL27 (human),,Other peptide,,,,,yes,yes,,,,,FLLPPSTACCTQLYRKPLSDKLLRKVIQVELQEADGDCHLQAFVLHLAQRSICIHPQNPSLSQWFEHQERKLHGTLPKLNFGMLRKMG,Phe-Leu-Leu-Pro-Pro-Ser-Thr-Ala-Cys-Cys-Thr-Gln-Leu-Tyr-Arg-Lys-Pro-Leu-Ser-Asp-Lys-Leu-Leu-Arg-Lys-Val-Ile-Gln-Val-Glu-Leu-Gln-Glu-Ala-Asp-Gly-Asp-Cys-His-Leu-Gln-Ala-Phe-Val-Leu-His-Leu-Ala-Gln-Arg-Ser-Ile-Cys-Ile-His-Pro-Gln-Asn-Pro-Ser- Leu-Ser-Gln-Trp-Phe-Glu-His-Gln-Glu-Arg-Lys-Leu-His-Gly-Thr-Leu-Pro-Lys-Leu-Asn-Phe-Gly-Met-Leu-Arg-Lys-Met-Gly,,,,
762,[125I]CCL2 (human),,Other peptide,,,,,yes,yes,,,,,QPDAINAPVTCCYNFTNRKISVQRLASYRRITSSKCPKEAVIFKTIVAKEICADPKQKWVQDSMDHLDKQTQTPKT,Gln-Pro-Asp-Ala-Ile-Asn-Ala-Pro-Val-Thr-Cys-Cys-Tyr-Asn-Phe-Thr-Asn-Arg-Lys-Ile-Ser-Val-Gln-Arg-Leu-Ala-Ser-Tyr-Arg-Arg-Ile-Thr-Ser-Ser-Lys-Cys-Pro-Lys-Glu-Ala-Val-Ile-Phe-Lys-Thr-Ile-Val-Ala-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Lys-Gln-Lys-Trp-Val-Gln-Asp-Ser-Met-Asp-His-Leu-Asp-Lys-Gln-Thr-Gln-Thr-Pro-Lys-Thr,,,,
763,[125I]CCL3 (human),,Other peptide,,,,,yes,yes,,,,,SLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA,Ser-Leu-Ala-Ala-Asp-Thr-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Thr-Ser-Arg-Gln-Ile-Pro-Gln-Asn-Phe-Ile-Ala-Asp-Tyr-Phe-Glu-Thr-Ser-Ser-Gln-Cys-Ser-Lys-Pro-Gly-Val-Ile-Phe-Leu-Thr-Lys-Arg-Ser-Arg-Gln-Val-Cys-Ala-Asp-Pro-Ser-Glu-Glu-Trp-Val-Gln-Lys-Tyr-Val-Ser-Asp-Leu-Glu-Leu-Ser-Ala,,,,
799,[125I]CCL4 (human),,Other peptide,,,,,yes,yes,,,,,APMGSDPPTACCFSYTARKLPRNFVVDYYETSSLCSQPAVVFQTKRSKQVCADPSESWVQEYVYDLELN,Ala-Pro-Met-Gly-Ser-Asp-Pro-Pro-Thr-Ala-Cys-Cys-Phe-Ser-Tyr-Thr-Ala-Arg-Lys-Leu-Pro-Arg-Asn-Phe-Val-Val-Asp-Tyr-Tyr-Glu-Thr-Ser-Ser-Leu-Cys-Ser-Gln-Pro-Ala-Val-Val-Phe-Gln-Thr-Lys-Arg-Ser-Lys-Gln-Val-Cys-Ala-Asp-Pro-Ser-Glu-Ser-Trp-Val-Gln-Glu-Tyr-Val-Tyr-Asp-Leu-Glu-Leu-Asn,,,,
764,[125I]CCL5 (human),,Other peptide,,,,,yes,yes,,,,,SPYSSDTTPCCFAYIARPLPRAHIKEYFYTSGKCSNPAVVFVTRKNRQVCANPEKKWVREYINSLEMS,Ser-Pro-Tyr-Ser-Ser-Asp-Thr-Thr-Pro-Cys-Cys-Phe-Ala-Tyr-Ile-Ala-Arg-Pro-Leu-Pro-Arg-Ala-His-Ile-Lys-Glu-Tyr-Phe-Tyr-Thr-Ser-Gly-Lys-Cys-Ser-Asn-Pro-Ala-Val-Val-Phe-Val-Thr-Arg-Lys-Asn-Arg-Gln-Val-Cys-Ala-Asn-Pro-Glu-Lys-Lys-Trp-Val-Arg-Glu-Tyr-Ile-Asn-Ser-Leu-Glu-Met-Ser,,,,
765,[125I]CCL7 (human),,Other peptide,,,,,yes,yes,,,,,QPVGINTSTTCCYRFINKKIPKQRLESYRRTTSSHCPREAVIFKTKLDKEICADPTQKWVQDFMKHLDKKTQTPKL,Gln-Pro-Val-Gly-Ile-Asn-Thr-Ser-Thr-Thr-Cys-Cys-Tyr-Arg-Phe-Ile-Asn-Lys-Lys-Ile-Pro-Lys-Gln-Arg-Leu-Glu-Ser-Tyr-Arg-Arg-Thr-Thr-Ser-Ser-His-Cys-Pro-Arg-Glu-Ala-Val-Ile-Phe-Lys-Thr-Lys-Leu-Asp-Lys-Glu-Ile-Cys-Ala-Asp-Pro-Thr-Gln-Lys-Trp-Val-Gln-Asp-Phe-Met-Lys-His-Leu-Asp-Lys-Lys-Thr-Gln-Thr-Pro-Lys-Leu,,,,
766,[125I]CCL8 (human),,Other peptide,,,,,yes,yes,,,,,QPDSVSIPITCCFNVINRKIPIQRLESYTRITNIQCPKEAVIFKTKRGKEVCADPKERWVRDSMKHLDQIFQNLKP,Gln-Pro-Asp-Ser-Val-Ser-Ile-Pro-Ile-Thr-Cys-Cys-Phe-Asn-Val-Ile-Asn-Arg-Lys-Ile-Pro-Ile-Gln-Arg-Leu-Glu-Ser-Tyr-Thr-Arg-Ile-Thr-Asn-Ile-Gln-Cys-Pro-Lys-Glu-Ala-Val-Ile-Phe-Lys-Thr-Lys-Arg-Gly-Lys-Glu-Val-Cys-Ala-Asp-Pro-Lys-Glu-Arg-Trp-Val-Arg-Asp-Ser-Met-Lys-His-Leu-Asp-Gln-Ile-Phe-Gln-Asn-Leu-Lys-Pro,,,,
1186,[125I]cetrorelix,,Other peptide,,,,,yes,yes,,,,,AFASYXLRPA,Ac-Nal-Cpa-Pal-Ser-Tyr-Cit-Leu-Arg-Pro-Ala-NH2,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N)C)CCCN=C(N)N)CC(C)C)CCCNC(=O)N)Cc1ccc(cc1)O)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(cc1)[125I])NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)C,MVDPNTCYCFVFOX-SZENRQNHSA-N
2022,[125I]CGP 23996,,Other peptide,,,,,yes,yes,,,,,KNFFWKTYTS,c[Aha Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser],,,,
594,[125I]CGP42112,,Other peptide,,,,,yes,yes,,,,,YKRHPI,Nic-[125I]Tyr-Lys-(N-α-Z-)Arg-His-Pro-Ile,,,CC[C@@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cccnc1)Cc1ccc(cc1)O)CCCCNC(=O)[C@@H](NC(=O)OCc1ccccc1)CCCN=C(N)N)Cc1[nH]cnc1)C,UXGNARZDONUMMK-LRMQDCNJSA-N
1027,[125I]CHIPS,,Other peptide,,,,,yes,yes,,,,,FTFEPFPTNEEIESNKKMLEKEKAYKESFKNSGLPTTLGKLDERLRNYLKKGTKNSAQFEKMVILTENKGYYTVYLNTPLAEDRKNVELLGKMYKTYFFKKGESKSSYVINGPGKTNEYAY,,,,,
3775,[125I]chorionic gonadotropin (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
4847,[125I]CNP (human),,Other peptide,,,,,yes,yes,,,,,GLSKGCFGLKLDRIGSMSGLGC,Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys,Disulphide bond formation between cysteine residues at positions 5 and 22,,,
3921,"[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP",,Other peptide,,,,,yes,yes,,,,,GPSQPTYPGDNATPEQMARYYSALRRYINMAXRQRY,Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Aib-Arg-Gln-Arg-Tyr-NH2,,,,
915,[125I]CRF (ovine),,Other peptide,,,,,yes,yes,,,,,SQEPPISLDLTFHLLREVLEMTKADQLAQQAHSNRKLLDIA,Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2,,,,
3776,[125I]CT (human),,Other peptide,,,,,yes,yes,,,,,CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP,Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2,,,,
3777,[125I]CT (salmon),,Other peptide,,,,,yes,yes,,,,,CSNLSTCVLGKLSQELHKLQTYPRTNTGSGTP,Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2,,,,
3660,[125I]CXCL10 (human),,Other peptide,,,,,yes,yes,,,,,VPLSRTVRCTCISISNQPVNPRSLEKLEIIPASQFCPRVEIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP,Val-Pro-Leu-Ser-Arg-Thr-Val-Arg-Cys-Thr-Cys-Ile-Ser-Ile-Ser-Asn-Gln-Pro-Val-Asn-Pro-Arg-Ser-Leu-Glu-Lys-Leu-Glu-Ile-Ile-Pro-Ala-Ser-Gln-Phe-Cys-Pro-Arg-Val-Glu-Ile-Ile-Ala-Thr-Met-Lys-Lys-Lys-Gly-Glu-Lys-Arg-Cys-Leu-Asn-Pro-Glu-Ser-Lys-Ala-Ile-Lys-Asn-Leu-Leu-Lys-Ala-Val-Ser-Lys-Glu-Arg-Ser-Lys-Arg-Ser-Pro,,,,
3661,[125I]CXCL11 (human),,Other peptide,,,,,yes,yes,,,,,FPMFKRGRCLCIGPGVKAVKVADIEKASIMYPSNNCDKIEVIITLKENKGQRCLNPKSKQARLIIKKVERKNF,Phe-Pro-Met-Phe-Lys-Arg-Gly-Arg-Cys-Leu-Cys-Ile-Gly-Pro-Gly-Val-Lys-Ala-Val-Lys-Val-Ala-Asp-Ile-Glu-Lys-Ala-Ser-Ile-Met-Tyr-Pro-Ser-Asn-Asn-Cys-Asp-Lys-Ile-Glu-Val-Ile-Ile-Thr-Leu-Lys-Glu-Asn-Lys-Gly-Gln-Arg-Cys-Leu-Asn-Pro-Lys-Ser-Lys-Gln-Ala-Arg-Leu-Ile-Ile-Lys-Lys-Val-Glu-Arg-Lys-Asn-Phe,,,,
849,[125I]CXCL12α (human),,Other peptide,,,,,yes,yes,,,,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNK,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu-Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys,,,,
850,[125I]CXCL12β (human),,Other peptide,,,,,yes,yes,,,,,KPVSLSYRCPCRFFESHVARANVKHLKILNTPNCALQIVARLKNNNRQVCIDPKLKWIQEYLEKALNKRFKM,Lys-Pro-Val-Ser-Leu-Ser-Tyr-Arg-Cys-Pro-Cys-Arg-Phe-Phe-Glu-Ser-His-Val-Ala-Arg-Ala-Asn-Val-Lys-His-Leu-Lys-Ile-Leu-Asn-Thr-Pro-Asn-Cys-Ala-Leu-Gln-Ile-Val-Ala-Arg-Leu-Lys-Asn-Asn-Asn-Arg-Gln-Val-Cys-Ile-Asp-Pro-Lys-Leu-Lys-Trp-Ile-Gln-Glu- Tyr-Leu-Glu-Lys-Ala-Leu-Asn-Lys-Arg-Phe-Lys-Met,,,,
8631,[125I]CXCL13 (mouse),,Other peptide,,,,,yes,yes,,,,,ILEAHYTNLKCRCSGVISTVVGLNIIDRIQVTPPGNGCPKTEVVIWTKMKKVICVNPRAKWLQRLLRHVQSKSLSSTPQAPVSKRRAA,Ile-Leu-Glu-Ala-His-Tyr-Thr-Asn-Leu-Lys-Cys-Arg-Cys-Ser-Gly-Val-Ile-Ser-Thr-Val-Val-Gly-Leu-Asn-Ile-Ile-Asp-Arg-Ile-Gln-Val-Thr-Pro-Pro-Gly-Asn-Gly-Cys-Pro-Lys-Thr-Glu-Val-Val-Ile-Trp-Thr-Lys-Met-Lys-Lys-Val-Ile-Cys-Val-Asn-Pro-Arg-Ala-Lys-Trp-Leu-Gln-Arg-Leu-Leu-Arg-His-Val-Gln-Ser-Lys-Ser-Leu-Ser-Ser-Thr-Pro-Gln-Ala-Pro-Val-Ser-Lys-Arg-Arg-Ala-Ala,,,,
3662,[125I]CXCL16 (human),,Other peptide,,,,,yes,yes,,,,,NEGSVTGSCYCGKRISSDSPPSVQFMNRLRKHLRAYHRCLYYTRFQLLSWSVCGGNKDPWVQELMSCLDLKECGHAYSGIVAHQKHLLPTSPPISQASEGASSDIHTPAQMLLSTLQSTQRPTLPVGSLSSDKELTRPNETTIHTAGHSLAAGPEAGENQKQPEKNAGPTARTSATVPVLCLLAIIFILTAALSYVLCKRRRGQSPQSSPDLPVHYIPVAPDSNT,,,,,
3677,[125I]CXCL1 (human),,Other peptide,,,,,yes,yes,,,,,ASVATELRCQCLQTLQGIHPKNIQSVNVKSPGPHCAQTEVIATLKNGRKACLNPASPIVKKIIEKMLNSDKSN,Ala-Ser-Val-Ala-Thr-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Leu-Gln-Gly-Ile-His-Pro-Lys-Asn-Ile-Gln-Ser-Val-Asn-Val-Lys-Ser-Pro-Gly-Pro-His-Cys-Ala-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Lys-Ala-Cys-Leu-Asn-Pro-Ala-Ser-Pro-Ile-Val-Lys-Lys-Ile-Ile-Glu-Lys-Met-Leu-Asn-Ser-Asp-Lys-Ser-Asn,,,,
3659,[125I]CXCL5 (human),,Other peptide,,,,,yes,yes,,,,,AGPAAAVLRELRCVCLQTTQGVHPKMISNLQVFAIGPQCSKVEVVASLKNGKEICLDPEAPFLKKVIQKILDGGNKEN,Ala-Gly-Pro-Ala-Ala-Ala-Val-Leu-Arg-Glu-Leu-Arg-Cys-Val-Cys-Leu-Gln-Thr-Thr-Gln-Gly-Val-His-Pro-Lys-Met-Ile-Ser-Asn-Leu-Gln-Val-Phe-Ala-Ile-Gly-Pro-Gln-Cys-Ser-Lys-Val-Glu-Val-Val-Ala-Ser-Leu-Lys-Asn-Gly-Lys-Glu-Ile-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Phe-Leu-Lys-Lys-Val-Ile-Gln-Lys-Ile-Leu-Asp-Gly-Gly-Asn-Lys-Glu-Asn,,,,
3658,[125I]CXCL7 (human),,Other peptide,,,,,yes,yes,,,,,SSTKGQTKRNLAKGKEESLDSDLYAELRCMCIKTTSGIHPKNIQSLEVIGKGTHCNQVEVIATLKDGRKICLDPDAPRIKKIVQKKLAGDESAD,Ser-Ser-Thr-Lys-Gly-Gln-Thr-Lys-Arg-Asn-Leu-Ala-Lys-Gly-Lys-Glu-Glu-Ser-Leu-Asp-Ser-Asp-Leu-Tyr-Ala-Glu-Leu-Arg-Cys-Met-Cys-Ile-Lys-Thr-Thr-Ser-Gly-Ile-His-Pro-Lys-Asn-Ile-Gln-Ser-Leu-Glu-Val-Ile-Gly-Lys-Gly-Thr-His-Cys-Asn-Gln-Val-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asp-Gly-Arg-Lys-Ile-Cys-Leu-Asp-Pro-Asp-Ala-Pro-Arg-Ile-Lys-Lys-Ile-Val-Gln-Lys-Lys-Leu-Ala-Gly-Asp-Glu-Ser-Ala-Asp,,,,
822,[125I]CXCL8 (human),,Other peptide,,,,,yes,yes,,,,,AVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS,Ala-Val-Leu-Pro-Arg-Ser-Ala-Lys-Glu-Leu-Arg-Cys-Gln-Cys-Ile-Lys-Thr-Tyr-Ser-Lys-Pro-Phe-His-Pro-Lys-Phe-Ile-Lys-Glu-Leu-Arg-Val-Ile-Glu-Ser-Gly-Pro-His-Cys-Ala-Asn-Thr-Glu-Ile-Ile-Val-Lys-Leu-Ser-Asp-Gly-Arg-Glu-Leu-Cys-Leu-Asp-Pro-Lys-Glu-Asn-Trp-Val-Gln-Arg-Val-Val-Glu-Lys-Phe-Leu-Lys-Arg-Ala-Glu-Asn-Ser,,,,
3664,[125I]CX3CL1 (human),,Other peptide,,,,,yes,yes,,,,,QHHGVTKCNITCSKMTSKIPVALLIHYQQNQASCGKRAIILETRQHRLFCADPKEQWVKDAMQHLDRQAAALTRNGGTFEKQIGEVKPRTTPAAGGMDESVVLEPEATGESSSLEPTPSSQEAQRALGTSPELPTGVTGSSGTRLPPTPKAQDGGPVGTELFRVPPVSTAATWQSSAPHQPGPSLWAEAKTSEAPSTQDPSTQASTASSPAPEENAPSEGQRVWGQGQSPRPENSLEREEMGPVPAHTDAFQDWGPGSMAHVSVVPVSSEGTPSREPVASGSWTPKAEEPIHATMDPQRLGVLITPVPDAQAATRRQAVGLLAFLGLLFCLGVAMFTYQSLQGCPRKMAGEMAEGLRYIPRSCGSNSYVLVPV,,,,,
2230,"[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP",,Other peptide,,,,,yes,yes,,,,,CIFINCPRY,Pmp-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
2231,"[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP",,Other peptide,,,,,yes,yes,,,,,CIFVNCPRY,Pmp-D-Ile-Phe-Val-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
2232,"[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP",,Other peptide,,,,,yes,yes,,,,,CYFINCPRY,Pmp-D-Tyr(Et)-Phe-Ile-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
2233,"[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP",,Other peptide,,,,,yes,yes,,,,,CYFVNCPRY,Pmp-D-(Et)Tyr-Phe-Val-Asn-Cys-Pro-Arg-Tyr-NH2,,,,
3778,"[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT",,Other peptide,,,,,yes,yes,,,,,CYITNCPXY,Pmp-(Me)Tyr-Ile-Thr-Asn-Cys-Pro-Orn-Tyr-NH2,,,,
1166,"[125I][des-Gly10,D-Ala6]GnRH N-ethylamide",,Other peptide,,,,,yes,yes,,,,,XHWSYGLRP,pGlu-His-Trp-Ser-Tyr-D-Ala-Leu-Arg-(Et)Pro-NH2,,,,
6666,"[125I]DTyr-Gly-[(Nle28,31)CCK-26-33",,Other peptide,,,,,yes,yes,,,,,YGDYXGWXDF,Tyr-Gly-Asp-Tys-Nle-Gly-Trp-Nle-Asp-Phe,,,,
631,"[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14)",,Other peptide,,,,,yes,yes,,,,,YQWAVXHFX,D-Tyr-Gln-Trp-Ala-Val-βAla-His-Phe-Nle,,,,
628,[125I][D-Tyr6]bombesin-(6-13)-methyl ester,,Other peptide,,,,,yes,yes,,,,,YQWAVGHL,D-Tyr-Gln-Trp-Ala-Val-Gly-His-Leu-O-CH3,,,,
4848,[125I]EGF (human),,Other peptide,,,,,yes,yes,,,,,NSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDLKWWELR,,,,,
991,"[125I]ET-1 (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,CSCSSLMDKECVYFCHLDIIW,Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp,,,,
992,[125I]ET-2 (human),,Other peptide,,,,,yes,yes,,,,,CSCSSWLDKECVYFCHLDIIW,Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp,,,,
1137,[125I]exendin-(9-39),,Other peptide,,,,,yes,yes,,,,,DLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS,Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser,,,,
1488,[125I]EYF,,Other peptide,,,,,yes,yes,,,,,EYWSLAAPQRF,Glu-Tyr-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2,,,,
3780,[125I]FSH (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
3781,[125I]gastrin,,Other peptide,,,,,yes,yes,,,,,,,,,,
4851,[125I]GDNF (rat),,Other peptide,,,,,yes,yes,,,,,SPDKQAAALPRRERNRQAAAASPENSRGKGRRGQRGKNRGCVLTAIHLNVTDLGLGYETKEELIFRYCSGSCEAAETMYDKILKNLSRSRRLTSDKVGQACCRPVAFDDDLSFLDDSLVYHILRKHSAKRCGCI,,,,,
3783,[125I]GHRH (human),,Other peptide,,,,,yes,yes,,,,,YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL,Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-[125I]Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2,,,,
1131,[125I]GIP (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
1134,[125I]GLP-1-(7-36)-amide,,Other peptide,,,,,yes,yes,,,,,HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR,His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N)CCCN=C(N)N)CCCCN)C(C)C)CC(C)C)Cc1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1nc[nH]c1)N)C)CCC(=O)O)Cc1ccccc1)CO)CC(=O)O)CO)CO)Cc1ccc(cc1)O)CC(C)C)CCC(=O)O)CCC(=O)N)C)C,DTHNMHAUYICORS-KTKZVXAJSA-N
3784,[125I]GLP-1-(7-37) (human),,Other peptide,,,,,yes,yes,,,,,HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG,His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly,,,,
3761,"[125I][Glp65Nle75,Tyr77]apelin-13",,Other peptide,,,,,yes,yes,,,,,XRPRLSHKGPXPY,pGlu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Tyr,,,,
3785,"[125I]glucagon (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,HSQGTFTSDYSKYLDSRRAQDFVQWLMNT,His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr,,,,
3786,"[125I]GnRH I (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,XHWSYGLRPG,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2,,,,
3787,[125I]GnRH II (human),,Other peptide,,,,,yes,yes,,,,,XHWSHGWYPG,pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2,,,,
1531,[125I]GR231118,,Other peptide,,,,,yes,yes,,,,,IEPXYRLRY,Ile-Glu-Pro-Dpr-Tyr-Arg-Leu-Arg-Tyr-CONH2,,,CC[C@@H]([C@@H](C(=N[C@@H]1CCC(=NC[C@@H](N=C(O)[C@@H]2CCCN2C(=O)[C@H](CCC(=NC[C@H](N=C([C@H]2N(C1=O)CCC2)O)C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N)O)Cc1ccc(cc1)O)O)CCCNC(=N)N)O)CC(C)C)O)CCCNC(=N)N)O)Cc1ccc(cc1)O)O)O)N=C([C@H]([C@H](CC)C)N)O)C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N[C@H](C(=N)O)Cc1ccc(cc1)O)O)CCCNC(=N)N)O)CC(C)C)O)CCCNC(=N)N)O)Cc1ccc(cc1)O)O)O)O)N)C,RJRBRCCJETZJLT-VHUVHYDGSA-N
3788,[125I]GRP (human),,Other peptide,,,,,yes,yes,,,,,VPLPAGGGTVLTKMYPRGNHWAVGHLM,Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2,,,,
1094,[125I][His9]ghrelin (human),,Other peptide,,,,,yes,yes,,,,,GSSFLSPEHQRVQQRKESKKPPAKLQPR,Gly-Ser-Ser(n-Octanoyl)-Phe-Leu-Ser-Pro-Glu-[125I]His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,"The third residue, a serine, is octanoylated.","The third residue, a serine, is octanoylated.",,
3791,[125I]Hpp-desArg10HOE140,,Other peptide,,,,,yes,yes,,,,,RRPXGXSXXR,3-4-hydroxyphenyl-propionyl-D-Arg-Arg-Pro-Hyp-Gly-Thi-Ser-D-Tic-Oic,,,,
3766,[125I]αCGRP (human),,Other peptide,,,,,yes,yes,,,,,ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2,,,,
1996,[125I]INSL3 (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
2001,[125I]INSL5 (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
1007,[125I]IRL1620,,Other peptide,,,,,yes,yes,,,,,DEEAVYFAHLDIIW,Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1c[nH]c2c1cccc2)[C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCC(=O)O)CC(=O)O)CCC(=O)O)CCC(=O)O)C)Cc1ccc(cc1)O)Cc1ccccc1)C)Cc1[nH]cnc1)CC(C)C)CC(=O)O)C,DXPHNGAMYPPTBJ-TZMIJSMNSA-N
832,[125I]KC-Tyr,,Other peptide,,,,,yes,yes,,,,,AYIANELRCQCLQTMAGIHLKNIQSLKVLPSGPHCTQTEVIATLKNGREACLDPEAPLVQKIVQKMLKGVPK,Ala-Tyr-Ile-Ala-Asn-Glu-Leu-Arg-Cys-Gln-Cys-Leu-Gln-Thr-Met-Ala-Gly-Ile-His-Leu-Lys-Asn-Ile-Gln-Ser-Leu-Lys-Val-Leu-Pro-Ser-Gly-Pro-His-Cys-Thr-Gln-Thr-Glu-Val-Ile-Ala-Thr-Leu-Lys-Asn-Gly-Arg-Glu-Ala-Cys-Leu-Asp-Pro-Glu-Ala-Pro-Leu-Val-Gln-Lys-Ile-Val-Gln-Lys-Met-Leu-Lys-Gly-Val-Pro-Lys,,,,
1281,[125I]kisspeptin-10 (human),,Other peptide,,,,,yes,yes,,,,,YNWNSFGLRF,Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,,,,
3792,[125I]kisspeptin-13 (human),,Other peptide,,,,,yes,yes,,,,,LPNYNWNSFGLRF,Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,,,,
4013,[125I]kisspeptin-14 (human),,Other peptide,,,,,yes,yes,,,,,DLPNYNWNSFGLRF,Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe,,,,
1282,[125I]kisspeptin-54 (human),,Other peptide,,,,,yes,yes,,,,,GTSLSPPPESSGSPQQPGLSAPHSRQIPAPQGAVLVQREKDLPNYNWNSFGLRF,Gly-Thr-Ser-Leu-Ser-Pro-Pro-Pro-Glu-Ser-Ser-Gly-Ser-Pro-Gln-Gln-Pro-Gly-Leu-Ser-Ala-Pro-His-Ser-Arg-Gln-Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2,,,,
3762,"[125I][Leu31,Pro34]NPY",,Other peptide,,,,,yes,yes,,,,,YPLKPPNPGEDAPAEDMARYYSALRHYINLLTRPRY,Tyr-Pro-Leu-Lys-Pro-Pro-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr,,,,
3793,[125I]LH,,Other peptide,,,,,yes,yes,,,,,,,,,,
2023,[125I]LTT-SRIF-28,,Other peptide,,,,,yes,yes,,,,,SANSNPALAPRERKAGCKNFFWKTYTSC,Ser-Ala-Asn-Ser-Asn-Pro-Ala-Leu-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Tyr-Thr-Ser-Cys,,,,
1296,"[125I]MCH (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,DFDMLRCMLGRVYRPCWQV,Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val,,,,
3763,[125I][MePhe7]NKB,,Other peptide,,,,,yes,yes,,,,,DMHDFFFGLM,Asp-Met-His-Asp-Phe-Phe-Phe(Me)-Gly-Leu-Met-NH2,,,,
818,[125I]mini-TyrRS,,Other peptide,,,,,yes,yes,,,,,GDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVI,,,,,
2061,[125I]MK-678,,Other peptide,,,,,yes,yes,,,,,AYWKVF,c[N(Me)Ala-Tyr-D-Trp-Lys-Val-Phe],,,,
3794,[125I]motilin (human),,Other peptide,,,,,yes,yes,,,,,FVPIFTYGELQRMQEKERNKGQ,Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln,,,,
9440,"[125I]N-biotin-[Ahx0, Bpa3]U-II (human)",,Other peptide,,,,,yes,yes,,,,,,,,,,
1326,[125I]NDP-MSH,,Other peptide,,,,,yes,yes,,,,,SYSXEHFRWGKPV,Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2,,,,
1475,[125I]neuromedin U-23 (rat),,Other peptide,,,,,yes,yes,,,,,YKVNEYQGPVAPSGGFFLFRPRN,Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,,,,
1474,[125I]neuromedin U-25 (human),,Other peptide,,,,,yes,yes,,,,,FRVDEEFQSPFASQSRGYFLFRPRN,Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2,,,,
1476,[125I]neuromedin U-8 (pig),,Other peptide,,,,,yes,yes,,,,,YFLFRPRN,Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn,,,,
1574,"[125I]neurotensin (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,XLYENKPRRPYIL,pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu,,,,
4849,[125I]NGF (human),,Other peptide,,,,,yes,yes,,,,,SSSHPIFHRGEFSVCDSVSVWVGDKTTATDIKGKEVMVLGEVNINNSVFKQYFFETKCRDPNPVDSGCRGIDSKHWNSYCTTTHTFVKALTMDGKQAAWRFIRIDTACVCVLSRKAVRRA,,,,,
3795,"[125I]NKA (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,HKTDSFVGLM,His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2,,,,
603,"[125I][Nle75,Tyr77]apelin-36 (human)",,Other peptide,,,,,yes,yes,,,,,LVQPRGPRSGPGPWQGGRRKFRRQRPRLSHKGPXPY,Leu-Val-Gln-Pro-Arg-Gly-Pro-Arg-Ser-Gly-Pro-Gly-Pro-Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Nle-Pro-Tyr,,,,
1791,"[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat)",,Other peptide,,,,,yes,yes,,,,,AVSEIQLXHNLGKHLASVERXQWLRKKLQDVHNY,Ala-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Nle-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2,,,,
3797,[125I]NPFF,,Other peptide,,,,,yes,yes,,,,,FLFQPQRF,Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2,,,,
1497,[125I]NPW-23 (human),,Other peptide,,,,,yes,yes,,,,,WYKHVASPRYHTVGRAAGLLMGL,Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu,,,,
1518,"[125I]NPY (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
2207,[125I]OH-LVA,,Other peptide,,,,,yes,yes,,,,,YFQNRPR,4-OH-phenylacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2,,,,
9464,[125I]-orexin-A,,Other peptide,,,,,yes,yes,,,,,,,,,,
3798,"[125I]orexin A (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,XPLPDCCRQKTCSCRLYELLHGAGNHAAGILTL,pGlu-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2,,,,
2261,[125I]PACAP-27,,Other peptide,,,,,yes,yes,,,,,HSDGIFTDSYSRYRKQMAVKKYLAAVL,His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2,"C-terminal residue is leucine amide. Residues containing 125I are Tyr10, Tyr13 and/or Tyr22.",,,
1001,[125I]PD151242,,Other peptide,,,,,yes,yes,,,,,LWY,(N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-D-Trp-D-Tyr,,,CC(C[C@@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)O)Cc1ccc(cc1)O)Cc1cn(c2c1cccc2)C)NC(=O)N1CCCCCC1)C,JVILFANCFWZBFU-ZGIBFIJWSA-N
3844,"[125I][Phe13,Tyr19]MCH",,Other peptide,,,,,yes,yes,,,,,DFDMLRCMLGRVFRPCWQY,Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr,,,,
3800,[125I]PP (human),,Other peptide,,,,,yes,yes,,,,,APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY,Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2,,,,
1559,"[125I][PP1-17,Ala31,Aib32]NPY (human)",,Other peptide,,,,,yes,yes,,,,,APLEPVYPGDNATPEQMARYYSALRHYINLAXRQRY,Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2,,,,
1875,[125I]PrRP-20 (human),,Other peptide,,,,,yes,yes,,,,,TPDINPAWYASRGIRPVGRF,Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2,,,,
4022,[125I]PrRP31,,Other peptide,,,,,yes,yes,,,,,SRTHRHSMEIRTPDINPAWYASRGIRPVGRF,Ser-Arg-Thr-His-Arg-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2,,,,
4073,[125I]psalmotoxin 1,,Other peptide,,,,,yes,yes,,,,,EDCIPKWKGCVNRHGDCCEGLECWKRRRSFEVCVPKTPKT,Glu-Asp-Cys-Ile-Pro-Lys-Trp-Lys-Gly-Cys-Val-Asn-Arg-His-Gly-Asp-Cys-Cys-Glu-Gly-Leu-Glu-Cys-Trp-Lys-Arg-Arg-Arg-Ser-Phe-Glu-Val-Cys-Val-Pro-Lys-Thr-Pro-Lys-Thr,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@H](O)C)CCCCN)[C@H](O)C)CCCCN)C(C)C)CS)C(C)C)CCC(=O)O)Cc1ccccc1)CO)CCCN=C(N)N)CCCN=C(N)N)CCCN=C(N)N)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)N)CC(=O)O)CS)CCCCN)CCCCN)CS)CC(=O)N)CCCN=C(N)N)Cc1nc[nH]c1)CC(=O)O)CS)CS)CCC(=O)O)CC(C)C)CCC(=O)O)CS,KUGGGQKBZWWKLY-ACYSAVFESA-N
601,[125I](Pyr1)apelin-13,,Other peptide,,,,,yes,yes,,,,,XRPRLSHKGPMPF,pGlu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,,,,
1519,[125I]PYY,,Other peptide,,,,,yes,yes,,,,,,,,,,
3802,[125I]PYY-(3-36) (human),,Other peptide,,,,,yes,yes,,,,,IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY,Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
1520,[125I]PYY (pig),,Other peptide,,,,,yes,yes,,,,,YPAKPEAPGEDASPEELSRYYASLRHYLNLVTRQRY,Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
3803,[125I]QRFP43 (human),,Other peptide,,,,,yes,yes,,,,,XDEGSEATGFLPAAGEKTSGPLGNLAEELNGYSRKKGGFSFRF,pGlu-Asp-Glu-Gly-Ser-Glu-Ala-Thr-Gly-Phe-Leu-Pro-Ala-Ala-Gly-Glu-Lys-Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2,,,,
3789,[125I]relaxin-3-B/INSL5 A chimera,,Other peptide,,,,,yes,yes,,,,,,,,,,
1999,[125I]relaxin-3 (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
5398,[125I]relaxin (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
1317,[125I]S36057,,Other peptide,,,,,yes,yes,,,,,YXRCMLGRVFRPCW,Tyr-Oaa-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp,,,,
993,[125I]sarafotoxin S6b,,Other peptide,,,,,yes,yes,,,,,CSCKDMTDKECLYFCHQDVIW,Cys-Ser-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-Leu-Tyr-Phe-Cys-His-Gln-Asp-Val-Ile-Trp,Disulphide bond formation between cysteine residues at positions 1 and 14,,,
6897,[125I][Sar1]Ang-II,,Other peptide,,,,,yes,yes,,,,,XRVYIHPF,[125I]Sar-Arg-Val-Tyr-Ile-His-Pro-Phe,,,,
6906,"[125I][Sar1,Ile8]Ang-II",,Other peptide,,,,,yes,yes,,,,,XRVYIHPI,Sar-Arg-Val-Tyr-Ile-His-Pro-Ile-OH,,,,
916,[125I]sauvagine (frog),,Other peptide,,,,,yes,yes,,,,,XGPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI,pGlu-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H]([C@H](CC)C)C(=O)N)[C@H](O)C)CC(=O)O)CC(C)C)CC(C)C)CC(C)C)CCCN=C(N)N)CC(=O)N)CC(=O)N)C)C)CCC(=O)N)CCC(=O)N)CCCCN)CCC(=O)O)CCCCN)CCC(=O)O)CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H](NC(=O)[C@H]([C@H](CC)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H]1CCC(=O)N1)CO)CC(=O)O)CC(C)C)CO)CC(C)C)CCC(=O)O)CC(C)C)CC(C)C)CCCN=C(N)N)CCCCN)CCSC)CCC(=O)O)CCC(=O)O,ILCVKEBXPLEGOY-ZLFMSJRASA-N
1153,[125I]secretin (pig),,Other peptide,,,,,yes,yes,,,,,HSDGTFTSELSRLRDSARLQRLLQGLV,His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2,,,,
3804,[125I]SHU9119,,Other peptide,,,,,yes,yes,,,,,CDHARWCK,Ac-Cys-Asp-His-D-Nal-Arg-Trp-Cys-Lys-NH2,,,,
3805,"[125I]SP (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,RPKPQQFFGLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,,,,
4850,[125I]Sta,,Other peptide,,,,,yes,yes,,,,,,,,,,
2382,[125I]tertiapin Y1/K12/Q13,,Other peptide,,,,,yes,yes,,,,,YLCNCNRIIIPKQCWKKCGKK,Tyr-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-Lys-Gln-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys,,,,
1168,[125I]triptorelin,,Other peptide,,,,,yes,yes,,,,,XHWSYWLRPG,pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2,,,,
3806,[125I]TSH (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
6198,[125I-Tyr]Ac2-26,,Other peptide,,,,,yes,yes,,,,,AMVSEFLKQAWFIENEEQEYVQTVK,(Ac)Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp-Phe-Ile-Glu-Asn-Glu-Glu-Gln-Glu-[125I]Tyr-Val-Gln-Thr-Val-Lys,The N-terminal alanine residue is N-linked acetylated.,,,
1095,[125I]Tyr-Ala-hexarelin,,Other peptide,,,,,yes,yes,,,,,YAHWAWFK,Tyr-Ala-His-Trp-Ala-Trp-Phe-Lys,,,,
914,"[125I]Tyr0-CRF (human, rat, mouse)",,Other peptide,,,,,yes,yes,,,,,YSEEPPISLDLTFHLLREVLEMARAEQLAQQAHSNRKLMEII,Tyr-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2,,,,
5389,[125I]Tyr0-sauvagine,,Other peptide,,,,,yes,yes,,,,,YXGPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI,Tyr-pGlu-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2,,,,
2024,[125I]Tyr10-CST14,,Other peptide,,,,,yes,yes,,,,,PCKNFFWKTYSSCK,Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Ser-Ser-Cys-Lys,,,,
1493,[125I]Tyr10NPS (human),,Other peptide,,,,,yes,yes,,,,,SFRNGVGTGYKKTSFQRAKS,Ser-Phe-Arg-Asn-Gly-Val-Gly-Thr-Gly-Tyr-Lys-Lys-Thr-Ser-Phe-Gln-Arg-Ala-Lys-Ser,,,,
3759,[125I](Tyr10)secretin-27 (rat),,Other peptide,,,,,yes,yes,,,,,HSDGTFTSEYSRLQDSARLQRLLQGLV,His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Arg-Leu-Gln-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val,,,,
1498,[125I][Tyr11]des-Br-NPB-23,,Other peptide,,,,,yes,yes,,,,,WYKPAAGHSSYSVGRAAGLLSGL,Trp-Tyr-Lys-Pro-Ala-Ala-Gly-His-Ser-Ser-[iodo]Tyr-Ser-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Gly-Leu,,,,
2060,[125I]Tyr11-SRIF-14,,Other peptide,,,,,yes,yes,,,,,AGCKNFFWKTYTSC,Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys,,,,
5391,[125I][Tyr26]galanin (human),,Other peptide,,,,,yes,yes,,,,,GWTLNSAGYLLGPHAVGNHRSFSDKYGLTS,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Tyr-Gly-Leu-Thr-Ser,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CO)[C@H](O)C)CC(C)C)Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)CN)CC(C)C)CC(=O)N)CO)C)CC(C)C)CC(C)C)Cc1nc[nH]c1)C)Cc1nc[nH]c1)CCCN=C(N)N)CO)Cc1ccccc1)CO)CC(=O)O,IBAFSRAMOWXNLI-CRUSWPMPSA-N
6117,[125I][Tyr26]galanin (pig),,Other peptide,,,,,yes,yes,,,,,GWTLNSAGYLLGPHAIDNHRSFHDKYGLA,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala,,,,
5390,[125I][Tyr26]galanin (rat/mouse),,Other peptide,,,,,yes,yes,,,,,GWTLNSAGYLLGPHAIDNHRSFSDKYGLT,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Tyr-Gly-Leu-Thr-NH2,,,,
2062,[125I]Tyr3 SMS 201-995,,Other peptide,,,,,yes,yes,,,,,FCFWKTCT,D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Threoninol,,,,
5630,"[125I][Tyr3,Thr8]octreotide",,Other peptide,,,,,yes,yes,,,,,FCYWKTCT,Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr,,,,
1280,[125I]Tyr45-kisspeptin-15,,Other peptide,,,,,yes,yes,,,,,KDLPYYNWNSFGLRF,Lys-Asp-Leu-Pro-Tyr-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe,,,,
623,[125I][Tyr4]bombesin,,Other peptide,,,,,yes,yes,,,,,XQRYGNQWAVGHLM,pGlu-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2,,,,
3810,[125I]Tyr4-des-octanoyl-ghrelin,,Other peptide,,,,,yes,yes,,,,,GSSYLSPEHQRVQQRKESKKPPAKLQPR,Gly-Ser-Ser-[125I]Tyr-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,,,,
1096,[125I][Tyr4]ghrelin (human),,Other peptide,,,,,yes,yes,,,,,GSSYLSPEHQRVQQRKESKKPPAKLQPR,Gly-Ser-Ser(n-Octanoyl)-[125I]Tyr-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg,,,,
1165,"[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH",,Other peptide,,,,,yes,yes,,,,,XHWSYALRPG,pGlu-His-Trp-Ser-[125]Tyr-D-Ala-(Me)Leu-Arg-(Et)Pro-Gly-NH2,,,,
2075,[125I]Tyr7-Sst3-ODN-8,,Other peptide,,,,,yes,yes,,,,,CFYWKTFC,"carbamoyl-D-Cys-Phe-[125I]Tyr-D-Agl(Me,2-naphthoyl)-Lys-Thr-Phe-Cys",,,,
3765,[125I][Tyr8]bradykinin,,Other peptide,,,,,yes,yes,,,,,RPPGFSPYR,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg,,,,
2158,[125I]U-II (human),,Other peptide,,,,,yes,yes,,,,,ETPDCFWKYCV,Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val,,,,
917,"[125I]urocortin 1 (mouse, rat)",,Other peptide,,,,,yes,yes,,,,,DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV,Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)C(C)C)CO)CC(=O)O)Cc1ccccc1)[C@H](CC)C)[C@H](CC)C)CCCN=C(N)N)CC(=O)N)CCC(=O)N)CCC(=O)O)C)CCCN=C(N)N)CCC(=O)O)CCCN=C(N)N)CCC(=O)N)CO)CCC(=O)N)[C@H](O)C)CCCN=C(N)N)C)CC(C)C)CCC(=O)O)CC(C)C)CC(C)C)[C@H](O)C)CCCN=C(N)N)CC(C)C)CC(C)C)Cc1nc[nH]c1)Cc1ccccc1)[C@H](O)C)CC(C)C)CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CC(=O)O)CC(C)C)CO)C,NLXKHYTZYFPOSU-MLGORUQISA-N
2277,"[125I]VIP (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,HSDAVFTDNYTRLRKQMAVKKYLNSILN,His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2,,,,
857,[125I]XCL1 (human),,Other peptide,,,,,yes,yes,,,,,VGSEVSDKRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG,Val-Gly-Ser-Glu-Val-Ser-Asp-Lys-Arg-Thr-Cys-Val-Ser-Leu-Thr-Thr-Gln-Arg-Leu-Pro-Val-Ser-Arg-Ile-Lys-Thr-Tyr-Thr-Ile-Thr-Glu-Gly-Ser-Leu-Arg-Ala-Val-Ile-Phe-Ile-Thr-Lys-Arg-Gly-Leu-Lys-Val-Cys-Ala-Asp-Pro-Gln-Ala-Thr-Trp-Val-Arg-Asp-Val-Val-Arg-Ser-Met-Asp-Arg-Lys-Ser-Asn-Thr-Arg-Asn-Asn-Met-Ile-Gln-Thr-Lys-Pro-Thr-Gly-Thr-Gln-Gln-Ser-Thr-Asn-Thr-Ala-Val-Thr-Leu-Thr-Gly,Disulphide bond formation between cysteine residues at positions 11 and 48,,,
1484,[125I]Y-RFRP-3,,Other peptide,,,,,yes,yes,,,,,YVPNLPQRF,[125I]Tyr-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2,,,,
994,"[18F]ET-1 (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,CSCSSLMDKECVYFCHLDIIW,Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp,"There are two disulfide bonds formed, between cysteine residues at positions 1 and 15 and cysteine residues at positions 3 and 11.","There are two disulfide bonds formed, between cysteine residues at positions 1 and 15 and cysteine residues at positions 3 and 11.",,
6097,"[19Lys,26Leu]-galparan",,Other peptide,,,,,,,,,,,GWTLNSAGYLLGPINLKAKAALAKKLL,Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Ile-Asn-Leu-Lys-Ala-Lys-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu,,,,
6098,[2Ala]-galparan,,Other peptide,,,,,,,,,,,GATLNSAGYLLGPINLKALAALAKKIL,Gly-Ala-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu,,,,
1991,[33P]relaxin (human),,Other peptide,,,,,yes,yes,,,,,,,,,,
6660,[3H]2-furoyl-LIGRL-NH2,,Other peptide,,,,,yes,yes,,,,,LIGRL,Leu-Ile-Gly-Arg-Leu,,,,
3981,[3H]α-bungarotoxin,,Other peptide,,,,,yes,yes,,,,,IVCHTTATSPISAVTCPPGENLCYRKMWCDAFCSSRGKVVELGCAATCPSKKPYEEVTCCSTDKCNPHPKQRPG,Ile-Val-Cys-His-Thr-Thr-Ala-Thr-Ser-Pro-Ile-Ser-Ala-Val-Thr-Cys-Pro-Pro-Gly-Glu-Asn-Leu-Cys-Tyr-Arg-Lys-Met-Trp-Cys-Asp-Ala-Phe-Cys-Ser-Ser-Arg-Gly-Lys-Val-Val-Glu-Leu-Gly-Cys-Ala-Ala-Thr-Cys-Pro-Ser-Lys-Lys-Pro-Tyr-Glu-Glu-Val-Thr-Cys-Cys-Ser-Thr-Asp-Lys-Cys-Asn-Pro-His-Pro-Lys-Gln-Arg-Pro-Gly,"Disulfide bridges between amino acids 3 - 23, 16 - 44, 29 - 33, 48 - 59, 60 - 65",,,
2175,"[3H]AVP (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,CYFQNCPRG,Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,,
3811,"[3H]BH-[Sar9,Met(O2)11]SP",,Other peptide,,,,,yes,yes,,,,,RPKPQQFFXLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met(O2)-NH2,,,,
3812,"[3H]BK (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,RPPGFSPFR,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,,,,
1003,[3H]BQ123,,Other peptide,,,,,yes,yes,,,,,DPVLW,D-Asp-Pro-D-Val-Leu-D-Trp,,,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)C(C(=O)O)[3H])C(C)C)C,VYCMAAOURFJIHD-HCGDBENESA-N
4765,"[3H]CCK-8 (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,DYMGWMDF,Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2,The C-terminal phenylalanine is amidated; the tyrosine residue at position 2 is sulfated tyrosine (Tyr(SO3H)),,,
9065,[3H][D-Ala2]deltorphin I,,Other peptide,,,,,yes,yes,,,,,YAFDVVG,Tyr-Ala-Phe-Asp-Val-Val-Gly-NH2,,,,
3815,[3H]DAMGO,,Other peptide,,,,,yes,yes,,,,,YAGFG,"[3,5-3H]Tyr-D-Ala-Gly-(NMe)Phe-Gly-ol",,,,
2227,[3H]d[Cha4]AVP,,Other peptide,,,,,yes,yes,,,,,CYFXNCPRG,deamino-Cys-Tyr-Phe-Cha-Asn-Cys-Pro-Arg-Gly,,,,
3813,[3H]d(CH2)5[Tyr(Me)2]AVP,,Other peptide,,,,,yes,yes,,,,,CYFQNCPRG,Pmp-(Me)Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2,,,,
2228,[3H]dDAVP,,Other peptide,,,,,yes,yes,,,,,CYFQNCPRG,deamino-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2,,,,
3816,[3H]deltorphin II,,Other peptide,,,,,yes,yes,,,,,YAFEVVG,Tyr-Ala-Phe-Glu-Val-Val-Gly-NH2,,,,
3817,"[3H]desGly-NH2[D-Ile2,Ile4]VP",,Other peptide,,,,,yes,yes,,,,,CIFINCPR,Cys-D-Ile-Phe-Ile-Asn-Cys-Pro-Arg,,,,
3819,[3H]DPDPE,,Other peptide,,,,,yes,yes,,,,,YXGFX,Tyr-D-Pen-Gly-Phe-D-Pen,,,,
4021,[3H]EYF,,Other peptide,,,,,yes,yes,,,,,EYWSLAAPQRF,Glu-Tyr-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2,,,,
1018,[3H]fMet-Leu-Phe,,Other peptide,,,,,yes,yes,,,,,MLP,fMet-Leu-Phe,,,,
3821,[3H]gastrin,,Other peptide,,,,,yes,yes,,,,,,,,,,
3822,[3H]GR100679,,Other peptide,,,,,yes,yes,,,,,GAWF,cyclohexylcarbonyl-Gly-Ala-D-Trp-Phe-NMe2,,,,
3823,[3H]haTRAP,,Other peptide,,,,,yes,yes,,,,,AFRARY,Ala-(p-fluoro)Phe-Ala-Arg-(cyclohexyl)Ala-homoArg-[3H]Tyr-NH2,,,,
3824,[3H]Leu-N/OFQ,,Other peptide,,,,,yes,yes,,,,,FGGFTGARKSARKLANQ,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-[3H]Leu-Ala-Asn-Gln,,,,
3825,[3H]Lys-[des-Arg9]BK,,Other peptide,,,,,yes,yes,,,,,KRPPGFSPF,Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe,,,,
3826,[3H]Lys-[Leu8][des-Arg9]BK,,Other peptide,,,,,yes,yes,,,,,KRPPGFSPL,Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu,,,,
3827,"[3H]MCH (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,DFDMLRCMLGRVYRPCWQV,Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val,,,,
3830,"[3H]neurotensin (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,XLYENKPRRPYIL,pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu,,,,
1688,[3H]N/OFQ,,Other peptide,,,,,yes,yes,,,,,FGGFTGARKSARKLANQ,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln,,,,
3831,[3H]NPC17731,,Other peptide,,,,,yes,yes,,,,,RRPXGFSXXR,D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-X-Oic-Arg,,,,
4019,[3H]NPVF,,Other peptide,,,,,yes,yes,,,,,VPNLPGRF,Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2,,,,
1521,"[3H]NPY (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY,Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2,,,,
2176,"[3H]OT (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,CYIQNCPLG,Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2,,,CC[C@@H]([C@@H]1NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)C,XNOPRXBHLZRZKH-DSZYJQQASA-N
899,[3H]PBC-264,,Other peptide,,,,,yes,yes,,,,,YXGWXDF,propionyl-Tyr-(SO3H)-gNle-mGly-Trp-(NMe)Nle-Asp-Phe-NH2,,,CCCC[C@H](NC(=O)[C@@H](NC(=O)C(C([3H])([3H])[3H])([3H])[3H])Cc1ccc(cc1)OS(=O)(=O)O)NCC(=O)C(=O)N[C@H](C(=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCC)NC)CC(=O)O)Cc1ccccc1)Cc1c[nH]c2c1cccc2,VNNMDTHCFFZSSJ-LWSGDBLMSA-N
3832,[3H]PL017,,Other peptide,,,,,yes,yes,,,,,YPFP,Tyr-Pro-(NMe)Phe-D-Pro-NH2,,,,
604,[3H](Pyr1)[Met(0)11]-apelin-13,,Other peptide,,,,,yes,yes,,,,,XRPRLSHKGPMPF,pGlu-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe,"N-terminal glutamate cyclisation, represented by X and pGlu","N-terminal glutamate cyclisation, represented by X and pGlu",,
3834,[3H]senktide,,Other peptide,,,,,yes,yes,,,,,DFFGLM,Suc-Asp-Phe-(Me)Phe-Gly-Leu-Met-NH2,,,,
3835,"[3H]SP (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,RPKPQQFFGLM,Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2,,,,
3836,"[3H]TRH (human, mouse, rat)",,Other peptide,,,,,yes,yes,,,,,XHP,pGlu-His-Pro-NH2,,,,
1687,[3H]Tyr14-N/OFQ,,Other peptide,,,,,yes,yes,,,,,FGGFTGARKSARKYANQ,Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Tyr-Ala-Asn-Gln,,,,
5628,[67Ga]NODAGA-[Tyr3]octreotide,,Other peptide,,,,,yes,yes,,,,,FCYWKTCT,[NODAGA] Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr,,,,
852,T134,,Other peptide,,,,,,,,,,,RRWCYRKKPYRXCR,Arg-Arg-Trp-Cys-Tyr-Arg-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys-Arg,,,NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@H](NC1=O)CCCCN)CCC2)Cc1ccc(cc1)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@H](C(=O)O)CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)N)CCCNC(=N)N,ZFIUCXJWTNZDRW-UYROLUPNSA-N
853,T140,,Other peptide,,,,,,,,,,,RRACYRKKPYRXCR,Arg-Arg-Nal-Cys-Tyr-Arg-Lys-Lys-Pro-Tyr-Arg-Cit-Cys-Arg,,,NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]2N(C(=O)[C@H](NC1=O)CCCCN)CCC2)Cc1ccc(cc1)O)CCCNC(=N)N)CCCNC(=O)N)C(=O)N[C@H](C(=O)O)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)N)CCCNC(=N)N)Cc1ccc2c(c1)cccc2,IMOHHNXUCDZLKM-ADZSTZGASA-N
5838,T20(DP178),,Other peptide,,,,,,,,,,,YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2,,,,
6245,T21/DP107,,Other peptide,,,,,,,,,,,NNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQ,Ac-Asn-Asn-Leu-Leu-Arg-Ala-Ile-Glu-Ala-Gln-Gln-His-Leu-Leu-Gln-Leu-Thr-Val-Trp-Gly-Ile-Lys-Gln-Leu-Gln-Ala-Arg-Ile-Leu-Ala-Val-Glu-Arg-Tyr-Leu-Lys-Asp-Gln-NH2,Acetylation of N-terminal asparagine residue; C-terminal residue is glutamine amide,,,
854,T22,,Other peptide,,,,,,,,,,,RRWCYRKCYKGYCYRKCR,Arg-Arg-Trp-Cys-Tyr-Arg-Lys-Cys-Tyr-Lys-Gly-Tyr-Cys-Tyr-Arg-Lys-Cys-Arg-NH2,,,NCCCC[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(cc2)O)NC(=O)[C@@H]2CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](C(=O)N)CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c3c1cccc3)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)N)CCCNC(=N)N)Cc1ccc(cc1)O)CCCNC(=N)N)CCCCN)C(=O)N[C@@H](Cc1ccc(cc1)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N2)Cc1ccc(cc1)O)CCCCN,MJULKHZUJYASFR-FQPMSUGVSA-N
10077,tadekinig alfa,,Other peptide,,,,,,,,,,tadekinig alfa,TPVSQTTTAATASVRSTKDPHCPSQPPVFPAAKQCPALEVTWPEVEVPLNGTLSLSCVACSRFPNFSILYWLGNGSFIEHLPGRLWEGSTSRERGSTGTQLCKALVLEQLTPALHSTNFSCVLVDPEQVVQRHVVLAQLWAGLRATLPPTQEALPSSHSSPQQQG,,,,,
3913,TAK 044,,Other peptide,,,,,,,,,,,DDDXLW,c[D-Asp-Asp(Php)-Asp-D-Thg-Leu-D-Trp]-4-oxobut-2-enoate,,,CC(C[C@@H]1NC(=O)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC1=O)Cc1c[nH]c2c1cccc2)CC(=O)O)CC(=O)N1CCC(CC1)c1ccccc1)c1cccs1)C,UOZMDLYHZJQAOO-YHIUFLQMSA-N
10222,TAK-448,,Other peptide,,,,,,,,,,,,Ac-D-Tyr-Hyp-Asn-Thr-Phe-Unk-Leu-Arg(Me)-Trp-NH2,,,CN=C(NCCC[C@@H](C(=O)N[C@H](C(=O)N)Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)NNC(=O)[C@@H](NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](NC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H](Cc1ccc(cc1)O)NC(=O)C)O)CC(=O)N)Cc1ccccc1)CC(C)C)N,MWXWMWSUUYXMRA-GRKBUMBKSA-N
7444,taliglucerase alfa,,Other peptide,,,yes,,,,,,,taliglucerase alfa,,,,,,
2319,tamapin,,Other peptide,,,,,,,,,P59869,,AFCNLRRCELSCRSLGLLGKCIGEECKCVPY,Ala-Phe-Cys-Asn-Leu-Arg-Arg-Cys-Glu-Leu-Ser-Cys-Arg-Ser-Leu-Gly-Leu-Leu-Gly-Lys-Cys-Ile-Gly-Glu-Glu-Cys-Lys-Cys-Val-Pro-Tyr-NH2,"C-terminal tyrosine residue is predicted to undergo amidation; disulphide bond formation between cysteine residues at positions 3 and 21, 8 and 26, and 12 and 28.",,,
2212,"[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP",,Other peptide,,,,,,,,,,,XYFVNKPR,tBaa-D-Tyr(Et)Phe-Val-Asn-Lys-Pro-Arg-NH2,,,,
1030,t-Boc-FLFLF,,Other peptide,,,,,,,,,,,FLFLF,Boc-Phe-Leu-Phe-Leu-Phe,,,,
1029,t-Boc-Met-Leu-Phe,,Other peptide,,,,,,,,,,,MLF,t-Boc-Met-Leu-Phe,,,,
2902,TC14012,,Other peptide,,,,,,,,,,,RRACYXKXPYRXCR,Arg-Arg-Nal-Cys-Tyr-Cit-Lys-D-Cit-Pro-Tyr-Arg-Cit-Cys-Arg-NH2,,,,
7049,teduglutide,,Other peptide,,,yes,,,,,,,teduglutide,HGDGSFSDEMNTILDNLAARDFINWLIQTKITD,His-Gly-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp,,,,
4448,teriparatide,,Other peptide,,,yes,,,,,,,teriparatide,SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF,Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe,,,,
2383,tertiapin-Q,,Other peptide,,,,,,,,,P56587,,ALCNCNRIIIPHMCWKKCGKK,Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Met-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH2,Amidation of C-terminal lysine residue,,,
6959,tesamorelin,,Other peptide,,,yes,,,,,,,tesamorelin,YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL,Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu,,,,
9784,tethered chemerin 9,,Other peptide,,,,,,,,,,,MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGSGNGNGNGNGNGNGNGNGNGNEQKLISEEDLGNGNGNGSGNSYFPGQFAFS,,,,,
3742,TFLLR-NH2,,Other peptide,,,,,,,,,,,TFLLR,Thr-Phe-Leu-Leu-Arg-NH2,,,CC(C[C@@H](C(=O)N[C@H](C(=O)N)CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]([C@H](O)C)N)CC(C)C)C,ANAMCEKSRDPIPX-GFGQVAFXSA-N
5360,TFRGAP-NH2,,Other peptide,,,,,,,,,,,TFRGAP,Thr-Phe-Arg-Gly-Ala-Pro-NH2,,,,
5860,THG213.29,,Other peptide,,,,,,,,,,,AtsyeaLLK,AlaThrSerTyrGluAlaLeuLysLys,,,,
678,"[Thi5,8,D-Phe7]bradykinin",,Other peptide,,,,,,,,,,,RPPGXSFXR,Arg-Pro-Pro-Gly-Thi-Ser-D-Phe-Thi-Arg,,,,
1573,Thr10contulakin-G,,Other peptide,,,,,,,,,,,QSEEGGSNATKKPYIL,pGlu-Ser-Glu-Glu-Gly-Gly-Ser-Asn-Ala-Thr-Lys-Lys-Pro-Tyr-Ile-Leu,,,,
2179,"[Thr4,Gly7]OT",,Other peptide,,,,,,,,,,,CYITNCGLG,Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)CS)CC(=O)N)[C@H](O)C)NC(=O)[C@@H](NC(=O)[C@H](C=S)N)Cc1ccc(cc1)O)C,SJRRTEZQOSELMP-IKNHWLCZSA-N
1816,TIP39-(3-39) (human/bovine),,Other peptide,,,,,,,,,,,ALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP,Ala-Leu-Ala-Asp-Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro,,,,
1827,TIP39-(7-39) (human/bovine),,Other peptide,,,,,,,,,,,DAAFRERARLLAALERRHWLNSYMHKLLVLDAP,Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro,,,,
1828,TIP39-(7-39) (mouse),,Other peptide,,,,,,,,,,,DAAFRERARLLAALERRRWLDSYMQKLLLLDAP,Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-Arg-Trp-Leu-Asp-Ser-Tyr-Met-Gln-Lys-Leu-Leu-Leu-Leu-Asp-Ala-Pro,,,,
1818,TIP39-(9-39) (human/bovine),,Other peptide,,,,,,,,,,,AFRERARLLAALERRHWLNSYMHKLLVLDAP,Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro,,,,
2166,tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide,,Other peptide,,,,,,,,,,,CXWXVCH,Cys-Apa-Trp-Orn-Val-Cys-His,,,,
2306,toxin BmP09,,Other peptide,,,,,,,,,Q9UAC8,,DNGYLLNKYTGCKIWCVINNESCNSECKLRRGNYGYCYFWKLACYCEGAPKSELWAYETNKCNGKM,Asp-Asn-Gly-Tyr-Leu-Leu-Asn-Lys-Tyr-Thr-Gly-Cys-Lys-Ile-Trp-Cys-Val-Ile-Asn-Asn-Glu-Ser-Cys-Asn-Ser-Glu-Cys-Lys-Leu-Arg-Arg-Gly-Asn-Tyr-Gly-Tyr-Cys-Tyr-Phe-Trp-Lys-Leu-Ala-Cys-Tyr-Cys-Glu-Gly-Ala-Pro-Lys-Ser-Glu-Leu-Trp-Ala-Tyr-Glu-Thr-Asn-Lys-Cys-Asn-Gly-Lys-Met,"Disulphide bonds between cysteine residues at positions 12 and 62, 16 and 37, 23 and 44, and 27 and 46",,,
9284,TP508,,Other peptide,,,,,,,,,,,AGYKPDEGKRGDACEGDSGGPFV,Ala-Gly-Tyr-Lys-Pro-Asp-Glu-Gly-Lys-Arg-Gly-Asp-Ala-Cys-Glu-Gly-Asp-Ser-Gly-Gly-Pro-Phe-Val,,,,
3914,trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2,,Other peptide,,,,,yes,yes,,,,,LIGRLX,trans-cinnamoyl-Leu-Ile-Gly-Arg-Leu-Orn-[N-[3H]propionyl]NH2,,,,
8414,trebananib,,Other peptide,,,,,,,,,,trebananib,MDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKGGGGGAQQEECEWDPWTCEHMGSGSATGGSGSTASSGSGSATHQEECEWDPWTCEHMLE,,,,,
9507,Tri-DAP,,Other peptide,,,,,,,,,,,,,,,,
1177,triptorelin,,Other peptide,,,yes,,,,,,,triptorelin,XHWSYWLRPG,pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2,,,OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1nc[nH]c1,VXKHXGOKWPXYNA-PGBVPBMZSA-N
1585,Trp11-neurotensin,,Other peptide,,,,,,,,,,,XLYENKPRRPWIL,pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Trp-Ile-Leu,,,,
1809,[Trp23]PTHrP-(1-36) (human),,Other peptide,,,,,,,,,,,AVSEHQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEI,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile,,,,
1808,"[Trp23,Tyr36]PTHrP-(1-36)-NH2 (human)",,Other peptide,,,,,,,,,,,AVSEHQLLHDKGKSIQDLRRRFWLHHLIAEIHTAEY,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-NH2,,,,
5782,"[Trp7, β-Ala8] neurokinin A-(4-10)",,Other peptide,,,,,,,,,,,DSFWALM,Asp-Ser-Phe-Trp-Ala-Leu-Met,,,,
1172,[Trp8]GnRH,,Other peptide,,,,,,,,,,,XHWSYGLWPG,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Trp-Pro-Gly-NH2,,,,
3916,trptorelix-1,,Other peptide,,,,,,,,,,,AFASYXWYPA,Ac-D-Nal-D-4Cpa-D-Pal-Ser-His-D-Cit-Trp-Tyr-Pro-D-Ala-NH2,,,,
6902,TRV120027,,Other peptide,,,,,,,,,,,XRVYIHPA,Sar-Arg-Val-Tyr-Ile-His-Pro-D-Ala-OH,,,,
692,Tyr0α-CGRP (human),,Other peptide,,,,,,,,,,,YACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF,Tyr-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2,,,,
1145,[Tyr34]GLP-2 (human),,Other peptide,,,,,,,,,,,HADGSFSDEMNTILDNLAARDFINWLIQTKITDY,His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-Tyr,,,,
1810,[Tyr34]PTH-(1-34) (human),,Other peptide,,,,,,,,,,,SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNY,Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr,,,,
1811,[Tyr34]PTH-(1-34)-NH2 (human),,Other peptide,,,,,,,,,,,SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNY,Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2,,,,
1812,[Tyr34]PTH-(3-34)-NH2 (human),,Other peptide,,,,,,,,,,,SEIQLMHNLGKHLNSMERVEWLRKKLQDVHNY,Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2,,,,
1813,[Tyr36]-PTHrP-(1-36) amide (human),,Other peptide,,,,,,,,,,,AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTAEY,Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-NH2,,,,
5649,Tyr3-octreotide,,Other peptide,,,,,,,,,,,FCYWKTCT,Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr,Disulphide bond: 2-7,,,
671,[Tyr8]bradykinin,,Other peptide,,,,,,,,,,,RPPGFSPYR,Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg,,,,
1173,[Tyr8]GnRH,,Other peptide,,,,,,,,,,,XHWSYGLYPG,pGlu-His-Trp-Ser-Tyr-Gly-Leu-Tyr-Pro-Gly-NH2,,,,
1694,UFP-101,,Other peptide,,,,,,,,,,,GGGFTGARKSARKRKNQ,N-(Bn)Gly-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Arg-Lys-Asn-Gln-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCCCN)CCCN=C(N)N)CCCCN)CCCN=C(N)N)C)CO)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)CNCc1ccccc1)C)CCCN=C(N)N,JEXLNFNIIVBCHM-OSMJMQRHSA-N
1685,UFP-102,,Other peptide,,,,,,,,,,,FGGFTGARKSARKRKNQ,Phe-Gly-Gly-(pF)Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Arg-Lys-Asn-Gln-NH2,,,,
3917,UFP-112,,Other peptide,,,,,,,,,,,FGGFTGXRKSARKRKNQ,Phe-Gly-Gly-(pF)Phe-Thr-Gly-Aib-Arg-Lys-Ser-Ala-Arg-Lys-Arg-Lys-Asn-Gln-NH2,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N)CCC(=O)N)CC(=O)N)CCCCN)CCCNC(=N)N)CCCCN)CCCNC(=N)N)C)CO)NC(=O)[C@@H](NC(=O)C(NC(=O)CNC(=O)[C@H]([C@H](O)C)NC(=O)[C@H](Cc1ccc(cc1)F)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)N)(C)C)CCCNC(=N)N,GVIRJSRJRJCCJE-HCYVKCTOSA-N
2152,U-II-(4-11) (human),,Other peptide,,,,,,,,,,,DCFWKYCV,Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val,,,,
8446,ularitide,,Other peptide,,,,,,,,,,ularitide,TAPRSLRRSSCFGGRMDRIGAQSGLGCNSFRY,Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr,Disulphide bond between cysteines 11 and 27.,,,
6249,uPar fragment,,Other peptide,,,,,,,,,,,GRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRRRPWCYVQVGLKPLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHN,,,,,
2167,urantide,,Other peptide,,,,,,,,,,,DXFWXYCV,Asp-Pen-Phe-D-Trp-Orn-Tyr-Cys-Val,,,,
9441,Urolinin,,Other peptide,,,,,,,,,,,,,,,,
922,urotensin 1 (fish),,Other peptide,,,,,,,,,P01145,,NDDPPISIDLTFHLLRNMIEMARIENEREQAGLNRKYLDEV,Asn-Asp-Asp-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Asn-Met-Ile-Glu-Met-Ala-Arg-Ile-Glu-Asn-Glu-Arg-Glu-Gln-Ala-Gly-Leu-Asn-Arg-Lys-Tyr-Leu-Asp-Glu-Val,,,,
6248,V3 peptide,,Other peptide,,,,,,,,,,,TRPNYNKRKRIHIGPGRAFYTTKNIIGTIRQAH,Thr-Arg-Pro-Asn-Tyr-Asn-Lys-Arg-Lys-Arg-Ile-His-Ile-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile-Gly-Thr-Ile-Arg-Gln-Ala-His-NH2,,,,
2180,[Val4]AVP,,Other peptide,,,,,,,,,,,CYFVNCPRG,Cys-Tyr-Phe-Val-Asn-Cys-Pro-Arg-Gly-NH2,,,NC(=O)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)NCC(=O)N)CCCN=C(N)N)N)Cc1ccc(cc1)O)Cc1ccccc1)C(C)C,JITASQOSGITBPR-FMCGBTBPSA-N
5542,vanillotoxin-1,,Other peptide,,,,,,,,,P0C244,,SECRWFMGGCDSTLDCCKHLSCKMGLYYCAWDGTF,Ser-Glu-Cys-Arg-Trp-Phe-Met-Gly-Gly-Cys-Asp-Ser-Thr-Leu-Asp-Cys-Cys-Lys-His-Leu-Ser-Cys-Lys-Met-Gly-Leu-Tyr-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Phe-NH2,"C-terminal phenylalanine is amidated; predicted disulphide bond formation between cysteine residues at positions 3 and 17, 10 and 22, and 16 and 29",,,
5543,vanillotoxin-2,,Other peptide,,,,,,,,,P0C245,,GACRWFLGGCKSTSDCCEHLSCKMGLDYCAWDGTF,Gly-Ala-Cys-Arg-Trp-Phe-Leu-Gly-Gly-Cys-Lys-Ser-Thr-Ser-Asp-Cys-Cys-Glu-His-Leu-Ser-Cys-Lys-Met-Gly-Leu-Asp-Tyr-Cys-Ala-Trp-Asp-Gly-Thr-Phe-NH2,"C-terminal phenylalanine is amidated; predicted disulphide bond formation between cysteine residues at positions 3 and 17, 10 and 22, and 16 and 29",,,
5544,vanillotoxin-3,,Other peptide,,,,,,,,,P0C246,,ECRWYLGGCKEDSECCEHLQCHSYWEWCLWDGSF,Glu-Cys-Arg-Trp-Tyr-Leu-Gly-Gly-Cys-Lys-Glu-Asp-Ser-Glu-Cys-Cys-Glu-His-Leu-Gln-Cys-His-Ser-Tyr-Trp-Glu-Trp-Cys-Leu-Trp-Asp-Gly-Ser-Phe-NH2,"C-terminal phenylalanine residue is amidated; predicted disulphide bond formation between cysteine residues at positions 2 and 16, 9 and 21, and 15 and 28",,,
2054,vapreotide,,Other peptide,,,yes,,,,,,,vapreotide,FCYWKVCW,D-Phe-Cys-Tyr-Trp-Lys-Val-Cys-Trp-NH2,,,,
1302,variant MCH,,Other peptide,,,,,,,,,,,DFDTLSCMLGRVYQSCWQV,Asp-Phe-Asp-Thr-Leu-Ser-Cys-Met-Leu-Gly-Arg-Val-Tyr-Gln-Ser-Cys-Trp-Gln-Val,,,,
774,vCCL4,,Other peptide,,,,,,,,,,,,,,,,
8496,vCXCL1,,Other peptide,,,,,,,,,,,TELRCCRLHRKWPPNKIILGNYWLHRDPRGPGCDKNEHLLYPDGRKPPGPGVCLSPDHLFSKWLDKHNDNRWYNVNITKSPGPRRINITLIGVRG,,,,,
7464,velaglucerase alfa,,Other peptide,,,yes,,,,,,,velaglucerase alfa,ARPCIPKSFGYSSVVCVCNATYCDSFDPPTFPALGTFSRYESTRSGRRMELSMGPIQANHTGTGLLLTLQPEQKFQKVKGFGGAMTDAAALNILALSPPAQNLLLKSYFSEEGIGYNIIRVPMASCDFSIRTYTYADTPDDFQLHNFSLPEEDTKLKIPLIHRALQLAQRPVSLLASPWTSPTWLKTNGAVNGKGSLKGQPGDIYHQTWARYFVKFLDAYAEHKLQFWAVTAENEPSAGLLSGYPFQCLGFTPEHQRDFIARDLGPTLANSTHHNVRLLMLDDQRLLLPHWAKVVLTDPEAAKYVHGIAVHWYLDFLAPAKATLGETHRLFPNTMLFASEACVGSKFWEQSVRLGSWDRGMQYSHSIITNLLYHVVGWTDWNLALNPEGGPNWVRNFVDSPIIVDITKDTFYKQPMFYHLGHFSKFIPEGSQRVGLVASQKNDLDAVALMHPDGSAVVVVLNRSSKDVPLTIKDPAVGFLETISPGYSIHTYLWRRQ,,"Disulfide bridges locations: 4-16, 18-23Glycosylation sites: Asn19, Asn59, Asn146, Asn270, Asn462",,,
8487,veldoreotide,,Other peptide,,,,,,,,,,,XFWWKTFG,Oaa-Phe-Trp-D-Trp-Lys-Thr-Phe-Gly,"The uncommon ω-amino acid at the N-terminal is linked via a covalent bond to the glycine residue at the C-terminal, forming a cyclic peptide. For an image of the structure of this peptide please see reference .",,NCCCC[C@@H]1NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CCCNC(=O)CCCN(C(=O)[C@@H](NC(=O)[C@@H](NC1=O)[C@H](O)C)Cc1ccccc1)CC(=O)N)Cc1ccccc1)Cc1c[nH]c2c1cccc2)Cc1c[nH]c2c1cccc2,ABFNTRQPWNXUHA-VEVJRHMJSA-N
768,viral macrophage inflammatory protein-II,,Other peptide,,,,,,,,,,,LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTA,,,,NCCCC[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)CCCN=C(N)N)CCCN=C(N)N)CCC(=O)N)C(C)C)C(=O)O)[C@H](O)C,JOEHPBQVSCDCHE-BKGQOYFSSA-N
10050,Vm24,,Other peptide,,,,,,,,,,,AAAISCVGSPECPPKCRAQGCKNGKCMNRKCKCYYC,Ala-Ala-Ala-Ile-Ser-Cys-Val-Gly-Ser-Pro-Glu-Cys-Pro-Pro-Lys-Cys-Arg-Ala-Gln-Gly-Cys-Lys-Asn-Gly-Lys-Cys-Met-Asn-Arg-Lys-Cys-Lys-Cys-Tyr-Tyr-Cys-NH2,"Disulfide bonds: Cys6-Cys26, Cys12-Cys31, Cys16-Cys33, Cys21-Cys36.",,,
816,vMCC-I,,Other peptide,,,,,,,,,,,,,,,,
815,vMIP-I,,Other peptide,,,,,,,,,,,,,,,,
4359,vMIP-III,,Other peptide,,,,,,,,,,,GATAAGCTGATATGCGGGTGGTACTGGACGTCCACCGTGTATTGTCGCCAGAAGGCAGTCATTTT,Gly-Ala-Thr-Ala-Ala-Gly-Cys-Thr-Gly-Ala-Thr-Ala-Thr-Gly-Cys-Gly-Gly-Gly-Thr-Gly-Gly-Thr-Ala-Cys-Thr-Gly-Gly-Ala-Cys-Gly-Thr-Cys-Cys-Ala-Cys-Cys-Gly-Thr-Gly-Thr-Ala-Thr-Thr-Gly-Thr-Cys-Gly-Cys-Cys-Ala-Gly-Ala-Ala-Gly-Gly-Cys-Ala-Gly-Thr-Cys-Ala-Thr-Thr-Thr-Thr,,,,
9068,vosoritide,,Other peptide,,,,,,,,,,vosoritide,PGQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC,Pro-Gly-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys,,,NCCCC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H]1CSSC[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC1=O)Cc1ccccc1)CC(C)C)CCCCN)CC(C)C)CC(=O)O)CCCNC(=N)N)[C@H](CC)C)C(=O)O)CCCCN)CO)CC(C)C)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H]1CCCN1)CCC(=O)N)CCC(=O)O)Cc1[nH]cnc1)CC(=O)N)C)CCCNC(=N)N)CCCCN)Cc1ccc(cc1)O)CCCCN)C)CC(=O)N,IGYWDDBBJPSOTG-WBAGYEQSSA-N
3984,waglerin-1,,Other peptide,,,,,,,,,P24335,,GGKPDLRPCHPPCHYIPRPKPR,Gly-Gly-Lys-Pro-Asp-Leu-Arg-Pro-Cys-His-Pro-Pro-Cys-His-Tyr-Ile-Pro-Arg-Pro-Lys-Pro-Arg,Disulphide bond formation between cysteine residues at positions 8 and 12,,,
5869,wFw-Isn-NH2,,Other peptide,,,,,,,,,,,WFW,Trp-Phe-Trp,,,,
1048,WKYMVm,,Other peptide,,,,,,,,,,,WKYMVM,Trp-Lys-Tyr-Met-Val-D-Met,,,,
1040,WRWWWW,,Other peptide,,,,,,,,,,,WRWWWW,Trp-Arg-Trp-Trp-Trp-Trp,,,,
5760,WWGKKYRASKLGLAR,,Other peptide,,,,,,,,,,,WWGKKYRASKLGLAR,Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg,,,,
3919,X4-HIV-1 gp120,,Other peptide,,,,,,,,,,,,,,,,
8722,YJ34,,Other peptide,,,,,,,,,,,VKCTGICE,Ac-Val-Lys-c[Cys-Thr-Gly-Ile-Cys]-Glu-NH2,,,,
5641,Y-KE88,,Other peptide,,,,,,,,,,,XRFFWKTF,Dab-Arg-Phe-Phe-Trp-Lys-Thr-Phe,,,,
1482,Y-RFRP-3,,Other peptide,,,,,,,,,,,YVPNLPQRF,Tyr-Val-Pro-Asn-Leu-Pro-Gln-Arg-Phe-NH2,,,,
5776,YSFKPMPLaR,,Other peptide,,,,,,,,,,,YSFKPMPLAR,Tyr-Ser-Phe-Lys-Pro-Met-Pro-Leu-D-Ala-Arg,,,,
6534,Z-Arg-Leu-Val-Agly-Ile-Val-OMe,,Other peptide,,,,,,,,,,,RLVXIV,Z-Arg-Leu-Val-Agly-Ile-Val-OMe,,,CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)OC)C(C)C)NC(=O)NNC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)OCc1ccccc1)CCCN=C(N)N)CC(C)C)C,ZLXFGUGFOLETFJ-POPCVQDUSA-N
5294,Z-DEVD-FMK,,Other peptide,,,,,,,,,,,DEVD,Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK,,,,
5295,Z-DQMD-FMK,,Other peptide,,,,,,,,,,,DQMD,Z-Asp(OMe)-Gln-Met-Asp(OMe)-FMK,,,,
5296,Z-IETD-FMK,,Other peptide,,,,,,,,,,,IETD,Z-Ile-Glu(OMe)-Thr-Asp(OMe)-FMK,,,,
10404,zilucoplan,,Other peptide,,,,,,,,,,zilucoplan,,,,,CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)O)CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)[C@H](C1CCCCC1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccn2)NC(=O)[C@@H](NC(=O)[C@H](C(C)(C)C)NC(=O)[C@@H](N(C(=O)[C@@H]1CC(=O)NCCCC[C@H](NC(=O)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)Cc1ccccc1)CCCNC(=N)N)CCC(=O)O)C(C)C)C)CC(=O)O)Cc1ccc(cc1)O)CCC(=O)O)Cc1ccc(cc1)O,JDXCOXKBIGBZSK-PSNKNOTQSA-N
5298,Z-LEHD-FMK,,Other peptide,,,,,,,,,,,LEHD,Z-Leu-Glu(OMe)-His-Asp(OMe)-FMK,,,,
5299,Z-VDVAD-FMK,,Other peptide,,,,,,,,,,,VDVAD,Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-FMK,,,,
5300,Z-VEID-FMK,,Other peptide,,,,,,,,,,,VEID,Z-Val-Glu(OMe)-Ile-Asp(OMe)-FMK,,,,
5301,Z-WEHD-FMK,,Other peptide,,,,,,,,,,,WEHD,Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK,,,,
9193,zyklophin,,Other peptide,,,,,,,,,,,,,,,NCCCC[C@@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(cc2)O)NCc2ccccc2)C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(CC)C)CCCN=C(N)N)CCCN=C(N)N,UWLIKQFWZOPOAX-HRFULILYSA-N
5302,Z-YVAD-FMK,,Other peptide,,,,,,,,,,,YVAD,Z-Tyr-Val-Ala-Asp(OMe)-FMK,,,COC(=O)C[C@@H](C(=O)CF)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)OCc1ccccc1)C,MVPQJUFFTWWKBT-LBDWYMBGSA-N
